data_2kzr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kzr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.4 m0 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.547 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 48.7 mtm180 -83.86 73.95 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.108 0.963 . . . . 0.0 109.141 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.91 136.17 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.375 0.67 . . . . 0.0 111.503 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -89.09 97.35 11.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.7 0.8 . . . . 0.0 110.17 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 t -81.17 100.05 8.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.778 0.831 . . . . 0.0 110.445 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -74.47 108.99 7.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.127 0.571 . . . . 0.0 110.23 -175.407 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.196 0.522 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -134.96 123.19 22.98 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.493 HD13 ' HB3' ' A' ' 2' ' ' ARG . 1.8 tm? -91.04 102.58 15.34 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -172.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.411 ' HG ' HG13 ' A' ' 33' ' ' ILE . 10.3 mp -92.23 107.03 18.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.45 0.7 . . . . 0.0 110.036 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.547 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 76.6 mt-30 -90.2 -177.13 5.06 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.716 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -19.47 22.09 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.329 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.93 114.92 10.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.462 0.705 . . . . 0.0 110.66 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.0 p -91.96 168.05 11.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.079 0.951 . . . . 0.0 109.163 170.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 p -59.26 -33.81 71.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.979 0.511 . . . . 0.0 111.753 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -101.13 24.67 9.09 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.402 0.681 . . . . 0.0 111.841 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 25' ' ' GLU . 73.1 m -72.33 127.4 32.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 74.3 mtm180 -79.77 169.16 18.35 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.176 0.59 . . . . 0.0 111.247 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 56' ' ' ASP . 7.5 tt -53.53 -54.33 38.83 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.179 1.392 . . . . 0.0 110.989 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -63.94 -26.04 68.41 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.219 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 14.0 mm-40 -77.08 -43.46 34.23 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.6 -66.79 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.726 1.21 . . . . 0.0 110.615 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.5 -21.29 65.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.314 0.645 . . . . 0.0 111.312 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.98 -41.95 70.16 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.848 0.717 . . . . 0.0 112.368 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -67.79 -39.69 84.02 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.6 mt -59.67 -39.8 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.652 0.781 . . . . 0.0 111.055 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.2 -24.63 67.74 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 111.788 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.16 -36.07 13.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.336 0.654 . . . . 0.0 111.713 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.411 HG13 ' HG ' ' A' ' 14' ' ' LEU . 12.6 mm -75.62 -68.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.933 0.893 . . . . 0.0 110.4 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.462 HG21 HG12 ' A' ' 36' ' ' ILE . 3.0 t -96.7 -7.2 34.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 6.85 87.95 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 114.01 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.462 HG12 HG21 ' A' ' 34' ' ' THR . 13.8 mm -84.52 114.57 25.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 144.75 64.36 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.584 0.754 . . . . 0.0 110.722 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -55.14 -21.44 27.87 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.651 2.901 . . . . 0.0 114.382 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.61 -20.2 51.98 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 113.778 0.271 . . . . 0.0 113.778 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.0 m -90.3 -16.5 29.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.18 0.592 . . . . 0.0 111.275 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.86 150.89 27.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.016 0.927 . . . . 0.0 110.568 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -130.17 145.87 51.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.679 1.192 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.501 HG13 HD23 ' A' ' 54' ' ' LEU . 45.6 mm -81.49 95.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.097 0.951 . . . . 0.0 108.872 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.68 139.39 51.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.039 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 47' ' ' TYR . 5.2 m -113.31 163.15 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.367 0.667 . . . . 0.0 110.21 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.18 -49.07 82.63 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.884 0.74 . . . . 0.0 113.267 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.417 ' O ' HG21 ' A' ' 45' ' ' VAL . 52.3 p90 -69.71 145.46 94.84 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.141 169.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.22 101.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 124.155 3.237 . . . . 0.0 115.592 -170.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.66 145.58 26.12 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.243 1.962 . . . . 0.0 111.096 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -91.67 15.88 11.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.286 0.635 . . . . 0.0 110.897 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.9 m 59.85 46.54 11.19 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.501 1.12 . . . . 0.0 110.369 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.93 130.03 42.07 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.299 -174.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.36 111.07 22.4 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.501 HD23 HG13 ' A' ' 43' ' ' ILE . 7.3 mp -72.7 87.9 1.27 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.279 1.031 . . . . 0.0 108.8 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 p -89.51 26.22 1.77 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.2 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.421 ' O ' HD13 ' A' ' 23' ' ' LEU . 10.3 t70 -145.67 -168.37 2.95 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 -29.16 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.63 0.772 . . . . 0.0 110.957 176.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.64 -8.0 51.2 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.876 1.27 . . . . 0.0 110.588 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.18 131.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.686 1.195 . . . . 0.0 111.414 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -96.33 168.63 10.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.662 0.785 . . . . 0.0 112.559 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.7 mt -69.69 -20.18 63.56 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.918 0.887 . . . . 0.0 111.552 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.94 73.18 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.434 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.07 -39.16 14.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.187 0.595 . . . . 0.0 109.816 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.3 mt -79.5 156.66 75.65 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 124.057 0.943 . . . . 0.0 111.438 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -72.94 18.51 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.767 2.978 . . . . 0.0 115.267 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.05 124.4 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.0 mt-30 -119.06 169.83 9.58 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.237 0.615 . . . . 0.0 109.845 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 p -68.47 96.46 0.69 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.336 0.654 . . . . 0.0 110.879 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.96 36.39 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.382 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 11.1 t70 -80.44 158.01 26.05 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.303 0.641 . . . . 0.0 110.689 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.88 97.93 10.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.57 0.748 . . . . 0.0 109.692 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.88 106.97 18.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.439 0.696 . . . . 0.0 109.44 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.31 93.28 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.845 0.858 . . . . 0.0 108.825 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.75 103.45 10.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.99 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' O ' HG21 ' A' ' 36' ' ' ILE . 11.4 pt-20 -78.75 170.09 17.21 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.203 174.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -129.61 106.99 9.11 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.109 0.964 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 CA--C 1.554 1.123 0 C-N-CA 122.921 0.488 . . . . 0.0 111.478 179.468 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.3 m0 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.404 ' HB3' HD12 ' A' ' 13' ' ' LEU . 44.7 mtp180 -83.29 83.29 7.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 109.452 174.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.491 ' HB ' HD13 ' A' ' 17' ' ' LEU . 69.1 t -100.34 141.94 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.923 0.889 . . . . 0.0 110.535 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.469 ' HB2' ' HA ' ' A' ' 71' ' ' MET . 41.1 mmt180 -81.57 135.97 35.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.916 0.886 . . . . 0.0 110.559 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 19.8 t -113.33 90.12 3.26 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -82.95 105.39 13.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.31 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 123.384 0.674 . . . . 0.0 110.436 -177.879 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 77.6 m-70 -123.2 173.74 7.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.623 0.769 . . . . 0.0 109.904 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.419 HD22 ' HD3' ' A' ' 4' ' ' ARG . 2.8 tm? -140.74 110.76 6.55 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -95.32 132.07 40.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.082 0.953 . . . . 0.0 108.52 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.405 HE21 HD11 ' A' ' 13' ' ' LEU . 15.0 mp0 -100.89 -32.91 10.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.104 0.561 . . . . 0.0 110.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.48 44.4 3.07 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.767 -0.651 . . . . 0.0 114.109 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.491 HD13 ' HB ' ' A' ' 3' ' ' VAL . 95.3 mt -114.52 115.2 26.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 124.134 0.974 . . . . 0.0 109.35 175.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 t -92.38 176.87 6.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.947 0.899 . . . . 0.0 109.475 172.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 p -60.63 -36.1 77.79 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.708 0.803 . . . . 0.0 111.858 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -116.35 48.09 1.32 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.388 0.675 . . . . 0.0 111.47 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.9 m -75.84 128.06 34.33 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.5 ' HG2' HG22 ' A' ' 60' ' ' THR . 61.6 mtm180 -92.14 -177.94 4.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 57' ' ' ARG . 5.9 tt -52.32 -56.91 11.68 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.087 0.955 . . . . 0.0 111.036 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.424 ' HG2' ' OE2' ' A' ' 25' ' ' GLU . 9.0 ptp180 -70.63 -19.58 62.81 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.594 0.559 . . . . 0.0 112.042 -164.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -93.49 -35.02 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.63 0.772 . . . . 0.0 110.976 173.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 43' ' ' ILE . 2.0 tm? -71.29 -68.23 0.46 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.606 0.762 . . . . 0.0 111.419 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.35 -38.23 62.63 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.844 0.715 . . . . 0.0 112.341 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.441 ' O ' HG12 ' A' ' 33' ' ' ILE . 43.7 mt-30 -70.53 -44.52 67.34 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -55.41 -41.35 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.935 0.894 . . . . 0.0 111.476 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -25.18 68.19 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.34 -31.36 16.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.676 0.79 . . . . 0.0 111.395 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 29' ' ' GLN . 28.8 mm -79.11 -65.59 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.324 1.05 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.515 HG22 HG12 ' A' ' 36' ' ' ILE . 10.1 t -101.91 -11.74 18.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.75 0.82 . . . . 0.0 111.341 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 -18.6 56.78 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.727 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 34' ' ' THR . 18.3 mm -67.34 121.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.045 0.422 . . . . 0.0 111.205 -169.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.75 141.26 80.13 Favored Pre-proline 0 C--N 1.351 0.663 0 O-C-N 124.281 0.988 . . . . 0.0 110.648 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.05 -28.62 70.43 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.394 2.729 . . . . 0.0 112.35 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.91 16.51 54.93 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.369 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -125.13 -11.29 7.03 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 110.52 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -127.16 155.53 43.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.022 0.929 . . . . 0.0 110.369 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 168.47 19.63 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.238 1.015 . . . . 0.0 109.161 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.586 HG12 HD11 ' A' ' 54' ' ' LEU . 30.8 mm -80.26 105.0 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.423 1.106 . . . . 0.0 109.842 -172.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.93 148.08 44.56 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 112.776 -2.011 . . . . 0.0 106.981 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.408 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 1.6 m -132.25 161.96 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.75 . . . . 0.0 110.248 -172.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.64 -42.29 96.13 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.805 0.69 . . . . 0.0 113.238 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -77.7 158.1 78.75 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.264 168.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -39.65 107.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.095 3.196 . . . . 0.0 115.292 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 67.9 Cg_endo -86.04 158.55 10.05 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.84 8.38 41.32 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.9 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.1 m 56.5 68.77 0.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.185 0.994 . . . . 0.0 110.221 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.77 114.35 18.62 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.678 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.06 155.59 22.61 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.586 HD11 HG12 ' A' ' 43' ' ' ILE . 4.7 mp -122.6 91.71 3.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.7 p -82.34 -46.08 14.07 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.397 0.679 . . . . 0.0 110.67 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -78.13 131.63 37.32 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.788 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -70.57 -22.04 62.62 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.728 0.811 . . . . 0.0 112.091 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.29 -1.86 53.23 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.6 tt -64.01 124.09 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.389 0.676 . . . . 0.0 110.893 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.5 HG22 ' HG2' ' A' ' 22' ' ' ARG . 50.7 p -95.96 173.56 7.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.164 0.586 . . . . 0.0 112.398 -169.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 mt -68.99 -10.77 59.17 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.399 0.679 . . . . 0.0 111.136 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.39 -29.01 73.72 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 112.301 -0.32 . . . . 0.0 112.301 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -88.27 -49.63 6.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.276 0.63 . . . . 0.0 110.12 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.419 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.8 mm? -81.59 151.77 68.86 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.743 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HD2' HG21 ' A' ' 43' ' ' ILE . 97.9 Cg_endo -77.66 42.79 1.22 Allowed 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.761 2.974 . . . . 0.0 115.185 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 43' ' ' ILE . 2.3 mp -83.28 112.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -109.84 170.66 7.93 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.2 p -67.56 105.51 1.88 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.029 0.532 . . . . 0.0 111.013 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.23 62.73 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 113.358 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.28 161.35 27.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.775 0.83 . . . . 0.0 110.168 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' A' ' 4' ' ' ARG . 19.1 ttm -103.89 112.34 25.26 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.245 0.618 . . . . 0.0 109.783 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -101.05 114.45 28.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.574 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.78 96.13 3.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.548 HG22 ' HG ' ' A' ' 5' ' ' CYS . 70.5 t -78.69 101.58 4.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.082 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -80.32 155.82 27.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.499 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.61 111.91 23.68 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 CA--C 1.552 1.046 0 C-N-CA 123.306 0.642 . . . . 0.0 111.037 175.253 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . 0.475 ' HB3' HG22 ' A' ' 3' ' ' VAL . 22.0 m0 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -87.99 70.85 9.44 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.775 0.798 . . . . 0.0 109.102 169.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 1' ' ' TRP . 76.8 t -77.8 137.28 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.864 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -93.27 140.23 29.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.466 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 12.5 t -122.41 97.94 5.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.018 0.927 . . . . 0.0 111.053 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HE3' ' SD ' ' A' ' 71' ' ' MET . 4.6 tppp? -74.82 102.71 4.8 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.567 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.472 0.653 0 C-N-CA 123.081 0.552 . . . . 0.0 111.015 -173.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.596 HG21 ' HE3' ' A' ' 71' ' ' MET . 24.0 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 91.2 m-70 -107.79 179.16 4.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.199 1.0 . . . . 0.0 109.517 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -144.01 122.8 12.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.2 mp -101.1 146.62 27.22 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.951 0.9 . . . . 0.0 110.394 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -118.39 165.27 14.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.137 1.375 . . . . 0.0 109.312 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.45 4.81 89.28 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.157 0.423 . . . . 0.0 114.157 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.48 130.84 35.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.465 0.65 . . . . 0.0 110.525 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -115.16 179.02 4.07 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.207 1.403 . . . . 0.0 109.159 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 p -72.72 -27.34 62.0 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.647 0.379 . . . . 0.0 111.158 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -108.61 25.95 11.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.735 0.814 . . . . 0.0 111.233 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 25' ' ' GLU . 7.3 m -66.0 127.66 32.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.077 0.551 . . . . 0.0 110.151 170.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -72.9 166.71 22.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.356 0.662 . . . . 0.0 111.183 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 54' ' ' LEU . 10.1 tt -61.2 -45.42 94.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.651 1.18 . . . . 0.0 110.618 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -61.53 -30.67 70.79 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.653 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.466 ' HB2' HG23 ' A' ' 21' ' ' THR . 6.3 mm-40 -79.88 -44.44 20.44 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 124.087 0.955 . . . . 0.0 109.534 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.56 -65.9 0.61 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.044 0.938 . . . . 0.0 109.718 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -64.42 -23.11 67.17 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.664 0.602 . . . . 0.0 111.509 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.21 -44.33 86.76 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 124.104 0.878 . . . . 0.0 111.695 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 23.7 mt-30 -67.92 -37.33 81.54 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.56 -42.03 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.493 0.717 . . . . 0.0 110.823 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -24.97 68.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.805 0.842 . . . . 0.0 111.705 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.4 -32.79 17.11 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.765 0.826 . . . . 0.0 111.571 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.464 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.8 mm -79.83 -69.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.517 HG21 HG12 ' A' ' 36' ' ' ILE . 9.2 t -98.76 -9.45 24.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.442 0.697 . . . . 0.0 111.488 -173.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.48 72.43 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.967 -0.352 . . . . 0.0 113.785 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 HG12 HG21 ' A' ' 34' ' ' THR . 24.9 mm -91.19 114.57 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.42 78.72 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.03 0.932 . . . . 0.0 111.023 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -53.76 -29.54 52.54 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.127 3.218 . . . . 0.0 114.572 -172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.96 -23.03 64.71 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.001 -0.333 . . . . 0.0 113.743 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -93.47 1.4 56.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.774 0.83 . . . . 0.0 111.562 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.45 169.14 13.96 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.032 0.933 . . . . 0.0 110.781 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.435 ' NH1' ' HB3' ' A' ' 51' ' ' CYS . 44.9 ttp180 -158.81 154.43 26.14 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.055 -169.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.521 HG12 HD21 ' A' ' 54' ' ' LEU . 37.4 mm -79.68 100.8 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 122.083 0.944 . . . . 0.0 109.674 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.4 mt -121.7 144.57 48.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.271 -1.786 . . . . 0.0 106.917 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 47' ' ' TYR . 2.6 m -125.88 164.31 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.493 0.717 . . . . 0.0 110.779 -172.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -36.08 92.75 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.78 0.675 . . . . 0.0 112.857 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.433 ' O ' HG22 ' A' ' 45' ' ' VAL . 46.4 p90 -81.72 156.2 70.48 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.177 167.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -43.09 108.36 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 124.227 3.285 . . . . 0.0 114.508 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -85.72 155.14 10.26 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.018 2.479 . . . . 0.0 112.624 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -89.81 6.82 40.04 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.994 0.518 . . . . 0.0 110.696 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.435 ' HB3' ' NH1' ' A' ' 42' ' ' ARG . 81.5 m 57.36 59.16 3.46 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.282 1.033 . . . . 0.0 110.123 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.84 144.34 52.91 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.46 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.45 138.8 31.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.208 0.603 . . . . 0.0 109.682 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 23' ' ' LEU . 7.0 mp -115.14 87.17 2.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.011 0.924 . . . . 0.0 108.74 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 m -111.03 19.81 18.09 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.81 0.844 . . . . 0.0 112.654 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -141.81 177.75 7.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -120.69 -40.53 2.64 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.496 0.718 . . . . 0.0 111.478 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.24 -16.0 34.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.936 0.894 . . . . 0.0 110.327 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.98 141.46 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.258 1.023 . . . . 0.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.6 p -111.75 -178.92 3.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 112.247 -166.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 mt -75.94 -4.73 42.62 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.178 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.25 -23.11 76.39 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 167.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -97.78 -59.09 1.84 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.428 0.691 . . . . 0.0 109.793 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.53 116.09 55.05 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.05 65.09 6.12 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.666 2.91 . . . . 0.0 113.816 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.492 HD12 HD13 ' A' ' 43' ' ' ILE . 1.9 mp -78.27 126.45 38.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 163.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.572 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 18.1 mt-30 -117.41 154.61 31.05 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.8 p -64.59 102.68 0.59 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.274 0.629 . . . . 0.0 111.363 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.59 16.19 66.67 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.411 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.572 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 10.5 t70 -80.08 160.92 25.61 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 123.489 0.716 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.596 ' HE3' HG21 ' A' ' 11' ' ' THR . 2.8 tpt -84.18 100.32 11.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.323 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.36 116.12 30.78 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.55 102.67 13.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 77.9 t -82.61 108.18 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.429 171.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.22 151.22 31.33 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.811 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -109.46 105.04 14.22 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 166.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 t70 . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 0.0 110.525 178.701 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 33.8 m0 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -103.0 160.4 14.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.875 0.87 . . . . 0.0 109.334 170.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.531 HG13 HD21 ' A' ' 72' ' ' LEU . 18.9 t -138.1 136.78 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.834 0.854 . . . . 0.0 109.709 171.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -104.8 95.58 5.97 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.7 p -84.14 102.35 12.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.909 0.484 . . . . 0.0 110.185 -175.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.75 99.03 7.26 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 123.25 0.62 . . . . 0.0 109.959 -174.188 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 96.5 m-70 -131.47 149.37 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.591 0.356 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.595 ' HB3' HE22 ' A' ' 15' ' ' GLN . 0.1 OUTLIER -98.76 113.47 25.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.207 0.603 . . . . 0.0 109.858 -173.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.8 mp -89.48 127.4 35.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.963 0.905 . . . . 0.0 109.033 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.595 HE22 ' HB3' ' A' ' 13' ' ' LEU . 26.2 mp0 -111.34 161.45 16.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 171.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 33.61 19.13 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.872 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.19 116.36 28.88 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -91.36 166.58 12.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.565 0.746 . . . . 0.0 109.606 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -64.81 -25.48 67.93 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 120.978 0.418 . . . . 0.0 111.705 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -92.7 3.2 56.05 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.779 0.832 . . . . 0.0 112.788 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.423 HG22 ' HB2' ' A' ' 26' ' ' LEU . 56.8 m -58.7 118.61 5.87 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.141 0.496 . . . . 0.0 110.812 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' A' ' 58' ' ' ASP . 81.8 mtm180 -87.21 -176.41 5.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.03 0.932 . . . . 0.0 111.478 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 54' ' ' LEU . 4.8 tt -54.89 -60.87 2.77 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.773 0.829 . . . . 0.0 109.045 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -55.91 -24.56 38.32 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.345 -1.298 . . . . 0.0 113.413 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 1.7 mm-40 -88.91 -53.89 4.39 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 ' HB2' HG22 ' A' ' 21' ' ' THR . 2.7 tm? -67.27 -65.78 0.64 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.162 0.985 . . . . 0.0 110.655 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.45 -18.83 65.58 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.328 0.392 . . . . 0.0 111.071 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.93 -37.58 60.55 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.713 0.633 . . . . 0.0 112.034 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 24.5 mt-30 -70.78 -38.84 73.43 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.88 -38.7 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 C-N-CA 123.803 0.841 . . . . 0.0 110.795 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.65 66.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.043 0.937 . . . . 0.0 111.914 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -35.6 13.57 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.924 0.89 . . . . 0.0 111.395 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.488 HG13 ' HG ' ' A' ' 14' ' ' LEU . 31.0 mm -72.1 -68.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.781 0.832 . . . . 0.0 110.449 -175.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.406 HG22 HG12 ' A' ' 36' ' ' ILE . 5.2 t -96.44 -16.19 21.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.342 0.657 . . . . 0.0 111.036 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 11.12 71.47 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.667 -0.518 . . . . 0.0 113.436 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.406 HG12 HG22 ' A' ' 34' ' ' THR . 26.5 mm -85.91 111.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.74 144.45 65.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.863 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.75 -24.81 73.15 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.203 2.602 . . . . 0.0 113.559 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.98 19.76 32.51 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 113.253 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -135.54 8.37 3.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 110.332 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.45 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 1.6 pt20 -144.47 162.07 37.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.511 0.725 . . . . 0.0 110.831 -177.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -129.37 -172.88 2.85 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.824 1.25 . . . . 0.0 108.645 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 72' ' ' LEU . 32.4 mm -112.26 106.65 21.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 29.8 mt -116.03 134.45 54.94 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.79 175.21 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.479 0.711 . . . . 0.0 111.199 -169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.7 -44.76 80.04 Favored Glycine 0 C--N 1.357 1.703 0 O-C-N 123.969 0.793 . . . . 0.0 114.186 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -87.0 163.34 40.88 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.536 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.61 108.52 0.15 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.572 2.848 . . . . 0.0 113.587 175.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.14 172.46 9.62 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.502 2.802 . . . . 0.0 112.493 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -101.64 11.99 37.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.929 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.9 m 56.03 84.37 0.08 Allowed 'General case' 0 C--N 1.36 1.022 0 C-N-CA 124.272 1.029 . . . . 0.0 109.646 -166.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.1 mt -79.68 95.39 5.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.351 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.22 96.14 8.36 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.662 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.439 ' HB3' HD12 ' A' ' 23' ' ' LEU . 8.0 mp -69.85 102.82 2.04 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -89.57 -36.89 15.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.948 0.899 . . . . 0.0 111.757 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -95.95 130.71 42.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.768 0.827 . . . . 0.0 110.302 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.44 68.08 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.131 0.573 . . . . 0.0 112.306 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.497 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 29.1 t70 -92.7 -2.77 55.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.855 0.862 . . . . 0.0 111.432 -172.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.4 tt -67.16 127.29 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.214 0.606 . . . . 0.0 110.748 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -99.24 177.0 5.34 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.928 0.491 . . . . 0.0 111.902 -168.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.19 -9.88 57.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 0.0 111.488 173.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.71 -25.85 74.85 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.99 -50.77 5.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.763 0.825 . . . . 0.0 110.055 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -91.05 121.72 67.53 Favored Pre-proline 0 N--CA 1.477 0.894 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.007 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.8 75.68 1.62 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.3 2.667 . . . . 0.0 113.583 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.33 131.68 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 27.9 mt-30 -118.19 155.82 29.84 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.3 t -70.94 111.61 6.47 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.21 17.2 56.2 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 123.604 0.621 . . . . 0.0 112.887 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.51 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.9 t70 -81.45 158.61 24.5 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.225 0.536 . . . . 0.0 110.246 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.4 93.69 9.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.783 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.531 HD21 HG13 ' A' ' 3' ' ' VAL . 3.9 mm? -92.36 99.44 12.2 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 4.1 mp -75.71 100.22 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.03 102.29 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.01 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 7.3 pt-20 -76.84 156.79 31.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.219 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.31 113.27 21.2 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 123.58 0.752 . . . . 0.0 110.583 176.783 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.7 m0 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.868 0.366 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -122.03 56.6 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.483 1.113 . . . . 0.0 109.241 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.566 ' HB ' HD13 ' A' ' 17' ' ' LEU . 10.8 t -83.81 135.64 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.73 -171.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -95.31 148.73 22.12 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.69 0.796 . . . . 0.0 110.123 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 p -122.17 104.2 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.459 0.704 . . . . 0.0 110.243 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -74.73 113.47 12.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.771 0.828 . . . . 0.0 109.321 171.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.723 0 C-N-CA 122.729 0.412 . . . . 0.0 110.199 177.298 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.261 0.553 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -111.0 179.8 3.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.987 0.915 . . . . 0.0 109.53 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.18 130.46 37.29 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HG ' HG13 ' A' ' 33' ' ' ILE . 4.5 mp -96.18 110.73 22.96 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.234 1.014 . . . . 0.0 109.772 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.06 -17.49 43.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 109.676 172.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -15.11 81.65 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.636 0.636 . . . . 0.0 113.54 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 3' ' ' VAL . 63.3 mt -72.67 114.43 10.8 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 117.336 0.568 . . . . 0.0 109.813 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.5 m -90.99 -167.08 1.73 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.176 0.991 . . . . 0.0 108.969 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.0 t -77.2 -45.58 26.13 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.779 0.432 . . . . 0.0 110.01 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.58 17.78 7.09 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.634 1.174 . . . . 0.0 112.794 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.8 m -65.9 115.92 6.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.141 0.577 . . . . 0.0 111.876 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.43 173.43 10.32 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.179 0.992 . . . . 0.0 110.219 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.39 -49.12 78.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.989 0.515 . . . . 0.0 111.894 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -19.93 65.31 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.648 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.85 -38.85 14.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 110.218 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.513 HD13 HD13 ' A' ' 43' ' ' ILE . 1.5 tm? -66.89 -67.21 0.47 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.874 1.27 . . . . 0.0 109.597 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 72.0 mt-30 -69.24 -20.79 63.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.103 0.561 . . . . 0.0 111.769 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.71 -33.15 75.32 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.918 0.761 . . . . 0.0 112.179 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.435 ' NE2' HD21 ' A' ' 17' ' ' LEU . 21.2 mt-30 -87.38 -32.23 19.68 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.286 0.634 . . . . 0.0 110.787 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.87 -39.85 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -61.72 -25.75 67.62 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.193 0.997 . . . . 0.0 111.974 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.05 -26.09 16.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.983 0.913 . . . . 0.0 111.748 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.514 HG13 ' HG ' ' A' ' 14' ' ' LEU . 22.3 mm -89.21 -68.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 111.257 -174.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.55 HG21 HG12 ' A' ' 36' ' ' ILE . 10.2 t -94.26 -7.69 41.3 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.92 0.488 . . . . 0.0 110.563 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.23 8.28 83.86 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 119.285 -0.731 . . . . 0.0 114.292 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.55 HG12 HG21 ' A' ' 34' ' ' THR . 11.0 mm -86.83 119.91 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 117.859 0.83 . . . . 0.0 109.178 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.98 139.44 82.98 Favored Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 124.165 0.916 . . . . 0.0 110.962 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 19.7 Cg_endo -56.64 -26.05 62.87 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.542 2.828 . . . . 0.0 114.252 -174.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.97 22.51 37.85 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 116.522 -0.308 . . . . 0.0 112.96 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 m -138.23 14.19 2.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.557 1.143 . . . . 0.0 109.949 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.42 171.87 19.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.375 0.67 . . . . 0.0 111.277 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -160.8 -173.85 4.13 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.631 1.172 . . . . 0.0 108.788 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.657 HG12 HD22 ' A' ' 54' ' ' LEU . 37.0 mm -106.13 113.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.2 mt -121.98 133.78 54.82 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 m -103.96 166.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.886 0.474 . . . . 0.0 110.831 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.06 -54.93 33.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 124.158 0.911 . . . . 0.0 112.715 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -67.19 151.68 96.89 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.268 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -49.25 106.66 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.612 2.875 . . . . 0.0 113.446 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.02 155.73 42.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.55 2.167 . . . . 0.0 111.651 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.91 10.81 22.42 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.673 0.789 . . . . 0.0 110.923 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.7 m 55.43 79.42 0.16 Allowed 'General case' 0 C--N 1.365 1.253 0 C-N-CA 124.417 1.087 . . . . 0.0 109.528 -167.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.52 138.33 57.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.777 -172.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -82.66 100.56 10.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.657 HD22 HG12 ' A' ' 43' ' ' ILE . 7.4 mp -98.03 88.84 4.35 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -126.72 -51.32 1.47 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.483 0.713 . . . . 0.0 111.357 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 59' ' ' ILE . 25.1 t70 -75.86 123.36 25.55 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.171 0.589 . . . . 0.0 110.916 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -29.73 52.95 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.7 -19.97 22.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 112.144 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.462 HG21 ' O ' ' A' ' 56' ' ' ASP . 12.1 tt -58.87 120.41 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 121.4 0.619 . . . . 0.0 110.747 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.9 p -92.67 177.32 6.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.072 0.549 . . . . 0.0 112.28 -170.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.83 -15.47 63.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.932 0.893 . . . . 0.0 111.362 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.99 78.4 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.271 -0.331 . . . . 0.0 112.271 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.3 -56.77 2.51 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.747 0.819 . . . . 0.0 109.701 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.5 mt -75.12 118.08 67.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.176 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.15 83.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.614 2.876 . . . . 0.0 114.838 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.436 HG21 HG11 ' A' ' 3' ' ' VAL . 3.1 mp -119.6 127.26 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 14.3 mt-30 -112.71 161.01 17.36 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.0 p -67.81 112.29 4.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.986 0.514 . . . . 0.0 110.147 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 22.94 59.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.188 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 29.0 t70 -82.97 166.27 18.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.74 0.816 . . . . 0.0 111.496 -175.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.473 ' HE3' ' HA ' ' A' ' 71' ' ' MET . 1.0 OUTLIER -98.82 103.66 15.63 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.87 0.868 . . . . 0.0 109.557 176.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 HD22 HG22 ' A' ' 43' ' ' ILE . 67.2 mt -98.86 104.12 16.13 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.399 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.6 91.98 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -82.13 109.56 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.548 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.91 145.36 38.29 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.21 102.13 10.84 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 123.674 0.79 . . . . 0.0 110.94 -178.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 24.0 m0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.41 ' HB2' HD13 ' A' ' 13' ' ' LEU . 14.0 ptp180 -133.9 124.91 27.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 72' ' ' LEU . 71.9 t -125.39 135.55 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.9 0.381 . . . . 0.0 111.493 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.412 ' HD3' HD23 ' A' ' 13' ' ' LEU . 40.3 mmt180 -82.12 110.96 17.81 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.379 1.072 . . . . 0.0 110.008 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' THR . 36.2 t -89.68 90.15 8.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 0.0 110.203 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -76.47 103.17 6.33 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.51 0.672 . . . . 0.0 112.157 -170.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 15.7 m . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -118.81 178.48 4.47 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.983 0.913 . . . . 0.0 110.493 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.412 HD23 ' HD3' ' A' ' 4' ' ' ARG . 3.1 tm? -125.18 131.02 53.27 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HG ' HG13 ' A' ' 33' ' ' ILE . 10.5 mp -100.1 132.82 45.24 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.323 0.649 . . . . 0.0 110.698 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.0 170.04 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.811 0.844 . . . . 0.0 109.996 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.4 23.23 77.63 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.067 172.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.67 133.23 43.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.02 0.528 . . . . 0.0 109.888 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.0 t -116.81 -166.26 1.15 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.354 1.062 . . . . 0.0 108.797 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.6 p -76.81 -36.4 56.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.993 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -104.57 20.55 18.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.926 0.49 . . . . 0.0 111.738 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -61.2 129.03 39.29 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.708 0.803 . . . . 0.0 110.142 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.542 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 78.3 mtm180 -88.19 -179.01 6.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.495 0.718 . . . . 0.0 111.848 -171.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.27 -63.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.103 0.961 . . . . 0.0 109.573 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -63.91 -15.27 58.68 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.902 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.542 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 12.2 mm-40 -87.04 -49.05 7.59 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -78.93 -66.78 0.82 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.358 1.063 . . . . 0.0 110.182 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -65.7 -19.96 66.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.001 0.52 . . . . 0.0 111.149 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.57 72.32 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.749 0.655 . . . . 0.0 111.877 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 33' ' ' ILE . 20.8 mt-30 -72.33 -38.85 68.53 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.11 -35.9 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.6 67.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.702 0.801 . . . . 0.0 111.99 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.43 -28.19 15.62 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.188 0.995 . . . . 0.0 112.065 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.442 HG13 ' HG ' ' A' ' 14' ' ' LEU . 27.8 mm -78.95 -61.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.304 1.042 . . . . 0.0 110.415 -174.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.442 HG21 HG12 ' A' ' 36' ' ' ILE . 3.8 t -109.42 -5.36 15.83 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.812 0.845 . . . . 0.0 111.435 -175.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.15 13.6 81.74 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.932 -0.371 . . . . 0.0 114.001 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 34' ' ' THR . 24.9 mm -90.88 115.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 141.88 69.49 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.707 0.803 . . . . 0.0 110.702 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.99 -27.64 64.98 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 123.421 2.747 . . . . 0.0 114.133 -174.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -15.23 78.3 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 120.085 -0.286 . . . . 0.0 113.813 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -93.78 -5.75 47.56 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.107 0.963 . . . . 0.0 111.445 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -130.19 161.59 30.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.106 0.963 . . . . 0.0 111.148 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -134.07 -172.17 2.92 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.244 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.449 HG12 HD11 ' A' ' 54' ' ' LEU . 49.8 mm -107.36 99.15 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -112.0 131.33 55.48 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.57 -174.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.721 0.808 . . . . 0.0 109.672 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.54 55.88 4.44 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.46 168.31 11.57 Favored Pre-proline 0 N--CA 1.483 1.209 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 168.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 100.31 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.982 1.788 . . . . 0.0 111.343 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.04 138.74 26.02 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.145 1.897 . . . . 0.0 113.089 -168.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.94 -0.88 23.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.891 0.876 . . . . 0.0 111.681 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.7 m 61.32 58.24 2.2 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.682 1.193 . . . . 0.0 109.678 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.18 99.92 0.73 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.113 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -86.06 125.7 33.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 43' ' ' ILE . 6.4 mp -88.96 106.57 18.51 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -111.83 19.6 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.601 0.76 . . . . 0.0 110.825 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 13.7 t70 -134.29 118.02 17.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -58.08 -34.26 69.96 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.897 0.879 . . . . 0.0 113.124 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.39 -0.71 54.65 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.05 0.94 . . . . 0.0 113.461 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.7 tt -61.6 122.18 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 118.757 0.708 . . . . 0.0 110.724 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.3 p -90.5 171.59 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.099 0.56 . . . . 0.0 111.921 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.457 HD12 HG22 ' A' ' 66' ' ' ILE . 21.9 mt -70.63 -7.96 48.21 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.95 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.89 -23.0 78.7 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.235 0.334 . . . . 0.0 112.743 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.467 ' HB2' HD22 ' A' ' 64' ' ' LEU . 9.2 m-20 -88.85 -47.29 8.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.065 0.546 . . . . 0.0 110.15 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 63' ' ' ASP . 2.5 mm? -90.35 157.31 45.05 Favored Pre-proline 0 CA--C 1.562 1.412 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.099 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.94 44.82 1.76 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.495 2.797 . . . . 0.0 114.516 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.583 HG13 HD11 ' A' ' 72' ' ' LEU . 4.0 mp -83.47 124.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -119.94 170.7 9.02 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.545 0.738 . . . . 0.0 109.171 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 t -74.63 111.56 9.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.76 13.43 59.43 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.218 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.08 170.03 17.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 30.7 ttm -117.4 113.74 22.53 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.589 0.756 . . . . 0.0 109.353 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.606 HD23 HG12 ' A' ' 3' ' ' VAL . 3.2 mp -90.64 105.69 17.99 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.476 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.75 89.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 75.3 t -72.11 107.27 2.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.386 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -77.13 159.85 29.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.697 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -125.19 121.52 34.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 CA--C 1.547 0.831 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.51 176.559 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.3 m0 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -93.24 82.55 4.53 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 66' ' ' ILE . 41.3 t -96.1 136.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -87.29 141.75 28.41 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.57 0.748 . . . . 0.0 110.327 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.592 ' SG ' HD12 ' A' ' 14' ' ' LEU . 86.3 m -130.91 101.88 5.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.327 0.651 . . . . 0.0 111.427 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 12.9 tppt? -74.95 118.69 18.19 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.436 1.094 . . . . 0.0 110.381 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.73 0 C-N-CA 123.329 0.651 . . . . 0.0 109.416 176.661 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.479 HG22 ' HE3' ' A' ' 71' ' ' MET . 15.5 m . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.402 ' HB3' HG22 ' A' ' 33' ' ' ILE . 77.7 m80 -112.02 112.55 24.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.207 1.003 . . . . 0.0 108.647 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.3 tp -80.07 121.55 25.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.093 0.557 . . . . 0.0 110.666 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.592 HD12 ' SG ' ' A' ' 5' ' ' CYS . 8.5 mp -81.41 133.46 35.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 174.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -105.33 153.37 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.526 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.04 23.82 74.51 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.472 HD23 HG22 ' A' ' 21' ' ' THR . 78.0 mt -77.17 117.96 19.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.672 0.736 . . . . 0.0 110.077 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 94.5 p -84.84 161.35 19.94 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.7 p -65.39 -17.6 64.66 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.541 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.546 HH22 ' HA3' ' A' ' 62' ' ' GLY . 6.9 mmp_? -107.22 18.49 21.61 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.144 0.977 . . . . 0.0 112.256 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.472 HG22 HD23 ' A' ' 17' ' ' LEU . 44.0 m -63.31 119.8 10.35 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.926 0.393 . . . . 0.0 110.303 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -82.39 176.58 9.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.864 0.866 . . . . 0.0 111.272 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.452 ' HB2' HG22 ' A' ' 59' ' ' ILE . 5.7 tt -51.33 -60.62 2.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.714 1.206 . . . . 0.0 110.21 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -54.12 -30.43 48.72 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.021 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.41 ' HB2' HG23 ' A' ' 21' ' ' THR . 9.0 mm-40 -83.98 -38.74 20.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.41 0.684 . . . . 0.0 110.128 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.24 -66.99 0.66 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.225 1.01 . . . . 0.0 109.564 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -67.15 -16.93 64.61 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.04 70.97 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.849 0.718 . . . . 0.0 112.022 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 33' ' ' ILE . 24.0 mt-30 -70.22 -39.51 75.06 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.47 HG13 HD21 ' A' ' 14' ' ' LEU . 88.5 mt -57.59 -42.63 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 123.612 0.765 . . . . 0.0 110.881 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.17 67.5 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.034 0.934 . . . . 0.0 112.397 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.51 -35.58 15.0 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.771 0.829 . . . . 0.0 111.435 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 29' ' ' GLN . 25.1 mt -86.32 -64.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.094 0.558 . . . . 0.0 111.109 -171.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.537 HG22 HG12 ' A' ' 36' ' ' ILE . 12.1 t -93.72 -2.86 53.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.557 0.343 . . . . 0.0 110.929 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.41 -10.07 56.18 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.555 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 34' ' ' THR . 22.5 mm -71.65 111.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.591 0.696 . . . . 0.0 109.949 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.65 144.45 44.69 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.135 0.974 . . . . 0.0 111.089 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.95 -28.17 86.88 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.082 2.521 . . . . 0.0 113.049 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.08 28.02 9.37 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.548 0.53 . . . . 0.0 113.402 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -138.87 11.64 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.39 1.076 . . . . 0.0 109.987 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.46 161.3 42.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.794 0.838 . . . . 0.0 110.741 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -143.32 -168.91 2.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.173 1.389 . . . . 0.0 109.21 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.478 HG12 HD11 ' A' ' 54' ' ' LEU . 24.2 mm -106.83 110.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.562 0.745 . . . . 0.0 109.112 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mm? -120.01 156.6 30.57 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.56 167.72 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.159 0.584 . . . . 0.0 111.046 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.72 -49.32 78.78 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.528 1.142 . . . . 0.0 113.041 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -74.12 158.72 85.28 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.631 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -46.53 111.41 0.36 Allowed 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.225 2.617 . . . . 0.0 114.227 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.72 -176.91 2.66 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.054 2.503 . . . . 0.0 111.614 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -126.0 30.15 5.72 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.4 0.68 . . . . 0.0 110.741 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 34.0 m 55.44 64.27 1.82 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.741 0.816 . . . . 0.0 109.713 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.75 109.35 4.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.98 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.23 115.72 27.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.912 1.285 . . . . 0.0 108.921 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.478 HD11 HG12 ' A' ' 43' ' ' ILE . 4.1 mp -82.7 93.45 7.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.499 0.72 . . . . 0.0 109.229 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.6 p -79.8 -52.58 7.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 111.213 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -83.45 131.67 35.01 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 123.476 0.71 . . . . 0.0 110.319 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -22.82 61.15 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.726 0.811 . . . . 0.0 112.951 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -91.58 -5.29 54.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.496 1.119 . . . . 0.0 111.252 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.452 HG22 ' HB2' ' A' ' 23' ' ' LEU . 13.9 tt -59.58 121.07 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.236 0.615 . . . . 0.0 111.626 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -91.37 173.57 7.84 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 0.0 111.278 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.426 HD11 HG23 ' A' ' 66' ' ' ILE . 45.4 mt -70.26 -4.76 23.42 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.605 0.762 . . . . 0.0 111.643 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.546 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -78.46 -30.61 48.84 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.846 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 -48.98 6.19 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.82 133.05 95.43 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.076 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.6 78.49 0.95 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.816 2.344 . . . . 0.0 111.96 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.486 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.1 mp -123.23 121.87 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.1 mm-40 -117.9 154.91 31.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.753 0.821 . . . . 0.0 109.069 174.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -65.25 106.81 1.42 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.803 . . . . 0.0 110.493 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.25 13.07 62.38 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 113.87 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.7 t70 -84.77 163.47 19.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.176 0.59 . . . . 0.0 110.447 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.517 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 5.7 tpt -91.83 101.64 14.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.486 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.5 mm? -101.61 123.15 45.15 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.231 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.5 mp -91.95 116.18 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.98 110.37 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.218 1.007 . . . . 0.0 108.286 169.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.81 138.65 39.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.4 108.77 20.21 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 123.215 0.606 . . . . 0.0 111.106 -177.558 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.0 m0 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -83.47 72.95 10.23 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.367 1.079 . . . . 0.0 109.55 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t -80.95 132.67 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.056 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -96.23 127.18 42.0 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.698 . . . . 0.0 109.585 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.406 ' SG ' HD13 ' A' ' 14' ' ' LEU . 84.4 m -113.25 114.88 27.34 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 0.0 110.36 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HE3' ' SD ' ' A' ' 71' ' ' MET . 5.2 tppp? -80.37 105.11 11.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 121.294 0.569 . . . . 0.0 111.501 -173.562 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m . . . . . 0 C--O 1.239 0.502 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.62 166.54 11.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.562 0.745 . . . . 0.0 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -118.27 120.5 37.85 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.664 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -103.35 111.47 23.9 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.022 0.929 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -89.96 171.47 9.55 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.848 0.859 . . . . 0.0 109.248 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.83 3.66 85.56 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.802 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.1 mt -95.96 127.52 42.04 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.837 0.855 . . . . 0.0 109.316 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -116.07 -166.82 1.18 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.952 1.301 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -70.01 -45.75 66.58 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.329 0.651 . . . . 0.0 111.432 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.523 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -107.18 39.25 1.92 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 ' HB2' ' A' ' 25' ' ' GLU . 20.1 m -70.46 122.79 20.31 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 166.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 26.6 mtm180 -76.24 170.14 16.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.622 0.769 . . . . 0.0 111.198 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.54 -49.73 75.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.679 0.791 . . . . 0.0 111.285 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.78 -32.38 65.59 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.752 0.657 . . . . 0.0 112.144 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.491 ' HB2' HG22 ' A' ' 21' ' ' THR . 42.1 mm-40 -78.12 -46.95 19.3 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.392 0.677 . . . . 0.0 109.684 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.09 -62.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.954 1.301 . . . . 0.0 110.812 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 59.2 mt-30 -64.96 -21.89 66.91 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.942 0.497 . . . . 0.0 111.707 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.71 93.91 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.89 0.744 . . . . 0.0 111.748 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -78.71 -37.24 42.04 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.261 -0.4 . . . . 0.0 110.514 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -55.97 -46.21 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.319 0.647 . . . . 0.0 110.808 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -63.26 -24.46 67.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.018 0.927 . . . . 0.0 112.182 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.45 -33.3 16.86 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.682 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.664 HG13 ' HG ' ' A' ' 14' ' ' LEU . 20.8 mm -85.13 -62.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.149 0.979 . . . . 0.0 111.21 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.45 HG21 HG12 ' A' ' 36' ' ' ILE . 10.2 t -96.21 -11.58 25.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.86 68.35 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.938 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.45 HG12 HG21 ' A' ' 34' ' ' THR . 6.6 mm -75.04 114.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.87 77.62 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.172 0.989 . . . . 0.0 111.233 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 37.0 Cg_endo -61.8 -17.83 57.29 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.089 2.526 . . . . 0.0 112.774 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 20.86 40.51 Favored Glycine 0 C--N 1.352 1.432 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.874 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -147.34 3.11 0.77 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.892 0.877 . . . . 0.0 111.992 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.7 pp0? -143.56 168.03 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.002 0.905 . . . . 0.0 112.3 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -153.15 166.41 32.58 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.724 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.605 HG22 HD12 ' A' ' 72' ' ' LEU . 1.8 mp -105.17 112.4 38.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 109.087 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -117.64 169.91 9.19 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 m -121.52 162.63 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 118.232 0.469 . . . . 0.0 111.24 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.25 72.44 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 115.428 -0.805 . . . . 0.0 113.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.419 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 45.4 p90 -95.08 173.24 4.58 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.093 172.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 34.2 Cg_exo -40.49 110.62 0.12 Allowed 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 123.512 2.808 . . . . 0.0 113.988 173.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.73 159.97 18.98 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.647 2.232 . . . . 0.0 112.349 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -76.79 -14.32 59.93 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.876 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.4 m 66.87 23.5 9.96 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 124.831 1.252 . . . . 0.0 109.476 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -56.83 129.46 41.47 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 125.698 1.599 . . . . 0.0 112.161 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.28 105.68 17.65 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.44 HD21 HD11 ' A' ' 43' ' ' ILE . 6.0 mp -74.63 95.93 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -120.35 6.38 10.67 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.949 0.9 . . . . 0.0 111.74 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.467 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.2 t70 -112.05 114.9 28.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -61.54 -29.39 69.98 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.523 0.729 . . . . 0.0 112.369 -174.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -94.13 -13.44 26.75 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.252 1.021 . . . . 0.0 111.883 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 56' ' ' ASP . 13.9 tt -60.69 133.32 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.523 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 71.2 p -104.59 168.48 9.05 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.735 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 34.1 mt -67.88 -10.13 50.56 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.473 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.66 -39.43 40.68 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.17 -35.04 42.56 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.762 0.791 . . . . 0.0 109.282 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 93.3 mt -80.99 157.68 71.07 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.923 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.2 34.24 0.43 Allowed 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 123.063 2.509 . . . . 0.0 113.089 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.561 HD12 HG21 ' A' ' 43' ' ' ILE . 2.4 mp -84.61 120.55 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.8 mt-30 -121.54 161.63 22.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.122 0.569 . . . . 0.0 109.507 171.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -66.9 114.02 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.02 0.528 . . . . 0.0 109.747 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.94 8.91 83.45 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.562 0.539 . . . . 0.0 113.883 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -80.44 160.22 25.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.695 0.398 . . . . 0.0 110.076 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.444 ' HE1' ' HA ' ' A' ' 71' ' ' MET . 0.1 OUTLIER -94.92 101.88 13.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.18 0.992 . . . . 0.0 109.613 -178.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 43' ' ' ILE . 3.8 mm? -104.95 109.27 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.792 0.837 . . . . 0.0 108.853 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.7 mp -75.27 105.99 4.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.161 0.584 . . . . 0.0 109.582 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.71 111.89 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.764 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 11.4 pt-20 -80.11 176.29 9.88 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.355 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -138.51 116.85 11.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 168.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 123.705 0.802 . . . . 0.0 110.03 -179.24 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . 0.436 ' H1 ' ' HD1' ' A' ' 1' ' ' TRP . 23.0 m0 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.474 ' HB3' HD12 ' A' ' 13' ' ' LEU . 82.2 mtm180 -86.59 86.42 7.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.79 0.836 . . . . 0.0 109.301 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t -99.54 141.61 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.145 0.978 . . . . 0.0 111.237 -170.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -98.87 97.32 8.52 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.505 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.5 m -80.3 100.91 8.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.598 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -76.86 103.4 6.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 109.297 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 122.65 0.38 . . . . 0.0 110.656 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -138.9 120.02 14.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.108 0.563 . . . . 0.0 109.522 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 2' ' ' ARG . 2.1 tm? -96.26 98.62 10.44 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.94 141.75 31.02 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.481 0.712 . . . . 0.0 111.433 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.84 179.36 3.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.282 1.033 . . . . 0.0 109.234 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.6 28.58 73.56 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.441 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 21' ' ' THR . 93.0 mt -106.09 113.73 27.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.292 0.637 . . . . 0.0 110.75 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' HD13 ' A' ' 61' ' ' LEU . 40.9 t -95.85 172.09 8.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 0.0 108.923 172.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.4 p -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 122.45 0.3 . . . . 0.0 111.808 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.99 22.07 13.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.817 0.447 . . . . 0.0 111.804 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.462 HG21 HD22 ' A' ' 17' ' ' LEU . 52.4 m -66.47 111.05 3.37 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 170.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HG2' HG22 ' A' ' 60' ' ' THR . 86.0 mtt-85 -74.12 -178.6 3.42 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.271 1.028 . . . . 0.0 111.971 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 54' ' ' LEU . 6.8 tt -56.76 -53.98 51.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 174.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -63.29 -22.1 66.66 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.37 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 25.3 mm-40 -87.2 -53.43 4.86 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.262 0.625 . . . . 0.0 109.665 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.531 ' HG ' HD22 ' A' ' 61' ' ' LEU . 2.5 tm? -70.89 -65.57 0.72 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.212 1.005 . . . . 0.0 110.191 -176.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -67.43 -17.23 64.63 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.64 0.588 . . . . 0.0 110.888 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.45 -37.54 53.4 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.753 0.658 . . . . 0.0 112.538 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 22.6 mt-30 -68.88 -39.46 79.77 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -59.68 -37.19 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.02 0.928 . . . . 0.0 111.204 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.73 -24.01 65.37 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.193 0.997 . . . . 0.0 111.926 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.69 -43.26 8.74 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.596 0.758 . . . . 0.0 111.322 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.0 mm -68.3 -63.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.383 1.073 . . . . 0.0 110.237 -172.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.507 HG23 HG12 ' A' ' 36' ' ' ILE . 8.9 t -109.31 0.99 19.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.67 0.788 . . . . 0.0 111.013 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.2 89.38 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 170.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.507 HG12 HG23 ' A' ' 34' ' ' THR . 9.8 mm -86.08 107.85 16.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 147.54 98.36 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.564 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -49.95 -33.3 33.51 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 124.11 3.207 . . . . 0.0 114.25 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 13.86 18.48 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.3 m -138.99 15.01 2.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 110.92 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 2.1 pt20 -146.81 155.26 42.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.514 0.725 . . . . 0.0 110.783 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -124.67 -173.91 2.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.169 0.988 . . . . 0.0 109.374 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.6 mm -110.4 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 28.4 mt -107.34 139.73 41.36 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 65' ' ' PRO . 6.7 m -120.19 178.34 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 122.867 0.467 . . . . 0.0 112.203 -164.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.97 -49.82 57.37 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 124.301 1.001 . . . . 0.0 113.654 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -79.01 163.11 61.89 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.367 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -42.04 104.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.884 3.056 . . . . 0.0 113.924 171.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.13 159.11 37.5 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.404 2.069 . . . . 0.0 112.736 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -89.33 8.19 31.85 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.412 1.085 . . . . 0.0 112.145 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.0 m 61.67 27.08 16.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.37 1.068 . . . . 0.0 110.264 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -61.62 108.44 0.98 Allowed 'General case' 0 C--N 1.357 0.91 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.751 -173.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.48 132.97 43.49 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.685 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 23' ' ' LEU . 7.1 mp -87.86 88.05 7.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.351 1.06 . . . . 0.0 108.359 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.0 t -93.87 13.93 21.06 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.435 0.694 . . . . 0.0 110.57 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.02 117.46 20.94 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.319 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -60.88 -30.28 70.06 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.169 0.987 . . . . 0.0 113.108 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -81.34 -23.44 37.75 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.581 1.152 . . . . 0.0 111.741 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.3 tt -56.16 134.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 -173.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.411 HG22 ' HG2' ' A' ' 22' ' ' ARG . 58.9 p -113.55 175.2 5.56 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.54 0.736 . . . . 0.0 111.05 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.531 HD22 ' HG ' ' A' ' 26' ' ' LEU . 50.7 mt -64.36 -22.01 66.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.96 0.504 . . . . 0.0 111.848 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.22 -17.05 61.03 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.241 0.338 . . . . 0.0 113.232 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.57 -45.31 6.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 0.0 111.191 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 52' ' ' LEU . 2.3 mm? -85.91 154.73 58.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 123.108 0.563 . . . . 0.0 110.946 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.419 ' HB2' HG13 ' A' ' 45' ' ' VAL . 2.2 Cg_endo -81.61 41.77 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.523 2.815 . . . . 0.0 113.083 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.76 108.64 3.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.58 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 21.0 mm-40 -105.7 166.42 10.47 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 p -64.4 99.51 0.3 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.199 0.6 . . . . 0.0 110.953 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 35.27 44.55 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.451 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -88.52 165.43 14.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.388 0.675 . . . . 0.0 111.047 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.52 98.21 11.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.802 0.841 . . . . 0.0 109.615 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 98.96 10.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.506 0.722 . . . . 0.0 110.21 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.8 mp -75.96 101.12 2.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 94.5 t -79.42 106.9 11.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.691 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 9.1 pt-20 -78.61 169.04 18.88 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.219 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -130.34 137.11 49.76 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 N--CA 1.482 1.13 0 C-N-CA 123.07 0.548 . . . . 0.0 111.861 -179.775 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . 0.512 ' HD1' ' H2 ' ' A' ' 1' ' ' TRP . 11.2 m0 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.446 ' HB2' HD11 ' A' ' 13' ' ' LEU . 23.1 ptt180 -88.17 65.39 8.1 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.689 1.233 . . . . 0.0 109.563 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.53 ' HB ' HD13 ' A' ' 17' ' ' LEU . 43.3 t -79.12 143.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.507 -169.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -98.69 142.86 29.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.357 1.063 . . . . 0.0 109.943 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.438 ' SG ' HD13 ' A' ' 14' ' ' LEU . 72.1 m -136.39 99.99 4.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.231 1.013 . . . . 0.0 110.076 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -74.41 113.16 11.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 109.433 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.729 0 C-N-CA 122.773 0.429 . . . . 0.0 110.228 179.879 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -112.62 152.1 29.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 0.0 110.861 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER -113.31 112.94 24.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HG ' HG13 ' A' ' 33' ' ' ILE . 5.5 mp -102.72 97.34 7.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.749 0.82 . . . . 0.0 109.041 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.431 ' HG3' HD13 ' A' ' 13' ' ' LEU . 78.5 mt-30 -78.86 -11.4 59.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.373 0.669 . . . . 0.0 110.951 169.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.52 -9.63 74.06 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.421 0.451 . . . . 0.0 114.049 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD13 ' HB ' ' A' ' 3' ' ' VAL . 71.1 mt -78.36 125.01 28.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.953 0.501 . . . . 0.0 110.382 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' HD11 ' A' ' 61' ' ' LEU . 44.5 m -103.43 -178.11 3.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.321 1.449 . . . . 0.0 109.577 171.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 m -65.61 -39.86 91.99 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.92 0.488 . . . . 0.0 112.079 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -104.5 29.15 6.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.819 0.448 . . . . 0.0 112.165 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.51 HG21 HD22 ' A' ' 17' ' ' LEU . 94.9 m -64.08 104.88 0.78 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 122.84 0.456 . . . . 0.0 111.318 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -66.9 173.63 3.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.904 1.282 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' A' ' 54' ' ' LEU . 6.3 tt -54.95 -50.87 67.81 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.451 0.7 . . . . 0.0 109.873 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 6.1 ptp180 -56.76 -26.26 56.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.972 0.909 . . . . 0.0 112.712 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.465 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 5.5 mm-40 -93.12 -35.46 13.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.897 0.879 . . . . 0.0 110.199 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -79.97 -68.69 0.65 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.035 0.934 . . . . 0.0 109.221 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.76 -19.01 65.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.604 0.565 . . . . 0.0 110.751 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.28 -43.86 77.65 Favored Glycine 0 C--N 1.345 1.051 0 O-C-N 123.929 0.768 . . . . 0.0 112.205 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.485 ' NE2' HD21 ' A' ' 17' ' ' LEU . 43.6 mt-30 -73.41 -38.91 65.42 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.11 -39.14 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.139 0.576 . . . . 0.0 111.249 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.19 68.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.612 0.765 . . . . 0.0 111.694 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.54 -23.35 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.068 0.947 . . . . 0.0 111.704 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.46 HG13 ' HG ' ' A' ' 14' ' ' LEU . 22.2 mm -86.91 -69.38 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.916 0.886 . . . . 0.0 109.886 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.482 HG21 HG12 ' A' ' 36' ' ' ILE . 3.1 t -96.51 -11.73 25.09 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.273 0.629 . . . . 0.0 111.514 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 12.46 77.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.92 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.482 HG12 HG21 ' A' ' 34' ' ' THR . 13.2 mm -85.84 113.81 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.77 142.26 44.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.221 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.66 -24.41 62.57 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.226 2.617 . . . . 0.0 113.348 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.29 19.3 53.29 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.337 0.398 . . . . 0.0 113.27 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -134.6 -3.6 2.62 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.92 145.67 48.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.613 0.765 . . . . 0.0 109.464 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -121.62 168.04 12.22 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 167.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 mm -103.66 112.0 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.5 mm? -113.61 178.69 4.19 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.1 164.7 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.812 0.445 . . . . 0.0 111.311 -171.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.57 1.82 50.23 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 114.507 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -120.21 172.68 4.35 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -37.45 103.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.017 3.145 . . . . 0.0 113.656 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.17 146.14 56.8 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.634 2.222 . . . . 0.0 112.613 -170.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.32 2.38 55.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.725 0.81 . . . . 0.0 110.826 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.0 m 56.14 74.35 0.39 Allowed 'General case' 0 C--N 1.365 1.258 0 C-N-CA 124.749 1.22 . . . . 0.0 110.482 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.7 mt -77.84 101.14 6.62 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.808 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.13 104.93 17.44 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.296 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.453 ' HB3' HD13 ' A' ' 23' ' ' LEU . 5.4 mp -73.85 85.21 1.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.2 t -82.41 -21.31 35.81 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.308 1.043 . . . . 0.0 110.984 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -107.81 136.98 46.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.884 0.874 . . . . 0.0 109.42 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -78.46 -22.45 47.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.579 0.751 . . . . 0.0 111.955 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -93.4 -2.56 54.53 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.448 0.699 . . . . 0.0 111.305 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.82 123.69 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.957 0.503 . . . . 0.0 110.539 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 p -104.51 177.35 4.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.891 0.476 . . . . 0.0 111.081 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 18' ' ' SER . 28.3 mt -74.55 -5.6 43.74 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.615 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.46 62.05 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.497 0.498 . . . . 0.0 111.902 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.92 -42.18 10.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.516 0.726 . . . . 0.0 109.279 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -78.84 152.22 77.21 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.171 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.49 25.49 0.54 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 124.14 3.227 . . . . 0.0 114.175 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.527 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.3 mp -77.08 128.69 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.5 mt-30 -118.03 -179.28 3.71 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.801 0.84 . . . . 0.0 108.917 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 p -68.41 -1.45 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 40.41 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.0 t70 -85.19 163.61 18.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.533 0.733 . . . . 0.0 111.577 -171.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.2 tpt -100.02 103.06 14.58 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.051 0.94 . . . . 0.0 109.508 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 66' ' ' ILE . 3.2 mm? -109.37 131.24 55.25 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -92.97 114.11 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.43 115.66 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.214 1.006 . . . . 0.0 109.079 167.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -87.48 159.51 18.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -117.2 113.61 22.47 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 CA--C 1.541 0.622 0 C-N-CA 124.061 0.945 . . . . 0.0 109.727 179.484 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . 0.507 ' H1 ' ' HD1' ' A' ' 1' ' ' TRP . 10.8 m0 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -90.95 83.33 5.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.066 0.946 . . . . 0.0 109.124 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.7 t -105.59 141.23 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.734 0.814 . . . . 0.0 111.126 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -88.61 147.28 24.65 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 110.915 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.2 p -131.56 115.37 16.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.348 0.659 . . . . 0.0 110.4 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.565 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 14.3 tppt? -79.7 124.21 28.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.403 1.081 . . . . 0.0 109.434 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 123.118 0.567 . . . . 0.0 110.044 177.912 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.514 HG21 ' HE2' ' A' ' 71' ' ' MET . 33.4 m . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.661 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.3 m-70 -102.95 177.84 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 tt -146.86 101.5 3.44 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.587 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.0 mp -79.16 113.34 17.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.969 0.908 . . . . 0.0 110.038 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -101.65 -9.39 20.96 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.357 0.663 . . . . 0.0 110.979 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.63 42.03 3.12 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 122.827 0.251 . . . . 0.0 113.165 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.5 mt -118.24 121.97 41.8 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.832 0.853 . . . . 0.0 109.835 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.2 p -97.44 171.97 8.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.373 1.069 . . . . 0.0 109.337 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 m -62.31 -29.34 70.37 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.281 0.632 . . . . 0.0 111.546 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -110.74 29.5 7.69 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.84 0.856 . . . . 0.0 112.142 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -70.88 121.11 17.49 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 166.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -89.93 169.6 11.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 110.093 -173.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 57' ' ' ARG . 24.9 tp -51.99 -51.56 56.43 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.856 0.863 . . . . 0.0 111.715 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.533 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 11.8 ptm180 -55.37 -34.1 64.0 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.731 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 44.0 mt-10 -88.26 -31.28 19.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.812 0.845 . . . . 0.0 110.877 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 43' ' ' ILE . 2.3 tm? -74.01 -66.4 0.72 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.034 0.934 . . . . 0.0 108.907 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -66.49 -20.84 66.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.192 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.37 -42.04 90.32 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.013 0.821 . . . . 0.0 111.67 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -73.71 -35.76 65.16 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.574 0.349 . . . . 0.0 110.078 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -62.72 -37.56 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 C-N-CA 123.287 0.635 . . . . 0.0 110.53 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.73 -24.61 67.84 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.813 0.845 . . . . 0.0 112.022 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.47 -25.5 16.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.908 0.883 . . . . 0.0 111.804 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.587 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.4 mm -82.4 -65.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.331 1.052 . . . . 0.0 110.488 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 36' ' ' ILE . 7.1 t -108.77 -0.36 20.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.98 0.912 . . . . 0.0 110.953 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.99 11.87 84.74 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.404 -0.664 . . . . 0.0 114.398 171.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 34' ' ' THR . 23.0 mm -85.78 131.49 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 117.791 0.796 . . . . 0.0 111.442 -175.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 130.93 93.64 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.201 1.0 . . . . 0.0 110.335 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.05 -24.97 68.56 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.335 2.69 . . . . 0.0 113.42 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.61 -3.57 90.19 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.859 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.5 m -107.41 -48.21 3.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.762 0.825 . . . . 0.0 110.309 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -76.91 153.77 34.35 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.269 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.69 168.36 23.85 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.448 1.099 . . . . 0.0 109.075 168.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.439 HD13 HD13 ' A' ' 26' ' ' LEU . 43.9 mm -79.41 103.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.259 1.028 . . . . 0.0 110.364 -174.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.2 mt -122.1 137.19 54.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.985 -1.916 . . . . 0.0 105.964 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 65' ' ' PRO . 16.3 m -125.68 179.1 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 122.733 0.413 . . . . 0.0 111.5 -169.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.65 -48.75 74.9 Favored Glycine 0 C--N 1.358 1.779 0 O-C-N 124.326 1.016 . . . . 0.0 113.654 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -80.7 155.82 73.19 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.929 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -45.29 108.04 0.13 Allowed 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 124.22 3.28 . . . . 0.0 113.593 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.04 169.14 8.97 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.946 2.431 . . . . 0.0 111.524 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.58 25.18 11.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.455 0.702 . . . . 0.0 111.417 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.1 m 53.2 65.07 1.62 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.03 0.932 . . . . 0.0 110.143 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.86 126.14 26.33 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.182 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -91.04 90.81 8.02 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.836 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.89 86.17 2.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -80.58 -41.46 23.99 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.0 0.92 . . . . 0.0 110.872 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 20.9 t0 -81.11 118.2 22.32 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.024 0.53 . . . . 0.0 110.385 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.517 ' HA ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.75 -29.13 62.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.07 0.948 . . . . 0.0 112.832 174.313 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -93.52 -2.39 54.41 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.761 0.824 . . . . 0.0 112.047 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 14.0 tt -69.73 126.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.989 -0.444 . . . . 0.0 111.177 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -91.12 172.04 8.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.37 0.605 . . . . 0.0 112.437 -171.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 66' ' ' ILE . 27.6 mt -65.43 -17.78 64.81 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.149 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -28.62 66.77 Favored Glycine 0 C--N 1.36 1.886 0 O-C-N 123.483 0.489 . . . . 0.0 113.14 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.81 -52.24 5.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.129 0.571 . . . . 0.0 110.402 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.9 155.45 82.89 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.969 0.908 . . . . 0.0 111.756 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HB2' HG11 ' A' ' 45' ' ' VAL . 4.4 Cg_exo -80.66 36.65 0.63 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.878 3.052 . . . . 0.0 114.126 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.542 HG13 HD23 ' A' ' 72' ' ' LEU . 2.0 mp -70.89 114.55 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 167.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 34.4 mt-30 -118.23 148.57 42.27 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -65.24 104.07 0.88 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.67 . . . . 0.0 110.659 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.88 11.51 52.98 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 114.113 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.602 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 27.9 t0 -89.53 160.68 16.59 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.273 0.629 . . . . 0.0 111.979 -173.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.565 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 4.8 tpt -96.21 108.31 20.77 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.766 1.226 . . . . 0.0 109.648 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.542 HD23 HG13 ' A' ' 66' ' ' ILE . 11.1 mp -109.67 126.12 53.34 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 0.0 110.288 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -85.88 103.29 12.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.53 111.65 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.618 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.99 155.41 19.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.71 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.524 ' HB2' HD12 ' A' ' 36' ' ' ILE . 10.0 tp10 -135.87 130.81 34.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.985 0.914 . . . . 0.0 109.446 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.354 0.662 . . . . 0.0 110.632 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . 0.432 ' H1 ' ' HD1' ' A' ' 1' ' ' TRP . 18.8 m0 . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.491 ' HB3' HD13 ' A' ' 13' ' ' LEU . 53.7 mtm180 -116.75 88.05 2.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.017 0.927 . . . . 0.0 108.775 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.447 HG11 HD22 ' A' ' 72' ' ' LEU . 82.3 t -89.43 137.36 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.455 0.702 . . . . 0.0 111.204 -170.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -87.45 138.67 31.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.746 0.819 . . . . 0.0 109.075 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 t -131.99 100.89 5.21 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.474 0.71 . . . . 0.0 111.11 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.0 tppp? -73.38 144.75 46.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.733 0.301 . . . . 0.0 111.34 -177.772 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.543 0.704 0 CA-C-O 121.112 0.482 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -122.97 164.66 18.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.33 1.452 . . . . 0.0 108.378 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.491 HD13 ' HB3' ' A' ' 2' ' ' ARG . 0.3 OUTLIER -128.85 102.55 6.59 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.661 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.1 mp -81.3 121.77 26.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.041 0.936 . . . . 0.0 110.358 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.481 ' NE2' HD12 ' A' ' 13' ' ' LEU . 83.5 mm-40 -98.9 159.92 14.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.158 0.983 . . . . 0.0 109.762 174.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.8 10.43 83.13 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.135 -0.484 . . . . 0.0 114.17 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.39 137.44 42.71 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.113 0.565 . . . . 0.0 109.609 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -112.66 177.92 4.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.639 1.176 . . . . 0.0 109.36 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.7 p -82.32 -26.85 32.64 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.912 0.387 . . . . 0.0 109.972 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -86.8 6.92 29.2 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.926 0.89 . . . . 0.0 112.191 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.418 HG21 ' HB2' ' A' ' 26' ' ' LEU . 93.5 m -62.9 112.34 2.52 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 110.826 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.88 179.36 7.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.287 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 4.9 tt -57.53 -56.33 23.27 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.74 0.816 . . . . 0.0 109.652 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -20.31 64.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.673 0.789 . . . . 0.0 112.097 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -79.62 -52.81 7.51 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.509 0.724 . . . . 0.0 109.246 172.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.418 ' HB2' HG21 ' A' ' 21' ' ' THR . 2.5 tm? -69.29 -66.72 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.879 1.272 . . . . 0.0 110.756 -169.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -65.13 -18.3 65.19 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.141 0.576 . . . . 0.0 111.7 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.46 -41.03 46.12 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.7 0.625 . . . . 0.0 111.983 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -70.13 -37.03 75.18 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.105 0.562 . . . . 0.0 110.06 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.55 -43.73 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 0.0 110.912 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.76 -26.36 67.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.761 0.825 . . . . 0.0 111.743 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.51 -27.96 19.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.632 0.773 . . . . 0.0 111.769 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.661 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.4 mm -84.27 -70.07 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.115 0.566 . . . . 0.0 110.722 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -88.53 -16.29 33.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.24 0.616 . . . . 0.0 111.154 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.81 -1.91 85.55 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.361 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 mm -77.64 112.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.54 144.53 63.61 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 124.022 0.929 . . . . 0.0 110.772 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.85 -24.35 63.78 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.26 2.64 . . . . 0.0 113.212 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.49 19.8 34.32 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.639 -0.255 . . . . 0.0 113.28 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.8 m -140.37 12.62 2.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.458 1.103 . . . . 0.0 110.618 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -148.9 144.03 26.6 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.993 0.517 . . . . 0.0 109.81 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.8 176.35 6.66 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.279 1.032 . . . . 0.0 108.904 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -101.21 101.12 11.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 32.2 mt -116.28 145.58 43.05 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 49' ' ' PRO . 17.4 m -114.7 168.55 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.299 0.639 . . . . 0.0 110.017 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.01 65.72 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.789 0.681 . . . . 0.0 113.77 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -80.29 160.87 66.92 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.606 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -47.52 110.77 0.33 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HB3' HG23 ' A' ' 45' ' ' VAL . 90.8 Cg_endo -81.53 -179.81 5.21 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.273 2.649 . . . . 0.0 112.307 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.74 13.46 28.38 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.503 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.7 m 54.72 66.43 1.24 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 123.828 0.851 . . . . 0.0 108.706 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.77 129.24 39.09 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.863 -165.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.9 90.14 3.52 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 108.801 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 9.7 mp -87.49 104.99 16.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -100.65 -51.94 3.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.602 0.761 . . . . 0.0 110.562 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -71.71 111.72 7.23 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.116 0.567 . . . . 0.0 111.317 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -53.09 -25.59 13.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.501 1.12 . . . . 0.0 113.554 175.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.51 -2.75 56.0 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.49 0.716 . . . . 0.0 112.11 -173.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.4 tt -71.78 125.43 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.729 0.412 . . . . 0.0 110.836 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.6 p -89.4 176.01 7.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.659 0.743 . . . . 0.0 112.317 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.7 mt -73.52 -7.51 52.12 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.828 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.17 71.95 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.395 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.35 -52.04 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.4 0.68 . . . . 0.0 110.519 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.43 148.22 54.92 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.216 0.607 . . . . 0.0 111.144 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 31.51 0.44 Allowed 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.805 3.003 . . . . 0.0 114.936 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.31 117.8 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -120.42 163.42 17.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 t -71.16 108.53 4.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.837 0.455 . . . . 0.0 110.191 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.57 0.15 62.87 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.581 0.551 . . . . 0.0 113.206 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.19 156.68 38.34 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.193 0.597 . . . . 0.0 110.549 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.421 ' HA ' ' HE2' ' A' ' 71' ' ' MET . 5.2 tpt -92.54 104.58 16.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.491 1.117 . . . . 0.0 109.021 -176.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.447 HD22 HG11 ' A' ' 3' ' ' VAL . 4.3 mm? -105.08 115.75 30.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.885 0.874 . . . . 0.0 109.11 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.4 mp -86.79 100.73 10.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -78.21 105.09 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.599 166.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.5 161.69 27.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.834 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -116.52 109.4 17.21 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 124.183 0.993 . . . . 0.0 110.92 179.466 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 38.5 m0 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.842 0.353 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -125.17 106.81 10.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 66' ' ' ILE . 37.3 t -130.75 139.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.922 -0.486 . . . . 0.0 110.35 -173.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -85.02 153.73 22.56 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.005 0.522 . . . . 0.0 111.72 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.506 ' SG ' HD21 ' A' ' 14' ' ' LEU . 95.3 m -130.72 112.14 12.81 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.395 1.078 . . . . 0.0 110.414 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.491 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 16.3 tppt? -82.34 107.67 15.19 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.426 1.09 . . . . 0.0 109.305 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 120.802 0.335 . . . . 0.0 111.253 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -101.36 179.21 4.42 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.975 0.91 . . . . 0.0 110.153 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.584 HD21 ' NE2' ' A' ' 15' ' ' GLN . 3.0 tt -135.35 106.27 6.62 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.506 HD21 ' SG ' ' A' ' 5' ' ' CYS . 4.3 mm? -66.0 108.68 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.684 0.794 . . . . 0.0 109.925 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.584 ' NE2' HD21 ' A' ' 13' ' ' LEU . 29.3 mm-40 -76.89 -45.77 26.89 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.199 0.999 . . . . 0.0 110.719 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.81 65.48 3.91 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.533 -0.758 . . . . 0.0 113.382 -174.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.9 mt -118.43 138.55 52.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.06 0.544 . . . . 0.0 110.29 172.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' HD13 ' A' ' 61' ' ' LEU . 21.3 m -115.75 -176.91 3.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.204 1.402 . . . . 0.0 108.722 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.2 m -73.47 -33.72 64.99 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.186 0.517 . . . . 0.0 110.681 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -104.37 28.18 7.15 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.844 -175.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.439 HG21 ' HB2' ' A' ' 26' ' ' LEU . 53.3 m -67.76 105.18 1.85 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.347 0.594 . . . . 0.0 109.686 171.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.536 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 36.2 mtm-85 -65.92 175.85 1.85 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.757 1.223 . . . . 0.0 111.637 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 54' ' ' LEU . 7.3 tt -56.39 -57.67 11.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.356 0.662 . . . . 0.0 109.28 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -50.51 -34.6 25.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.9 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 18.6 mm-40 -76.11 -51.03 13.07 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.002 0.429 . . . . 0.0 110.087 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.592 HD12 HD11 ' A' ' 43' ' ' ILE . 2.4 tm? -70.76 -67.27 0.52 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.317 1.047 . . . . 0.0 110.68 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -66.55 -20.38 66.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.599 0.562 . . . . 0.0 111.618 -176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.22 -37.01 43.59 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.729 0.643 . . . . 0.0 112.192 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.41 ' O ' HG12 ' A' ' 33' ' ' ILE . 22.8 mt-30 -70.63 -39.73 73.53 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -62.76 -36.63 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.312 0.645 . . . . 0.0 110.615 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -26.34 68.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.439 0.695 . . . . 0.0 111.536 173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.81 -23.04 20.72 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.92 0.888 . . . . 0.0 111.766 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 29' ' ' GLN . 16.0 mm -82.78 -70.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.372 0.669 . . . . 0.0 110.374 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.403 HG22 HG12 ' A' ' 36' ' ' ILE . 4.8 t -97.77 -7.75 29.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.16 19.23 78.72 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 119.712 -0.493 . . . . 0.0 113.321 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 75' ' ' GLU . 11.0 mm -98.49 108.26 21.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.84 155.07 55.13 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.498 1.119 . . . . 0.0 112.157 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.12 -31.71 84.19 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.419 2.746 . . . . 0.0 114.599 -174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.02 3.1 80.44 Favored Glycine 0 N--CA 1.476 1.353 0 O-C-N 123.124 0.265 . . . . 0.0 113.346 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.409 ' HA ' ' HB3' ' A' ' 77' ' ' ASP . 19.1 m -107.25 -2.93 20.28 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.198 0.999 . . . . 0.0 110.179 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -144.53 162.45 36.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.974 0.416 . . . . 0.0 111.86 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.48 -176.35 5.08 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.18 1.392 . . . . 0.0 108.885 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.592 HD11 HD12 ' A' ' 26' ' ' LEU . 29.0 mm -105.8 110.63 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.535 . . . . 0.0 109.723 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -121.34 160.18 24.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -131.92 173.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.755 0.822 . . . . 0.0 111.125 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.48 -5.1 87.86 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.814 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 54.0 p90 -113.51 163.2 19.07 Favored Pre-proline 0 N--CA 1.479 1.017 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 10.8 Cg_endo -50.89 109.21 0.28 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 122.88 2.387 . . . . 0.0 112.489 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.33 169.81 12.33 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.746 2.297 . . . . 0.0 112.159 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -88.08 5.73 39.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.706 0.802 . . . . 0.0 111.335 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 90.3 m 56.27 83.05 0.1 Allowed 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -158.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.61 95.6 3.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 110.512 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.75 114.0 20.1 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.143 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 23' ' ' LEU . 4.7 mp -79.46 84.83 5.3 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 p -67.9 -50.56 55.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.468 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.58 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 19.3 t70 -76.25 157.55 32.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.083 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -92.52 -34.78 13.93 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.286 1.034 . . . . 0.0 111.815 -173.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.51 -3.07 50.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.9 1.28 . . . . 0.0 110.431 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.58 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 15.8 tt -60.85 133.51 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.637 1.175 . . . . 0.0 111.883 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -108.69 -177.9 3.44 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.555 HD22 ' HG ' ' A' ' 26' ' ' LEU . 49.7 mt -75.64 -10.05 59.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 112.061 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 -25.09 73.79 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.52 -59.33 2.16 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 109.846 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.75 129.79 75.47 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.282 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -63.21 78.26 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.918 3.079 . . . . 0.0 114.053 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.637 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -108.11 108.78 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 12.3 mm100 -103.31 155.05 18.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.972 0.509 . . . . 0.0 109.989 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.6 p -62.79 100.97 0.22 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.786 0.835 . . . . 0.0 111.826 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.53 46.08 8.22 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.608 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 6.0 t70 -110.25 169.71 8.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.309 0.644 . . . . 0.0 110.374 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.529 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 4.1 tpt -102.18 103.29 13.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.308 0.643 . . . . 0.0 109.991 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.637 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.6 mm? -106.01 114.68 28.96 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.475 0.71 . . . . 0.0 109.679 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 2.8 mp -82.13 108.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.667 0.787 . . . . 0.0 109.737 -176.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 75.8 t -82.97 116.42 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.706 1.203 . . . . 0.0 108.933 170.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 36' ' ' ILE . 11.9 pt-20 -82.31 170.23 15.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.646 0.26 . . . . 0.0 110.699 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -129.57 114.6 16.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 27.7 t70 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 124.342 1.057 . . . . 0.0 110.703 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 32.0 m0 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -81.16 94.8 6.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.9 144.3 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.189 0.995 . . . . 0.0 109.861 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -100.01 141.87 32.25 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.002 0.521 . . . . 0.0 110.903 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 31.2 p -122.85 112.49 17.94 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 0.0 111.369 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HB3' HG13 ' A' ' 73' ' ' ILE . 13.3 tppt? -81.03 106.1 12.77 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.9 0 C-N-CA 123.064 0.546 . . . . 0.0 111.518 -170.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.529 HG22 ' HE3' ' A' ' 71' ' ' MET . 3.8 m . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 21.2 m-70 -104.78 179.31 4.31 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.046 0.939 . . . . 0.0 109.538 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD12 ' NE2' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -130.66 129.5 42.72 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' HG ' HG13 ' A' ' 33' ' ' ILE . 5.5 mp -99.98 118.21 35.91 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.48 1.112 . . . . 0.0 109.906 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.403 ' NE2' HD12 ' A' ' 13' ' ' LEU . 80.8 mm-40 -94.4 156.88 16.28 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.468 0.707 . . . . 0.0 109.199 171.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.16 81.72 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.536 -0.591 . . . . 0.0 114.409 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.89 118.57 12.9 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 110.072 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.4 m -114.01 172.99 6.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.197 0.999 . . . . 0.0 109.602 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.2 p -59.09 -35.22 73.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.832 0.853 . . . . 0.0 112.728 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -95.64 3.45 53.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.505 0.722 . . . . 0.0 112.636 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 25' ' ' GLU . 45.2 m -55.21 113.15 1.27 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.586 0.708 . . . . 0.0 111.495 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.56 172.18 11.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.177 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 54' ' ' LEU . 8.8 tt -59.15 -48.0 83.23 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.677 0.791 . . . . 0.0 110.536 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -25.15 67.37 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.998 0.519 . . . . 0.0 112.366 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.441 ' HB2' HG23 ' A' ' 21' ' ' THR . 64.2 mm-40 -78.73 -53.05 7.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.572 0.749 . . . . 0.0 109.875 175.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.06 -55.35 29.98 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.47 1.508 . . . . 0.0 111.236 -173.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.556 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 15.1 mm100 -57.78 -34.22 69.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.358 1.063 . . . . 0.0 111.967 177.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.73 -34.26 77.61 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.969 0.793 . . . . 0.0 111.678 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -76.52 -39.31 53.35 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 123.195 0.598 . . . . 0.0 110.408 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -56.82 -44.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.403 0.681 . . . . 0.0 110.7 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.21 -24.16 67.57 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.586 0.754 . . . . 0.0 111.843 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.65 -28.42 19.49 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.79 0.836 . . . . 0.0 112.135 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.408 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.9 mm -91.66 -51.19 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.139 0.976 . . . . 0.0 111.782 -171.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.537 HG23 HG12 ' A' ' 36' ' ' ILE . 15.0 t -115.91 -5.88 12.03 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.344 0.658 . . . . 0.0 111.28 -178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.51 -10.32 74.35 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 168.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 34' ' ' THR . 4.1 mm -82.4 118.5 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 117.953 0.876 . . . . 0.0 109.778 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.82 149.01 96.84 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.05 0.94 . . . . 0.0 111.3 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 11.7 Cg_endo -50.53 -41.01 54.14 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 124.198 3.265 . . . . 0.0 113.854 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.25 27.53 5.59 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.179 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.7 m -146.6 12.99 1.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.616 1.166 . . . . 0.0 109.033 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -155.7 151.05 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.188 0.518 . . . . 0.0 110.402 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -125.96 174.48 8.38 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.491 1.116 . . . . 0.0 108.143 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 72' ' ' LEU . 47.3 mm -106.72 114.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.7 mm? -119.5 166.42 13.13 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 47' ' ' TYR . 4.0 m -129.35 161.26 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.374 0.67 . . . . 0.0 110.462 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -43.57 96.16 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.616 0.573 . . . . 0.0 113.035 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.469 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 32.8 p90 -72.77 163.25 69.58 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.161 167.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 14.6 Cg_endo -52.61 114.61 1.76 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.904 2.403 . . . . 0.0 114.071 -173.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.68 178.66 2.75 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.366 2.71 . . . . 0.0 110.919 170.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.08 19.94 6.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.789 0.835 . . . . 0.0 109.601 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.4 m 57.04 82.37 0.12 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.591 1.157 . . . . 0.0 109.602 -164.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 43' ' ' ILE . 95.3 mt -53.11 131.11 36.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.593 0.757 . . . . 0.0 111.34 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -82.73 106.17 14.35 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.792 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.493 ' HB3' HD11 ' A' ' 23' ' ' LEU . 7.2 mp -105.35 80.49 1.59 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.816 0.846 . . . . 0.0 109.097 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 p -102.71 -34.42 9.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.779 0.831 . . . . 0.0 110.945 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.61 -175.52 5.8 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.483 0.713 . . . . 0.0 109.95 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -31.1 1.48 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.621 0.768 . . . . 0.0 110.795 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.35 -19.58 42.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.876 0.87 . . . . 0.0 110.913 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.96 123.38 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 124.163 0.985 . . . . 0.0 111.109 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -96.54 -179.36 4.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -166.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.9 mt -68.92 -15.41 63.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.901 0.88 . . . . 0.0 111.838 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.6 -17.8 73.2 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.462 -0.336 . . . . 0.0 112.393 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.76 -63.06 1.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.924 0.89 . . . . 0.0 109.616 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.09 116.68 46.81 Favored Pre-proline 0 N--CA 1.486 1.345 0 CA-C-O 117.646 -1.168 . . . . 0.0 107.999 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -55.64 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.995 3.13 . . . . 0.0 115.055 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.486 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -110.4 121.66 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 166.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 37.8 mt-30 -119.53 166.22 13.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.287 0.635 . . . . 0.0 109.668 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.6 m -63.74 95.92 0.12 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.819 0.848 . . . . 0.0 110.925 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.93 29.41 23.31 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.436 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 23.6 t70 -87.79 160.47 18.02 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.148 0.579 . . . . 0.0 109.893 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.529 ' HE3' HG22 ' A' ' 11' ' ' THR . 4.7 tpt -96.9 100.98 12.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 110.261 -176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.1 mm? -104.94 112.79 26.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.671 0.788 . . . . 0.0 109.429 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -81.78 114.47 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.76 115.91 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 108.467 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.9 179.89 6.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 110.665 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -131.94 106.57 8.13 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 CA--C 1.554 1.118 0 C-N-CA 124.737 1.215 . . . . 0.0 110.9 173.084 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.9 m0 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.681 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 78.3 mtm180 -80.35 69.93 6.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.151 0.98 . . . . 0.0 109.564 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.484 ' HB ' HD12 ' A' ' 17' ' ' LEU . 96.3 t -79.21 132.95 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.739 0.816 . . . . 0.0 111.142 -171.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.03 140.82 31.6 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.452 0.701 . . . . 0.0 109.958 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 4.0 t -125.37 96.98 5.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.045 0.938 . . . . 0.0 110.255 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.1 102.67 9.48 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.362 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.169 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.513 HG23 ' HE3' ' A' ' 71' ' ' MET . 2.1 m . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 120.689 0.281 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 79.7 m-70 -118.82 178.06 4.62 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.491 1.116 . . . . 0.0 108.42 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 2' ' ' ARG . 1.3 tm? -146.31 114.18 6.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.6 mp -104.97 105.87 16.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.75 1.22 . . . . 0.0 109.224 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.681 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 78.2 mt-30 -84.17 -17.76 38.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.337 0.655 . . . . 0.0 111.067 172.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.62 24.64 4.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.484 HD12 ' HB ' ' A' ' 3' ' ' VAL . 87.0 mt -110.33 123.95 50.78 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.728 0.811 . . . . 0.0 109.486 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.411 ' O ' HD11 ' A' ' 61' ' ' LEU . 25.9 m -113.67 171.43 7.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.546 1.138 . . . . 0.0 108.97 172.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -57.84 -41.66 82.8 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.002 0.429 . . . . 0.0 112.128 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -92.19 17.05 10.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.654 0.782 . . . . 0.0 112.076 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -68.19 122.41 18.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.212 0.605 . . . . 0.0 110.119 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -78.57 177.15 8.8 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.824 0.45 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tt -55.08 -50.82 68.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.148 0.979 . . . . 0.0 110.537 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -61.38 -30.36 70.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.421 -173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -80.55 -46.66 15.41 Favored 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 122.588 0.355 . . . . 0.0 110.389 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.76 -68.31 0.35 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.92 0.888 . . . . 0.0 110.594 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -66.87 -20.65 65.96 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.07 0.548 . . . . 0.0 111.519 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.13 -38.14 59.48 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.885 0.741 . . . . 0.0 112.328 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -74.05 -39.55 63.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.127 0.571 . . . . 0.0 109.6 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.8 mt -57.46 -40.64 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.558 0.743 . . . . 0.0 110.669 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.83 -24.39 67.74 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.055 0.942 . . . . 0.0 111.844 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.51 -32.35 15.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.858 0.863 . . . . 0.0 111.786 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.6 mm -79.94 -65.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.395 1.078 . . . . 0.0 110.283 -174.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.459 HG22 HG12 ' A' ' 36' ' ' ILE . 10.1 t -99.45 -15.93 18.54 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.407 0.683 . . . . 0.0 111.3 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.32 82.97 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.202 -0.777 . . . . 0.0 114.338 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.459 HG12 HG22 ' A' ' 34' ' ' THR . 13.7 mm -78.76 119.56 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.169 0.984 . . . . 0.0 108.348 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.11 142.52 85.64 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 124.235 0.96 . . . . 0.0 111.24 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.73 -27.67 72.09 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.406 2.737 . . . . 0.0 113.256 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.42 27.04 14.8 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.119 0.39 . . . . 0.0 112.589 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.6 m -142.14 7.66 1.81 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.482 1.113 . . . . 0.0 109.698 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -148.71 149.16 30.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.946 0.898 . . . . 0.0 109.983 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.23 -175.31 3.53 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.312 1.045 . . . . 0.0 108.973 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.518 HG23 ' HD2' ' A' ' 65' ' ' PRO . 49.2 mm -104.49 109.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.27 0.628 . . . . 0.0 109.616 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 34.8 mt -122.04 151.79 40.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 49' ' ' PRO . 17.1 m -132.39 173.72 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.48 0.712 . . . . 0.0 110.907 -174.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.4 -49.01 66.32 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.874 0.734 . . . . 0.0 113.835 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -79.47 158.11 74.18 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.644 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -46.24 104.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.485 2.79 . . . . 0.0 114.624 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HB3' HG21 ' A' ' 45' ' ' VAL . 98.6 Cg_endo -82.81 156.88 15.77 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.886 2.391 . . . . 0.0 112.808 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -75.75 -22.52 56.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.6 0.76 . . . . 0.0 112.147 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.2 m 65.92 35.93 6.25 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.369 1.068 . . . . 0.0 109.014 -171.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -39.59 140.93 0.44 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.922 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.31 106.74 16.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.463 0.705 . . . . 0.0 110.209 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.5 mp -86.05 96.79 9.98 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.514 0.726 . . . . 0.0 109.429 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -109.1 -39.73 5.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.87 0.868 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.63 145.24 41.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.389 0.676 . . . . 0.0 110.693 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.57 -20.67 15.58 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.093 0.957 . . . . 0.0 110.551 -177.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.45 -19.52 49.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.326 1.05 . . . . 0.0 111.251 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 tt -57.71 126.13 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.667 0.787 . . . . 0.0 111.46 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -106.34 175.9 5.34 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.095 0.958 . . . . 0.0 111.104 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 21.1 mt -74.1 -1.07 18.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.8 0.84 . . . . 0.0 111.473 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.92 -39.04 64.65 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.818 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.54 -48.53 6.81 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 96.1 mt -59.77 139.23 90.07 Favored Pre-proline 0 CA--C 1.558 1.266 0 O-C-N 123.871 0.732 . . . . 0.0 110.36 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.518 ' HD2' HG23 ' A' ' 43' ' ' ILE . 6.3 Cg_exo -79.2 45.1 1.84 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.436 2.757 . . . . 0.0 113.385 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.491 ' HA ' HD22 ' A' ' 72' ' ' LEU . 2.1 mp -93.41 119.5 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 171.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 36.2 mm-40 -116.47 166.79 11.68 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.027 0.531 . . . . 0.0 109.573 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 p -64.59 109.92 2.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.29 0.636 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 78.57 10.15 86.44 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.11 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.1 t70 -76.65 159.18 30.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.24 0.616 . . . . 0.0 111.353 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.515 ' HA ' ' HE1' ' A' ' 71' ' ' MET . 2.9 tpt -86.08 101.88 13.35 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.454 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 66' ' ' ILE . 4.6 mm? -102.04 113.18 26.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.267 1.027 . . . . 0.0 108.883 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.9 mp -88.48 99.89 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.67 105.77 5.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.844 170.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.4 149.85 36.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.366 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -110.2 105.02 13.93 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 CA--C 1.567 1.63 0 C-N-CA 123.66 0.784 . . . . 0.0 110.349 172.506 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 9.0 m0 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.431 ' HB3' HD13 ' A' ' 13' ' ' LEU . 54.2 mtt180 -87.22 74.11 9.6 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 66' ' ' ILE . 34.7 t -87.21 138.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.672 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -89.54 158.2 17.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.573 0.749 . . . . 0.0 110.519 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 28.1 p -142.97 114.57 8.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.214 0.606 . . . . 0.0 109.627 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -79.02 109.61 13.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.57 0 C-N-CA 122.977 0.511 . . . . 0.0 110.313 -174.095 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.607 HG22 ' HE2' ' A' ' 71' ' ' MET . 11.3 m . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 32.4 m80 -94.59 160.73 14.5 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.1 -174.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 2' ' ' ARG . 2.7 tm? -119.14 115.3 23.96 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.561 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -98.79 132.45 44.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 109.207 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.46 173.03 12.02 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.05 12.47 76.64 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 1' ' ' TRP . 98.5 mt -83.54 115.38 22.07 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.369 0.668 . . . . 0.0 109.491 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.3 t -79.23 173.75 12.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.484 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.1 p -64.09 -35.62 81.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.996 0.427 . . . . 0.0 110.595 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -104.72 33.46 3.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.07 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.426 HG23 HD23 ' A' ' 17' ' ' LEU . 74.6 m -69.26 113.01 6.21 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 171.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -77.52 178.28 7.37 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.349 1.059 . . . . 0.0 111.234 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 54' ' ' LEU . 8.4 tt -57.16 -54.9 41.55 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.436 0.695 . . . . 0.0 110.228 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -14.43 63.04 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.231 -174.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.36 -49.41 8.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.611 0.764 . . . . 0.0 109.24 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.425 HD13 HD13 ' A' ' 43' ' ' ILE . 2.4 tm? -75.51 -64.55 1.05 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.668 1.187 . . . . 0.0 110.464 -170.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.8 -20.17 64.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.23 0.612 . . . . 0.0 111.083 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.24 -43.76 88.08 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 124.011 0.82 . . . . 0.0 111.902 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.75 -36.24 67.66 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 119.509 -0.282 . . . . 0.0 110.268 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.92 -44.47 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.268 0.627 . . . . 0.0 110.343 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.74 66.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.167 0.987 . . . . 0.0 112.116 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.57 -40.01 12.9 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.317 0.647 . . . . 0.0 111.605 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.561 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.8 mm -69.13 -65.97 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.227 1.011 . . . . 0.0 110.629 -173.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.432 HG23 HG12 ' A' ' 36' ' ' ILE . 5.0 t -99.85 -11.87 20.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.291 -175.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.07 86.1 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.499 -0.612 . . . . 0.0 114.122 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.432 HG12 HG23 ' A' ' 34' ' ' THR . 13.3 mm -83.37 118.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.52 146.44 73.04 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.798 0.839 . . . . 0.0 111.474 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.43 -30.86 92.75 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.165 2.577 . . . . 0.0 112.419 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.64 32.55 5.24 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.531 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -141.86 2.12 1.53 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 110.163 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -148.96 163.63 36.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.897 0.879 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 176.03 10.64 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.393 0.677 . . . . 0.0 110.042 173.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.425 HD13 HD13 ' A' ' 26' ' ' LEU . 44.7 mm -84.05 113.8 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 17.7 mt -132.43 123.63 27.06 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.43 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 16.3 m -102.78 173.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.975 0.51 . . . . 0.0 112.197 -169.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -46.42 93.78 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 124.353 1.033 . . . . 0.0 114.235 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -79.34 158.3 74.25 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 117.959 -1.019 . . . . 0.0 108.912 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.95 107.1 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.403 2.736 . . . . 0.0 113.628 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 63.1 Cg_endo -77.31 155.86 32.8 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.509 2.139 . . . . 0.0 112.179 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -94.78 34.33 1.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.646 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 62.8 m 75.66 -54.3 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.773 1.629 . . . . 0.0 110.726 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.5 mt 68.01 90.96 0.09 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.869 1.267 . . . . 0.0 110.682 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.22 101.14 13.86 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.801 0.84 . . . . 0.0 110.252 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.572 ' HB3' HD11 ' A' ' 23' ' ' LEU . 6.1 mp -78.05 99.41 6.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -124.87 39.24 4.02 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.186 0.594 . . . . 0.0 111.009 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 59' ' ' ILE . 28.1 t70 -163.59 146.01 9.73 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.591 0.756 . . . . 0.0 109.856 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -76.66 -31.66 57.46 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.953 0.501 . . . . 0.0 111.394 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.65 -3.92 54.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.717 0.807 . . . . 0.0 112.286 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 56' ' ' ASP . 10.7 tt -64.08 123.62 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.108 0.48 . . . . 0.0 110.485 -176.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.7 p -101.89 176.62 5.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -166.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 mt -69.23 -12.19 61.46 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.621 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.97 -22.0 69.77 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.77 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.49 -53.07 3.88 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.84 150.47 92.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.57 43.53 1.51 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.98 2.453 . . . . 0.0 114.661 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.556 HG13 HD23 ' A' ' 72' ' ' LEU . 2.6 mp -73.0 119.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 38.1 mt-30 -118.64 157.24 27.79 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 p -64.02 103.67 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.435 0.694 . . . . 0.0 111.442 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.41 21.97 57.42 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.967 -0.561 . . . . 0.0 113.402 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 9.8 t70 -79.76 160.9 26.02 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.856 0.463 . . . . 0.0 110.294 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.607 ' HE2' HG22 ' A' ' 11' ' ' THR . 1.8 tpt -91.16 98.79 11.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.714 0.805 . . . . 0.0 109.56 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.556 HD23 HG13 ' A' ' 66' ' ' ILE . 6.7 mp -93.83 104.71 16.77 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.8 mp -72.12 90.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -84.24 95.63 4.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.686 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -77.99 153.23 32.61 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.174 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -104.96 99.25 8.87 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 CA--C 1.558 1.28 0 C-N-CA 123.89 0.876 . . . . 0.0 109.846 171.634 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 16.3 m0 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.585 0.231 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.506 ' HB3' HD23 ' A' ' 13' ' ' LEU . 75.4 mtt180 -108.47 71.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.067 0.947 . . . . 0.0 108.684 173.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.426 HG11 HG22 ' A' ' 66' ' ' ILE . 71.7 t -79.09 123.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.642 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -81.79 141.49 33.44 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.538 ' SG ' HD12 ' A' ' 14' ' ' LEU . 92.3 m -135.54 105.67 6.3 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.715 0.406 . . . . 0.0 111.19 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -79.84 98.41 7.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 109.981 -175.776 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.47 HG23 ' HE3' ' A' ' 71' ' ' MET . 4.5 m . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -109.69 176.25 5.14 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.777 0.831 . . . . 0.0 109.76 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 2' ' ' ARG . 10.4 tt -151.19 116.06 5.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.635 ' HG ' HG13 ' A' ' 33' ' ' ILE . 7.3 mp -90.63 131.02 36.58 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.811 1.244 . . . . 0.0 109.607 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -92.09 164.44 13.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.578 0.751 . . . . 0.0 110.571 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.97 -97.19 1.62 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-O 118.833 -0.982 . . . . 0.0 111.225 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.551 HD13 HD13 ' A' ' 61' ' ' LEU . 4.1 mm? 42.16 104.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.567 1.547 . . . . 0.0 113.217 -175.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.9 t -73.18 154.2 40.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -62.71 -21.97 66.16 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 121.222 0.534 . . . . 0.0 110.674 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 74.1 mtt180 -110.01 29.99 7.13 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.289 1.036 . . . . 0.0 111.522 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.8 m -66.57 112.0 3.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -65.79 163.43 16.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.307 1.043 . . . . 0.0 110.969 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.481 HD11 HD21 ' A' ' 54' ' ' LEU . 23.5 tp -53.55 -52.2 60.45 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.07 0.948 . . . . 0.0 111.697 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 ptt85 -60.02 -24.1 64.23 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.159 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.26 -38.02 14.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.533 0.733 . . . . 0.0 110.058 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -66.09 0.64 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.534 1.134 . . . . 0.0 110.091 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.81 -17.41 64.51 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.458 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.47 -37.26 85.37 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.687 0.617 . . . . 0.0 112.076 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -75.63 -40.45 56.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.243 0.617 . . . . 0.0 110.419 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HB ' HE22 ' A' ' 41' ' ' GLN . 82.1 mt -61.78 -35.83 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.537 0.735 . . . . 0.0 110.926 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -24.99 66.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.128 0.971 . . . . 0.0 112.009 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.01 -42.83 9.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.976 0.911 . . . . 0.0 111.161 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.635 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.1 mm -66.11 -50.69 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 112.011 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.518 HG22 HG12 ' A' ' 36' ' ' ILE . 7.2 t -124.04 -1.32 8.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.122 0.569 . . . . 0.0 111.377 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 -0.23 89.56 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 34' ' ' THR . 11.4 mm -82.54 103.78 10.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.76 152.53 67.95 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.951 0.9 . . . . 0.0 111.426 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.84 -38.51 57.6 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.76 2.974 . . . . 0.0 114.547 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.25 30.45 5.95 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.44 -0.346 . . . . 0.0 113.325 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -132.42 -3.47 3.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.063 0.945 . . . . 0.0 110.09 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.408 HE22 ' HB ' ' A' ' 30' ' ' ILE . 1.5 pt20 -140.19 163.75 31.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.594 0.758 . . . . 0.0 111.376 -171.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -147.97 170.94 16.62 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.767 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.424 HG23 HD11 ' A' ' 72' ' ' LEU . 49.2 mm -96.61 110.24 24.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.443 -175.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 mt -123.8 159.18 30.09 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.718 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.11 -179.21 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.216 1.007 . . . . 0.0 110.27 -171.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.36 -46.15 65.31 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.934 0.771 . . . . 0.0 113.205 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -74.87 162.15 74.69 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.404 171.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.17 108.63 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.941 2.427 . . . . 0.0 111.867 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.25 172.81 15.29 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.186 2.591 . . . . 0.0 111.979 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.25 -2.12 57.7 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.495 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.6 m 51.28 65.13 1.58 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 124.119 0.968 . . . . 0.0 109.11 -172.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 mp -67.32 134.04 50.8 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.792 -165.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.35 88.19 5.04 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.481 HD21 HD11 ' A' ' 23' ' ' LEU . 5.5 mp -77.43 88.3 3.8 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 p -97.11 -49.16 5.1 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.999 0.92 . . . . 0.0 110.867 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.39 123.63 24.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.999 0.92 . . . . 0.0 110.255 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.56 -20.49 59.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.997 0.519 . . . . 0.0 112.31 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -89.67 -8.24 52.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.968 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.7 tt -64.11 123.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 121.404 0.621 . . . . 0.0 110.32 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 64.8 p -97.34 175.19 6.35 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.469 -170.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.551 HD13 HD13 ' A' ' 17' ' ' LEU . 23.4 mt -69.76 -13.81 62.47 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.55 173.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.15 -29.45 72.9 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.736 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -93.88 -60.75 1.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.55 143.36 86.33 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.715 1.206 . . . . 0.0 111.238 -174.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.13 39.65 0.84 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.552 2.834 . . . . 0.0 114.429 -173.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.519 HG13 ' HG ' ' A' ' 72' ' ' LEU . 3.1 mp -87.26 120.56 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 172.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.414 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 24.1 mm-40 -119.97 159.28 25.01 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.821 0.848 . . . . 0.0 110.213 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.6 p -68.23 112.05 4.91 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.509 0.723 . . . . 0.0 110.853 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.99 12.82 82.17 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.639 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 20.2 t70 -86.17 160.52 19.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.697 0.799 . . . . 0.0 109.798 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.47 ' HE3' HG23 ' A' ' 11' ' ' THR . 0.8 OUTLIER -95.77 97.59 9.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.017 0.927 . . . . 0.0 110.355 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.519 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.1 mm? -96.55 113.58 25.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.521 0.728 . . . . 0.0 109.622 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.2 mp -78.76 103.2 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.3 t -82.29 104.52 11.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.344 171.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.69 159.71 28.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.294 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -124.49 124.84 43.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 123.488 0.715 . . . . 0.0 111.174 178.384 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . 0.416 ' HB3' HG22 ' A' ' 3' ' ' VAL . 13.2 m0 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.455 ' HG3' HD12 ' A' ' 13' ' ' LEU . 11.0 mpt_? -79.75 67.37 5.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.704 0.802 . . . . 0.0 109.742 173.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG22 ' HB3' ' A' ' 1' ' ' TRP . 72.1 t -77.39 119.95 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.75 0.42 . . . . 0.0 109.875 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -93.99 128.38 40.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 95.8 m -117.79 111.3 18.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.372 0.669 . . . . 0.0 110.402 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -75.41 127.45 33.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.718 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 0.0 109.785 175.32 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.527 HG23 ' HE3' ' A' ' 71' ' ' MET . 15.9 m . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -92.51 142.6 27.23 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.858 0.863 . . . . 0.0 108.805 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.455 HD12 ' HG3' ' A' ' 2' ' ' ARG . 2.7 tm? -103.3 105.21 15.43 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.538 ' HG ' HG13 ' A' ' 33' ' ' ILE . 8.2 mp -86.93 139.03 31.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.339 0.655 . . . . 0.0 110.918 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.31 164.2 16.02 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.867 1.267 . . . . 0.0 109.675 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.89 79.53 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.321 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 61' ' ' LEU . 3.6 mm? -82.61 108.32 15.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 61' ' ' LEU . 44.4 t -84.7 170.03 13.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.852 168.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -69.1 -22.59 63.97 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.162 0.506 . . . . 0.0 111.054 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -111.6 23.26 14.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.293 1.037 . . . . 0.0 111.75 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.7 m -63.34 108.35 1.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -69.99 172.07 8.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.096 0.958 . . . . 0.0 111.689 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.6 tp -50.64 -55.82 14.66 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.276 1.031 . . . . 0.0 111.574 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.1 ptm180 -49.51 -37.47 26.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.612 1.165 . . . . 0.0 113.353 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 10.8 mm-40 -85.81 -35.97 20.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.288 0.635 . . . . 0.0 110.962 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.66 -66.07 0.79 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.065 0.946 . . . . 0.0 109.033 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -67.46 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.272 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.96 89.58 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.032 0.833 . . . . 0.0 111.959 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -72.95 -45.06 60.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.32 -39.49 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.44 0.696 . . . . 0.0 111.116 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.49 67.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.65 0.78 . . . . 0.0 111.678 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.3 14.83 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.545 0.738 . . . . 0.0 111.351 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.538 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.2 mm -76.46 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.342 1.057 . . . . 0.0 110.914 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.49 HG21 HG12 ' A' ' 36' ' ' ILE . 7.5 t -102.09 -9.96 20.1 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 0.0 111.019 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.65 69.76 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 119.783 -0.454 . . . . 0.0 114.034 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.49 HG12 HG21 ' A' ' 34' ' ' THR . 21.2 mm -90.44 127.73 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.67 138.83 61.41 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.782 0.833 . . . . 0.0 110.676 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 -39.31 83.77 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.559 2.839 . . . . 0.0 113.342 -174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.78 22.08 26.75 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.737 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -124.83 -5.14 7.51 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.234 1.014 . . . . 0.0 109.902 174.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.558 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 1.3 pp0? -130.23 143.77 50.97 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 124.201 1.0 . . . . 0.0 109.236 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -135.05 179.12 6.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.728 0.811 . . . . 0.0 109.341 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.499 HD12 HD12 ' A' ' 66' ' ' ILE . 45.9 mm -94.47 92.46 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 121.995 0.903 . . . . 0.0 109.077 -174.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.4 mt -110.09 149.33 30.2 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 65' ' ' PRO . 9.4 m -134.02 179.73 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.113 0.565 . . . . 0.0 111.371 -167.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.02 11.01 8.27 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.333 -0.848 . . . . 0.0 114.736 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -144.33 160.72 47.59 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.162 1.385 . . . . 0.0 108.042 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -39.55 109.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.713 2.942 . . . . 0.0 113.99 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -80.68 -171.93 1.38 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.368 2.712 . . . . 0.0 112.172 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -122.73 15.23 10.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.65 0.78 . . . . 0.0 110.735 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.5 m 55.5 73.26 0.43 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.042 0.937 . . . . 0.0 109.474 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.71 108.87 8.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.886 -171.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -97.42 126.65 42.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.297 1.039 . . . . 0.0 108.205 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 mp -100.24 78.98 2.1 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 m -75.05 -28.51 60.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.294 0.638 . . . . 0.0 110.796 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.65 152.65 31.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.453 0.471 . . . . 0.0 109.773 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -103.46 -29.21 11.32 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.444 0.698 . . . . 0.0 111.641 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -89.62 -11.82 41.49 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.494 0.718 . . . . 0.0 110.753 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.62 134.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 111.695 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.0 p -117.48 179.07 4.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 111.39 -169.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 17' ' ' LEU . 40.3 mt -68.49 -13.44 62.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.634 0.774 . . . . 0.0 111.572 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.17 80.03 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.336 0.398 . . . . 0.0 112.396 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -84.74 -55.86 3.88 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.126 0.57 . . . . 0.0 109.534 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.24 152.0 92.33 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.434 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.526 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.2 Cg_exo -69.09 21.65 0.15 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.811 3.007 . . . . 0.0 115.488 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.499 HD12 HD12 ' A' ' 43' ' ' ILE . 3.2 mp -73.92 116.62 16.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 172.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -118.75 173.92 6.58 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -71.16 101.67 2.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.16 0.584 . . . . 0.0 109.943 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 89.03 20.42 46.44 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.176 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.33 162.28 25.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.037 0.535 . . . . 0.0 111.007 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.527 ' HE3' HG23 ' A' ' 11' ' ' THR . 3.6 tpt -102.85 104.73 15.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.947 0.899 . . . . 0.0 109.696 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.13 112.16 25.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.044 0.937 . . . . 0.0 108.992 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.82 97.88 4.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.24 104.98 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.155 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.558 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 8.0 pt-20 -76.44 167.55 21.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.854 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.27 103.99 5.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 CA--C 1.551 0.989 0 C-N-CA 123.391 0.676 . . . . 0.0 110.507 173.673 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . 0.445 ' HB3' HG23 ' A' ' 3' ' ' VAL . 14.1 m0 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.511 ' HG2' HE22 ' A' ' 15' ' ' GLN . 82.1 mtt85 -79.19 69.76 5.45 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.381 0.673 . . . . 0.0 109.513 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 1' ' ' TRP . 89.6 t -83.94 129.64 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.346 0.658 . . . . 0.0 110.084 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -88.59 141.1 28.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.36 0.664 . . . . 0.0 109.209 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.1 m -138.33 101.34 4.36 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.332 0.653 . . . . 0.0 110.526 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -73.3 112.56 9.48 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.982 0.913 . . . . 0.0 109.734 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 123.394 0.677 . . . . 0.0 110.23 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.473 HG21 ' HE3' ' A' ' 71' ' ' MET . 3.9 m . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -89.6 115.29 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.772 0.829 . . . . 0.0 109.636 -174.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.85 104.16 14.56 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.809 0.444 . . . . 0.0 110.548 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.63 127.91 34.08 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 111.076 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.511 HE22 ' HG2' ' A' ' 2' ' ' ARG . 32.3 mm-40 -113.3 176.22 5.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.781 1.233 . . . . 0.0 110.103 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.28 3.45 61.52 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.5 mt -84.42 129.38 34.87 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 123.804 0.842 . . . . 0.0 111.065 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.433 ' O ' HD12 ' A' ' 61' ' ' LEU . 17.8 m -108.37 -176.56 3.08 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.374 168.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.7 p -66.2 -29.58 69.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.058 0.456 . . . . 0.0 110.69 171.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.98 23.41 8.99 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.88 0.872 . . . . 0.0 112.713 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.3 m -80.51 130.38 35.1 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 82.2 mtm180 -98.83 177.76 5.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.731 0.812 . . . . 0.0 110.384 -174.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 57' ' ' ARG . 5.4 tt -48.16 -59.53 3.33 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.181 1.392 . . . . 0.0 110.717 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 9.3 ptp180 -61.66 -26.8 68.24 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.637 -173.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 46.9 mt-10 -91.55 -30.04 16.62 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.979 0.912 . . . . 0.0 110.459 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.82 -67.24 0.78 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.749 0.82 . . . . 0.0 109.197 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.4 -16.26 63.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.777 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.45 -39.56 56.48 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.524 0.515 . . . . 0.0 111.929 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -73.83 -35.94 64.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.098 0.559 . . . . 0.0 110.284 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.12 -44.14 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.339 0.656 . . . . 0.0 109.704 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.04 68.07 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.775 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.42 -29.12 23.11 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.61 0.764 . . . . 0.0 111.856 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.1 mt -89.19 -69.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 117.878 0.308 . . . . 0.0 111.069 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 36' ' ' ILE . 9.5 t -88.43 -5.48 58.24 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.95 6.55 87.36 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.303 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.539 HG12 HG21 ' A' ' 34' ' ' THR . 11.7 mm -82.61 107.71 14.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.55 145.41 49.6 Favored Pre-proline 0 N--CA 1.48 1.058 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.539 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -54.28 -32.05 69.62 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.474 2.783 . . . . 0.0 113.658 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.86 24.67 19.91 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 116.4 -0.364 . . . . 0.0 113.544 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 m -131.96 4.66 4.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.527 1.131 . . . . 0.0 109.863 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -137.09 149.48 47.4 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.506 1.122 . . . . 0.0 109.347 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -120.19 -166.16 1.27 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 72' ' ' LEU . 41.1 mm -123.31 105.7 16.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 4.3 mp -121.14 172.39 8.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.081 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 2.7 m -139.85 162.02 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 109.869 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.8 87.86 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 124.325 1.016 . . . . 0.0 113.368 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -72.6 155.41 91.03 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 117.756 -1.116 . . . . 0.0 109.597 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -33.61 100.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.397 3.116 0 C-N-CA 124.821 3.681 . . . . 0.0 114.763 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 99.0 Cg_endo -81.26 158.7 20.08 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.683 2.256 . . . . 0.0 113.421 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 30.5 mm-40 -101.14 90.34 4.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.0 m -47.79 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.636 1.174 . . . . 0.0 111.543 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.459 HD12 ' HB ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -99.44 167.53 10.56 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 111.805 179.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.06 144.51 40.07 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.75 93.22 4.78 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -85.47 -47.65 9.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.181 0.592 . . . . 0.0 110.239 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 12.8 t70 -73.25 107.3 5.48 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 -174.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.463 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.53 -24.58 32.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.93 -7.06 41.08 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.94 0.896 . . . . 0.0 112.272 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 tt -63.39 136.83 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.021 0.528 . . . . 0.0 111.146 -174.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 10.0 m -109.9 168.01 9.74 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.503 0.721 . . . . 0.0 111.601 -164.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 18' ' ' SER . 32.7 mt -59.55 -25.35 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.484 1.114 . . . . 0.0 112.895 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.63 -29.33 74.9 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.422 0.451 . . . . 0.0 112.881 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.57 -45.93 12.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.703 0.801 . . . . 0.0 109.87 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.98 160.04 72.15 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.698 0.799 . . . . 0.0 111.56 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.6 37.32 0.5 Allowed 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.294 2.662 . . . . 0.0 114.403 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.4 ' HA ' HD23 ' A' ' 72' ' ' LEU . 3.1 mp -88.28 114.13 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 29.5 mm-40 -118.4 158.48 25.21 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 p -67.46 109.48 3.22 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.506 0.722 . . . . 0.0 111.018 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 88.96 -1.55 83.32 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 21.8 t70 -73.67 159.27 33.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.556 0.742 . . . . 0.0 111.339 -172.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.487 ' HA ' ' HE1' ' A' ' 71' ' ' MET . 4.6 tpt -91.31 102.25 14.96 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.703 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.48 HD13 HG23 ' A' ' 43' ' ' ILE . 4.0 mm? -100.57 135.81 41.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.489 1.116 . . . . 0.0 108.314 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.9 mp -100.58 113.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 54.7 t -94.08 109.51 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.73 172.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.01 159.66 22.14 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 175.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -117.39 119.0 33.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 122.974 0.51 . . . . 0.0 110.911 178.881 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 33.4 m0 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.482 ' HB3' HD11 ' A' ' 13' ' ' LEU . 71.0 mtm180 -82.85 85.01 7.18 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.0 t -98.23 146.16 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.766 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HG2' HD23 ' A' ' 13' ' ' LEU . 95.8 mtt180 -88.79 150.84 22.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.592 0.757 . . . . 0.0 110.891 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 27.3 p -125.9 128.17 47.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.467 1.107 . . . . 0.0 108.925 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.2 tppp? -102.3 110.97 23.08 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.019 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.547 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.741 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.441 HG23 ' HE3' ' A' ' 71' ' ' MET . 19.5 m . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 74.3 m80 -108.99 162.74 13.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.587 0.755 . . . . 0.0 109.695 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 2' ' ' ARG . 3.2 tm? -120.92 116.78 25.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.459 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.3 mp -87.74 160.64 17.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.432 0.693 . . . . 0.0 110.98 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -134.91 168.5 18.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.829 1.251 . . . . 0.0 108.273 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.05 82.21 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.014 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 94.3 mt -90.05 118.6 29.72 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.806 0.442 . . . . 0.0 110.072 178.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 t -86.4 174.79 8.77 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.478 1.111 . . . . 0.0 109.803 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.6 p -69.27 -29.63 67.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.265 0.626 . . . . 0.0 110.576 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 33.72 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.311 0.645 . . . . 0.0 112.285 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HG ' ' A' ' 61' ' ' LEU . 30.6 m -66.89 118.16 9.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -66.76 164.0 18.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.827 0.451 . . . . 0.0 110.763 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.475 HD21 ' HA ' ' A' ' 57' ' ' ARG . 6.0 tt -50.32 -53.58 27.7 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.73 1.212 . . . . 0.0 110.74 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -16.87 63.64 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.374 -173.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -84.3 -45.76 12.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.851 0.86 . . . . 0.0 109.432 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.519 ' HG ' HD21 ' A' ' 61' ' ' LEU . 1.6 tm? -69.02 -62.42 1.38 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.156 1.383 . . . . 0.0 110.766 -173.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -63.72 -22.43 66.9 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.753 0.658 . . . . 0.0 111.323 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.89 -38.43 94.25 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 124.015 0.822 . . . . 0.0 112.464 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -73.44 -42.6 61.8 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -61.41 -35.9 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.514 0.726 . . . . 0.0 111.271 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.36 67.42 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.894 0.877 . . . . 0.0 111.587 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.96 -35.97 11.77 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.136 0.974 . . . . 0.0 111.638 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.459 HG13 ' HG ' ' A' ' 14' ' ' LEU . 19.0 mm -76.01 -52.2 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.781 1.232 . . . . 0.0 111.648 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.544 HG23 HG12 ' A' ' 36' ' ' ILE . 7.9 t -115.33 -7.36 12.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.162 0.585 . . . . 0.0 110.717 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 21.36 63.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.57 -0.572 . . . . 0.0 114.073 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.544 HG12 HG23 ' A' ' 34' ' ' THR . 25.1 mm -95.03 124.81 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.679 0.739 . . . . 0.0 109.906 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.97 139.08 87.45 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 123.876 0.87 . . . . 0.0 110.813 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.41 -22.07 48.29 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.726 2.951 . . . . 0.0 114.095 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.45 29.95 11.25 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.823 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.5 m -135.53 -35.75 0.8 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.578 1.151 . . . . 0.0 109.054 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -85.9 142.85 28.56 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.935 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -130.99 170.34 14.61 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 125.234 1.414 . . . . 0.0 107.674 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 64' ' ' LEU . 44.2 mm -95.95 105.5 17.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 122.082 0.944 . . . . 0.0 109.875 -173.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.6 mt -113.95 155.02 26.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 113.477 -1.692 . . . . 0.0 106.648 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.65 164.86 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 122.723 0.409 . . . . 0.0 109.942 -166.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.17 73.65 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 124.026 0.822 . . . . 0.0 114.193 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -74.96 151.99 86.48 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.147 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -39.66 101.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.812 3.008 . . . . 0.0 113.575 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.39 157.58 41.05 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.93 2.42 . . . . 0.0 112.486 -171.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.22 3.01 55.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.077 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.93 71.29 0.52 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.8 1.24 . . . . 0.0 110.642 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.73 124.69 28.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.656 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -90.46 108.03 19.53 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.385 1.074 . . . . 0.0 109.225 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 8.4 mp -79.75 95.08 5.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.662 0.785 . . . . 0.0 109.413 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.8 t -106.77 25.85 10.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.853 0.861 . . . . 0.0 110.116 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -126.05 -157.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.37 1.068 . . . . 0.0 108.749 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' HA ' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -147.95 -31.39 0.29 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.056 0.844 . . . . 0.0 111.293 173.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.82 -8.9 42.26 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.609 0.764 . . . . 0.0 111.996 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.64 121.72 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 123.337 0.655 . . . . 0.0 110.843 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -92.84 174.64 7.15 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 66' ' ' ILE . 25.0 mt -71.0 -11.34 60.92 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.692 0.797 . . . . 0.0 111.998 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.38 -27.08 72.11 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.293 0.371 . . . . 0.0 112.202 170.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -87.03 -47.81 8.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.486 0.714 . . . . 0.0 110.134 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.471 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.7 mm? -80.57 154.87 73.89 Favored Pre-proline 0 CA--C 1.556 1.19 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.743 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.93 40.97 1.0 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.188 2.592 . . . . 0.0 114.747 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.547 HG21 HD11 ' A' ' 61' ' ' LEU . 2.4 mp -76.77 122.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.8 mt-30 -118.43 156.95 28.11 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.8 p -63.39 110.93 2.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.566 0.746 . . . . 0.0 111.274 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.31 30.86 68.97 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.619 0.574 . . . . 0.0 113.481 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 5.9 t70 -84.69 172.53 11.46 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.488 ' HE1' ' HA ' ' A' ' 71' ' ' MET . 3.2 tpt -98.75 100.6 11.83 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' A' ' 66' ' ' ILE . 76.2 mt -91.41 143.19 26.87 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -105.67 102.07 13.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.93 106.12 11.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.01 151.72 37.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.523 0.678 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -122.08 146.81 46.84 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.802 -173.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 123.004 0.522 . . . . 0.0 110.445 178.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.4 m0 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.547 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 48.7 mtm180 -83.86 73.95 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.108 0.963 . . . . 0.0 109.141 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.91 136.17 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.375 0.67 . . . . 0.0 111.503 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -89.09 97.35 11.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.7 0.8 . . . . 0.0 110.17 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 t -81.17 100.05 8.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.778 0.831 . . . . 0.0 110.445 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -74.47 108.99 7.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.76 -172.81 3.9 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.127 0.571 . . . . 0.0 110.23 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -67.3 125.16 25.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.438 0.695 . . . . 0.0 110.556 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.25 -12.37 61.87 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.205 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.38 -159.09 16.03 Favored Glycine 0 C--N 1.345 1.071 0 C-N-CA 122.936 0.303 . . . . 0.0 112.484 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.4 p -71.17 146.8 48.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.047 0.939 . . . . 0.0 111.607 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -134.96 123.19 22.98 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.493 HD13 ' HB3' ' A' ' 2' ' ' ARG . 1.8 tm? -91.04 102.58 15.34 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -172.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.411 ' HG ' HG13 ' A' ' 33' ' ' ILE . 10.3 mp -92.23 107.03 18.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.45 0.7 . . . . 0.0 110.036 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.547 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 76.6 mt-30 -90.2 -177.13 5.06 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.716 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -19.47 22.09 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.329 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.93 114.92 10.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.462 0.705 . . . . 0.0 110.66 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.0 p -91.96 168.05 11.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.079 0.951 . . . . 0.0 109.163 170.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 p -59.26 -33.81 71.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.979 0.511 . . . . 0.0 111.753 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -101.13 24.67 9.09 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.402 0.681 . . . . 0.0 111.841 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 25' ' ' GLU . 73.1 m -72.33 127.4 32.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 74.3 mtm180 -79.77 169.16 18.35 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.176 0.59 . . . . 0.0 111.247 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 56' ' ' ASP . 7.5 tt -53.53 -54.33 38.83 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.179 1.392 . . . . 0.0 110.989 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -63.94 -26.04 68.41 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.219 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 14.0 mm-40 -77.08 -43.46 34.23 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.6 -66.79 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.726 1.21 . . . . 0.0 110.615 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.5 -21.29 65.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.314 0.645 . . . . 0.0 111.312 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.98 -41.95 70.16 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.848 0.717 . . . . 0.0 112.368 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -67.79 -39.69 84.02 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.6 mt -59.67 -39.8 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.652 0.781 . . . . 0.0 111.055 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.2 -24.63 67.74 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 111.788 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.16 -36.07 13.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.336 0.654 . . . . 0.0 111.713 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.411 HG13 ' HG ' ' A' ' 14' ' ' LEU . 12.6 mm -75.62 -68.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.933 0.893 . . . . 0.0 110.4 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.462 HG21 HG12 ' A' ' 36' ' ' ILE . 3.0 t -96.7 -7.2 34.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 6.85 87.95 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 114.01 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.462 HG12 HG21 ' A' ' 34' ' ' THR . 13.8 mm -84.52 114.57 25.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 144.75 64.36 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.584 0.754 . . . . 0.0 110.722 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -55.14 -21.44 27.87 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.651 2.901 . . . . 0.0 114.382 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.61 -20.2 51.98 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 113.778 0.271 . . . . 0.0 113.778 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.433 ' OG ' ' HB3' ' A' ' 80' ' ' ARG . 44.0 m -90.3 -16.5 29.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.18 0.592 . . . . 0.0 111.275 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.86 150.89 27.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.016 0.927 . . . . 0.0 110.568 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -130.17 145.87 51.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.679 1.192 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.501 HG13 HD23 ' A' ' 54' ' ' LEU . 45.6 mm -81.49 95.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.097 0.951 . . . . 0.0 108.872 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.68 139.39 51.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.039 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 47' ' ' TYR . 5.2 m -113.31 163.15 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.367 0.667 . . . . 0.0 110.21 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.18 -49.07 82.63 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.884 0.74 . . . . 0.0 113.267 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.417 ' O ' HG21 ' A' ' 45' ' ' VAL . 52.3 p90 -69.71 145.46 94.84 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.141 169.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.22 101.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 124.155 3.237 . . . . 0.0 115.592 -170.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.66 145.58 26.12 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.243 1.962 . . . . 0.0 111.096 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -91.67 15.88 11.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.286 0.635 . . . . 0.0 110.897 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.9 m 59.85 46.54 11.19 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.501 1.12 . . . . 0.0 110.369 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.93 130.03 42.07 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.299 -174.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.36 111.07 22.4 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.501 HD23 HG13 ' A' ' 43' ' ' ILE . 7.3 mp -72.7 87.9 1.27 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.279 1.031 . . . . 0.0 108.8 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 p -89.51 26.22 1.77 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.2 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.421 ' O ' HD13 ' A' ' 23' ' ' LEU . 10.3 t70 -145.67 -168.37 2.95 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 -29.16 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.63 0.772 . . . . 0.0 110.957 176.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.64 -8.0 51.2 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.876 1.27 . . . . 0.0 110.588 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.18 131.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.686 1.195 . . . . 0.0 111.414 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -96.33 168.63 10.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.662 0.785 . . . . 0.0 112.559 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.7 mt -69.69 -20.18 63.56 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.918 0.887 . . . . 0.0 111.552 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.94 73.18 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.434 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.07 -39.16 14.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.187 0.595 . . . . 0.0 109.816 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.3 mt -79.5 156.66 75.65 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 124.057 0.943 . . . . 0.0 111.438 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -72.94 18.51 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.767 2.978 . . . . 0.0 115.267 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.05 124.4 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.0 mt-30 -119.06 169.83 9.58 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.237 0.615 . . . . 0.0 109.845 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 p -68.47 96.46 0.69 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.336 0.654 . . . . 0.0 110.879 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.96 36.39 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.382 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.538 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 11.1 t70 -80.44 158.01 26.05 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.303 0.641 . . . . 0.0 110.689 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.88 97.93 10.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.57 0.748 . . . . 0.0 109.692 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.88 106.97 18.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.439 0.696 . . . . 0.0 109.44 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.31 93.28 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.845 0.858 . . . . 0.0 108.825 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.75 103.45 10.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.99 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' O ' HG21 ' A' ' 36' ' ' ILE . 11.4 pt-20 -78.75 170.09 17.21 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.203 174.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -129.61 106.99 9.11 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.109 0.964 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -80.17 -4.01 51.3 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.921 0.488 . . . . 0.0 111.478 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 78.66 -51.16 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 126.175 1.79 . . . . 0.0 112.196 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -71.92 99.6 2.26 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.234 1.016 . . . . 0.0 110.332 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.433 ' HB3' ' OG ' ' A' ' 40' ' ' SER . 12.6 ptt180 -149.44 156.56 39.4 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.344 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.27 89.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.076 2.517 . . . . 0.0 113.008 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -101.24 104.72 15.77 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.31 -9.11 1.72 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.783 0.833 . . . . 0.0 110.335 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.7 m -131.54 146.89 63.84 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.851 0.861 . . . . 0.0 110.315 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.01 -14.99 13.29 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.812 2.341 . . . . 0.0 112.209 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.309 1.043 . . . . 0.0 108.56 177.519 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.3 m0 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.404 ' HB3' HD12 ' A' ' 13' ' ' LEU . 44.7 mtp180 -83.29 83.29 7.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 109.452 174.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.491 ' HB ' HD13 ' A' ' 17' ' ' LEU . 69.1 t -100.34 141.94 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.923 0.889 . . . . 0.0 110.535 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.469 ' HB2' ' HA ' ' A' ' 71' ' ' MET . 41.1 mmt180 -81.57 135.97 35.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.916 0.886 . . . . 0.0 110.559 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 19.8 t -113.33 90.12 3.26 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -82.95 105.39 13.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.31 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.2 169.92 14.2 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.384 0.674 . . . . 0.0 110.436 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.569 ' HD3' ' HB3' ' A' ' 76' ' ' GLU . 11.0 ptmm? -71.71 -9.51 58.38 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.096 172.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.78 25.16 17.36 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.175 166.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.38 172.8 36.84 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 117.271 0.535 . . . . 0.0 113.17 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m -87.64 132.71 33.99 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 77.6 m-70 -123.2 173.74 7.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.623 0.769 . . . . 0.0 109.904 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.419 HD22 ' HD3' ' A' ' 4' ' ' ARG . 2.8 tm? -140.74 110.76 6.55 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -95.32 132.07 40.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.082 0.953 . . . . 0.0 108.52 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.405 HE21 HD11 ' A' ' 13' ' ' LEU . 15.0 mp0 -100.89 -32.91 10.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.104 0.561 . . . . 0.0 110.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.48 44.4 3.07 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.767 -0.651 . . . . 0.0 114.109 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.491 HD13 ' HB ' ' A' ' 3' ' ' VAL . 95.3 mt -114.52 115.2 26.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 124.134 0.974 . . . . 0.0 109.35 175.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.3 t -92.38 176.87 6.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.947 0.899 . . . . 0.0 109.475 172.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 p -60.63 -36.1 77.79 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.708 0.803 . . . . 0.0 111.858 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -116.35 48.09 1.32 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.388 0.675 . . . . 0.0 111.47 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.9 m -75.84 128.06 34.33 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.5 ' HG2' HG22 ' A' ' 60' ' ' THR . 61.6 mtm180 -92.14 -177.94 4.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 57' ' ' ARG . 5.9 tt -52.32 -56.91 11.68 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.087 0.955 . . . . 0.0 111.036 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.424 ' HG2' ' OE2' ' A' ' 25' ' ' GLU . 9.0 ptp180 -70.63 -19.58 62.81 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.594 0.559 . . . . 0.0 112.042 -164.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -93.49 -35.02 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.63 0.772 . . . . 0.0 110.976 173.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 HD11 HD12 ' A' ' 43' ' ' ILE . 2.0 tm? -71.29 -68.23 0.46 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.606 0.762 . . . . 0.0 111.419 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.35 -38.23 62.63 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.844 0.715 . . . . 0.0 112.341 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.441 ' O ' HG12 ' A' ' 33' ' ' ILE . 43.7 mt-30 -70.53 -44.52 67.34 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -55.41 -41.35 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.935 0.894 . . . . 0.0 111.476 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -25.18 68.19 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.34 -31.36 16.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.676 0.79 . . . . 0.0 111.395 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 29' ' ' GLN . 28.8 mm -79.11 -65.59 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.324 1.05 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.515 HG22 HG12 ' A' ' 36' ' ' ILE . 10.1 t -101.91 -11.74 18.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.75 0.82 . . . . 0.0 111.341 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 -18.6 56.78 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.727 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 34' ' ' THR . 18.3 mm -67.34 121.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.045 0.422 . . . . 0.0 111.205 -169.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.75 141.26 80.13 Favored Pre-proline 0 C--N 1.351 0.663 0 O-C-N 124.281 0.988 . . . . 0.0 110.648 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.05 -28.62 70.43 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.394 2.729 . . . . 0.0 112.35 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.91 16.51 54.93 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.369 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -125.13 -11.29 7.03 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 110.52 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -127.16 155.53 43.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.022 0.929 . . . . 0.0 110.369 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 168.47 19.63 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.238 1.015 . . . . 0.0 109.161 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.586 HG12 HD11 ' A' ' 54' ' ' LEU . 30.8 mm -80.26 105.0 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.423 1.106 . . . . 0.0 109.842 -172.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.93 148.08 44.56 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 112.776 -2.011 . . . . 0.0 106.981 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.408 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 1.6 m -132.25 161.96 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.75 . . . . 0.0 110.248 -172.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.64 -42.29 96.13 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.805 0.69 . . . . 0.0 113.238 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -77.7 158.1 78.75 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.264 168.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -39.65 107.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.095 3.196 . . . . 0.0 115.292 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 67.9 Cg_endo -86.04 158.55 10.05 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.84 8.38 41.32 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.9 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.1 m 56.5 68.77 0.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.185 0.994 . . . . 0.0 110.221 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.77 114.35 18.62 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.678 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.06 155.59 22.61 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.586 HD11 HG12 ' A' ' 43' ' ' ILE . 4.7 mp -122.6 91.71 3.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.7 p -82.34 -46.08 14.07 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.397 0.679 . . . . 0.0 110.67 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -78.13 131.63 37.32 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.788 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -70.57 -22.04 62.62 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.728 0.811 . . . . 0.0 112.091 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.29 -1.86 53.23 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.6 tt -64.01 124.09 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.389 0.676 . . . . 0.0 110.893 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.5 HG22 ' HG2' ' A' ' 22' ' ' ARG . 50.7 p -95.96 173.56 7.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.164 0.586 . . . . 0.0 112.398 -169.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 mt -68.99 -10.77 59.17 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.399 0.679 . . . . 0.0 111.136 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.39 -29.01 73.72 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 112.301 -0.32 . . . . 0.0 112.301 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -88.27 -49.63 6.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.276 0.63 . . . . 0.0 110.12 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.419 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.8 mm? -81.59 151.77 68.86 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.743 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HD2' HG21 ' A' ' 43' ' ' ILE . 97.9 Cg_endo -77.66 42.79 1.22 Allowed 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.761 2.974 . . . . 0.0 115.185 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 43' ' ' ILE . 2.3 mp -83.28 112.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -109.84 170.66 7.93 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.2 p -67.56 105.51 1.88 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.029 0.532 . . . . 0.0 111.013 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.23 62.73 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 113.358 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.28 161.35 27.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.775 0.83 . . . . 0.0 110.168 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' A' ' 4' ' ' ARG . 19.1 ttm -103.89 112.34 25.26 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.245 0.618 . . . . 0.0 109.783 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -101.05 114.45 28.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.574 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.78 96.13 3.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.548 HG22 ' HG ' ' A' ' 5' ' ' CYS . 70.5 t -78.69 101.58 4.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.082 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -80.32 155.82 27.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.499 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . 36.3 tt0 -109.61 111.91 23.68 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 169.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.14 -8.44 54.73 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.306 0.642 . . . . 0.0 111.037 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 69.17 40.15 1.59 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 124.89 1.276 . . . . 0.0 110.347 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -96.03 30.99 2.25 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.073 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 67.44 120.18 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 125.276 1.43 . . . . 0.0 110.866 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.47 129.1 29.67 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 122.605 2.203 . . . . 0.0 111.665 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt 61.54 101.77 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.03 1.332 . . . . 0.0 111.522 -170.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.23 28.98 5.43 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.041 0.936 . . . . 0.0 109.728 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.8 p -161.59 168.42 11.31 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 124.696 1.198 . . . . 0.0 109.69 -171.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -36.08 -35.73 0.18 Allowed 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 124.744 3.629 . . . . 0.0 114.895 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.253 1.286 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 164.886 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.475 ' HB3' HG22 ' A' ' 3' ' ' VAL . 22.0 m0 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -87.99 70.85 9.44 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.775 0.798 . . . . 0.0 109.102 169.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 1' ' ' TRP . 76.8 t -77.8 137.28 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.864 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -93.27 140.23 29.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.466 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 12.5 t -122.41 97.94 5.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.018 0.927 . . . . 0.0 111.053 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HE3' ' SD ' ' A' ' 71' ' ' MET . 4.6 tppp? -74.82 102.71 4.8 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.567 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -150.88 -172.56 4.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.081 0.552 . . . . 0.0 111.015 -173.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -58.1 114.43 2.36 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.158 0.983 . . . . 0.0 111.099 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.92 -8.57 25.47 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.911 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.05 -154.56 16.86 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.517 0.58 . . . . 0.0 111.954 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.596 HG21 ' HE3' ' A' ' 71' ' ' MET . 24.0 m -84.84 121.39 27.66 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.397 0.679 . . . . 0.0 109.845 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 91.2 m-70 -107.79 179.16 4.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.199 1.0 . . . . 0.0 109.517 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -144.01 122.8 12.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.2 mp -101.1 146.62 27.22 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.951 0.9 . . . . 0.0 110.394 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -118.39 165.27 14.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.137 1.375 . . . . 0.0 109.312 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.45 4.81 89.28 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.157 0.423 . . . . 0.0 114.157 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.48 130.84 35.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.465 0.65 . . . . 0.0 110.525 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -115.16 179.02 4.07 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.207 1.403 . . . . 0.0 109.159 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 p -72.72 -27.34 62.0 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.647 0.379 . . . . 0.0 111.158 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -108.61 25.95 11.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.735 0.814 . . . . 0.0 111.233 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 25' ' ' GLU . 7.3 m -66.0 127.66 32.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.077 0.551 . . . . 0.0 110.151 170.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -72.9 166.71 22.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.356 0.662 . . . . 0.0 111.183 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 54' ' ' LEU . 10.1 tt -61.2 -45.42 94.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.651 1.18 . . . . 0.0 110.618 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -61.53 -30.67 70.79 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.653 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.466 ' HB2' HG23 ' A' ' 21' ' ' THR . 6.3 mm-40 -79.88 -44.44 20.44 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 124.087 0.955 . . . . 0.0 109.534 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.56 -65.9 0.61 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.044 0.938 . . . . 0.0 109.718 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -64.42 -23.11 67.17 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.664 0.602 . . . . 0.0 111.509 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.21 -44.33 86.76 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 124.104 0.878 . . . . 0.0 111.695 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 23.7 mt-30 -67.92 -37.33 81.54 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.56 -42.03 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.493 0.717 . . . . 0.0 110.823 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -24.97 68.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.805 0.842 . . . . 0.0 111.705 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.4 -32.79 17.11 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.765 0.826 . . . . 0.0 111.571 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.464 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.8 mm -79.83 -69.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.517 HG21 HG12 ' A' ' 36' ' ' ILE . 9.2 t -98.76 -9.45 24.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.442 0.697 . . . . 0.0 111.488 -173.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.48 72.43 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.967 -0.352 . . . . 0.0 113.785 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 HG12 HG21 ' A' ' 34' ' ' THR . 24.9 mm -91.19 114.57 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.42 78.72 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.03 0.932 . . . . 0.0 111.023 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -53.76 -29.54 52.54 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.127 3.218 . . . . 0.0 114.572 -172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.96 -23.03 64.71 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.001 -0.333 . . . . 0.0 113.743 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -93.47 1.4 56.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.774 0.83 . . . . 0.0 111.562 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.45 169.14 13.96 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.032 0.933 . . . . 0.0 110.781 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.435 ' NH1' ' HB3' ' A' ' 51' ' ' CYS . 44.9 ttp180 -158.81 154.43 26.14 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.055 -169.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.521 HG12 HD21 ' A' ' 54' ' ' LEU . 37.4 mm -79.68 100.8 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 122.083 0.944 . . . . 0.0 109.674 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.4 mt -121.7 144.57 48.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.271 -1.786 . . . . 0.0 106.917 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 47' ' ' TYR . 2.6 m -125.88 164.31 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.493 0.717 . . . . 0.0 110.779 -172.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -36.08 92.75 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.78 0.675 . . . . 0.0 112.857 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' O ' HG22 ' A' ' 45' ' ' VAL . 46.4 p90 -81.72 156.2 70.48 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.177 167.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -43.09 108.36 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 124.227 3.285 . . . . 0.0 114.508 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -85.72 155.14 10.26 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.018 2.479 . . . . 0.0 112.624 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -89.81 6.82 40.04 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.994 0.518 . . . . 0.0 110.696 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.435 ' HB3' ' NH1' ' A' ' 42' ' ' ARG . 81.5 m 57.36 59.16 3.46 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.282 1.033 . . . . 0.0 110.123 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.84 144.34 52.91 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.46 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.45 138.8 31.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.208 0.603 . . . . 0.0 109.682 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 23' ' ' LEU . 7.0 mp -115.14 87.17 2.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.011 0.924 . . . . 0.0 108.74 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 m -111.03 19.81 18.09 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.81 0.844 . . . . 0.0 112.654 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -141.81 177.75 7.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -120.69 -40.53 2.64 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.496 0.718 . . . . 0.0 111.478 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.24 -16.0 34.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.936 0.894 . . . . 0.0 110.327 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.98 141.46 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.258 1.023 . . . . 0.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.6 p -111.75 -178.92 3.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 112.247 -166.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 mt -75.94 -4.73 42.62 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.178 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.25 -23.11 76.39 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 167.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -97.78 -59.09 1.84 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.428 0.691 . . . . 0.0 109.793 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.53 116.09 55.05 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.05 65.09 6.12 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.666 2.91 . . . . 0.0 113.816 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.492 HD12 HD13 ' A' ' 43' ' ' ILE . 1.9 mp -78.27 126.45 38.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 163.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.572 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 18.1 mt-30 -117.41 154.61 31.05 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.8 p -64.59 102.68 0.59 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.274 0.629 . . . . 0.0 111.363 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.59 16.19 66.67 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.411 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.572 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 10.5 t70 -80.08 160.92 25.61 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 123.489 0.716 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.596 ' HE3' HG21 ' A' ' 11' ' ' THR . 2.8 tpt -84.18 100.32 11.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.323 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.36 116.12 30.78 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.55 102.67 13.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 77.9 t -82.61 108.18 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.429 171.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.22 151.22 31.33 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.811 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -109.46 105.04 14.22 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 166.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.05 -20.33 66.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 0.0 110.525 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 68.58 12.18 8.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.953 1.301 . . . . 0.0 111.831 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -76.46 -45.33 31.7 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 54.64 107.6 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.546 1.538 . . . . 0.0 113.748 172.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.97 157.38 62.05 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.634 2.222 . . . . 0.0 111.447 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -76.99 81.18 3.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.05 155.54 9.9 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.542 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 p -154.56 92.49 2.93 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 123.766 0.826 . . . . 0.0 109.561 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.38 78.58 2.29 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.489 2.126 . . . . 0.0 110.433 172.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--O 1.25 1.09 0 C-N-CA 124.374 1.07 . . . . 0.0 109.504 -172.619 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 33.8 m0 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -103.0 160.4 14.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.875 0.87 . . . . 0.0 109.334 170.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.531 HG13 HD21 ' A' ' 72' ' ' LEU . 18.9 t -138.1 136.78 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.834 0.854 . . . . 0.0 109.709 171.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -104.8 95.58 5.97 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.7 p -84.14 102.35 12.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.909 0.484 . . . . 0.0 110.185 -175.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.75 99.03 7.26 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.68 102.35 8.0 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.25 0.62 . . . . 0.0 109.959 -174.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 60.32 26.55 16.07 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.37 1.068 . . . . 0.0 111.75 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.46 -34.08 6.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.172 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.69 99.0 1.32 Allowed Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -83.55 127.75 33.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.261 0.624 . . . . 0.0 109.654 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 96.5 m-70 -131.47 149.37 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.591 0.356 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.595 ' HB3' HE22 ' A' ' 15' ' ' GLN . 0.1 OUTLIER -98.76 113.47 25.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.207 0.603 . . . . 0.0 109.858 -173.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.488 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.8 mp -89.48 127.4 35.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.963 0.905 . . . . 0.0 109.033 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.595 HE22 ' HB3' ' A' ' 13' ' ' LEU . 26.2 mp0 -111.34 161.45 16.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 171.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 33.61 19.13 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.872 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.19 116.36 28.88 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -91.36 166.58 12.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.565 0.746 . . . . 0.0 109.606 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -64.81 -25.48 67.93 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 120.978 0.418 . . . . 0.0 111.705 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -92.7 3.2 56.05 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.779 0.832 . . . . 0.0 112.788 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.423 HG22 ' HB2' ' A' ' 26' ' ' LEU . 56.8 m -58.7 118.61 5.87 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.141 0.496 . . . . 0.0 110.812 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' A' ' 58' ' ' ASP . 81.8 mtm180 -87.21 -176.41 5.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.03 0.932 . . . . 0.0 111.478 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 54' ' ' LEU . 4.8 tt -54.89 -60.87 2.77 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.773 0.829 . . . . 0.0 109.045 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -55.91 -24.56 38.32 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.345 -1.298 . . . . 0.0 113.413 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 1.7 mm-40 -88.91 -53.89 4.39 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' HB2' HG22 ' A' ' 21' ' ' THR . 2.7 tm? -67.27 -65.78 0.64 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.162 0.985 . . . . 0.0 110.655 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.45 -18.83 65.58 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.328 0.392 . . . . 0.0 111.071 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.93 -37.58 60.55 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.713 0.633 . . . . 0.0 112.034 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 24.5 mt-30 -70.78 -38.84 73.43 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.88 -38.7 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 C-N-CA 123.803 0.841 . . . . 0.0 110.795 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.65 66.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.043 0.937 . . . . 0.0 111.914 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -35.6 13.57 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.924 0.89 . . . . 0.0 111.395 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.488 HG13 ' HG ' ' A' ' 14' ' ' LEU . 31.0 mm -72.1 -68.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.781 0.832 . . . . 0.0 110.449 -175.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.406 HG22 HG12 ' A' ' 36' ' ' ILE . 5.2 t -96.44 -16.19 21.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.342 0.657 . . . . 0.0 111.036 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 11.12 71.47 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.667 -0.518 . . . . 0.0 113.436 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.406 HG12 HG22 ' A' ' 34' ' ' THR . 26.5 mm -85.91 111.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.74 144.45 65.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.863 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.75 -24.81 73.15 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.203 2.602 . . . . 0.0 113.559 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.98 19.76 32.51 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 113.253 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -135.54 8.37 3.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 110.332 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.45 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 1.6 pt20 -144.47 162.07 37.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.511 0.725 . . . . 0.0 110.831 -177.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -129.37 -172.88 2.85 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.824 1.25 . . . . 0.0 108.645 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.46 HG23 HD11 ' A' ' 72' ' ' LEU . 32.4 mm -112.26 106.65 21.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 29.8 mt -116.03 134.45 54.94 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.79 175.21 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.479 0.711 . . . . 0.0 111.199 -169.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.7 -44.76 80.04 Favored Glycine 0 C--N 1.357 1.703 0 O-C-N 123.969 0.793 . . . . 0.0 114.186 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -87.0 163.34 40.88 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.536 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.61 108.52 0.15 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.572 2.848 . . . . 0.0 113.587 175.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.14 172.46 9.62 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.502 2.802 . . . . 0.0 112.493 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -101.64 11.99 37.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.929 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.9 m 56.03 84.37 0.08 Allowed 'General case' 0 C--N 1.36 1.022 0 C-N-CA 124.272 1.029 . . . . 0.0 109.646 -166.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.1 mt -79.68 95.39 5.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.351 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.22 96.14 8.36 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.662 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.439 ' HB3' HD12 ' A' ' 23' ' ' LEU . 8.0 mp -69.85 102.82 2.04 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -89.57 -36.89 15.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.948 0.899 . . . . 0.0 111.757 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -95.95 130.71 42.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.768 0.827 . . . . 0.0 110.302 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.44 68.08 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.131 0.573 . . . . 0.0 112.306 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.497 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 29.1 t70 -92.7 -2.77 55.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.855 0.862 . . . . 0.0 111.432 -172.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.4 tt -67.16 127.29 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.214 0.606 . . . . 0.0 110.748 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -99.24 177.0 5.34 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.928 0.491 . . . . 0.0 111.902 -168.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.19 -9.88 57.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 0.0 111.488 173.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.71 -25.85 74.85 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.99 -50.77 5.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.763 0.825 . . . . 0.0 110.055 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -91.05 121.72 67.53 Favored Pre-proline 0 N--CA 1.477 0.894 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.007 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.8 75.68 1.62 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.3 2.667 . . . . 0.0 113.583 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.33 131.68 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 27.9 mt-30 -118.19 155.82 29.84 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.3 t -70.94 111.61 6.47 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.21 17.2 56.2 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 123.604 0.621 . . . . 0.0 112.887 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.51 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.9 t70 -81.45 158.61 24.5 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.225 0.536 . . . . 0.0 110.246 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.4 93.69 9.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.783 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.531 HD21 HG13 ' A' ' 3' ' ' VAL . 3.9 mm? -92.36 99.44 12.2 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 4.1 mp -75.71 100.22 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.1 t -79.03 102.29 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.01 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.45 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 7.3 pt-20 -76.84 156.79 31.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.219 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.31 113.27 21.2 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.22 -17.87 53.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.58 0.752 . . . . 0.0 110.583 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 67.07 29.43 7.93 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.204 1.402 . . . . 0.0 111.135 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.3 m -53.11 -54.25 38.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.519 1.128 . . . . 0.0 111.687 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 54.77 66.94 3.61 Favored Pre-proline 0 CA--C 1.558 1.252 0 O-C-N 124.51 1.131 . . . . 0.0 111.566 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.83 163.72 23.33 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.371 2.048 . . . . 0.0 111.513 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.58 87.64 1.22 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.599 0.714 . . . . 0.0 109.793 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.4 141.94 29.11 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.302 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.0 p -140.68 142.32 28.17 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.615 0.766 . . . . 0.0 109.558 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.87 -20.51 67.02 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.696 2.264 . . . . 0.0 112.608 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.25 1.101 0 C-N-CA 124.822 1.249 . . . . 0.0 110.555 175.549 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.7 m0 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.868 0.366 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -122.03 56.6 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.483 1.113 . . . . 0.0 109.241 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.566 ' HB ' HD13 ' A' ' 17' ' ' LEU . 10.8 t -83.81 135.64 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.73 -171.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -95.31 148.73 22.12 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.69 0.796 . . . . 0.0 110.123 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 p -122.17 104.2 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.459 0.704 . . . . 0.0 110.243 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -74.73 113.47 12.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.771 0.828 . . . . 0.0 109.321 171.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.6 164.1 21.97 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 122.729 0.412 . . . . 0.0 110.199 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.475 ' HD3' ' HB3' ' A' ' 76' ' ' GLU . 26.0 mtpp -63.24 -31.15 72.22 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.169 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.74 32.73 6.71 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 123.694 0.621 . . . . 0.0 112.413 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.55 159.85 17.06 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 114.172 0.429 . . . . 0.0 114.172 171.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 m -102.27 115.26 30.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.669 0.788 . . . . 0.0 110.077 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -111.0 179.8 3.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.987 0.915 . . . . 0.0 109.53 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.18 130.46 37.29 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.514 ' HG ' HG13 ' A' ' 33' ' ' ILE . 4.5 mp -96.18 110.73 22.96 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.234 1.014 . . . . 0.0 109.772 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.06 -17.49 43.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 109.676 172.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -15.11 81.65 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.636 0.636 . . . . 0.0 113.54 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 3' ' ' VAL . 63.3 mt -72.67 114.43 10.8 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 117.336 0.568 . . . . 0.0 109.813 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.5 m -90.99 -167.08 1.73 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.176 0.991 . . . . 0.0 108.969 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.0 t -77.2 -45.58 26.13 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.779 0.432 . . . . 0.0 110.01 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.58 17.78 7.09 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.634 1.174 . . . . 0.0 112.794 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.8 m -65.9 115.92 6.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.141 0.577 . . . . 0.0 111.876 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.43 173.43 10.32 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.179 0.992 . . . . 0.0 110.219 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.39 -49.12 78.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.989 0.515 . . . . 0.0 111.894 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -19.93 65.31 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.648 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.85 -38.85 14.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 110.218 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.513 HD13 HD13 ' A' ' 43' ' ' ILE . 1.5 tm? -66.89 -67.21 0.47 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.874 1.27 . . . . 0.0 109.597 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.479 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 72.0 mt-30 -69.24 -20.79 63.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.103 0.561 . . . . 0.0 111.769 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.71 -33.15 75.32 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.918 0.761 . . . . 0.0 112.179 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.435 ' NE2' HD21 ' A' ' 17' ' ' LEU . 21.2 mt-30 -87.38 -32.23 19.68 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.286 0.634 . . . . 0.0 110.787 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.87 -39.85 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -61.72 -25.75 67.62 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.193 0.997 . . . . 0.0 111.974 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.05 -26.09 16.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.983 0.913 . . . . 0.0 111.748 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.514 HG13 ' HG ' ' A' ' 14' ' ' LEU . 22.3 mm -89.21 -68.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 111.257 -174.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.55 HG21 HG12 ' A' ' 36' ' ' ILE . 10.2 t -94.26 -7.69 41.3 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.92 0.488 . . . . 0.0 110.563 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.23 8.28 83.86 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 119.285 -0.731 . . . . 0.0 114.292 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.55 HG12 HG21 ' A' ' 34' ' ' THR . 11.0 mm -86.83 119.91 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 117.859 0.83 . . . . 0.0 109.178 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.98 139.44 82.98 Favored Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 124.165 0.916 . . . . 0.0 110.962 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 19.7 Cg_endo -56.64 -26.05 62.87 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.542 2.828 . . . . 0.0 114.252 -174.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.97 22.51 37.85 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 116.522 -0.308 . . . . 0.0 112.96 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 m -138.23 14.19 2.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.557 1.143 . . . . 0.0 109.949 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.42 171.87 19.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.375 0.67 . . . . 0.0 111.277 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -160.8 -173.85 4.13 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.631 1.172 . . . . 0.0 108.788 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.657 HG12 HD22 ' A' ' 54' ' ' LEU . 37.0 mm -106.13 113.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.2 mt -121.98 133.78 54.82 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 m -103.96 166.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.886 0.474 . . . . 0.0 110.831 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.06 -54.93 33.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 124.158 0.911 . . . . 0.0 112.715 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -67.19 151.68 96.89 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.268 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -49.25 106.66 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.612 2.875 . . . . 0.0 113.446 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.02 155.73 42.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.55 2.167 . . . . 0.0 111.651 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.91 10.81 22.42 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.673 0.789 . . . . 0.0 110.923 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.7 m 55.43 79.42 0.16 Allowed 'General case' 0 C--N 1.365 1.253 0 C-N-CA 124.417 1.087 . . . . 0.0 109.528 -167.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.52 138.33 57.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.777 -172.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -82.66 100.56 10.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.657 HD22 HG12 ' A' ' 43' ' ' ILE . 7.4 mp -98.03 88.84 4.35 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -126.72 -51.32 1.47 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.483 0.713 . . . . 0.0 111.357 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.462 ' O ' HG21 ' A' ' 59' ' ' ILE . 25.1 t70 -75.86 123.36 25.55 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.171 0.589 . . . . 0.0 110.916 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -29.73 52.95 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.7 -19.97 22.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 112.144 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.462 HG21 ' O ' ' A' ' 56' ' ' ASP . 12.1 tt -58.87 120.41 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 121.4 0.619 . . . . 0.0 110.747 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.9 p -92.67 177.32 6.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.072 0.549 . . . . 0.0 112.28 -170.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.83 -15.47 63.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.932 0.893 . . . . 0.0 111.362 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.99 78.4 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.271 -0.331 . . . . 0.0 112.271 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.3 -56.77 2.51 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.747 0.819 . . . . 0.0 109.701 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.5 mt -75.12 118.08 67.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.176 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.15 83.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.614 2.876 . . . . 0.0 114.838 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.436 HG21 HG11 ' A' ' 3' ' ' VAL . 3.1 mp -119.6 127.26 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 14.3 mt-30 -112.71 161.01 17.36 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.0 p -67.81 112.29 4.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.986 0.514 . . . . 0.0 110.147 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 22.94 59.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.188 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 29.0 t70 -82.97 166.27 18.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.74 0.816 . . . . 0.0 111.496 -175.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.473 ' HE3' ' HA ' ' A' ' 71' ' ' MET . 1.0 OUTLIER -98.82 103.66 15.63 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.87 0.868 . . . . 0.0 109.557 176.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 HD22 HG22 ' A' ' 43' ' ' ILE . 67.2 mt -98.86 104.12 16.13 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.399 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.6 91.98 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -82.13 109.56 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.548 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.91 145.36 38.29 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.475 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . 40.7 tt0 -110.21 102.13 10.84 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.26 -31.21 72.33 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.674 0.79 . . . . 0.0 110.94 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 73.15 14.36 4.63 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.49 1.516 . . . . 0.0 112.569 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.452 HG23 ' HG3' ' A' ' 80' ' ' ARG . 9.3 t -70.62 -35.59 73.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.862 0.465 . . . . 0.0 110.661 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.452 ' HG3' HG23 ' A' ' 79' ' ' THR . 77.4 mtp180 -116.79 152.92 49.07 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.027 0.931 . . . . 0.0 108.806 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.13 152.06 67.24 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.041 1.827 . . . . 0.0 111.934 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.9 116.58 7.2 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 173.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.12 155.28 33.72 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.403 0.681 . . . . 0.0 110.233 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.8 t -117.85 99.58 52.14 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.55 -22.87 20.6 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.398 2.066 . . . . 0.0 112.494 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 CA--C 1.554 1.114 0 C-N-CA 124.159 0.984 . . . . 0.0 109.298 178.018 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 24.0 m0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.41 ' HB2' HD13 ' A' ' 13' ' ' LEU . 14.0 ptp180 -133.9 124.91 27.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 72' ' ' LEU . 71.9 t -125.39 135.55 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.9 0.381 . . . . 0.0 111.493 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.412 ' HD3' HD23 ' A' ' 13' ' ' LEU . 40.3 mmt180 -82.12 110.96 17.81 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.379 1.072 . . . . 0.0 110.008 177.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' THR . 36.2 t -89.68 90.15 8.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 0.0 110.203 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -76.47 103.17 6.33 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . . . -142.73 176.56 8.95 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.51 0.672 . . . . 0.0 112.157 -170.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -73.18 -6.21 44.29 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.759 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.23 33.53 6.2 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.41 -178.01 52.72 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.065 0.364 . . . . 0.0 113.113 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 15.7 m -101.02 117.99 36.12 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -118.81 178.48 4.47 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.983 0.913 . . . . 0.0 110.493 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.412 HD23 ' HD3' ' A' ' 4' ' ' ARG . 3.1 tm? -125.18 131.02 53.27 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HG ' HG13 ' A' ' 33' ' ' ILE . 10.5 mp -100.1 132.82 45.24 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.323 0.649 . . . . 0.0 110.698 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.0 170.04 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.811 0.844 . . . . 0.0 109.996 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.4 23.23 77.63 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.067 172.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.67 133.23 43.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.02 0.528 . . . . 0.0 109.888 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.0 t -116.81 -166.26 1.15 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.354 1.062 . . . . 0.0 108.797 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.6 p -76.81 -36.4 56.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.993 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -104.57 20.55 18.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.926 0.49 . . . . 0.0 111.738 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -61.2 129.03 39.29 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.708 0.803 . . . . 0.0 110.142 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.542 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 78.3 mtm180 -88.19 -179.01 6.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.495 0.718 . . . . 0.0 111.848 -171.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.27 -63.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.103 0.961 . . . . 0.0 109.573 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -63.91 -15.27 58.68 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.902 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.542 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 12.2 mm-40 -87.04 -49.05 7.59 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -78.93 -66.78 0.82 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.358 1.063 . . . . 0.0 110.182 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -65.7 -19.96 66.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.001 0.52 . . . . 0.0 111.149 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.57 72.32 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.749 0.655 . . . . 0.0 111.877 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.428 ' O ' HG12 ' A' ' 33' ' ' ILE . 20.8 mt-30 -72.33 -38.85 68.53 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.11 -35.9 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.6 67.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.702 0.801 . . . . 0.0 111.99 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.43 -28.19 15.62 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.188 0.995 . . . . 0.0 112.065 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.442 HG13 ' HG ' ' A' ' 14' ' ' LEU . 27.8 mm -78.95 -61.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.304 1.042 . . . . 0.0 110.415 -174.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.442 HG21 HG12 ' A' ' 36' ' ' ILE . 3.8 t -109.42 -5.36 15.83 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.812 0.845 . . . . 0.0 111.435 -175.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.15 13.6 81.74 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.932 -0.371 . . . . 0.0 114.001 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 34' ' ' THR . 24.9 mm -90.88 115.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 141.88 69.49 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.707 0.803 . . . . 0.0 110.702 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.99 -27.64 64.98 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 123.421 2.747 . . . . 0.0 114.133 -174.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -15.23 78.3 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 120.085 -0.286 . . . . 0.0 113.813 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -93.78 -5.75 47.56 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.107 0.963 . . . . 0.0 111.445 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -130.19 161.59 30.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.106 0.963 . . . . 0.0 111.148 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -134.07 -172.17 2.92 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.244 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 HG12 HD11 ' A' ' 54' ' ' LEU . 49.8 mm -107.36 99.15 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -112.0 131.33 55.48 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.57 -174.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.721 0.808 . . . . 0.0 109.672 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.54 55.88 4.44 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.46 168.31 11.57 Favored Pre-proline 0 N--CA 1.483 1.209 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 168.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 100.31 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.982 1.788 . . . . 0.0 111.343 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.04 138.74 26.02 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.145 1.897 . . . . 0.0 113.089 -168.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.94 -0.88 23.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.891 0.876 . . . . 0.0 111.681 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.7 m 61.32 58.24 2.2 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.682 1.193 . . . . 0.0 109.678 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.18 99.92 0.73 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.113 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -86.06 125.7 33.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 43' ' ' ILE . 6.4 mp -88.96 106.57 18.51 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -111.83 19.6 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.601 0.76 . . . . 0.0 110.825 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 13.7 t70 -134.29 118.02 17.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -58.08 -34.26 69.96 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.897 0.879 . . . . 0.0 113.124 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.39 -0.71 54.65 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.05 0.94 . . . . 0.0 113.461 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.7 tt -61.6 122.18 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 118.757 0.708 . . . . 0.0 110.724 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.3 p -90.5 171.59 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.099 0.56 . . . . 0.0 111.921 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.457 HD12 HG22 ' A' ' 66' ' ' ILE . 21.9 mt -70.63 -7.96 48.21 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.95 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.89 -23.0 78.7 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.235 0.334 . . . . 0.0 112.743 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.467 ' HB2' HD22 ' A' ' 64' ' ' LEU . 9.2 m-20 -88.85 -47.29 8.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.065 0.546 . . . . 0.0 110.15 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.467 HD22 ' HB2' ' A' ' 63' ' ' ASP . 2.5 mm? -90.35 157.31 45.05 Favored Pre-proline 0 CA--C 1.562 1.412 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.099 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.94 44.82 1.76 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.495 2.797 . . . . 0.0 114.516 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.583 HG13 HD11 ' A' ' 72' ' ' LEU . 4.0 mp -83.47 124.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -119.94 170.7 9.02 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.545 0.738 . . . . 0.0 109.171 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 t -74.63 111.56 9.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.76 13.43 59.43 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.218 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.08 170.03 17.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 30.7 ttm -117.4 113.74 22.53 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.589 0.756 . . . . 0.0 109.353 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.606 HD23 HG12 ' A' ' 3' ' ' VAL . 3.2 mp -90.64 105.69 17.99 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.476 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.75 89.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 75.3 t -72.11 107.27 2.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.386 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -77.13 159.85 29.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.697 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -125.19 121.52 34.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.15 -21.97 66.35 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.51 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 63.36 33.42 13.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.501 1.12 . . . . 0.0 110.937 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.417 HG21 ' HG3' ' A' ' 80' ' ' ARG . 6.4 t -68.82 -33.04 73.17 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.19 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.417 ' HG3' HG21 ' A' ' 79' ' ' THR . 8.1 ppt_? -162.05 153.7 15.69 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.842 0.857 . . . . 0.0 109.641 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.03 164.64 33.04 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.598 2.199 . . . . 0.0 113.015 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -70.98 86.6 0.72 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.89 0.876 . . . . 0.0 109.107 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.01 135.38 33.68 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.871 0.869 . . . . 0.0 110.808 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.7 t -102.94 134.65 19.69 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.574 0.749 . . . . 0.0 109.319 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -58.41 -30.78 92.42 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.948 2.432 . . . . 0.0 112.893 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--O 1.248 1.011 0 C-N-CA 124.063 0.945 . . . . 0.0 109.556 178.189 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.3 m0 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -93.24 82.55 4.53 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 66' ' ' ILE . 41.3 t -96.1 136.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -87.29 141.75 28.41 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.57 0.748 . . . . 0.0 110.327 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.592 ' SG ' HD12 ' A' ' 14' ' ' LEU . 86.3 m -130.91 101.88 5.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.327 0.651 . . . . 0.0 111.427 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 12.9 tppt? -74.95 118.69 18.19 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.436 1.094 . . . . 0.0 110.381 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.13 -173.92 4.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.329 0.651 . . . . 0.0 109.416 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.09 130.95 45.0 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.564 0.346 . . . . 0.0 110.107 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.46 -22.44 30.68 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.805 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.41 -163.19 24.66 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 123.172 0.415 . . . . 0.0 112.073 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.479 HG22 ' HE3' ' A' ' 71' ' ' MET . 15.5 m -85.12 125.95 33.21 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.402 ' HB3' HG22 ' A' ' 33' ' ' ILE . 77.7 m80 -112.02 112.55 24.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.207 1.003 . . . . 0.0 108.647 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.3 tp -80.07 121.55 25.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.093 0.557 . . . . 0.0 110.666 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.592 HD12 ' SG ' ' A' ' 5' ' ' CYS . 8.5 mp -81.41 133.46 35.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 174.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -105.33 153.37 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.526 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.04 23.82 74.51 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.472 HD23 HG22 ' A' ' 21' ' ' THR . 78.0 mt -77.17 117.96 19.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.672 0.736 . . . . 0.0 110.077 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 94.5 p -84.84 161.35 19.94 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.7 p -65.39 -17.6 64.66 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.541 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.546 HH22 ' HA3' ' A' ' 62' ' ' GLY . 6.9 mmp_? -107.22 18.49 21.61 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.144 0.977 . . . . 0.0 112.256 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.472 HG22 HD23 ' A' ' 17' ' ' LEU . 44.0 m -63.31 119.8 10.35 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.926 0.393 . . . . 0.0 110.303 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -82.39 176.58 9.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.864 0.866 . . . . 0.0 111.272 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.452 ' HB2' HG22 ' A' ' 59' ' ' ILE . 5.7 tt -51.33 -60.62 2.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.714 1.206 . . . . 0.0 110.21 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -54.12 -30.43 48.72 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.021 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.41 ' HB2' HG23 ' A' ' 21' ' ' THR . 9.0 mm-40 -83.98 -38.74 20.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.41 0.684 . . . . 0.0 110.128 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.24 -66.99 0.66 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.225 1.01 . . . . 0.0 109.564 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -67.15 -16.93 64.61 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.04 70.97 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.849 0.718 . . . . 0.0 112.022 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 33' ' ' ILE . 24.0 mt-30 -70.22 -39.51 75.06 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.47 HG13 HD21 ' A' ' 14' ' ' LEU . 88.5 mt -57.59 -42.63 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 123.612 0.765 . . . . 0.0 110.881 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.17 67.5 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.034 0.934 . . . . 0.0 112.397 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.51 -35.58 15.0 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.771 0.829 . . . . 0.0 111.435 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 29' ' ' GLN . 25.1 mt -86.32 -64.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.094 0.558 . . . . 0.0 111.109 -171.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.537 HG22 HG12 ' A' ' 36' ' ' ILE . 12.1 t -93.72 -2.86 53.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.557 0.343 . . . . 0.0 110.929 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.41 -10.07 56.18 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.555 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 34' ' ' THR . 22.5 mm -71.65 111.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.591 0.696 . . . . 0.0 109.949 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.65 144.45 44.69 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.135 0.974 . . . . 0.0 111.089 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.95 -28.17 86.88 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.082 2.521 . . . . 0.0 113.049 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.08 28.02 9.37 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.548 0.53 . . . . 0.0 113.402 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -138.87 11.64 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.39 1.076 . . . . 0.0 109.987 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.46 161.3 42.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.794 0.838 . . . . 0.0 110.741 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -143.32 -168.91 2.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.173 1.389 . . . . 0.0 109.21 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 HG12 HD11 ' A' ' 54' ' ' LEU . 24.2 mm -106.83 110.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.562 0.745 . . . . 0.0 109.112 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mm? -120.01 156.6 30.57 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.56 167.72 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.159 0.584 . . . . 0.0 111.046 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.72 -49.32 78.78 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.528 1.142 . . . . 0.0 113.041 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -74.12 158.72 85.28 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.631 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -46.53 111.41 0.36 Allowed 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.225 2.617 . . . . 0.0 114.227 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.72 -176.91 2.66 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.054 2.503 . . . . 0.0 111.614 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -126.0 30.15 5.72 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.4 0.68 . . . . 0.0 110.741 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 34.0 m 55.44 64.27 1.82 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.741 0.816 . . . . 0.0 109.713 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.75 109.35 4.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.98 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.23 115.72 27.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.912 1.285 . . . . 0.0 108.921 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.478 HD11 HG12 ' A' ' 43' ' ' ILE . 4.1 mp -82.7 93.45 7.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.499 0.72 . . . . 0.0 109.229 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.6 p -79.8 -52.58 7.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 111.213 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -83.45 131.67 35.01 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 123.476 0.71 . . . . 0.0 110.319 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -22.82 61.15 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.726 0.811 . . . . 0.0 112.951 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -91.58 -5.29 54.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.496 1.119 . . . . 0.0 111.252 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.452 HG22 ' HB2' ' A' ' 23' ' ' LEU . 13.9 tt -59.58 121.07 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.236 0.615 . . . . 0.0 111.626 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -91.37 173.57 7.84 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 0.0 111.278 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.426 HD11 HG23 ' A' ' 66' ' ' ILE . 45.4 mt -70.26 -4.76 23.42 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.605 0.762 . . . . 0.0 111.643 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.546 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -78.46 -30.61 48.84 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.846 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 -48.98 6.19 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.82 133.05 95.43 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.076 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.6 78.49 0.95 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.816 2.344 . . . . 0.0 111.96 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.486 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.1 mp -123.23 121.87 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.1 mm-40 -117.9 154.91 31.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.753 0.821 . . . . 0.0 109.069 174.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -65.25 106.81 1.42 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.803 . . . . 0.0 110.493 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.25 13.07 62.38 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 113.87 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.7 t70 -84.77 163.47 19.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.176 0.59 . . . . 0.0 110.447 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.517 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 5.7 tpt -91.83 101.64 14.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.486 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.5 mm? -101.61 123.15 45.15 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.231 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.5 mp -91.95 116.18 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.98 110.37 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.218 1.007 . . . . 0.0 108.286 169.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.81 138.65 39.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.4 108.77 20.21 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.1 -21.92 49.72 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.215 0.606 . . . . 0.0 111.106 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 62.28 28.63 17.08 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.465 1.106 . . . . 0.0 111.861 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -76.55 -6.53 52.31 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.683 0.793 . . . . 0.0 112.083 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -162.18 159.91 21.28 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.968 0.907 . . . . 0.0 109.657 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.82 158.66 56.94 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.077 1.851 . . . . 0.0 110.664 166.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -140.98 142.26 34.32 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.026 0.531 . . . . 0.0 109.812 -174.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.85 114.89 28.39 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.6 p -102.83 103.41 33.01 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.332 0.653 . . . . 0.0 109.974 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.63 163.07 26.95 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.465 2.11 . . . . 0.0 112.08 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 C--O 1.253 1.258 0 C-N-CA 123.565 0.746 . . . . 0.0 109.486 178.037 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.0 m0 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -83.47 72.95 10.23 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.367 1.079 . . . . 0.0 109.55 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t -80.95 132.67 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.056 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -96.23 127.18 42.0 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.698 . . . . 0.0 109.585 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.406 ' SG ' HD13 ' A' ' 14' ' ' LEU . 84.4 m -113.25 114.88 27.34 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 0.0 110.36 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HE3' ' SD ' ' A' ' 71' ' ' MET . 5.2 tppp? -80.37 105.11 11.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 176.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.24 178.64 6.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.294 0.569 . . . . 0.0 111.501 -173.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 76' ' ' GLU . 31.9 mmmt -71.64 -25.06 61.98 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.561 1.144 . . . . 0.0 111.775 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.9 26.82 14.76 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.74 -175.68 42.2 Favored Glycine 0 C--N 1.353 1.48 0 C-N-CA 122.971 0.32 . . . . 0.0 113.348 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -86.46 124.13 32.45 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.894 0.478 . . . . 0.0 109.811 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.62 166.54 11.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.562 0.745 . . . . 0.0 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -118.27 120.5 37.85 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.664 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -103.35 111.47 23.9 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.022 0.929 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -89.96 171.47 9.55 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.848 0.859 . . . . 0.0 109.248 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.83 3.66 85.56 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.802 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.1 mt -95.96 127.52 42.04 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.837 0.855 . . . . 0.0 109.316 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -116.07 -166.82 1.18 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.952 1.301 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -70.01 -45.75 66.58 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.329 0.651 . . . . 0.0 111.432 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.523 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -107.18 39.25 1.92 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.491 HG22 ' HB2' ' A' ' 25' ' ' GLU . 20.1 m -70.46 122.79 20.31 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 166.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 26.6 mtm180 -76.24 170.14 16.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.622 0.769 . . . . 0.0 111.198 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.54 -49.73 75.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.679 0.791 . . . . 0.0 111.285 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.78 -32.38 65.59 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.752 0.657 . . . . 0.0 112.144 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.491 ' HB2' HG22 ' A' ' 21' ' ' THR . 42.1 mm-40 -78.12 -46.95 19.3 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.392 0.677 . . . . 0.0 109.684 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.09 -62.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.954 1.301 . . . . 0.0 110.812 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 59.2 mt-30 -64.96 -21.89 66.91 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.942 0.497 . . . . 0.0 111.707 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.71 93.91 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.89 0.744 . . . . 0.0 111.748 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -78.71 -37.24 42.04 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.261 -0.4 . . . . 0.0 110.514 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -55.97 -46.21 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.319 0.647 . . . . 0.0 110.808 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -63.26 -24.46 67.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.018 0.927 . . . . 0.0 112.182 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.45 -33.3 16.86 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.682 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.664 HG13 ' HG ' ' A' ' 14' ' ' LEU . 20.8 mm -85.13 -62.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.149 0.979 . . . . 0.0 111.21 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.45 HG21 HG12 ' A' ' 36' ' ' ILE . 10.2 t -96.21 -11.58 25.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.86 68.35 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.938 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.45 HG12 HG21 ' A' ' 34' ' ' THR . 6.6 mm -75.04 114.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.87 77.62 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.172 0.989 . . . . 0.0 111.233 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 37.0 Cg_endo -61.8 -17.83 57.29 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.089 2.526 . . . . 0.0 112.774 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 20.86 40.51 Favored Glycine 0 C--N 1.352 1.432 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.874 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -147.34 3.11 0.77 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.892 0.877 . . . . 0.0 111.992 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 38' ' ' PRO . 3.7 pp0? -143.56 168.03 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.002 0.905 . . . . 0.0 112.3 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -153.15 166.41 32.58 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.724 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.605 HG22 HD12 ' A' ' 72' ' ' LEU . 1.8 mp -105.17 112.4 38.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 109.087 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -117.64 169.91 9.19 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 m -121.52 162.63 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 118.232 0.469 . . . . 0.0 111.24 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.25 72.44 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 115.428 -0.805 . . . . 0.0 113.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.419 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 45.4 p90 -95.08 173.24 4.58 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.093 172.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 34.2 Cg_exo -40.49 110.62 0.12 Allowed 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 123.512 2.808 . . . . 0.0 113.988 173.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.73 159.97 18.98 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.647 2.232 . . . . 0.0 112.349 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -76.79 -14.32 59.93 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.876 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.4 m 66.87 23.5 9.96 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 124.831 1.252 . . . . 0.0 109.476 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -56.83 129.46 41.47 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 125.698 1.599 . . . . 0.0 112.161 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.28 105.68 17.65 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.44 HD21 HD11 ' A' ' 43' ' ' ILE . 6.0 mp -74.63 95.93 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -120.35 6.38 10.67 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.949 0.9 . . . . 0.0 111.74 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.467 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.2 t70 -112.05 114.9 28.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -61.54 -29.39 69.98 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.523 0.729 . . . . 0.0 112.369 -174.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -94.13 -13.44 26.75 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.252 1.021 . . . . 0.0 111.883 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 56' ' ' ASP . 13.9 tt -60.69 133.32 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.523 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 71.2 p -104.59 168.48 9.05 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.735 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 34.1 mt -67.88 -10.13 50.56 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.473 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.66 -39.43 40.68 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.17 -35.04 42.56 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.762 0.791 . . . . 0.0 109.282 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 93.3 mt -80.99 157.68 71.07 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.923 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.2 34.24 0.43 Allowed 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 123.063 2.509 . . . . 0.0 113.089 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.561 HD12 HG21 ' A' ' 43' ' ' ILE . 2.4 mp -84.61 120.55 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.8 mt-30 -121.54 161.63 22.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.122 0.569 . . . . 0.0 109.507 171.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -66.9 114.02 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.02 0.528 . . . . 0.0 109.747 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.94 8.91 83.45 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.562 0.539 . . . . 0.0 113.883 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -80.44 160.22 25.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.695 0.398 . . . . 0.0 110.076 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.444 ' HE1' ' HA ' ' A' ' 71' ' ' MET . 0.1 OUTLIER -94.92 101.88 13.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.18 0.992 . . . . 0.0 109.613 -178.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 43' ' ' ILE . 3.8 mm? -104.95 109.27 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.792 0.837 . . . . 0.0 108.853 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.7 mp -75.27 105.99 4.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.161 0.584 . . . . 0.0 109.582 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.71 111.89 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.764 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 11.4 pt-20 -80.11 176.29 9.88 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.355 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.517 ' HB3' ' HG3' ' A' ' 8' ' ' LYS . 38.6 tt0 -138.51 116.85 11.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.61 -19.41 14.36 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.705 0.802 . . . . 0.0 110.03 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.469 ' HG3' ' HG2' ' A' ' 76' ' ' GLU . 26.8 mt-30 59.91 12.94 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.882 1.273 . . . . 0.0 113.702 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -71.23 -32.23 68.53 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.087 0.555 . . . . 0.0 111.183 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -142.15 79.1 16.39 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.067 0.947 . . . . 0.0 108.526 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.43 174.9 10.12 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.752 2.301 . . . . 0.0 112.124 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -142.19 106.01 4.71 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.159 0.584 . . . . 0.0 110.333 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.62 106.9 4.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.922 0.889 . . . . 0.0 109.018 174.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.8 m -145.73 99.38 4.41 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.908 0.883 . . . . 0.0 108.89 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.46 -25.66 67.51 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.171 2.581 . . . . 0.0 113.168 170.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.9 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 123.334 0.654 . . . . 0.0 109.695 172.544 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.436 ' H1 ' ' HD1' ' A' ' 1' ' ' TRP . 23.0 m0 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.474 ' HB3' HD12 ' A' ' 13' ' ' LEU . 82.2 mtm180 -86.59 86.42 7.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.79 0.836 . . . . 0.0 109.301 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t -99.54 141.61 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.145 0.978 . . . . 0.0 111.237 -170.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -98.87 97.32 8.52 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.505 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.5 m -80.3 100.91 8.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.598 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -76.86 103.4 6.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 109.297 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . . . -134.46 172.26 13.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.65 0.38 . . . . 0.0 110.656 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -59.26 112.47 1.74 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.216 173.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.74 9.36 14.31 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.403 -171.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.79 -166.37 18.04 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 122.943 0.306 . . . . 0.0 113.14 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -81.75 157.8 24.39 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -138.9 120.02 14.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.108 0.563 . . . . 0.0 109.522 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.474 HD12 ' HB3' ' A' ' 2' ' ' ARG . 2.1 tm? -96.26 98.62 10.44 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.94 141.75 31.02 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.481 0.712 . . . . 0.0 111.433 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.84 179.36 3.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.282 1.033 . . . . 0.0 109.234 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.6 28.58 73.56 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.441 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 21' ' ' THR . 93.0 mt -106.09 113.73 27.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.292 0.637 . . . . 0.0 110.75 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' HD13 ' A' ' 61' ' ' LEU . 40.9 t -95.85 172.09 8.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 0.0 108.923 172.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.4 p -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 122.45 0.3 . . . . 0.0 111.808 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.99 22.07 13.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.817 0.447 . . . . 0.0 111.804 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.462 HG21 HD22 ' A' ' 17' ' ' LEU . 52.4 m -66.47 111.05 3.37 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 170.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HG2' HG22 ' A' ' 60' ' ' THR . 86.0 mtt-85 -74.12 -178.6 3.42 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.271 1.028 . . . . 0.0 111.971 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 54' ' ' LEU . 6.8 tt -56.76 -53.98 51.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 174.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -63.29 -22.1 66.66 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.37 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 25.3 mm-40 -87.2 -53.43 4.86 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.262 0.625 . . . . 0.0 109.665 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.531 ' HG ' HD22 ' A' ' 61' ' ' LEU . 2.5 tm? -70.89 -65.57 0.72 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.212 1.005 . . . . 0.0 110.191 -176.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -67.43 -17.23 64.63 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.64 0.588 . . . . 0.0 110.888 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.45 -37.54 53.4 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.753 0.658 . . . . 0.0 112.538 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 22.6 mt-30 -68.88 -39.46 79.77 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.6 mt -59.68 -37.19 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.02 0.928 . . . . 0.0 111.204 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.73 -24.01 65.37 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.193 0.997 . . . . 0.0 111.926 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.69 -43.26 8.74 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.596 0.758 . . . . 0.0 111.322 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.0 mm -68.3 -63.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.383 1.073 . . . . 0.0 110.237 -172.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.507 HG23 HG12 ' A' ' 36' ' ' ILE . 8.9 t -109.31 0.99 19.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.67 0.788 . . . . 0.0 111.013 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.2 89.38 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 170.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.507 HG12 HG23 ' A' ' 34' ' ' THR . 9.8 mm -86.08 107.85 16.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 147.54 98.36 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.564 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -49.95 -33.3 33.51 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 124.11 3.207 . . . . 0.0 114.25 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 13.86 18.48 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.3 m -138.99 15.01 2.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 110.92 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.4 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 2.1 pt20 -146.81 155.26 42.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.514 0.725 . . . . 0.0 110.783 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -124.67 -173.91 2.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.169 0.988 . . . . 0.0 109.374 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.6 mm -110.4 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 28.4 mt -107.34 139.73 41.36 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 65' ' ' PRO . 6.7 m -120.19 178.34 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 122.867 0.467 . . . . 0.0 112.203 -164.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.97 -49.82 57.37 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 124.301 1.001 . . . . 0.0 113.654 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -79.01 163.11 61.89 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.367 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -42.04 104.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.884 3.056 . . . . 0.0 113.924 171.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.13 159.11 37.5 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.404 2.069 . . . . 0.0 112.736 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -89.33 8.19 31.85 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.412 1.085 . . . . 0.0 112.145 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.0 m 61.67 27.08 16.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.37 1.068 . . . . 0.0 110.264 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -61.62 108.44 0.98 Allowed 'General case' 0 C--N 1.357 0.91 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.751 -173.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.48 132.97 43.49 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.685 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 23' ' ' LEU . 7.1 mp -87.86 88.05 7.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.351 1.06 . . . . 0.0 108.359 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.0 t -93.87 13.93 21.06 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.435 0.694 . . . . 0.0 110.57 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.02 117.46 20.94 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.319 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -60.88 -30.28 70.06 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.169 0.987 . . . . 0.0 113.108 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -81.34 -23.44 37.75 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.581 1.152 . . . . 0.0 111.741 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.3 tt -56.16 134.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 -173.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.411 HG22 ' HG2' ' A' ' 22' ' ' ARG . 58.9 p -113.55 175.2 5.56 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.54 0.736 . . . . 0.0 111.05 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.531 HD22 ' HG ' ' A' ' 26' ' ' LEU . 50.7 mt -64.36 -22.01 66.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.96 0.504 . . . . 0.0 111.848 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.22 -17.05 61.03 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.241 0.338 . . . . 0.0 113.232 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.57 -45.31 6.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 0.0 111.191 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.522 HD13 HD13 ' A' ' 52' ' ' LEU . 2.3 mm? -85.91 154.73 58.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 123.108 0.563 . . . . 0.0 110.946 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.419 ' HB2' HG13 ' A' ' 45' ' ' VAL . 2.2 Cg_endo -81.61 41.77 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.523 2.815 . . . . 0.0 113.083 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.76 108.64 3.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.58 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 21.0 mm-40 -105.7 166.42 10.47 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 p -64.4 99.51 0.3 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.199 0.6 . . . . 0.0 110.953 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 35.27 44.55 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.451 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -88.52 165.43 14.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.388 0.675 . . . . 0.0 111.047 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.52 98.21 11.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.802 0.841 . . . . 0.0 109.615 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 98.96 10.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.506 0.722 . . . . 0.0 110.21 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.8 mp -75.96 101.12 2.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 94.5 t -79.42 106.9 11.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.691 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 9.1 pt-20 -78.61 169.04 18.88 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.219 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HG2' ' H ' ' A' ' 78' ' ' GLN . 23.8 tt0 -130.34 137.11 49.76 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 170.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.94 -16.97 62.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.07 0.548 . . . . 0.0 111.861 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.454 ' H ' ' HG2' ' A' ' 76' ' ' GLU . 0.1 OUTLIER 71.38 1.23 3.76 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.567 1.147 . . . . 0.0 113.083 175.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -78.42 -10.91 59.89 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.153 0.581 . . . . 0.0 110.626 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 65.59 91.75 0.07 OUTLIER Pre-proline 0 C--N 1.361 1.066 0 C-N-CA 125.237 1.415 . . . . 0.0 109.765 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.46 124.71 12.37 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.715 2.277 . . . . 0.0 113.127 -172.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -87.96 122.92 32.15 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.27 177.83 8.52 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.761 0.824 . . . . 0.0 110.709 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.8 p -125.0 90.45 51.04 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.997 0.919 . . . . 0.0 108.852 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.45 85.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 123.486 2.791 . . . . 0.0 113.248 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.551 1.003 0 C-N-CA 124.77 1.228 . . . . 0.0 108.374 -177.013 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.512 ' HD1' ' H2 ' ' A' ' 1' ' ' TRP . 11.2 m0 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.446 ' HB2' HD11 ' A' ' 13' ' ' LEU . 23.1 ptt180 -88.17 65.39 8.1 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.689 1.233 . . . . 0.0 109.563 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.53 ' HB ' HD13 ' A' ' 17' ' ' LEU . 43.3 t -79.12 143.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.507 -169.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -98.69 142.86 29.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.357 1.063 . . . . 0.0 109.943 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.438 ' SG ' HD13 ' A' ' 14' ' ' LEU . 72.1 m -136.39 99.99 4.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.231 1.013 . . . . 0.0 110.076 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -74.41 113.16 11.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 109.433 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.52 100.78 5.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.773 0.429 . . . . 0.0 110.228 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.51 ' HE3' ' HB3' ' A' ' 76' ' ' GLU . 33.5 mmtp 59.57 23.56 12.27 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.065 1.346 . . . . 0.0 112.61 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.51 -31.47 7.79 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.1 87.04 0.48 Allowed Glycine 0 C--N 1.354 1.54 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -77.15 111.18 12.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.753 0.821 . . . . 0.0 109.297 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -112.62 152.1 29.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 0.0 110.861 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER -113.31 112.94 24.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HG ' HG13 ' A' ' 33' ' ' ILE . 5.5 mp -102.72 97.34 7.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.749 0.82 . . . . 0.0 109.041 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.431 ' HG3' HD13 ' A' ' 13' ' ' LEU . 78.5 mt-30 -78.86 -11.4 59.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.373 0.669 . . . . 0.0 110.951 169.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.52 -9.63 74.06 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.421 0.451 . . . . 0.0 114.049 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD13 ' HB ' ' A' ' 3' ' ' VAL . 71.1 mt -78.36 125.01 28.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.953 0.501 . . . . 0.0 110.382 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' HD11 ' A' ' 61' ' ' LEU . 44.5 m -103.43 -178.11 3.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.321 1.449 . . . . 0.0 109.577 171.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 m -65.61 -39.86 91.99 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.92 0.488 . . . . 0.0 112.079 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -104.5 29.15 6.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.819 0.448 . . . . 0.0 112.165 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.51 HG21 HD22 ' A' ' 17' ' ' LEU . 94.9 m -64.08 104.88 0.78 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 122.84 0.456 . . . . 0.0 111.318 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -66.9 173.63 3.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.904 1.282 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.453 HD13 ' HB3' ' A' ' 54' ' ' LEU . 6.3 tt -54.95 -50.87 67.81 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.451 0.7 . . . . 0.0 109.873 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.465 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 6.1 ptp180 -56.76 -26.26 56.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.972 0.909 . . . . 0.0 112.712 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.465 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 5.5 mm-40 -93.12 -35.46 13.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.897 0.879 . . . . 0.0 110.199 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -79.97 -68.69 0.65 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.035 0.934 . . . . 0.0 109.221 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.76 -19.01 65.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.604 0.565 . . . . 0.0 110.751 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.28 -43.86 77.65 Favored Glycine 0 C--N 1.345 1.051 0 O-C-N 123.929 0.768 . . . . 0.0 112.205 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.485 ' NE2' HD21 ' A' ' 17' ' ' LEU . 43.6 mt-30 -73.41 -38.91 65.42 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.11 -39.14 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.139 0.576 . . . . 0.0 111.249 175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.19 68.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.612 0.765 . . . . 0.0 111.694 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.54 -23.35 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.068 0.947 . . . . 0.0 111.704 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.46 HG13 ' HG ' ' A' ' 14' ' ' LEU . 22.2 mm -86.91 -69.38 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.916 0.886 . . . . 0.0 109.886 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.482 HG21 HG12 ' A' ' 36' ' ' ILE . 3.1 t -96.51 -11.73 25.09 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.273 0.629 . . . . 0.0 111.514 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 12.46 77.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.92 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.482 HG12 HG21 ' A' ' 34' ' ' THR . 13.2 mm -85.84 113.81 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.77 142.26 44.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.221 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.66 -24.41 62.57 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.226 2.617 . . . . 0.0 113.348 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.29 19.3 53.29 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.337 0.398 . . . . 0.0 113.27 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -134.6 -3.6 2.62 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.92 145.67 48.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.613 0.765 . . . . 0.0 109.464 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -121.62 168.04 12.22 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 167.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.5 mm -103.66 112.0 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.5 mm? -113.61 178.69 4.19 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.1 164.7 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.812 0.445 . . . . 0.0 111.311 -171.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.57 1.82 50.23 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 114.507 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -120.21 172.68 4.35 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -37.45 103.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.017 3.145 . . . . 0.0 113.656 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.17 146.14 56.8 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.634 2.222 . . . . 0.0 112.613 -170.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.32 2.38 55.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.725 0.81 . . . . 0.0 110.826 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.0 m 56.14 74.35 0.39 Allowed 'General case' 0 C--N 1.365 1.258 0 C-N-CA 124.749 1.22 . . . . 0.0 110.482 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.7 mt -77.84 101.14 6.62 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.808 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.13 104.93 17.44 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.296 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.453 ' HB3' HD13 ' A' ' 23' ' ' LEU . 5.4 mp -73.85 85.21 1.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.2 t -82.41 -21.31 35.81 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.308 1.043 . . . . 0.0 110.984 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -107.81 136.98 46.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.884 0.874 . . . . 0.0 109.42 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -78.46 -22.45 47.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.579 0.751 . . . . 0.0 111.955 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -93.4 -2.56 54.53 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.448 0.699 . . . . 0.0 111.305 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.82 123.69 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.957 0.503 . . . . 0.0 110.539 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 p -104.51 177.35 4.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.891 0.476 . . . . 0.0 111.081 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 18' ' ' SER . 28.3 mt -74.55 -5.6 43.74 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.615 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.46 62.05 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.497 0.498 . . . . 0.0 111.902 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.92 -42.18 10.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.516 0.726 . . . . 0.0 109.279 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -78.84 152.22 77.21 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.171 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.49 25.49 0.54 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 124.14 3.227 . . . . 0.0 114.175 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.527 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.3 mp -77.08 128.69 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.5 mt-30 -118.03 -179.28 3.71 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.801 0.84 . . . . 0.0 108.917 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 p -68.41 -1.45 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 40.41 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.0 t70 -85.19 163.61 18.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.533 0.733 . . . . 0.0 111.577 -171.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.2 tpt -100.02 103.06 14.58 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.051 0.94 . . . . 0.0 109.508 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 66' ' ' ILE . 3.2 mm? -109.37 131.24 55.25 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -92.97 114.11 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.43 115.66 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.214 1.006 . . . . 0.0 109.079 167.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -87.48 159.51 18.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.51 ' HB3' ' HE3' ' A' ' 8' ' ' LYS . 36.8 tt0 -117.2 113.61 22.47 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.33 -25.48 64.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.061 0.945 . . . . 0.0 109.727 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 45.78 40.52 6.5 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 126.031 1.732 . . . . 0.0 113.2 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -57.05 -42.65 80.91 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.606 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -174.34 150.01 1.46 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.089 0.956 . . . . 0.0 109.962 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.55 117.26 4.73 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.902 2.402 . . . . 0.0 110.624 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -70.81 120.54 16.56 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.79 0.436 . . . . 0.0 111.437 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.39 -2.65 57.48 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.878 0.871 . . . . 0.0 111.501 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.1 m -79.16 152.11 76.23 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.312 1.045 . . . . 0.0 111.402 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.09 132.44 49.31 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.278 2.652 . . . . 0.0 112.825 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.552 1.045 0 C-N-CA 123.914 0.886 . . . . 0.0 109.423 -177.638 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.507 ' H1 ' ' HD1' ' A' ' 1' ' ' TRP . 10.8 m0 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -90.95 83.33 5.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.066 0.946 . . . . 0.0 109.124 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.7 t -105.59 141.23 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.734 0.814 . . . . 0.0 111.126 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -88.61 147.28 24.65 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 110.915 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.2 p -131.56 115.37 16.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.348 0.659 . . . . 0.0 110.4 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.565 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 14.3 tppt? -79.7 124.21 28.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.403 1.081 . . . . 0.0 109.434 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.4 172.09 15.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.118 0.567 . . . . 0.0 110.044 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.721 ' HE2' ' HB3' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -69.51 -23.58 63.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.45 20.73 25.34 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.384 0.427 . . . . 0.0 112.502 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.32 174.17 28.65 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 123.335 0.493 . . . . 0.0 112.609 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.514 HG21 ' HE2' ' A' ' 71' ' ' MET . 33.4 m -85.53 117.94 24.74 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.661 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.3 m-70 -102.95 177.84 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 tt -146.86 101.5 3.44 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.587 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.0 mp -79.16 113.34 17.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.969 0.908 . . . . 0.0 110.038 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -101.65 -9.39 20.96 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.357 0.663 . . . . 0.0 110.979 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.63 42.03 3.12 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 122.827 0.251 . . . . 0.0 113.165 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.5 mt -118.24 121.97 41.8 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.832 0.853 . . . . 0.0 109.835 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.2 p -97.44 171.97 8.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.373 1.069 . . . . 0.0 109.337 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 m -62.31 -29.34 70.37 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.281 0.632 . . . . 0.0 111.546 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -110.74 29.5 7.69 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.84 0.856 . . . . 0.0 112.142 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -70.88 121.11 17.49 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 166.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -89.93 169.6 11.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 110.093 -173.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 57' ' ' ARG . 24.9 tp -51.99 -51.56 56.43 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.856 0.863 . . . . 0.0 111.715 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.533 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 11.8 ptm180 -55.37 -34.1 64.0 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.731 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 44.0 mt-10 -88.26 -31.28 19.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.812 0.845 . . . . 0.0 110.877 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 43' ' ' ILE . 2.3 tm? -74.01 -66.4 0.72 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.034 0.934 . . . . 0.0 108.907 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -66.49 -20.84 66.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.192 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.37 -42.04 90.32 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.013 0.821 . . . . 0.0 111.67 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -73.71 -35.76 65.16 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.574 0.349 . . . . 0.0 110.078 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -62.72 -37.56 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 C-N-CA 123.287 0.635 . . . . 0.0 110.53 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.73 -24.61 67.84 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.813 0.845 . . . . 0.0 112.022 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.47 -25.5 16.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.908 0.883 . . . . 0.0 111.804 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.587 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.4 mm -82.4 -65.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.331 1.052 . . . . 0.0 110.488 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 36' ' ' ILE . 7.1 t -108.77 -0.36 20.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.98 0.912 . . . . 0.0 110.953 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.99 11.87 84.74 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.404 -0.664 . . . . 0.0 114.398 171.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 34' ' ' THR . 23.0 mm -85.78 131.49 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 117.791 0.796 . . . . 0.0 111.442 -175.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 130.93 93.64 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.201 1.0 . . . . 0.0 110.335 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.05 -24.97 68.56 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.335 2.69 . . . . 0.0 113.42 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.61 -3.57 90.19 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.859 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.5 m -107.41 -48.21 3.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.762 0.825 . . . . 0.0 110.309 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -76.91 153.77 34.35 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.269 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.69 168.36 23.85 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.448 1.099 . . . . 0.0 109.075 168.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.439 HD13 HD13 ' A' ' 26' ' ' LEU . 43.9 mm -79.41 103.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.259 1.028 . . . . 0.0 110.364 -174.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.2 mt -122.1 137.19 54.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.985 -1.916 . . . . 0.0 105.964 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 65' ' ' PRO . 16.3 m -125.68 179.1 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 122.733 0.413 . . . . 0.0 111.5 -169.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.65 -48.75 74.9 Favored Glycine 0 C--N 1.358 1.779 0 O-C-N 124.326 1.016 . . . . 0.0 113.654 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -80.7 155.82 73.19 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.929 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -45.29 108.04 0.13 Allowed 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 124.22 3.28 . . . . 0.0 113.593 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.04 169.14 8.97 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.946 2.431 . . . . 0.0 111.524 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.58 25.18 11.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.455 0.702 . . . . 0.0 111.417 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.1 m 53.2 65.07 1.62 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.03 0.932 . . . . 0.0 110.143 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.86 126.14 26.33 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.182 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -91.04 90.81 8.02 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.836 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.89 86.17 2.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -80.58 -41.46 23.99 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.0 0.92 . . . . 0.0 110.872 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 20.9 t0 -81.11 118.2 22.32 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.024 0.53 . . . . 0.0 110.385 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.517 ' HA ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.75 -29.13 62.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.07 0.948 . . . . 0.0 112.832 174.313 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -93.52 -2.39 54.41 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.761 0.824 . . . . 0.0 112.047 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 14.0 tt -69.73 126.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.989 -0.444 . . . . 0.0 111.177 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -91.12 172.04 8.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.37 0.605 . . . . 0.0 112.437 -171.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 66' ' ' ILE . 27.6 mt -65.43 -17.78 64.81 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.149 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -28.62 66.77 Favored Glycine 0 C--N 1.36 1.886 0 O-C-N 123.483 0.489 . . . . 0.0 113.14 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.81 -52.24 5.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.129 0.571 . . . . 0.0 110.402 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.9 155.45 82.89 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.969 0.908 . . . . 0.0 111.756 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.525 ' HB2' HG11 ' A' ' 45' ' ' VAL . 4.4 Cg_exo -80.66 36.65 0.63 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.878 3.052 . . . . 0.0 114.126 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.542 HG13 HD23 ' A' ' 72' ' ' LEU . 2.0 mp -70.89 114.55 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 167.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 34.4 mt-30 -118.23 148.57 42.27 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -65.24 104.07 0.88 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.67 . . . . 0.0 110.659 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.88 11.51 52.98 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 114.113 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.602 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 27.9 t0 -89.53 160.68 16.59 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.273 0.629 . . . . 0.0 111.979 -173.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.565 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 4.8 tpt -96.21 108.31 20.77 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.766 1.226 . . . . 0.0 109.648 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.542 HD23 HG13 ' A' ' 66' ' ' ILE . 11.1 mp -109.67 126.12 53.34 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 0.0 110.288 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -85.88 103.29 12.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.53 111.65 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.618 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.99 155.41 19.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.71 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.721 ' HB3' ' HE2' ' A' ' 8' ' ' LYS . 10.0 tp10 -135.87 130.81 34.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.985 0.914 . . . . 0.0 109.446 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -89.54 -5.46 57.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.354 0.662 . . . . 0.0 110.632 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.409 ' H ' ' HG3' ' A' ' 76' ' ' GLU . 48.4 mt-30 70.88 26.32 3.7 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.809 1.644 . . . . 0.0 110.169 -173.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.5 m -76.67 -38.56 54.31 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.234 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 66.89 165.46 0.12 Allowed Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 124.658 1.183 . . . . 0.0 111.269 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.54 121.2 9.22 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.634 1.556 . . . . 0.0 110.264 164.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -70.19 79.69 0.52 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.793 0.837 . . . . 0.0 111.126 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.01 169.4 5.65 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.238 1.015 . . . . 0.0 110.368 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.8 p -130.94 91.29 37.04 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 124.003 0.921 . . . . 0.0 109.126 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.32 -51.54 9.82 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.072 2.514 . . . . 0.0 112.028 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 CA--C 1.553 1.088 0 C-N-CA 124.298 1.039 . . . . 0.0 108.901 173.01 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.432 ' H1 ' ' HD1' ' A' ' 1' ' ' TRP . 18.8 m0 . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.491 ' HB3' HD13 ' A' ' 13' ' ' LEU . 53.7 mtm180 -116.75 88.05 2.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.017 0.927 . . . . 0.0 108.775 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.447 HG11 HD22 ' A' ' 72' ' ' LEU . 82.3 t -89.43 137.36 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.455 0.702 . . . . 0.0 111.204 -170.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -87.45 138.67 31.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.746 0.819 . . . . 0.0 109.075 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 t -131.99 100.89 5.21 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.474 0.71 . . . . 0.0 111.11 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.0 tppp? -73.38 144.75 46.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.88 -168.94 2.52 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.733 0.301 . . . . 0.0 111.34 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.623 ' HZ1' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -50.65 -28.61 9.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.108 1.363 . . . . 0.0 112.8 176.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.27 87.14 0.1 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.05 167.04 19.73 Favored Glycine 0 C--N 1.346 1.136 0 C-N-CA 123.251 0.453 . . . . 0.0 113.29 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -106.42 150.54 25.94 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.499 0.72 . . . . 0.0 110.436 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -122.97 164.66 18.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.33 1.452 . . . . 0.0 108.378 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.491 HD13 ' HB3' ' A' ' 2' ' ' ARG . 0.3 OUTLIER -128.85 102.55 6.59 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.661 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.1 mp -81.3 121.77 26.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.041 0.936 . . . . 0.0 110.358 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.481 ' NE2' HD12 ' A' ' 13' ' ' LEU . 83.5 mm-40 -98.9 159.92 14.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.158 0.983 . . . . 0.0 109.762 174.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.8 10.43 83.13 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.135 -0.484 . . . . 0.0 114.17 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.39 137.44 42.71 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.113 0.565 . . . . 0.0 109.609 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -112.66 177.92 4.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.639 1.176 . . . . 0.0 109.36 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.7 p -82.32 -26.85 32.64 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.912 0.387 . . . . 0.0 109.972 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -86.8 6.92 29.2 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.926 0.89 . . . . 0.0 112.191 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.418 HG21 ' HB2' ' A' ' 26' ' ' LEU . 93.5 m -62.9 112.34 2.52 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 110.826 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.88 179.36 7.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.287 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 4.9 tt -57.53 -56.33 23.27 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.74 0.816 . . . . 0.0 109.652 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -20.31 64.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.673 0.789 . . . . 0.0 112.097 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -79.62 -52.81 7.51 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.509 0.724 . . . . 0.0 109.246 172.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.418 ' HB2' HG21 ' A' ' 21' ' ' THR . 2.5 tm? -69.29 -66.72 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.879 1.272 . . . . 0.0 110.756 -169.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -65.13 -18.3 65.19 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.141 0.576 . . . . 0.0 111.7 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.46 -41.03 46.12 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.7 0.625 . . . . 0.0 111.983 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -70.13 -37.03 75.18 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.105 0.562 . . . . 0.0 110.06 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.55 -43.73 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 0.0 110.912 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.76 -26.36 67.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.761 0.825 . . . . 0.0 111.743 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.51 -27.96 19.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.632 0.773 . . . . 0.0 111.769 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.661 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.4 mm -84.27 -70.07 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.115 0.566 . . . . 0.0 110.722 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -88.53 -16.29 33.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.24 0.616 . . . . 0.0 111.154 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.81 -1.91 85.55 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.361 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 mm -77.64 112.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.54 144.53 63.61 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 124.022 0.929 . . . . 0.0 110.772 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -57.85 -24.35 63.78 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.26 2.64 . . . . 0.0 113.212 -175.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.49 19.8 34.32 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.639 -0.255 . . . . 0.0 113.28 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.8 m -140.37 12.62 2.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.458 1.103 . . . . 0.0 110.618 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -148.9 144.03 26.6 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.993 0.517 . . . . 0.0 109.81 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.8 176.35 6.66 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.279 1.032 . . . . 0.0 108.904 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -101.21 101.12 11.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 32.2 mt -116.28 145.58 43.05 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 49' ' ' PRO . 17.4 m -114.7 168.55 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.299 0.639 . . . . 0.0 110.017 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.01 65.72 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.789 0.681 . . . . 0.0 113.77 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -80.29 160.87 66.92 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.606 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -47.52 110.77 0.33 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HB3' HG23 ' A' ' 45' ' ' VAL . 90.8 Cg_endo -81.53 -179.81 5.21 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.273 2.649 . . . . 0.0 112.307 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.74 13.46 28.38 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.503 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.7 m 54.72 66.43 1.24 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 123.828 0.851 . . . . 0.0 108.706 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.77 129.24 39.09 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.863 -165.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.9 90.14 3.52 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 108.801 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 9.7 mp -87.49 104.99 16.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -100.65 -51.94 3.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.602 0.761 . . . . 0.0 110.562 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -71.71 111.72 7.23 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.116 0.567 . . . . 0.0 111.317 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -53.09 -25.59 13.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.501 1.12 . . . . 0.0 113.554 175.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.51 -2.75 56.0 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.49 0.716 . . . . 0.0 112.11 -173.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.4 tt -71.78 125.43 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.729 0.412 . . . . 0.0 110.836 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.6 p -89.4 176.01 7.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.659 0.743 . . . . 0.0 112.317 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.7 mt -73.52 -7.51 52.12 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.828 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.17 71.95 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.395 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.35 -52.04 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.4 0.68 . . . . 0.0 110.519 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.43 148.22 54.92 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.216 0.607 . . . . 0.0 111.144 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 31.51 0.44 Allowed 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.805 3.003 . . . . 0.0 114.936 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.31 117.8 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -120.42 163.42 17.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 t -71.16 108.53 4.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.837 0.455 . . . . 0.0 110.191 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.57 0.15 62.87 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.581 0.551 . . . . 0.0 113.206 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.19 156.68 38.34 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.193 0.597 . . . . 0.0 110.549 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HA ' ' HE2' ' A' ' 71' ' ' MET . 5.2 tpt -92.54 104.58 16.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.491 1.117 . . . . 0.0 109.021 -176.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.447 HD22 HG11 ' A' ' 3' ' ' VAL . 4.3 mm? -105.08 115.75 30.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.885 0.874 . . . . 0.0 109.11 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.4 mp -86.79 100.73 10.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -78.21 105.09 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.599 166.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.5 161.69 27.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.834 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -116.52 109.4 17.21 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -78.79 -17.46 55.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.183 0.993 . . . . 0.0 110.92 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 66.54 13.27 9.22 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.514 1.126 . . . . 0.0 113.259 172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 t -72.99 -19.36 61.23 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.89 0.476 . . . . 0.0 111.39 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 43.99 76.04 0.58 Allowed Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 125.85 1.66 . . . . 0.0 111.589 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -87.18 -177.5 2.18 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 123.138 2.559 . . . . 0.0 112.966 -169.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -97.4 22.99 8.05 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.598 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.44 104.19 2.23 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 124.053 0.941 . . . . 0.0 110.488 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.0 t 64.72 77.84 0.28 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.16 1.384 . . . . 0.0 111.243 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.9 82.57 0.77 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.183 2.589 . . . . 0.0 111.39 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.216 1.007 . . . . 0.0 109.167 -177.404 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 38.5 m0 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.842 0.353 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -125.17 106.81 10.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 66' ' ' ILE . 37.3 t -130.75 139.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.922 -0.486 . . . . 0.0 110.35 -173.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -85.02 153.73 22.56 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.005 0.522 . . . . 0.0 111.72 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.506 ' SG ' HD21 ' A' ' 14' ' ' LEU . 95.3 m -130.72 112.14 12.81 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.395 1.078 . . . . 0.0 110.414 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.491 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 16.3 tppt? -82.34 107.67 15.19 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.426 1.09 . . . . 0.0 109.305 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . . . -146.47 177.94 8.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.802 0.335 . . . . 0.0 111.253 -176.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.15 -34.81 75.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.368 1.067 . . . . 0.0 112.304 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.8 26.92 4.52 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.439 -0.346 . . . . 0.0 113.299 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.88 169.86 41.37 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.0 m -89.87 102.98 15.68 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -101.36 179.21 4.42 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.975 0.91 . . . . 0.0 110.153 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.584 HD21 ' NE2' ' A' ' 15' ' ' GLN . 3.0 tt -135.35 106.27 6.62 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.506 HD21 ' SG ' ' A' ' 5' ' ' CYS . 4.3 mm? -66.0 108.68 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.684 0.794 . . . . 0.0 109.925 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.584 ' NE2' HD21 ' A' ' 13' ' ' LEU . 29.3 mm-40 -76.89 -45.77 26.89 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.199 0.999 . . . . 0.0 110.719 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.81 65.48 3.91 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.533 -0.758 . . . . 0.0 113.382 -174.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.9 mt -118.43 138.55 52.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.06 0.544 . . . . 0.0 110.29 172.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.416 ' O ' HD13 ' A' ' 61' ' ' LEU . 21.3 m -115.75 -176.91 3.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.204 1.402 . . . . 0.0 108.722 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.2 m -73.47 -33.72 64.99 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.186 0.517 . . . . 0.0 110.681 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -104.37 28.18 7.15 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.844 -175.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.439 HG21 ' HB2' ' A' ' 26' ' ' LEU . 53.3 m -67.76 105.18 1.85 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.347 0.594 . . . . 0.0 109.686 171.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.536 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 36.2 mtm-85 -65.92 175.85 1.85 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.757 1.223 . . . . 0.0 111.637 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 54' ' ' LEU . 7.3 tt -56.39 -57.67 11.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.356 0.662 . . . . 0.0 109.28 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -50.51 -34.6 25.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.9 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 18.6 mm-40 -76.11 -51.03 13.07 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.002 0.429 . . . . 0.0 110.087 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.592 HD12 HD11 ' A' ' 43' ' ' ILE . 2.4 tm? -70.76 -67.27 0.52 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.317 1.047 . . . . 0.0 110.68 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -66.55 -20.38 66.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.599 0.562 . . . . 0.0 111.618 -176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.22 -37.01 43.59 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.729 0.643 . . . . 0.0 112.192 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.41 ' O ' HG12 ' A' ' 33' ' ' ILE . 22.8 mt-30 -70.63 -39.73 73.53 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -62.76 -36.63 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.312 0.645 . . . . 0.0 110.615 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -26.34 68.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.439 0.695 . . . . 0.0 111.536 173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.81 -23.04 20.72 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.92 0.888 . . . . 0.0 111.766 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 29' ' ' GLN . 16.0 mm -82.78 -70.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.372 0.669 . . . . 0.0 110.374 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.403 HG22 HG12 ' A' ' 36' ' ' ILE . 4.8 t -97.77 -7.75 29.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.16 19.23 78.72 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 119.712 -0.493 . . . . 0.0 113.321 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 75' ' ' GLU . 11.0 mm -98.49 108.26 21.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.84 155.07 55.13 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.498 1.119 . . . . 0.0 112.157 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.12 -31.71 84.19 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.419 2.746 . . . . 0.0 114.599 -174.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.02 3.1 80.44 Favored Glycine 0 N--CA 1.476 1.353 0 O-C-N 123.124 0.265 . . . . 0.0 113.346 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.409 ' HA ' ' HB3' ' A' ' 77' ' ' ASP . 19.1 m -107.25 -2.93 20.28 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.198 0.999 . . . . 0.0 110.179 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -144.53 162.45 36.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.974 0.416 . . . . 0.0 111.86 -176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.48 -176.35 5.08 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.18 1.392 . . . . 0.0 108.885 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.592 HD11 HD12 ' A' ' 26' ' ' LEU . 29.0 mm -105.8 110.63 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.535 . . . . 0.0 109.723 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -121.34 160.18 24.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -131.92 173.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.755 0.822 . . . . 0.0 111.125 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.48 -5.1 87.86 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.814 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 54.0 p90 -113.51 163.2 19.07 Favored Pre-proline 0 N--CA 1.479 1.017 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 10.8 Cg_endo -50.89 109.21 0.28 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 122.88 2.387 . . . . 0.0 112.489 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.33 169.81 12.33 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.746 2.297 . . . . 0.0 112.159 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -88.08 5.73 39.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.706 0.802 . . . . 0.0 111.335 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 90.3 m 56.27 83.05 0.1 Allowed 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -158.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.61 95.6 3.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 110.512 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.75 114.0 20.1 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.143 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 23' ' ' LEU . 4.7 mp -79.46 84.83 5.3 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 p -67.9 -50.56 55.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.468 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.58 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 19.3 t70 -76.25 157.55 32.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.083 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -92.52 -34.78 13.93 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.286 1.034 . . . . 0.0 111.815 -173.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.51 -3.07 50.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.9 1.28 . . . . 0.0 110.431 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.58 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 15.8 tt -60.85 133.51 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.637 1.175 . . . . 0.0 111.883 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -108.69 -177.9 3.44 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.555 HD22 ' HG ' ' A' ' 26' ' ' LEU . 49.7 mt -75.64 -10.05 59.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 112.061 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 -25.09 73.79 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.52 -59.33 2.16 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 109.846 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.75 129.79 75.47 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.282 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -63.21 78.26 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.918 3.079 . . . . 0.0 114.053 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.637 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -108.11 108.78 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 12.3 mm100 -103.31 155.05 18.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.972 0.509 . . . . 0.0 109.989 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.6 p -62.79 100.97 0.22 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.786 0.835 . . . . 0.0 111.826 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.53 46.08 8.22 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.608 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 6.0 t70 -110.25 169.71 8.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.309 0.644 . . . . 0.0 110.374 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.529 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 4.1 tpt -102.18 103.29 13.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.308 0.643 . . . . 0.0 109.991 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.637 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.6 mm? -106.01 114.68 28.96 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.475 0.71 . . . . 0.0 109.679 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 2.8 mp -82.13 108.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.667 0.787 . . . . 0.0 109.737 -176.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 75.8 t -82.97 116.42 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.706 1.203 . . . . 0.0 108.933 170.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' O ' HG23 ' A' ' 36' ' ' ILE . 11.9 pt-20 -82.31 170.23 15.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.646 0.26 . . . . 0.0 110.699 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -129.57 114.6 16.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 27.7 t70 -94.72 -23.05 17.73 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.342 1.057 . . . . 0.0 110.703 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 63.7 36.02 11.01 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.553 1.141 . . . . 0.0 111.81 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.408 HG23 ' OG ' ' A' ' 40' ' ' SER . 10.1 t -66.95 -22.61 65.93 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 54.94 76.67 0.49 Allowed Pre-proline 0 C--N 1.361 1.092 0 C-N-CA 124.474 1.11 . . . . 0.0 110.727 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.8 171.42 14.39 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.914 2.41 . . . . 0.0 112.945 -173.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -67.47 95.24 0.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.0 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.65 -9.93 59.76 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.586 0.755 . . . . 0.0 111.671 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 m -107.09 101.64 39.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.837 0.855 . . . . 0.0 109.322 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.87 -14.41 42.96 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.962 2.441 . . . . 0.0 113.449 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.555 1.164 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.861 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 32.0 m0 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -81.16 94.8 6.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.9 144.3 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.189 0.995 . . . . 0.0 109.861 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -100.01 141.87 32.25 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.002 0.521 . . . . 0.0 110.903 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 31.2 p -122.85 112.49 17.94 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 0.0 111.369 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HB3' HG13 ' A' ' 73' ' ' ILE . 13.3 tppt? -81.03 106.1 12.77 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.23 -168.12 2.38 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.064 0.546 . . . . 0.0 111.518 -170.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -51.84 -40.32 60.33 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.638 1.175 . . . . 0.0 112.582 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.44 28.86 9.9 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.333 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.49 -153.46 49.22 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.995 0.331 . . . . 0.0 112.785 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.529 HG22 ' HE3' ' A' ' 71' ' ' MET . 3.8 m -83.79 112.76 20.39 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.588 0.755 . . . . 0.0 110.337 -176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 21.2 m-70 -104.78 179.31 4.31 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.046 0.939 . . . . 0.0 109.538 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD12 ' NE2' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -130.66 129.5 42.72 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' HG ' HG13 ' A' ' 33' ' ' ILE . 5.5 mp -99.98 118.21 35.91 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.48 1.112 . . . . 0.0 109.906 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.403 ' NE2' HD12 ' A' ' 13' ' ' LEU . 80.8 mm-40 -94.4 156.88 16.28 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.468 0.707 . . . . 0.0 109.199 171.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.16 81.72 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.536 -0.591 . . . . 0.0 114.409 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.89 118.57 12.9 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 110.072 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.4 m -114.01 172.99 6.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.197 0.999 . . . . 0.0 109.602 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.2 p -59.09 -35.22 73.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.832 0.853 . . . . 0.0 112.728 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -95.64 3.45 53.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.505 0.722 . . . . 0.0 112.636 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 25' ' ' GLU . 45.2 m -55.21 113.15 1.27 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.586 0.708 . . . . 0.0 111.495 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.56 172.18 11.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.177 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 54' ' ' LEU . 8.8 tt -59.15 -48.0 83.23 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.677 0.791 . . . . 0.0 110.536 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -25.15 67.37 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.998 0.519 . . . . 0.0 112.366 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.441 ' HB2' HG23 ' A' ' 21' ' ' THR . 64.2 mm-40 -78.73 -53.05 7.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.572 0.749 . . . . 0.0 109.875 175.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.06 -55.35 29.98 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.47 1.508 . . . . 0.0 111.236 -173.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.556 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 15.1 mm100 -57.78 -34.22 69.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.358 1.063 . . . . 0.0 111.967 177.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.73 -34.26 77.61 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.969 0.793 . . . . 0.0 111.678 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -76.52 -39.31 53.35 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 123.195 0.598 . . . . 0.0 110.408 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -56.82 -44.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.403 0.681 . . . . 0.0 110.7 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.21 -24.16 67.57 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.586 0.754 . . . . 0.0 111.843 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.65 -28.42 19.49 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.79 0.836 . . . . 0.0 112.135 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.408 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.9 mm -91.66 -51.19 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.139 0.976 . . . . 0.0 111.782 -171.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.537 HG23 HG12 ' A' ' 36' ' ' ILE . 15.0 t -115.91 -5.88 12.03 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.344 0.658 . . . . 0.0 111.28 -178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.51 -10.32 74.35 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 168.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 34' ' ' THR . 4.1 mm -82.4 118.5 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 117.953 0.876 . . . . 0.0 109.778 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.82 149.01 96.84 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.05 0.94 . . . . 0.0 111.3 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 11.7 Cg_endo -50.53 -41.01 54.14 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 124.198 3.265 . . . . 0.0 113.854 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.25 27.53 5.59 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.179 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.7 m -146.6 12.99 1.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.616 1.166 . . . . 0.0 109.033 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -155.7 151.05 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.188 0.518 . . . . 0.0 110.402 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -125.96 174.48 8.38 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.491 1.116 . . . . 0.0 108.143 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 72' ' ' LEU . 47.3 mm -106.72 114.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.7 mm? -119.5 166.42 13.13 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 47' ' ' TYR . 4.0 m -129.35 161.26 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.374 0.67 . . . . 0.0 110.462 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -43.57 96.16 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.616 0.573 . . . . 0.0 113.035 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.469 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 32.8 p90 -72.77 163.25 69.58 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.161 167.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 14.6 Cg_endo -52.61 114.61 1.76 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.904 2.403 . . . . 0.0 114.071 -173.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.68 178.66 2.75 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.366 2.71 . . . . 0.0 110.919 170.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.08 19.94 6.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.789 0.835 . . . . 0.0 109.601 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.4 m 57.04 82.37 0.12 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.591 1.157 . . . . 0.0 109.602 -164.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.407 HD12 HG21 ' A' ' 43' ' ' ILE . 95.3 mt -53.11 131.11 36.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.593 0.757 . . . . 0.0 111.34 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -82.73 106.17 14.35 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.792 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.493 ' HB3' HD11 ' A' ' 23' ' ' LEU . 7.2 mp -105.35 80.49 1.59 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.816 0.846 . . . . 0.0 109.097 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 p -102.71 -34.42 9.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.779 0.831 . . . . 0.0 110.945 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.61 -175.52 5.8 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.483 0.713 . . . . 0.0 109.95 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -31.1 1.48 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.621 0.768 . . . . 0.0 110.795 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.35 -19.58 42.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.876 0.87 . . . . 0.0 110.913 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.96 123.38 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 124.163 0.985 . . . . 0.0 111.109 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -96.54 -179.36 4.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -166.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.9 mt -68.92 -15.41 63.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.901 0.88 . . . . 0.0 111.838 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.6 -17.8 73.2 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.462 -0.336 . . . . 0.0 112.393 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.76 -63.06 1.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.924 0.89 . . . . 0.0 109.616 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.09 116.68 46.81 Favored Pre-proline 0 N--CA 1.486 1.345 0 CA-C-O 117.646 -1.168 . . . . 0.0 107.999 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -55.64 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.995 3.13 . . . . 0.0 115.055 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.486 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -110.4 121.66 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 166.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 37.8 mt-30 -119.53 166.22 13.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.287 0.635 . . . . 0.0 109.668 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.6 m -63.74 95.92 0.12 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.819 0.848 . . . . 0.0 110.925 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.93 29.41 23.31 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.436 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.525 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 23.6 t70 -87.79 160.47 18.02 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.148 0.579 . . . . 0.0 109.893 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.529 ' HE3' HG22 ' A' ' 11' ' ' THR . 4.7 tpt -96.9 100.98 12.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 110.261 -176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.1 mm? -104.94 112.79 26.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.671 0.788 . . . . 0.0 109.429 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -81.78 114.47 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.76 115.91 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 108.467 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.9 179.89 6.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 110.665 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -131.94 106.57 8.13 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.64 -13.49 62.13 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.737 1.215 . . . . 0.0 110.9 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 66.44 36.42 5.14 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.642 1.177 . . . . 0.0 111.896 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 m -88.83 41.08 1.0 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.759 0.824 . . . . 0.0 110.139 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 53.47 77.7 0.43 Allowed Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 125.023 1.329 . . . . 0.0 110.394 -169.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.61 -176.43 0.42 Allowed 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.153 2.569 . . . . 0.0 113.618 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 7.9 mmpt? 75.9 -24.6 0.22 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.263 1.425 . . . . 0.0 113.524 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.39 83.85 1.08 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 167.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.2 t -123.89 107.83 30.79 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.334 -168.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.52 141.65 38.77 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.354 2.036 . . . . 0.0 111.156 165.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.25 1.114 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.459 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.9 m0 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.681 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 78.3 mtm180 -80.35 69.93 6.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.151 0.98 . . . . 0.0 109.564 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.484 ' HB ' HD12 ' A' ' 17' ' ' LEU . 96.3 t -79.21 132.95 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.739 0.816 . . . . 0.0 111.142 -171.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -84.03 140.82 31.6 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.452 0.701 . . . . 0.0 109.958 178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 4.0 t -125.37 96.98 5.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.045 0.938 . . . . 0.0 110.255 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.1 102.67 9.48 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.67 122.74 35.81 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp 66.27 17.62 10.75 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.854 1.262 . . . . 0.0 112.209 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.98 -8.76 79.36 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 112.955 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.78 119.88 6.64 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.513 HG23 ' HE3' ' A' ' 71' ' ' MET . 2.1 m -79.97 136.05 36.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.749 0.42 . . . . 0.0 110.247 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 79.7 m-70 -118.82 178.06 4.62 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.491 1.116 . . . . 0.0 108.42 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 2' ' ' ARG . 1.3 tm? -146.31 114.18 6.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.6 mp -104.97 105.87 16.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.75 1.22 . . . . 0.0 109.224 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.681 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 78.2 mt-30 -84.17 -17.76 38.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.337 0.655 . . . . 0.0 111.067 172.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.62 24.64 4.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.484 HD12 ' HB ' ' A' ' 3' ' ' VAL . 87.0 mt -110.33 123.95 50.78 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.728 0.811 . . . . 0.0 109.486 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.411 ' O ' HD11 ' A' ' 61' ' ' LEU . 25.9 m -113.67 171.43 7.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.546 1.138 . . . . 0.0 108.97 172.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -57.84 -41.66 82.8 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.002 0.429 . . . . 0.0 112.128 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -92.19 17.05 10.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.654 0.782 . . . . 0.0 112.076 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -68.19 122.41 18.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.212 0.605 . . . . 0.0 110.119 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -78.57 177.15 8.8 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.824 0.45 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 tt -55.08 -50.82 68.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.148 0.979 . . . . 0.0 110.537 174.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -61.38 -30.36 70.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.421 -173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -80.55 -46.66 15.41 Favored 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 122.588 0.355 . . . . 0.0 110.389 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.76 -68.31 0.35 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.92 0.888 . . . . 0.0 110.594 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -66.87 -20.65 65.96 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.07 0.548 . . . . 0.0 111.519 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.13 -38.14 59.48 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.885 0.741 . . . . 0.0 112.328 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -74.05 -39.55 63.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.127 0.571 . . . . 0.0 109.6 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.8 mt -57.46 -40.64 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.558 0.743 . . . . 0.0 110.669 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.83 -24.39 67.74 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.055 0.942 . . . . 0.0 111.844 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.51 -32.35 15.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.858 0.863 . . . . 0.0 111.786 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.6 mm -79.94 -65.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.395 1.078 . . . . 0.0 110.283 -174.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.459 HG22 HG12 ' A' ' 36' ' ' ILE . 10.1 t -99.45 -15.93 18.54 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.407 0.683 . . . . 0.0 111.3 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.32 82.97 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.202 -0.777 . . . . 0.0 114.338 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.459 HG12 HG22 ' A' ' 34' ' ' THR . 13.7 mm -78.76 119.56 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.169 0.984 . . . . 0.0 108.348 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.11 142.52 85.64 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 124.235 0.96 . . . . 0.0 111.24 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.73 -27.67 72.09 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.406 2.737 . . . . 0.0 113.256 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.42 27.04 14.8 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.119 0.39 . . . . 0.0 112.589 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.6 m -142.14 7.66 1.81 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.482 1.113 . . . . 0.0 109.698 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -148.71 149.16 30.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.946 0.898 . . . . 0.0 109.983 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.23 -175.31 3.53 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.312 1.045 . . . . 0.0 108.973 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.518 HG23 ' HD2' ' A' ' 65' ' ' PRO . 49.2 mm -104.49 109.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.27 0.628 . . . . 0.0 109.616 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 34.8 mt -122.04 151.79 40.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.532 HG21 ' HB3' ' A' ' 49' ' ' PRO . 17.1 m -132.39 173.72 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.48 0.712 . . . . 0.0 110.907 -174.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.4 -49.01 66.32 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.874 0.734 . . . . 0.0 113.835 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -79.47 158.11 74.18 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.644 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -46.24 104.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.485 2.79 . . . . 0.0 114.624 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HB3' HG21 ' A' ' 45' ' ' VAL . 98.6 Cg_endo -82.81 156.88 15.77 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.886 2.391 . . . . 0.0 112.808 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -75.75 -22.52 56.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.6 0.76 . . . . 0.0 112.147 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.2 m 65.92 35.93 6.25 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.369 1.068 . . . . 0.0 109.014 -171.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -39.59 140.93 0.44 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.922 177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.31 106.74 16.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.463 0.705 . . . . 0.0 110.209 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.5 mp -86.05 96.79 9.98 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.514 0.726 . . . . 0.0 109.429 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -109.1 -39.73 5.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.87 0.868 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.63 145.24 41.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.389 0.676 . . . . 0.0 110.693 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.57 -20.67 15.58 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.093 0.957 . . . . 0.0 110.551 -177.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.45 -19.52 49.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.326 1.05 . . . . 0.0 111.251 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 tt -57.71 126.13 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.667 0.787 . . . . 0.0 111.46 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -106.34 175.9 5.34 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.095 0.958 . . . . 0.0 111.104 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 21.1 mt -74.1 -1.07 18.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.8 0.84 . . . . 0.0 111.473 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.92 -39.04 64.65 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.818 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.54 -48.53 6.81 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 96.1 mt -59.77 139.23 90.07 Favored Pre-proline 0 CA--C 1.558 1.266 0 O-C-N 123.871 0.732 . . . . 0.0 110.36 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.518 ' HD2' HG23 ' A' ' 43' ' ' ILE . 6.3 Cg_exo -79.2 45.1 1.84 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.436 2.757 . . . . 0.0 113.385 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.491 ' HA ' HD22 ' A' ' 72' ' ' LEU . 2.1 mp -93.41 119.5 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 171.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 36.2 mm-40 -116.47 166.79 11.68 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.027 0.531 . . . . 0.0 109.573 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 p -64.59 109.92 2.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.29 0.636 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 78.57 10.15 86.44 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.11 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.1 t70 -76.65 159.18 30.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.24 0.616 . . . . 0.0 111.353 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.515 ' HA ' ' HE1' ' A' ' 71' ' ' MET . 2.9 tpt -86.08 101.88 13.35 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.454 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 66' ' ' ILE . 4.6 mm? -102.04 113.18 26.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.267 1.027 . . . . 0.0 108.883 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.9 mp -88.48 99.89 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.67 105.77 5.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.844 170.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.4 149.85 36.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.366 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -110.2 105.02 13.93 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.36 -5.47 47.34 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 123.66 0.784 . . . . 0.0 110.349 172.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 67.94 -86.61 0.03 OUTLIER 'General case' 0 C--N 1.362 1.139 0 C-N-CA 126.073 1.749 . . . . 0.0 108.804 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.416 HG23 ' HD3' ' A' ' 81' ' ' PRO . 10.1 t 38.58 -67.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 127.883 2.473 . . . . 0.0 115.524 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 69.8 76.42 0.24 Allowed Pre-proline 0 C--N 1.35 0.621 0 C-N-CA 125.757 1.623 . . . . 0.0 110.699 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.416 ' HD3' HG23 ' A' ' 79' ' ' THR . 45.4 Cg_endo -83.03 -153.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.102 2.535 . . . . 0.0 110.898 175.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -61.07 -33.73 73.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 122.839 0.456 . . . . 0.0 111.246 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 69.64 -72.88 0.1 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.516 1.526 . . . . 0.0 111.342 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -91.81 113.54 59.16 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.186 0.994 . . . . 0.0 108.81 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.26 -8.28 14.0 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.592 2.194 . . . . 0.0 112.071 172.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.8 p . . . . . 0 CA--C 1.553 1.078 0 C-N-CA 124.532 1.133 . . . . 0.0 110.565 179.252 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 9.0 m0 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.431 ' HB3' HD13 ' A' ' 13' ' ' LEU . 54.2 mtt180 -87.22 74.11 9.6 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 66' ' ' ILE . 34.7 t -87.21 138.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.672 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -89.54 158.2 17.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.573 0.749 . . . . 0.0 110.519 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 28.1 p -142.97 114.57 8.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.214 0.606 . . . . 0.0 109.627 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -79.02 109.61 13.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.95 103.21 4.74 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 122.977 0.511 . . . . 0.0 110.313 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 76' ' ' GLU . 31.0 mmmt 61.47 29.61 18.49 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.717 1.207 . . . . 0.0 111.511 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.39 -27.74 8.24 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.679 -174.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.18 100.25 0.63 Allowed Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.607 HG22 ' HE2' ' A' ' 71' ' ' MET . 11.3 m -82.92 92.28 7.29 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 32.4 m80 -94.59 160.73 14.5 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.1 -174.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 2' ' ' ARG . 2.7 tm? -119.14 115.3 23.96 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.561 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -98.79 132.45 44.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 109.207 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.46 173.03 12.02 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.05 12.47 76.64 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 1' ' ' TRP . 98.5 mt -83.54 115.38 22.07 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.369 0.668 . . . . 0.0 109.491 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.3 t -79.23 173.75 12.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.484 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.1 p -64.09 -35.62 81.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.996 0.427 . . . . 0.0 110.595 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -104.72 33.46 3.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.07 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.426 HG23 HD23 ' A' ' 17' ' ' LEU . 74.6 m -69.26 113.01 6.21 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 171.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -77.52 178.28 7.37 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.349 1.059 . . . . 0.0 111.234 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 54' ' ' LEU . 8.4 tt -57.16 -54.9 41.55 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.436 0.695 . . . . 0.0 110.228 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -14.43 63.04 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.231 -174.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.36 -49.41 8.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.611 0.764 . . . . 0.0 109.24 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.425 HD13 HD13 ' A' ' 43' ' ' ILE . 2.4 tm? -75.51 -64.55 1.05 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.668 1.187 . . . . 0.0 110.464 -170.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.8 -20.17 64.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.23 0.612 . . . . 0.0 111.083 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.24 -43.76 88.08 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 124.011 0.82 . . . . 0.0 111.902 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.75 -36.24 67.66 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 119.509 -0.282 . . . . 0.0 110.268 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.92 -44.47 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.268 0.627 . . . . 0.0 110.343 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.74 66.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.167 0.987 . . . . 0.0 112.116 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.57 -40.01 12.9 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.317 0.647 . . . . 0.0 111.605 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.561 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.8 mm -69.13 -65.97 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.227 1.011 . . . . 0.0 110.629 -173.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.432 HG23 HG12 ' A' ' 36' ' ' ILE . 5.0 t -99.85 -11.87 20.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.291 -175.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.07 86.1 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.499 -0.612 . . . . 0.0 114.122 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.432 HG12 HG23 ' A' ' 34' ' ' THR . 13.3 mm -83.37 118.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.52 146.44 73.04 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.798 0.839 . . . . 0.0 111.474 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.43 -30.86 92.75 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.165 2.577 . . . . 0.0 112.419 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.64 32.55 5.24 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.531 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -141.86 2.12 1.53 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 110.163 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -148.96 163.63 36.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.897 0.879 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 176.03 10.64 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.393 0.677 . . . . 0.0 110.042 173.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.425 HD13 HD13 ' A' ' 26' ' ' LEU . 44.7 mm -84.05 113.8 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 17.7 mt -132.43 123.63 27.06 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.43 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 16.3 m -102.78 173.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.975 0.51 . . . . 0.0 112.197 -169.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -46.42 93.78 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 124.353 1.033 . . . . 0.0 114.235 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -79.34 158.3 74.25 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 117.959 -1.019 . . . . 0.0 108.912 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.95 107.1 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.403 2.736 . . . . 0.0 113.628 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 63.1 Cg_endo -77.31 155.86 32.8 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.509 2.139 . . . . 0.0 112.179 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -94.78 34.33 1.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.646 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 62.8 m 75.66 -54.3 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.773 1.629 . . . . 0.0 110.726 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.5 mt 68.01 90.96 0.09 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.869 1.267 . . . . 0.0 110.682 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.22 101.14 13.86 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.801 0.84 . . . . 0.0 110.252 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.572 ' HB3' HD11 ' A' ' 23' ' ' LEU . 6.1 mp -78.05 99.41 6.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -124.87 39.24 4.02 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.186 0.594 . . . . 0.0 111.009 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 59' ' ' ILE . 28.1 t70 -163.59 146.01 9.73 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.591 0.756 . . . . 0.0 109.856 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -76.66 -31.66 57.46 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.953 0.501 . . . . 0.0 111.394 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.65 -3.92 54.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.717 0.807 . . . . 0.0 112.286 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 56' ' ' ASP . 10.7 tt -64.08 123.62 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.108 0.48 . . . . 0.0 110.485 -176.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.7 p -101.89 176.62 5.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -166.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 mt -69.23 -12.19 61.46 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.621 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.97 -22.0 69.77 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.77 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.49 -53.07 3.88 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.84 150.47 92.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.57 43.53 1.51 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.98 2.453 . . . . 0.0 114.661 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.556 HG13 HD23 ' A' ' 72' ' ' LEU . 2.6 mp -73.0 119.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 38.1 mt-30 -118.64 157.24 27.79 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 p -64.02 103.67 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.435 0.694 . . . . 0.0 111.442 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.41 21.97 57.42 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.967 -0.561 . . . . 0.0 113.402 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 9.8 t70 -79.76 160.9 26.02 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.856 0.463 . . . . 0.0 110.294 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.607 ' HE2' HG22 ' A' ' 11' ' ' THR . 1.8 tpt -91.16 98.79 11.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.714 0.805 . . . . 0.0 109.56 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.556 HD23 HG13 ' A' ' 66' ' ' ILE . 6.7 mp -93.83 104.71 16.77 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.8 mp -72.12 90.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -84.24 95.63 4.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.686 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -77.99 153.23 32.61 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.174 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . 40.6 tt0 -104.96 99.25 8.87 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -72.28 -12.79 61.31 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.89 0.876 . . . . 0.0 109.846 171.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 69.9 -80.26 0.04 OUTLIER 'General case' 0 C--N 1.364 1.201 0 C-N-CA 126.243 1.817 . . . . 0.0 109.736 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t 38.55 -62.84 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 128.301 2.641 . . . . 0.0 116.874 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 83.97 80.68 0.07 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 127.055 2.142 . . . . 0.0 108.809 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -88.97 159.9 5.93 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.875 2.384 . . . . 0.0 112.426 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -98.24 100.78 12.1 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.46 135.3 47.11 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.067 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -76.27 134.55 70.38 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.479 0.712 . . . . 0.0 109.732 173.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.48 -41.55 76.91 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.4 2.733 . . . . 0.0 112.978 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.556 1.2 0 C-N-CA 123.47 0.708 . . . . 0.0 109.679 -179.823 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 16.3 m0 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.585 0.231 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.506 ' HB3' HD23 ' A' ' 13' ' ' LEU . 75.4 mtt180 -108.47 71.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.067 0.947 . . . . 0.0 108.684 173.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.426 HG11 HG22 ' A' ' 66' ' ' ILE . 71.7 t -79.09 123.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.642 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -81.79 141.49 33.44 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.538 ' SG ' HD12 ' A' ' 14' ' ' LEU . 92.3 m -135.54 105.67 6.3 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.715 0.406 . . . . 0.0 111.19 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -79.84 98.41 7.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.18 96.81 7.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 109.981 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt 70.39 -75.45 0.07 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.953 1.301 . . . . 0.0 111.312 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.33 25.42 1.24 Allowed Glycine 0 C--N 1.346 1.101 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.58 105.35 0.57 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.47 HG23 ' HE3' ' A' ' 71' ' ' MET . 4.5 m -76.98 118.58 19.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.131 0.573 . . . . 0.0 109.78 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -109.69 176.25 5.14 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.777 0.831 . . . . 0.0 109.76 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.506 HD23 ' HB3' ' A' ' 2' ' ' ARG . 10.4 tt -151.19 116.06 5.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.635 ' HG ' HG13 ' A' ' 33' ' ' ILE . 7.3 mp -90.63 131.02 36.58 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.811 1.244 . . . . 0.0 109.607 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -92.09 164.44 13.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.578 0.751 . . . . 0.0 110.571 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.97 -97.19 1.62 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-O 118.833 -0.982 . . . . 0.0 111.225 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.551 HD13 HD13 ' A' ' 61' ' ' LEU . 4.1 mm? 42.16 104.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.567 1.547 . . . . 0.0 113.217 -175.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.9 t -73.18 154.2 40.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -62.71 -21.97 66.16 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 121.222 0.534 . . . . 0.0 110.674 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 74.1 mtt180 -110.01 29.99 7.13 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.289 1.036 . . . . 0.0 111.522 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.8 m -66.57 112.0 3.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -65.79 163.43 16.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.307 1.043 . . . . 0.0 110.969 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.481 HD11 HD21 ' A' ' 54' ' ' LEU . 23.5 tp -53.55 -52.2 60.45 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.07 0.948 . . . . 0.0 111.697 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 ptt85 -60.02 -24.1 64.23 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.159 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.26 -38.02 14.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.533 0.733 . . . . 0.0 110.058 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -66.09 0.64 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.534 1.134 . . . . 0.0 110.091 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.81 -17.41 64.51 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.458 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.47 -37.26 85.37 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.687 0.617 . . . . 0.0 112.076 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -75.63 -40.45 56.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.243 0.617 . . . . 0.0 110.419 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HB ' HE22 ' A' ' 41' ' ' GLN . 82.1 mt -61.78 -35.83 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.537 0.735 . . . . 0.0 110.926 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -24.99 66.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.128 0.971 . . . . 0.0 112.009 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.01 -42.83 9.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.976 0.911 . . . . 0.0 111.161 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.635 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.1 mm -66.11 -50.69 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 112.011 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.518 HG22 HG12 ' A' ' 36' ' ' ILE . 7.2 t -124.04 -1.32 8.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.122 0.569 . . . . 0.0 111.377 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 -0.23 89.56 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 34' ' ' THR . 11.4 mm -82.54 103.78 10.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.76 152.53 67.95 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.951 0.9 . . . . 0.0 111.426 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.84 -38.51 57.6 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.76 2.974 . . . . 0.0 114.547 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.25 30.45 5.95 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.44 -0.346 . . . . 0.0 113.325 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -132.42 -3.47 3.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.063 0.945 . . . . 0.0 110.09 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.408 HE22 ' HB ' ' A' ' 30' ' ' ILE . 1.5 pt20 -140.19 163.75 31.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.594 0.758 . . . . 0.0 111.376 -171.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -147.97 170.94 16.62 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.767 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.424 HG23 HD11 ' A' ' 72' ' ' LEU . 49.2 mm -96.61 110.24 24.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.443 -175.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 mt -123.8 159.18 30.09 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.718 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.11 -179.21 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.216 1.007 . . . . 0.0 110.27 -171.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.36 -46.15 65.31 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.934 0.771 . . . . 0.0 113.205 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -74.87 162.15 74.69 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.404 171.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.17 108.63 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.941 2.427 . . . . 0.0 111.867 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -74.25 172.81 15.29 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.186 2.591 . . . . 0.0 111.979 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.25 -2.12 57.7 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.495 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.6 m 51.28 65.13 1.58 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 124.119 0.968 . . . . 0.0 109.11 -172.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 mp -67.32 134.04 50.8 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.792 -165.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.35 88.19 5.04 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.481 HD21 HD11 ' A' ' 23' ' ' LEU . 5.5 mp -77.43 88.3 3.8 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 p -97.11 -49.16 5.1 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.999 0.92 . . . . 0.0 110.867 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.39 123.63 24.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.999 0.92 . . . . 0.0 110.255 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.56 -20.49 59.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.997 0.519 . . . . 0.0 112.31 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -89.67 -8.24 52.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.968 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.7 tt -64.11 123.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 121.404 0.621 . . . . 0.0 110.32 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 64.8 p -97.34 175.19 6.35 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.469 -170.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.551 HD13 HD13 ' A' ' 17' ' ' LEU . 23.4 mt -69.76 -13.81 62.47 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.55 173.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.15 -29.45 72.9 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.736 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -93.88 -60.75 1.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.55 143.36 86.33 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.715 1.206 . . . . 0.0 111.238 -174.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.13 39.65 0.84 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.552 2.834 . . . . 0.0 114.429 -173.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.519 HG13 ' HG ' ' A' ' 72' ' ' LEU . 3.1 mp -87.26 120.56 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 172.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.414 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 24.1 mm-40 -119.97 159.28 25.01 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.821 0.848 . . . . 0.0 110.213 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.6 p -68.23 112.05 4.91 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.509 0.723 . . . . 0.0 110.853 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.99 12.82 82.17 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.639 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 20.2 t70 -86.17 160.52 19.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.697 0.799 . . . . 0.0 109.798 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.47 ' HE3' HG23 ' A' ' 11' ' ' THR . 0.8 OUTLIER -95.77 97.59 9.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.017 0.927 . . . . 0.0 110.355 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.519 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.1 mm? -96.55 113.58 25.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.521 0.728 . . . . 0.0 109.622 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.2 mp -78.76 103.2 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.3 t -82.29 104.52 11.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.344 171.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.69 159.71 28.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.294 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 78' ' ' GLN . 38.5 tt0 -124.49 124.84 43.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.17 -23.62 57.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.488 0.715 . . . . 0.0 111.174 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 76' ' ' GLU . 76.9 mt-30 68.41 30.79 5.25 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.968 1.307 . . . . 0.0 110.583 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.6 t -68.27 -10.39 54.34 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.858 0.863 . . . . 0.0 111.945 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 61.32 72.25 0.7 Allowed Pre-proline 0 C--N 1.362 1.138 0 C-N-CA 124.336 1.054 . . . . 0.0 108.499 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.88 135.05 49.71 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.389 2.726 . . . . 0.0 114.525 -166.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -65.5 -33.26 75.52 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.437 169.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.81 78.3 0.87 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.25 1.02 . . . . 0.0 109.697 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.456 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 41.1 m -95.1 -175.42 0.47 Allowed Pre-proline 0 CA--C 1.563 1.466 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.833 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 84' ' ' SER . 17.7 Cg_exo -40.15 101.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.85 0 C-N-CA 122.939 2.426 . . . . 0.0 113.34 166.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.251 1.182 0 C-N-CA 123.981 0.913 . . . . 0.0 109.253 -173.277 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.416 ' HB3' HG22 ' A' ' 3' ' ' VAL . 13.2 m0 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.455 ' HG3' HD12 ' A' ' 13' ' ' LEU . 11.0 mpt_? -79.75 67.37 5.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.704 0.802 . . . . 0.0 109.742 173.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG22 ' HB3' ' A' ' 1' ' ' TRP . 72.1 t -77.39 119.95 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.75 0.42 . . . . 0.0 109.875 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -93.99 128.38 40.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 95.8 m -117.79 111.3 18.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.372 0.669 . . . . 0.0 110.402 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -75.41 127.45 33.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.718 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.04 -174.26 4.65 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 0.0 109.785 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 36.3 mtmt -67.21 127.43 32.59 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.77 -5.67 43.5 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -170.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -160.76 14.0 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.211 0.434 . . . . 0.0 112.603 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.527 HG23 ' HE3' ' A' ' 71' ' ' MET . 15.9 m -94.73 118.84 32.37 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.423 0.689 . . . . 0.0 109.751 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -92.51 142.6 27.23 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.858 0.863 . . . . 0.0 108.805 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.455 HD12 ' HG3' ' A' ' 2' ' ' ARG . 2.7 tm? -103.3 105.21 15.43 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.538 ' HG ' HG13 ' A' ' 33' ' ' ILE . 8.2 mp -86.93 139.03 31.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.339 0.655 . . . . 0.0 110.918 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.31 164.2 16.02 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.867 1.267 . . . . 0.0 109.675 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.89 79.53 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.321 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 61' ' ' LEU . 3.6 mm? -82.61 108.32 15.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' HD13 ' A' ' 61' ' ' LEU . 44.4 t -84.7 170.03 13.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.852 168.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -69.1 -22.59 63.97 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.162 0.506 . . . . 0.0 111.054 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -111.6 23.26 14.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.293 1.037 . . . . 0.0 111.75 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.7 m -63.34 108.35 1.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -69.99 172.07 8.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.096 0.958 . . . . 0.0 111.689 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.6 tp -50.64 -55.82 14.66 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.276 1.031 . . . . 0.0 111.574 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.1 ptm180 -49.51 -37.47 26.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.612 1.165 . . . . 0.0 113.353 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 10.8 mm-40 -85.81 -35.97 20.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.288 0.635 . . . . 0.0 110.962 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.66 -66.07 0.79 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.065 0.946 . . . . 0.0 109.033 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -67.46 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.272 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.96 89.58 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.032 0.833 . . . . 0.0 111.959 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -72.95 -45.06 60.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.32 -39.49 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.44 0.696 . . . . 0.0 111.116 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.49 67.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.65 0.78 . . . . 0.0 111.678 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.3 14.83 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.545 0.738 . . . . 0.0 111.351 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.538 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.2 mm -76.46 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.342 1.057 . . . . 0.0 110.914 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.49 HG21 HG12 ' A' ' 36' ' ' ILE . 7.5 t -102.09 -9.96 20.1 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 0.0 111.019 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.65 69.76 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 119.783 -0.454 . . . . 0.0 114.034 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.49 HG12 HG21 ' A' ' 34' ' ' THR . 21.2 mm -90.44 127.73 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.67 138.83 61.41 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.782 0.833 . . . . 0.0 110.676 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 -39.31 83.77 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.559 2.839 . . . . 0.0 113.342 -174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' HA3' ' HG2' ' A' ' 81' ' ' PRO . . . -89.78 22.08 26.75 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.737 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -124.83 -5.14 7.51 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.234 1.014 . . . . 0.0 109.902 174.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.558 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 1.3 pp0? -130.23 143.77 50.97 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 124.201 1.0 . . . . 0.0 109.236 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -135.05 179.12 6.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.728 0.811 . . . . 0.0 109.341 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.499 HD12 HD12 ' A' ' 66' ' ' ILE . 45.9 mm -94.47 92.46 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 121.995 0.903 . . . . 0.0 109.077 -174.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.4 mt -110.09 149.33 30.2 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 65' ' ' PRO . 9.4 m -134.02 179.73 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.113 0.565 . . . . 0.0 111.371 -167.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.02 11.01 8.27 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.333 -0.848 . . . . 0.0 114.736 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -144.33 160.72 47.59 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.162 1.385 . . . . 0.0 108.042 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -39.55 109.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.713 2.942 . . . . 0.0 113.99 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -80.68 -171.93 1.38 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.368 2.712 . . . . 0.0 112.172 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -122.73 15.23 10.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.65 0.78 . . . . 0.0 110.735 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.5 m 55.5 73.26 0.43 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.042 0.937 . . . . 0.0 109.474 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.71 108.87 8.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.886 -171.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -97.42 126.65 42.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.297 1.039 . . . . 0.0 108.205 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 mp -100.24 78.98 2.1 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 m -75.05 -28.51 60.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.294 0.638 . . . . 0.0 110.796 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.65 152.65 31.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.453 0.471 . . . . 0.0 109.773 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -103.46 -29.21 11.32 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.444 0.698 . . . . 0.0 111.641 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -89.62 -11.82 41.49 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.494 0.718 . . . . 0.0 110.753 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.62 134.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 111.695 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.0 p -117.48 179.07 4.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 111.39 -169.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 17' ' ' LEU . 40.3 mt -68.49 -13.44 62.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.634 0.774 . . . . 0.0 111.572 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.17 80.03 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.336 0.398 . . . . 0.0 112.396 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -84.74 -55.86 3.88 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.126 0.57 . . . . 0.0 109.534 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.24 152.0 92.33 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.434 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.526 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.2 Cg_exo -69.09 21.65 0.15 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.811 3.007 . . . . 0.0 115.488 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.499 HD12 HD12 ' A' ' 43' ' ' ILE . 3.2 mp -73.92 116.62 16.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 172.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -118.75 173.92 6.58 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -71.16 101.67 2.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.16 0.584 . . . . 0.0 109.943 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 89.03 20.42 46.44 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.176 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.33 162.28 25.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.037 0.535 . . . . 0.0 111.007 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.527 ' HE3' HG23 ' A' ' 11' ' ' THR . 3.6 tpt -102.85 104.73 15.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.947 0.899 . . . . 0.0 109.696 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.13 112.16 25.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.044 0.937 . . . . 0.0 108.992 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.82 97.88 4.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.24 104.98 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.155 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.558 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 8.0 pt-20 -76.44 167.55 21.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.854 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.27 103.99 5.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.22 -15.87 56.03 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.391 0.676 . . . . 0.0 110.507 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 63.31 27.99 15.55 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.295 1.438 . . . . 0.0 111.376 -173.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -63.45 -38.88 92.83 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.477 0.711 . . . . 0.0 110.567 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 38.91 68.31 1.98 Allowed Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 126.02 1.728 . . . . 0.0 113.981 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.501 ' HG2' ' HA3' ' A' ' 39' ' ' GLY . 2.5 Cg_endo -83.85 130.19 4.95 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.929 2.419 . . . . 0.0 110.754 172.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -94.37 41.35 1.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.76 0.824 . . . . 0.0 110.917 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.45 99.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.873 173.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.4 p -144.0 86.89 8.24 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.244 1.018 . . . . 0.0 108.587 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.31 -60.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.831 2.354 . . . . 0.0 111.578 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.612 1.165 . . . . 0.0 108.616 177.488 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.445 ' HB3' HG23 ' A' ' 3' ' ' VAL . 14.1 m0 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.511 ' HG2' HE22 ' A' ' 15' ' ' GLN . 82.1 mtt85 -79.19 69.76 5.45 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.381 0.673 . . . . 0.0 109.513 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 1' ' ' TRP . 89.6 t -83.94 129.64 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.346 0.658 . . . . 0.0 110.084 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -88.59 141.1 28.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.36 0.664 . . . . 0.0 109.209 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 71.1 m -138.33 101.34 4.36 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.332 0.653 . . . . 0.0 110.526 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -73.3 112.56 9.48 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.982 0.913 . . . . 0.0 109.734 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 74' ' ' VAL . . . -144.38 123.53 12.92 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.394 0.677 . . . . 0.0 110.23 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 56.41 56.58 5.58 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.05 1.34 . . . . 0.0 112.86 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.1 26.63 73.99 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.576 -0.738 . . . . 0.0 114.41 174.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.58 144.19 10.5 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.473 HG21 ' HE3' ' A' ' 71' ' ' MET . 3.9 m -93.64 102.1 14.27 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -89.6 115.29 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.772 0.829 . . . . 0.0 109.636 -174.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.85 104.16 14.56 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.809 0.444 . . . . 0.0 110.548 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.63 127.91 34.08 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 111.076 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.511 HE22 ' HG2' ' A' ' 2' ' ' ARG . 32.3 mm-40 -113.3 176.22 5.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.781 1.233 . . . . 0.0 110.103 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.28 3.45 61.52 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.5 mt -84.42 129.38 34.87 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 123.804 0.842 . . . . 0.0 111.065 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.433 ' O ' HD12 ' A' ' 61' ' ' LEU . 17.8 m -108.37 -176.56 3.08 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.374 168.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.7 p -66.2 -29.58 69.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.058 0.456 . . . . 0.0 110.69 171.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.98 23.41 8.99 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.88 0.872 . . . . 0.0 112.713 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.3 m -80.51 130.38 35.1 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 82.2 mtm180 -98.83 177.76 5.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.731 0.812 . . . . 0.0 110.384 -174.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 57' ' ' ARG . 5.4 tt -48.16 -59.53 3.33 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.181 1.392 . . . . 0.0 110.717 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 9.3 ptp180 -61.66 -26.8 68.24 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.637 -173.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.499 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 46.9 mt-10 -91.55 -30.04 16.62 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.979 0.912 . . . . 0.0 110.459 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.82 -67.24 0.78 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.749 0.82 . . . . 0.0 109.197 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.4 -16.26 63.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.777 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.45 -39.56 56.48 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.524 0.515 . . . . 0.0 111.929 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -73.83 -35.94 64.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.098 0.559 . . . . 0.0 110.284 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.12 -44.14 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.339 0.656 . . . . 0.0 109.704 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.04 68.07 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.775 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.42 -29.12 23.11 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.61 0.764 . . . . 0.0 111.856 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.1 mt -89.19 -69.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 117.878 0.308 . . . . 0.0 111.069 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 36' ' ' ILE . 9.5 t -88.43 -5.48 58.24 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.95 6.55 87.36 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.303 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.539 HG12 HG21 ' A' ' 34' ' ' THR . 11.7 mm -82.61 107.71 14.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.55 145.41 49.6 Favored Pre-proline 0 N--CA 1.48 1.058 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.539 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -54.28 -32.05 69.62 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.474 2.783 . . . . 0.0 113.658 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.86 24.67 19.91 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 116.4 -0.364 . . . . 0.0 113.544 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 m -131.96 4.66 4.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.527 1.131 . . . . 0.0 109.863 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -137.09 149.48 47.4 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.506 1.122 . . . . 0.0 109.347 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -120.19 -166.16 1.27 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.48 HG23 HD13 ' A' ' 72' ' ' LEU . 41.1 mm -123.31 105.7 16.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 4.3 mp -121.14 172.39 8.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.081 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 2.7 m -139.85 162.02 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 109.869 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.8 87.86 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 124.325 1.016 . . . . 0.0 113.368 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -72.6 155.41 91.03 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 117.756 -1.116 . . . . 0.0 109.597 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -33.61 100.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.397 3.116 0 C-N-CA 124.821 3.681 . . . . 0.0 114.763 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 99.0 Cg_endo -81.26 158.7 20.08 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.683 2.256 . . . . 0.0 113.421 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 30.5 mm-40 -101.14 90.34 4.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.0 m -47.79 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.636 1.174 . . . . 0.0 111.543 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.459 HD12 ' HB ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -99.44 167.53 10.56 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 111.805 179.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.06 144.51 40.07 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.75 93.22 4.78 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -85.47 -47.65 9.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.181 0.592 . . . . 0.0 110.239 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 12.8 t70 -73.25 107.3 5.48 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 -174.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.463 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.53 -24.58 32.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.93 -7.06 41.08 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.94 0.896 . . . . 0.0 112.272 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 tt -63.39 136.83 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.021 0.528 . . . . 0.0 111.146 -174.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 10.0 m -109.9 168.01 9.74 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.503 0.721 . . . . 0.0 111.601 -164.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 18' ' ' SER . 32.7 mt -59.55 -25.35 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.484 1.114 . . . . 0.0 112.895 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.63 -29.33 74.9 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.422 0.451 . . . . 0.0 112.881 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.57 -45.93 12.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.703 0.801 . . . . 0.0 109.87 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.98 160.04 72.15 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.698 0.799 . . . . 0.0 111.56 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.6 37.32 0.5 Allowed 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.294 2.662 . . . . 0.0 114.403 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.4 ' HA ' HD23 ' A' ' 72' ' ' LEU . 3.1 mp -88.28 114.13 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 29.5 mm-40 -118.4 158.48 25.21 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 p -67.46 109.48 3.22 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.506 0.722 . . . . 0.0 111.018 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 88.96 -1.55 83.32 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 21.8 t70 -73.67 159.27 33.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.556 0.742 . . . . 0.0 111.339 -172.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.487 ' HE1' ' HA ' ' A' ' 71' ' ' MET . 4.6 tpt -91.31 102.25 14.96 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.703 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.48 HD13 HG23 ' A' ' 43' ' ' ILE . 4.0 mm? -100.57 135.81 41.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.489 1.116 . . . . 0.0 108.314 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.9 mp -100.58 113.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 7' ' ' ALA . 54.7 t -94.08 109.51 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.73 172.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.01 159.66 22.14 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 175.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -117.39 119.0 33.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -92.44 -26.1 18.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.974 0.51 . . . . 0.0 110.911 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 69.52 12.61 8.23 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.393 1.477 . . . . 0.0 113.052 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -67.54 -29.29 68.64 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.317 0.247 . . . . 0.0 110.986 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 58.85 76.53 0.45 Allowed Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 124.927 1.291 . . . . 0.0 111.403 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -89.91 148.04 4.79 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.716 2.278 . . . . 0.0 112.688 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.667 ' HZ1' ' HB3' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -73.83 109.04 7.03 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.338 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.02 143.95 47.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.115 0.966 . . . . 0.0 109.117 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.3 p -91.21 106.01 14.63 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.13 -44.53 1.77 Allowed 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.323 2.015 . . . . 0.0 111.715 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--O 1.25 1.104 0 C-N-CA 124.775 1.23 . . . . 0.0 107.865 177.308 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 33.4 m0 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.482 ' HB3' HD11 ' A' ' 13' ' ' LEU . 71.0 mtm180 -82.85 85.01 7.18 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.0 t -98.23 146.16 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.766 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' HG2' HD23 ' A' ' 13' ' ' LEU . 95.8 mtt180 -88.79 150.84 22.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.592 0.757 . . . . 0.0 110.891 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 27.3 p -125.9 128.17 47.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.467 1.107 . . . . 0.0 108.925 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.2 tppp? -102.3 110.97 23.08 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.019 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.36 171.04 15.07 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -29.47 62.33 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.83 0.452 . . . . 0.0 110.055 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.65 -15.16 61.51 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.728 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.78 163.89 10.53 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 123.685 0.66 . . . . 0.0 111.778 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.441 HG23 ' HE3' ' A' ' 71' ' ' MET . 19.5 m -83.08 112.07 19.46 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 74.3 m80 -108.99 162.74 13.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.587 0.755 . . . . 0.0 109.695 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 2' ' ' ARG . 3.2 tm? -120.92 116.78 25.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.459 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.3 mp -87.74 160.64 17.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.432 0.693 . . . . 0.0 110.98 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -134.91 168.5 18.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.829 1.251 . . . . 0.0 108.273 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.05 82.21 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.014 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 94.3 mt -90.05 118.6 29.72 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.806 0.442 . . . . 0.0 110.072 178.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.6 t -86.4 174.79 8.77 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.478 1.111 . . . . 0.0 109.803 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.6 p -69.27 -29.63 67.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.265 0.626 . . . . 0.0 110.576 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 33.72 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.311 0.645 . . . . 0.0 112.285 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HG ' ' A' ' 61' ' ' LEU . 30.6 m -66.89 118.16 9.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -66.76 164.0 18.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.827 0.451 . . . . 0.0 110.763 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.475 HD21 ' HA ' ' A' ' 57' ' ' ARG . 6.0 tt -50.32 -53.58 27.7 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.73 1.212 . . . . 0.0 110.74 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -16.87 63.64 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.374 -173.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -84.3 -45.76 12.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.851 0.86 . . . . 0.0 109.432 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.519 ' HG ' HD21 ' A' ' 61' ' ' LEU . 1.6 tm? -69.02 -62.42 1.38 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.156 1.383 . . . . 0.0 110.766 -173.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -63.72 -22.43 66.9 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.753 0.658 . . . . 0.0 111.323 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.89 -38.43 94.25 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 124.015 0.822 . . . . 0.0 112.464 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -73.44 -42.6 61.8 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -61.41 -35.9 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.514 0.726 . . . . 0.0 111.271 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.36 67.42 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.894 0.877 . . . . 0.0 111.587 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.96 -35.97 11.77 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.136 0.974 . . . . 0.0 111.638 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.459 HG13 ' HG ' ' A' ' 14' ' ' LEU . 19.0 mm -76.01 -52.2 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.781 1.232 . . . . 0.0 111.648 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.544 HG23 HG12 ' A' ' 36' ' ' ILE . 7.9 t -115.33 -7.36 12.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.162 0.585 . . . . 0.0 110.717 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 21.36 63.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.57 -0.572 . . . . 0.0 114.073 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.544 HG12 HG23 ' A' ' 34' ' ' THR . 25.1 mm -95.03 124.81 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.679 0.739 . . . . 0.0 109.906 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' HB3' ' HG3' ' A' ' 81' ' ' PRO . . . -58.97 139.08 87.45 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 123.876 0.87 . . . . 0.0 110.813 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.41 -22.07 48.29 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.726 2.951 . . . . 0.0 114.095 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.45 29.95 11.25 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.823 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.5 m -135.53 -35.75 0.8 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.578 1.151 . . . . 0.0 109.054 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -85.9 142.85 28.56 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.935 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -130.99 170.34 14.61 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 125.234 1.414 . . . . 0.0 107.674 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 64' ' ' LEU . 44.2 mm -95.95 105.5 17.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 122.082 0.944 . . . . 0.0 109.875 -173.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.6 mt -113.95 155.02 26.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 113.477 -1.692 . . . . 0.0 106.648 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.65 164.86 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 122.723 0.409 . . . . 0.0 109.942 -166.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.17 73.65 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 124.026 0.822 . . . . 0.0 114.193 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -74.96 151.99 86.48 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.147 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -39.66 101.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.812 3.008 . . . . 0.0 113.575 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.39 157.58 41.05 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.93 2.42 . . . . 0.0 112.486 -171.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.22 3.01 55.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.077 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.93 71.29 0.52 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.8 1.24 . . . . 0.0 110.642 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.4 mt -79.73 124.69 28.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.656 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -90.46 108.03 19.53 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.385 1.074 . . . . 0.0 109.225 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 8.4 mp -79.75 95.08 5.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.662 0.785 . . . . 0.0 109.413 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.8 t -106.77 25.85 10.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.853 0.861 . . . . 0.0 110.116 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -126.05 -157.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.37 1.068 . . . . 0.0 108.749 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' HA ' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -147.95 -31.39 0.29 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.056 0.844 . . . . 0.0 111.293 173.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.82 -8.9 42.26 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.609 0.764 . . . . 0.0 111.996 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.64 121.72 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 123.337 0.655 . . . . 0.0 110.843 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -92.84 174.64 7.15 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 66' ' ' ILE . 25.0 mt -71.0 -11.34 60.92 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.692 0.797 . . . . 0.0 111.998 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.38 -27.08 72.11 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.293 0.371 . . . . 0.0 112.202 170.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -87.03 -47.81 8.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.486 0.714 . . . . 0.0 110.134 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.471 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.7 mm? -80.57 154.87 73.89 Favored Pre-proline 0 CA--C 1.556 1.19 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.743 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -78.93 40.97 1.0 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.188 2.592 . . . . 0.0 114.747 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.547 HG21 HD11 ' A' ' 61' ' ' LEU . 2.4 mp -76.77 122.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.8 mt-30 -118.43 156.95 28.11 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.8 p -63.39 110.93 2.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.566 0.746 . . . . 0.0 111.274 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.31 30.86 68.97 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.619 0.574 . . . . 0.0 113.481 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 5.9 t70 -84.69 172.53 11.46 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.488 ' HE1' ' HA ' ' A' ' 71' ' ' MET . 3.2 tpt -98.75 100.6 11.83 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' A' ' 66' ' ' ILE . 76.2 mt -91.41 143.19 26.87 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -105.67 102.07 13.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.93 106.12 11.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.01 151.72 37.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.523 0.678 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -122.08 146.81 46.84 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.802 -173.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -118.49 -30.9 5.06 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.004 0.522 . . . . 0.0 110.445 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 64.64 32.68 11.21 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.643 1.177 . . . . 0.0 111.047 -175.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -63.55 -14.64 53.25 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.358 1.063 . . . . 0.0 113.328 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 61.14 76.99 0.38 Allowed Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.526 1.131 . . . . 0.0 110.25 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HG3' ' HB3' ' A' ' 37' ' ' ALA . 94.3 Cg_endo -76.27 179.34 6.46 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.74 2.294 . . . . 0.0 112.406 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -119.18 138.18 53.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.221 1.008 . . . . 0.0 109.281 175.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.5 134.52 39.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.774 0.83 . . . . 0.0 111.05 -174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.6 p -129.06 100.7 20.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.263 1.025 . . . . 0.0 108.437 175.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.23 -46.53 32.87 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 123.683 2.922 . . . . 0.0 112.948 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.247 0.957 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 174.68 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.4 m0 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 13' ' ' LEU . 48.7 mtm180 -83.86 73.95 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.108 0.963 . . . . 0.0 109.141 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.91 136.17 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.375 0.67 . . . . 0.0 111.503 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -89.09 97.35 11.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.7 0.8 . . . . 0.0 110.17 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 t -81.17 100.05 8.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.778 0.831 . . . . 0.0 110.445 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -74.47 108.99 7.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.127 0.571 . . . . 0.0 110.23 -175.407 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.196 0.522 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -134.96 123.19 22.98 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 2' ' ' ARG . 1.8 tm? -91.04 102.58 15.34 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -172.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 33' ' ' ILE . 10.3 mp -92.23 107.03 18.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.45 0.7 . . . . 0.0 110.036 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.549 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 76.6 mt-30 -90.2 -177.13 5.06 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.716 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -19.47 22.09 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.329 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.93 114.92 10.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.462 0.705 . . . . 0.0 110.66 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.403 ' O ' HD12 ' A' ' 61' ' ' LEU . 69.0 p -91.96 168.05 11.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.079 0.951 . . . . 0.0 109.163 170.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 p -59.26 -33.81 71.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.979 0.511 . . . . 0.0 111.753 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -101.13 24.67 9.09 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.402 0.681 . . . . 0.0 111.841 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 25' ' ' GLU . 73.1 m -72.33 127.4 32.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 74.3 mtm180 -79.77 169.16 18.35 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.176 0.59 . . . . 0.0 111.247 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 56' ' ' ASP . 7.5 tt -53.53 -54.33 38.83 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.179 1.392 . . . . 0.0 110.989 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 15.7 ptt180 -63.94 -26.04 68.41 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.219 -177.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 14.0 mm-40 -77.08 -43.46 34.23 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.6 -66.79 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.726 1.21 . . . . 0.0 110.615 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.5 -21.29 65.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.314 0.645 . . . . 0.0 111.312 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.98 -41.95 70.16 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.848 0.717 . . . . 0.0 112.368 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 21.3 mt-30 -67.79 -39.69 84.02 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.6 mt -59.67 -39.8 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.652 0.781 . . . . 0.0 111.055 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.2 -24.63 67.74 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 111.788 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.16 -36.07 13.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.336 0.654 . . . . 0.0 111.713 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 HD11 ' A' ' 14' ' ' LEU . 12.6 mm -75.62 -68.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.933 0.893 . . . . 0.0 110.4 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.494 HG23 HG12 ' A' ' 36' ' ' ILE . 3.0 t -96.7 -7.2 34.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 6.85 87.95 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 114.01 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.494 HG12 HG23 ' A' ' 34' ' ' THR . 13.8 mm -84.52 114.57 25.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 144.75 64.36 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.584 0.754 . . . . 0.0 110.722 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -55.14 -21.44 27.87 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.651 2.901 . . . . 0.0 114.382 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.61 -20.2 51.98 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 113.778 0.271 . . . . 0.0 113.778 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.0 m -90.3 -16.5 29.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.18 0.592 . . . . 0.0 111.275 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.86 150.89 27.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.016 0.927 . . . . 0.0 110.568 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -130.17 145.87 51.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.679 1.192 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.596 HG13 HD21 ' A' ' 54' ' ' LEU . 45.6 mm -81.49 95.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.097 0.951 . . . . 0.0 108.872 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.68 139.39 51.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.039 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 5.2 m -113.31 163.15 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.367 0.667 . . . . 0.0 110.21 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.18 -49.07 82.63 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.884 0.74 . . . . 0.0 113.267 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 45' ' ' VAL . 52.3 p90 -69.71 145.46 94.84 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.141 169.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.22 101.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 124.155 3.237 . . . . 0.0 115.592 -170.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 71.8 Cg_endo -76.66 145.58 26.12 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.243 1.962 . . . . 0.0 111.096 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -91.67 15.88 11.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.286 0.635 . . . . 0.0 110.897 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.9 m 59.85 46.54 11.19 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.501 1.12 . . . . 0.0 110.369 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -55.93 130.03 42.07 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.299 -174.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.36 111.07 22.4 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.596 HD21 HG13 ' A' ' 43' ' ' ILE . 7.3 mp -72.7 87.9 1.27 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.279 1.031 . . . . 0.0 108.8 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 p -89.51 26.22 1.77 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.2 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.43 ' O ' HD13 ' A' ' 23' ' ' LEU . 10.3 t70 -145.67 -168.37 2.95 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 -29.16 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.63 0.772 . . . . 0.0 110.957 176.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.64 -8.0 51.2 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.876 1.27 . . . . 0.0 110.588 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.18 131.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.686 1.195 . . . . 0.0 111.414 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -96.33 168.63 10.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.662 0.785 . . . . 0.0 112.559 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 18' ' ' SER . 47.7 mt -69.69 -20.18 63.56 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.918 0.887 . . . . 0.0 111.552 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.94 73.18 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.434 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.07 -39.16 14.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.187 0.595 . . . . 0.0 109.816 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.3 mt -79.5 156.66 75.65 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 124.057 0.943 . . . . 0.0 111.438 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -72.94 18.51 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.767 2.978 . . . . 0.0 115.267 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.05 124.4 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 48.9 mt-30 -119.06 169.83 9.58 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.237 0.615 . . . . 0.0 109.845 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 p -68.47 96.46 0.69 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.336 0.654 . . . . 0.0 110.879 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.96 36.39 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.382 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 11.1 t70 -80.44 158.01 26.05 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.303 0.641 . . . . 0.0 110.689 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.88 97.93 10.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.57 0.748 . . . . 0.0 109.692 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.88 106.97 18.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.439 0.696 . . . . 0.0 109.44 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.31 93.28 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.845 0.858 . . . . 0.0 108.825 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.75 103.45 10.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.99 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.455 ' O ' HG21 ' A' ' 36' ' ' ILE . 11.4 pt-20 -78.75 170.09 17.21 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.203 174.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -129.61 106.99 9.11 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.109 0.964 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 CA--C 1.554 1.123 0 C-N-CA 122.921 0.488 . . . . 0.0 111.478 179.468 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.3 m0 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HB3' HD11 ' A' ' 13' ' ' LEU . 44.7 mtp180 -83.29 83.29 7.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 109.452 174.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 17' ' ' LEU . 69.1 t -100.34 141.94 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.923 0.889 . . . . 0.0 110.535 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 71' ' ' MET . 41.1 mmt180 -81.57 135.97 35.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.916 0.886 . . . . 0.0 110.559 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 19.8 t -113.33 90.12 3.26 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -82.95 105.39 13.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.31 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 123.384 0.674 . . . . 0.0 110.436 -177.879 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 77.6 m-70 -123.2 173.74 7.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.623 0.769 . . . . 0.0 109.904 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 2' ' ' ARG . 2.8 tm? -140.74 110.76 6.55 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -95.32 132.07 40.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.082 0.953 . . . . 0.0 108.52 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.89 -32.91 10.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.104 0.561 . . . . 0.0 110.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.48 44.4 3.07 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.767 -0.651 . . . . 0.0 114.109 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 3' ' ' VAL . 95.3 mt -114.52 115.2 26.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 124.134 0.974 . . . . 0.0 109.35 175.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 61' ' ' LEU . 17.3 t -92.38 176.87 6.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.947 0.899 . . . . 0.0 109.475 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 p -60.63 -36.1 77.79 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.708 0.803 . . . . 0.0 111.858 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -116.35 48.09 1.32 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.388 0.675 . . . . 0.0 111.47 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.9 m -75.84 128.06 34.33 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HG2' HG22 ' A' ' 60' ' ' THR . 61.6 mtm180 -92.14 -177.94 4.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 57' ' ' ARG . 5.9 tt -52.32 -56.91 11.68 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.087 0.955 . . . . 0.0 111.036 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.445 ' HG2' ' OE2' ' A' ' 25' ' ' GLU . 9.0 ptp180 -70.63 -19.58 62.81 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.594 0.559 . . . . 0.0 112.042 -164.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -93.49 -35.02 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.63 0.772 . . . . 0.0 110.976 173.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.418 HD11 HD11 ' A' ' 43' ' ' ILE . 2.0 tm? -71.29 -68.23 0.46 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.606 0.762 . . . . 0.0 111.419 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.35 -38.23 62.63 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.844 0.715 . . . . 0.0 112.341 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.468 ' O ' HG12 ' A' ' 33' ' ' ILE . 61.3 mt-30 -70.53 -44.52 67.34 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -55.41 -41.35 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.935 0.894 . . . . 0.0 111.476 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -25.18 68.19 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.34 -31.36 16.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.676 0.79 . . . . 0.0 111.395 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 29' ' ' GLN . 28.8 mm -79.11 -65.59 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.324 1.05 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.547 HG23 HG12 ' A' ' 36' ' ' ILE . 10.1 t -101.91 -11.74 18.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.75 0.82 . . . . 0.0 111.341 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 -18.6 56.78 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.727 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.547 HG12 HG23 ' A' ' 34' ' ' THR . 18.3 mm -67.34 121.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.045 0.422 . . . . 0.0 111.205 -169.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.75 141.26 80.13 Favored Pre-proline 0 C--N 1.351 0.663 0 O-C-N 124.281 0.988 . . . . 0.0 110.648 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.05 -28.62 70.43 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.394 2.729 . . . . 0.0 112.35 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.91 16.51 54.93 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.369 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -125.13 -11.29 7.03 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 110.52 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -127.16 155.53 43.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.022 0.929 . . . . 0.0 110.369 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 168.47 19.63 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.238 1.015 . . . . 0.0 109.161 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 54' ' ' LEU . 30.8 mm -80.26 105.0 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.423 1.106 . . . . 0.0 109.842 -172.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.93 148.08 44.56 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 112.776 -2.011 . . . . 0.0 106.981 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.452 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 1.6 m -132.25 161.96 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.75 . . . . 0.0 110.248 -172.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.64 -42.29 96.13 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.805 0.69 . . . . 0.0 113.238 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -77.7 158.1 78.75 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.264 168.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -39.65 107.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.095 3.196 . . . . 0.0 115.292 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 67.9 Cg_endo -86.04 158.55 10.05 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.84 8.38 41.32 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.9 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.1 m 56.5 68.77 0.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.185 0.994 . . . . 0.0 110.221 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.77 114.35 18.62 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.678 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.06 155.59 22.61 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 43' ' ' ILE . 4.7 mp -122.6 91.71 3.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.7 p -82.34 -46.08 14.07 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.397 0.679 . . . . 0.0 110.67 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -78.13 131.63 37.32 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.788 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -70.57 -22.04 62.62 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.728 0.811 . . . . 0.0 112.091 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.29 -1.86 53.23 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.6 tt -64.01 124.09 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.389 0.676 . . . . 0.0 110.893 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 22' ' ' ARG . 50.7 p -95.96 173.56 7.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.164 0.586 . . . . 0.0 112.398 -169.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 18' ' ' SER . 27.0 mt -68.99 -10.77 59.17 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.399 0.679 . . . . 0.0 111.136 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.39 -29.01 73.72 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 112.301 -0.32 . . . . 0.0 112.301 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -88.27 -49.63 6.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.276 0.63 . . . . 0.0 110.12 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.8 mm? -81.59 151.77 68.86 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.743 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.456 ' HD2' HG21 ' A' ' 43' ' ' ILE . 97.9 Cg_endo -77.66 42.79 1.22 Allowed 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.761 2.974 . . . . 0.0 115.185 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.476 HD11 HD12 ' A' ' 43' ' ' ILE . 2.3 mp -83.28 112.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -109.84 170.66 7.93 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.2 p -67.56 105.51 1.88 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.029 0.532 . . . . 0.0 111.013 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.23 62.73 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 113.358 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.28 161.35 27.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.775 0.83 . . . . 0.0 110.168 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.48 ' HA ' ' HB2' ' A' ' 4' ' ' ARG . 19.1 ttm -103.89 112.34 25.26 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.245 0.618 . . . . 0.0 109.783 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -101.05 114.45 28.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.574 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.78 96.13 3.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.409 HG21 ' SG ' ' A' ' 5' ' ' CYS . 70.5 t -78.69 101.58 4.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.082 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -80.32 155.82 27.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.499 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.61 111.91 23.68 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 169.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 CA--C 1.552 1.046 0 C-N-CA 123.306 0.642 . . . . 0.0 111.037 175.253 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' TRP . . . . . 0.483 ' HB3' HG23 ' A' ' 3' ' ' VAL . 22.0 m0 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.448 ' HB2' HD11 ' A' ' 13' ' ' LEU . 3.9 ptp180 -87.99 70.85 9.44 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.775 0.798 . . . . 0.0 109.102 169.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 1' ' ' TRP . 76.8 t -77.8 137.28 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.864 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -93.27 140.23 29.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.466 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 12.5 t -122.41 97.94 5.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.018 0.927 . . . . 0.0 111.053 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HE3' ' SD ' ' A' ' 71' ' ' MET . 4.6 tppp? -74.82 102.71 4.8 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.472 0.653 0 C-N-CA 123.081 0.552 . . . . 0.0 111.015 -173.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 42.8 m80 -107.79 179.16 4.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.199 1.0 . . . . 0.0 109.517 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 2' ' ' ARG . 2.0 tm? -144.01 122.8 12.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.473 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.2 mp -101.1 146.62 27.22 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.951 0.9 . . . . 0.0 110.394 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -118.39 165.27 14.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.137 1.375 . . . . 0.0 109.312 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.45 4.81 89.28 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.157 0.423 . . . . 0.0 114.157 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.48 130.84 35.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.465 0.65 . . . . 0.0 110.525 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -115.16 179.02 4.07 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.207 1.403 . . . . 0.0 109.159 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 p -72.72 -27.34 62.0 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.647 0.379 . . . . 0.0 111.158 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -108.61 25.95 11.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.735 0.814 . . . . 0.0 111.233 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 25' ' ' GLU . 7.3 m -66.0 127.66 32.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.077 0.551 . . . . 0.0 110.151 170.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -72.9 166.71 22.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.356 0.662 . . . . 0.0 111.183 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 54' ' ' LEU . 10.1 tt -61.2 -45.42 94.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.651 1.18 . . . . 0.0 110.618 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -61.53 -30.67 70.79 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.653 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 21' ' ' THR . 6.3 mm-40 -79.88 -44.44 20.44 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 124.087 0.955 . . . . 0.0 109.534 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.56 -65.9 0.61 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.044 0.938 . . . . 0.0 109.718 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.416 ' HA ' HD12 ' A' ' 30' ' ' ILE . 32.4 mt-30 -64.42 -23.11 67.17 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.664 0.602 . . . . 0.0 111.509 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.21 -44.33 86.76 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 124.104 0.878 . . . . 0.0 111.695 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 33' ' ' ILE . 76.1 mt-30 -67.92 -37.33 81.54 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 27' ' ' GLN . 97.4 mt -59.56 -42.03 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.493 0.717 . . . . 0.0 110.823 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -24.97 68.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.805 0.842 . . . . 0.0 111.705 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.4 -32.79 17.11 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.765 0.826 . . . . 0.0 111.571 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.473 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.8 mm -79.83 -69.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.536 HG23 HG12 ' A' ' 36' ' ' ILE . 9.2 t -98.76 -9.45 24.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.442 0.697 . . . . 0.0 111.488 -173.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.48 72.43 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.967 -0.352 . . . . 0.0 113.785 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.536 HG12 HG23 ' A' ' 34' ' ' THR . 24.9 mm -91.19 114.57 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.42 78.72 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.03 0.932 . . . . 0.0 111.023 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -53.76 -29.54 52.54 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.127 3.218 . . . . 0.0 114.572 -172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.96 -23.03 64.71 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.001 -0.333 . . . . 0.0 113.743 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -93.47 1.4 56.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.774 0.83 . . . . 0.0 111.562 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.45 169.14 13.96 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.032 0.933 . . . . 0.0 110.781 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 51' ' ' CYS . 44.9 ttp180 -158.81 154.43 26.14 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.055 -169.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 66' ' ' ILE . 37.4 mm -79.68 100.8 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 122.083 0.944 . . . . 0.0 109.674 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.4 mt -121.7 144.57 48.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.271 -1.786 . . . . 0.0 106.917 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 47' ' ' TYR . 2.6 m -125.88 164.31 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.493 0.717 . . . . 0.0 110.779 -172.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -36.08 92.75 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.78 0.675 . . . . 0.0 112.857 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 45' ' ' VAL . 46.4 p90 -81.72 156.2 70.48 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.177 167.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -43.09 108.36 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 124.227 3.285 . . . . 0.0 114.508 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -85.72 155.14 10.26 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.018 2.479 . . . . 0.0 112.624 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -89.81 6.82 40.04 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.994 0.518 . . . . 0.0 110.696 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HB3' ' NH1' ' A' ' 42' ' ' ARG . 81.5 m 57.36 59.16 3.46 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.282 1.033 . . . . 0.0 110.123 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.84 144.34 52.91 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.46 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.45 138.8 31.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.208 0.603 . . . . 0.0 109.682 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.673 ' HB3' HD11 ' A' ' 23' ' ' LEU . 7.0 mp -115.14 87.17 2.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.011 0.924 . . . . 0.0 108.74 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 m -111.03 19.81 18.09 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.81 0.844 . . . . 0.0 112.654 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HD13 ' A' ' 23' ' ' LEU . 11.1 t70 -141.81 177.75 7.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -120.69 -40.53 2.64 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.496 0.718 . . . . 0.0 111.478 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.24 -16.0 34.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.936 0.894 . . . . 0.0 110.327 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.98 141.46 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.258 1.023 . . . . 0.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.6 p -111.75 -178.92 3.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 112.247 -166.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 mt -75.94 -4.73 42.62 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.178 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.25 -23.11 76.39 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 167.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -97.78 -59.09 1.84 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.428 0.691 . . . . 0.0 109.793 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.53 116.09 55.05 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.05 65.09 6.12 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.666 2.91 . . . . 0.0 113.816 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 43' ' ' ILE . 1.9 mp -78.27 126.45 38.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 163.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 18.1 mt-30 -117.41 154.61 31.05 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.8 p -64.59 102.68 0.59 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.274 0.629 . . . . 0.0 111.363 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.59 16.19 66.67 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.411 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 10.5 t70 -80.08 160.92 25.61 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 123.489 0.716 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.447 ' SD ' ' HE3' ' A' ' 6' ' ' LYS . 2.8 tpt -84.18 100.32 11.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.323 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.36 116.12 30.78 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.55 102.67 13.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 77.9 t -82.61 108.18 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.429 171.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.22 151.22 31.33 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.811 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -109.46 105.04 14.22 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 166.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 t70 . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 0.0 110.525 178.701 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 33.8 m0 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -103.0 160.4 14.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.875 0.87 . . . . 0.0 109.334 170.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.561 HG13 HD23 ' A' ' 72' ' ' LEU . 18.9 t -138.1 136.78 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.834 0.854 . . . . 0.0 109.709 171.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -104.8 95.58 5.97 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.7 p -84.14 102.35 12.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.909 0.484 . . . . 0.0 110.185 -175.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.75 99.03 7.26 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 123.25 0.62 . . . . 0.0 109.959 -174.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 96.5 m-70 -131.47 149.37 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.591 0.356 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.76 113.47 25.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.207 0.603 . . . . 0.0 109.858 -173.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.466 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.8 mp -89.48 127.4 35.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.963 0.905 . . . . 0.0 109.033 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -111.34 161.45 16.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 171.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 33.61 19.13 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.872 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.19 116.36 28.88 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -91.36 166.58 12.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.565 0.746 . . . . 0.0 109.606 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -64.81 -25.48 67.93 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 120.978 0.418 . . . . 0.0 111.705 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -92.7 3.2 56.05 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.779 0.832 . . . . 0.0 112.788 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 25' ' ' GLU . 56.8 m -58.7 118.61 5.87 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.141 0.496 . . . . 0.0 110.812 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 58' ' ' ASP . 81.8 mtm180 -87.21 -176.41 5.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.03 0.932 . . . . 0.0 111.478 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 54' ' ' LEU . 4.8 tt -54.89 -60.87 2.77 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.773 0.829 . . . . 0.0 109.045 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -55.91 -24.56 38.32 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.345 -1.298 . . . . 0.0 113.413 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 1.7 mm-40 -88.91 -53.89 4.39 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HB2' HG22 ' A' ' 21' ' ' THR . 2.7 tm? -67.27 -65.78 0.64 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.162 0.985 . . . . 0.0 110.655 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.45 -18.83 65.58 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.328 0.392 . . . . 0.0 111.071 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.93 -37.58 60.55 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.713 0.633 . . . . 0.0 112.034 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 33' ' ' ILE . 98.7 mt-30 -70.78 -38.84 73.43 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.88 -38.7 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 C-N-CA 123.803 0.841 . . . . 0.0 110.795 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.65 66.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.043 0.937 . . . . 0.0 111.914 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -35.6 13.57 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.924 0.89 . . . . 0.0 111.395 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG13 ' HG ' ' A' ' 14' ' ' LEU . 31.0 mm -72.1 -68.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.781 0.832 . . . . 0.0 110.449 -175.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.421 HG23 HG12 ' A' ' 36' ' ' ILE . 5.2 t -96.44 -16.19 21.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.342 0.657 . . . . 0.0 111.036 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 11.12 71.47 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.667 -0.518 . . . . 0.0 113.436 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.421 HG12 HG23 ' A' ' 34' ' ' THR . 26.5 mm -85.91 111.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.74 144.45 65.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.863 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.75 -24.81 73.15 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.203 2.602 . . . . 0.0 113.559 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.98 19.76 32.51 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 113.253 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -135.54 8.37 3.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 110.332 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 1.6 pt20 -144.47 162.07 37.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.511 0.725 . . . . 0.0 110.831 -177.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -129.37 -172.88 2.85 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.824 1.25 . . . . 0.0 108.645 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.517 HG23 HD12 ' A' ' 72' ' ' LEU . 32.4 mm -112.26 106.65 21.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.61 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 29.8 mt -116.03 134.45 54.94 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.79 175.21 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.479 0.711 . . . . 0.0 111.199 -169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.7 -44.76 80.04 Favored Glycine 0 C--N 1.357 1.703 0 O-C-N 123.969 0.793 . . . . 0.0 114.186 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -87.0 163.34 40.88 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.536 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 83.1 Cg_exo -45.61 108.52 0.15 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.572 2.848 . . . . 0.0 113.587 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 48' ' ' PRO . 2.3 Cg_endo -84.14 172.46 9.62 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.502 2.802 . . . . 0.0 112.493 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -101.64 11.99 37.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.929 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.9 m 56.03 84.37 0.08 Allowed 'General case' 0 C--N 1.36 1.022 0 C-N-CA 124.272 1.029 . . . . 0.0 109.646 -166.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 69.1 mt -79.68 95.39 5.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.351 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.22 96.14 8.36 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.662 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.455 ' HB3' HD12 ' A' ' 23' ' ' LEU . 8.0 mp -69.85 102.82 2.04 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -89.57 -36.89 15.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.948 0.899 . . . . 0.0 111.757 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 59' ' ' ILE . 34.9 t70 -95.95 130.71 42.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.768 0.827 . . . . 0.0 110.302 -177.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.44 68.08 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.131 0.573 . . . . 0.0 112.306 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 29.1 t70 -92.7 -2.77 55.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.855 0.862 . . . . 0.0 111.432 -172.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 56' ' ' ASP . 13.4 tt -67.16 127.29 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.214 0.606 . . . . 0.0 110.748 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -99.24 177.0 5.34 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.928 0.491 . . . . 0.0 111.902 -168.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.19 -9.88 57.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 0.0 111.488 173.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.71 -25.85 74.85 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.99 -50.77 5.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.763 0.825 . . . . 0.0 110.055 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -91.05 121.72 67.53 Favored Pre-proline 0 N--CA 1.477 0.894 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.007 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.8 75.68 1.62 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.3 2.667 . . . . 0.0 113.583 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.33 131.68 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 27.9 mt-30 -118.19 155.82 29.84 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.3 t -70.94 111.61 6.47 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.21 17.2 56.2 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 123.604 0.621 . . . . 0.0 112.887 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.9 t70 -81.45 158.61 24.5 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.225 0.536 . . . . 0.0 110.246 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.4 93.69 9.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.783 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.561 HD23 HG13 ' A' ' 3' ' ' VAL . 3.9 mm? -92.36 99.44 12.2 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 4.1 mp -75.71 100.22 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 93.1 t -79.03 102.29 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.01 173.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 7.3 pt-20 -76.84 156.79 31.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.219 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.31 113.27 21.2 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 123.58 0.752 . . . . 0.0 110.583 176.783 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.7 m0 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.868 0.366 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -122.03 56.6 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.483 1.113 . . . . 0.0 109.241 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.578 ' HB ' HD12 ' A' ' 17' ' ' LEU . 10.8 t -83.81 135.64 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.73 -171.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -95.31 148.73 22.12 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.69 0.796 . . . . 0.0 110.123 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 p -122.17 104.2 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.459 0.704 . . . . 0.0 110.243 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -74.73 113.47 12.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.771 0.828 . . . . 0.0 109.321 171.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.723 0 C-N-CA 122.729 0.412 . . . . 0.0 110.199 177.298 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.261 0.553 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -111.0 179.8 3.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.987 0.915 . . . . 0.0 109.53 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.18 130.46 37.29 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.524 ' HG ' HG13 ' A' ' 33' ' ' ILE . 4.5 mp -96.18 110.73 22.96 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.234 1.014 . . . . 0.0 109.772 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.06 -17.49 43.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 109.676 172.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -15.11 81.65 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.636 0.636 . . . . 0.0 113.54 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' A' ' 3' ' ' VAL . 63.3 mt -72.67 114.43 10.8 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 117.336 0.568 . . . . 0.0 109.813 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.5 m -90.99 -167.08 1.73 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.176 0.991 . . . . 0.0 108.969 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.0 t -77.2 -45.58 26.13 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.779 0.432 . . . . 0.0 110.01 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.58 17.78 7.09 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.634 1.174 . . . . 0.0 112.794 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.8 m -65.9 115.92 6.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.141 0.577 . . . . 0.0 111.876 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.43 173.43 10.32 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.179 0.992 . . . . 0.0 110.219 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.39 -49.12 78.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.989 0.515 . . . . 0.0 111.894 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -19.93 65.31 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.648 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.85 -38.85 14.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 110.218 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 43' ' ' ILE . 1.5 tm? -66.89 -67.21 0.47 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.874 1.27 . . . . 0.0 109.597 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 23.8 mt-30 -69.24 -20.79 63.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.103 0.561 . . . . 0.0 111.769 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.71 -33.15 75.32 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.918 0.761 . . . . 0.0 112.179 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -87.38 -32.23 19.68 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.286 0.634 . . . . 0.0 110.787 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.87 -39.85 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -61.72 -25.75 67.62 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.193 0.997 . . . . 0.0 111.974 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.05 -26.09 16.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.983 0.913 . . . . 0.0 111.748 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.524 HG13 ' HG ' ' A' ' 14' ' ' LEU . 22.3 mm -89.21 -68.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 111.257 -174.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.583 HG23 HG12 ' A' ' 36' ' ' ILE . 10.2 t -94.26 -7.69 41.3 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.92 0.488 . . . . 0.0 110.563 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.23 8.28 83.86 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 119.285 -0.731 . . . . 0.0 114.292 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 34' ' ' THR . 11.0 mm -86.83 119.91 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 117.859 0.83 . . . . 0.0 109.178 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.98 139.44 82.98 Favored Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 124.165 0.916 . . . . 0.0 110.962 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 19.7 Cg_endo -56.64 -26.05 62.87 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.542 2.828 . . . . 0.0 114.252 -174.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.97 22.51 37.85 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 116.522 -0.308 . . . . 0.0 112.96 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 m -138.23 14.19 2.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.557 1.143 . . . . 0.0 109.949 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.42 171.87 19.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.375 0.67 . . . . 0.0 111.277 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -160.8 -173.85 4.13 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.631 1.172 . . . . 0.0 108.788 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.801 HG12 HD21 ' A' ' 54' ' ' LEU . 37.0 mm -106.13 113.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.2 mt -121.98 133.78 54.82 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 m -103.96 166.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.886 0.474 . . . . 0.0 110.831 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.06 -54.93 33.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 124.158 0.911 . . . . 0.0 112.715 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -67.19 151.68 96.89 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.268 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -49.25 106.66 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.612 2.875 . . . . 0.0 113.446 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.02 155.73 42.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.55 2.167 . . . . 0.0 111.651 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.91 10.81 22.42 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.673 0.789 . . . . 0.0 110.923 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.7 m 55.43 79.42 0.16 Allowed 'General case' 0 C--N 1.365 1.253 0 C-N-CA 124.417 1.087 . . . . 0.0 109.528 -167.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.52 138.33 57.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.777 -172.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -82.66 100.56 10.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.801 HD21 HG12 ' A' ' 43' ' ' ILE . 7.4 mp -98.03 88.84 4.35 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -126.72 -51.32 1.47 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.483 0.713 . . . . 0.0 111.357 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 59' ' ' ILE . 25.1 t70 -75.86 123.36 25.55 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.171 0.589 . . . . 0.0 110.916 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -29.73 52.95 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.7 -19.97 22.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 112.144 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 56' ' ' ASP . 12.1 tt -58.87 120.41 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 121.4 0.619 . . . . 0.0 110.747 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.9 p -92.67 177.32 6.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.072 0.549 . . . . 0.0 112.28 -170.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.83 -15.47 63.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.932 0.893 . . . . 0.0 111.362 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.99 78.4 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.271 -0.331 . . . . 0.0 112.271 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.3 -56.77 2.51 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.747 0.819 . . . . 0.0 109.701 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.5 mt -75.12 118.08 67.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.176 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.15 83.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.614 2.876 . . . . 0.0 114.838 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.446 HD11 HG13 ' A' ' 43' ' ' ILE . 3.1 mp -119.6 127.26 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 59.6 mt-30 -112.71 161.01 17.36 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.0 p -67.81 112.29 4.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.986 0.514 . . . . 0.0 110.147 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 22.94 59.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.188 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 29.0 t70 -82.97 166.27 18.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.74 0.816 . . . . 0.0 111.496 -175.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.82 103.66 15.63 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.87 0.868 . . . . 0.0 109.557 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.432 HD22 HG23 ' A' ' 43' ' ' ILE . 67.2 mt -98.86 104.12 16.13 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.399 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.6 91.98 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -82.13 109.56 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.548 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.91 145.36 38.29 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.21 102.13 10.84 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 123.674 0.79 . . . . 0.0 110.94 -178.882 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 24.0 m0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 13' ' ' LEU . 14.0 ptp180 -133.9 124.91 27.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.594 HG11 HD22 ' A' ' 72' ' ' LEU . 71.9 t -125.39 135.55 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.9 0.381 . . . . 0.0 111.493 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -82.12 110.96 17.81 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.379 1.072 . . . . 0.0 110.008 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 11' ' ' THR . 36.2 t -89.68 90.15 8.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 0.0 110.203 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -76.47 103.17 6.33 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.51 0.672 . . . . 0.0 112.157 -170.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 15.7 m . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -118.81 178.48 4.47 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.983 0.913 . . . . 0.0 110.493 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 2' ' ' ARG . 3.1 tm? -125.18 131.02 53.27 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.427 ' HG ' HG13 ' A' ' 33' ' ' ILE . 10.5 mp -100.1 132.82 45.24 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.323 0.649 . . . . 0.0 110.698 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.0 170.04 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.811 0.844 . . . . 0.0 109.996 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.4 23.23 77.63 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.067 172.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.67 133.23 43.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.02 0.528 . . . . 0.0 109.888 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.0 t -116.81 -166.26 1.15 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.354 1.062 . . . . 0.0 108.797 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.6 p -76.81 -36.4 56.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.993 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -104.57 20.55 18.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.926 0.49 . . . . 0.0 111.738 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -61.2 129.03 39.29 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.708 0.803 . . . . 0.0 110.142 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.549 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 78.3 mtm180 -88.19 -179.01 6.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.495 0.718 . . . . 0.0 111.848 -171.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.27 -63.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.103 0.961 . . . . 0.0 109.573 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -63.91 -15.27 58.68 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.902 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 12.2 mm-40 -87.04 -49.05 7.59 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -78.93 -66.78 0.82 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.358 1.063 . . . . 0.0 110.182 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -65.7 -19.96 66.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.001 0.52 . . . . 0.0 111.149 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.57 72.32 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.749 0.655 . . . . 0.0 111.877 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' ILE . 20.8 mt-30 -72.33 -38.85 68.53 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.11 -35.9 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.6 67.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.702 0.801 . . . . 0.0 111.99 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.43 -28.19 15.62 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.188 0.995 . . . . 0.0 112.065 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 29' ' ' GLN . 27.8 mm -78.95 -61.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.304 1.042 . . . . 0.0 110.415 -174.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 36' ' ' ILE . 3.8 t -109.42 -5.36 15.83 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.812 0.845 . . . . 0.0 111.435 -175.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.15 13.6 81.74 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.932 -0.371 . . . . 0.0 114.001 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 34' ' ' THR . 24.9 mm -90.88 115.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 141.88 69.49 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.707 0.803 . . . . 0.0 110.702 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.99 -27.64 64.98 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 123.421 2.747 . . . . 0.0 114.133 -174.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -15.23 78.3 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 120.085 -0.286 . . . . 0.0 113.813 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -93.78 -5.75 47.56 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.107 0.963 . . . . 0.0 111.445 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -130.19 161.59 30.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.106 0.963 . . . . 0.0 111.148 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -134.07 -172.17 2.92 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.244 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.534 HG12 HD11 ' A' ' 54' ' ' LEU . 49.8 mm -107.36 99.15 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -112.0 131.33 55.48 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.57 -174.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.721 0.808 . . . . 0.0 109.672 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.54 55.88 4.44 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.46 168.31 11.57 Favored Pre-proline 0 N--CA 1.483 1.209 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 168.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 100.31 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.982 1.788 . . . . 0.0 111.343 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.04 138.74 26.02 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.145 1.897 . . . . 0.0 113.089 -168.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.94 -0.88 23.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.891 0.876 . . . . 0.0 111.681 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.7 m 61.32 58.24 2.2 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.682 1.193 . . . . 0.0 109.678 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.18 99.92 0.73 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.113 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -86.06 125.7 33.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.534 HD11 HG12 ' A' ' 43' ' ' ILE . 6.4 mp -88.96 106.57 18.51 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -111.83 19.6 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.601 0.76 . . . . 0.0 110.825 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 13.7 t70 -134.29 118.02 17.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -58.08 -34.26 69.96 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.897 0.879 . . . . 0.0 113.124 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.39 -0.71 54.65 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.05 0.94 . . . . 0.0 113.461 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.7 tt -61.6 122.18 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 118.757 0.708 . . . . 0.0 110.724 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.3 p -90.5 171.59 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.099 0.56 . . . . 0.0 111.921 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.444 HD13 HG21 ' A' ' 66' ' ' ILE . 21.9 mt -70.63 -7.96 48.21 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.95 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.89 -23.0 78.7 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.235 0.334 . . . . 0.0 112.743 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.479 ' HB2' HD22 ' A' ' 64' ' ' LEU . 9.2 m-20 -88.85 -47.29 8.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.065 0.546 . . . . 0.0 110.15 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 63' ' ' ASP . 2.5 mm? -90.35 157.31 45.05 Favored Pre-proline 0 CA--C 1.562 1.412 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.099 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.94 44.82 1.76 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.495 2.797 . . . . 0.0 114.516 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.612 HG13 HD11 ' A' ' 72' ' ' LEU . 4.0 mp -83.47 124.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -119.94 170.7 9.02 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.545 0.738 . . . . 0.0 109.171 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 t -74.63 111.56 9.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.76 13.43 59.43 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.218 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.08 170.03 17.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 30.7 ttm -117.4 113.74 22.53 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.589 0.756 . . . . 0.0 109.353 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.612 HD11 HG13 ' A' ' 66' ' ' ILE . 3.2 mp -90.64 105.69 17.99 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.476 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.75 89.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 75.3 t -72.11 107.27 2.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.386 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -77.13 159.85 29.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.697 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -125.19 121.52 34.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 CA--C 1.547 0.831 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.51 176.559 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.3 m0 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -93.24 82.55 4.53 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 66' ' ' ILE . 41.3 t -96.1 136.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -87.29 141.75 28.41 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.57 0.748 . . . . 0.0 110.327 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.608 ' SG ' HD13 ' A' ' 14' ' ' LEU . 86.3 m -130.91 101.88 5.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.327 0.651 . . . . 0.0 111.427 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.528 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 12.9 tppt? -74.95 118.69 18.19 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.436 1.094 . . . . 0.0 110.381 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.73 0 C-N-CA 123.329 0.651 . . . . 0.0 109.416 176.661 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.424 ' HB3' HG22 ' A' ' 33' ' ' ILE . 77.7 m80 -112.02 112.55 24.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.207 1.003 . . . . 0.0 108.647 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.3 tp -80.07 121.55 25.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.093 0.557 . . . . 0.0 110.666 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.608 HD13 ' SG ' ' A' ' 5' ' ' CYS . 8.5 mp -81.41 133.46 35.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 174.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -105.33 153.37 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.526 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.04 23.82 74.51 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD22 HG21 ' A' ' 21' ' ' THR . 78.0 mt -77.17 117.96 19.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.672 0.736 . . . . 0.0 110.077 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 94.5 p -84.84 161.35 19.94 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.7 p -65.39 -17.6 64.66 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.541 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.584 HH22 ' HA3' ' A' ' 62' ' ' GLY . 6.9 mmp_? -107.22 18.49 21.61 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.144 0.977 . . . . 0.0 112.256 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.482 HG21 HD22 ' A' ' 17' ' ' LEU . 44.0 m -63.31 119.8 10.35 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.926 0.393 . . . . 0.0 110.303 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -82.39 176.58 9.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.864 0.866 . . . . 0.0 111.272 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HB2' HG22 ' A' ' 59' ' ' ILE . 5.7 tt -51.33 -60.62 2.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.714 1.206 . . . . 0.0 110.21 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -54.12 -30.43 48.72 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.021 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 21' ' ' THR . 9.0 mm-40 -83.98 -38.74 20.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.41 0.684 . . . . 0.0 110.128 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.24 -66.99 0.66 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.225 1.01 . . . . 0.0 109.564 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -67.15 -16.93 64.61 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.04 70.97 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.849 0.718 . . . . 0.0 112.022 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.441 ' O ' HG13 ' A' ' 33' ' ' ILE . 24.0 mt-30 -70.22 -39.51 75.06 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.527 HG13 HD21 ' A' ' 14' ' ' LEU . 88.5 mt -57.59 -42.63 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 123.612 0.765 . . . . 0.0 110.881 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.17 67.5 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.034 0.934 . . . . 0.0 112.397 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.51 -35.58 15.0 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.771 0.829 . . . . 0.0 111.435 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 29' ' ' GLN . 25.1 mt -86.32 -64.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.094 0.558 . . . . 0.0 111.109 -171.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.58 HG23 HG12 ' A' ' 36' ' ' ILE . 12.1 t -93.72 -2.86 53.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.557 0.343 . . . . 0.0 110.929 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.41 -10.07 56.18 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.555 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 34' ' ' THR . 22.5 mm -71.65 111.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.591 0.696 . . . . 0.0 109.949 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.65 144.45 44.69 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.135 0.974 . . . . 0.0 111.089 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.95 -28.17 86.88 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.082 2.521 . . . . 0.0 113.049 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.08 28.02 9.37 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.548 0.53 . . . . 0.0 113.402 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -138.87 11.64 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.39 1.076 . . . . 0.0 109.987 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.46 161.3 42.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.794 0.838 . . . . 0.0 110.741 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -143.32 -168.91 2.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.173 1.389 . . . . 0.0 109.21 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 54' ' ' LEU . 24.2 mm -106.83 110.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.562 0.745 . . . . 0.0 109.112 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mm? -120.01 156.6 30.57 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.56 167.72 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.159 0.584 . . . . 0.0 111.046 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.72 -49.32 78.78 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.528 1.142 . . . . 0.0 113.041 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -74.12 158.72 85.28 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.631 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -46.53 111.41 0.36 Allowed 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.225 2.617 . . . . 0.0 114.227 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.72 -176.91 2.66 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.054 2.503 . . . . 0.0 111.614 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -126.0 30.15 5.72 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.4 0.68 . . . . 0.0 110.741 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 34.0 m 55.44 64.27 1.82 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.741 0.816 . . . . 0.0 109.713 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.75 109.35 4.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.98 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.23 115.72 27.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.912 1.285 . . . . 0.0 108.921 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 43' ' ' ILE . 4.1 mp -82.7 93.45 7.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.499 0.72 . . . . 0.0 109.229 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.6 p -79.8 -52.58 7.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 111.213 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -83.45 131.67 35.01 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 123.476 0.71 . . . . 0.0 110.319 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -22.82 61.15 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.726 0.811 . . . . 0.0 112.951 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -91.58 -5.29 54.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.496 1.119 . . . . 0.0 111.252 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 23' ' ' LEU . 13.9 tt -59.58 121.07 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.236 0.615 . . . . 0.0 111.626 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -91.37 173.57 7.84 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 0.0 111.278 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.432 HD13 HG21 ' A' ' 66' ' ' ILE . 45.4 mt -70.26 -4.76 23.42 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.605 0.762 . . . . 0.0 111.643 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.584 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -78.46 -30.61 48.84 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.846 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 -48.98 6.19 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.82 133.05 95.43 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.076 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.6 78.49 0.95 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.816 2.344 . . . . 0.0 111.96 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.468 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.1 mp -123.23 121.87 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.1 mm-40 -117.9 154.91 31.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.753 0.821 . . . . 0.0 109.069 174.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -65.25 106.81 1.42 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.803 . . . . 0.0 110.493 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.25 13.07 62.38 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 113.87 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.7 t70 -84.77 163.47 19.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.176 0.59 . . . . 0.0 110.447 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.528 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 5.7 tpt -91.83 101.64 14.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.468 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.5 mm? -101.61 123.15 45.15 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.231 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.5 mp -91.95 116.18 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.98 110.37 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.218 1.007 . . . . 0.0 108.286 169.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.81 138.65 39.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.4 108.77 20.21 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 123.215 0.606 . . . . 0.0 111.106 -177.558 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.0 m0 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -83.47 72.95 10.23 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.367 1.079 . . . . 0.0 109.55 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG13 HD23 ' A' ' 72' ' ' LEU . 95.8 t -80.95 132.67 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.056 -172.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -96.23 127.18 42.0 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.698 . . . . 0.0 109.585 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' HD13 ' A' ' 14' ' ' LEU . 84.4 m -113.25 114.88 27.34 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 0.0 110.36 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -80.37 105.11 11.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 121.294 0.569 . . . . 0.0 111.501 -173.562 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.485 HG23 ' HE1' ' A' ' 71' ' ' MET . 20.5 m . . . . . 0 C--O 1.239 0.502 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.62 166.54 11.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.562 0.745 . . . . 0.0 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -118.27 120.5 37.85 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.658 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -103.35 111.47 23.9 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.022 0.929 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -89.96 171.47 9.55 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.848 0.859 . . . . 0.0 109.248 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.83 3.66 85.56 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.802 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.1 mt -95.96 127.52 42.04 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.837 0.855 . . . . 0.0 109.316 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -116.07 -166.82 1.18 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.952 1.301 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -70.01 -45.75 66.58 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.329 0.651 . . . . 0.0 111.432 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -107.18 39.25 1.92 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 25' ' ' GLU . 20.1 m -70.46 122.79 20.31 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 166.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.457 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 26.6 mtm180 -76.24 170.14 16.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.622 0.769 . . . . 0.0 111.198 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 54' ' ' LEU . 44.5 tp -57.54 -49.73 75.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.679 0.791 . . . . 0.0 111.285 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.78 -32.38 65.59 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.752 0.657 . . . . 0.0 112.144 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.509 ' HB2' HG23 ' A' ' 21' ' ' THR . 42.1 mm-40 -78.12 -46.95 19.3 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.392 0.677 . . . . 0.0 109.684 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.09 -62.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.954 1.301 . . . . 0.0 110.812 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 59.2 mt-30 -64.96 -21.89 66.91 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.942 0.497 . . . . 0.0 111.707 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.71 93.91 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.89 0.744 . . . . 0.0 111.748 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -78.71 -37.24 42.04 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.261 -0.4 . . . . 0.0 110.514 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -55.97 -46.21 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.319 0.647 . . . . 0.0 110.808 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -63.26 -24.46 67.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.018 0.927 . . . . 0.0 112.182 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.45 -33.3 16.86 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.682 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.658 HG13 ' HG ' ' A' ' 14' ' ' LEU . 20.8 mm -85.13 -62.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.149 0.979 . . . . 0.0 111.21 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.454 HG23 HG12 ' A' ' 36' ' ' ILE . 10.2 t -96.21 -11.58 25.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.86 68.35 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.938 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 34' ' ' THR . 6.6 mm -75.04 114.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.87 77.62 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.172 0.989 . . . . 0.0 111.233 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 37.0 Cg_endo -61.8 -17.83 57.29 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.089 2.526 . . . . 0.0 112.774 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 20.86 40.51 Favored Glycine 0 C--N 1.352 1.432 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.874 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -147.34 3.11 0.77 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.892 0.877 . . . . 0.0 111.992 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 3.7 pp0? -143.56 168.03 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.002 0.905 . . . . 0.0 112.3 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -153.15 166.41 32.58 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.724 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.618 HG23 HD12 ' A' ' 72' ' ' LEU . 1.8 mp -105.17 112.4 38.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 109.087 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -117.64 169.91 9.19 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' TYR . 6.9 m -121.52 162.63 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 118.232 0.469 . . . . 0.0 111.24 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.25 72.44 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 115.428 -0.805 . . . . 0.0 113.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.426 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 45.4 p90 -95.08 173.24 4.58 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.093 172.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 34.2 Cg_exo -40.49 110.62 0.12 Allowed 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 123.512 2.808 . . . . 0.0 113.988 173.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.73 159.97 18.98 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.647 2.232 . . . . 0.0 112.349 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -76.79 -14.32 59.93 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.876 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.4 m 66.87 23.5 9.96 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 124.831 1.252 . . . . 0.0 109.476 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.5 pt? -56.83 129.46 41.47 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 125.698 1.599 . . . . 0.0 112.161 -172.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.28 105.68 17.65 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 43' ' ' ILE . 6.0 mp -74.63 95.93 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -120.35 6.38 10.67 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.949 0.9 . . . . 0.0 111.74 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 59' ' ' ILE . 12.2 t70 -112.05 114.9 28.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -61.54 -29.39 69.98 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.523 0.729 . . . . 0.0 112.369 -174.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -94.13 -13.44 26.75 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.252 1.021 . . . . 0.0 111.883 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 56' ' ' ASP . 13.9 tt -60.69 133.32 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 71.2 p -104.59 168.48 9.05 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.735 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 34.1 mt -67.88 -10.13 50.56 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.473 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.66 -39.43 40.68 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.17 -35.04 42.56 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.762 0.791 . . . . 0.0 109.282 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 93.3 mt -80.99 157.68 71.07 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.923 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.2 34.24 0.43 Allowed 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 123.063 2.509 . . . . 0.0 113.089 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 43' ' ' ILE . 2.4 mp -84.61 120.55 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.8 mt-30 -121.54 161.63 22.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.122 0.569 . . . . 0.0 109.507 171.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -66.9 114.02 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.02 0.528 . . . . 0.0 109.747 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.94 8.91 83.45 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.562 0.539 . . . . 0.0 113.883 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -80.44 160.22 25.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.695 0.398 . . . . 0.0 110.076 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.485 ' HE1' HG23 ' A' ' 11' ' ' THR . 0.1 OUTLIER -94.92 101.88 13.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.18 0.992 . . . . 0.0 109.613 -178.244 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.618 HD12 HG23 ' A' ' 43' ' ' ILE . 3.8 mm? -104.95 109.27 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.792 0.837 . . . . 0.0 108.853 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.7 mp -75.27 105.99 4.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.161 0.584 . . . . 0.0 109.582 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.71 111.89 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.764 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 11.4 pt-20 -80.11 176.29 9.88 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.355 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -138.51 116.85 11.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 168.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 123.705 0.802 . . . . 0.0 110.03 -179.24 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 23.0 m0 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.556 ' HB3' HD11 ' A' ' 13' ' ' LEU . 82.2 mtm180 -86.59 86.42 7.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.79 0.836 . . . . 0.0 109.301 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t -99.54 141.61 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.145 0.978 . . . . 0.0 111.237 -170.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -98.87 97.32 8.52 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.505 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.5 m -80.3 100.91 8.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.598 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -76.86 103.4 6.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 109.297 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.601 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 122.65 0.38 . . . . 0.0 110.656 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -138.9 120.02 14.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.108 0.563 . . . . 0.0 109.522 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' A' ' 2' ' ' ARG . 2.1 tm? -96.26 98.62 10.44 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.94 141.75 31.02 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.481 0.712 . . . . 0.0 111.433 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.84 179.36 3.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.282 1.033 . . . . 0.0 109.234 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.6 28.58 73.56 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.441 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.497 HD22 HG21 ' A' ' 21' ' ' THR . 93.0 mt -106.09 113.73 27.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.292 0.637 . . . . 0.0 110.75 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.9 t -95.85 172.09 8.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 0.0 108.923 172.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.4 p -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 122.45 0.3 . . . . 0.0 111.808 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.99 22.07 13.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.817 0.447 . . . . 0.0 111.804 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.497 HG21 HD22 ' A' ' 17' ' ' LEU . 52.4 m -66.47 111.05 3.37 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 170.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.426 ' HG2' HG22 ' A' ' 60' ' ' THR . 86.0 mtt-85 -74.12 -178.6 3.42 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.271 1.028 . . . . 0.0 111.971 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 54' ' ' LEU . 6.8 tt -56.76 -53.98 51.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 174.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -63.29 -22.1 66.66 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.37 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 25.3 mm-40 -87.2 -53.43 4.86 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.262 0.625 . . . . 0.0 109.665 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.55 ' HG ' HD21 ' A' ' 61' ' ' LEU . 2.5 tm? -70.89 -65.57 0.72 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.212 1.005 . . . . 0.0 110.191 -176.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -67.43 -17.23 64.63 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.64 0.588 . . . . 0.0 110.888 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.45 -37.54 53.4 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.753 0.658 . . . . 0.0 112.538 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 70.4 mt-30 -68.88 -39.46 79.77 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.406 ' HB ' HE22 ' A' ' 41' ' ' GLN . 85.6 mt -59.68 -37.19 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.02 0.928 . . . . 0.0 111.204 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.73 -24.01 65.37 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.193 0.997 . . . . 0.0 111.926 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.69 -43.26 8.74 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.596 0.758 . . . . 0.0 111.322 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 29' ' ' GLN . 17.0 mm -68.3 -63.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.383 1.073 . . . . 0.0 110.237 -172.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 36' ' ' ILE . 8.9 t -109.31 0.99 19.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.67 0.788 . . . . 0.0 111.013 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.2 89.38 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 170.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 34' ' ' THR . 9.8 mm -86.08 107.85 16.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 147.54 98.36 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.564 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -49.95 -33.3 33.51 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 124.11 3.207 . . . . 0.0 114.25 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 13.86 18.48 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.3 m -138.99 15.01 2.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 110.92 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 2.1 pt20 -146.81 155.26 42.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.514 0.725 . . . . 0.0 110.783 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -124.67 -173.91 2.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.169 0.988 . . . . 0.0 109.374 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.6 mm -110.4 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 28.4 mt -107.34 139.73 41.36 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 65' ' ' PRO . 6.7 m -120.19 178.34 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 122.867 0.467 . . . . 0.0 112.203 -164.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.97 -49.82 57.37 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 124.301 1.001 . . . . 0.0 113.654 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -79.01 163.11 61.89 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.367 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -42.04 104.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.884 3.056 . . . . 0.0 113.924 171.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.13 159.11 37.5 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.404 2.069 . . . . 0.0 112.736 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -89.33 8.19 31.85 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.412 1.085 . . . . 0.0 112.145 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.0 m 61.67 27.08 16.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.37 1.068 . . . . 0.0 110.264 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -61.62 108.44 0.98 Allowed 'General case' 0 C--N 1.357 0.91 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.751 -173.18 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.48 132.97 43.49 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.685 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.528 ' HB3' HD12 ' A' ' 23' ' ' LEU . 7.1 mp -87.86 88.05 7.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.351 1.06 . . . . 0.0 108.359 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.0 t -93.87 13.93 21.06 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.435 0.694 . . . . 0.0 110.57 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.02 117.46 20.94 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.319 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -60.88 -30.28 70.06 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.169 0.987 . . . . 0.0 113.108 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -81.34 -23.44 37.75 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.581 1.152 . . . . 0.0 111.741 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.3 tt -56.16 134.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 -173.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' HG2' ' A' ' 22' ' ' ARG . 58.9 p -113.55 175.2 5.56 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.54 0.736 . . . . 0.0 111.05 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.55 HD21 ' HG ' ' A' ' 26' ' ' LEU . 50.7 mt -64.36 -22.01 66.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.96 0.504 . . . . 0.0 111.848 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.22 -17.05 61.03 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.241 0.338 . . . . 0.0 113.232 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.57 -45.31 6.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 0.0 111.191 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 52' ' ' LEU . 2.3 mm? -85.91 154.73 58.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 123.108 0.563 . . . . 0.0 110.946 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.426 ' HB2' HG11 ' A' ' 45' ' ' VAL . 2.2 Cg_endo -81.61 41.77 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.523 2.815 . . . . 0.0 113.083 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.76 108.64 3.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.597 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 21.0 mm-40 -105.7 166.42 10.47 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 p -64.4 99.51 0.3 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.199 0.6 . . . . 0.0 110.953 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 35.27 44.55 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.451 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -88.52 165.43 14.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.388 0.675 . . . . 0.0 111.047 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.52 98.21 11.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.802 0.841 . . . . 0.0 109.615 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 98.96 10.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.506 0.722 . . . . 0.0 110.21 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.8 mp -75.96 101.12 2.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 94.5 t -79.42 106.9 11.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.691 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 9.1 pt-20 -78.61 169.04 18.88 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.219 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -130.34 137.11 49.76 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 N--CA 1.482 1.13 0 C-N-CA 123.07 0.548 . . . . 0.0 111.861 -179.775 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 11.2 m0 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.465 ' HB2' HD11 ' A' ' 13' ' ' LEU . 23.1 ptt180 -88.17 65.39 8.1 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.689 1.233 . . . . 0.0 109.563 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.539 ' HB ' HD12 ' A' ' 17' ' ' LEU . 43.3 t -79.12 143.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.507 -169.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -98.69 142.86 29.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.357 1.063 . . . . 0.0 109.943 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.448 ' SG ' HD13 ' A' ' 14' ' ' LEU . 72.1 m -136.39 99.99 4.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.231 1.013 . . . . 0.0 110.076 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -74.41 113.16 11.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 109.433 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.729 0 C-N-CA 122.773 0.429 . . . . 0.0 110.228 179.879 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -112.62 152.1 29.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 0.0 110.861 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER -113.31 112.94 24.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.448 HD13 ' SG ' ' A' ' 5' ' ' CYS . 5.5 mp -102.72 97.34 7.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.749 0.82 . . . . 0.0 109.041 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.446 ' HG3' HD12 ' A' ' 13' ' ' LEU . 78.5 mt-30 -78.86 -11.4 59.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.373 0.669 . . . . 0.0 110.951 169.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.52 -9.63 74.06 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.421 0.451 . . . . 0.0 114.049 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 21' ' ' THR . 71.1 mt -78.36 125.01 28.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.953 0.501 . . . . 0.0 110.382 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.483 ' O ' HD12 ' A' ' 61' ' ' LEU . 44.5 m -103.43 -178.11 3.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.321 1.449 . . . . 0.0 109.577 171.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 m -65.61 -39.86 91.99 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.92 0.488 . . . . 0.0 112.079 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -104.5 29.15 6.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.819 0.448 . . . . 0.0 112.165 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.547 HG21 HD22 ' A' ' 17' ' ' LEU . 94.9 m -64.08 104.88 0.78 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 122.84 0.456 . . . . 0.0 111.318 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -66.9 173.63 3.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.904 1.282 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' LEU . 6.3 tt -54.95 -50.87 67.81 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.451 0.7 . . . . 0.0 109.873 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.472 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 6.1 ptp180 -56.76 -26.26 56.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.972 0.909 . . . . 0.0 112.712 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 5.5 mm-40 -93.12 -35.46 13.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.897 0.879 . . . . 0.0 110.199 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -79.97 -68.69 0.65 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.035 0.934 . . . . 0.0 109.221 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.76 -19.01 65.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.604 0.565 . . . . 0.0 110.751 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.28 -43.86 77.65 Favored Glycine 0 C--N 1.345 1.051 0 O-C-N 123.929 0.768 . . . . 0.0 112.205 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.512 ' NE2' HD23 ' A' ' 17' ' ' LEU . 43.6 mt-30 -73.41 -38.91 65.42 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HB ' HE22 ' A' ' 41' ' ' GLN . 95.6 mt -57.11 -39.14 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.139 0.576 . . . . 0.0 111.249 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.19 68.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.612 0.765 . . . . 0.0 111.694 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.54 -23.35 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.068 0.947 . . . . 0.0 111.704 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 29' ' ' GLN . 22.2 mm -86.91 -69.38 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.916 0.886 . . . . 0.0 109.886 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.48 HG23 HG12 ' A' ' 36' ' ' ILE . 3.1 t -96.51 -11.73 25.09 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.273 0.629 . . . . 0.0 111.514 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 12.46 77.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.92 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.48 HG12 HG23 ' A' ' 34' ' ' THR . 13.2 mm -85.84 113.81 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.77 142.26 44.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.221 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.66 -24.41 62.57 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.226 2.617 . . . . 0.0 113.348 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.29 19.3 53.29 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.337 0.398 . . . . 0.0 113.27 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -134.6 -3.6 2.62 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.401 HE22 ' HB ' ' A' ' 30' ' ' ILE . 1.0 OUTLIER -123.92 145.67 48.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.613 0.765 . . . . 0.0 109.464 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -121.62 168.04 12.22 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 167.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 66' ' ' ILE . 46.5 mm -103.66 112.0 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.5 mm? -113.61 178.69 4.19 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.1 164.7 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.812 0.445 . . . . 0.0 111.311 -171.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.57 1.82 50.23 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 114.507 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -120.21 172.68 4.35 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -37.45 103.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.017 3.145 . . . . 0.0 113.656 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.17 146.14 56.8 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.634 2.222 . . . . 0.0 112.613 -170.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.32 2.38 55.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.725 0.81 . . . . 0.0 110.826 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.0 m 56.14 74.35 0.39 Allowed 'General case' 0 C--N 1.365 1.258 0 C-N-CA 124.749 1.22 . . . . 0.0 110.482 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.7 mt -77.84 101.14 6.62 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.808 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.13 104.93 17.44 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.296 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 23' ' ' LEU . 5.4 mp -73.85 85.21 1.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.2 t -82.41 -21.31 35.81 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.308 1.043 . . . . 0.0 110.984 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -107.81 136.98 46.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.884 0.874 . . . . 0.0 109.42 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -78.46 -22.45 47.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.579 0.751 . . . . 0.0 111.955 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -93.4 -2.56 54.53 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.448 0.699 . . . . 0.0 111.305 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.82 123.69 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.957 0.503 . . . . 0.0 110.539 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 p -104.51 177.35 4.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.891 0.476 . . . . 0.0 111.081 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 18' ' ' SER . 28.3 mt -74.55 -5.6 43.74 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.615 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.46 62.05 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.497 0.498 . . . . 0.0 111.902 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.92 -42.18 10.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.516 0.726 . . . . 0.0 109.279 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -78.84 152.22 77.21 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.171 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.49 25.49 0.54 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 124.14 3.227 . . . . 0.0 114.175 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.503 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.3 mp -77.08 128.69 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.5 mt-30 -118.03 -179.28 3.71 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.801 0.84 . . . . 0.0 108.917 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 p -68.41 -1.45 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 40.41 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.0 t70 -85.19 163.61 18.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.533 0.733 . . . . 0.0 111.577 -171.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.2 tpt -100.02 103.06 14.58 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.051 0.94 . . . . 0.0 109.508 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.503 ' HG ' HG13 ' A' ' 66' ' ' ILE . 3.2 mm? -109.37 131.24 55.25 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -92.97 114.11 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.43 115.66 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.214 1.006 . . . . 0.0 109.079 167.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -87.48 159.51 18.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -117.2 113.61 22.47 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 CA--C 1.541 0.622 0 C-N-CA 124.061 0.945 . . . . 0.0 109.727 179.484 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 10.8 m0 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -90.95 83.33 5.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.066 0.946 . . . . 0.0 109.124 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.7 t -105.59 141.23 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.734 0.814 . . . . 0.0 111.126 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -88.61 147.28 24.65 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 110.915 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.2 p -131.56 115.37 16.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.348 0.659 . . . . 0.0 110.4 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.574 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 14.3 tppt? -79.7 124.21 28.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.403 1.081 . . . . 0.0 109.434 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 123.118 0.567 . . . . 0.0 110.044 177.912 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.67 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.3 m-70 -102.95 177.84 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 tt -146.86 101.5 3.44 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.0 mp -79.16 113.34 17.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.969 0.908 . . . . 0.0 110.038 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -101.65 -9.39 20.96 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.357 0.663 . . . . 0.0 110.979 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.63 42.03 3.12 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 122.827 0.251 . . . . 0.0 113.165 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.5 mt -118.24 121.97 41.8 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.832 0.853 . . . . 0.0 109.835 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.2 p -97.44 171.97 8.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.373 1.069 . . . . 0.0 109.337 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 m -62.31 -29.34 70.37 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.281 0.632 . . . . 0.0 111.546 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -110.74 29.5 7.69 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.84 0.856 . . . . 0.0 112.142 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -70.88 121.11 17.49 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 166.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -89.93 169.6 11.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 110.093 -173.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 57' ' ' ARG . 24.9 tp -51.99 -51.56 56.43 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.856 0.863 . . . . 0.0 111.715 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 11.8 ptm180 -55.37 -34.1 64.0 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.731 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.563 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 44.0 mt-10 -88.26 -31.28 19.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.812 0.845 . . . . 0.0 110.877 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 43' ' ' ILE . 2.3 tm? -74.01 -66.4 0.72 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.034 0.934 . . . . 0.0 108.907 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -66.49 -20.84 66.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.192 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.37 -42.04 90.32 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.013 0.821 . . . . 0.0 111.67 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -73.71 -35.76 65.16 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.574 0.349 . . . . 0.0 110.078 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.43 ' HB ' HE22 ' A' ' 41' ' ' GLN . 84.2 mt -62.72 -37.56 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 C-N-CA 123.287 0.635 . . . . 0.0 110.53 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.73 -24.61 67.84 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.813 0.845 . . . . 0.0 112.022 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.47 -25.5 16.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.908 0.883 . . . . 0.0 111.804 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.563 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.4 mm -82.4 -65.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.331 1.052 . . . . 0.0 110.488 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.556 HG23 HG12 ' A' ' 36' ' ' ILE . 7.1 t -108.77 -0.36 20.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.98 0.912 . . . . 0.0 110.953 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.99 11.87 84.74 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.404 -0.664 . . . . 0.0 114.398 171.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 76' ' ' GLU . 23.0 mm -85.78 131.49 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 117.791 0.796 . . . . 0.0 111.442 -175.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 130.93 93.64 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.201 1.0 . . . . 0.0 110.335 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.05 -24.97 68.56 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.335 2.69 . . . . 0.0 113.42 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.61 -3.57 90.19 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.859 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.5 m -107.41 -48.21 3.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.762 0.825 . . . . 0.0 110.309 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.43 HE22 ' HB ' ' A' ' 30' ' ' ILE . 3.2 pt20 -76.91 153.77 34.35 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.269 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.69 168.36 23.85 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.448 1.099 . . . . 0.0 109.075 168.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.444 HG21 ' HD2' ' A' ' 65' ' ' PRO . 43.9 mm -79.41 103.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.259 1.028 . . . . 0.0 110.364 -174.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.2 mt -122.1 137.19 54.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.985 -1.916 . . . . 0.0 105.964 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 65' ' ' PRO . 16.3 m -125.68 179.1 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 122.733 0.413 . . . . 0.0 111.5 -169.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.65 -48.75 74.9 Favored Glycine 0 C--N 1.358 1.779 0 O-C-N 124.326 1.016 . . . . 0.0 113.654 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -80.7 155.82 73.19 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.929 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -45.29 108.04 0.13 Allowed 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 124.22 3.28 . . . . 0.0 113.593 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.04 169.14 8.97 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.946 2.431 . . . . 0.0 111.524 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.58 25.18 11.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.455 0.702 . . . . 0.0 111.417 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.1 m 53.2 65.07 1.62 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.03 0.932 . . . . 0.0 110.143 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.86 126.14 26.33 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.182 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -91.04 90.81 8.02 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.836 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.89 86.17 2.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -80.58 -41.46 23.99 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.0 0.92 . . . . 0.0 110.872 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 20.9 t0 -81.11 118.2 22.32 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.024 0.53 . . . . 0.0 110.385 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HA ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.75 -29.13 62.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.07 0.948 . . . . 0.0 112.832 174.313 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -93.52 -2.39 54.41 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.761 0.824 . . . . 0.0 112.047 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 14.0 tt -69.73 126.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.989 -0.444 . . . . 0.0 111.177 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -91.12 172.04 8.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.37 0.605 . . . . 0.0 112.437 -171.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 66' ' ' ILE . 27.6 mt -65.43 -17.78 64.81 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.149 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -28.62 66.77 Favored Glycine 0 C--N 1.36 1.886 0 O-C-N 123.483 0.489 . . . . 0.0 113.14 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.81 -52.24 5.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.129 0.571 . . . . 0.0 110.402 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.9 155.45 82.89 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.969 0.908 . . . . 0.0 111.756 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' HG11 ' A' ' 45' ' ' VAL . 4.4 Cg_exo -80.66 36.65 0.63 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.878 3.052 . . . . 0.0 114.126 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.568 HG13 HD21 ' A' ' 72' ' ' LEU . 2.0 mp -70.89 114.55 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 167.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.631 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 34.4 mt-30 -118.23 148.57 42.27 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -65.24 104.07 0.88 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.67 . . . . 0.0 110.659 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.88 11.51 52.98 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 114.113 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.631 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 27.9 t0 -89.53 160.68 16.59 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.273 0.629 . . . . 0.0 111.979 -173.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.574 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 4.8 tpt -96.21 108.31 20.77 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.766 1.226 . . . . 0.0 109.648 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.568 HD21 HG13 ' A' ' 66' ' ' ILE . 11.1 mp -109.67 126.12 53.34 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 0.0 110.288 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -85.88 103.29 12.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.53 111.65 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.618 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.99 155.41 19.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.71 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.601 ' HB2' HD12 ' A' ' 36' ' ' ILE . 10.0 tp10 -135.87 130.81 34.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.985 0.914 . . . . 0.0 109.446 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.354 0.662 . . . . 0.0 110.632 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 18.8 m0 . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.505 ' HB3' HD11 ' A' ' 13' ' ' LEU . 53.7 mtm180 -116.75 88.05 2.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.017 0.927 . . . . 0.0 108.775 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.487 HG13 HD23 ' A' ' 72' ' ' LEU . 82.3 t -89.43 137.36 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.455 0.702 . . . . 0.0 111.204 -170.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -87.45 138.67 31.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.746 0.819 . . . . 0.0 109.075 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 t -131.99 100.89 5.21 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.474 0.71 . . . . 0.0 111.11 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.488 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.0 tppp? -73.38 144.75 46.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.733 0.301 . . . . 0.0 111.34 -177.772 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.543 0.704 0 CA-C-O 121.112 0.482 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -122.97 164.66 18.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.33 1.452 . . . . 0.0 108.378 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 2' ' ' ARG . 0.3 OUTLIER -128.85 102.55 6.59 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.654 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.1 mp -81.3 121.77 26.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.041 0.936 . . . . 0.0 110.358 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.505 ' NE2' HD12 ' A' ' 13' ' ' LEU . 83.5 mm-40 -98.9 159.92 14.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.158 0.983 . . . . 0.0 109.762 174.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.8 10.43 83.13 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.135 -0.484 . . . . 0.0 114.17 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.39 137.44 42.71 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.113 0.565 . . . . 0.0 109.609 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -112.66 177.92 4.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.639 1.176 . . . . 0.0 109.36 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.7 p -82.32 -26.85 32.64 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.912 0.387 . . . . 0.0 109.972 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -86.8 6.92 29.2 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.926 0.89 . . . . 0.0 112.191 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.426 HG22 ' HB2' ' A' ' 26' ' ' LEU . 93.5 m -62.9 112.34 2.52 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 110.826 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.88 179.36 7.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.287 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 4.9 tt -57.53 -56.33 23.27 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.74 0.816 . . . . 0.0 109.652 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -20.31 64.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.673 0.789 . . . . 0.0 112.097 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -79.62 -52.81 7.51 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.509 0.724 . . . . 0.0 109.246 172.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.426 ' HB2' HG22 ' A' ' 21' ' ' THR . 2.5 tm? -69.29 -66.72 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.879 1.272 . . . . 0.0 110.756 -169.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -65.13 -18.3 65.19 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.141 0.576 . . . . 0.0 111.7 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.46 -41.03 46.12 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.7 0.625 . . . . 0.0 111.983 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -70.13 -37.03 75.18 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.105 0.562 . . . . 0.0 110.06 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.55 -43.73 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 0.0 110.912 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.417 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -60.76 -26.36 67.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.761 0.825 . . . . 0.0 111.743 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.51 -27.96 19.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.632 0.773 . . . . 0.0 111.769 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.654 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.4 mm -84.27 -70.07 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.115 0.566 . . . . 0.0 110.722 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 36' ' ' ILE . 6.4 t -88.53 -16.29 33.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.24 0.616 . . . . 0.0 111.154 -175.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.81 -1.91 85.55 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.361 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.401 ' H ' HG23 ' A' ' 34' ' ' THR . 18.9 mm -77.64 112.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.54 144.53 63.61 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 124.022 0.929 . . . . 0.0 110.772 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 31' ' ' ALA . 28.2 Cg_endo -57.85 -24.35 63.78 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.26 2.64 . . . . 0.0 113.212 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.49 19.8 34.32 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.639 -0.255 . . . . 0.0 113.28 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.8 m -140.37 12.62 2.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.458 1.103 . . . . 0.0 110.618 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -148.9 144.03 26.6 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.993 0.517 . . . . 0.0 109.81 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.8 176.35 6.66 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.279 1.032 . . . . 0.0 108.904 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -101.21 101.12 11.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 32.2 mt -116.28 145.58 43.05 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 49' ' ' PRO . 17.4 m -114.7 168.55 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.299 0.639 . . . . 0.0 110.017 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.01 65.72 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.789 0.681 . . . . 0.0 113.77 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -80.29 160.87 66.92 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.606 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -47.52 110.77 0.33 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HB3' HG22 ' A' ' 45' ' ' VAL . 90.8 Cg_endo -81.53 -179.81 5.21 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.273 2.649 . . . . 0.0 112.307 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.74 13.46 28.38 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.503 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.7 m 54.72 66.43 1.24 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 123.828 0.851 . . . . 0.0 108.706 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.77 129.24 39.09 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.863 -165.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.9 90.14 3.52 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 108.801 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 9.7 mp -87.49 104.99 16.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -100.65 -51.94 3.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.602 0.761 . . . . 0.0 110.562 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' O ' HG22 ' A' ' 59' ' ' ILE . 13.9 t0 -71.71 111.72 7.23 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.116 0.567 . . . . 0.0 111.317 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.546 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -53.09 -25.59 13.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.501 1.12 . . . . 0.0 113.554 175.322 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.51 -2.75 56.0 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.49 0.716 . . . . 0.0 112.11 -173.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 56' ' ' ASP . 15.4 tt -71.78 125.43 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.729 0.412 . . . . 0.0 110.836 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.6 p -89.4 176.01 7.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.659 0.743 . . . . 0.0 112.317 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.7 mt -73.52 -7.51 52.12 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.828 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.17 71.95 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.395 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.35 -52.04 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.4 0.68 . . . . 0.0 110.519 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.43 148.22 54.92 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.216 0.607 . . . . 0.0 111.144 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 31.51 0.44 Allowed 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.805 3.003 . . . . 0.0 114.936 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.31 117.8 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -120.42 163.42 17.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 t -71.16 108.53 4.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.837 0.455 . . . . 0.0 110.191 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.57 0.15 62.87 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.581 0.551 . . . . 0.0 113.206 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.19 156.68 38.34 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.193 0.597 . . . . 0.0 110.549 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.2 tpt -92.54 104.58 16.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.491 1.117 . . . . 0.0 109.021 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.487 HD23 HG13 ' A' ' 3' ' ' VAL . 4.3 mm? -105.08 115.75 30.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.885 0.874 . . . . 0.0 109.11 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.4 mp -86.79 100.73 10.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -78.21 105.09 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.599 166.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.5 161.69 27.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.834 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -116.52 109.4 17.21 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 124.183 0.993 . . . . 0.0 110.92 179.466 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 38.5 m0 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.842 0.353 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -125.17 106.81 10.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.469 HG11 HG23 ' A' ' 66' ' ' ILE . 37.3 t -130.75 139.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.922 -0.486 . . . . 0.0 110.35 -173.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -85.02 153.73 22.56 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.005 0.522 . . . . 0.0 111.72 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.545 ' SG ' HD23 ' A' ' 14' ' ' LEU . 95.3 m -130.72 112.14 12.81 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.395 1.078 . . . . 0.0 110.414 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 16.3 tppt? -82.34 107.67 15.19 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.426 1.09 . . . . 0.0 109.305 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.582 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 120.802 0.335 . . . . 0.0 111.253 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -101.36 179.21 4.42 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.975 0.91 . . . . 0.0 110.153 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD22 ' OE1' ' A' ' 15' ' ' GLN . 3.0 tt -135.35 106.27 6.62 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.545 HD23 ' SG ' ' A' ' 5' ' ' CYS . 4.3 mm? -66.0 108.68 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.684 0.794 . . . . 0.0 109.925 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.446 ' OE1' HD22 ' A' ' 13' ' ' LEU . 14.0 mm100 -76.89 -45.77 26.89 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.199 0.999 . . . . 0.0 110.719 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.81 65.48 3.91 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.533 -0.758 . . . . 0.0 113.382 -174.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.9 mt -118.43 138.55 52.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.06 0.544 . . . . 0.0 110.29 172.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.42 ' O ' HD12 ' A' ' 61' ' ' LEU . 21.3 m -115.75 -176.91 3.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.204 1.402 . . . . 0.0 108.722 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.2 m -73.47 -33.72 64.99 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.186 0.517 . . . . 0.0 110.681 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -104.37 28.18 7.15 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.844 -175.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 26' ' ' LEU . 53.3 m -67.76 105.18 1.85 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.347 0.594 . . . . 0.0 109.686 171.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 36.2 mtm-85 -65.92 175.85 1.85 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.757 1.223 . . . . 0.0 111.637 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 54' ' ' LEU . 7.3 tt -56.39 -57.67 11.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.356 0.662 . . . . 0.0 109.28 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -50.51 -34.6 25.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.9 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 18.6 mm-40 -76.11 -51.03 13.07 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.002 0.429 . . . . 0.0 110.087 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 43' ' ' ILE . 2.4 tm? -70.76 -67.27 0.52 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.317 1.047 . . . . 0.0 110.68 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.432 ' HA ' HE22 ' A' ' 41' ' ' GLN . 40.2 mt-30 -66.55 -20.38 66.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.599 0.562 . . . . 0.0 111.618 -176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.22 -37.01 43.59 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.729 0.643 . . . . 0.0 112.192 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.431 ' O ' HG12 ' A' ' 33' ' ' ILE . 92.0 mt-30 -70.63 -39.73 73.53 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -62.76 -36.63 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.312 0.645 . . . . 0.0 110.615 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -26.34 68.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.439 0.695 . . . . 0.0 111.536 173.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.81 -23.04 20.72 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.92 0.888 . . . . 0.0 111.766 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 29' ' ' GLN . 16.0 mm -82.78 -70.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.372 0.669 . . . . 0.0 110.374 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.44 HG23 HG12 ' A' ' 36' ' ' ILE . 4.8 t -97.77 -7.75 29.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.16 19.23 78.72 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 119.712 -0.493 . . . . 0.0 113.321 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.44 HG12 HG23 ' A' ' 34' ' ' THR . 11.0 mm -98.49 108.26 21.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.84 155.07 55.13 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.498 1.119 . . . . 0.0 112.157 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.12 -31.71 84.19 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.419 2.746 . . . . 0.0 114.599 -174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.02 3.1 80.44 Favored Glycine 0 N--CA 1.476 1.353 0 O-C-N 123.124 0.265 . . . . 0.0 113.346 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.412 ' HA ' ' HB3' ' A' ' 77' ' ' ASP . 19.1 m -107.25 -2.93 20.28 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.198 0.999 . . . . 0.0 110.179 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.432 HE22 ' HA ' ' A' ' 27' ' ' GLN . 1.4 pp0? -144.53 162.45 36.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.974 0.416 . . . . 0.0 111.86 -176.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.48 -176.35 5.08 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.18 1.392 . . . . 0.0 108.885 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.596 HD11 HD11 ' A' ' 26' ' ' LEU . 29.0 mm -105.8 110.63 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.535 . . . . 0.0 109.723 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -121.34 160.18 24.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -131.92 173.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.755 0.822 . . . . 0.0 111.125 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.48 -5.1 87.86 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.814 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.418 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 54.0 p90 -113.51 163.2 19.07 Favored Pre-proline 0 N--CA 1.479 1.017 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 10.8 Cg_endo -50.89 109.21 0.28 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 122.88 2.387 . . . . 0.0 112.489 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.33 169.81 12.33 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.746 2.297 . . . . 0.0 112.159 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -88.08 5.73 39.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.706 0.802 . . . . 0.0 111.335 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 90.3 m 56.27 83.05 0.1 Allowed 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -158.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.61 95.6 3.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 110.512 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.75 114.0 20.1 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.143 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.488 ' HB3' HD12 ' A' ' 23' ' ' LEU . 4.7 mp -79.46 84.83 5.3 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 p -67.9 -50.56 55.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.468 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 19.3 t70 -76.25 157.55 32.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.083 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -92.52 -34.78 13.93 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.286 1.034 . . . . 0.0 111.815 -173.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.51 -3.07 50.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.9 1.28 . . . . 0.0 110.431 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.588 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 15.8 tt -60.85 133.51 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.637 1.175 . . . . 0.0 111.883 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -108.69 -177.9 3.44 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.578 HD21 ' HG ' ' A' ' 26' ' ' LEU . 49.7 mt -75.64 -10.05 59.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 112.061 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 -25.09 73.79 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.52 -59.33 2.16 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 109.846 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.75 129.79 75.47 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.282 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -63.21 78.26 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.918 3.079 . . . . 0.0 114.053 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.627 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -108.11 108.78 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 12.3 mm100 -103.31 155.05 18.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.972 0.509 . . . . 0.0 109.989 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.6 p -62.79 100.97 0.22 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.786 0.835 . . . . 0.0 111.826 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.53 46.08 8.22 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.608 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 6.0 t70 -110.25 169.71 8.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.309 0.644 . . . . 0.0 110.374 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.1 tpt -102.18 103.29 13.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.308 0.643 . . . . 0.0 109.991 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.6 mm? -106.01 114.68 28.96 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.475 0.71 . . . . 0.0 109.679 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 2.8 mp -82.13 108.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.667 0.787 . . . . 0.0 109.737 -176.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 75.8 t -82.97 116.42 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.706 1.203 . . . . 0.0 108.933 170.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.439 ' O ' HG21 ' A' ' 36' ' ' ILE . 11.9 pt-20 -82.31 170.23 15.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.646 0.26 . . . . 0.0 110.699 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -129.57 114.6 16.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 27.7 t70 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 124.342 1.057 . . . . 0.0 110.703 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 32.0 m0 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -81.16 94.8 6.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.9 144.3 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.189 0.995 . . . . 0.0 109.861 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -100.01 141.87 32.25 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.002 0.521 . . . . 0.0 110.903 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 31.2 p -122.85 112.49 17.94 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 0.0 111.369 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HB3' HG13 ' A' ' 73' ' ' ILE . 13.3 tppt? -81.03 106.1 12.77 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.9 0 C-N-CA 123.064 0.546 . . . . 0.0 111.518 -170.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 21.2 m-70 -104.78 179.31 4.31 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.046 0.939 . . . . 0.0 109.538 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' NE2' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -130.66 129.5 42.72 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.437 ' HG ' HG13 ' A' ' 33' ' ' ILE . 5.5 mp -99.98 118.21 35.91 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.48 1.112 . . . . 0.0 109.906 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.464 ' NE2' HD12 ' A' ' 13' ' ' LEU . 80.8 mm-40 -94.4 156.88 16.28 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.468 0.707 . . . . 0.0 109.199 171.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.16 81.72 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.536 -0.591 . . . . 0.0 114.409 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.89 118.57 12.9 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 110.072 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.4 m -114.01 172.99 6.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.197 0.999 . . . . 0.0 109.602 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.2 p -59.09 -35.22 73.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.832 0.853 . . . . 0.0 112.728 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -95.64 3.45 53.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.505 0.722 . . . . 0.0 112.636 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 25' ' ' GLU . 45.2 m -55.21 113.15 1.27 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.586 0.708 . . . . 0.0 111.495 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.56 172.18 11.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.177 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 54' ' ' LEU . 8.8 tt -59.15 -48.0 83.23 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.677 0.791 . . . . 0.0 110.536 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -25.15 67.37 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.998 0.519 . . . . 0.0 112.366 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 21' ' ' THR . 64.2 mm-40 -78.73 -53.05 7.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.572 0.749 . . . . 0.0 109.875 175.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.06 -55.35 29.98 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.47 1.508 . . . . 0.0 111.236 -173.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 15.1 mm100 -57.78 -34.22 69.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.358 1.063 . . . . 0.0 111.967 177.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.73 -34.26 77.61 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.969 0.793 . . . . 0.0 111.678 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -76.52 -39.31 53.35 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 123.195 0.598 . . . . 0.0 110.408 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -56.82 -44.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.403 0.681 . . . . 0.0 110.7 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.21 -24.16 67.57 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.586 0.754 . . . . 0.0 111.843 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.65 -28.42 19.49 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.79 0.836 . . . . 0.0 112.135 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.437 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.9 mm -91.66 -51.19 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.139 0.976 . . . . 0.0 111.782 -171.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.541 HG23 HG12 ' A' ' 36' ' ' ILE . 15.0 t -115.91 -5.88 12.03 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.344 0.658 . . . . 0.0 111.28 -178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.51 -10.32 74.35 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 168.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.541 HG12 HG23 ' A' ' 34' ' ' THR . 4.1 mm -82.4 118.5 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 117.953 0.876 . . . . 0.0 109.778 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.82 149.01 96.84 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.05 0.94 . . . . 0.0 111.3 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 11.7 Cg_endo -50.53 -41.01 54.14 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 124.198 3.265 . . . . 0.0 113.854 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.25 27.53 5.59 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.179 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.7 m -146.6 12.99 1.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.616 1.166 . . . . 0.0 109.033 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -155.7 151.05 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.188 0.518 . . . . 0.0 110.402 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -125.96 174.48 8.38 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.491 1.116 . . . . 0.0 108.143 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.514 HG12 HD21 ' A' ' 54' ' ' LEU . 47.3 mm -106.72 114.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.7 mm? -119.5 166.42 13.13 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 47' ' ' TYR . 4.0 m -129.35 161.26 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.374 0.67 . . . . 0.0 110.462 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -43.57 96.16 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.616 0.573 . . . . 0.0 113.035 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.48 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 32.8 p90 -72.77 163.25 69.58 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.161 167.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 14.6 Cg_endo -52.61 114.61 1.76 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.904 2.403 . . . . 0.0 114.071 -173.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 9.7 Cg_endo -88.68 178.66 2.75 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.366 2.71 . . . . 0.0 110.919 170.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.08 19.94 6.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.789 0.835 . . . . 0.0 109.601 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.4 m 57.04 82.37 0.12 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.591 1.157 . . . . 0.0 109.602 -164.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 43' ' ' ILE . 95.3 mt -53.11 131.11 36.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.593 0.757 . . . . 0.0 111.34 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -82.73 106.17 14.35 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.792 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.514 HD21 HG12 ' A' ' 43' ' ' ILE . 7.2 mp -105.35 80.49 1.59 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.816 0.846 . . . . 0.0 109.097 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 p -102.71 -34.42 9.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.779 0.831 . . . . 0.0 110.945 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' O ' HD13 ' A' ' 23' ' ' LEU . 8.8 t70 -82.61 -175.52 5.8 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.483 0.713 . . . . 0.0 109.95 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -31.1 1.48 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.621 0.768 . . . . 0.0 110.795 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.35 -19.58 42.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.876 0.87 . . . . 0.0 110.913 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.96 123.38 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 124.163 0.985 . . . . 0.0 111.109 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -96.54 -179.36 4.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -166.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.9 mt -68.92 -15.41 63.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.901 0.88 . . . . 0.0 111.838 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.6 -17.8 73.2 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.462 -0.336 . . . . 0.0 112.393 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.76 -63.06 1.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.924 0.89 . . . . 0.0 109.616 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.09 116.68 46.81 Favored Pre-proline 0 N--CA 1.486 1.345 0 CA-C-O 117.646 -1.168 . . . . 0.0 107.999 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -55.64 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.995 3.13 . . . . 0.0 115.055 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.464 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -110.4 121.66 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 166.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 37.8 mt-30 -119.53 166.22 13.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.287 0.635 . . . . 0.0 109.668 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.6 m -63.74 95.92 0.12 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.819 0.848 . . . . 0.0 110.925 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.93 29.41 23.31 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.436 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 23.6 t70 -87.79 160.47 18.02 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.148 0.579 . . . . 0.0 109.893 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.7 tpt -96.9 100.98 12.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 110.261 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.1 mm? -104.94 112.79 26.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.671 0.788 . . . . 0.0 109.429 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -81.78 114.47 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.76 115.91 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 108.467 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.9 179.89 6.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 110.665 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -131.94 106.57 8.13 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 CA--C 1.554 1.118 0 C-N-CA 124.737 1.215 . . . . 0.0 110.9 173.084 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.9 m0 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.675 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 78.3 mtm180 -80.35 69.93 6.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.151 0.98 . . . . 0.0 109.564 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.487 ' HB ' HD12 ' A' ' 17' ' ' LEU . 96.3 t -79.21 132.95 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.739 0.816 . . . . 0.0 111.142 -171.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.4 ' CB ' ' HE3' ' A' ' 71' ' ' MET . 99.0 mtt180 -84.03 140.82 31.6 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.452 0.701 . . . . 0.0 109.958 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 4.0 t -125.37 96.98 5.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.045 0.938 . . . . 0.0 110.255 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.1 102.67 9.48 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.362 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.169 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 120.689 0.281 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 79.7 m-70 -118.82 178.06 4.62 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.491 1.116 . . . . 0.0 108.42 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 2' ' ' ARG . 1.3 tm? -146.31 114.18 6.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.6 mp -104.97 105.87 16.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.75 1.22 . . . . 0.0 109.224 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.675 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 78.2 mt-30 -84.17 -17.76 38.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.337 0.655 . . . . 0.0 111.067 172.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.62 24.64 4.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.487 HD12 ' HB ' ' A' ' 3' ' ' VAL . 87.0 mt -110.33 123.95 50.78 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.728 0.811 . . . . 0.0 109.486 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 61' ' ' LEU . 25.9 m -113.67 171.43 7.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.546 1.138 . . . . 0.0 108.97 172.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -57.84 -41.66 82.8 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.002 0.429 . . . . 0.0 112.128 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -92.19 17.05 10.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.654 0.782 . . . . 0.0 112.076 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -68.19 122.41 18.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.212 0.605 . . . . 0.0 110.119 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -78.57 177.15 8.8 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.824 0.45 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 56' ' ' ASP . 7.3 tt -55.08 -50.82 68.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.148 0.979 . . . . 0.0 110.537 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -61.38 -30.36 70.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.421 -173.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -80.55 -46.66 15.41 Favored 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 122.588 0.355 . . . . 0.0 110.389 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.76 -68.31 0.35 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.92 0.888 . . . . 0.0 110.594 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -66.87 -20.65 65.96 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.07 0.548 . . . . 0.0 111.519 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.13 -38.14 59.48 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.885 0.741 . . . . 0.0 112.328 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -74.05 -39.55 63.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.127 0.571 . . . . 0.0 109.6 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.8 mt -57.46 -40.64 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.558 0.743 . . . . 0.0 110.669 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.83 -24.39 67.74 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.055 0.942 . . . . 0.0 111.844 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.51 -32.35 15.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.858 0.863 . . . . 0.0 111.786 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.6 mm -79.94 -65.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.395 1.078 . . . . 0.0 110.283 -174.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.471 HG23 HG12 ' A' ' 36' ' ' ILE . 10.1 t -99.45 -15.93 18.54 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.407 0.683 . . . . 0.0 111.3 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.32 82.97 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.202 -0.777 . . . . 0.0 114.338 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 34' ' ' THR . 13.7 mm -78.76 119.56 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.169 0.984 . . . . 0.0 108.348 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.11 142.52 85.64 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 124.235 0.96 . . . . 0.0 111.24 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.73 -27.67 72.09 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.406 2.737 . . . . 0.0 113.256 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.42 27.04 14.8 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.119 0.39 . . . . 0.0 112.589 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.6 m -142.14 7.66 1.81 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.482 1.113 . . . . 0.0 109.698 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -148.71 149.16 30.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.946 0.898 . . . . 0.0 109.983 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.23 -175.31 3.53 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.312 1.045 . . . . 0.0 108.973 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.542 HG21 ' HD2' ' A' ' 65' ' ' PRO . 49.2 mm -104.49 109.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.27 0.628 . . . . 0.0 109.616 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 34.8 mt -122.04 151.79 40.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 49' ' ' PRO . 17.1 m -132.39 173.72 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.48 0.712 . . . . 0.0 110.907 -174.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.4 -49.01 66.32 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.874 0.734 . . . . 0.0 113.835 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -79.47 158.11 74.18 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.644 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -46.24 104.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.485 2.79 . . . . 0.0 114.624 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HB3' HG22 ' A' ' 45' ' ' VAL . 98.6 Cg_endo -82.81 156.88 15.77 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.886 2.391 . . . . 0.0 112.808 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -75.75 -22.52 56.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.6 0.76 . . . . 0.0 112.147 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.2 m 65.92 35.93 6.25 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.369 1.068 . . . . 0.0 109.014 -171.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.3 pt? -39.59 140.93 0.44 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.922 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.31 106.74 16.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.463 0.705 . . . . 0.0 110.209 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 23' ' ' LEU . 8.5 mp -86.05 96.79 9.98 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.514 0.726 . . . . 0.0 109.429 175.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -109.1 -39.73 5.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.87 0.868 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.447 ' O ' HD13 ' A' ' 23' ' ' LEU . 20.3 t0 -75.63 145.24 41.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.389 0.676 . . . . 0.0 110.693 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.57 -20.67 15.58 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.093 0.957 . . . . 0.0 110.551 -177.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.45 -19.52 49.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.326 1.05 . . . . 0.0 111.251 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 tt -57.71 126.13 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.667 0.787 . . . . 0.0 111.46 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -106.34 175.9 5.34 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.095 0.958 . . . . 0.0 111.104 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 21.1 mt -74.1 -1.07 18.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.8 0.84 . . . . 0.0 111.473 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.92 -39.04 64.65 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.818 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.54 -48.53 6.81 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 96.1 mt -59.77 139.23 90.07 Favored Pre-proline 0 CA--C 1.558 1.266 0 O-C-N 123.871 0.732 . . . . 0.0 110.36 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HD2' HG21 ' A' ' 43' ' ' ILE . 6.3 Cg_exo -79.2 45.1 1.84 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.436 2.757 . . . . 0.0 113.385 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.499 ' HA ' HD21 ' A' ' 72' ' ' LEU . 2.1 mp -93.41 119.5 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 171.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 36.2 mm-40 -116.47 166.79 11.68 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.027 0.531 . . . . 0.0 109.573 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 p -64.59 109.92 2.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.29 0.636 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 78.57 10.15 86.44 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.11 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.1 t70 -76.65 159.18 30.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.24 0.616 . . . . 0.0 111.353 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.4 ' HE3' ' CB ' ' A' ' 4' ' ' ARG . 2.9 tpt -86.08 101.88 13.35 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.454 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 66' ' ' ILE . 4.6 mm? -102.04 113.18 26.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.267 1.027 . . . . 0.0 108.883 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.9 mp -88.48 99.89 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.67 105.77 5.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.844 170.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.4 149.85 36.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.366 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -110.2 105.02 13.93 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 CA--C 1.567 1.63 0 C-N-CA 123.66 0.784 . . . . 0.0 110.349 172.506 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' TRP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 9.0 m0 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.462 ' HB3' HD11 ' A' ' 13' ' ' LEU . 54.2 mtt180 -87.22 74.11 9.6 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG11 HG23 ' A' ' 66' ' ' ILE . 34.7 t -87.21 138.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.672 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -89.54 158.2 17.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.573 0.749 . . . . 0.0 110.519 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 28.1 p -142.97 114.57 8.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.214 0.606 . . . . 0.0 109.627 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -79.02 109.61 13.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.57 0 C-N-CA 122.977 0.511 . . . . 0.0 110.313 -174.095 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 32.4 m80 -94.59 160.73 14.5 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.1 -174.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.462 HD11 ' HB3' ' A' ' 2' ' ' ARG . 2.7 tm? -119.14 115.3 23.96 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.556 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -98.79 132.45 44.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 109.207 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.46 173.03 12.02 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.05 12.47 76.64 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 1' ' ' TRP . 98.5 mt -83.54 115.38 22.07 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.369 0.668 . . . . 0.0 109.491 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.3 t -79.23 173.75 12.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.484 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.1 p -64.09 -35.62 81.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.996 0.427 . . . . 0.0 110.595 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -104.72 33.46 3.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.07 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.446 HG21 HD22 ' A' ' 17' ' ' LEU . 74.6 m -69.26 113.01 6.21 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 171.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -77.52 178.28 7.37 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.349 1.059 . . . . 0.0 111.234 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 54' ' ' LEU . 8.4 tt -57.16 -54.9 41.55 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.436 0.695 . . . . 0.0 110.228 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -14.43 63.04 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.231 -174.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.36 -49.41 8.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.611 0.764 . . . . 0.0 109.24 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 43' ' ' ILE . 2.4 tm? -75.51 -64.55 1.05 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.668 1.187 . . . . 0.0 110.464 -170.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.8 -20.17 64.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.23 0.612 . . . . 0.0 111.083 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.24 -43.76 88.08 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 124.011 0.82 . . . . 0.0 111.902 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.75 -36.24 67.66 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 119.509 -0.282 . . . . 0.0 110.268 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.92 -44.47 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.268 0.627 . . . . 0.0 110.343 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.74 66.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.167 0.987 . . . . 0.0 112.116 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.57 -40.01 12.9 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.317 0.647 . . . . 0.0 111.605 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.556 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.8 mm -69.13 -65.97 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.227 1.011 . . . . 0.0 110.629 -173.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.424 HG23 HG12 ' A' ' 36' ' ' ILE . 5.0 t -99.85 -11.87 20.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.291 -175.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.07 86.1 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.499 -0.612 . . . . 0.0 114.122 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.424 HG12 HG23 ' A' ' 34' ' ' THR . 13.3 mm -83.37 118.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.52 146.44 73.04 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.798 0.839 . . . . 0.0 111.474 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.43 -30.86 92.75 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.165 2.577 . . . . 0.0 112.419 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.64 32.55 5.24 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.531 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -141.86 2.12 1.53 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 110.163 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -148.96 163.63 36.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.897 0.879 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 176.03 10.64 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.393 0.677 . . . . 0.0 110.042 173.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.406 HD11 HD11 ' A' ' 26' ' ' LEU . 44.7 mm -84.05 113.8 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 17.7 mt -132.43 123.63 27.06 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 16.3 m -102.78 173.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.975 0.51 . . . . 0.0 112.197 -169.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -46.42 93.78 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 124.353 1.033 . . . . 0.0 114.235 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -79.34 158.3 74.25 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 117.959 -1.019 . . . . 0.0 108.912 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.95 107.1 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.403 2.736 . . . . 0.0 113.628 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 63.1 Cg_endo -77.31 155.86 32.8 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.509 2.139 . . . . 0.0 112.179 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -94.78 34.33 1.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.646 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 62.8 m 75.66 -54.3 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.773 1.629 . . . . 0.0 110.726 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.5 mt 68.01 90.96 0.09 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.869 1.267 . . . . 0.0 110.682 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.22 101.14 13.86 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.801 0.84 . . . . 0.0 110.252 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.662 ' HB3' HD12 ' A' ' 23' ' ' LEU . 6.1 mp -78.05 99.41 6.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -124.87 39.24 4.02 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.186 0.594 . . . . 0.0 111.009 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 59' ' ' ILE . 28.1 t70 -163.59 146.01 9.73 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.591 0.756 . . . . 0.0 109.856 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -76.66 -31.66 57.46 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.953 0.501 . . . . 0.0 111.394 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.65 -3.92 54.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.717 0.807 . . . . 0.0 112.286 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 56' ' ' ASP . 10.7 tt -64.08 123.62 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.108 0.48 . . . . 0.0 110.485 -176.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.7 p -101.89 176.62 5.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -166.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 mt -69.23 -12.19 61.46 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.621 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.97 -22.0 69.77 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.77 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.49 -53.07 3.88 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.84 150.47 92.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.57 43.53 1.51 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.98 2.453 . . . . 0.0 114.661 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.569 HG13 HD21 ' A' ' 72' ' ' LEU . 2.6 mp -73.0 119.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 38.1 mt-30 -118.64 157.24 27.79 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 p -64.02 103.67 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.435 0.694 . . . . 0.0 111.442 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.41 21.97 57.42 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.967 -0.561 . . . . 0.0 113.402 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 9.8 t70 -79.76 160.9 26.02 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.856 0.463 . . . . 0.0 110.294 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 tpt -91.16 98.79 11.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.714 0.805 . . . . 0.0 109.56 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.569 HD21 HG13 ' A' ' 66' ' ' ILE . 6.7 mp -93.83 104.71 16.77 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.8 mp -72.12 90.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -84.24 95.63 4.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.686 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -77.99 153.23 32.61 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.174 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -104.96 99.25 8.87 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 CA--C 1.558 1.28 0 C-N-CA 123.89 0.876 . . . . 0.0 109.846 171.634 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' TRP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 16.3 m0 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.585 0.231 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.52 ' HB3' HD21 ' A' ' 13' ' ' LEU . 75.4 mtt180 -108.47 71.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.067 0.947 . . . . 0.0 108.684 173.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 66' ' ' ILE . 71.7 t -79.09 123.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.642 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.435 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 66.0 mtt180 -81.79 141.49 33.44 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 14' ' ' LEU . 92.3 m -135.54 105.67 6.3 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.715 0.406 . . . . 0.0 111.19 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -79.84 98.41 7.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 109.981 -175.776 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -109.69 176.25 5.14 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.777 0.831 . . . . 0.0 109.76 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 2' ' ' ARG . 10.4 tt -151.19 116.06 5.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.614 ' HG ' HG13 ' A' ' 33' ' ' ILE . 7.3 mp -90.63 131.02 36.58 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.811 1.244 . . . . 0.0 109.607 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -92.09 164.44 13.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.578 0.751 . . . . 0.0 110.571 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.97 -97.19 1.62 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-O 118.833 -0.982 . . . . 0.0 111.225 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 61' ' ' LEU . 4.1 mm? 42.16 104.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.567 1.547 . . . . 0.0 113.217 -175.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.9 t -73.18 154.2 40.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -62.71 -21.97 66.16 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 121.222 0.534 . . . . 0.0 110.674 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 74.1 mtt180 -110.01 29.99 7.13 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.289 1.036 . . . . 0.0 111.522 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.8 m -66.57 112.0 3.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -65.79 163.43 16.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.307 1.043 . . . . 0.0 110.969 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.433 HD13 HD23 ' A' ' 54' ' ' LEU . 23.5 tp -53.55 -52.2 60.45 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.07 0.948 . . . . 0.0 111.697 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 ptt85 -60.02 -24.1 64.23 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.159 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.26 -38.02 14.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.533 0.733 . . . . 0.0 110.058 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -66.09 0.64 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.534 1.134 . . . . 0.0 110.091 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.81 -17.41 64.51 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.458 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.47 -37.26 85.37 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.687 0.617 . . . . 0.0 112.076 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -75.63 -40.45 56.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.243 0.617 . . . . 0.0 110.419 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.438 ' HB ' HE22 ' A' ' 41' ' ' GLN . 82.1 mt -61.78 -35.83 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.537 0.735 . . . . 0.0 110.926 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -24.99 66.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.128 0.971 . . . . 0.0 112.009 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.01 -42.83 9.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.976 0.911 . . . . 0.0 111.161 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.614 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.1 mm -66.11 -50.69 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 112.011 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.559 HG23 HG12 ' A' ' 36' ' ' ILE . 7.2 t -124.04 -1.32 8.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.122 0.569 . . . . 0.0 111.377 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 -0.23 89.56 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 34' ' ' THR . 11.4 mm -82.54 103.78 10.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.76 152.53 67.95 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.951 0.9 . . . . 0.0 111.426 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.84 -38.51 57.6 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.76 2.974 . . . . 0.0 114.547 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.25 30.45 5.95 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.44 -0.346 . . . . 0.0 113.325 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -132.42 -3.47 3.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.063 0.945 . . . . 0.0 110.09 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.438 HE22 ' HB ' ' A' ' 30' ' ' ILE . 1.5 pt20 -140.19 163.75 31.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.594 0.758 . . . . 0.0 111.376 -171.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -147.97 170.94 16.62 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.767 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 72' ' ' LEU . 49.2 mm -96.61 110.24 24.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.443 -175.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 mt -123.8 159.18 30.09 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.718 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' ' HG3' ' A' ' 49' ' ' PRO . 5.2 m -141.11 -179.21 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.216 1.007 . . . . 0.0 110.27 -171.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.36 -46.15 65.31 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.934 0.771 . . . . 0.0 113.205 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -74.87 162.15 74.69 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.404 171.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 12.6 Cg_endo -53.17 108.63 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.941 2.427 . . . . 0.0 111.867 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 2.8 Cg_exo -74.25 172.81 15.29 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.186 2.591 . . . . 0.0 111.979 -174.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.25 -2.12 57.7 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.495 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.6 m 51.28 65.13 1.58 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 124.119 0.968 . . . . 0.0 109.11 -172.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 mp -67.32 134.04 50.8 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.792 -165.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.35 88.19 5.04 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.433 HD23 HD13 ' A' ' 23' ' ' LEU . 5.5 mp -77.43 88.3 3.8 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 p -97.11 -49.16 5.1 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.999 0.92 . . . . 0.0 110.867 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 59' ' ' ILE . 21.6 t70 -73.39 123.63 24.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.999 0.92 . . . . 0.0 110.255 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.56 -20.49 59.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.997 0.519 . . . . 0.0 112.31 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -89.67 -8.24 52.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.968 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 56' ' ' ASP . 14.7 tt -64.11 123.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 121.404 0.621 . . . . 0.0 110.32 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.456 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 64.8 p -97.34 175.19 6.35 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.469 -170.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.565 HD11 HD12 ' A' ' 17' ' ' LEU . 23.4 mt -69.76 -13.81 62.47 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.55 173.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.15 -29.45 72.9 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.736 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -93.88 -60.75 1.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.55 143.36 86.33 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.715 1.206 . . . . 0.0 111.238 -174.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.13 39.65 0.84 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.552 2.834 . . . . 0.0 114.429 -173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.512 HG13 ' HG ' ' A' ' 72' ' ' LEU . 3.1 mp -87.26 120.56 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 172.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 24.1 mm-40 -119.97 159.28 25.01 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.821 0.848 . . . . 0.0 110.213 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.6 p -68.23 112.05 4.91 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.509 0.723 . . . . 0.0 110.853 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.99 12.82 82.17 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.639 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 20.2 t70 -86.17 160.52 19.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.697 0.799 . . . . 0.0 109.798 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.435 ' HE3' ' HB3' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -95.77 97.59 9.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.017 0.927 . . . . 0.0 110.355 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.512 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.1 mm? -96.55 113.58 25.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.521 0.728 . . . . 0.0 109.622 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.2 mp -78.76 103.2 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.3 t -82.29 104.52 11.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.344 171.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.69 159.71 28.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.294 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -124.49 124.84 43.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 123.488 0.715 . . . . 0.0 111.174 178.384 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' TRP . . . . . 0.425 ' HB3' HG23 ' A' ' 3' ' ' VAL . 13.2 m0 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.488 ' HG3' HD11 ' A' ' 13' ' ' LEU . 11.0 mpt_? -79.75 67.37 5.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.704 0.802 . . . . 0.0 109.742 173.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 1' ' ' TRP . 72.1 t -77.39 119.95 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.75 0.42 . . . . 0.0 109.875 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -93.99 128.38 40.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 95.8 m -117.79 111.3 18.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.372 0.669 . . . . 0.0 110.402 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 13.9 tppt? -75.41 127.45 33.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.718 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 0.0 109.785 175.32 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -92.51 142.6 27.23 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.858 0.863 . . . . 0.0 108.805 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.488 HD11 ' HG3' ' A' ' 2' ' ' ARG . 2.7 tm? -103.3 105.21 15.43 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.535 ' HG ' HG13 ' A' ' 33' ' ' ILE . 8.2 mp -86.93 139.03 31.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.339 0.655 . . . . 0.0 110.918 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.31 164.2 16.02 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.867 1.267 . . . . 0.0 109.675 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.89 79.53 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.321 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 61' ' ' LEU . 3.6 mm? -82.61 108.32 15.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.466 ' O ' HD12 ' A' ' 61' ' ' LEU . 44.4 t -84.7 170.03 13.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.852 168.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -69.1 -22.59 63.97 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.162 0.506 . . . . 0.0 111.054 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -111.6 23.26 14.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.293 1.037 . . . . 0.0 111.75 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.7 m -63.34 108.35 1.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -69.99 172.07 8.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.096 0.958 . . . . 0.0 111.689 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.6 tp -50.64 -55.82 14.66 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.276 1.031 . . . . 0.0 111.574 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.1 ptm180 -49.51 -37.47 26.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.612 1.165 . . . . 0.0 113.353 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 10.8 mm-40 -85.81 -35.97 20.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.288 0.635 . . . . 0.0 110.962 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.66 -66.07 0.79 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.065 0.946 . . . . 0.0 109.033 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -67.46 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.272 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.96 89.58 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.032 0.833 . . . . 0.0 111.959 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -72.95 -45.06 60.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.32 -39.49 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.44 0.696 . . . . 0.0 111.116 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.49 67.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.65 0.78 . . . . 0.0 111.678 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.3 14.83 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.545 0.738 . . . . 0.0 111.351 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.535 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.2 mm -76.46 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.342 1.057 . . . . 0.0 110.914 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.519 HG23 HG12 ' A' ' 36' ' ' ILE . 7.5 t -102.09 -9.96 20.1 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 0.0 111.019 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.65 69.76 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 119.783 -0.454 . . . . 0.0 114.034 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG12 HG23 ' A' ' 34' ' ' THR . 21.2 mm -90.44 127.73 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.67 138.83 61.41 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.782 0.833 . . . . 0.0 110.676 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 -39.31 83.77 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.559 2.839 . . . . 0.0 113.342 -174.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.78 22.08 26.75 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.737 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -124.83 -5.14 7.51 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.234 1.014 . . . . 0.0 109.902 174.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.568 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -130.23 143.77 50.97 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 124.201 1.0 . . . . 0.0 109.236 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -135.05 179.12 6.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.728 0.811 . . . . 0.0 109.341 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 66' ' ' ILE . 45.9 mm -94.47 92.46 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 121.995 0.903 . . . . 0.0 109.077 -174.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.4 mt -110.09 149.33 30.2 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 65' ' ' PRO . 9.4 m -134.02 179.73 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.113 0.565 . . . . 0.0 111.371 -167.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.02 11.01 8.27 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.333 -0.848 . . . . 0.0 114.736 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -144.33 160.72 47.59 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.162 1.385 . . . . 0.0 108.042 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -39.55 109.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.713 2.942 . . . . 0.0 113.99 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -80.68 -171.93 1.38 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.368 2.712 . . . . 0.0 112.172 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -122.73 15.23 10.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.65 0.78 . . . . 0.0 110.735 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.5 m 55.5 73.26 0.43 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.042 0.937 . . . . 0.0 109.474 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.71 108.87 8.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.886 -171.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -97.42 126.65 42.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.297 1.039 . . . . 0.0 108.205 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 mp -100.24 78.98 2.1 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 m -75.05 -28.51 60.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.294 0.638 . . . . 0.0 110.796 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.65 152.65 31.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.453 0.471 . . . . 0.0 109.773 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.54 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -103.46 -29.21 11.32 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.444 0.698 . . . . 0.0 111.641 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -89.62 -11.82 41.49 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.494 0.718 . . . . 0.0 110.753 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.62 134.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 111.695 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.0 p -117.48 179.07 4.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 111.39 -169.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.581 HD11 HD12 ' A' ' 17' ' ' LEU . 40.3 mt -68.49 -13.44 62.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.634 0.774 . . . . 0.0 111.572 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.17 80.03 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.336 0.398 . . . . 0.0 112.396 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -84.74 -55.86 3.88 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.126 0.57 . . . . 0.0 109.534 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.24 152.0 92.33 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.434 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.545 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.2 Cg_exo -69.09 21.65 0.15 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.811 3.007 . . . . 0.0 115.488 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 43' ' ' ILE . 3.2 mp -73.92 116.62 16.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 172.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -118.75 173.92 6.58 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -71.16 101.67 2.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.16 0.584 . . . . 0.0 109.943 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 89.03 20.42 46.44 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.176 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.33 162.28 25.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.037 0.535 . . . . 0.0 111.007 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.409 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 3.6 tpt -102.85 104.73 15.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.947 0.899 . . . . 0.0 109.696 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.417 HD23 HG13 ' A' ' 3' ' ' VAL . 3.7 mm? -105.13 112.16 25.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.044 0.937 . . . . 0.0 108.992 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.82 97.88 4.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.24 104.98 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.155 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.568 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 8.0 pt-20 -76.44 167.55 21.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.854 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.27 103.99 5.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 CA--C 1.551 0.989 0 C-N-CA 123.391 0.676 . . . . 0.0 110.507 173.673 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' TRP . . . . . 0.457 ' HB3' HG23 ' A' ' 3' ' ' VAL . 14.1 m0 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.433 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 82.1 mtt85 -79.19 69.76 5.45 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.381 0.673 . . . . 0.0 109.513 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 1' ' ' TRP . 89.6 t -83.94 129.64 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.346 0.658 . . . . 0.0 110.084 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -88.59 141.1 28.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.36 0.664 . . . . 0.0 109.209 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 71.1 m -138.33 101.34 4.36 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.332 0.653 . . . . 0.0 110.526 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -73.3 112.56 9.48 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.982 0.913 . . . . 0.0 109.734 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 123.394 0.677 . . . . 0.0 110.23 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -89.6 115.29 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.772 0.829 . . . . 0.0 109.636 -174.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.85 104.16 14.56 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.809 0.444 . . . . 0.0 110.548 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.63 127.91 34.08 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 111.076 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -113.3 176.22 5.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.781 1.233 . . . . 0.0 110.103 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.28 3.45 61.52 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 1' ' ' TRP . 82.5 mt -84.42 129.38 34.87 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 123.804 0.842 . . . . 0.0 111.065 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.458 ' O ' HD12 ' A' ' 61' ' ' LEU . 17.8 m -108.37 -176.56 3.08 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.374 168.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.7 p -66.2 -29.58 69.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.058 0.456 . . . . 0.0 110.69 171.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.98 23.41 8.99 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.88 0.872 . . . . 0.0 112.713 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.3 m -80.51 130.38 35.1 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 82.2 mtm180 -98.83 177.76 5.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.731 0.812 . . . . 0.0 110.384 -174.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 57' ' ' ARG . 5.4 tt -48.16 -59.53 3.33 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.181 1.392 . . . . 0.0 110.717 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.526 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 9.3 ptp180 -61.66 -26.8 68.24 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.637 -173.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 46.9 mt-10 -91.55 -30.04 16.62 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.979 0.912 . . . . 0.0 110.459 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.82 -67.24 0.78 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.749 0.82 . . . . 0.0 109.197 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.4 -16.26 63.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.777 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.45 -39.56 56.48 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.524 0.515 . . . . 0.0 111.929 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -73.83 -35.94 64.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.098 0.559 . . . . 0.0 110.284 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.12 -44.14 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.339 0.656 . . . . 0.0 109.704 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.04 68.07 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.775 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.42 -29.12 23.11 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.61 0.764 . . . . 0.0 111.856 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.1 mt -89.19 -69.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 117.878 0.308 . . . . 0.0 111.069 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.589 HG23 HG12 ' A' ' 36' ' ' ILE . 9.5 t -88.43 -5.48 58.24 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.95 6.55 87.36 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.303 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.589 HG12 HG23 ' A' ' 34' ' ' THR . 11.7 mm -82.61 107.71 14.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.55 145.41 49.6 Favored Pre-proline 0 N--CA 1.48 1.058 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.539 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -54.28 -32.05 69.62 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.474 2.783 . . . . 0.0 113.658 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.86 24.67 19.91 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 116.4 -0.364 . . . . 0.0 113.544 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 m -131.96 4.66 4.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.527 1.131 . . . . 0.0 109.863 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -137.09 149.48 47.4 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.506 1.122 . . . . 0.0 109.347 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -120.19 -166.16 1.27 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.515 HG23 HD12 ' A' ' 72' ' ' LEU . 41.1 mm -123.31 105.7 16.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 4.3 mp -121.14 172.39 8.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.081 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.513 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 2.7 m -139.85 162.02 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 109.869 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.8 87.86 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 124.325 1.016 . . . . 0.0 113.368 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -72.6 155.41 91.03 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 117.756 -1.116 . . . . 0.0 109.597 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -33.61 100.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.397 3.116 0 C-N-CA 124.821 3.681 . . . . 0.0 114.763 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.513 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 99.0 Cg_endo -81.26 158.7 20.08 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.683 2.256 . . . . 0.0 113.421 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 30.5 mm-40 -101.14 90.34 4.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.0 m -47.79 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.636 1.174 . . . . 0.0 111.543 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -99.44 167.53 10.56 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 111.805 179.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.06 144.51 40.07 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.75 93.22 4.78 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -85.47 -47.65 9.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.181 0.592 . . . . 0.0 110.239 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 12.8 t70 -73.25 107.3 5.48 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 -174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.53 -24.58 32.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.93 -7.06 41.08 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.94 0.896 . . . . 0.0 112.272 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 tt -63.39 136.83 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.021 0.528 . . . . 0.0 111.146 -174.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 10.0 m -109.9 168.01 9.74 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.503 0.721 . . . . 0.0 111.601 -164.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 18' ' ' SER . 32.7 mt -59.55 -25.35 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.484 1.114 . . . . 0.0 112.895 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.63 -29.33 74.9 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.422 0.451 . . . . 0.0 112.881 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.57 -45.93 12.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.703 0.801 . . . . 0.0 109.87 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.98 160.04 72.15 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.698 0.799 . . . . 0.0 111.56 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.6 37.32 0.5 Allowed 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.294 2.662 . . . . 0.0 114.403 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 mp -88.28 114.13 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 29.5 mm-40 -118.4 158.48 25.21 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 p -67.46 109.48 3.22 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.506 0.722 . . . . 0.0 111.018 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 88.96 -1.55 83.32 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 21.8 t70 -73.67 159.27 33.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.556 0.742 . . . . 0.0 111.339 -172.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.6 tpt -91.31 102.25 14.96 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.703 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 43' ' ' ILE . 4.0 mm? -100.57 135.81 41.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.489 1.116 . . . . 0.0 108.314 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.9 mp -100.58 113.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 54.7 t -94.08 109.51 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.73 172.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 36' ' ' ILE . 10.1 pt-20 -83.01 159.66 22.14 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 175.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -117.39 119.0 33.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 122.974 0.51 . . . . 0.0 110.911 178.881 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' TRP . . . . . 0.455 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 33.4 m0 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.54 ' HB3' HD11 ' A' ' 13' ' ' LEU . 71.0 mtm180 -82.85 85.01 7.18 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 69' ' ' GLY . 15.0 t -98.23 146.16 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.766 -175.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HG2' HD23 ' A' ' 13' ' ' LEU . 95.8 mtt180 -88.79 150.84 22.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.592 0.757 . . . . 0.0 110.891 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 27.3 p -125.9 128.17 47.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.467 1.107 . . . . 0.0 108.925 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.2 tppp? -102.3 110.97 23.08 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.019 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.547 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.741 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 74.3 m80 -108.99 162.74 13.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.587 0.755 . . . . 0.0 109.695 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.54 HD11 ' HB3' ' A' ' 2' ' ' ARG . 3.2 tm? -120.92 116.78 25.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.462 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.3 mp -87.74 160.64 17.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.432 0.693 . . . . 0.0 110.98 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -134.91 168.5 18.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.829 1.251 . . . . 0.0 108.273 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.05 82.21 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.014 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 94.3 mt -90.05 118.6 29.72 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.806 0.442 . . . . 0.0 110.072 178.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.6 t -86.4 174.79 8.77 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.478 1.111 . . . . 0.0 109.803 168.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.6 p -69.27 -29.63 67.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.265 0.626 . . . . 0.0 110.576 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 33.72 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.311 0.645 . . . . 0.0 112.285 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HG ' ' A' ' 61' ' ' LEU . 30.6 m -66.89 118.16 9.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -66.76 164.0 18.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.827 0.451 . . . . 0.0 110.763 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.495 HD22 ' HA ' ' A' ' 57' ' ' ARG . 6.0 tt -50.32 -53.58 27.7 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.73 1.212 . . . . 0.0 110.74 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -16.87 63.64 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.374 -173.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -84.3 -45.76 12.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.851 0.86 . . . . 0.0 109.432 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 61' ' ' LEU . 1.6 tm? -69.02 -62.42 1.38 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.156 1.383 . . . . 0.0 110.766 -173.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -63.72 -22.43 66.9 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.753 0.658 . . . . 0.0 111.323 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.89 -38.43 94.25 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 124.015 0.822 . . . . 0.0 112.464 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -73.44 -42.6 61.8 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -61.41 -35.9 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.514 0.726 . . . . 0.0 111.271 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.36 67.42 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.894 0.877 . . . . 0.0 111.587 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.96 -35.97 11.77 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.136 0.974 . . . . 0.0 111.638 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.462 HG13 ' HG ' ' A' ' 14' ' ' LEU . 19.0 mm -76.01 -52.2 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.781 1.232 . . . . 0.0 111.648 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.588 HG23 HG12 ' A' ' 36' ' ' ILE . 7.9 t -115.33 -7.36 12.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.162 0.585 . . . . 0.0 110.717 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 21.36 63.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.57 -0.572 . . . . 0.0 114.073 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.588 HG12 HG23 ' A' ' 34' ' ' THR . 25.1 mm -95.03 124.81 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.679 0.739 . . . . 0.0 109.906 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.97 139.08 87.45 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 123.876 0.87 . . . . 0.0 110.813 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.41 -22.07 48.29 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.726 2.951 . . . . 0.0 114.095 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.45 29.95 11.25 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.823 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.5 m -135.53 -35.75 0.8 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.578 1.151 . . . . 0.0 109.054 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -85.9 142.85 28.56 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.935 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -130.99 170.34 14.61 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 125.234 1.414 . . . . 0.0 107.674 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.483 HG21 ' HB3' ' A' ' 64' ' ' LEU . 44.2 mm -95.95 105.5 17.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 122.082 0.944 . . . . 0.0 109.875 -173.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.6 mt -113.95 155.02 26.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 113.477 -1.692 . . . . 0.0 106.648 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.65 164.86 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 122.723 0.409 . . . . 0.0 109.942 -166.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.17 73.65 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 124.026 0.822 . . . . 0.0 114.193 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -74.96 151.99 86.48 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.147 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -39.66 101.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.812 3.008 . . . . 0.0 113.575 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.39 157.58 41.05 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.93 2.42 . . . . 0.0 112.486 -171.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.22 3.01 55.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.077 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.93 71.29 0.52 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.8 1.24 . . . . 0.0 110.642 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.431 HD12 ' HD3' ' A' ' 65' ' ' PRO . 65.4 mt -79.73 124.69 28.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.656 -173.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -90.46 108.03 19.53 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.385 1.074 . . . . 0.0 109.225 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 8.4 mp -79.75 95.08 5.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.662 0.785 . . . . 0.0 109.413 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.8 t -106.77 25.85 10.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.853 0.861 . . . . 0.0 110.116 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -126.05 -157.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.37 1.068 . . . . 0.0 108.749 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -147.95 -31.39 0.29 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.056 0.844 . . . . 0.0 111.293 173.667 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.82 -8.9 42.26 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.609 0.764 . . . . 0.0 111.996 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.64 121.72 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 123.337 0.655 . . . . 0.0 110.843 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -92.84 174.64 7.15 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 66' ' ' ILE . 25.0 mt -71.0 -11.34 60.92 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.692 0.797 . . . . 0.0 111.998 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.38 -27.08 72.11 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.293 0.371 . . . . 0.0 112.202 170.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -87.03 -47.81 8.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.486 0.714 . . . . 0.0 110.134 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.7 mm? -80.57 154.87 73.89 Favored Pre-proline 0 CA--C 1.556 1.19 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.743 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HD3' HD12 ' A' ' 52' ' ' LEU . 70.7 Cg_endo -78.93 40.97 1.0 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.188 2.592 . . . . 0.0 114.747 -176.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 61' ' ' LEU . 2.4 mp -76.77 122.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.8 mt-30 -118.43 156.95 28.11 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.8 p -63.39 110.93 2.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.566 0.746 . . . . 0.0 111.274 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 3' ' ' VAL . . . 70.31 30.86 68.97 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.619 0.574 . . . . 0.0 113.481 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 5.9 t70 -84.69 172.53 11.46 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 tpt -98.75 100.6 11.83 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 66' ' ' ILE . 76.2 mt -91.41 143.19 26.87 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -105.67 102.07 13.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.93 106.12 11.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.01 151.72 37.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.523 0.678 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -122.08 146.81 46.84 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.802 -173.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 123.004 0.522 . . . . 0.0 110.445 178.936 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.4 m0 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 13' ' ' LEU . 48.7 mtm180 -83.86 73.95 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.108 0.963 . . . . 0.0 109.141 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.91 136.17 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.375 0.67 . . . . 0.0 111.503 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -89.09 97.35 11.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.7 0.8 . . . . 0.0 110.17 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 t -81.17 100.05 8.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.778 0.831 . . . . 0.0 110.445 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -74.47 108.99 7.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.76 -172.81 3.9 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.127 0.571 . . . . 0.0 110.23 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -67.3 125.16 25.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.438 0.695 . . . . 0.0 110.556 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.25 -12.37 61.87 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.205 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.38 -159.09 16.03 Favored Glycine 0 C--N 1.345 1.071 0 C-N-CA 122.936 0.303 . . . . 0.0 112.484 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.4 p -71.17 146.8 48.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.047 0.939 . . . . 0.0 111.607 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -134.96 123.19 22.98 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 2' ' ' ARG . 1.8 tm? -91.04 102.58 15.34 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -172.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 33' ' ' ILE . 10.3 mp -92.23 107.03 18.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.45 0.7 . . . . 0.0 110.036 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.549 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 76.6 mt-30 -90.2 -177.13 5.06 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.716 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -19.47 22.09 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.329 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.93 114.92 10.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.462 0.705 . . . . 0.0 110.66 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.403 ' O ' HD12 ' A' ' 61' ' ' LEU . 69.0 p -91.96 168.05 11.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.079 0.951 . . . . 0.0 109.163 170.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 p -59.26 -33.81 71.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.979 0.511 . . . . 0.0 111.753 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -101.13 24.67 9.09 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.402 0.681 . . . . 0.0 111.841 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 25' ' ' GLU . 73.1 m -72.33 127.4 32.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 74.3 mtm180 -79.77 169.16 18.35 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.176 0.59 . . . . 0.0 111.247 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 56' ' ' ASP . 7.5 tt -53.53 -54.33 38.83 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.179 1.392 . . . . 0.0 110.989 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 15.7 ptt180 -63.94 -26.04 68.41 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.219 -177.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 14.0 mm-40 -77.08 -43.46 34.23 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.6 -66.79 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.726 1.21 . . . . 0.0 110.615 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.5 -21.29 65.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.314 0.645 . . . . 0.0 111.312 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.98 -41.95 70.16 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.848 0.717 . . . . 0.0 112.368 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 21.3 mt-30 -67.79 -39.69 84.02 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.6 mt -59.67 -39.8 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.652 0.781 . . . . 0.0 111.055 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.2 -24.63 67.74 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 111.788 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.16 -36.07 13.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.336 0.654 . . . . 0.0 111.713 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 HD11 ' A' ' 14' ' ' LEU . 12.6 mm -75.62 -68.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.933 0.893 . . . . 0.0 110.4 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.494 HG23 HG12 ' A' ' 36' ' ' ILE . 3.0 t -96.7 -7.2 34.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 6.85 87.95 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 114.01 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.494 HG12 HG23 ' A' ' 34' ' ' THR . 13.8 mm -84.52 114.57 25.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 144.75 64.36 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.584 0.754 . . . . 0.0 110.722 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -55.14 -21.44 27.87 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.651 2.901 . . . . 0.0 114.382 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.61 -20.2 51.98 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 113.778 0.271 . . . . 0.0 113.778 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 80' ' ' ARG . 44.0 m -90.3 -16.5 29.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.18 0.592 . . . . 0.0 111.275 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.86 150.89 27.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.016 0.927 . . . . 0.0 110.568 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -130.17 145.87 51.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.679 1.192 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.596 HG13 HD21 ' A' ' 54' ' ' LEU . 45.6 mm -81.49 95.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.097 0.951 . . . . 0.0 108.872 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.68 139.39 51.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.039 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 5.2 m -113.31 163.15 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.367 0.667 . . . . 0.0 110.21 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.18 -49.07 82.63 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.884 0.74 . . . . 0.0 113.267 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 45' ' ' VAL . 52.3 p90 -69.71 145.46 94.84 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.141 169.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.22 101.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 124.155 3.237 . . . . 0.0 115.592 -170.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 71.8 Cg_endo -76.66 145.58 26.12 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.243 1.962 . . . . 0.0 111.096 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -91.67 15.88 11.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.286 0.635 . . . . 0.0 110.897 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.9 m 59.85 46.54 11.19 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.501 1.12 . . . . 0.0 110.369 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -55.93 130.03 42.07 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.299 -174.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.36 111.07 22.4 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.596 HD21 HG13 ' A' ' 43' ' ' ILE . 7.3 mp -72.7 87.9 1.27 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.279 1.031 . . . . 0.0 108.8 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 p -89.51 26.22 1.77 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.2 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.43 ' O ' HD13 ' A' ' 23' ' ' LEU . 10.3 t70 -145.67 -168.37 2.95 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 -29.16 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.63 0.772 . . . . 0.0 110.957 176.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.64 -8.0 51.2 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.876 1.27 . . . . 0.0 110.588 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.18 131.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.686 1.195 . . . . 0.0 111.414 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -96.33 168.63 10.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.662 0.785 . . . . 0.0 112.559 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 18' ' ' SER . 47.7 mt -69.69 -20.18 63.56 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.918 0.887 . . . . 0.0 111.552 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.94 73.18 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.434 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.07 -39.16 14.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.187 0.595 . . . . 0.0 109.816 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.3 mt -79.5 156.66 75.65 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 124.057 0.943 . . . . 0.0 111.438 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -72.94 18.51 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.767 2.978 . . . . 0.0 115.267 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.05 124.4 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 48.9 mt-30 -119.06 169.83 9.58 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.237 0.615 . . . . 0.0 109.845 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 p -68.47 96.46 0.69 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.336 0.654 . . . . 0.0 110.879 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.96 36.39 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.382 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 11.1 t70 -80.44 158.01 26.05 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.303 0.641 . . . . 0.0 110.689 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.88 97.93 10.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.57 0.748 . . . . 0.0 109.692 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.88 106.97 18.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.439 0.696 . . . . 0.0 109.44 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.31 93.28 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.845 0.858 . . . . 0.0 108.825 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.75 103.45 10.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.99 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.455 ' O ' HG21 ' A' ' 36' ' ' ILE . 11.4 pt-20 -78.75 170.09 17.21 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.203 174.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -129.61 106.99 9.11 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.109 0.964 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -80.17 -4.01 51.3 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.921 0.488 . . . . 0.0 111.478 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 78.66 -51.16 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 126.175 1.79 . . . . 0.0 112.196 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -71.92 99.6 2.26 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.234 1.016 . . . . 0.0 110.332 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.44 ' HB3' ' OG ' ' A' ' 40' ' ' SER . 12.6 ptt180 -149.44 156.56 39.4 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.344 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.27 89.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.076 2.517 . . . . 0.0 113.008 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -101.24 104.72 15.77 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.31 -9.11 1.72 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.783 0.833 . . . . 0.0 110.335 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.7 m -131.54 146.89 63.84 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.851 0.861 . . . . 0.0 110.315 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.01 -14.99 13.29 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.812 2.341 . . . . 0.0 112.209 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.309 1.043 . . . . 0.0 108.56 177.519 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.3 m0 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HB3' HD11 ' A' ' 13' ' ' LEU . 44.7 mtp180 -83.29 83.29 7.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 109.452 174.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 17' ' ' LEU . 69.1 t -100.34 141.94 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.923 0.889 . . . . 0.0 110.535 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 71' ' ' MET . 41.1 mmt180 -81.57 135.97 35.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.916 0.886 . . . . 0.0 110.559 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 19.8 t -113.33 90.12 3.26 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -82.95 105.39 13.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.31 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.2 169.92 14.2 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.384 0.674 . . . . 0.0 110.436 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.592 ' HD3' ' HB3' ' A' ' 76' ' ' GLU . 11.0 ptmm? -71.71 -9.51 58.38 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.096 172.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.78 25.16 17.36 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.175 166.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.38 172.8 36.84 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 117.271 0.535 . . . . 0.0 113.17 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m -87.64 132.71 33.99 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 77.6 m-70 -123.2 173.74 7.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.623 0.769 . . . . 0.0 109.904 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 2' ' ' ARG . 2.8 tm? -140.74 110.76 6.55 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -95.32 132.07 40.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.082 0.953 . . . . 0.0 108.52 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.89 -32.91 10.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.104 0.561 . . . . 0.0 110.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.48 44.4 3.07 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.767 -0.651 . . . . 0.0 114.109 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 3' ' ' VAL . 95.3 mt -114.52 115.2 26.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 124.134 0.974 . . . . 0.0 109.35 175.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 61' ' ' LEU . 17.3 t -92.38 176.87 6.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.947 0.899 . . . . 0.0 109.475 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 p -60.63 -36.1 77.79 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.708 0.803 . . . . 0.0 111.858 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -116.35 48.09 1.32 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.388 0.675 . . . . 0.0 111.47 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.9 m -75.84 128.06 34.33 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HG2' HG22 ' A' ' 60' ' ' THR . 61.6 mtm180 -92.14 -177.94 4.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 57' ' ' ARG . 5.9 tt -52.32 -56.91 11.68 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.087 0.955 . . . . 0.0 111.036 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.445 ' HG2' ' OE2' ' A' ' 25' ' ' GLU . 9.0 ptp180 -70.63 -19.58 62.81 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.594 0.559 . . . . 0.0 112.042 -164.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -93.49 -35.02 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.63 0.772 . . . . 0.0 110.976 173.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.418 HD11 HD11 ' A' ' 43' ' ' ILE . 2.0 tm? -71.29 -68.23 0.46 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.606 0.762 . . . . 0.0 111.419 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.35 -38.23 62.63 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.844 0.715 . . . . 0.0 112.341 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.468 ' O ' HG12 ' A' ' 33' ' ' ILE . 61.3 mt-30 -70.53 -44.52 67.34 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -55.41 -41.35 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.935 0.894 . . . . 0.0 111.476 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -25.18 68.19 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.34 -31.36 16.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.676 0.79 . . . . 0.0 111.395 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 29' ' ' GLN . 28.8 mm -79.11 -65.59 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.324 1.05 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.547 HG23 HG12 ' A' ' 36' ' ' ILE . 10.1 t -101.91 -11.74 18.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.75 0.82 . . . . 0.0 111.341 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 -18.6 56.78 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.727 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.547 HG12 HG23 ' A' ' 34' ' ' THR . 18.3 mm -67.34 121.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.045 0.422 . . . . 0.0 111.205 -169.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.75 141.26 80.13 Favored Pre-proline 0 C--N 1.351 0.663 0 O-C-N 124.281 0.988 . . . . 0.0 110.648 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.05 -28.62 70.43 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.394 2.729 . . . . 0.0 112.35 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.91 16.51 54.93 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.369 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -125.13 -11.29 7.03 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 110.52 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -127.16 155.53 43.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.022 0.929 . . . . 0.0 110.369 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 168.47 19.63 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.238 1.015 . . . . 0.0 109.161 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 54' ' ' LEU . 30.8 mm -80.26 105.0 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.423 1.106 . . . . 0.0 109.842 -172.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.93 148.08 44.56 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 112.776 -2.011 . . . . 0.0 106.981 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.452 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 1.6 m -132.25 161.96 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.75 . . . . 0.0 110.248 -172.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.64 -42.29 96.13 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.805 0.69 . . . . 0.0 113.238 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -77.7 158.1 78.75 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.264 168.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -39.65 107.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.095 3.196 . . . . 0.0 115.292 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 67.9 Cg_endo -86.04 158.55 10.05 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.84 8.38 41.32 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.9 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.1 m 56.5 68.77 0.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.185 0.994 . . . . 0.0 110.221 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.77 114.35 18.62 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.678 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.06 155.59 22.61 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 43' ' ' ILE . 4.7 mp -122.6 91.71 3.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.7 p -82.34 -46.08 14.07 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.397 0.679 . . . . 0.0 110.67 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -78.13 131.63 37.32 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.788 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -70.57 -22.04 62.62 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.728 0.811 . . . . 0.0 112.091 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.29 -1.86 53.23 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.6 tt -64.01 124.09 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.389 0.676 . . . . 0.0 110.893 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 22' ' ' ARG . 50.7 p -95.96 173.56 7.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.164 0.586 . . . . 0.0 112.398 -169.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 18' ' ' SER . 27.0 mt -68.99 -10.77 59.17 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.399 0.679 . . . . 0.0 111.136 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.39 -29.01 73.72 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 112.301 -0.32 . . . . 0.0 112.301 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -88.27 -49.63 6.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.276 0.63 . . . . 0.0 110.12 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.8 mm? -81.59 151.77 68.86 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.743 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.456 ' HD2' HG21 ' A' ' 43' ' ' ILE . 97.9 Cg_endo -77.66 42.79 1.22 Allowed 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.761 2.974 . . . . 0.0 115.185 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.476 HD11 HD12 ' A' ' 43' ' ' ILE . 2.3 mp -83.28 112.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -109.84 170.66 7.93 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.2 p -67.56 105.51 1.88 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.029 0.532 . . . . 0.0 111.013 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.23 62.73 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 113.358 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.28 161.35 27.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.775 0.83 . . . . 0.0 110.168 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.48 ' HA ' ' HB2' ' A' ' 4' ' ' ARG . 19.1 ttm -103.89 112.34 25.26 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.245 0.618 . . . . 0.0 109.783 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -101.05 114.45 28.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.574 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.78 96.13 3.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.409 HG21 ' SG ' ' A' ' 5' ' ' CYS . 70.5 t -78.69 101.58 4.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.082 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -80.32 155.82 27.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.499 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.592 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . 36.3 tt0 -109.61 111.91 23.68 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 169.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.14 -8.44 54.73 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.306 0.642 . . . . 0.0 111.037 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 69.17 40.15 1.59 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 124.89 1.276 . . . . 0.0 110.347 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -96.03 30.99 2.25 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.073 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 67.44 120.18 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 125.276 1.43 . . . . 0.0 110.866 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.47 129.1 29.67 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 122.605 2.203 . . . . 0.0 111.665 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt 61.54 101.77 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.03 1.332 . . . . 0.0 111.522 -170.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.23 28.98 5.43 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.041 0.936 . . . . 0.0 109.728 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.8 p -161.59 168.42 11.31 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 124.696 1.198 . . . . 0.0 109.69 -171.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -36.08 -35.73 0.18 Allowed 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 124.744 3.629 . . . . 0.0 114.895 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.253 1.286 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 164.886 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.483 ' HB3' HG23 ' A' ' 3' ' ' VAL . 22.0 m0 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.448 ' HB2' HD11 ' A' ' 13' ' ' LEU . 3.9 ptp180 -87.99 70.85 9.44 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.775 0.798 . . . . 0.0 109.102 169.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 1' ' ' TRP . 76.8 t -77.8 137.28 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.864 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -93.27 140.23 29.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.466 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 12.5 t -122.41 97.94 5.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.018 0.927 . . . . 0.0 111.053 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HE3' ' SD ' ' A' ' 71' ' ' MET . 4.6 tppp? -74.82 102.71 4.8 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -150.88 -172.56 4.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.081 0.552 . . . . 0.0 111.015 -173.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -58.1 114.43 2.36 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.158 0.983 . . . . 0.0 111.099 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.92 -8.57 25.47 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.911 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.05 -154.56 16.86 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.517 0.58 . . . . 0.0 111.954 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.0 m -84.84 121.39 27.66 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.397 0.679 . . . . 0.0 109.845 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 91.2 m-70 -107.79 179.16 4.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.199 1.0 . . . . 0.0 109.517 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 2' ' ' ARG . 2.0 tm? -144.01 122.8 12.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.473 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.2 mp -101.1 146.62 27.22 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.951 0.9 . . . . 0.0 110.394 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -118.39 165.27 14.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.137 1.375 . . . . 0.0 109.312 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.45 4.81 89.28 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.157 0.423 . . . . 0.0 114.157 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.48 130.84 35.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.465 0.65 . . . . 0.0 110.525 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -115.16 179.02 4.07 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.207 1.403 . . . . 0.0 109.159 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 p -72.72 -27.34 62.0 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.647 0.379 . . . . 0.0 111.158 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -108.61 25.95 11.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.735 0.814 . . . . 0.0 111.233 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 25' ' ' GLU . 7.3 m -66.0 127.66 32.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.077 0.551 . . . . 0.0 110.151 170.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -72.9 166.71 22.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.356 0.662 . . . . 0.0 111.183 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 54' ' ' LEU . 10.1 tt -61.2 -45.42 94.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.651 1.18 . . . . 0.0 110.618 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -61.53 -30.67 70.79 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.653 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 21' ' ' THR . 6.3 mm-40 -79.88 -44.44 20.44 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 124.087 0.955 . . . . 0.0 109.534 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.56 -65.9 0.61 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.044 0.938 . . . . 0.0 109.718 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.416 ' HA ' HD12 ' A' ' 30' ' ' ILE . 32.4 mt-30 -64.42 -23.11 67.17 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.664 0.602 . . . . 0.0 111.509 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.21 -44.33 86.76 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 124.104 0.878 . . . . 0.0 111.695 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 33' ' ' ILE . 76.1 mt-30 -67.92 -37.33 81.54 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 27' ' ' GLN . 97.4 mt -59.56 -42.03 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.493 0.717 . . . . 0.0 110.823 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -24.97 68.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.805 0.842 . . . . 0.0 111.705 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.4 -32.79 17.11 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.765 0.826 . . . . 0.0 111.571 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.473 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.8 mm -79.83 -69.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.536 HG23 HG12 ' A' ' 36' ' ' ILE . 9.2 t -98.76 -9.45 24.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.442 0.697 . . . . 0.0 111.488 -173.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.48 72.43 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.967 -0.352 . . . . 0.0 113.785 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.536 HG12 HG23 ' A' ' 34' ' ' THR . 24.9 mm -91.19 114.57 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.42 78.72 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.03 0.932 . . . . 0.0 111.023 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -53.76 -29.54 52.54 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.127 3.218 . . . . 0.0 114.572 -172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.96 -23.03 64.71 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.001 -0.333 . . . . 0.0 113.743 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -93.47 1.4 56.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.774 0.83 . . . . 0.0 111.562 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.45 169.14 13.96 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.032 0.933 . . . . 0.0 110.781 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 51' ' ' CYS . 44.9 ttp180 -158.81 154.43 26.14 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.055 -169.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 66' ' ' ILE . 37.4 mm -79.68 100.8 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 122.083 0.944 . . . . 0.0 109.674 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.4 mt -121.7 144.57 48.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.271 -1.786 . . . . 0.0 106.917 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 47' ' ' TYR . 2.6 m -125.88 164.31 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.493 0.717 . . . . 0.0 110.779 -172.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -36.08 92.75 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.78 0.675 . . . . 0.0 112.857 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 45' ' ' VAL . 46.4 p90 -81.72 156.2 70.48 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.177 167.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -43.09 108.36 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 124.227 3.285 . . . . 0.0 114.508 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -85.72 155.14 10.26 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.018 2.479 . . . . 0.0 112.624 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -89.81 6.82 40.04 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.994 0.518 . . . . 0.0 110.696 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HB3' ' NH1' ' A' ' 42' ' ' ARG . 81.5 m 57.36 59.16 3.46 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.282 1.033 . . . . 0.0 110.123 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.84 144.34 52.91 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.46 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.45 138.8 31.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.208 0.603 . . . . 0.0 109.682 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.673 ' HB3' HD11 ' A' ' 23' ' ' LEU . 7.0 mp -115.14 87.17 2.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.011 0.924 . . . . 0.0 108.74 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 m -111.03 19.81 18.09 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.81 0.844 . . . . 0.0 112.654 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HD13 ' A' ' 23' ' ' LEU . 11.1 t70 -141.81 177.75 7.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -120.69 -40.53 2.64 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.496 0.718 . . . . 0.0 111.478 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.24 -16.0 34.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.936 0.894 . . . . 0.0 110.327 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.98 141.46 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.258 1.023 . . . . 0.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.6 p -111.75 -178.92 3.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 112.247 -166.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 mt -75.94 -4.73 42.62 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.178 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.25 -23.11 76.39 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 167.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -97.78 -59.09 1.84 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.428 0.691 . . . . 0.0 109.793 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.53 116.09 55.05 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.05 65.09 6.12 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.666 2.91 . . . . 0.0 113.816 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 43' ' ' ILE . 1.9 mp -78.27 126.45 38.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 163.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 18.1 mt-30 -117.41 154.61 31.05 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.8 p -64.59 102.68 0.59 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.274 0.629 . . . . 0.0 111.363 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.59 16.19 66.67 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.411 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 10.5 t70 -80.08 160.92 25.61 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 123.489 0.716 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.447 ' SD ' ' HE3' ' A' ' 6' ' ' LYS . 2.8 tpt -84.18 100.32 11.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.323 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.36 116.12 30.78 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.55 102.67 13.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 77.9 t -82.61 108.18 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.429 171.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.22 151.22 31.33 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.811 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -109.46 105.04 14.22 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 166.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.05 -20.33 66.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 0.0 110.525 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 68.58 12.18 8.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.953 1.301 . . . . 0.0 111.831 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -76.46 -45.33 31.7 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 54.64 107.6 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.546 1.538 . . . . 0.0 113.748 172.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.97 157.38 62.05 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.634 2.222 . . . . 0.0 111.447 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.439 ' HA ' ' HE3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -76.99 81.18 3.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.05 155.54 9.9 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.542 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 p -154.56 92.49 2.93 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 123.766 0.826 . . . . 0.0 109.561 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.38 78.58 2.29 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.489 2.126 . . . . 0.0 110.433 172.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--O 1.25 1.09 0 C-N-CA 124.374 1.07 . . . . 0.0 109.504 -172.619 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 33.8 m0 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -103.0 160.4 14.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.875 0.87 . . . . 0.0 109.334 170.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.561 HG13 HD23 ' A' ' 72' ' ' LEU . 18.9 t -138.1 136.78 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.834 0.854 . . . . 0.0 109.709 171.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -104.8 95.58 5.97 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.7 p -84.14 102.35 12.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.909 0.484 . . . . 0.0 110.185 -175.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.75 99.03 7.26 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -122.68 102.35 8.0 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.25 0.62 . . . . 0.0 109.959 -174.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 60.32 26.55 16.07 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.37 1.068 . . . . 0.0 111.75 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.46 -34.08 6.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.172 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.69 99.0 1.32 Allowed Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -83.55 127.75 33.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.261 0.624 . . . . 0.0 109.654 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 96.5 m-70 -131.47 149.37 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.591 0.356 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.76 113.47 25.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.207 0.603 . . . . 0.0 109.858 -173.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.466 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.8 mp -89.48 127.4 35.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.963 0.905 . . . . 0.0 109.033 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -111.34 161.45 16.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 171.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 33.61 19.13 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.872 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.19 116.36 28.88 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -91.36 166.58 12.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.565 0.746 . . . . 0.0 109.606 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -64.81 -25.48 67.93 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 120.978 0.418 . . . . 0.0 111.705 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -92.7 3.2 56.05 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.779 0.832 . . . . 0.0 112.788 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 25' ' ' GLU . 56.8 m -58.7 118.61 5.87 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.141 0.496 . . . . 0.0 110.812 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 58' ' ' ASP . 81.8 mtm180 -87.21 -176.41 5.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.03 0.932 . . . . 0.0 111.478 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 54' ' ' LEU . 4.8 tt -54.89 -60.87 2.77 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.773 0.829 . . . . 0.0 109.045 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -55.91 -24.56 38.32 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.345 -1.298 . . . . 0.0 113.413 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 1.7 mm-40 -88.91 -53.89 4.39 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HB2' HG22 ' A' ' 21' ' ' THR . 2.7 tm? -67.27 -65.78 0.64 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.162 0.985 . . . . 0.0 110.655 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.45 -18.83 65.58 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.328 0.392 . . . . 0.0 111.071 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.93 -37.58 60.55 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.713 0.633 . . . . 0.0 112.034 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 33' ' ' ILE . 98.7 mt-30 -70.78 -38.84 73.43 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.88 -38.7 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 C-N-CA 123.803 0.841 . . . . 0.0 110.795 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.65 66.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.043 0.937 . . . . 0.0 111.914 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -35.6 13.57 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.924 0.89 . . . . 0.0 111.395 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG13 ' HG ' ' A' ' 14' ' ' LEU . 31.0 mm -72.1 -68.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.781 0.832 . . . . 0.0 110.449 -175.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.421 HG23 HG12 ' A' ' 36' ' ' ILE . 5.2 t -96.44 -16.19 21.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.342 0.657 . . . . 0.0 111.036 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 11.12 71.47 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.667 -0.518 . . . . 0.0 113.436 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.421 HG12 HG23 ' A' ' 34' ' ' THR . 26.5 mm -85.91 111.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.74 144.45 65.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.863 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.75 -24.81 73.15 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.203 2.602 . . . . 0.0 113.559 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.98 19.76 32.51 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 113.253 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -135.54 8.37 3.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 110.332 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 1.6 pt20 -144.47 162.07 37.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.511 0.725 . . . . 0.0 110.831 -177.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -129.37 -172.88 2.85 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.824 1.25 . . . . 0.0 108.645 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.517 HG23 HD12 ' A' ' 72' ' ' LEU . 32.4 mm -112.26 106.65 21.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.61 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 29.8 mt -116.03 134.45 54.94 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.79 175.21 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.479 0.711 . . . . 0.0 111.199 -169.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.7 -44.76 80.04 Favored Glycine 0 C--N 1.357 1.703 0 O-C-N 123.969 0.793 . . . . 0.0 114.186 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -87.0 163.34 40.88 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.536 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 83.1 Cg_exo -45.61 108.52 0.15 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.572 2.848 . . . . 0.0 113.587 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 48' ' ' PRO . 2.3 Cg_endo -84.14 172.46 9.62 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.502 2.802 . . . . 0.0 112.493 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -101.64 11.99 37.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.929 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.9 m 56.03 84.37 0.08 Allowed 'General case' 0 C--N 1.36 1.022 0 C-N-CA 124.272 1.029 . . . . 0.0 109.646 -166.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 69.1 mt -79.68 95.39 5.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.351 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.22 96.14 8.36 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.662 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.455 ' HB3' HD12 ' A' ' 23' ' ' LEU . 8.0 mp -69.85 102.82 2.04 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -89.57 -36.89 15.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.948 0.899 . . . . 0.0 111.757 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 59' ' ' ILE . 34.9 t70 -95.95 130.71 42.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.768 0.827 . . . . 0.0 110.302 -177.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.44 68.08 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.131 0.573 . . . . 0.0 112.306 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 29.1 t70 -92.7 -2.77 55.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.855 0.862 . . . . 0.0 111.432 -172.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 56' ' ' ASP . 13.4 tt -67.16 127.29 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.214 0.606 . . . . 0.0 110.748 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -99.24 177.0 5.34 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.928 0.491 . . . . 0.0 111.902 -168.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.19 -9.88 57.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 0.0 111.488 173.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.71 -25.85 74.85 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.99 -50.77 5.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.763 0.825 . . . . 0.0 110.055 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -91.05 121.72 67.53 Favored Pre-proline 0 N--CA 1.477 0.894 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.007 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.8 75.68 1.62 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.3 2.667 . . . . 0.0 113.583 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.33 131.68 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 27.9 mt-30 -118.19 155.82 29.84 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.3 t -70.94 111.61 6.47 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.21 17.2 56.2 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 123.604 0.621 . . . . 0.0 112.887 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.9 t70 -81.45 158.61 24.5 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.225 0.536 . . . . 0.0 110.246 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.4 93.69 9.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.783 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.561 HD23 HG13 ' A' ' 3' ' ' VAL . 3.9 mm? -92.36 99.44 12.2 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 4.1 mp -75.71 100.22 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 93.1 t -79.03 102.29 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.01 173.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 7.3 pt-20 -76.84 156.79 31.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.219 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.31 113.27 21.2 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.22 -17.87 53.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.58 0.752 . . . . 0.0 110.583 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 67.07 29.43 7.93 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.204 1.402 . . . . 0.0 111.135 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.3 m -53.11 -54.25 38.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.519 1.128 . . . . 0.0 111.687 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 54.77 66.94 3.61 Favored Pre-proline 0 CA--C 1.558 1.252 0 O-C-N 124.51 1.131 . . . . 0.0 111.566 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.83 163.72 23.33 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.371 2.048 . . . . 0.0 111.513 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.58 87.64 1.22 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.599 0.714 . . . . 0.0 109.793 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.4 141.94 29.11 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.302 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.0 p -140.68 142.32 28.17 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.615 0.766 . . . . 0.0 109.558 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.87 -20.51 67.02 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.696 2.264 . . . . 0.0 112.608 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.25 1.101 0 C-N-CA 124.822 1.249 . . . . 0.0 110.555 175.549 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.7 m0 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.868 0.366 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -122.03 56.6 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.483 1.113 . . . . 0.0 109.241 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.578 ' HB ' HD12 ' A' ' 17' ' ' LEU . 10.8 t -83.81 135.64 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.73 -171.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -95.31 148.73 22.12 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.69 0.796 . . . . 0.0 110.123 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 p -122.17 104.2 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.459 0.704 . . . . 0.0 110.243 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -74.73 113.47 12.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.771 0.828 . . . . 0.0 109.321 171.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.6 164.1 21.97 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 122.729 0.412 . . . . 0.0 110.199 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.471 ' HD3' ' HB3' ' A' ' 76' ' ' GLU . 26.0 mtpp -63.24 -31.15 72.22 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.169 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.74 32.73 6.71 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 123.694 0.621 . . . . 0.0 112.413 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.55 159.85 17.06 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 114.172 0.429 . . . . 0.0 114.172 171.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 m -102.27 115.26 30.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.669 0.788 . . . . 0.0 110.077 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -111.0 179.8 3.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.987 0.915 . . . . 0.0 109.53 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.18 130.46 37.29 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.524 ' HG ' HG13 ' A' ' 33' ' ' ILE . 4.5 mp -96.18 110.73 22.96 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.234 1.014 . . . . 0.0 109.772 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.06 -17.49 43.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 109.676 172.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -15.11 81.65 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.636 0.636 . . . . 0.0 113.54 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' A' ' 3' ' ' VAL . 63.3 mt -72.67 114.43 10.8 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 117.336 0.568 . . . . 0.0 109.813 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.5 m -90.99 -167.08 1.73 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.176 0.991 . . . . 0.0 108.969 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.0 t -77.2 -45.58 26.13 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.779 0.432 . . . . 0.0 110.01 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.58 17.78 7.09 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.634 1.174 . . . . 0.0 112.794 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.8 m -65.9 115.92 6.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.141 0.577 . . . . 0.0 111.876 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.43 173.43 10.32 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.179 0.992 . . . . 0.0 110.219 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.39 -49.12 78.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.989 0.515 . . . . 0.0 111.894 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -19.93 65.31 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.648 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.85 -38.85 14.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 110.218 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 43' ' ' ILE . 1.5 tm? -66.89 -67.21 0.47 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.874 1.27 . . . . 0.0 109.597 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 23.8 mt-30 -69.24 -20.79 63.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.103 0.561 . . . . 0.0 111.769 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.71 -33.15 75.32 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.918 0.761 . . . . 0.0 112.179 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -87.38 -32.23 19.68 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.286 0.634 . . . . 0.0 110.787 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.87 -39.85 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -61.72 -25.75 67.62 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.193 0.997 . . . . 0.0 111.974 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.05 -26.09 16.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.983 0.913 . . . . 0.0 111.748 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.524 HG13 ' HG ' ' A' ' 14' ' ' LEU . 22.3 mm -89.21 -68.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 111.257 -174.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.583 HG23 HG12 ' A' ' 36' ' ' ILE . 10.2 t -94.26 -7.69 41.3 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.92 0.488 . . . . 0.0 110.563 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.23 8.28 83.86 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 119.285 -0.731 . . . . 0.0 114.292 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 34' ' ' THR . 11.0 mm -86.83 119.91 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 117.859 0.83 . . . . 0.0 109.178 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.98 139.44 82.98 Favored Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 124.165 0.916 . . . . 0.0 110.962 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 19.7 Cg_endo -56.64 -26.05 62.87 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.542 2.828 . . . . 0.0 114.252 -174.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.97 22.51 37.85 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 116.522 -0.308 . . . . 0.0 112.96 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 m -138.23 14.19 2.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.557 1.143 . . . . 0.0 109.949 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.42 171.87 19.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.375 0.67 . . . . 0.0 111.277 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -160.8 -173.85 4.13 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.631 1.172 . . . . 0.0 108.788 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.801 HG12 HD21 ' A' ' 54' ' ' LEU . 37.0 mm -106.13 113.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.2 mt -121.98 133.78 54.82 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 m -103.96 166.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.886 0.474 . . . . 0.0 110.831 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.06 -54.93 33.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 124.158 0.911 . . . . 0.0 112.715 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -67.19 151.68 96.89 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.268 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -49.25 106.66 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.612 2.875 . . . . 0.0 113.446 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.02 155.73 42.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.55 2.167 . . . . 0.0 111.651 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.91 10.81 22.42 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.673 0.789 . . . . 0.0 110.923 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.7 m 55.43 79.42 0.16 Allowed 'General case' 0 C--N 1.365 1.253 0 C-N-CA 124.417 1.087 . . . . 0.0 109.528 -167.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.52 138.33 57.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.777 -172.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -82.66 100.56 10.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.801 HD21 HG12 ' A' ' 43' ' ' ILE . 7.4 mp -98.03 88.84 4.35 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -126.72 -51.32 1.47 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.483 0.713 . . . . 0.0 111.357 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 59' ' ' ILE . 25.1 t70 -75.86 123.36 25.55 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.171 0.589 . . . . 0.0 110.916 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -29.73 52.95 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.7 -19.97 22.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 112.144 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 56' ' ' ASP . 12.1 tt -58.87 120.41 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 121.4 0.619 . . . . 0.0 110.747 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.9 p -92.67 177.32 6.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.072 0.549 . . . . 0.0 112.28 -170.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.83 -15.47 63.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.932 0.893 . . . . 0.0 111.362 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.99 78.4 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.271 -0.331 . . . . 0.0 112.271 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.3 -56.77 2.51 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.747 0.819 . . . . 0.0 109.701 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.5 mt -75.12 118.08 67.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.176 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.15 83.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.614 2.876 . . . . 0.0 114.838 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.446 HD11 HG13 ' A' ' 43' ' ' ILE . 3.1 mp -119.6 127.26 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 59.6 mt-30 -112.71 161.01 17.36 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.0 p -67.81 112.29 4.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.986 0.514 . . . . 0.0 110.147 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 22.94 59.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.188 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 29.0 t70 -82.97 166.27 18.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.74 0.816 . . . . 0.0 111.496 -175.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.82 103.66 15.63 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.87 0.868 . . . . 0.0 109.557 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.432 HD22 HG23 ' A' ' 43' ' ' ILE . 67.2 mt -98.86 104.12 16.13 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.399 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.6 91.98 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -82.13 109.56 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.548 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.91 145.36 38.29 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.471 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . 40.7 tt0 -110.21 102.13 10.84 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.26 -31.21 72.33 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.674 0.79 . . . . 0.0 110.94 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 73.15 14.36 4.63 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.49 1.516 . . . . 0.0 112.569 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.462 HG23 ' HG3' ' A' ' 80' ' ' ARG . 9.3 t -70.62 -35.59 73.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.862 0.465 . . . . 0.0 110.661 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.462 ' HG3' HG23 ' A' ' 79' ' ' THR . 77.4 mtp180 -116.79 152.92 49.07 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.027 0.931 . . . . 0.0 108.806 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.13 152.06 67.24 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.041 1.827 . . . . 0.0 111.934 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.9 116.58 7.2 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 173.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.12 155.28 33.72 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.403 0.681 . . . . 0.0 110.233 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.8 t -117.85 99.58 52.14 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.55 -22.87 20.6 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.398 2.066 . . . . 0.0 112.494 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 CA--C 1.554 1.114 0 C-N-CA 124.159 0.984 . . . . 0.0 109.298 178.018 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 24.0 m0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 13' ' ' LEU . 14.0 ptp180 -133.9 124.91 27.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.594 HG11 HD22 ' A' ' 72' ' ' LEU . 71.9 t -125.39 135.55 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.9 0.381 . . . . 0.0 111.493 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -82.12 110.96 17.81 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.379 1.072 . . . . 0.0 110.008 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 11' ' ' THR . 36.2 t -89.68 90.15 8.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 0.0 110.203 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -76.47 103.17 6.33 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -142.73 176.56 8.95 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.51 0.672 . . . . 0.0 112.157 -170.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HG3' ' HB3' ' A' ' 76' ' ' GLU . 13.6 mmmm -73.18 -6.21 44.29 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.759 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.23 33.53 6.2 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.41 -178.01 52.72 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.065 0.364 . . . . 0.0 113.113 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 15.7 m -101.02 117.99 36.12 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -118.81 178.48 4.47 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.983 0.913 . . . . 0.0 110.493 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 2' ' ' ARG . 3.1 tm? -125.18 131.02 53.27 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.427 ' HG ' HG13 ' A' ' 33' ' ' ILE . 10.5 mp -100.1 132.82 45.24 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.323 0.649 . . . . 0.0 110.698 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.0 170.04 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.811 0.844 . . . . 0.0 109.996 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.4 23.23 77.63 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.067 172.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.67 133.23 43.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.02 0.528 . . . . 0.0 109.888 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.0 t -116.81 -166.26 1.15 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.354 1.062 . . . . 0.0 108.797 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.6 p -76.81 -36.4 56.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.993 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -104.57 20.55 18.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.926 0.49 . . . . 0.0 111.738 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -61.2 129.03 39.29 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.708 0.803 . . . . 0.0 110.142 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.549 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 78.3 mtm180 -88.19 -179.01 6.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.495 0.718 . . . . 0.0 111.848 -171.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.27 -63.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.103 0.961 . . . . 0.0 109.573 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -63.91 -15.27 58.68 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.902 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 12.2 mm-40 -87.04 -49.05 7.59 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -78.93 -66.78 0.82 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.358 1.063 . . . . 0.0 110.182 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -65.7 -19.96 66.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.001 0.52 . . . . 0.0 111.149 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.57 72.32 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.749 0.655 . . . . 0.0 111.877 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' ILE . 20.8 mt-30 -72.33 -38.85 68.53 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.11 -35.9 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.6 67.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.702 0.801 . . . . 0.0 111.99 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.43 -28.19 15.62 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.188 0.995 . . . . 0.0 112.065 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 29' ' ' GLN . 27.8 mm -78.95 -61.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.304 1.042 . . . . 0.0 110.415 -174.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 36' ' ' ILE . 3.8 t -109.42 -5.36 15.83 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.812 0.845 . . . . 0.0 111.435 -175.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.15 13.6 81.74 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.932 -0.371 . . . . 0.0 114.001 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 34' ' ' THR . 24.9 mm -90.88 115.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 141.88 69.49 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.707 0.803 . . . . 0.0 110.702 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.99 -27.64 64.98 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 123.421 2.747 . . . . 0.0 114.133 -174.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -15.23 78.3 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 120.085 -0.286 . . . . 0.0 113.813 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -93.78 -5.75 47.56 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.107 0.963 . . . . 0.0 111.445 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -130.19 161.59 30.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.106 0.963 . . . . 0.0 111.148 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -134.07 -172.17 2.92 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.244 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.534 HG12 HD11 ' A' ' 54' ' ' LEU . 49.8 mm -107.36 99.15 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -112.0 131.33 55.48 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.57 -174.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.721 0.808 . . . . 0.0 109.672 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.54 55.88 4.44 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.46 168.31 11.57 Favored Pre-proline 0 N--CA 1.483 1.209 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 168.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 100.31 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.982 1.788 . . . . 0.0 111.343 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.04 138.74 26.02 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.145 1.897 . . . . 0.0 113.089 -168.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.94 -0.88 23.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.891 0.876 . . . . 0.0 111.681 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.7 m 61.32 58.24 2.2 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.682 1.193 . . . . 0.0 109.678 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.18 99.92 0.73 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.113 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -86.06 125.7 33.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.534 HD11 HG12 ' A' ' 43' ' ' ILE . 6.4 mp -88.96 106.57 18.51 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -111.83 19.6 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.601 0.76 . . . . 0.0 110.825 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 13.7 t70 -134.29 118.02 17.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -58.08 -34.26 69.96 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.897 0.879 . . . . 0.0 113.124 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.39 -0.71 54.65 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.05 0.94 . . . . 0.0 113.461 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.7 tt -61.6 122.18 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 118.757 0.708 . . . . 0.0 110.724 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.3 p -90.5 171.59 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.099 0.56 . . . . 0.0 111.921 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.444 HD13 HG21 ' A' ' 66' ' ' ILE . 21.9 mt -70.63 -7.96 48.21 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.95 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.89 -23.0 78.7 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.235 0.334 . . . . 0.0 112.743 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.479 ' HB2' HD22 ' A' ' 64' ' ' LEU . 9.2 m-20 -88.85 -47.29 8.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.065 0.546 . . . . 0.0 110.15 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 63' ' ' ASP . 2.5 mm? -90.35 157.31 45.05 Favored Pre-proline 0 CA--C 1.562 1.412 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.099 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.94 44.82 1.76 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.495 2.797 . . . . 0.0 114.516 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.612 HG13 HD11 ' A' ' 72' ' ' LEU . 4.0 mp -83.47 124.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -119.94 170.7 9.02 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.545 0.738 . . . . 0.0 109.171 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 t -74.63 111.56 9.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.76 13.43 59.43 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.218 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.08 170.03 17.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 30.7 ttm -117.4 113.74 22.53 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.589 0.756 . . . . 0.0 109.353 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.612 HD11 HG13 ' A' ' 66' ' ' ILE . 3.2 mp -90.64 105.69 17.99 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.476 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.75 89.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 75.3 t -72.11 107.27 2.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.386 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -77.13 159.85 29.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.697 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 78' ' ' GLN . 43.1 tt0 -125.19 121.52 34.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.15 -21.97 66.35 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.51 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 76' ' ' GLU . 46.3 mt-30 63.36 33.42 13.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.501 1.12 . . . . 0.0 110.937 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.43 HG23 ' HG3' ' A' ' 80' ' ' ARG . 6.4 t -68.82 -33.04 73.17 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.19 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' HG3' HG23 ' A' ' 79' ' ' THR . 8.1 ppt_? -162.05 153.7 15.69 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.842 0.857 . . . . 0.0 109.641 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.03 164.64 33.04 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.598 2.199 . . . . 0.0 113.015 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -70.98 86.6 0.72 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.89 0.876 . . . . 0.0 109.107 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.01 135.38 33.68 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.871 0.869 . . . . 0.0 110.808 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.7 t -102.94 134.65 19.69 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.574 0.749 . . . . 0.0 109.319 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -58.41 -30.78 92.42 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.948 2.432 . . . . 0.0 112.893 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--O 1.248 1.011 0 C-N-CA 124.063 0.945 . . . . 0.0 109.556 178.189 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.3 m0 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -93.24 82.55 4.53 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 66' ' ' ILE . 41.3 t -96.1 136.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -87.29 141.75 28.41 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.57 0.748 . . . . 0.0 110.327 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.608 ' SG ' HD13 ' A' ' 14' ' ' LEU . 86.3 m -130.91 101.88 5.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.327 0.651 . . . . 0.0 111.427 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.528 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 12.9 tppt? -74.95 118.69 18.19 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.436 1.094 . . . . 0.0 110.381 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.13 -173.92 4.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.329 0.651 . . . . 0.0 109.416 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.09 130.95 45.0 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.564 0.346 . . . . 0.0 110.107 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.46 -22.44 30.68 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.805 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.41 -163.19 24.66 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 123.172 0.415 . . . . 0.0 112.073 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.5 m -85.12 125.95 33.21 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' HB3' HG22 ' A' ' 33' ' ' ILE . 77.7 m80 -112.02 112.55 24.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.207 1.003 . . . . 0.0 108.647 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.3 tp -80.07 121.55 25.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.093 0.557 . . . . 0.0 110.666 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.608 HD13 ' SG ' ' A' ' 5' ' ' CYS . 8.5 mp -81.41 133.46 35.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 174.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -105.33 153.37 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.526 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.04 23.82 74.51 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD22 HG21 ' A' ' 21' ' ' THR . 78.0 mt -77.17 117.96 19.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.672 0.736 . . . . 0.0 110.077 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 94.5 p -84.84 161.35 19.94 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.7 p -65.39 -17.6 64.66 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.541 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.584 HH22 ' HA3' ' A' ' 62' ' ' GLY . 6.9 mmp_? -107.22 18.49 21.61 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.144 0.977 . . . . 0.0 112.256 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.482 HG21 HD22 ' A' ' 17' ' ' LEU . 44.0 m -63.31 119.8 10.35 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.926 0.393 . . . . 0.0 110.303 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -82.39 176.58 9.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.864 0.866 . . . . 0.0 111.272 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HB2' HG22 ' A' ' 59' ' ' ILE . 5.7 tt -51.33 -60.62 2.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.714 1.206 . . . . 0.0 110.21 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -54.12 -30.43 48.72 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.021 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 21' ' ' THR . 9.0 mm-40 -83.98 -38.74 20.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.41 0.684 . . . . 0.0 110.128 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.24 -66.99 0.66 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.225 1.01 . . . . 0.0 109.564 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -67.15 -16.93 64.61 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.04 70.97 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.849 0.718 . . . . 0.0 112.022 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.441 ' O ' HG13 ' A' ' 33' ' ' ILE . 24.0 mt-30 -70.22 -39.51 75.06 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.527 HG13 HD21 ' A' ' 14' ' ' LEU . 88.5 mt -57.59 -42.63 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 123.612 0.765 . . . . 0.0 110.881 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.17 67.5 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.034 0.934 . . . . 0.0 112.397 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.51 -35.58 15.0 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.771 0.829 . . . . 0.0 111.435 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 29' ' ' GLN . 25.1 mt -86.32 -64.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.094 0.558 . . . . 0.0 111.109 -171.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.58 HG23 HG12 ' A' ' 36' ' ' ILE . 12.1 t -93.72 -2.86 53.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.557 0.343 . . . . 0.0 110.929 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.41 -10.07 56.18 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.555 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 34' ' ' THR . 22.5 mm -71.65 111.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.591 0.696 . . . . 0.0 109.949 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.65 144.45 44.69 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.135 0.974 . . . . 0.0 111.089 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.95 -28.17 86.88 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.082 2.521 . . . . 0.0 113.049 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.08 28.02 9.37 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.548 0.53 . . . . 0.0 113.402 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -138.87 11.64 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.39 1.076 . . . . 0.0 109.987 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.46 161.3 42.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.794 0.838 . . . . 0.0 110.741 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -143.32 -168.91 2.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.173 1.389 . . . . 0.0 109.21 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 54' ' ' LEU . 24.2 mm -106.83 110.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.562 0.745 . . . . 0.0 109.112 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mm? -120.01 156.6 30.57 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.56 167.72 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.159 0.584 . . . . 0.0 111.046 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.72 -49.32 78.78 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.528 1.142 . . . . 0.0 113.041 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -74.12 158.72 85.28 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.631 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -46.53 111.41 0.36 Allowed 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.225 2.617 . . . . 0.0 114.227 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.72 -176.91 2.66 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.054 2.503 . . . . 0.0 111.614 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -126.0 30.15 5.72 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.4 0.68 . . . . 0.0 110.741 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 34.0 m 55.44 64.27 1.82 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.741 0.816 . . . . 0.0 109.713 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.75 109.35 4.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.98 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.23 115.72 27.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.912 1.285 . . . . 0.0 108.921 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 43' ' ' ILE . 4.1 mp -82.7 93.45 7.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.499 0.72 . . . . 0.0 109.229 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.6 p -79.8 -52.58 7.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 111.213 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -83.45 131.67 35.01 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 123.476 0.71 . . . . 0.0 110.319 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -22.82 61.15 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.726 0.811 . . . . 0.0 112.951 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -91.58 -5.29 54.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.496 1.119 . . . . 0.0 111.252 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 23' ' ' LEU . 13.9 tt -59.58 121.07 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.236 0.615 . . . . 0.0 111.626 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -91.37 173.57 7.84 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 0.0 111.278 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.432 HD13 HG21 ' A' ' 66' ' ' ILE . 45.4 mt -70.26 -4.76 23.42 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.605 0.762 . . . . 0.0 111.643 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.584 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -78.46 -30.61 48.84 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.846 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 -48.98 6.19 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.82 133.05 95.43 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.076 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.6 78.49 0.95 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.816 2.344 . . . . 0.0 111.96 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.468 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.1 mp -123.23 121.87 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.1 mm-40 -117.9 154.91 31.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.753 0.821 . . . . 0.0 109.069 174.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -65.25 106.81 1.42 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.803 . . . . 0.0 110.493 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.25 13.07 62.38 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 113.87 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.7 t70 -84.77 163.47 19.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.176 0.59 . . . . 0.0 110.447 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.528 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 5.7 tpt -91.83 101.64 14.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.468 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.5 mm? -101.61 123.15 45.15 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.231 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.5 mp -91.95 116.18 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.98 110.37 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.218 1.007 . . . . 0.0 108.286 169.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.81 138.65 39.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.4 108.77 20.21 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.1 -21.92 49.72 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.215 0.606 . . . . 0.0 111.106 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 62.28 28.63 17.08 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.465 1.106 . . . . 0.0 111.861 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -76.55 -6.53 52.31 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.683 0.793 . . . . 0.0 112.083 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -162.18 159.91 21.28 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.968 0.907 . . . . 0.0 109.657 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.82 158.66 56.94 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.077 1.851 . . . . 0.0 110.664 166.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -140.98 142.26 34.32 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.026 0.531 . . . . 0.0 109.812 -174.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.85 114.89 28.39 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.6 p -102.83 103.41 33.01 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.332 0.653 . . . . 0.0 109.974 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.63 163.07 26.95 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.465 2.11 . . . . 0.0 112.08 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 C--O 1.253 1.258 0 C-N-CA 123.565 0.746 . . . . 0.0 109.486 178.037 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.0 m0 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -83.47 72.95 10.23 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.367 1.079 . . . . 0.0 109.55 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG13 HD23 ' A' ' 72' ' ' LEU . 95.8 t -80.95 132.67 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.056 -172.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -96.23 127.18 42.0 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.698 . . . . 0.0 109.585 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' HD13 ' A' ' 14' ' ' LEU . 84.4 m -113.25 114.88 27.34 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 0.0 110.36 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -80.37 105.11 11.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.24 178.64 6.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.294 0.569 . . . . 0.0 111.501 -173.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.547 ' HG3' ' HB3' ' A' ' 76' ' ' GLU . 31.9 mmmt -71.64 -25.06 61.98 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.561 1.144 . . . . 0.0 111.775 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.9 26.82 14.76 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.74 -175.68 42.2 Favored Glycine 0 C--N 1.353 1.48 0 C-N-CA 122.971 0.32 . . . . 0.0 113.348 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.485 HG23 ' HE1' ' A' ' 71' ' ' MET . 20.5 m -86.46 124.13 32.45 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.894 0.478 . . . . 0.0 109.811 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.62 166.54 11.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.562 0.745 . . . . 0.0 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -118.27 120.5 37.85 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.658 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -103.35 111.47 23.9 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.022 0.929 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -89.96 171.47 9.55 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.848 0.859 . . . . 0.0 109.248 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.83 3.66 85.56 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.802 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.1 mt -95.96 127.52 42.04 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.837 0.855 . . . . 0.0 109.316 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -116.07 -166.82 1.18 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.952 1.301 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -70.01 -45.75 66.58 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.329 0.651 . . . . 0.0 111.432 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -107.18 39.25 1.92 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 25' ' ' GLU . 20.1 m -70.46 122.79 20.31 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 166.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.457 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 26.6 mtm180 -76.24 170.14 16.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.622 0.769 . . . . 0.0 111.198 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 54' ' ' LEU . 44.5 tp -57.54 -49.73 75.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.679 0.791 . . . . 0.0 111.285 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.78 -32.38 65.59 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.752 0.657 . . . . 0.0 112.144 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.509 ' HB2' HG23 ' A' ' 21' ' ' THR . 42.1 mm-40 -78.12 -46.95 19.3 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.392 0.677 . . . . 0.0 109.684 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.09 -62.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.954 1.301 . . . . 0.0 110.812 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 59.2 mt-30 -64.96 -21.89 66.91 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.942 0.497 . . . . 0.0 111.707 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.71 93.91 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.89 0.744 . . . . 0.0 111.748 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -78.71 -37.24 42.04 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.261 -0.4 . . . . 0.0 110.514 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -55.97 -46.21 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.319 0.647 . . . . 0.0 110.808 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -63.26 -24.46 67.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.018 0.927 . . . . 0.0 112.182 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.45 -33.3 16.86 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.682 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.658 HG13 ' HG ' ' A' ' 14' ' ' LEU . 20.8 mm -85.13 -62.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.149 0.979 . . . . 0.0 111.21 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.454 HG23 HG12 ' A' ' 36' ' ' ILE . 10.2 t -96.21 -11.58 25.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.86 68.35 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.938 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 34' ' ' THR . 6.6 mm -75.04 114.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.87 77.62 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.172 0.989 . . . . 0.0 111.233 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 37.0 Cg_endo -61.8 -17.83 57.29 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.089 2.526 . . . . 0.0 112.774 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 20.86 40.51 Favored Glycine 0 C--N 1.352 1.432 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.874 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -147.34 3.11 0.77 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.892 0.877 . . . . 0.0 111.992 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 3.7 pp0? -143.56 168.03 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.002 0.905 . . . . 0.0 112.3 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -153.15 166.41 32.58 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.724 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.618 HG23 HD12 ' A' ' 72' ' ' LEU . 1.8 mp -105.17 112.4 38.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 109.087 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -117.64 169.91 9.19 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' TYR . 6.9 m -121.52 162.63 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 118.232 0.469 . . . . 0.0 111.24 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.25 72.44 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 115.428 -0.805 . . . . 0.0 113.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.426 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 45.4 p90 -95.08 173.24 4.58 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.093 172.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 34.2 Cg_exo -40.49 110.62 0.12 Allowed 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 123.512 2.808 . . . . 0.0 113.988 173.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.73 159.97 18.98 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.647 2.232 . . . . 0.0 112.349 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -76.79 -14.32 59.93 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.876 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.4 m 66.87 23.5 9.96 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 124.831 1.252 . . . . 0.0 109.476 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.5 pt? -56.83 129.46 41.47 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 125.698 1.599 . . . . 0.0 112.161 -172.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.28 105.68 17.65 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 43' ' ' ILE . 6.0 mp -74.63 95.93 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -120.35 6.38 10.67 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.949 0.9 . . . . 0.0 111.74 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 59' ' ' ILE . 12.2 t70 -112.05 114.9 28.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -61.54 -29.39 69.98 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.523 0.729 . . . . 0.0 112.369 -174.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -94.13 -13.44 26.75 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.252 1.021 . . . . 0.0 111.883 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 56' ' ' ASP . 13.9 tt -60.69 133.32 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 71.2 p -104.59 168.48 9.05 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.735 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 34.1 mt -67.88 -10.13 50.56 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.473 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.66 -39.43 40.68 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.17 -35.04 42.56 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.762 0.791 . . . . 0.0 109.282 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 93.3 mt -80.99 157.68 71.07 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.923 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.2 34.24 0.43 Allowed 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 123.063 2.509 . . . . 0.0 113.089 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 43' ' ' ILE . 2.4 mp -84.61 120.55 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.8 mt-30 -121.54 161.63 22.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.122 0.569 . . . . 0.0 109.507 171.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -66.9 114.02 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.02 0.528 . . . . 0.0 109.747 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.94 8.91 83.45 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.562 0.539 . . . . 0.0 113.883 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -80.44 160.22 25.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.695 0.398 . . . . 0.0 110.076 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.485 ' HE1' HG23 ' A' ' 11' ' ' THR . 0.1 OUTLIER -94.92 101.88 13.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.18 0.992 . . . . 0.0 109.613 -178.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.618 HD12 HG23 ' A' ' 43' ' ' ILE . 3.8 mm? -104.95 109.27 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.792 0.837 . . . . 0.0 108.853 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.7 mp -75.27 105.99 4.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.161 0.584 . . . . 0.0 109.582 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.71 111.89 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.764 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 11.4 pt-20 -80.11 176.29 9.88 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.355 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.547 ' HB3' ' HG3' ' A' ' 8' ' ' LYS . 38.6 tt0 -138.51 116.85 11.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.61 -19.41 14.36 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.705 0.802 . . . . 0.0 110.03 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.489 ' HG3' ' HG2' ' A' ' 76' ' ' GLU . 26.8 mt-30 59.91 12.94 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.882 1.273 . . . . 0.0 113.702 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -71.23 -32.23 68.53 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.087 0.555 . . . . 0.0 111.183 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -142.15 79.1 16.39 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.067 0.947 . . . . 0.0 108.526 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.43 174.9 10.12 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.752 2.301 . . . . 0.0 112.124 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -142.19 106.01 4.71 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.159 0.584 . . . . 0.0 110.333 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.62 106.9 4.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.922 0.889 . . . . 0.0 109.018 174.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.8 m -145.73 99.38 4.41 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.908 0.883 . . . . 0.0 108.89 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.46 -25.66 67.51 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.171 2.581 . . . . 0.0 113.168 170.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.9 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 123.334 0.654 . . . . 0.0 109.695 172.544 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 23.0 m0 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.556 ' HB3' HD11 ' A' ' 13' ' ' LEU . 82.2 mtm180 -86.59 86.42 7.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.79 0.836 . . . . 0.0 109.301 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t -99.54 141.61 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.145 0.978 . . . . 0.0 111.237 -170.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -98.87 97.32 8.52 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.505 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.5 m -80.3 100.91 8.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.598 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -76.86 103.4 6.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 109.297 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.601 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -134.46 172.26 13.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.65 0.38 . . . . 0.0 110.656 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -59.26 112.47 1.74 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.216 173.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.74 9.36 14.31 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.403 -171.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.79 -166.37 18.04 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 122.943 0.306 . . . . 0.0 113.14 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -81.75 157.8 24.39 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -138.9 120.02 14.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.108 0.563 . . . . 0.0 109.522 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' A' ' 2' ' ' ARG . 2.1 tm? -96.26 98.62 10.44 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.94 141.75 31.02 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.481 0.712 . . . . 0.0 111.433 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.84 179.36 3.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.282 1.033 . . . . 0.0 109.234 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.6 28.58 73.56 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.441 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.497 HD22 HG21 ' A' ' 21' ' ' THR . 93.0 mt -106.09 113.73 27.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.292 0.637 . . . . 0.0 110.75 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.9 t -95.85 172.09 8.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 0.0 108.923 172.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.4 p -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 122.45 0.3 . . . . 0.0 111.808 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.99 22.07 13.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.817 0.447 . . . . 0.0 111.804 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.497 HG21 HD22 ' A' ' 17' ' ' LEU . 52.4 m -66.47 111.05 3.37 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 170.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.426 ' HG2' HG22 ' A' ' 60' ' ' THR . 86.0 mtt-85 -74.12 -178.6 3.42 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.271 1.028 . . . . 0.0 111.971 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 54' ' ' LEU . 6.8 tt -56.76 -53.98 51.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 174.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -63.29 -22.1 66.66 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.37 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 25.3 mm-40 -87.2 -53.43 4.86 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.262 0.625 . . . . 0.0 109.665 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.55 ' HG ' HD21 ' A' ' 61' ' ' LEU . 2.5 tm? -70.89 -65.57 0.72 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.212 1.005 . . . . 0.0 110.191 -176.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -67.43 -17.23 64.63 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.64 0.588 . . . . 0.0 110.888 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.45 -37.54 53.4 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.753 0.658 . . . . 0.0 112.538 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 70.4 mt-30 -68.88 -39.46 79.77 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.406 ' HB ' HE22 ' A' ' 41' ' ' GLN . 85.6 mt -59.68 -37.19 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.02 0.928 . . . . 0.0 111.204 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.73 -24.01 65.37 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.193 0.997 . . . . 0.0 111.926 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.69 -43.26 8.74 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.596 0.758 . . . . 0.0 111.322 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 29' ' ' GLN . 17.0 mm -68.3 -63.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.383 1.073 . . . . 0.0 110.237 -172.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 36' ' ' ILE . 8.9 t -109.31 0.99 19.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.67 0.788 . . . . 0.0 111.013 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.2 89.38 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 170.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 34' ' ' THR . 9.8 mm -86.08 107.85 16.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 147.54 98.36 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.564 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -49.95 -33.3 33.51 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 124.11 3.207 . . . . 0.0 114.25 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 13.86 18.48 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.3 m -138.99 15.01 2.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 110.92 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 2.1 pt20 -146.81 155.26 42.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.514 0.725 . . . . 0.0 110.783 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -124.67 -173.91 2.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.169 0.988 . . . . 0.0 109.374 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.6 mm -110.4 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 28.4 mt -107.34 139.73 41.36 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 65' ' ' PRO . 6.7 m -120.19 178.34 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 122.867 0.467 . . . . 0.0 112.203 -164.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.97 -49.82 57.37 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 124.301 1.001 . . . . 0.0 113.654 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -79.01 163.11 61.89 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.367 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -42.04 104.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.884 3.056 . . . . 0.0 113.924 171.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.13 159.11 37.5 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.404 2.069 . . . . 0.0 112.736 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -89.33 8.19 31.85 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.412 1.085 . . . . 0.0 112.145 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.0 m 61.67 27.08 16.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.37 1.068 . . . . 0.0 110.264 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -61.62 108.44 0.98 Allowed 'General case' 0 C--N 1.357 0.91 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.751 -173.18 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.48 132.97 43.49 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.685 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.528 ' HB3' HD12 ' A' ' 23' ' ' LEU . 7.1 mp -87.86 88.05 7.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.351 1.06 . . . . 0.0 108.359 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.0 t -93.87 13.93 21.06 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.435 0.694 . . . . 0.0 110.57 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.02 117.46 20.94 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.319 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -60.88 -30.28 70.06 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.169 0.987 . . . . 0.0 113.108 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -81.34 -23.44 37.75 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.581 1.152 . . . . 0.0 111.741 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.3 tt -56.16 134.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 -173.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' HG2' ' A' ' 22' ' ' ARG . 58.9 p -113.55 175.2 5.56 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.54 0.736 . . . . 0.0 111.05 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.55 HD21 ' HG ' ' A' ' 26' ' ' LEU . 50.7 mt -64.36 -22.01 66.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.96 0.504 . . . . 0.0 111.848 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.22 -17.05 61.03 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.241 0.338 . . . . 0.0 113.232 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.57 -45.31 6.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 0.0 111.191 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 52' ' ' LEU . 2.3 mm? -85.91 154.73 58.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 123.108 0.563 . . . . 0.0 110.946 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.426 ' HB2' HG11 ' A' ' 45' ' ' VAL . 2.2 Cg_endo -81.61 41.77 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.523 2.815 . . . . 0.0 113.083 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.76 108.64 3.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.597 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 21.0 mm-40 -105.7 166.42 10.47 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 p -64.4 99.51 0.3 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.199 0.6 . . . . 0.0 110.953 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 35.27 44.55 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.451 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -88.52 165.43 14.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.388 0.675 . . . . 0.0 111.047 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.52 98.21 11.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.802 0.841 . . . . 0.0 109.615 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 98.96 10.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.506 0.722 . . . . 0.0 110.21 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.8 mp -75.96 101.12 2.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 94.5 t -79.42 106.9 11.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.691 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 9.1 pt-20 -78.61 169.04 18.88 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.219 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 78' ' ' GLN . 23.8 tt0 -130.34 137.11 49.76 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 170.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.94 -16.97 62.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.07 0.548 . . . . 0.0 111.861 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.506 ' H ' ' HG2' ' A' ' 76' ' ' GLU . 17.9 mm-40 71.38 1.23 3.76 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.567 1.147 . . . . 0.0 113.083 175.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -78.42 -10.91 59.89 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.153 0.581 . . . . 0.0 110.626 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 65.59 91.75 0.07 OUTLIER Pre-proline 0 C--N 1.361 1.066 0 C-N-CA 125.237 1.415 . . . . 0.0 109.765 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.46 124.71 12.37 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.715 2.277 . . . . 0.0 113.127 -172.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -87.96 122.92 32.15 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.27 177.83 8.52 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.761 0.824 . . . . 0.0 110.709 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.8 p -125.0 90.45 51.04 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.997 0.919 . . . . 0.0 108.852 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.45 85.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 123.486 2.791 . . . . 0.0 113.248 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.551 1.003 0 C-N-CA 124.77 1.228 . . . . 0.0 108.374 -177.013 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 11.2 m0 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.465 ' HB2' HD11 ' A' ' 13' ' ' LEU . 23.1 ptt180 -88.17 65.39 8.1 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.689 1.233 . . . . 0.0 109.563 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.539 ' HB ' HD12 ' A' ' 17' ' ' LEU . 43.3 t -79.12 143.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.507 -169.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -98.69 142.86 29.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.357 1.063 . . . . 0.0 109.943 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.448 ' SG ' HD13 ' A' ' 14' ' ' LEU . 72.1 m -136.39 99.99 4.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.231 1.013 . . . . 0.0 110.076 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -74.41 113.16 11.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 109.433 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.52 100.78 5.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.773 0.429 . . . . 0.0 110.228 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HE3' ' HB3' ' A' ' 76' ' ' GLU . 33.5 mmtp 59.57 23.56 12.27 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.065 1.346 . . . . 0.0 112.61 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.51 -31.47 7.79 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.1 87.04 0.48 Allowed Glycine 0 C--N 1.354 1.54 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -77.15 111.18 12.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.753 0.821 . . . . 0.0 109.297 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -112.62 152.1 29.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 0.0 110.861 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER -113.31 112.94 24.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.448 HD13 ' SG ' ' A' ' 5' ' ' CYS . 5.5 mp -102.72 97.34 7.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.749 0.82 . . . . 0.0 109.041 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.446 ' HG3' HD12 ' A' ' 13' ' ' LEU . 78.5 mt-30 -78.86 -11.4 59.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.373 0.669 . . . . 0.0 110.951 169.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.52 -9.63 74.06 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.421 0.451 . . . . 0.0 114.049 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 21' ' ' THR . 71.1 mt -78.36 125.01 28.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.953 0.501 . . . . 0.0 110.382 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.483 ' O ' HD12 ' A' ' 61' ' ' LEU . 44.5 m -103.43 -178.11 3.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.321 1.449 . . . . 0.0 109.577 171.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 m -65.61 -39.86 91.99 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.92 0.488 . . . . 0.0 112.079 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -104.5 29.15 6.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.819 0.448 . . . . 0.0 112.165 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.547 HG21 HD22 ' A' ' 17' ' ' LEU . 94.9 m -64.08 104.88 0.78 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 122.84 0.456 . . . . 0.0 111.318 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -66.9 173.63 3.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.904 1.282 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' LEU . 6.3 tt -54.95 -50.87 67.81 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.451 0.7 . . . . 0.0 109.873 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.472 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 6.1 ptp180 -56.76 -26.26 56.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.972 0.909 . . . . 0.0 112.712 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 5.5 mm-40 -93.12 -35.46 13.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.897 0.879 . . . . 0.0 110.199 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -79.97 -68.69 0.65 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.035 0.934 . . . . 0.0 109.221 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.76 -19.01 65.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.604 0.565 . . . . 0.0 110.751 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.28 -43.86 77.65 Favored Glycine 0 C--N 1.345 1.051 0 O-C-N 123.929 0.768 . . . . 0.0 112.205 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.512 ' NE2' HD23 ' A' ' 17' ' ' LEU . 43.6 mt-30 -73.41 -38.91 65.42 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HB ' HE22 ' A' ' 41' ' ' GLN . 95.6 mt -57.11 -39.14 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.139 0.576 . . . . 0.0 111.249 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.19 68.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.612 0.765 . . . . 0.0 111.694 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.54 -23.35 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.068 0.947 . . . . 0.0 111.704 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 29' ' ' GLN . 22.2 mm -86.91 -69.38 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.916 0.886 . . . . 0.0 109.886 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.48 HG23 HG12 ' A' ' 36' ' ' ILE . 3.1 t -96.51 -11.73 25.09 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.273 0.629 . . . . 0.0 111.514 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 12.46 77.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.92 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.48 HG12 HG23 ' A' ' 34' ' ' THR . 13.2 mm -85.84 113.81 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.77 142.26 44.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.221 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.66 -24.41 62.57 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.226 2.617 . . . . 0.0 113.348 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.29 19.3 53.29 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.337 0.398 . . . . 0.0 113.27 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -134.6 -3.6 2.62 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.401 HE22 ' HB ' ' A' ' 30' ' ' ILE . 1.0 OUTLIER -123.92 145.67 48.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.613 0.765 . . . . 0.0 109.464 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -121.62 168.04 12.22 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 167.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 66' ' ' ILE . 46.5 mm -103.66 112.0 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.5 mm? -113.61 178.69 4.19 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.1 164.7 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.812 0.445 . . . . 0.0 111.311 -171.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.57 1.82 50.23 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 114.507 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -120.21 172.68 4.35 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -37.45 103.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.017 3.145 . . . . 0.0 113.656 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.17 146.14 56.8 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.634 2.222 . . . . 0.0 112.613 -170.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.32 2.38 55.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.725 0.81 . . . . 0.0 110.826 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.0 m 56.14 74.35 0.39 Allowed 'General case' 0 C--N 1.365 1.258 0 C-N-CA 124.749 1.22 . . . . 0.0 110.482 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.7 mt -77.84 101.14 6.62 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.808 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.13 104.93 17.44 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.296 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 23' ' ' LEU . 5.4 mp -73.85 85.21 1.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.2 t -82.41 -21.31 35.81 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.308 1.043 . . . . 0.0 110.984 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -107.81 136.98 46.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.884 0.874 . . . . 0.0 109.42 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -78.46 -22.45 47.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.579 0.751 . . . . 0.0 111.955 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -93.4 -2.56 54.53 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.448 0.699 . . . . 0.0 111.305 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.82 123.69 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.957 0.503 . . . . 0.0 110.539 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 p -104.51 177.35 4.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.891 0.476 . . . . 0.0 111.081 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 18' ' ' SER . 28.3 mt -74.55 -5.6 43.74 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.615 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.46 62.05 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.497 0.498 . . . . 0.0 111.902 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.92 -42.18 10.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.516 0.726 . . . . 0.0 109.279 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -78.84 152.22 77.21 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.171 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.49 25.49 0.54 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 124.14 3.227 . . . . 0.0 114.175 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.503 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.3 mp -77.08 128.69 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.5 mt-30 -118.03 -179.28 3.71 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.801 0.84 . . . . 0.0 108.917 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 p -68.41 -1.45 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 40.41 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.0 t70 -85.19 163.61 18.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.533 0.733 . . . . 0.0 111.577 -171.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.2 tpt -100.02 103.06 14.58 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.051 0.94 . . . . 0.0 109.508 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.503 ' HG ' HG13 ' A' ' 66' ' ' ILE . 3.2 mm? -109.37 131.24 55.25 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -92.97 114.11 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.43 115.66 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.214 1.006 . . . . 0.0 109.079 167.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -87.48 159.51 18.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.518 ' HB3' ' HE3' ' A' ' 8' ' ' LYS . 36.8 tt0 -117.2 113.61 22.47 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.33 -25.48 64.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.061 0.945 . . . . 0.0 109.727 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 45.78 40.52 6.5 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 126.031 1.732 . . . . 0.0 113.2 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -57.05 -42.65 80.91 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.606 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -174.34 150.01 1.46 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.089 0.956 . . . . 0.0 109.962 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.55 117.26 4.73 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.902 2.402 . . . . 0.0 110.624 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -70.81 120.54 16.56 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.79 0.436 . . . . 0.0 111.437 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.39 -2.65 57.48 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.878 0.871 . . . . 0.0 111.501 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.1 m -79.16 152.11 76.23 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.312 1.045 . . . . 0.0 111.402 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.09 132.44 49.31 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.278 2.652 . . . . 0.0 112.825 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.552 1.045 0 C-N-CA 123.914 0.886 . . . . 0.0 109.423 -177.638 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 10.8 m0 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -90.95 83.33 5.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.066 0.946 . . . . 0.0 109.124 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.7 t -105.59 141.23 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.734 0.814 . . . . 0.0 111.126 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -88.61 147.28 24.65 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 110.915 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.2 p -131.56 115.37 16.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.348 0.659 . . . . 0.0 110.4 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.574 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 14.3 tppt? -79.7 124.21 28.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.403 1.081 . . . . 0.0 109.434 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.4 172.09 15.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.118 0.567 . . . . 0.0 110.044 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.724 ' HE2' ' HB3' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -69.51 -23.58 63.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.45 20.73 25.34 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.384 0.427 . . . . 0.0 112.502 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.32 174.17 28.65 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 123.335 0.493 . . . . 0.0 112.609 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.4 m -85.53 117.94 24.74 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.67 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.3 m-70 -102.95 177.84 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 tt -146.86 101.5 3.44 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.0 mp -79.16 113.34 17.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.969 0.908 . . . . 0.0 110.038 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -101.65 -9.39 20.96 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.357 0.663 . . . . 0.0 110.979 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.63 42.03 3.12 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 122.827 0.251 . . . . 0.0 113.165 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.5 mt -118.24 121.97 41.8 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.832 0.853 . . . . 0.0 109.835 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.2 p -97.44 171.97 8.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.373 1.069 . . . . 0.0 109.337 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 m -62.31 -29.34 70.37 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.281 0.632 . . . . 0.0 111.546 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -110.74 29.5 7.69 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.84 0.856 . . . . 0.0 112.142 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -70.88 121.11 17.49 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 166.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -89.93 169.6 11.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 110.093 -173.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 57' ' ' ARG . 24.9 tp -51.99 -51.56 56.43 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.856 0.863 . . . . 0.0 111.715 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 11.8 ptm180 -55.37 -34.1 64.0 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.731 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.563 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 44.0 mt-10 -88.26 -31.28 19.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.812 0.845 . . . . 0.0 110.877 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 43' ' ' ILE . 2.3 tm? -74.01 -66.4 0.72 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.034 0.934 . . . . 0.0 108.907 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -66.49 -20.84 66.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.192 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.37 -42.04 90.32 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.013 0.821 . . . . 0.0 111.67 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -73.71 -35.76 65.16 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.574 0.349 . . . . 0.0 110.078 178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.43 ' HB ' HE22 ' A' ' 41' ' ' GLN . 84.2 mt -62.72 -37.56 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 C-N-CA 123.287 0.635 . . . . 0.0 110.53 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.73 -24.61 67.84 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.813 0.845 . . . . 0.0 112.022 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.47 -25.5 16.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.908 0.883 . . . . 0.0 111.804 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.563 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.4 mm -82.4 -65.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.331 1.052 . . . . 0.0 110.488 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.556 HG23 HG12 ' A' ' 36' ' ' ILE . 7.1 t -108.77 -0.36 20.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.98 0.912 . . . . 0.0 110.953 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.99 11.87 84.74 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.404 -0.664 . . . . 0.0 114.398 171.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 76' ' ' GLU . 23.0 mm -85.78 131.49 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 117.791 0.796 . . . . 0.0 111.442 -175.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 130.93 93.64 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.201 1.0 . . . . 0.0 110.335 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.05 -24.97 68.56 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.335 2.69 . . . . 0.0 113.42 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.61 -3.57 90.19 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.859 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.5 m -107.41 -48.21 3.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.762 0.825 . . . . 0.0 110.309 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.43 HE22 ' HB ' ' A' ' 30' ' ' ILE . 3.2 pt20 -76.91 153.77 34.35 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.269 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.69 168.36 23.85 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.448 1.099 . . . . 0.0 109.075 168.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.444 HG21 ' HD2' ' A' ' 65' ' ' PRO . 43.9 mm -79.41 103.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.259 1.028 . . . . 0.0 110.364 -174.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.2 mt -122.1 137.19 54.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.985 -1.916 . . . . 0.0 105.964 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 65' ' ' PRO . 16.3 m -125.68 179.1 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 122.733 0.413 . . . . 0.0 111.5 -169.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.65 -48.75 74.9 Favored Glycine 0 C--N 1.358 1.779 0 O-C-N 124.326 1.016 . . . . 0.0 113.654 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -80.7 155.82 73.19 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.929 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -45.29 108.04 0.13 Allowed 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 124.22 3.28 . . . . 0.0 113.593 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.04 169.14 8.97 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.946 2.431 . . . . 0.0 111.524 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.58 25.18 11.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.455 0.702 . . . . 0.0 111.417 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.1 m 53.2 65.07 1.62 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.03 0.932 . . . . 0.0 110.143 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.86 126.14 26.33 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.182 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -91.04 90.81 8.02 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.836 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.89 86.17 2.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -80.58 -41.46 23.99 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.0 0.92 . . . . 0.0 110.872 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 20.9 t0 -81.11 118.2 22.32 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.024 0.53 . . . . 0.0 110.385 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HA ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.75 -29.13 62.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.07 0.948 . . . . 0.0 112.832 174.313 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -93.52 -2.39 54.41 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.761 0.824 . . . . 0.0 112.047 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 14.0 tt -69.73 126.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.989 -0.444 . . . . 0.0 111.177 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -91.12 172.04 8.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.37 0.605 . . . . 0.0 112.437 -171.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 66' ' ' ILE . 27.6 mt -65.43 -17.78 64.81 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.149 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -28.62 66.77 Favored Glycine 0 C--N 1.36 1.886 0 O-C-N 123.483 0.489 . . . . 0.0 113.14 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.81 -52.24 5.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.129 0.571 . . . . 0.0 110.402 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.9 155.45 82.89 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.969 0.908 . . . . 0.0 111.756 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' HG11 ' A' ' 45' ' ' VAL . 4.4 Cg_exo -80.66 36.65 0.63 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.878 3.052 . . . . 0.0 114.126 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.568 HG13 HD21 ' A' ' 72' ' ' LEU . 2.0 mp -70.89 114.55 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 167.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.631 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 34.4 mt-30 -118.23 148.57 42.27 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -65.24 104.07 0.88 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.67 . . . . 0.0 110.659 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.88 11.51 52.98 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 114.113 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.631 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 27.9 t0 -89.53 160.68 16.59 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.273 0.629 . . . . 0.0 111.979 -173.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.574 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 4.8 tpt -96.21 108.31 20.77 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.766 1.226 . . . . 0.0 109.648 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.568 HD21 HG13 ' A' ' 66' ' ' ILE . 11.1 mp -109.67 126.12 53.34 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 0.0 110.288 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -85.88 103.29 12.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.53 111.65 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.618 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.99 155.41 19.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.71 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.724 ' HB3' ' HE2' ' A' ' 8' ' ' LYS . 10.0 tp10 -135.87 130.81 34.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.985 0.914 . . . . 0.0 109.446 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -89.54 -5.46 57.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.354 0.662 . . . . 0.0 110.632 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.488 ' H ' ' HG3' ' A' ' 76' ' ' GLU . 48.4 mt-30 70.88 26.32 3.7 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.809 1.644 . . . . 0.0 110.169 -173.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.5 m -76.67 -38.56 54.31 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.234 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 66.89 165.46 0.12 Allowed Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 124.658 1.183 . . . . 0.0 111.269 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.54 121.2 9.22 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.634 1.556 . . . . 0.0 110.264 164.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -70.19 79.69 0.52 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.793 0.837 . . . . 0.0 111.126 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.01 169.4 5.65 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.238 1.015 . . . . 0.0 110.368 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.8 p -130.94 91.29 37.04 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 124.003 0.921 . . . . 0.0 109.126 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.32 -51.54 9.82 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.072 2.514 . . . . 0.0 112.028 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 CA--C 1.553 1.088 0 C-N-CA 124.298 1.039 . . . . 0.0 108.901 173.01 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 18.8 m0 . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.505 ' HB3' HD11 ' A' ' 13' ' ' LEU . 53.7 mtm180 -116.75 88.05 2.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.017 0.927 . . . . 0.0 108.775 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.487 HG13 HD23 ' A' ' 72' ' ' LEU . 82.3 t -89.43 137.36 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.455 0.702 . . . . 0.0 111.204 -170.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -87.45 138.67 31.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.746 0.819 . . . . 0.0 109.075 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 t -131.99 100.89 5.21 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.474 0.71 . . . . 0.0 111.11 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.488 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.0 tppp? -73.38 144.75 46.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.88 -168.94 2.52 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.733 0.301 . . . . 0.0 111.34 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.65 -28.61 9.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.108 1.363 . . . . 0.0 112.8 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.27 87.14 0.1 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.05 167.04 19.73 Favored Glycine 0 C--N 1.346 1.136 0 C-N-CA 123.251 0.453 . . . . 0.0 113.29 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -106.42 150.54 25.94 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.499 0.72 . . . . 0.0 110.436 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -122.97 164.66 18.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.33 1.452 . . . . 0.0 108.378 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 2' ' ' ARG . 0.3 OUTLIER -128.85 102.55 6.59 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.654 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.1 mp -81.3 121.77 26.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.041 0.936 . . . . 0.0 110.358 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.505 ' NE2' HD12 ' A' ' 13' ' ' LEU . 83.5 mm-40 -98.9 159.92 14.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.158 0.983 . . . . 0.0 109.762 174.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.8 10.43 83.13 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.135 -0.484 . . . . 0.0 114.17 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.39 137.44 42.71 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.113 0.565 . . . . 0.0 109.609 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -112.66 177.92 4.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.639 1.176 . . . . 0.0 109.36 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.7 p -82.32 -26.85 32.64 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.912 0.387 . . . . 0.0 109.972 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -86.8 6.92 29.2 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.926 0.89 . . . . 0.0 112.191 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.426 HG22 ' HB2' ' A' ' 26' ' ' LEU . 93.5 m -62.9 112.34 2.52 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 110.826 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.88 179.36 7.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.287 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 4.9 tt -57.53 -56.33 23.27 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.74 0.816 . . . . 0.0 109.652 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -20.31 64.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.673 0.789 . . . . 0.0 112.097 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -79.62 -52.81 7.51 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.509 0.724 . . . . 0.0 109.246 172.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.426 ' HB2' HG22 ' A' ' 21' ' ' THR . 2.5 tm? -69.29 -66.72 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.879 1.272 . . . . 0.0 110.756 -169.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -65.13 -18.3 65.19 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.141 0.576 . . . . 0.0 111.7 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.46 -41.03 46.12 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.7 0.625 . . . . 0.0 111.983 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -70.13 -37.03 75.18 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.105 0.562 . . . . 0.0 110.06 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.55 -43.73 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 0.0 110.912 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.417 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -60.76 -26.36 67.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.761 0.825 . . . . 0.0 111.743 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.51 -27.96 19.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.632 0.773 . . . . 0.0 111.769 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.654 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.4 mm -84.27 -70.07 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.115 0.566 . . . . 0.0 110.722 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 36' ' ' ILE . 6.4 t -88.53 -16.29 33.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.24 0.616 . . . . 0.0 111.154 -175.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.81 -1.91 85.55 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.361 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.401 ' H ' HG23 ' A' ' 34' ' ' THR . 18.9 mm -77.64 112.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.54 144.53 63.61 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 124.022 0.929 . . . . 0.0 110.772 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 31' ' ' ALA . 28.2 Cg_endo -57.85 -24.35 63.78 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.26 2.64 . . . . 0.0 113.212 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.49 19.8 34.32 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.639 -0.255 . . . . 0.0 113.28 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.8 m -140.37 12.62 2.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.458 1.103 . . . . 0.0 110.618 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -148.9 144.03 26.6 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.993 0.517 . . . . 0.0 109.81 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.8 176.35 6.66 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.279 1.032 . . . . 0.0 108.904 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -101.21 101.12 11.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 32.2 mt -116.28 145.58 43.05 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 49' ' ' PRO . 17.4 m -114.7 168.55 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.299 0.639 . . . . 0.0 110.017 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.01 65.72 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.789 0.681 . . . . 0.0 113.77 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -80.29 160.87 66.92 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.606 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -47.52 110.77 0.33 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HB3' HG22 ' A' ' 45' ' ' VAL . 90.8 Cg_endo -81.53 -179.81 5.21 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.273 2.649 . . . . 0.0 112.307 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.74 13.46 28.38 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.503 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.7 m 54.72 66.43 1.24 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 123.828 0.851 . . . . 0.0 108.706 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.77 129.24 39.09 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.863 -165.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.9 90.14 3.52 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 108.801 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 9.7 mp -87.49 104.99 16.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -100.65 -51.94 3.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.602 0.761 . . . . 0.0 110.562 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' O ' HG22 ' A' ' 59' ' ' ILE . 13.9 t0 -71.71 111.72 7.23 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.116 0.567 . . . . 0.0 111.317 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.546 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -53.09 -25.59 13.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.501 1.12 . . . . 0.0 113.554 175.322 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.51 -2.75 56.0 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.49 0.716 . . . . 0.0 112.11 -173.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 56' ' ' ASP . 15.4 tt -71.78 125.43 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.729 0.412 . . . . 0.0 110.836 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.6 p -89.4 176.01 7.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.659 0.743 . . . . 0.0 112.317 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.7 mt -73.52 -7.51 52.12 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.828 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.17 71.95 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.395 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.35 -52.04 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.4 0.68 . . . . 0.0 110.519 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.43 148.22 54.92 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.216 0.607 . . . . 0.0 111.144 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 31.51 0.44 Allowed 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.805 3.003 . . . . 0.0 114.936 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.31 117.8 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -120.42 163.42 17.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 t -71.16 108.53 4.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.837 0.455 . . . . 0.0 110.191 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.57 0.15 62.87 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.581 0.551 . . . . 0.0 113.206 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.19 156.68 38.34 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.193 0.597 . . . . 0.0 110.549 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.2 tpt -92.54 104.58 16.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.491 1.117 . . . . 0.0 109.021 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.487 HD23 HG13 ' A' ' 3' ' ' VAL . 4.3 mm? -105.08 115.75 30.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.885 0.874 . . . . 0.0 109.11 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.4 mp -86.79 100.73 10.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -78.21 105.09 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.599 166.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.5 161.69 27.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.834 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -116.52 109.4 17.21 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -78.79 -17.46 55.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.183 0.993 . . . . 0.0 110.92 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 66.54 13.27 9.22 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.514 1.126 . . . . 0.0 113.259 172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 t -72.99 -19.36 61.23 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.89 0.476 . . . . 0.0 111.39 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 43.99 76.04 0.58 Allowed Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 125.85 1.66 . . . . 0.0 111.589 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -87.18 -177.5 2.18 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 123.138 2.559 . . . . 0.0 112.966 -169.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -97.4 22.99 8.05 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.598 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.44 104.19 2.23 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 124.053 0.941 . . . . 0.0 110.488 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.0 t 64.72 77.84 0.28 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.16 1.384 . . . . 0.0 111.243 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.9 82.57 0.77 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.183 2.589 . . . . 0.0 111.39 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.216 1.007 . . . . 0.0 109.167 -177.404 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 38.5 m0 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.842 0.353 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -125.17 106.81 10.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.469 HG11 HG23 ' A' ' 66' ' ' ILE . 37.3 t -130.75 139.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.922 -0.486 . . . . 0.0 110.35 -173.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -85.02 153.73 22.56 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.005 0.522 . . . . 0.0 111.72 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.545 ' SG ' HD23 ' A' ' 14' ' ' LEU . 95.3 m -130.72 112.14 12.81 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.395 1.078 . . . . 0.0 110.414 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 16.3 tppt? -82.34 107.67 15.19 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.426 1.09 . . . . 0.0 109.305 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.582 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -146.47 177.94 8.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.802 0.335 . . . . 0.0 111.253 -176.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.15 -34.81 75.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.368 1.067 . . . . 0.0 112.304 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.8 26.92 4.52 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.439 -0.346 . . . . 0.0 113.299 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.88 169.86 41.37 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.0 m -89.87 102.98 15.68 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -101.36 179.21 4.42 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.975 0.91 . . . . 0.0 110.153 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD22 ' OE1' ' A' ' 15' ' ' GLN . 3.0 tt -135.35 106.27 6.62 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.545 HD23 ' SG ' ' A' ' 5' ' ' CYS . 4.3 mm? -66.0 108.68 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.684 0.794 . . . . 0.0 109.925 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.446 ' OE1' HD22 ' A' ' 13' ' ' LEU . 14.0 mm100 -76.89 -45.77 26.89 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.199 0.999 . . . . 0.0 110.719 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.81 65.48 3.91 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.533 -0.758 . . . . 0.0 113.382 -174.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.9 mt -118.43 138.55 52.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.06 0.544 . . . . 0.0 110.29 172.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.42 ' O ' HD12 ' A' ' 61' ' ' LEU . 21.3 m -115.75 -176.91 3.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.204 1.402 . . . . 0.0 108.722 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.2 m -73.47 -33.72 64.99 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.186 0.517 . . . . 0.0 110.681 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -104.37 28.18 7.15 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.844 -175.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 26' ' ' LEU . 53.3 m -67.76 105.18 1.85 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.347 0.594 . . . . 0.0 109.686 171.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 36.2 mtm-85 -65.92 175.85 1.85 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.757 1.223 . . . . 0.0 111.637 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 54' ' ' LEU . 7.3 tt -56.39 -57.67 11.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.356 0.662 . . . . 0.0 109.28 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -50.51 -34.6 25.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.9 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 18.6 mm-40 -76.11 -51.03 13.07 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.002 0.429 . . . . 0.0 110.087 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 43' ' ' ILE . 2.4 tm? -70.76 -67.27 0.52 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.317 1.047 . . . . 0.0 110.68 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.432 ' HA ' HE22 ' A' ' 41' ' ' GLN . 40.2 mt-30 -66.55 -20.38 66.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.599 0.562 . . . . 0.0 111.618 -176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.22 -37.01 43.59 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.729 0.643 . . . . 0.0 112.192 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.431 ' O ' HG12 ' A' ' 33' ' ' ILE . 92.0 mt-30 -70.63 -39.73 73.53 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -62.76 -36.63 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.312 0.645 . . . . 0.0 110.615 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -26.34 68.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.439 0.695 . . . . 0.0 111.536 173.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.81 -23.04 20.72 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.92 0.888 . . . . 0.0 111.766 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 29' ' ' GLN . 16.0 mm -82.78 -70.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.372 0.669 . . . . 0.0 110.374 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.44 HG23 HG12 ' A' ' 36' ' ' ILE . 4.8 t -97.77 -7.75 29.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.16 19.23 78.72 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 119.712 -0.493 . . . . 0.0 113.321 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.44 HG12 HG23 ' A' ' 34' ' ' THR . 11.0 mm -98.49 108.26 21.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.84 155.07 55.13 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.498 1.119 . . . . 0.0 112.157 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.12 -31.71 84.19 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.419 2.746 . . . . 0.0 114.599 -174.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.02 3.1 80.44 Favored Glycine 0 N--CA 1.476 1.353 0 O-C-N 123.124 0.265 . . . . 0.0 113.346 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.412 ' HA ' ' HB3' ' A' ' 77' ' ' ASP . 19.1 m -107.25 -2.93 20.28 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.198 0.999 . . . . 0.0 110.179 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.432 HE22 ' HA ' ' A' ' 27' ' ' GLN . 1.4 pp0? -144.53 162.45 36.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.974 0.416 . . . . 0.0 111.86 -176.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.48 -176.35 5.08 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.18 1.392 . . . . 0.0 108.885 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.596 HD11 HD11 ' A' ' 26' ' ' LEU . 29.0 mm -105.8 110.63 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.535 . . . . 0.0 109.723 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -121.34 160.18 24.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -131.92 173.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.755 0.822 . . . . 0.0 111.125 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.48 -5.1 87.86 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.814 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 54.0 p90 -113.51 163.2 19.07 Favored Pre-proline 0 N--CA 1.479 1.017 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 10.8 Cg_endo -50.89 109.21 0.28 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 122.88 2.387 . . . . 0.0 112.489 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.33 169.81 12.33 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.746 2.297 . . . . 0.0 112.159 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -88.08 5.73 39.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.706 0.802 . . . . 0.0 111.335 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 90.3 m 56.27 83.05 0.1 Allowed 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -158.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.61 95.6 3.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 110.512 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.75 114.0 20.1 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.143 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.488 ' HB3' HD12 ' A' ' 23' ' ' LEU . 4.7 mp -79.46 84.83 5.3 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 p -67.9 -50.56 55.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.468 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 19.3 t70 -76.25 157.55 32.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.083 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -92.52 -34.78 13.93 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.286 1.034 . . . . 0.0 111.815 -173.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.51 -3.07 50.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.9 1.28 . . . . 0.0 110.431 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.588 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 15.8 tt -60.85 133.51 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.637 1.175 . . . . 0.0 111.883 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -108.69 -177.9 3.44 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.578 HD21 ' HG ' ' A' ' 26' ' ' LEU . 49.7 mt -75.64 -10.05 59.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 112.061 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 -25.09 73.79 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.52 -59.33 2.16 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 109.846 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.75 129.79 75.47 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.282 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -63.21 78.26 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.918 3.079 . . . . 0.0 114.053 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.627 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -108.11 108.78 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 12.3 mm100 -103.31 155.05 18.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.972 0.509 . . . . 0.0 109.989 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.6 p -62.79 100.97 0.22 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.786 0.835 . . . . 0.0 111.826 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.53 46.08 8.22 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.608 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 6.0 t70 -110.25 169.71 8.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.309 0.644 . . . . 0.0 110.374 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.1 tpt -102.18 103.29 13.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.308 0.643 . . . . 0.0 109.991 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.6 mm? -106.01 114.68 28.96 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.475 0.71 . . . . 0.0 109.679 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 2.8 mp -82.13 108.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.667 0.787 . . . . 0.0 109.737 -176.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 75.8 t -82.97 116.42 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.706 1.203 . . . . 0.0 108.933 170.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.439 ' O ' HG21 ' A' ' 36' ' ' ILE . 11.9 pt-20 -82.31 170.23 15.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.646 0.26 . . . . 0.0 110.699 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -129.57 114.6 16.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 27.7 t70 -94.72 -23.05 17.73 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.342 1.057 . . . . 0.0 110.703 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 63.7 36.02 11.01 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.553 1.141 . . . . 0.0 111.81 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.412 HG22 ' OG ' ' A' ' 40' ' ' SER . 10.1 t -66.95 -22.61 65.93 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 54.94 76.67 0.49 Allowed Pre-proline 0 C--N 1.361 1.092 0 C-N-CA 124.474 1.11 . . . . 0.0 110.727 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.8 171.42 14.39 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.914 2.41 . . . . 0.0 112.945 -173.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -67.47 95.24 0.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.0 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.65 -9.93 59.76 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.586 0.755 . . . . 0.0 111.671 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 m -107.09 101.64 39.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.837 0.855 . . . . 0.0 109.322 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.87 -14.41 42.96 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.962 2.441 . . . . 0.0 113.449 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.555 1.164 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.861 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 32.0 m0 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -81.16 94.8 6.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.9 144.3 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.189 0.995 . . . . 0.0 109.861 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -100.01 141.87 32.25 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.002 0.521 . . . . 0.0 110.903 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 31.2 p -122.85 112.49 17.94 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 0.0 111.369 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HB3' HG13 ' A' ' 73' ' ' ILE . 13.3 tppt? -81.03 106.1 12.77 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.23 -168.12 2.38 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.064 0.546 . . . . 0.0 111.518 -170.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -51.84 -40.32 60.33 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.638 1.175 . . . . 0.0 112.582 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.44 28.86 9.9 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.333 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.49 -153.46 49.22 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.995 0.331 . . . . 0.0 112.785 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 m -83.79 112.76 20.39 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.588 0.755 . . . . 0.0 110.337 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 21.2 m-70 -104.78 179.31 4.31 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.046 0.939 . . . . 0.0 109.538 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' NE2' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -130.66 129.5 42.72 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.437 ' HG ' HG13 ' A' ' 33' ' ' ILE . 5.5 mp -99.98 118.21 35.91 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.48 1.112 . . . . 0.0 109.906 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.464 ' NE2' HD12 ' A' ' 13' ' ' LEU . 80.8 mm-40 -94.4 156.88 16.28 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.468 0.707 . . . . 0.0 109.199 171.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.16 81.72 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.536 -0.591 . . . . 0.0 114.409 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.89 118.57 12.9 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 110.072 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.4 m -114.01 172.99 6.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.197 0.999 . . . . 0.0 109.602 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.2 p -59.09 -35.22 73.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.832 0.853 . . . . 0.0 112.728 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -95.64 3.45 53.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.505 0.722 . . . . 0.0 112.636 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 25' ' ' GLU . 45.2 m -55.21 113.15 1.27 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.586 0.708 . . . . 0.0 111.495 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.56 172.18 11.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.177 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 54' ' ' LEU . 8.8 tt -59.15 -48.0 83.23 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.677 0.791 . . . . 0.0 110.536 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -25.15 67.37 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.998 0.519 . . . . 0.0 112.366 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 21' ' ' THR . 64.2 mm-40 -78.73 -53.05 7.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.572 0.749 . . . . 0.0 109.875 175.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.06 -55.35 29.98 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.47 1.508 . . . . 0.0 111.236 -173.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 15.1 mm100 -57.78 -34.22 69.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.358 1.063 . . . . 0.0 111.967 177.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.73 -34.26 77.61 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.969 0.793 . . . . 0.0 111.678 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -76.52 -39.31 53.35 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 123.195 0.598 . . . . 0.0 110.408 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -56.82 -44.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.403 0.681 . . . . 0.0 110.7 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.21 -24.16 67.57 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.586 0.754 . . . . 0.0 111.843 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.65 -28.42 19.49 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.79 0.836 . . . . 0.0 112.135 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.437 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.9 mm -91.66 -51.19 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.139 0.976 . . . . 0.0 111.782 -171.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.541 HG23 HG12 ' A' ' 36' ' ' ILE . 15.0 t -115.91 -5.88 12.03 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.344 0.658 . . . . 0.0 111.28 -178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.51 -10.32 74.35 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 168.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.541 HG12 HG23 ' A' ' 34' ' ' THR . 4.1 mm -82.4 118.5 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 117.953 0.876 . . . . 0.0 109.778 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.82 149.01 96.84 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.05 0.94 . . . . 0.0 111.3 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 11.7 Cg_endo -50.53 -41.01 54.14 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 124.198 3.265 . . . . 0.0 113.854 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.25 27.53 5.59 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.179 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.7 m -146.6 12.99 1.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.616 1.166 . . . . 0.0 109.033 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -155.7 151.05 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.188 0.518 . . . . 0.0 110.402 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -125.96 174.48 8.38 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.491 1.116 . . . . 0.0 108.143 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.514 HG12 HD21 ' A' ' 54' ' ' LEU . 47.3 mm -106.72 114.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.7 mm? -119.5 166.42 13.13 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 47' ' ' TYR . 4.0 m -129.35 161.26 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.374 0.67 . . . . 0.0 110.462 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -43.57 96.16 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.616 0.573 . . . . 0.0 113.035 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.48 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 32.8 p90 -72.77 163.25 69.58 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.161 167.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 14.6 Cg_endo -52.61 114.61 1.76 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.904 2.403 . . . . 0.0 114.071 -173.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 9.7 Cg_endo -88.68 178.66 2.75 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.366 2.71 . . . . 0.0 110.919 170.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.08 19.94 6.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.789 0.835 . . . . 0.0 109.601 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.4 m 57.04 82.37 0.12 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.591 1.157 . . . . 0.0 109.602 -164.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 43' ' ' ILE . 95.3 mt -53.11 131.11 36.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.593 0.757 . . . . 0.0 111.34 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -82.73 106.17 14.35 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.792 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.514 HD21 HG12 ' A' ' 43' ' ' ILE . 7.2 mp -105.35 80.49 1.59 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.816 0.846 . . . . 0.0 109.097 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 p -102.71 -34.42 9.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.779 0.831 . . . . 0.0 110.945 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' O ' HD13 ' A' ' 23' ' ' LEU . 8.8 t70 -82.61 -175.52 5.8 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.483 0.713 . . . . 0.0 109.95 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -31.1 1.48 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.621 0.768 . . . . 0.0 110.795 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.35 -19.58 42.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.876 0.87 . . . . 0.0 110.913 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.96 123.38 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 124.163 0.985 . . . . 0.0 111.109 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -96.54 -179.36 4.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -166.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.9 mt -68.92 -15.41 63.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.901 0.88 . . . . 0.0 111.838 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.6 -17.8 73.2 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.462 -0.336 . . . . 0.0 112.393 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.76 -63.06 1.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.924 0.89 . . . . 0.0 109.616 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.09 116.68 46.81 Favored Pre-proline 0 N--CA 1.486 1.345 0 CA-C-O 117.646 -1.168 . . . . 0.0 107.999 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -55.64 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.995 3.13 . . . . 0.0 115.055 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.464 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -110.4 121.66 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 166.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 37.8 mt-30 -119.53 166.22 13.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.287 0.635 . . . . 0.0 109.668 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.6 m -63.74 95.92 0.12 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.819 0.848 . . . . 0.0 110.925 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.93 29.41 23.31 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.436 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 23.6 t70 -87.79 160.47 18.02 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.148 0.579 . . . . 0.0 109.893 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.7 tpt -96.9 100.98 12.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 110.261 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.1 mm? -104.94 112.79 26.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.671 0.788 . . . . 0.0 109.429 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -81.78 114.47 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.76 115.91 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 108.467 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.9 179.89 6.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 110.665 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -131.94 106.57 8.13 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.64 -13.49 62.13 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.737 1.215 . . . . 0.0 110.9 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 66.44 36.42 5.14 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.642 1.177 . . . . 0.0 111.896 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 m -88.83 41.08 1.0 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.759 0.824 . . . . 0.0 110.139 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 53.47 77.7 0.43 Allowed Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 125.023 1.329 . . . . 0.0 110.394 -169.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.61 -176.43 0.42 Allowed 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.153 2.569 . . . . 0.0 113.618 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.495 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . 7.9 mmpt? 75.9 -24.6 0.22 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.263 1.425 . . . . 0.0 113.524 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.39 83.85 1.08 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 167.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.2 t -123.89 107.83 30.79 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.334 -168.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.52 141.65 38.77 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.354 2.036 . . . . 0.0 111.156 165.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.25 1.114 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.459 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.9 m0 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.675 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 78.3 mtm180 -80.35 69.93 6.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.151 0.98 . . . . 0.0 109.564 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.487 ' HB ' HD12 ' A' ' 17' ' ' LEU . 96.3 t -79.21 132.95 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.739 0.816 . . . . 0.0 111.142 -171.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.4 ' CB ' ' HE3' ' A' ' 71' ' ' MET . 99.0 mtt180 -84.03 140.82 31.6 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.452 0.701 . . . . 0.0 109.958 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 4.0 t -125.37 96.98 5.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.045 0.938 . . . . 0.0 110.255 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.1 102.67 9.48 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.67 122.74 35.81 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp 66.27 17.62 10.75 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.854 1.262 . . . . 0.0 112.209 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.98 -8.76 79.36 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 112.955 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.78 119.88 6.64 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -79.97 136.05 36.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.749 0.42 . . . . 0.0 110.247 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 79.7 m-70 -118.82 178.06 4.62 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.491 1.116 . . . . 0.0 108.42 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 2' ' ' ARG . 1.3 tm? -146.31 114.18 6.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.6 mp -104.97 105.87 16.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.75 1.22 . . . . 0.0 109.224 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.675 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 78.2 mt-30 -84.17 -17.76 38.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.337 0.655 . . . . 0.0 111.067 172.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.62 24.64 4.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD12 ' HB ' ' A' ' 3' ' ' VAL . 87.0 mt -110.33 123.95 50.78 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.728 0.811 . . . . 0.0 109.486 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 61' ' ' LEU . 25.9 m -113.67 171.43 7.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.546 1.138 . . . . 0.0 108.97 172.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -57.84 -41.66 82.8 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.002 0.429 . . . . 0.0 112.128 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -92.19 17.05 10.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.654 0.782 . . . . 0.0 112.076 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -68.19 122.41 18.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.212 0.605 . . . . 0.0 110.119 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -78.57 177.15 8.8 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.824 0.45 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 56' ' ' ASP . 7.3 tt -55.08 -50.82 68.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.148 0.979 . . . . 0.0 110.537 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -61.38 -30.36 70.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.421 -173.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -80.55 -46.66 15.41 Favored 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 122.588 0.355 . . . . 0.0 110.389 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.76 -68.31 0.35 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.92 0.888 . . . . 0.0 110.594 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -66.87 -20.65 65.96 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.07 0.548 . . . . 0.0 111.519 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.13 -38.14 59.48 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.885 0.741 . . . . 0.0 112.328 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -74.05 -39.55 63.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.127 0.571 . . . . 0.0 109.6 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.8 mt -57.46 -40.64 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.558 0.743 . . . . 0.0 110.669 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.83 -24.39 67.74 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.055 0.942 . . . . 0.0 111.844 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.51 -32.35 15.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.858 0.863 . . . . 0.0 111.786 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.6 mm -79.94 -65.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.395 1.078 . . . . 0.0 110.283 -174.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.471 HG23 HG12 ' A' ' 36' ' ' ILE . 10.1 t -99.45 -15.93 18.54 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.407 0.683 . . . . 0.0 111.3 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.32 82.97 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.202 -0.777 . . . . 0.0 114.338 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 34' ' ' THR . 13.7 mm -78.76 119.56 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.169 0.984 . . . . 0.0 108.348 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.11 142.52 85.64 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 124.235 0.96 . . . . 0.0 111.24 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.73 -27.67 72.09 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.406 2.737 . . . . 0.0 113.256 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.42 27.04 14.8 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.119 0.39 . . . . 0.0 112.589 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.6 m -142.14 7.66 1.81 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.482 1.113 . . . . 0.0 109.698 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -148.71 149.16 30.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.946 0.898 . . . . 0.0 109.983 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.23 -175.31 3.53 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.312 1.045 . . . . 0.0 108.973 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.542 HG21 ' HD2' ' A' ' 65' ' ' PRO . 49.2 mm -104.49 109.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.27 0.628 . . . . 0.0 109.616 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 34.8 mt -122.04 151.79 40.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 49' ' ' PRO . 17.1 m -132.39 173.72 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.48 0.712 . . . . 0.0 110.907 -174.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.4 -49.01 66.32 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.874 0.734 . . . . 0.0 113.835 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -79.47 158.11 74.18 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.644 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -46.24 104.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.485 2.79 . . . . 0.0 114.624 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HB3' HG22 ' A' ' 45' ' ' VAL . 98.6 Cg_endo -82.81 156.88 15.77 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.886 2.391 . . . . 0.0 112.808 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -75.75 -22.52 56.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.6 0.76 . . . . 0.0 112.147 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.2 m 65.92 35.93 6.25 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.369 1.068 . . . . 0.0 109.014 -171.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.3 pt? -39.59 140.93 0.44 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.922 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.31 106.74 16.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.463 0.705 . . . . 0.0 110.209 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 23' ' ' LEU . 8.5 mp -86.05 96.79 9.98 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.514 0.726 . . . . 0.0 109.429 175.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -109.1 -39.73 5.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.87 0.868 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' O ' HD13 ' A' ' 23' ' ' LEU . 20.3 t0 -75.63 145.24 41.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.389 0.676 . . . . 0.0 110.693 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.57 -20.67 15.58 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.093 0.957 . . . . 0.0 110.551 -177.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.45 -19.52 49.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.326 1.05 . . . . 0.0 111.251 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 tt -57.71 126.13 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.667 0.787 . . . . 0.0 111.46 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -106.34 175.9 5.34 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.095 0.958 . . . . 0.0 111.104 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 21.1 mt -74.1 -1.07 18.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.8 0.84 . . . . 0.0 111.473 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.92 -39.04 64.65 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.818 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.54 -48.53 6.81 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 96.1 mt -59.77 139.23 90.07 Favored Pre-proline 0 CA--C 1.558 1.266 0 O-C-N 123.871 0.732 . . . . 0.0 110.36 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HD2' HG21 ' A' ' 43' ' ' ILE . 6.3 Cg_exo -79.2 45.1 1.84 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.436 2.757 . . . . 0.0 113.385 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.499 ' HA ' HD21 ' A' ' 72' ' ' LEU . 2.1 mp -93.41 119.5 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 171.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 36.2 mm-40 -116.47 166.79 11.68 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.027 0.531 . . . . 0.0 109.573 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 p -64.59 109.92 2.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.29 0.636 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 78.57 10.15 86.44 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.11 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.1 t70 -76.65 159.18 30.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.24 0.616 . . . . 0.0 111.353 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.4 ' HE3' ' CB ' ' A' ' 4' ' ' ARG . 2.9 tpt -86.08 101.88 13.35 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.454 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 66' ' ' ILE . 4.6 mm? -102.04 113.18 26.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.267 1.027 . . . . 0.0 108.883 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.9 mp -88.48 99.89 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.67 105.77 5.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.844 170.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.4 149.85 36.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.366 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 78' ' ' GLN . 34.7 tt0 -110.2 105.02 13.93 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.36 -5.47 47.34 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 123.66 0.784 . . . . 0.0 110.349 172.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 76' ' ' GLU . 55.3 mt-30 67.94 -86.61 0.03 OUTLIER 'General case' 0 C--N 1.362 1.139 0 C-N-CA 126.073 1.749 . . . . 0.0 108.804 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.419 HG23 ' HD3' ' A' ' 81' ' ' PRO . 10.1 t 38.58 -67.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 127.883 2.473 . . . . 0.0 115.524 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 69.8 76.42 0.24 Allowed Pre-proline 0 C--N 1.35 0.621 0 C-N-CA 125.757 1.623 . . . . 0.0 110.699 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD3' HG23 ' A' ' 79' ' ' THR . 45.4 Cg_endo -83.03 -153.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.102 2.535 . . . . 0.0 110.898 175.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -61.07 -33.73 73.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 122.839 0.456 . . . . 0.0 111.246 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 69.64 -72.88 0.1 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.516 1.526 . . . . 0.0 111.342 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -91.81 113.54 59.16 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.186 0.994 . . . . 0.0 108.81 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.26 -8.28 14.0 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.592 2.194 . . . . 0.0 112.071 172.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.8 p . . . . . 0 CA--C 1.553 1.078 0 C-N-CA 124.532 1.133 . . . . 0.0 110.565 179.252 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 9.0 m0 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.462 ' HB3' HD11 ' A' ' 13' ' ' LEU . 54.2 mtt180 -87.22 74.11 9.6 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG11 HG23 ' A' ' 66' ' ' ILE . 34.7 t -87.21 138.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.672 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -89.54 158.2 17.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.573 0.749 . . . . 0.0 110.519 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 28.1 p -142.97 114.57 8.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.214 0.606 . . . . 0.0 109.627 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -79.02 109.61 13.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.95 103.21 4.74 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 122.977 0.511 . . . . 0.0 110.313 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 76' ' ' GLU . 31.0 mmmt 61.47 29.61 18.49 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.717 1.207 . . . . 0.0 111.511 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.39 -27.74 8.24 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.679 -174.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.18 100.25 0.63 Allowed Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -82.92 92.28 7.29 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 32.4 m80 -94.59 160.73 14.5 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.1 -174.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.462 HD11 ' HB3' ' A' ' 2' ' ' ARG . 2.7 tm? -119.14 115.3 23.96 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.556 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -98.79 132.45 44.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 109.207 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.46 173.03 12.02 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.05 12.47 76.64 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 1' ' ' TRP . 98.5 mt -83.54 115.38 22.07 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.369 0.668 . . . . 0.0 109.491 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.3 t -79.23 173.75 12.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.484 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.1 p -64.09 -35.62 81.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.996 0.427 . . . . 0.0 110.595 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -104.72 33.46 3.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.07 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.446 HG21 HD22 ' A' ' 17' ' ' LEU . 74.6 m -69.26 113.01 6.21 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 171.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -77.52 178.28 7.37 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.349 1.059 . . . . 0.0 111.234 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 54' ' ' LEU . 8.4 tt -57.16 -54.9 41.55 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.436 0.695 . . . . 0.0 110.228 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -14.43 63.04 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.231 -174.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.36 -49.41 8.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.611 0.764 . . . . 0.0 109.24 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 43' ' ' ILE . 2.4 tm? -75.51 -64.55 1.05 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.668 1.187 . . . . 0.0 110.464 -170.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.8 -20.17 64.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.23 0.612 . . . . 0.0 111.083 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.24 -43.76 88.08 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 124.011 0.82 . . . . 0.0 111.902 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.75 -36.24 67.66 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 119.509 -0.282 . . . . 0.0 110.268 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.92 -44.47 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.268 0.627 . . . . 0.0 110.343 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.74 66.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.167 0.987 . . . . 0.0 112.116 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.57 -40.01 12.9 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.317 0.647 . . . . 0.0 111.605 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.556 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.8 mm -69.13 -65.97 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.227 1.011 . . . . 0.0 110.629 -173.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.424 HG23 HG12 ' A' ' 36' ' ' ILE . 5.0 t -99.85 -11.87 20.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.291 -175.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.07 86.1 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.499 -0.612 . . . . 0.0 114.122 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.424 HG12 HG23 ' A' ' 34' ' ' THR . 13.3 mm -83.37 118.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.52 146.44 73.04 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.798 0.839 . . . . 0.0 111.474 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.43 -30.86 92.75 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.165 2.577 . . . . 0.0 112.419 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.64 32.55 5.24 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.531 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -141.86 2.12 1.53 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 110.163 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -148.96 163.63 36.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.897 0.879 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 176.03 10.64 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.393 0.677 . . . . 0.0 110.042 173.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.406 HD11 HD11 ' A' ' 26' ' ' LEU . 44.7 mm -84.05 113.8 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 17.7 mt -132.43 123.63 27.06 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 16.3 m -102.78 173.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.975 0.51 . . . . 0.0 112.197 -169.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -46.42 93.78 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 124.353 1.033 . . . . 0.0 114.235 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -79.34 158.3 74.25 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 117.959 -1.019 . . . . 0.0 108.912 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.95 107.1 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.403 2.736 . . . . 0.0 113.628 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 63.1 Cg_endo -77.31 155.86 32.8 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.509 2.139 . . . . 0.0 112.179 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -94.78 34.33 1.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.646 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 62.8 m 75.66 -54.3 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.773 1.629 . . . . 0.0 110.726 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.5 mt 68.01 90.96 0.09 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.869 1.267 . . . . 0.0 110.682 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.22 101.14 13.86 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.801 0.84 . . . . 0.0 110.252 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.662 ' HB3' HD12 ' A' ' 23' ' ' LEU . 6.1 mp -78.05 99.41 6.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -124.87 39.24 4.02 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.186 0.594 . . . . 0.0 111.009 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 59' ' ' ILE . 28.1 t70 -163.59 146.01 9.73 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.591 0.756 . . . . 0.0 109.856 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -76.66 -31.66 57.46 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.953 0.501 . . . . 0.0 111.394 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.65 -3.92 54.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.717 0.807 . . . . 0.0 112.286 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 56' ' ' ASP . 10.7 tt -64.08 123.62 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.108 0.48 . . . . 0.0 110.485 -176.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.7 p -101.89 176.62 5.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -166.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 mt -69.23 -12.19 61.46 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.621 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.97 -22.0 69.77 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.77 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.49 -53.07 3.88 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.84 150.47 92.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.57 43.53 1.51 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.98 2.453 . . . . 0.0 114.661 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.569 HG13 HD21 ' A' ' 72' ' ' LEU . 2.6 mp -73.0 119.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 38.1 mt-30 -118.64 157.24 27.79 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 p -64.02 103.67 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.435 0.694 . . . . 0.0 111.442 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.41 21.97 57.42 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.967 -0.561 . . . . 0.0 113.402 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 9.8 t70 -79.76 160.9 26.02 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.856 0.463 . . . . 0.0 110.294 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 tpt -91.16 98.79 11.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.714 0.805 . . . . 0.0 109.56 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.569 HD21 HG13 ' A' ' 66' ' ' ILE . 6.7 mp -93.83 104.71 16.77 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.8 mp -72.12 90.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -84.24 95.63 4.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.686 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -77.99 153.23 32.61 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.174 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . 40.6 tt0 -104.96 99.25 8.87 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -72.28 -12.79 61.31 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.89 0.876 . . . . 0.0 109.846 171.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 69.9 -80.26 0.04 OUTLIER 'General case' 0 C--N 1.364 1.201 0 C-N-CA 126.243 1.817 . . . . 0.0 109.736 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t 38.55 -62.84 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 128.301 2.641 . . . . 0.0 116.874 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 83.97 80.68 0.07 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 127.055 2.142 . . . . 0.0 108.809 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -88.97 159.9 5.93 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.875 2.384 . . . . 0.0 112.426 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -98.24 100.78 12.1 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.46 135.3 47.11 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.067 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -76.27 134.55 70.38 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.479 0.712 . . . . 0.0 109.732 173.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.48 -41.55 76.91 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.4 2.733 . . . . 0.0 112.978 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.556 1.2 0 C-N-CA 123.47 0.708 . . . . 0.0 109.679 -179.823 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 16.3 m0 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.585 0.231 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.52 ' HB3' HD21 ' A' ' 13' ' ' LEU . 75.4 mtt180 -108.47 71.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.067 0.947 . . . . 0.0 108.684 173.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 66' ' ' ILE . 71.7 t -79.09 123.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.642 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.435 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 66.0 mtt180 -81.79 141.49 33.44 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 14' ' ' LEU . 92.3 m -135.54 105.67 6.3 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.715 0.406 . . . . 0.0 111.19 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -79.84 98.41 7.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.18 96.81 7.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 109.981 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt 70.39 -75.45 0.07 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.953 1.301 . . . . 0.0 111.312 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.33 25.42 1.24 Allowed Glycine 0 C--N 1.346 1.101 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.58 105.35 0.57 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -76.98 118.58 19.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.131 0.573 . . . . 0.0 109.78 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -109.69 176.25 5.14 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.777 0.831 . . . . 0.0 109.76 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 2' ' ' ARG . 10.4 tt -151.19 116.06 5.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.614 ' HG ' HG13 ' A' ' 33' ' ' ILE . 7.3 mp -90.63 131.02 36.58 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.811 1.244 . . . . 0.0 109.607 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -92.09 164.44 13.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.578 0.751 . . . . 0.0 110.571 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.97 -97.19 1.62 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-O 118.833 -0.982 . . . . 0.0 111.225 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 61' ' ' LEU . 4.1 mm? 42.16 104.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.567 1.547 . . . . 0.0 113.217 -175.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.9 t -73.18 154.2 40.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -62.71 -21.97 66.16 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 121.222 0.534 . . . . 0.0 110.674 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 74.1 mtt180 -110.01 29.99 7.13 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.289 1.036 . . . . 0.0 111.522 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.8 m -66.57 112.0 3.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -65.79 163.43 16.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.307 1.043 . . . . 0.0 110.969 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.433 HD13 HD23 ' A' ' 54' ' ' LEU . 23.5 tp -53.55 -52.2 60.45 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.07 0.948 . . . . 0.0 111.697 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 ptt85 -60.02 -24.1 64.23 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.159 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.26 -38.02 14.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.533 0.733 . . . . 0.0 110.058 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -66.09 0.64 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.534 1.134 . . . . 0.0 110.091 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.81 -17.41 64.51 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.458 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.47 -37.26 85.37 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.687 0.617 . . . . 0.0 112.076 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -75.63 -40.45 56.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.243 0.617 . . . . 0.0 110.419 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.438 ' HB ' HE22 ' A' ' 41' ' ' GLN . 82.1 mt -61.78 -35.83 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.537 0.735 . . . . 0.0 110.926 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -24.99 66.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.128 0.971 . . . . 0.0 112.009 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.01 -42.83 9.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.976 0.911 . . . . 0.0 111.161 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.614 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.1 mm -66.11 -50.69 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 112.011 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.559 HG23 HG12 ' A' ' 36' ' ' ILE . 7.2 t -124.04 -1.32 8.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.122 0.569 . . . . 0.0 111.377 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 -0.23 89.56 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 34' ' ' THR . 11.4 mm -82.54 103.78 10.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.76 152.53 67.95 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.951 0.9 . . . . 0.0 111.426 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.84 -38.51 57.6 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.76 2.974 . . . . 0.0 114.547 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.25 30.45 5.95 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.44 -0.346 . . . . 0.0 113.325 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -132.42 -3.47 3.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.063 0.945 . . . . 0.0 110.09 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.438 HE22 ' HB ' ' A' ' 30' ' ' ILE . 1.5 pt20 -140.19 163.75 31.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.594 0.758 . . . . 0.0 111.376 -171.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -147.97 170.94 16.62 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.767 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 72' ' ' LEU . 49.2 mm -96.61 110.24 24.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.443 -175.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 mt -123.8 159.18 30.09 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.718 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' ' HG3' ' A' ' 49' ' ' PRO . 5.2 m -141.11 -179.21 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.216 1.007 . . . . 0.0 110.27 -171.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.36 -46.15 65.31 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.934 0.771 . . . . 0.0 113.205 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -74.87 162.15 74.69 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.404 171.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 12.6 Cg_endo -53.17 108.63 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.941 2.427 . . . . 0.0 111.867 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 2.8 Cg_exo -74.25 172.81 15.29 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.186 2.591 . . . . 0.0 111.979 -174.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.25 -2.12 57.7 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.495 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.6 m 51.28 65.13 1.58 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 124.119 0.968 . . . . 0.0 109.11 -172.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 mp -67.32 134.04 50.8 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.792 -165.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.35 88.19 5.04 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.433 HD23 HD13 ' A' ' 23' ' ' LEU . 5.5 mp -77.43 88.3 3.8 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 p -97.11 -49.16 5.1 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.999 0.92 . . . . 0.0 110.867 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 59' ' ' ILE . 21.6 t70 -73.39 123.63 24.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.999 0.92 . . . . 0.0 110.255 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.56 -20.49 59.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.997 0.519 . . . . 0.0 112.31 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -89.67 -8.24 52.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.968 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 56' ' ' ASP . 14.7 tt -64.11 123.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 121.404 0.621 . . . . 0.0 110.32 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.456 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 64.8 p -97.34 175.19 6.35 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.469 -170.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.565 HD11 HD12 ' A' ' 17' ' ' LEU . 23.4 mt -69.76 -13.81 62.47 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.55 173.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.15 -29.45 72.9 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.736 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -93.88 -60.75 1.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.55 143.36 86.33 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.715 1.206 . . . . 0.0 111.238 -174.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.13 39.65 0.84 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.552 2.834 . . . . 0.0 114.429 -173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.512 HG13 ' HG ' ' A' ' 72' ' ' LEU . 3.1 mp -87.26 120.56 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 172.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 24.1 mm-40 -119.97 159.28 25.01 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.821 0.848 . . . . 0.0 110.213 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.6 p -68.23 112.05 4.91 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.509 0.723 . . . . 0.0 110.853 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.99 12.82 82.17 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.639 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 20.2 t70 -86.17 160.52 19.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.697 0.799 . . . . 0.0 109.798 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.435 ' HE3' ' HB3' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -95.77 97.59 9.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.017 0.927 . . . . 0.0 110.355 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.512 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.1 mm? -96.55 113.58 25.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.521 0.728 . . . . 0.0 109.622 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.2 mp -78.76 103.2 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.3 t -82.29 104.52 11.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.344 171.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.69 159.71 28.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.294 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 78' ' ' GLN . 38.5 tt0 -124.49 124.84 43.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.17 -23.62 57.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.488 0.715 . . . . 0.0 111.174 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.498 ' H ' ' HG2' ' A' ' 76' ' ' GLU . 76.9 mt-30 68.41 30.79 5.25 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.968 1.307 . . . . 0.0 110.583 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.6 t -68.27 -10.39 54.34 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.858 0.863 . . . . 0.0 111.945 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 61.32 72.25 0.7 Allowed Pre-proline 0 C--N 1.362 1.138 0 C-N-CA 124.336 1.054 . . . . 0.0 108.499 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.88 135.05 49.71 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.389 2.726 . . . . 0.0 114.525 -166.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -65.5 -33.26 75.52 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.437 169.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.81 78.3 0.87 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.25 1.02 . . . . 0.0 109.697 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 41.1 m -95.1 -175.42 0.47 Allowed Pre-proline 0 CA--C 1.563 1.466 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.833 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 84' ' ' SER . 17.7 Cg_exo -40.15 101.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.85 0 C-N-CA 122.939 2.426 . . . . 0.0 113.34 166.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.251 1.182 0 C-N-CA 123.981 0.913 . . . . 0.0 109.253 -173.277 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.425 ' HB3' HG23 ' A' ' 3' ' ' VAL . 13.2 m0 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.488 ' HG3' HD11 ' A' ' 13' ' ' LEU . 11.0 mpt_? -79.75 67.37 5.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.704 0.802 . . . . 0.0 109.742 173.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 1' ' ' TRP . 72.1 t -77.39 119.95 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.75 0.42 . . . . 0.0 109.875 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -93.99 128.38 40.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 95.8 m -117.79 111.3 18.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.372 0.669 . . . . 0.0 110.402 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 13.9 tppt? -75.41 127.45 33.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.718 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.04 -174.26 4.65 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 0.0 109.785 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 36.3 mtmt -67.21 127.43 32.59 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.77 -5.67 43.5 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -170.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -160.76 14.0 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.211 0.434 . . . . 0.0 112.603 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.9 m -94.73 118.84 32.37 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.423 0.689 . . . . 0.0 109.751 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -92.51 142.6 27.23 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.858 0.863 . . . . 0.0 108.805 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.488 HD11 ' HG3' ' A' ' 2' ' ' ARG . 2.7 tm? -103.3 105.21 15.43 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' HG ' HG13 ' A' ' 33' ' ' ILE . 8.2 mp -86.93 139.03 31.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.339 0.655 . . . . 0.0 110.918 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.31 164.2 16.02 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.867 1.267 . . . . 0.0 109.675 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.89 79.53 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.321 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 61' ' ' LEU . 3.6 mm? -82.61 108.32 15.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.466 ' O ' HD12 ' A' ' 61' ' ' LEU . 44.4 t -84.7 170.03 13.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.852 168.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -69.1 -22.59 63.97 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.162 0.506 . . . . 0.0 111.054 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -111.6 23.26 14.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.293 1.037 . . . . 0.0 111.75 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.7 m -63.34 108.35 1.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -69.99 172.07 8.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.096 0.958 . . . . 0.0 111.689 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.6 tp -50.64 -55.82 14.66 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.276 1.031 . . . . 0.0 111.574 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.1 ptm180 -49.51 -37.47 26.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.612 1.165 . . . . 0.0 113.353 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 10.8 mm-40 -85.81 -35.97 20.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.288 0.635 . . . . 0.0 110.962 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.66 -66.07 0.79 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.065 0.946 . . . . 0.0 109.033 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -67.46 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.272 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.96 89.58 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.032 0.833 . . . . 0.0 111.959 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -72.95 -45.06 60.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.32 -39.49 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.44 0.696 . . . . 0.0 111.116 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.49 67.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.65 0.78 . . . . 0.0 111.678 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.3 14.83 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.545 0.738 . . . . 0.0 111.351 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.535 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.2 mm -76.46 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.342 1.057 . . . . 0.0 110.914 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.519 HG23 HG12 ' A' ' 36' ' ' ILE . 7.5 t -102.09 -9.96 20.1 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 0.0 111.019 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.65 69.76 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 119.783 -0.454 . . . . 0.0 114.034 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG12 HG23 ' A' ' 34' ' ' THR . 21.2 mm -90.44 127.73 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.67 138.83 61.41 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.782 0.833 . . . . 0.0 110.676 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 -39.31 83.77 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.559 2.839 . . . . 0.0 113.342 -174.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' HA3' ' HG2' ' A' ' 81' ' ' PRO . . . -89.78 22.08 26.75 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.737 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -124.83 -5.14 7.51 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.234 1.014 . . . . 0.0 109.902 174.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.568 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -130.23 143.77 50.97 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 124.201 1.0 . . . . 0.0 109.236 -179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -135.05 179.12 6.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.728 0.811 . . . . 0.0 109.341 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 66' ' ' ILE . 45.9 mm -94.47 92.46 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 121.995 0.903 . . . . 0.0 109.077 -174.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.4 mt -110.09 149.33 30.2 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 65' ' ' PRO . 9.4 m -134.02 179.73 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.113 0.565 . . . . 0.0 111.371 -167.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.02 11.01 8.27 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.333 -0.848 . . . . 0.0 114.736 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -144.33 160.72 47.59 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.162 1.385 . . . . 0.0 108.042 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -39.55 109.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.713 2.942 . . . . 0.0 113.99 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -80.68 -171.93 1.38 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.368 2.712 . . . . 0.0 112.172 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -122.73 15.23 10.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.65 0.78 . . . . 0.0 110.735 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.5 m 55.5 73.26 0.43 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.042 0.937 . . . . 0.0 109.474 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.71 108.87 8.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.886 -171.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -97.42 126.65 42.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.297 1.039 . . . . 0.0 108.205 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 mp -100.24 78.98 2.1 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 m -75.05 -28.51 60.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.294 0.638 . . . . 0.0 110.796 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.65 152.65 31.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.453 0.471 . . . . 0.0 109.773 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -103.46 -29.21 11.32 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.444 0.698 . . . . 0.0 111.641 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -89.62 -11.82 41.49 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.494 0.718 . . . . 0.0 110.753 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.62 134.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 111.695 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.0 p -117.48 179.07 4.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 111.39 -169.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.581 HD11 HD12 ' A' ' 17' ' ' LEU . 40.3 mt -68.49 -13.44 62.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.634 0.774 . . . . 0.0 111.572 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.17 80.03 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.336 0.398 . . . . 0.0 112.396 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -84.74 -55.86 3.88 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.126 0.57 . . . . 0.0 109.534 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.24 152.0 92.33 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.434 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.545 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.2 Cg_exo -69.09 21.65 0.15 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.811 3.007 . . . . 0.0 115.488 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 43' ' ' ILE . 3.2 mp -73.92 116.62 16.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 172.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -118.75 173.92 6.58 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -71.16 101.67 2.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.16 0.584 . . . . 0.0 109.943 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 89.03 20.42 46.44 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.176 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.33 162.28 25.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.037 0.535 . . . . 0.0 111.007 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.409 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 3.6 tpt -102.85 104.73 15.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.947 0.899 . . . . 0.0 109.696 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.417 HD23 HG13 ' A' ' 3' ' ' VAL . 3.7 mm? -105.13 112.16 25.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.044 0.937 . . . . 0.0 108.992 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.82 97.88 4.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.24 104.98 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.155 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.568 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 8.0 pt-20 -76.44 167.55 21.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.854 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.27 103.99 5.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.22 -15.87 56.03 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.391 0.676 . . . . 0.0 110.507 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 63.31 27.99 15.55 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.295 1.438 . . . . 0.0 111.376 -173.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -63.45 -38.88 92.83 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.477 0.711 . . . . 0.0 110.567 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 38.91 68.31 1.98 Allowed Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 126.02 1.728 . . . . 0.0 113.981 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HG2' ' HA3' ' A' ' 39' ' ' GLY . 2.5 Cg_endo -83.85 130.19 4.95 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.929 2.419 . . . . 0.0 110.754 172.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -94.37 41.35 1.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.76 0.824 . . . . 0.0 110.917 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.45 99.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.873 173.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.4 p -144.0 86.89 8.24 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.244 1.018 . . . . 0.0 108.587 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.31 -60.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.831 2.354 . . . . 0.0 111.578 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.612 1.165 . . . . 0.0 108.616 177.488 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.457 ' HB3' HG23 ' A' ' 3' ' ' VAL . 14.1 m0 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.433 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 82.1 mtt85 -79.19 69.76 5.45 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.381 0.673 . . . . 0.0 109.513 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 1' ' ' TRP . 89.6 t -83.94 129.64 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.346 0.658 . . . . 0.0 110.084 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -88.59 141.1 28.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.36 0.664 . . . . 0.0 109.209 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 71.1 m -138.33 101.34 4.36 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.332 0.653 . . . . 0.0 110.526 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -73.3 112.56 9.48 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.982 0.913 . . . . 0.0 109.734 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -144.38 123.53 12.92 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.394 0.677 . . . . 0.0 110.23 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 56.41 56.58 5.58 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.05 1.34 . . . . 0.0 112.86 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.1 26.63 73.99 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.576 -0.738 . . . . 0.0 114.41 174.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.58 144.19 10.5 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -93.64 102.1 14.27 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -89.6 115.29 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.772 0.829 . . . . 0.0 109.636 -174.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.85 104.16 14.56 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.809 0.444 . . . . 0.0 110.548 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.63 127.91 34.08 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 111.076 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -113.3 176.22 5.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.781 1.233 . . . . 0.0 110.103 177.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.28 3.45 61.52 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 1' ' ' TRP . 82.5 mt -84.42 129.38 34.87 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 123.804 0.842 . . . . 0.0 111.065 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.458 ' O ' HD12 ' A' ' 61' ' ' LEU . 17.8 m -108.37 -176.56 3.08 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.374 168.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.7 p -66.2 -29.58 69.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.058 0.456 . . . . 0.0 110.69 171.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.98 23.41 8.99 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.88 0.872 . . . . 0.0 112.713 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.3 m -80.51 130.38 35.1 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 82.2 mtm180 -98.83 177.76 5.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.731 0.812 . . . . 0.0 110.384 -174.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 57' ' ' ARG . 5.4 tt -48.16 -59.53 3.33 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.181 1.392 . . . . 0.0 110.717 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.526 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 9.3 ptp180 -61.66 -26.8 68.24 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.637 -173.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 46.9 mt-10 -91.55 -30.04 16.62 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.979 0.912 . . . . 0.0 110.459 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.82 -67.24 0.78 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.749 0.82 . . . . 0.0 109.197 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.4 -16.26 63.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.777 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.45 -39.56 56.48 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.524 0.515 . . . . 0.0 111.929 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -73.83 -35.94 64.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.098 0.559 . . . . 0.0 110.284 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.12 -44.14 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.339 0.656 . . . . 0.0 109.704 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.04 68.07 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.775 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.42 -29.12 23.11 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.61 0.764 . . . . 0.0 111.856 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.1 mt -89.19 -69.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 117.878 0.308 . . . . 0.0 111.069 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.589 HG23 HG12 ' A' ' 36' ' ' ILE . 9.5 t -88.43 -5.48 58.24 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.95 6.55 87.36 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.303 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.589 HG12 HG23 ' A' ' 34' ' ' THR . 11.7 mm -82.61 107.71 14.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.55 145.41 49.6 Favored Pre-proline 0 N--CA 1.48 1.058 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.539 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -54.28 -32.05 69.62 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.474 2.783 . . . . 0.0 113.658 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.86 24.67 19.91 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 116.4 -0.364 . . . . 0.0 113.544 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 m -131.96 4.66 4.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.527 1.131 . . . . 0.0 109.863 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -137.09 149.48 47.4 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.506 1.122 . . . . 0.0 109.347 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -120.19 -166.16 1.27 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.515 HG23 HD12 ' A' ' 72' ' ' LEU . 41.1 mm -123.31 105.7 16.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 4.3 mp -121.14 172.39 8.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.081 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.513 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 2.7 m -139.85 162.02 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 109.869 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.8 87.86 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 124.325 1.016 . . . . 0.0 113.368 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -72.6 155.41 91.03 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 117.756 -1.116 . . . . 0.0 109.597 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -33.61 100.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.397 3.116 0 C-N-CA 124.821 3.681 . . . . 0.0 114.763 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.513 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 99.0 Cg_endo -81.26 158.7 20.08 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.683 2.256 . . . . 0.0 113.421 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 30.5 mm-40 -101.14 90.34 4.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.0 m -47.79 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.636 1.174 . . . . 0.0 111.543 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -99.44 167.53 10.56 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 111.805 179.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.06 144.51 40.07 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.75 93.22 4.78 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -85.47 -47.65 9.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.181 0.592 . . . . 0.0 110.239 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 12.8 t70 -73.25 107.3 5.48 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 -174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.53 -24.58 32.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.93 -7.06 41.08 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.94 0.896 . . . . 0.0 112.272 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 tt -63.39 136.83 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.021 0.528 . . . . 0.0 111.146 -174.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 10.0 m -109.9 168.01 9.74 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.503 0.721 . . . . 0.0 111.601 -164.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 18' ' ' SER . 32.7 mt -59.55 -25.35 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.484 1.114 . . . . 0.0 112.895 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.63 -29.33 74.9 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.422 0.451 . . . . 0.0 112.881 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.57 -45.93 12.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.703 0.801 . . . . 0.0 109.87 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.98 160.04 72.15 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.698 0.799 . . . . 0.0 111.56 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.6 37.32 0.5 Allowed 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.294 2.662 . . . . 0.0 114.403 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 mp -88.28 114.13 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 29.5 mm-40 -118.4 158.48 25.21 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 p -67.46 109.48 3.22 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.506 0.722 . . . . 0.0 111.018 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 88.96 -1.55 83.32 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 21.8 t70 -73.67 159.27 33.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.556 0.742 . . . . 0.0 111.339 -172.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.6 tpt -91.31 102.25 14.96 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.703 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 43' ' ' ILE . 4.0 mm? -100.57 135.81 41.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.489 1.116 . . . . 0.0 108.314 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.9 mp -100.58 113.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 54.7 t -94.08 109.51 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.73 172.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 36' ' ' ILE . 10.1 pt-20 -83.01 159.66 22.14 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 175.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -117.39 119.0 33.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -92.44 -26.1 18.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.974 0.51 . . . . 0.0 110.911 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 69.52 12.61 8.23 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.393 1.477 . . . . 0.0 113.052 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -67.54 -29.29 68.64 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.317 0.247 . . . . 0.0 110.986 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 58.85 76.53 0.45 Allowed Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 124.927 1.291 . . . . 0.0 111.403 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -89.91 148.04 4.79 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.716 2.278 . . . . 0.0 112.688 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.83 109.04 7.03 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.02 143.95 47.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.115 0.966 . . . . 0.0 109.117 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.3 p -91.21 106.01 14.63 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.13 -44.53 1.77 Allowed 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.323 2.015 . . . . 0.0 111.715 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--O 1.25 1.104 0 C-N-CA 124.775 1.23 . . . . 0.0 107.865 177.308 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' TRP . . . . . 0.455 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 33.4 m0 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.54 ' HB3' HD11 ' A' ' 13' ' ' LEU . 71.0 mtm180 -82.85 85.01 7.18 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 69' ' ' GLY . 15.0 t -98.23 146.16 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.766 -175.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HG2' HD23 ' A' ' 13' ' ' LEU . 95.8 mtt180 -88.79 150.84 22.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.592 0.757 . . . . 0.0 110.891 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 27.3 p -125.9 128.17 47.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.467 1.107 . . . . 0.0 108.925 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.2 tppp? -102.3 110.97 23.08 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.019 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.36 171.04 15.07 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -29.47 62.33 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.83 0.452 . . . . 0.0 110.055 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.65 -15.16 61.51 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.728 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.78 163.89 10.53 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 123.685 0.66 . . . . 0.0 111.778 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.5 m -83.08 112.07 19.46 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 74.3 m80 -108.99 162.74 13.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.587 0.755 . . . . 0.0 109.695 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.54 HD11 ' HB3' ' A' ' 2' ' ' ARG . 3.2 tm? -120.92 116.78 25.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.462 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.3 mp -87.74 160.64 17.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.432 0.693 . . . . 0.0 110.98 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -134.91 168.5 18.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.829 1.251 . . . . 0.0 108.273 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.05 82.21 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.014 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 94.3 mt -90.05 118.6 29.72 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.806 0.442 . . . . 0.0 110.072 178.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.6 t -86.4 174.79 8.77 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.478 1.111 . . . . 0.0 109.803 168.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.6 p -69.27 -29.63 67.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.265 0.626 . . . . 0.0 110.576 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 33.72 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.311 0.645 . . . . 0.0 112.285 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HG ' ' A' ' 61' ' ' LEU . 30.6 m -66.89 118.16 9.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -66.76 164.0 18.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.827 0.451 . . . . 0.0 110.763 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.495 HD22 ' HA ' ' A' ' 57' ' ' ARG . 6.0 tt -50.32 -53.58 27.7 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.73 1.212 . . . . 0.0 110.74 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -16.87 63.64 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.374 -173.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -84.3 -45.76 12.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.851 0.86 . . . . 0.0 109.432 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 61' ' ' LEU . 1.6 tm? -69.02 -62.42 1.38 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.156 1.383 . . . . 0.0 110.766 -173.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -63.72 -22.43 66.9 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.753 0.658 . . . . 0.0 111.323 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.89 -38.43 94.25 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 124.015 0.822 . . . . 0.0 112.464 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -73.44 -42.6 61.8 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -61.41 -35.9 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.514 0.726 . . . . 0.0 111.271 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.36 67.42 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.894 0.877 . . . . 0.0 111.587 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.96 -35.97 11.77 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.136 0.974 . . . . 0.0 111.638 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.462 HG13 ' HG ' ' A' ' 14' ' ' LEU . 19.0 mm -76.01 -52.2 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.781 1.232 . . . . 0.0 111.648 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.588 HG23 HG12 ' A' ' 36' ' ' ILE . 7.9 t -115.33 -7.36 12.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.162 0.585 . . . . 0.0 110.717 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 21.36 63.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.57 -0.572 . . . . 0.0 114.073 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.588 HG12 HG23 ' A' ' 34' ' ' THR . 25.1 mm -95.03 124.81 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.679 0.739 . . . . 0.0 109.906 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' HB2' ' HG3' ' A' ' 81' ' ' PRO . . . -58.97 139.08 87.45 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 123.876 0.87 . . . . 0.0 110.813 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.41 -22.07 48.29 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.726 2.951 . . . . 0.0 114.095 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.45 29.95 11.25 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.823 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.5 m -135.53 -35.75 0.8 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.578 1.151 . . . . 0.0 109.054 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -85.9 142.85 28.56 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.935 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -130.99 170.34 14.61 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 125.234 1.414 . . . . 0.0 107.674 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.483 HG21 ' HB3' ' A' ' 64' ' ' LEU . 44.2 mm -95.95 105.5 17.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 122.082 0.944 . . . . 0.0 109.875 -173.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.6 mt -113.95 155.02 26.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 113.477 -1.692 . . . . 0.0 106.648 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.65 164.86 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 122.723 0.409 . . . . 0.0 109.942 -166.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.17 73.65 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 124.026 0.822 . . . . 0.0 114.193 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -74.96 151.99 86.48 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.147 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -39.66 101.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.812 3.008 . . . . 0.0 113.575 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.39 157.58 41.05 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.93 2.42 . . . . 0.0 112.486 -171.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.22 3.01 55.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.077 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.93 71.29 0.52 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.8 1.24 . . . . 0.0 110.642 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.431 HD12 ' HD3' ' A' ' 65' ' ' PRO . 65.4 mt -79.73 124.69 28.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.656 -173.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -90.46 108.03 19.53 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.385 1.074 . . . . 0.0 109.225 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 8.4 mp -79.75 95.08 5.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.662 0.785 . . . . 0.0 109.413 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.8 t -106.77 25.85 10.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.853 0.861 . . . . 0.0 110.116 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -126.05 -157.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.37 1.068 . . . . 0.0 108.749 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -147.95 -31.39 0.29 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.056 0.844 . . . . 0.0 111.293 173.667 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.82 -8.9 42.26 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.609 0.764 . . . . 0.0 111.996 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.64 121.72 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 123.337 0.655 . . . . 0.0 110.843 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -92.84 174.64 7.15 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 66' ' ' ILE . 25.0 mt -71.0 -11.34 60.92 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.692 0.797 . . . . 0.0 111.998 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.38 -27.08 72.11 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.293 0.371 . . . . 0.0 112.202 170.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -87.03 -47.81 8.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.486 0.714 . . . . 0.0 110.134 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.7 mm? -80.57 154.87 73.89 Favored Pre-proline 0 CA--C 1.556 1.19 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.743 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HD3' HD12 ' A' ' 52' ' ' LEU . 70.7 Cg_endo -78.93 40.97 1.0 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.188 2.592 . . . . 0.0 114.747 -176.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 61' ' ' LEU . 2.4 mp -76.77 122.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.8 mt-30 -118.43 156.95 28.11 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.8 p -63.39 110.93 2.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.566 0.746 . . . . 0.0 111.274 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 3' ' ' VAL . . . 70.31 30.86 68.97 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.619 0.574 . . . . 0.0 113.481 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 5.9 t70 -84.69 172.53 11.46 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 tpt -98.75 100.6 11.83 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 66' ' ' ILE . 76.2 mt -91.41 143.19 26.87 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -105.67 102.07 13.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.93 106.12 11.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.01 151.72 37.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.523 0.678 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -122.08 146.81 46.84 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.802 -173.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -118.49 -30.9 5.06 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.004 0.522 . . . . 0.0 110.445 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 64.64 32.68 11.21 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.643 1.177 . . . . 0.0 111.047 -175.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -63.55 -14.64 53.25 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.358 1.063 . . . . 0.0 113.328 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 61.14 76.99 0.38 Allowed Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.526 1.131 . . . . 0.0 110.25 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HG3' ' HB2' ' A' ' 37' ' ' ALA . 94.3 Cg_endo -76.27 179.34 6.46 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.74 2.294 . . . . 0.0 112.406 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -119.18 138.18 53.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.221 1.008 . . . . 0.0 109.281 175.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.5 134.52 39.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.774 0.83 . . . . 0.0 111.05 -174.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.411 ' HA ' ' HD2' ' A' ' 85' ' ' PRO . 17.6 p -129.06 100.7 20.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.263 1.025 . . . . 0.0 108.437 175.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 84' ' ' SER . 12.9 Cg_endo -54.23 -46.53 32.87 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 123.683 2.922 . . . . 0.0 112.948 -177.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.247 0.957 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 174.68 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.4 m0 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 13' ' ' LEU . 48.7 mtm180 -83.86 73.95 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.108 0.963 . . . . 0.0 109.141 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.91 136.17 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.375 0.67 . . . . 0.0 111.503 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -89.09 97.35 11.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.7 0.8 . . . . 0.0 110.17 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 t -81.17 100.05 8.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.778 0.831 . . . . 0.0 110.445 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -74.47 108.99 7.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 123.127 0.571 . . . . 0.0 110.23 -175.407 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 121.196 0.522 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -134.96 123.19 22.98 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 2' ' ' ARG . 1.8 tm? -91.04 102.58 15.34 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -172.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 33' ' ' ILE . 10.3 mp -92.23 107.03 18.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.45 0.7 . . . . 0.0 110.036 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.549 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 76.6 mt-30 -90.2 -177.13 5.06 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.716 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -19.47 22.09 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.329 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.93 114.92 10.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.462 0.705 . . . . 0.0 110.66 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.403 ' O ' HD12 ' A' ' 61' ' ' LEU . 69.0 p -91.96 168.05 11.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.079 0.951 . . . . 0.0 109.163 170.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 p -59.26 -33.81 71.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.979 0.511 . . . . 0.0 111.753 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -101.13 24.67 9.09 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.402 0.681 . . . . 0.0 111.841 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 25' ' ' GLU . 73.1 m -72.33 127.4 32.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 74.3 mtm180 -79.77 169.16 18.35 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.176 0.59 . . . . 0.0 111.247 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 56' ' ' ASP . 7.5 tt -53.53 -54.33 38.83 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.179 1.392 . . . . 0.0 110.989 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 15.7 ptt180 -63.94 -26.04 68.41 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.219 -177.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 14.0 mm-40 -77.08 -43.46 34.23 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.6 -66.79 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.726 1.21 . . . . 0.0 110.615 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.5 -21.29 65.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.314 0.645 . . . . 0.0 111.312 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.98 -41.95 70.16 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.848 0.717 . . . . 0.0 112.368 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 21.3 mt-30 -67.79 -39.69 84.02 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.6 mt -59.67 -39.8 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.652 0.781 . . . . 0.0 111.055 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.2 -24.63 67.74 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 111.788 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.16 -36.07 13.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.336 0.654 . . . . 0.0 111.713 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 HD11 ' A' ' 14' ' ' LEU . 12.6 mm -75.62 -68.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.933 0.893 . . . . 0.0 110.4 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.494 HG23 HG12 ' A' ' 36' ' ' ILE . 3.0 t -96.7 -7.2 34.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 6.85 87.95 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 114.01 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.494 HG12 HG23 ' A' ' 34' ' ' THR . 13.8 mm -84.52 114.57 25.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 144.75 64.36 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.584 0.754 . . . . 0.0 110.722 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -55.14 -21.44 27.87 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.651 2.901 . . . . 0.0 114.382 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.61 -20.2 51.98 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 113.778 0.271 . . . . 0.0 113.778 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.0 m -90.3 -16.5 29.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.18 0.592 . . . . 0.0 111.275 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.86 150.89 27.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.016 0.927 . . . . 0.0 110.568 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -130.17 145.87 51.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.679 1.192 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.596 HG13 HD21 ' A' ' 54' ' ' LEU . 45.6 mm -81.49 95.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.097 0.951 . . . . 0.0 108.872 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.68 139.39 51.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.039 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 5.2 m -113.31 163.15 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.367 0.667 . . . . 0.0 110.21 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.18 -49.07 82.63 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.884 0.74 . . . . 0.0 113.267 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 45' ' ' VAL . 52.3 p90 -69.71 145.46 94.84 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.141 169.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.22 101.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 124.155 3.237 . . . . 0.0 115.592 -170.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 71.8 Cg_endo -76.66 145.58 26.12 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.243 1.962 . . . . 0.0 111.096 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -91.67 15.88 11.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.286 0.635 . . . . 0.0 110.897 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.9 m 59.85 46.54 11.19 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.501 1.12 . . . . 0.0 110.369 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -55.93 130.03 42.07 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.299 -174.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.36 111.07 22.4 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.596 HD21 HG13 ' A' ' 43' ' ' ILE . 7.3 mp -72.7 87.9 1.27 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.279 1.031 . . . . 0.0 108.8 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 p -89.51 26.22 1.77 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.2 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.43 ' O ' HD13 ' A' ' 23' ' ' LEU . 10.3 t70 -145.67 -168.37 2.95 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 -29.16 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.63 0.772 . . . . 0.0 110.957 176.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.64 -8.0 51.2 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.876 1.27 . . . . 0.0 110.588 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.18 131.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.686 1.195 . . . . 0.0 111.414 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -96.33 168.63 10.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.662 0.785 . . . . 0.0 112.559 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 18' ' ' SER . 47.7 mt -69.69 -20.18 63.56 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.918 0.887 . . . . 0.0 111.552 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.94 73.18 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.434 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.07 -39.16 14.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.187 0.595 . . . . 0.0 109.816 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.3 mt -79.5 156.66 75.65 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 124.057 0.943 . . . . 0.0 111.438 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -72.94 18.51 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.767 2.978 . . . . 0.0 115.267 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.05 124.4 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.0 mt-30 -119.06 169.83 9.58 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.237 0.615 . . . . 0.0 109.845 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 p -68.47 96.46 0.69 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.336 0.654 . . . . 0.0 110.879 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.96 36.39 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.382 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 11.1 t70 -80.44 158.01 26.05 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.303 0.641 . . . . 0.0 110.689 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.88 97.93 10.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.57 0.748 . . . . 0.0 109.692 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.88 106.97 18.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.439 0.696 . . . . 0.0 109.44 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.31 93.28 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.845 0.858 . . . . 0.0 108.825 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.75 103.45 10.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.99 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.455 ' O ' HG21 ' A' ' 36' ' ' ILE . 11.4 pt-20 -78.75 170.09 17.21 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.203 174.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -129.61 106.99 9.11 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.109 0.964 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 . . . . . 0 CA--C 1.554 1.123 0 C-N-CA 122.921 0.488 . . . . 0.0 111.478 179.468 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.3 m0 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HB3' HD11 ' A' ' 13' ' ' LEU . 44.7 mtp180 -83.29 83.29 7.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 109.452 174.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 17' ' ' LEU . 69.1 t -100.34 141.94 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.923 0.889 . . . . 0.0 110.535 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 71' ' ' MET . 41.1 mmt180 -81.57 135.97 35.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.916 0.886 . . . . 0.0 110.559 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 19.8 t -113.33 90.12 3.26 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -82.95 105.39 13.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.31 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 123.384 0.674 . . . . 0.0 110.436 -177.879 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 77.6 m-70 -123.2 173.74 7.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.623 0.769 . . . . 0.0 109.904 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.445 HD12 HE21 ' A' ' 15' ' ' GLN . 2.8 tm? -140.74 110.76 6.55 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -95.32 132.07 40.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.082 0.953 . . . . 0.0 108.52 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.445 HE21 HD12 ' A' ' 13' ' ' LEU . 15.0 mp0 -100.89 -32.91 10.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.104 0.561 . . . . 0.0 110.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.48 44.4 3.07 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.767 -0.651 . . . . 0.0 114.109 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 3' ' ' VAL . 95.3 mt -114.52 115.2 26.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 124.134 0.974 . . . . 0.0 109.35 175.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 61' ' ' LEU . 17.3 t -92.38 176.87 6.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.947 0.899 . . . . 0.0 109.475 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 p -60.63 -36.1 77.79 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.708 0.803 . . . . 0.0 111.858 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -116.35 48.09 1.32 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.388 0.675 . . . . 0.0 111.47 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.9 m -75.84 128.06 34.33 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HG2' HG22 ' A' ' 60' ' ' THR . 61.6 mtm180 -92.14 -177.94 4.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 57' ' ' ARG . 5.9 tt -52.32 -56.91 11.68 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.087 0.955 . . . . 0.0 111.036 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.445 ' HG2' ' OE2' ' A' ' 25' ' ' GLU . 9.0 ptp180 -70.63 -19.58 62.81 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.594 0.559 . . . . 0.0 112.042 -164.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -93.49 -35.02 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.63 0.772 . . . . 0.0 110.976 173.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.418 HD11 HD11 ' A' ' 43' ' ' ILE . 2.0 tm? -71.29 -68.23 0.46 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.606 0.762 . . . . 0.0 111.419 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.35 -38.23 62.63 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.844 0.715 . . . . 0.0 112.341 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.468 ' O ' HG12 ' A' ' 33' ' ' ILE . 43.7 mt-30 -70.53 -44.52 67.34 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -55.41 -41.35 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.935 0.894 . . . . 0.0 111.476 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -25.18 68.19 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.34 -31.36 16.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.676 0.79 . . . . 0.0 111.395 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 29' ' ' GLN . 28.8 mm -79.11 -65.59 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.324 1.05 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.547 HG23 HG12 ' A' ' 36' ' ' ILE . 10.1 t -101.91 -11.74 18.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.75 0.82 . . . . 0.0 111.341 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 -18.6 56.78 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.727 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.547 HG12 HG23 ' A' ' 34' ' ' THR . 18.3 mm -67.34 121.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.045 0.422 . . . . 0.0 111.205 -169.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.75 141.26 80.13 Favored Pre-proline 0 C--N 1.351 0.663 0 O-C-N 124.281 0.988 . . . . 0.0 110.648 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.05 -28.62 70.43 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.394 2.729 . . . . 0.0 112.35 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.91 16.51 54.93 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.369 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -125.13 -11.29 7.03 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 110.52 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -127.16 155.53 43.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.022 0.929 . . . . 0.0 110.369 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 168.47 19.63 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.238 1.015 . . . . 0.0 109.161 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 54' ' ' LEU . 30.8 mm -80.26 105.0 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.423 1.106 . . . . 0.0 109.842 -172.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.93 148.08 44.56 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 112.776 -2.011 . . . . 0.0 106.981 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.452 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 1.6 m -132.25 161.96 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.75 . . . . 0.0 110.248 -172.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.64 -42.29 96.13 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.805 0.69 . . . . 0.0 113.238 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -77.7 158.1 78.75 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.264 168.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -39.65 107.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.095 3.196 . . . . 0.0 115.292 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 67.9 Cg_endo -86.04 158.55 10.05 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.84 8.38 41.32 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.9 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.1 m 56.5 68.77 0.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.185 0.994 . . . . 0.0 110.221 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.77 114.35 18.62 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.678 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.06 155.59 22.61 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 43' ' ' ILE . 4.7 mp -122.6 91.71 3.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.7 p -82.34 -46.08 14.07 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.397 0.679 . . . . 0.0 110.67 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -78.13 131.63 37.32 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.788 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -70.57 -22.04 62.62 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.728 0.811 . . . . 0.0 112.091 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.29 -1.86 53.23 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.6 tt -64.01 124.09 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.389 0.676 . . . . 0.0 110.893 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 22' ' ' ARG . 50.7 p -95.96 173.56 7.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.164 0.586 . . . . 0.0 112.398 -169.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 18' ' ' SER . 27.0 mt -68.99 -10.77 59.17 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.399 0.679 . . . . 0.0 111.136 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.39 -29.01 73.72 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 112.301 -0.32 . . . . 0.0 112.301 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -88.27 -49.63 6.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.276 0.63 . . . . 0.0 110.12 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.8 mm? -81.59 151.77 68.86 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.743 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.456 ' HD2' HG21 ' A' ' 43' ' ' ILE . 97.9 Cg_endo -77.66 42.79 1.22 Allowed 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.761 2.974 . . . . 0.0 115.185 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.476 HD11 HD12 ' A' ' 43' ' ' ILE . 2.3 mp -83.28 112.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -109.84 170.66 7.93 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.2 p -67.56 105.51 1.88 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.029 0.532 . . . . 0.0 111.013 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.23 62.73 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 113.358 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.28 161.35 27.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.775 0.83 . . . . 0.0 110.168 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.48 ' HA ' ' HB2' ' A' ' 4' ' ' ARG . 19.1 ttm -103.89 112.34 25.26 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.245 0.618 . . . . 0.0 109.783 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -101.05 114.45 28.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.574 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.78 96.13 3.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.409 HG21 ' SG ' ' A' ' 5' ' ' CYS . 70.5 t -78.69 101.58 4.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.082 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -80.32 155.82 27.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.499 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.61 111.91 23.68 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 169.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 CA--C 1.552 1.046 0 C-N-CA 123.306 0.642 . . . . 0.0 111.037 175.253 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . 0.483 ' HB3' HG23 ' A' ' 3' ' ' VAL . 22.0 m0 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.448 ' HB2' HD11 ' A' ' 13' ' ' LEU . 3.9 ptp180 -87.99 70.85 9.44 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.775 0.798 . . . . 0.0 109.102 169.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 1' ' ' TRP . 76.8 t -77.8 137.28 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.864 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -93.27 140.23 29.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.466 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 12.5 t -122.41 97.94 5.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.018 0.927 . . . . 0.0 111.053 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HE3' ' SD ' ' A' ' 71' ' ' MET . 4.6 tppp? -74.82 102.71 4.8 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.472 0.653 0 C-N-CA 123.081 0.552 . . . . 0.0 111.015 -173.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 91.2 m-70 -107.79 179.16 4.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.199 1.0 . . . . 0.0 109.517 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 2' ' ' ARG . 2.0 tm? -144.01 122.8 12.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.473 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.2 mp -101.1 146.62 27.22 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.951 0.9 . . . . 0.0 110.394 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -118.39 165.27 14.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.137 1.375 . . . . 0.0 109.312 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.45 4.81 89.28 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.157 0.423 . . . . 0.0 114.157 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.48 130.84 35.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.465 0.65 . . . . 0.0 110.525 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -115.16 179.02 4.07 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.207 1.403 . . . . 0.0 109.159 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 p -72.72 -27.34 62.0 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.647 0.379 . . . . 0.0 111.158 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -108.61 25.95 11.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.735 0.814 . . . . 0.0 111.233 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 25' ' ' GLU . 7.3 m -66.0 127.66 32.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.077 0.551 . . . . 0.0 110.151 170.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -72.9 166.71 22.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.356 0.662 . . . . 0.0 111.183 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 54' ' ' LEU . 10.1 tt -61.2 -45.42 94.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.651 1.18 . . . . 0.0 110.618 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -61.53 -30.67 70.79 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.653 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 21' ' ' THR . 6.3 mm-40 -79.88 -44.44 20.44 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 124.087 0.955 . . . . 0.0 109.534 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.56 -65.9 0.61 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.044 0.938 . . . . 0.0 109.718 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.416 ' HA ' HD12 ' A' ' 30' ' ' ILE . 32.4 mt-30 -64.42 -23.11 67.17 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.664 0.602 . . . . 0.0 111.509 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.21 -44.33 86.76 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 124.104 0.878 . . . . 0.0 111.695 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 33' ' ' ILE . 23.7 mt-30 -67.92 -37.33 81.54 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 27' ' ' GLN . 97.4 mt -59.56 -42.03 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.493 0.717 . . . . 0.0 110.823 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -24.97 68.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.805 0.842 . . . . 0.0 111.705 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.4 -32.79 17.11 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.765 0.826 . . . . 0.0 111.571 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.473 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.8 mm -79.83 -69.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.536 HG23 HG12 ' A' ' 36' ' ' ILE . 9.2 t -98.76 -9.45 24.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.442 0.697 . . . . 0.0 111.488 -173.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.48 72.43 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.967 -0.352 . . . . 0.0 113.785 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.536 HG12 HG23 ' A' ' 34' ' ' THR . 24.9 mm -91.19 114.57 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.42 78.72 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.03 0.932 . . . . 0.0 111.023 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -53.76 -29.54 52.54 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.127 3.218 . . . . 0.0 114.572 -172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.96 -23.03 64.71 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.001 -0.333 . . . . 0.0 113.743 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -93.47 1.4 56.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.774 0.83 . . . . 0.0 111.562 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.45 169.14 13.96 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.032 0.933 . . . . 0.0 110.781 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 51' ' ' CYS . 44.9 ttp180 -158.81 154.43 26.14 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.055 -169.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 66' ' ' ILE . 37.4 mm -79.68 100.8 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 122.083 0.944 . . . . 0.0 109.674 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.4 mt -121.7 144.57 48.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.271 -1.786 . . . . 0.0 106.917 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 47' ' ' TYR . 2.6 m -125.88 164.31 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.493 0.717 . . . . 0.0 110.779 -172.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -36.08 92.75 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.78 0.675 . . . . 0.0 112.857 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 45' ' ' VAL . 46.4 p90 -81.72 156.2 70.48 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.177 167.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -43.09 108.36 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 124.227 3.285 . . . . 0.0 114.508 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -85.72 155.14 10.26 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.018 2.479 . . . . 0.0 112.624 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -89.81 6.82 40.04 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.994 0.518 . . . . 0.0 110.696 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HB3' ' NH1' ' A' ' 42' ' ' ARG . 81.5 m 57.36 59.16 3.46 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.282 1.033 . . . . 0.0 110.123 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.84 144.34 52.91 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.46 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.45 138.8 31.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.208 0.603 . . . . 0.0 109.682 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.673 ' HB3' HD11 ' A' ' 23' ' ' LEU . 7.0 mp -115.14 87.17 2.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.011 0.924 . . . . 0.0 108.74 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 m -111.03 19.81 18.09 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.81 0.844 . . . . 0.0 112.654 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HD13 ' A' ' 23' ' ' LEU . 11.1 t70 -141.81 177.75 7.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -120.69 -40.53 2.64 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.496 0.718 . . . . 0.0 111.478 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.24 -16.0 34.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.936 0.894 . . . . 0.0 110.327 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.98 141.46 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.258 1.023 . . . . 0.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.6 p -111.75 -178.92 3.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 112.247 -166.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 mt -75.94 -4.73 42.62 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.178 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.25 -23.11 76.39 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 167.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -97.78 -59.09 1.84 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.428 0.691 . . . . 0.0 109.793 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.53 116.09 55.05 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.05 65.09 6.12 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.666 2.91 . . . . 0.0 113.816 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 43' ' ' ILE . 1.9 mp -78.27 126.45 38.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 163.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 18.1 mt-30 -117.41 154.61 31.05 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.8 p -64.59 102.68 0.59 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.274 0.629 . . . . 0.0 111.363 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.59 16.19 66.67 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.411 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 10.5 t70 -80.08 160.92 25.61 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 123.489 0.716 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.447 ' SD ' ' HE3' ' A' ' 6' ' ' LYS . 2.8 tpt -84.18 100.32 11.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.323 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.36 116.12 30.78 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.55 102.67 13.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 77.9 t -82.61 108.18 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.429 171.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.22 151.22 31.33 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.811 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -109.46 105.04 14.22 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 166.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 t70 . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 0.0 110.525 178.701 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 33.8 m0 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -103.0 160.4 14.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.875 0.87 . . . . 0.0 109.334 170.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.561 HG13 HD23 ' A' ' 72' ' ' LEU . 18.9 t -138.1 136.78 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.834 0.854 . . . . 0.0 109.709 171.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -104.8 95.58 5.97 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.7 p -84.14 102.35 12.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.909 0.484 . . . . 0.0 110.185 -175.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.75 99.03 7.26 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 123.25 0.62 . . . . 0.0 109.959 -174.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 96.5 m-70 -131.47 149.37 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.591 0.356 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.643 ' HB3' HE22 ' A' ' 15' ' ' GLN . 0.1 OUTLIER -98.76 113.47 25.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.207 0.603 . . . . 0.0 109.858 -173.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.466 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.8 mp -89.48 127.4 35.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.963 0.905 . . . . 0.0 109.033 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.643 HE22 ' HB3' ' A' ' 13' ' ' LEU . 26.2 mp0 -111.34 161.45 16.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 171.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 33.61 19.13 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.872 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.19 116.36 28.88 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -91.36 166.58 12.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.565 0.746 . . . . 0.0 109.606 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -64.81 -25.48 67.93 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 120.978 0.418 . . . . 0.0 111.705 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -92.7 3.2 56.05 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.779 0.832 . . . . 0.0 112.788 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 25' ' ' GLU . 56.8 m -58.7 118.61 5.87 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.141 0.496 . . . . 0.0 110.812 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 58' ' ' ASP . 81.8 mtm180 -87.21 -176.41 5.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.03 0.932 . . . . 0.0 111.478 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 54' ' ' LEU . 4.8 tt -54.89 -60.87 2.77 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.773 0.829 . . . . 0.0 109.045 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -55.91 -24.56 38.32 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.345 -1.298 . . . . 0.0 113.413 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 1.7 mm-40 -88.91 -53.89 4.39 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HB2' HG22 ' A' ' 21' ' ' THR . 2.7 tm? -67.27 -65.78 0.64 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.162 0.985 . . . . 0.0 110.655 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.45 -18.83 65.58 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.328 0.392 . . . . 0.0 111.071 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.93 -37.58 60.55 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.713 0.633 . . . . 0.0 112.034 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 33' ' ' ILE . 24.5 mt-30 -70.78 -38.84 73.43 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.88 -38.7 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 C-N-CA 123.803 0.841 . . . . 0.0 110.795 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.65 66.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.043 0.937 . . . . 0.0 111.914 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -35.6 13.57 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.924 0.89 . . . . 0.0 111.395 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG13 ' HG ' ' A' ' 14' ' ' LEU . 31.0 mm -72.1 -68.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.781 0.832 . . . . 0.0 110.449 -175.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.421 HG23 HG12 ' A' ' 36' ' ' ILE . 5.2 t -96.44 -16.19 21.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.342 0.657 . . . . 0.0 111.036 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 11.12 71.47 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.667 -0.518 . . . . 0.0 113.436 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.421 HG12 HG23 ' A' ' 34' ' ' THR . 26.5 mm -85.91 111.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.74 144.45 65.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.863 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.75 -24.81 73.15 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.203 2.602 . . . . 0.0 113.559 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.98 19.76 32.51 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 113.253 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -135.54 8.37 3.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 110.332 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 1.6 pt20 -144.47 162.07 37.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.511 0.725 . . . . 0.0 110.831 -177.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -129.37 -172.88 2.85 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.824 1.25 . . . . 0.0 108.645 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.517 HG23 HD12 ' A' ' 72' ' ' LEU . 32.4 mm -112.26 106.65 21.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.61 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 29.8 mt -116.03 134.45 54.94 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.79 175.21 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.479 0.711 . . . . 0.0 111.199 -169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.7 -44.76 80.04 Favored Glycine 0 C--N 1.357 1.703 0 O-C-N 123.969 0.793 . . . . 0.0 114.186 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -87.0 163.34 40.88 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.536 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 83.1 Cg_exo -45.61 108.52 0.15 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.572 2.848 . . . . 0.0 113.587 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 48' ' ' PRO . 2.3 Cg_endo -84.14 172.46 9.62 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.502 2.802 . . . . 0.0 112.493 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -101.64 11.99 37.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.929 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.9 m 56.03 84.37 0.08 Allowed 'General case' 0 C--N 1.36 1.022 0 C-N-CA 124.272 1.029 . . . . 0.0 109.646 -166.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 69.1 mt -79.68 95.39 5.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.351 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.22 96.14 8.36 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.662 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.455 ' HB3' HD12 ' A' ' 23' ' ' LEU . 8.0 mp -69.85 102.82 2.04 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -89.57 -36.89 15.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.948 0.899 . . . . 0.0 111.757 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 59' ' ' ILE . 34.9 t70 -95.95 130.71 42.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.768 0.827 . . . . 0.0 110.302 -177.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.44 68.08 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.131 0.573 . . . . 0.0 112.306 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 29.1 t70 -92.7 -2.77 55.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.855 0.862 . . . . 0.0 111.432 -172.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 56' ' ' ASP . 13.4 tt -67.16 127.29 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.214 0.606 . . . . 0.0 110.748 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -99.24 177.0 5.34 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.928 0.491 . . . . 0.0 111.902 -168.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.19 -9.88 57.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 0.0 111.488 173.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.71 -25.85 74.85 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.99 -50.77 5.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.763 0.825 . . . . 0.0 110.055 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -91.05 121.72 67.53 Favored Pre-proline 0 N--CA 1.477 0.894 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.007 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.8 75.68 1.62 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.3 2.667 . . . . 0.0 113.583 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.33 131.68 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 27.9 mt-30 -118.19 155.82 29.84 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.3 t -70.94 111.61 6.47 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.21 17.2 56.2 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 123.604 0.621 . . . . 0.0 112.887 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.9 t70 -81.45 158.61 24.5 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.225 0.536 . . . . 0.0 110.246 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.4 93.69 9.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.783 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.561 HD23 HG13 ' A' ' 3' ' ' VAL . 3.9 mm? -92.36 99.44 12.2 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 4.1 mp -75.71 100.22 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 93.1 t -79.03 102.29 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.01 173.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 7.3 pt-20 -76.84 156.79 31.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.219 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.31 113.27 21.2 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 123.58 0.752 . . . . 0.0 110.583 176.783 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.7 m0 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.868 0.366 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -122.03 56.6 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.483 1.113 . . . . 0.0 109.241 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.578 ' HB ' HD12 ' A' ' 17' ' ' LEU . 10.8 t -83.81 135.64 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.73 -171.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -95.31 148.73 22.12 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.69 0.796 . . . . 0.0 110.123 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 p -122.17 104.2 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.459 0.704 . . . . 0.0 110.243 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -74.73 113.47 12.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.771 0.828 . . . . 0.0 109.321 171.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.723 0 C-N-CA 122.729 0.412 . . . . 0.0 110.199 177.298 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.261 0.553 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -111.0 179.8 3.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.987 0.915 . . . . 0.0 109.53 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.18 130.46 37.29 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.524 ' HG ' HG13 ' A' ' 33' ' ' ILE . 4.5 mp -96.18 110.73 22.96 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.234 1.014 . . . . 0.0 109.772 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.06 -17.49 43.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 109.676 172.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -15.11 81.65 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.636 0.636 . . . . 0.0 113.54 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' A' ' 3' ' ' VAL . 63.3 mt -72.67 114.43 10.8 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 117.336 0.568 . . . . 0.0 109.813 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.5 m -90.99 -167.08 1.73 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.176 0.991 . . . . 0.0 108.969 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.0 t -77.2 -45.58 26.13 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.779 0.432 . . . . 0.0 110.01 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.58 17.78 7.09 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.634 1.174 . . . . 0.0 112.794 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.8 m -65.9 115.92 6.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.141 0.577 . . . . 0.0 111.876 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.43 173.43 10.32 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.179 0.992 . . . . 0.0 110.219 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.39 -49.12 78.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.989 0.515 . . . . 0.0 111.894 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -19.93 65.31 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.648 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.85 -38.85 14.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 110.218 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 43' ' ' ILE . 1.5 tm? -66.89 -67.21 0.47 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.874 1.27 . . . . 0.0 109.597 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 72.0 mt-30 -69.24 -20.79 63.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.103 0.561 . . . . 0.0 111.769 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.71 -33.15 75.32 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.918 0.761 . . . . 0.0 112.179 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.444 ' NE2' HD23 ' A' ' 17' ' ' LEU . 21.2 mt-30 -87.38 -32.23 19.68 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.286 0.634 . . . . 0.0 110.787 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.87 -39.85 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -61.72 -25.75 67.62 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.193 0.997 . . . . 0.0 111.974 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.05 -26.09 16.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.983 0.913 . . . . 0.0 111.748 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.524 HG13 ' HG ' ' A' ' 14' ' ' LEU . 22.3 mm -89.21 -68.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 111.257 -174.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.583 HG23 HG12 ' A' ' 36' ' ' ILE . 10.2 t -94.26 -7.69 41.3 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.92 0.488 . . . . 0.0 110.563 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.23 8.28 83.86 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 119.285 -0.731 . . . . 0.0 114.292 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 34' ' ' THR . 11.0 mm -86.83 119.91 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 117.859 0.83 . . . . 0.0 109.178 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.98 139.44 82.98 Favored Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 124.165 0.916 . . . . 0.0 110.962 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 19.7 Cg_endo -56.64 -26.05 62.87 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.542 2.828 . . . . 0.0 114.252 -174.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.97 22.51 37.85 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 116.522 -0.308 . . . . 0.0 112.96 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 m -138.23 14.19 2.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.557 1.143 . . . . 0.0 109.949 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.42 171.87 19.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.375 0.67 . . . . 0.0 111.277 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -160.8 -173.85 4.13 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.631 1.172 . . . . 0.0 108.788 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.801 HG12 HD21 ' A' ' 54' ' ' LEU . 37.0 mm -106.13 113.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.2 mt -121.98 133.78 54.82 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 m -103.96 166.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.886 0.474 . . . . 0.0 110.831 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.06 -54.93 33.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 124.158 0.911 . . . . 0.0 112.715 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -67.19 151.68 96.89 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.268 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -49.25 106.66 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.612 2.875 . . . . 0.0 113.446 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.02 155.73 42.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.55 2.167 . . . . 0.0 111.651 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.91 10.81 22.42 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.673 0.789 . . . . 0.0 110.923 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.7 m 55.43 79.42 0.16 Allowed 'General case' 0 C--N 1.365 1.253 0 C-N-CA 124.417 1.087 . . . . 0.0 109.528 -167.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.52 138.33 57.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.777 -172.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -82.66 100.56 10.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.801 HD21 HG12 ' A' ' 43' ' ' ILE . 7.4 mp -98.03 88.84 4.35 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -126.72 -51.32 1.47 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.483 0.713 . . . . 0.0 111.357 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 59' ' ' ILE . 25.1 t70 -75.86 123.36 25.55 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.171 0.589 . . . . 0.0 110.916 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -29.73 52.95 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.7 -19.97 22.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 112.144 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 56' ' ' ASP . 12.1 tt -58.87 120.41 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 121.4 0.619 . . . . 0.0 110.747 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.9 p -92.67 177.32 6.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.072 0.549 . . . . 0.0 112.28 -170.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.83 -15.47 63.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.932 0.893 . . . . 0.0 111.362 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.99 78.4 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.271 -0.331 . . . . 0.0 112.271 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.3 -56.77 2.51 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.747 0.819 . . . . 0.0 109.701 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.5 mt -75.12 118.08 67.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.176 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.15 83.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.614 2.876 . . . . 0.0 114.838 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.446 HG23 HG11 ' A' ' 3' ' ' VAL . 3.1 mp -119.6 127.26 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 14.3 mt-30 -112.71 161.01 17.36 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.0 p -67.81 112.29 4.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.986 0.514 . . . . 0.0 110.147 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 22.94 59.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.188 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 29.0 t70 -82.97 166.27 18.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.74 0.816 . . . . 0.0 111.496 -175.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.82 103.66 15.63 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.87 0.868 . . . . 0.0 109.557 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.432 HD22 HG23 ' A' ' 43' ' ' ILE . 67.2 mt -98.86 104.12 16.13 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.399 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.6 91.98 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -82.13 109.56 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.548 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.91 145.36 38.29 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.21 102.13 10.84 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 123.674 0.79 . . . . 0.0 110.94 -178.882 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 24.0 m0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 13' ' ' LEU . 14.0 ptp180 -133.9 124.91 27.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.594 HG11 HD22 ' A' ' 72' ' ' LEU . 71.9 t -125.39 135.55 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.9 0.381 . . . . 0.0 111.493 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -82.12 110.96 17.81 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.379 1.072 . . . . 0.0 110.008 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 11' ' ' THR . 36.2 t -89.68 90.15 8.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 0.0 110.203 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -76.47 103.17 6.33 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.51 0.672 . . . . 0.0 112.157 -170.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 15.7 m . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -118.81 178.48 4.47 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.983 0.913 . . . . 0.0 110.493 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 2' ' ' ARG . 3.1 tm? -125.18 131.02 53.27 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.427 ' HG ' HG13 ' A' ' 33' ' ' ILE . 10.5 mp -100.1 132.82 45.24 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.323 0.649 . . . . 0.0 110.698 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.0 170.04 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.811 0.844 . . . . 0.0 109.996 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.4 23.23 77.63 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.067 172.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.67 133.23 43.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.02 0.528 . . . . 0.0 109.888 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.0 t -116.81 -166.26 1.15 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.354 1.062 . . . . 0.0 108.797 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.6 p -76.81 -36.4 56.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.993 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -104.57 20.55 18.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.926 0.49 . . . . 0.0 111.738 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -61.2 129.03 39.29 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.708 0.803 . . . . 0.0 110.142 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.549 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 78.3 mtm180 -88.19 -179.01 6.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.495 0.718 . . . . 0.0 111.848 -171.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.27 -63.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.103 0.961 . . . . 0.0 109.573 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -63.91 -15.27 58.68 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.902 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 12.2 mm-40 -87.04 -49.05 7.59 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -78.93 -66.78 0.82 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.358 1.063 . . . . 0.0 110.182 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -65.7 -19.96 66.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.001 0.52 . . . . 0.0 111.149 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.57 72.32 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.749 0.655 . . . . 0.0 111.877 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' ILE . 20.8 mt-30 -72.33 -38.85 68.53 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.11 -35.9 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.6 67.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.702 0.801 . . . . 0.0 111.99 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.43 -28.19 15.62 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.188 0.995 . . . . 0.0 112.065 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 29' ' ' GLN . 27.8 mm -78.95 -61.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.304 1.042 . . . . 0.0 110.415 -174.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 36' ' ' ILE . 3.8 t -109.42 -5.36 15.83 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.812 0.845 . . . . 0.0 111.435 -175.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.15 13.6 81.74 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.932 -0.371 . . . . 0.0 114.001 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 34' ' ' THR . 24.9 mm -90.88 115.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 141.88 69.49 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.707 0.803 . . . . 0.0 110.702 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.99 -27.64 64.98 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 123.421 2.747 . . . . 0.0 114.133 -174.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -15.23 78.3 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 120.085 -0.286 . . . . 0.0 113.813 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -93.78 -5.75 47.56 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.107 0.963 . . . . 0.0 111.445 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -130.19 161.59 30.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.106 0.963 . . . . 0.0 111.148 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -134.07 -172.17 2.92 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.244 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.534 HG12 HD11 ' A' ' 54' ' ' LEU . 49.8 mm -107.36 99.15 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -112.0 131.33 55.48 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.57 -174.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.721 0.808 . . . . 0.0 109.672 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.54 55.88 4.44 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.46 168.31 11.57 Favored Pre-proline 0 N--CA 1.483 1.209 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 168.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 100.31 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.982 1.788 . . . . 0.0 111.343 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.04 138.74 26.02 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.145 1.897 . . . . 0.0 113.089 -168.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.94 -0.88 23.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.891 0.876 . . . . 0.0 111.681 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.7 m 61.32 58.24 2.2 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.682 1.193 . . . . 0.0 109.678 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.18 99.92 0.73 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.113 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -86.06 125.7 33.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.534 HD11 HG12 ' A' ' 43' ' ' ILE . 6.4 mp -88.96 106.57 18.51 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -111.83 19.6 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.601 0.76 . . . . 0.0 110.825 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 13.7 t70 -134.29 118.02 17.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -58.08 -34.26 69.96 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.897 0.879 . . . . 0.0 113.124 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.39 -0.71 54.65 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.05 0.94 . . . . 0.0 113.461 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.7 tt -61.6 122.18 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 118.757 0.708 . . . . 0.0 110.724 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.3 p -90.5 171.59 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.099 0.56 . . . . 0.0 111.921 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.444 HD13 HG21 ' A' ' 66' ' ' ILE . 21.9 mt -70.63 -7.96 48.21 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.95 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.89 -23.0 78.7 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.235 0.334 . . . . 0.0 112.743 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.479 ' HB2' HD22 ' A' ' 64' ' ' LEU . 9.2 m-20 -88.85 -47.29 8.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.065 0.546 . . . . 0.0 110.15 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 63' ' ' ASP . 2.5 mm? -90.35 157.31 45.05 Favored Pre-proline 0 CA--C 1.562 1.412 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.099 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.94 44.82 1.76 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.495 2.797 . . . . 0.0 114.516 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.612 HG13 HD11 ' A' ' 72' ' ' LEU . 4.0 mp -83.47 124.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -119.94 170.7 9.02 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.545 0.738 . . . . 0.0 109.171 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 t -74.63 111.56 9.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.76 13.43 59.43 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.218 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.08 170.03 17.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 30.7 ttm -117.4 113.74 22.53 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.589 0.756 . . . . 0.0 109.353 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.612 HD11 HG13 ' A' ' 66' ' ' ILE . 3.2 mp -90.64 105.69 17.99 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.476 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.75 89.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 75.3 t -72.11 107.27 2.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.386 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -77.13 159.85 29.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.697 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -125.19 121.52 34.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 CA--C 1.547 0.831 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.51 176.559 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.3 m0 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -93.24 82.55 4.53 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 66' ' ' ILE . 41.3 t -96.1 136.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -87.29 141.75 28.41 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.57 0.748 . . . . 0.0 110.327 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.608 ' SG ' HD13 ' A' ' 14' ' ' LEU . 86.3 m -130.91 101.88 5.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.327 0.651 . . . . 0.0 111.427 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.528 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 12.9 tppt? -74.95 118.69 18.19 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.436 1.094 . . . . 0.0 110.381 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.73 0 C-N-CA 123.329 0.651 . . . . 0.0 109.416 176.661 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.424 ' HB3' HG22 ' A' ' 33' ' ' ILE . 77.7 m80 -112.02 112.55 24.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.207 1.003 . . . . 0.0 108.647 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.3 tp -80.07 121.55 25.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.093 0.557 . . . . 0.0 110.666 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.608 HD13 ' SG ' ' A' ' 5' ' ' CYS . 8.5 mp -81.41 133.46 35.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 174.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -105.33 153.37 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.526 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.04 23.82 74.51 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD22 HG21 ' A' ' 21' ' ' THR . 78.0 mt -77.17 117.96 19.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.672 0.736 . . . . 0.0 110.077 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 94.5 p -84.84 161.35 19.94 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.7 p -65.39 -17.6 64.66 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.541 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.584 HH22 ' HA3' ' A' ' 62' ' ' GLY . 6.9 mmp_? -107.22 18.49 21.61 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.144 0.977 . . . . 0.0 112.256 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.482 HG21 HD22 ' A' ' 17' ' ' LEU . 44.0 m -63.31 119.8 10.35 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.926 0.393 . . . . 0.0 110.303 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -82.39 176.58 9.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.864 0.866 . . . . 0.0 111.272 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HB2' HG22 ' A' ' 59' ' ' ILE . 5.7 tt -51.33 -60.62 2.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.714 1.206 . . . . 0.0 110.21 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -54.12 -30.43 48.72 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.021 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 21' ' ' THR . 9.0 mm-40 -83.98 -38.74 20.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.41 0.684 . . . . 0.0 110.128 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.24 -66.99 0.66 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.225 1.01 . . . . 0.0 109.564 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -67.15 -16.93 64.61 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.04 70.97 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.849 0.718 . . . . 0.0 112.022 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.441 ' O ' HG13 ' A' ' 33' ' ' ILE . 24.0 mt-30 -70.22 -39.51 75.06 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.527 HG13 HD21 ' A' ' 14' ' ' LEU . 88.5 mt -57.59 -42.63 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 123.612 0.765 . . . . 0.0 110.881 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.17 67.5 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.034 0.934 . . . . 0.0 112.397 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.51 -35.58 15.0 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.771 0.829 . . . . 0.0 111.435 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 29' ' ' GLN . 25.1 mt -86.32 -64.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.094 0.558 . . . . 0.0 111.109 -171.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.58 HG23 HG12 ' A' ' 36' ' ' ILE . 12.1 t -93.72 -2.86 53.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.557 0.343 . . . . 0.0 110.929 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.41 -10.07 56.18 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.555 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 34' ' ' THR . 22.5 mm -71.65 111.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.591 0.696 . . . . 0.0 109.949 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.65 144.45 44.69 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.135 0.974 . . . . 0.0 111.089 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.95 -28.17 86.88 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.082 2.521 . . . . 0.0 113.049 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.08 28.02 9.37 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.548 0.53 . . . . 0.0 113.402 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -138.87 11.64 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.39 1.076 . . . . 0.0 109.987 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.46 161.3 42.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.794 0.838 . . . . 0.0 110.741 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -143.32 -168.91 2.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.173 1.389 . . . . 0.0 109.21 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 54' ' ' LEU . 24.2 mm -106.83 110.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.562 0.745 . . . . 0.0 109.112 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mm? -120.01 156.6 30.57 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.56 167.72 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.159 0.584 . . . . 0.0 111.046 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.72 -49.32 78.78 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.528 1.142 . . . . 0.0 113.041 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -74.12 158.72 85.28 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.631 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -46.53 111.41 0.36 Allowed 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.225 2.617 . . . . 0.0 114.227 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.72 -176.91 2.66 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.054 2.503 . . . . 0.0 111.614 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -126.0 30.15 5.72 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.4 0.68 . . . . 0.0 110.741 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 34.0 m 55.44 64.27 1.82 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.741 0.816 . . . . 0.0 109.713 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.75 109.35 4.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.98 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.23 115.72 27.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.912 1.285 . . . . 0.0 108.921 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 43' ' ' ILE . 4.1 mp -82.7 93.45 7.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.499 0.72 . . . . 0.0 109.229 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.6 p -79.8 -52.58 7.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 111.213 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -83.45 131.67 35.01 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 123.476 0.71 . . . . 0.0 110.319 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -22.82 61.15 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.726 0.811 . . . . 0.0 112.951 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -91.58 -5.29 54.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.496 1.119 . . . . 0.0 111.252 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 23' ' ' LEU . 13.9 tt -59.58 121.07 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.236 0.615 . . . . 0.0 111.626 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -91.37 173.57 7.84 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 0.0 111.278 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.432 HD13 HG21 ' A' ' 66' ' ' ILE . 45.4 mt -70.26 -4.76 23.42 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.605 0.762 . . . . 0.0 111.643 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.584 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -78.46 -30.61 48.84 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.846 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 -48.98 6.19 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.82 133.05 95.43 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.076 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.6 78.49 0.95 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.816 2.344 . . . . 0.0 111.96 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.468 HG23 HG11 ' A' ' 3' ' ' VAL . 2.1 mp -123.23 121.87 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.1 mm-40 -117.9 154.91 31.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.753 0.821 . . . . 0.0 109.069 174.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -65.25 106.81 1.42 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.803 . . . . 0.0 110.493 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.25 13.07 62.38 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 113.87 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.7 t70 -84.77 163.47 19.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.176 0.59 . . . . 0.0 110.447 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.528 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 5.7 tpt -91.83 101.64 14.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.468 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.5 mm? -101.61 123.15 45.15 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.231 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.5 mp -91.95 116.18 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.98 110.37 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.218 1.007 . . . . 0.0 108.286 169.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.81 138.65 39.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.4 108.77 20.21 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 . . . . . 0 CA--C 1.549 0.931 0 C-N-CA 123.215 0.606 . . . . 0.0 111.106 -177.558 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.0 m0 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -83.47 72.95 10.23 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.367 1.079 . . . . 0.0 109.55 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.404 HG13 HD23 ' A' ' 72' ' ' LEU . 95.8 t -80.95 132.67 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.056 -172.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -96.23 127.18 42.0 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.698 . . . . 0.0 109.585 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' HD13 ' A' ' 14' ' ' LEU . 84.4 m -113.25 114.88 27.34 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 0.0 110.36 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -80.37 105.11 11.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 121.294 0.569 . . . . 0.0 111.501 -173.562 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.485 HG23 ' HE1' ' A' ' 71' ' ' MET . 20.5 m . . . . . 0 C--O 1.239 0.502 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.62 166.54 11.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.562 0.745 . . . . 0.0 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -118.27 120.5 37.85 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.658 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -103.35 111.47 23.9 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.022 0.929 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -89.96 171.47 9.55 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.848 0.859 . . . . 0.0 109.248 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.83 3.66 85.56 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.802 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.1 mt -95.96 127.52 42.04 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.837 0.855 . . . . 0.0 109.316 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -116.07 -166.82 1.18 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.952 1.301 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -70.01 -45.75 66.58 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.329 0.651 . . . . 0.0 111.432 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -107.18 39.25 1.92 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 25' ' ' GLU . 20.1 m -70.46 122.79 20.31 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 166.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.457 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 26.6 mtm180 -76.24 170.14 16.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.622 0.769 . . . . 0.0 111.198 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 54' ' ' LEU . 44.5 tp -57.54 -49.73 75.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.679 0.791 . . . . 0.0 111.285 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.78 -32.38 65.59 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.752 0.657 . . . . 0.0 112.144 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.509 ' HB2' HG23 ' A' ' 21' ' ' THR . 42.1 mm-40 -78.12 -46.95 19.3 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.392 0.677 . . . . 0.0 109.684 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.09 -62.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.954 1.301 . . . . 0.0 110.812 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 59.2 mt-30 -64.96 -21.89 66.91 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.942 0.497 . . . . 0.0 111.707 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.71 93.91 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.89 0.744 . . . . 0.0 111.748 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -78.71 -37.24 42.04 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.261 -0.4 . . . . 0.0 110.514 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -55.97 -46.21 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.319 0.647 . . . . 0.0 110.808 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -63.26 -24.46 67.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.018 0.927 . . . . 0.0 112.182 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.45 -33.3 16.86 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.682 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.658 HG13 ' HG ' ' A' ' 14' ' ' LEU . 20.8 mm -85.13 -62.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.149 0.979 . . . . 0.0 111.21 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.454 HG23 HG12 ' A' ' 36' ' ' ILE . 10.2 t -96.21 -11.58 25.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.86 68.35 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.938 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 34' ' ' THR . 6.6 mm -75.04 114.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.87 77.62 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.172 0.989 . . . . 0.0 111.233 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 37.0 Cg_endo -61.8 -17.83 57.29 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.089 2.526 . . . . 0.0 112.774 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 20.86 40.51 Favored Glycine 0 C--N 1.352 1.432 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.874 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -147.34 3.11 0.77 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.892 0.877 . . . . 0.0 111.992 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 3.7 pp0? -143.56 168.03 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.002 0.905 . . . . 0.0 112.3 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -153.15 166.41 32.58 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.724 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.618 HG23 HD12 ' A' ' 72' ' ' LEU . 1.8 mp -105.17 112.4 38.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 109.087 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -117.64 169.91 9.19 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' TYR . 6.9 m -121.52 162.63 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 118.232 0.469 . . . . 0.0 111.24 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.25 72.44 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 115.428 -0.805 . . . . 0.0 113.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.426 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 45.4 p90 -95.08 173.24 4.58 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.093 172.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 34.2 Cg_exo -40.49 110.62 0.12 Allowed 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 123.512 2.808 . . . . 0.0 113.988 173.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.73 159.97 18.98 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.647 2.232 . . . . 0.0 112.349 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -76.79 -14.32 59.93 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.876 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.4 m 66.87 23.5 9.96 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 124.831 1.252 . . . . 0.0 109.476 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.5 pt? -56.83 129.46 41.47 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 125.698 1.599 . . . . 0.0 112.161 -172.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.28 105.68 17.65 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 43' ' ' ILE . 6.0 mp -74.63 95.93 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -120.35 6.38 10.67 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.949 0.9 . . . . 0.0 111.74 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 59' ' ' ILE . 12.2 t70 -112.05 114.9 28.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -61.54 -29.39 69.98 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.523 0.729 . . . . 0.0 112.369 -174.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -94.13 -13.44 26.75 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.252 1.021 . . . . 0.0 111.883 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 56' ' ' ASP . 13.9 tt -60.69 133.32 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 71.2 p -104.59 168.48 9.05 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.735 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 34.1 mt -67.88 -10.13 50.56 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.473 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.66 -39.43 40.68 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.17 -35.04 42.56 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.762 0.791 . . . . 0.0 109.282 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 93.3 mt -80.99 157.68 71.07 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.923 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.2 34.24 0.43 Allowed 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 123.063 2.509 . . . . 0.0 113.089 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 43' ' ' ILE . 2.4 mp -84.61 120.55 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.8 mt-30 -121.54 161.63 22.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.122 0.569 . . . . 0.0 109.507 171.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -66.9 114.02 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.02 0.528 . . . . 0.0 109.747 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.94 8.91 83.45 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.562 0.539 . . . . 0.0 113.883 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -80.44 160.22 25.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.695 0.398 . . . . 0.0 110.076 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.485 ' HE1' HG23 ' A' ' 11' ' ' THR . 0.1 OUTLIER -94.92 101.88 13.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.18 0.992 . . . . 0.0 109.613 -178.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.618 HD12 HG23 ' A' ' 43' ' ' ILE . 3.8 mm? -104.95 109.27 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.792 0.837 . . . . 0.0 108.853 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.7 mp -75.27 105.99 4.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.161 0.584 . . . . 0.0 109.582 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.71 111.89 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.764 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 11.4 pt-20 -80.11 176.29 9.88 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.355 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -138.51 116.85 11.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 168.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 CA--C 1.549 0.92 0 C-N-CA 123.705 0.802 . . . . 0.0 110.03 -179.24 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 23.0 m0 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.556 ' HB3' HD11 ' A' ' 13' ' ' LEU . 82.2 mtm180 -86.59 86.42 7.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.79 0.836 . . . . 0.0 109.301 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t -99.54 141.61 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.145 0.978 . . . . 0.0 111.237 -170.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -98.87 97.32 8.52 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.505 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.5 m -80.3 100.91 8.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.598 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -76.86 103.4 6.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 109.297 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.601 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 122.65 0.38 . . . . 0.0 110.656 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -138.9 120.02 14.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.108 0.563 . . . . 0.0 109.522 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' A' ' 2' ' ' ARG . 2.1 tm? -96.26 98.62 10.44 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.94 141.75 31.02 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.481 0.712 . . . . 0.0 111.433 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.84 179.36 3.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.282 1.033 . . . . 0.0 109.234 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.6 28.58 73.56 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.441 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.497 HD22 HG21 ' A' ' 21' ' ' THR . 93.0 mt -106.09 113.73 27.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.292 0.637 . . . . 0.0 110.75 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.9 t -95.85 172.09 8.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 0.0 108.923 172.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.4 p -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 122.45 0.3 . . . . 0.0 111.808 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.99 22.07 13.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.817 0.447 . . . . 0.0 111.804 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.497 HG21 HD22 ' A' ' 17' ' ' LEU . 52.4 m -66.47 111.05 3.37 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 170.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.426 ' HG2' HG22 ' A' ' 60' ' ' THR . 86.0 mtt-85 -74.12 -178.6 3.42 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.271 1.028 . . . . 0.0 111.971 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 54' ' ' LEU . 6.8 tt -56.76 -53.98 51.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 174.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -63.29 -22.1 66.66 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.37 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 25.3 mm-40 -87.2 -53.43 4.86 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.262 0.625 . . . . 0.0 109.665 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.55 ' HG ' HD21 ' A' ' 61' ' ' LEU . 2.5 tm? -70.89 -65.57 0.72 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.212 1.005 . . . . 0.0 110.191 -176.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -67.43 -17.23 64.63 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.64 0.588 . . . . 0.0 110.888 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.45 -37.54 53.4 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.753 0.658 . . . . 0.0 112.538 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 22.6 mt-30 -68.88 -39.46 79.77 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.406 ' HB ' HE22 ' A' ' 41' ' ' GLN . 85.6 mt -59.68 -37.19 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.02 0.928 . . . . 0.0 111.204 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.73 -24.01 65.37 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.193 0.997 . . . . 0.0 111.926 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.69 -43.26 8.74 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.596 0.758 . . . . 0.0 111.322 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 29' ' ' GLN . 17.0 mm -68.3 -63.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.383 1.073 . . . . 0.0 110.237 -172.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 36' ' ' ILE . 8.9 t -109.31 0.99 19.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.67 0.788 . . . . 0.0 111.013 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.2 89.38 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 170.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 34' ' ' THR . 9.8 mm -86.08 107.85 16.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 147.54 98.36 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.564 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -49.95 -33.3 33.51 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 124.11 3.207 . . . . 0.0 114.25 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 13.86 18.48 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.3 m -138.99 15.01 2.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 110.92 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 2.1 pt20 -146.81 155.26 42.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.514 0.725 . . . . 0.0 110.783 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -124.67 -173.91 2.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.169 0.988 . . . . 0.0 109.374 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.6 mm -110.4 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 28.4 mt -107.34 139.73 41.36 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 65' ' ' PRO . 6.7 m -120.19 178.34 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 122.867 0.467 . . . . 0.0 112.203 -164.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.97 -49.82 57.37 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 124.301 1.001 . . . . 0.0 113.654 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -79.01 163.11 61.89 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.367 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -42.04 104.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.884 3.056 . . . . 0.0 113.924 171.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.13 159.11 37.5 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.404 2.069 . . . . 0.0 112.736 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -89.33 8.19 31.85 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.412 1.085 . . . . 0.0 112.145 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.0 m 61.67 27.08 16.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.37 1.068 . . . . 0.0 110.264 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -61.62 108.44 0.98 Allowed 'General case' 0 C--N 1.357 0.91 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.751 -173.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.48 132.97 43.49 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.685 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.528 ' HB3' HD12 ' A' ' 23' ' ' LEU . 7.1 mp -87.86 88.05 7.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.351 1.06 . . . . 0.0 108.359 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.0 t -93.87 13.93 21.06 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.435 0.694 . . . . 0.0 110.57 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.02 117.46 20.94 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.319 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -60.88 -30.28 70.06 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.169 0.987 . . . . 0.0 113.108 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -81.34 -23.44 37.75 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.581 1.152 . . . . 0.0 111.741 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.3 tt -56.16 134.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 -173.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' HG2' ' A' ' 22' ' ' ARG . 58.9 p -113.55 175.2 5.56 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.54 0.736 . . . . 0.0 111.05 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.55 HD21 ' HG ' ' A' ' 26' ' ' LEU . 50.7 mt -64.36 -22.01 66.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.96 0.504 . . . . 0.0 111.848 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.22 -17.05 61.03 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.241 0.338 . . . . 0.0 113.232 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.57 -45.31 6.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 0.0 111.191 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 52' ' ' LEU . 2.3 mm? -85.91 154.73 58.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 123.108 0.563 . . . . 0.0 110.946 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.426 ' HB2' HG11 ' A' ' 45' ' ' VAL . 2.2 Cg_endo -81.61 41.77 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.523 2.815 . . . . 0.0 113.083 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.76 108.64 3.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.597 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 21.0 mm-40 -105.7 166.42 10.47 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 p -64.4 99.51 0.3 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.199 0.6 . . . . 0.0 110.953 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 35.27 44.55 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.451 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -88.52 165.43 14.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.388 0.675 . . . . 0.0 111.047 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.52 98.21 11.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.802 0.841 . . . . 0.0 109.615 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 98.96 10.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.506 0.722 . . . . 0.0 110.21 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.8 mp -75.96 101.12 2.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 94.5 t -79.42 106.9 11.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.691 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 9.1 pt-20 -78.61 169.04 18.88 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.219 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -130.34 137.11 49.76 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 170.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 N--CA 1.482 1.13 0 C-N-CA 123.07 0.548 . . . . 0.0 111.861 -179.775 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 11.2 m0 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.465 ' HB2' HD11 ' A' ' 13' ' ' LEU . 23.1 ptt180 -88.17 65.39 8.1 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.689 1.233 . . . . 0.0 109.563 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.539 ' HB ' HD12 ' A' ' 17' ' ' LEU . 43.3 t -79.12 143.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.507 -169.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -98.69 142.86 29.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.357 1.063 . . . . 0.0 109.943 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.448 ' SG ' HD13 ' A' ' 14' ' ' LEU . 72.1 m -136.39 99.99 4.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.231 1.013 . . . . 0.0 110.076 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -74.41 113.16 11.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 109.433 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.729 0 C-N-CA 122.773 0.429 . . . . 0.0 110.228 179.879 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -112.62 152.1 29.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 0.0 110.861 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER -113.31 112.94 24.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.448 HD13 ' SG ' ' A' ' 5' ' ' CYS . 5.5 mp -102.72 97.34 7.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.749 0.82 . . . . 0.0 109.041 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.446 ' HG3' HD12 ' A' ' 13' ' ' LEU . 78.5 mt-30 -78.86 -11.4 59.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.373 0.669 . . . . 0.0 110.951 169.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.52 -9.63 74.06 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.421 0.451 . . . . 0.0 114.049 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 21' ' ' THR . 71.1 mt -78.36 125.01 28.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.953 0.501 . . . . 0.0 110.382 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.483 ' O ' HD12 ' A' ' 61' ' ' LEU . 44.5 m -103.43 -178.11 3.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.321 1.449 . . . . 0.0 109.577 171.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 m -65.61 -39.86 91.99 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.92 0.488 . . . . 0.0 112.079 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -104.5 29.15 6.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.819 0.448 . . . . 0.0 112.165 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.547 HG21 HD22 ' A' ' 17' ' ' LEU . 94.9 m -64.08 104.88 0.78 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 122.84 0.456 . . . . 0.0 111.318 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -66.9 173.63 3.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.904 1.282 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' LEU . 6.3 tt -54.95 -50.87 67.81 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.451 0.7 . . . . 0.0 109.873 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.472 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 6.1 ptp180 -56.76 -26.26 56.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.972 0.909 . . . . 0.0 112.712 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 5.5 mm-40 -93.12 -35.46 13.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.897 0.879 . . . . 0.0 110.199 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -79.97 -68.69 0.65 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.035 0.934 . . . . 0.0 109.221 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.76 -19.01 65.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.604 0.565 . . . . 0.0 110.751 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.28 -43.86 77.65 Favored Glycine 0 C--N 1.345 1.051 0 O-C-N 123.929 0.768 . . . . 0.0 112.205 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.512 ' NE2' HD23 ' A' ' 17' ' ' LEU . 43.6 mt-30 -73.41 -38.91 65.42 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HB ' HE22 ' A' ' 41' ' ' GLN . 95.6 mt -57.11 -39.14 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.139 0.576 . . . . 0.0 111.249 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.19 68.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.612 0.765 . . . . 0.0 111.694 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.54 -23.35 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.068 0.947 . . . . 0.0 111.704 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 29' ' ' GLN . 22.2 mm -86.91 -69.38 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.916 0.886 . . . . 0.0 109.886 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.48 HG23 HG12 ' A' ' 36' ' ' ILE . 3.1 t -96.51 -11.73 25.09 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.273 0.629 . . . . 0.0 111.514 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 12.46 77.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.92 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.48 HG12 HG23 ' A' ' 34' ' ' THR . 13.2 mm -85.84 113.81 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.77 142.26 44.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.221 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.66 -24.41 62.57 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.226 2.617 . . . . 0.0 113.348 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.29 19.3 53.29 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.337 0.398 . . . . 0.0 113.27 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -134.6 -3.6 2.62 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.401 HE22 ' HB ' ' A' ' 30' ' ' ILE . 1.0 OUTLIER -123.92 145.67 48.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.613 0.765 . . . . 0.0 109.464 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -121.62 168.04 12.22 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 167.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 66' ' ' ILE . 46.5 mm -103.66 112.0 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.5 mm? -113.61 178.69 4.19 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.1 164.7 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.812 0.445 . . . . 0.0 111.311 -171.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.57 1.82 50.23 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 114.507 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -120.21 172.68 4.35 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -37.45 103.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.017 3.145 . . . . 0.0 113.656 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.17 146.14 56.8 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.634 2.222 . . . . 0.0 112.613 -170.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.32 2.38 55.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.725 0.81 . . . . 0.0 110.826 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.0 m 56.14 74.35 0.39 Allowed 'General case' 0 C--N 1.365 1.258 0 C-N-CA 124.749 1.22 . . . . 0.0 110.482 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.7 mt -77.84 101.14 6.62 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.808 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.13 104.93 17.44 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.296 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 23' ' ' LEU . 5.4 mp -73.85 85.21 1.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.2 t -82.41 -21.31 35.81 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.308 1.043 . . . . 0.0 110.984 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -107.81 136.98 46.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.884 0.874 . . . . 0.0 109.42 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -78.46 -22.45 47.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.579 0.751 . . . . 0.0 111.955 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -93.4 -2.56 54.53 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.448 0.699 . . . . 0.0 111.305 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.82 123.69 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.957 0.503 . . . . 0.0 110.539 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 p -104.51 177.35 4.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.891 0.476 . . . . 0.0 111.081 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 18' ' ' SER . 28.3 mt -74.55 -5.6 43.74 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.615 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.46 62.05 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.497 0.498 . . . . 0.0 111.902 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.92 -42.18 10.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.516 0.726 . . . . 0.0 109.279 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -78.84 152.22 77.21 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.171 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.49 25.49 0.54 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 124.14 3.227 . . . . 0.0 114.175 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.503 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.3 mp -77.08 128.69 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.5 mt-30 -118.03 -179.28 3.71 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.801 0.84 . . . . 0.0 108.917 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 p -68.41 -1.45 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 40.41 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.0 t70 -85.19 163.61 18.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.533 0.733 . . . . 0.0 111.577 -171.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.2 tpt -100.02 103.06 14.58 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.051 0.94 . . . . 0.0 109.508 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.503 ' HG ' HG13 ' A' ' 66' ' ' ILE . 3.2 mm? -109.37 131.24 55.25 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -92.97 114.11 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.43 115.66 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.214 1.006 . . . . 0.0 109.079 167.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -87.48 159.51 18.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -117.2 113.61 22.47 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 . . . . . 0 CA--C 1.541 0.622 0 C-N-CA 124.061 0.945 . . . . 0.0 109.727 179.484 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 10.8 m0 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -90.95 83.33 5.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.066 0.946 . . . . 0.0 109.124 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.7 t -105.59 141.23 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.734 0.814 . . . . 0.0 111.126 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -88.61 147.28 24.65 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 110.915 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.2 p -131.56 115.37 16.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.348 0.659 . . . . 0.0 110.4 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.574 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 14.3 tppt? -79.7 124.21 28.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.403 1.081 . . . . 0.0 109.434 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 123.118 0.567 . . . . 0.0 110.044 177.912 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.67 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.3 m-70 -102.95 177.84 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 tt -146.86 101.5 3.44 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.0 mp -79.16 113.34 17.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.969 0.908 . . . . 0.0 110.038 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -101.65 -9.39 20.96 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.357 0.663 . . . . 0.0 110.979 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.63 42.03 3.12 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 122.827 0.251 . . . . 0.0 113.165 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.455 HD23 HE22 ' A' ' 29' ' ' GLN . 96.5 mt -118.24 121.97 41.8 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.832 0.853 . . . . 0.0 109.835 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.2 p -97.44 171.97 8.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.373 1.069 . . . . 0.0 109.337 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 m -62.31 -29.34 70.37 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.281 0.632 . . . . 0.0 111.546 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -110.74 29.5 7.69 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.84 0.856 . . . . 0.0 112.142 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -70.88 121.11 17.49 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 166.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -89.93 169.6 11.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 110.093 -173.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 57' ' ' ARG . 24.9 tp -51.99 -51.56 56.43 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.856 0.863 . . . . 0.0 111.715 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 11.8 ptm180 -55.37 -34.1 64.0 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.731 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.563 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 44.0 mt-10 -88.26 -31.28 19.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.812 0.845 . . . . 0.0 110.877 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 43' ' ' ILE . 2.3 tm? -74.01 -66.4 0.72 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.034 0.934 . . . . 0.0 108.907 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -66.49 -20.84 66.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.192 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.37 -42.04 90.32 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.013 0.821 . . . . 0.0 111.67 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.455 HE22 HD23 ' A' ' 17' ' ' LEU . 20.9 mt-30 -73.71 -35.76 65.16 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.574 0.349 . . . . 0.0 110.078 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.43 ' HB ' HE22 ' A' ' 41' ' ' GLN . 84.2 mt -62.72 -37.56 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 C-N-CA 123.287 0.635 . . . . 0.0 110.53 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.73 -24.61 67.84 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.813 0.845 . . . . 0.0 112.022 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.47 -25.5 16.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.908 0.883 . . . . 0.0 111.804 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.563 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.4 mm -82.4 -65.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.331 1.052 . . . . 0.0 110.488 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.556 HG23 HG12 ' A' ' 36' ' ' ILE . 7.1 t -108.77 -0.36 20.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.98 0.912 . . . . 0.0 110.953 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.99 11.87 84.74 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.404 -0.664 . . . . 0.0 114.398 171.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 76' ' ' GLU . 23.0 mm -85.78 131.49 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 117.791 0.796 . . . . 0.0 111.442 -175.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 130.93 93.64 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.201 1.0 . . . . 0.0 110.335 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.05 -24.97 68.56 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.335 2.69 . . . . 0.0 113.42 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.61 -3.57 90.19 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.859 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.5 m -107.41 -48.21 3.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.762 0.825 . . . . 0.0 110.309 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.43 HE22 ' HB ' ' A' ' 30' ' ' ILE . 3.2 pt20 -76.91 153.77 34.35 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.269 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.69 168.36 23.85 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.448 1.099 . . . . 0.0 109.075 168.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.444 HG21 ' HD2' ' A' ' 65' ' ' PRO . 43.9 mm -79.41 103.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.259 1.028 . . . . 0.0 110.364 -174.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.2 mt -122.1 137.19 54.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.985 -1.916 . . . . 0.0 105.964 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 65' ' ' PRO . 16.3 m -125.68 179.1 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 122.733 0.413 . . . . 0.0 111.5 -169.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.65 -48.75 74.9 Favored Glycine 0 C--N 1.358 1.779 0 O-C-N 124.326 1.016 . . . . 0.0 113.654 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -80.7 155.82 73.19 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.929 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -45.29 108.04 0.13 Allowed 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 124.22 3.28 . . . . 0.0 113.593 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.04 169.14 8.97 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.946 2.431 . . . . 0.0 111.524 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.58 25.18 11.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.455 0.702 . . . . 0.0 111.417 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.1 m 53.2 65.07 1.62 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.03 0.932 . . . . 0.0 110.143 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.86 126.14 26.33 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.182 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -91.04 90.81 8.02 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.836 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.89 86.17 2.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -80.58 -41.46 23.99 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.0 0.92 . . . . 0.0 110.872 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 20.9 t0 -81.11 118.2 22.32 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.024 0.53 . . . . 0.0 110.385 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HA ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.75 -29.13 62.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.07 0.948 . . . . 0.0 112.832 174.313 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -93.52 -2.39 54.41 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.761 0.824 . . . . 0.0 112.047 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 14.0 tt -69.73 126.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.989 -0.444 . . . . 0.0 111.177 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -91.12 172.04 8.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.37 0.605 . . . . 0.0 112.437 -171.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 66' ' ' ILE . 27.6 mt -65.43 -17.78 64.81 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.149 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -28.62 66.77 Favored Glycine 0 C--N 1.36 1.886 0 O-C-N 123.483 0.489 . . . . 0.0 113.14 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.81 -52.24 5.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.129 0.571 . . . . 0.0 110.402 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.9 155.45 82.89 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.969 0.908 . . . . 0.0 111.756 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' HG11 ' A' ' 45' ' ' VAL . 4.4 Cg_exo -80.66 36.65 0.63 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.878 3.052 . . . . 0.0 114.126 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.568 HG13 HD21 ' A' ' 72' ' ' LEU . 2.0 mp -70.89 114.55 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 167.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.631 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 34.4 mt-30 -118.23 148.57 42.27 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -65.24 104.07 0.88 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.67 . . . . 0.0 110.659 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.88 11.51 52.98 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 114.113 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.631 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 27.9 t0 -89.53 160.68 16.59 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.273 0.629 . . . . 0.0 111.979 -173.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.574 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 4.8 tpt -96.21 108.31 20.77 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.766 1.226 . . . . 0.0 109.648 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.568 HD21 HG13 ' A' ' 66' ' ' ILE . 11.1 mp -109.67 126.12 53.34 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 0.0 110.288 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -85.88 103.29 12.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.53 111.65 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.618 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.99 155.41 19.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.71 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.601 ' HB2' HD12 ' A' ' 36' ' ' ILE . 10.0 tp10 -135.87 130.81 34.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.985 0.914 . . . . 0.0 109.446 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.354 0.662 . . . . 0.0 110.632 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 18.8 m0 . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.505 ' HB3' HD11 ' A' ' 13' ' ' LEU . 53.7 mtm180 -116.75 88.05 2.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.017 0.927 . . . . 0.0 108.775 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.487 HG13 HD23 ' A' ' 72' ' ' LEU . 82.3 t -89.43 137.36 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.455 0.702 . . . . 0.0 111.204 -170.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -87.45 138.67 31.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.746 0.819 . . . . 0.0 109.075 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 t -131.99 100.89 5.21 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.474 0.71 . . . . 0.0 111.11 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.488 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.0 tppp? -73.38 144.75 46.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.733 0.301 . . . . 0.0 111.34 -177.772 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.543 0.704 0 CA-C-O 121.112 0.482 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -122.97 164.66 18.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.33 1.452 . . . . 0.0 108.378 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 2' ' ' ARG . 0.3 OUTLIER -128.85 102.55 6.59 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.654 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.1 mp -81.3 121.77 26.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.041 0.936 . . . . 0.0 110.358 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.505 ' NE2' HD12 ' A' ' 13' ' ' LEU . 83.5 mm-40 -98.9 159.92 14.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.158 0.983 . . . . 0.0 109.762 174.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.8 10.43 83.13 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.135 -0.484 . . . . 0.0 114.17 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.39 137.44 42.71 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.113 0.565 . . . . 0.0 109.609 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -112.66 177.92 4.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.639 1.176 . . . . 0.0 109.36 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.7 p -82.32 -26.85 32.64 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.912 0.387 . . . . 0.0 109.972 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -86.8 6.92 29.2 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.926 0.89 . . . . 0.0 112.191 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.426 HG22 ' HB2' ' A' ' 26' ' ' LEU . 93.5 m -62.9 112.34 2.52 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 110.826 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.88 179.36 7.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.287 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 4.9 tt -57.53 -56.33 23.27 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.74 0.816 . . . . 0.0 109.652 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -20.31 64.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.673 0.789 . . . . 0.0 112.097 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -79.62 -52.81 7.51 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.509 0.724 . . . . 0.0 109.246 172.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.426 ' HB2' HG22 ' A' ' 21' ' ' THR . 2.5 tm? -69.29 -66.72 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.879 1.272 . . . . 0.0 110.756 -169.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -65.13 -18.3 65.19 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.141 0.576 . . . . 0.0 111.7 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.46 -41.03 46.12 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.7 0.625 . . . . 0.0 111.983 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -70.13 -37.03 75.18 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.105 0.562 . . . . 0.0 110.06 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.55 -43.73 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 0.0 110.912 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.417 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -60.76 -26.36 67.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.761 0.825 . . . . 0.0 111.743 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.51 -27.96 19.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.632 0.773 . . . . 0.0 111.769 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.654 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.4 mm -84.27 -70.07 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.115 0.566 . . . . 0.0 110.722 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 36' ' ' ILE . 6.4 t -88.53 -16.29 33.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.24 0.616 . . . . 0.0 111.154 -175.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.81 -1.91 85.55 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.361 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.401 ' H ' HG23 ' A' ' 34' ' ' THR . 18.9 mm -77.64 112.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.54 144.53 63.61 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 124.022 0.929 . . . . 0.0 110.772 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 31' ' ' ALA . 28.2 Cg_endo -57.85 -24.35 63.78 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.26 2.64 . . . . 0.0 113.212 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.49 19.8 34.32 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.639 -0.255 . . . . 0.0 113.28 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.8 m -140.37 12.62 2.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.458 1.103 . . . . 0.0 110.618 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -148.9 144.03 26.6 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.993 0.517 . . . . 0.0 109.81 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.8 176.35 6.66 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.279 1.032 . . . . 0.0 108.904 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -101.21 101.12 11.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 32.2 mt -116.28 145.58 43.05 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 49' ' ' PRO . 17.4 m -114.7 168.55 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.299 0.639 . . . . 0.0 110.017 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.01 65.72 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.789 0.681 . . . . 0.0 113.77 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -80.29 160.87 66.92 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.606 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -47.52 110.77 0.33 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HB3' HG22 ' A' ' 45' ' ' VAL . 90.8 Cg_endo -81.53 -179.81 5.21 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.273 2.649 . . . . 0.0 112.307 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.74 13.46 28.38 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.503 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.7 m 54.72 66.43 1.24 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 123.828 0.851 . . . . 0.0 108.706 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.77 129.24 39.09 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.863 -165.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.9 90.14 3.52 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 108.801 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 9.7 mp -87.49 104.99 16.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -100.65 -51.94 3.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.602 0.761 . . . . 0.0 110.562 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' O ' HG22 ' A' ' 59' ' ' ILE . 13.9 t0 -71.71 111.72 7.23 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.116 0.567 . . . . 0.0 111.317 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.546 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -53.09 -25.59 13.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.501 1.12 . . . . 0.0 113.554 175.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.51 -2.75 56.0 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.49 0.716 . . . . 0.0 112.11 -173.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 56' ' ' ASP . 15.4 tt -71.78 125.43 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.729 0.412 . . . . 0.0 110.836 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.6 p -89.4 176.01 7.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.659 0.743 . . . . 0.0 112.317 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.7 mt -73.52 -7.51 52.12 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.828 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.17 71.95 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.395 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.35 -52.04 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.4 0.68 . . . . 0.0 110.519 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.43 148.22 54.92 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.216 0.607 . . . . 0.0 111.144 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 31.51 0.44 Allowed 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.805 3.003 . . . . 0.0 114.936 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.31 117.8 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -120.42 163.42 17.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 t -71.16 108.53 4.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.837 0.455 . . . . 0.0 110.191 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.57 0.15 62.87 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.581 0.551 . . . . 0.0 113.206 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.19 156.68 38.34 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.193 0.597 . . . . 0.0 110.549 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.2 tpt -92.54 104.58 16.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.491 1.117 . . . . 0.0 109.021 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.487 HD23 HG13 ' A' ' 3' ' ' VAL . 4.3 mm? -105.08 115.75 30.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.885 0.874 . . . . 0.0 109.11 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.4 mp -86.79 100.73 10.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -78.21 105.09 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.599 166.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.5 161.69 27.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.834 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -116.52 109.4 17.21 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 124.183 0.993 . . . . 0.0 110.92 179.466 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 38.5 m0 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.842 0.353 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -125.17 106.81 10.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.469 HG11 HG23 ' A' ' 66' ' ' ILE . 37.3 t -130.75 139.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.922 -0.486 . . . . 0.0 110.35 -173.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -85.02 153.73 22.56 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.005 0.522 . . . . 0.0 111.72 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.545 ' SG ' HD23 ' A' ' 14' ' ' LEU . 95.3 m -130.72 112.14 12.81 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.395 1.078 . . . . 0.0 110.414 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 16.3 tppt? -82.34 107.67 15.19 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.426 1.09 . . . . 0.0 109.305 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.582 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 120.802 0.335 . . . . 0.0 111.253 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -101.36 179.21 4.42 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.975 0.91 . . . . 0.0 110.153 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.595 HD22 ' NE2' ' A' ' 15' ' ' GLN . 3.0 tt -135.35 106.27 6.62 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.545 HD23 ' SG ' ' A' ' 5' ' ' CYS . 4.3 mm? -66.0 108.68 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.684 0.794 . . . . 0.0 109.925 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.595 ' NE2' HD22 ' A' ' 13' ' ' LEU . 29.3 mm-40 -76.89 -45.77 26.89 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.199 0.999 . . . . 0.0 110.719 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.81 65.48 3.91 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.533 -0.758 . . . . 0.0 113.382 -174.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.9 mt -118.43 138.55 52.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.06 0.544 . . . . 0.0 110.29 172.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.42 ' O ' HD12 ' A' ' 61' ' ' LEU . 21.3 m -115.75 -176.91 3.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.204 1.402 . . . . 0.0 108.722 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.2 m -73.47 -33.72 64.99 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.186 0.517 . . . . 0.0 110.681 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -104.37 28.18 7.15 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.844 -175.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 26' ' ' LEU . 53.3 m -67.76 105.18 1.85 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.347 0.594 . . . . 0.0 109.686 171.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 36.2 mtm-85 -65.92 175.85 1.85 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.757 1.223 . . . . 0.0 111.637 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 54' ' ' LEU . 7.3 tt -56.39 -57.67 11.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.356 0.662 . . . . 0.0 109.28 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -50.51 -34.6 25.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.9 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 18.6 mm-40 -76.11 -51.03 13.07 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.002 0.429 . . . . 0.0 110.087 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 43' ' ' ILE . 2.4 tm? -70.76 -67.27 0.52 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.317 1.047 . . . . 0.0 110.68 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.432 ' HA ' HE22 ' A' ' 41' ' ' GLN . 40.2 mt-30 -66.55 -20.38 66.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.599 0.562 . . . . 0.0 111.618 -176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.22 -37.01 43.59 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.729 0.643 . . . . 0.0 112.192 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.431 ' O ' HG12 ' A' ' 33' ' ' ILE . 22.8 mt-30 -70.63 -39.73 73.53 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -62.76 -36.63 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.312 0.645 . . . . 0.0 110.615 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -26.34 68.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.439 0.695 . . . . 0.0 111.536 173.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.81 -23.04 20.72 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.92 0.888 . . . . 0.0 111.766 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 29' ' ' GLN . 16.0 mm -82.78 -70.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.372 0.669 . . . . 0.0 110.374 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.44 HG23 HG12 ' A' ' 36' ' ' ILE . 4.8 t -97.77 -7.75 29.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.16 19.23 78.72 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 119.712 -0.493 . . . . 0.0 113.321 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.44 HG12 HG23 ' A' ' 34' ' ' THR . 11.0 mm -98.49 108.26 21.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.84 155.07 55.13 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.498 1.119 . . . . 0.0 112.157 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.12 -31.71 84.19 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.419 2.746 . . . . 0.0 114.599 -174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.02 3.1 80.44 Favored Glycine 0 N--CA 1.476 1.353 0 O-C-N 123.124 0.265 . . . . 0.0 113.346 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.412 ' HA ' ' HB3' ' A' ' 77' ' ' ASP . 19.1 m -107.25 -2.93 20.28 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.198 0.999 . . . . 0.0 110.179 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.432 HE22 ' HA ' ' A' ' 27' ' ' GLN . 1.4 pp0? -144.53 162.45 36.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.974 0.416 . . . . 0.0 111.86 -176.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.48 -176.35 5.08 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.18 1.392 . . . . 0.0 108.885 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.596 HD11 HD11 ' A' ' 26' ' ' LEU . 29.0 mm -105.8 110.63 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.535 . . . . 0.0 109.723 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -121.34 160.18 24.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -131.92 173.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.755 0.822 . . . . 0.0 111.125 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.48 -5.1 87.86 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.814 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.418 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 54.0 p90 -113.51 163.2 19.07 Favored Pre-proline 0 N--CA 1.479 1.017 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 10.8 Cg_endo -50.89 109.21 0.28 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 122.88 2.387 . . . . 0.0 112.489 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.33 169.81 12.33 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.746 2.297 . . . . 0.0 112.159 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -88.08 5.73 39.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.706 0.802 . . . . 0.0 111.335 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 90.3 m 56.27 83.05 0.1 Allowed 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -158.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.61 95.6 3.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 110.512 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.75 114.0 20.1 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.143 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.488 ' HB3' HD12 ' A' ' 23' ' ' LEU . 4.7 mp -79.46 84.83 5.3 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 p -67.9 -50.56 55.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.468 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 19.3 t70 -76.25 157.55 32.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.083 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -92.52 -34.78 13.93 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.286 1.034 . . . . 0.0 111.815 -173.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.51 -3.07 50.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.9 1.28 . . . . 0.0 110.431 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.588 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 15.8 tt -60.85 133.51 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.637 1.175 . . . . 0.0 111.883 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -108.69 -177.9 3.44 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.578 HD21 ' HG ' ' A' ' 26' ' ' LEU . 49.7 mt -75.64 -10.05 59.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 112.061 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 -25.09 73.79 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.52 -59.33 2.16 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 109.846 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.75 129.79 75.47 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.282 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -63.21 78.26 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.918 3.079 . . . . 0.0 114.053 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.627 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -108.11 108.78 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 12.3 mm100 -103.31 155.05 18.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.972 0.509 . . . . 0.0 109.989 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.6 p -62.79 100.97 0.22 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.786 0.835 . . . . 0.0 111.826 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.53 46.08 8.22 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.608 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 6.0 t70 -110.25 169.71 8.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.309 0.644 . . . . 0.0 110.374 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.1 tpt -102.18 103.29 13.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.308 0.643 . . . . 0.0 109.991 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.6 mm? -106.01 114.68 28.96 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.475 0.71 . . . . 0.0 109.679 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 2.8 mp -82.13 108.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.667 0.787 . . . . 0.0 109.737 -176.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 75.8 t -82.97 116.42 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.706 1.203 . . . . 0.0 108.933 170.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.439 ' O ' HG21 ' A' ' 36' ' ' ILE . 11.9 pt-20 -82.31 170.23 15.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.646 0.26 . . . . 0.0 110.699 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -129.57 114.6 16.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 27.7 t70 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 124.342 1.057 . . . . 0.0 110.703 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 32.0 m0 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -81.16 94.8 6.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.9 144.3 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.189 0.995 . . . . 0.0 109.861 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -100.01 141.87 32.25 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.002 0.521 . . . . 0.0 110.903 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 31.2 p -122.85 112.49 17.94 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 0.0 111.369 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HB3' HG13 ' A' ' 73' ' ' ILE . 13.3 tppt? -81.03 106.1 12.77 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.9 0 C-N-CA 123.064 0.546 . . . . 0.0 111.518 -170.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.551 0.991 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 21.2 m-70 -104.78 179.31 4.31 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.046 0.939 . . . . 0.0 109.538 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' NE2' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -130.66 129.5 42.72 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.437 ' HG ' HG13 ' A' ' 33' ' ' ILE . 5.5 mp -99.98 118.21 35.91 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.48 1.112 . . . . 0.0 109.906 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.464 ' NE2' HD12 ' A' ' 13' ' ' LEU . 80.8 mm-40 -94.4 156.88 16.28 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.468 0.707 . . . . 0.0 109.199 171.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.16 81.72 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.536 -0.591 . . . . 0.0 114.409 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.89 118.57 12.9 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 110.072 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.4 m -114.01 172.99 6.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.197 0.999 . . . . 0.0 109.602 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.2 p -59.09 -35.22 73.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.832 0.853 . . . . 0.0 112.728 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -95.64 3.45 53.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.505 0.722 . . . . 0.0 112.636 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 25' ' ' GLU . 45.2 m -55.21 113.15 1.27 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.586 0.708 . . . . 0.0 111.495 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.56 172.18 11.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.177 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 54' ' ' LEU . 8.8 tt -59.15 -48.0 83.23 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.677 0.791 . . . . 0.0 110.536 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -25.15 67.37 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.998 0.519 . . . . 0.0 112.366 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 21' ' ' THR . 64.2 mm-40 -78.73 -53.05 7.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.572 0.749 . . . . 0.0 109.875 175.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.06 -55.35 29.98 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.47 1.508 . . . . 0.0 111.236 -173.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 15.1 mm100 -57.78 -34.22 69.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.358 1.063 . . . . 0.0 111.967 177.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.73 -34.26 77.61 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.969 0.793 . . . . 0.0 111.678 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -76.52 -39.31 53.35 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 123.195 0.598 . . . . 0.0 110.408 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -56.82 -44.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.403 0.681 . . . . 0.0 110.7 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.21 -24.16 67.57 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.586 0.754 . . . . 0.0 111.843 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.65 -28.42 19.49 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.79 0.836 . . . . 0.0 112.135 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.437 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.9 mm -91.66 -51.19 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.139 0.976 . . . . 0.0 111.782 -171.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.541 HG23 HG12 ' A' ' 36' ' ' ILE . 15.0 t -115.91 -5.88 12.03 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.344 0.658 . . . . 0.0 111.28 -178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.51 -10.32 74.35 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 168.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.541 HG12 HG23 ' A' ' 34' ' ' THR . 4.1 mm -82.4 118.5 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 117.953 0.876 . . . . 0.0 109.778 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.82 149.01 96.84 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.05 0.94 . . . . 0.0 111.3 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 11.7 Cg_endo -50.53 -41.01 54.14 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 124.198 3.265 . . . . 0.0 113.854 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.25 27.53 5.59 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.179 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.7 m -146.6 12.99 1.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.616 1.166 . . . . 0.0 109.033 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -155.7 151.05 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.188 0.518 . . . . 0.0 110.402 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -125.96 174.48 8.38 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.491 1.116 . . . . 0.0 108.143 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.514 HG12 HD21 ' A' ' 54' ' ' LEU . 47.3 mm -106.72 114.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.7 mm? -119.5 166.42 13.13 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 47' ' ' TYR . 4.0 m -129.35 161.26 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.374 0.67 . . . . 0.0 110.462 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -43.57 96.16 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.616 0.573 . . . . 0.0 113.035 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.48 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 32.8 p90 -72.77 163.25 69.58 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.161 167.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 14.6 Cg_endo -52.61 114.61 1.76 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.904 2.403 . . . . 0.0 114.071 -173.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 9.7 Cg_endo -88.68 178.66 2.75 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.366 2.71 . . . . 0.0 110.919 170.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.08 19.94 6.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.789 0.835 . . . . 0.0 109.601 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.4 m 57.04 82.37 0.12 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.591 1.157 . . . . 0.0 109.602 -164.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 43' ' ' ILE . 95.3 mt -53.11 131.11 36.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.593 0.757 . . . . 0.0 111.34 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -82.73 106.17 14.35 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.792 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.514 HD21 HG12 ' A' ' 43' ' ' ILE . 7.2 mp -105.35 80.49 1.59 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.816 0.846 . . . . 0.0 109.097 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 p -102.71 -34.42 9.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.779 0.831 . . . . 0.0 110.945 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' O ' HD13 ' A' ' 23' ' ' LEU . 8.8 t70 -82.61 -175.52 5.8 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.483 0.713 . . . . 0.0 109.95 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -31.1 1.48 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.621 0.768 . . . . 0.0 110.795 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.35 -19.58 42.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.876 0.87 . . . . 0.0 110.913 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.96 123.38 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 124.163 0.985 . . . . 0.0 111.109 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -96.54 -179.36 4.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -166.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.9 mt -68.92 -15.41 63.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.901 0.88 . . . . 0.0 111.838 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.6 -17.8 73.2 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.462 -0.336 . . . . 0.0 112.393 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.76 -63.06 1.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.924 0.89 . . . . 0.0 109.616 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.09 116.68 46.81 Favored Pre-proline 0 N--CA 1.486 1.345 0 CA-C-O 117.646 -1.168 . . . . 0.0 107.999 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -55.64 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.995 3.13 . . . . 0.0 115.055 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.464 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -110.4 121.66 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 166.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 37.8 mt-30 -119.53 166.22 13.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.287 0.635 . . . . 0.0 109.668 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.6 m -63.74 95.92 0.12 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.819 0.848 . . . . 0.0 110.925 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.93 29.41 23.31 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.436 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 23.6 t70 -87.79 160.47 18.02 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.148 0.579 . . . . 0.0 109.893 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.7 tpt -96.9 100.98 12.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 110.261 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.1 mm? -104.94 112.79 26.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.671 0.788 . . . . 0.0 109.429 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -81.78 114.47 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.76 115.91 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 108.467 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.9 179.89 6.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 110.665 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -131.94 106.57 8.13 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t70 . . . . . 0 CA--C 1.554 1.118 0 C-N-CA 124.737 1.215 . . . . 0.0 110.9 173.084 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.9 m0 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.675 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 78.3 mtm180 -80.35 69.93 6.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.151 0.98 . . . . 0.0 109.564 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.487 ' HB ' HD12 ' A' ' 17' ' ' LEU . 96.3 t -79.21 132.95 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.739 0.816 . . . . 0.0 111.142 -171.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.4 ' CB ' ' HE3' ' A' ' 71' ' ' MET . 99.0 mtt180 -84.03 140.82 31.6 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.452 0.701 . . . . 0.0 109.958 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 4.0 t -125.37 96.98 5.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.045 0.938 . . . . 0.0 110.255 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.1 102.67 9.48 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.362 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.169 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 120.689 0.281 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 79.7 m-70 -118.82 178.06 4.62 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.491 1.116 . . . . 0.0 108.42 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 2' ' ' ARG . 1.3 tm? -146.31 114.18 6.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.6 mp -104.97 105.87 16.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.75 1.22 . . . . 0.0 109.224 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.675 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 78.2 mt-30 -84.17 -17.76 38.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.337 0.655 . . . . 0.0 111.067 172.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.62 24.64 4.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.487 HD12 ' HB ' ' A' ' 3' ' ' VAL . 87.0 mt -110.33 123.95 50.78 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.728 0.811 . . . . 0.0 109.486 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 61' ' ' LEU . 25.9 m -113.67 171.43 7.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.546 1.138 . . . . 0.0 108.97 172.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -57.84 -41.66 82.8 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.002 0.429 . . . . 0.0 112.128 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -92.19 17.05 10.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.654 0.782 . . . . 0.0 112.076 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -68.19 122.41 18.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.212 0.605 . . . . 0.0 110.119 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -78.57 177.15 8.8 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.824 0.45 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 56' ' ' ASP . 7.3 tt -55.08 -50.82 68.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.148 0.979 . . . . 0.0 110.537 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -61.38 -30.36 70.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.421 -173.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -80.55 -46.66 15.41 Favored 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 122.588 0.355 . . . . 0.0 110.389 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.76 -68.31 0.35 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.92 0.888 . . . . 0.0 110.594 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -66.87 -20.65 65.96 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.07 0.548 . . . . 0.0 111.519 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.13 -38.14 59.48 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.885 0.741 . . . . 0.0 112.328 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -74.05 -39.55 63.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.127 0.571 . . . . 0.0 109.6 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.8 mt -57.46 -40.64 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.558 0.743 . . . . 0.0 110.669 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.83 -24.39 67.74 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.055 0.942 . . . . 0.0 111.844 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.51 -32.35 15.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.858 0.863 . . . . 0.0 111.786 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.6 mm -79.94 -65.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.395 1.078 . . . . 0.0 110.283 -174.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.471 HG23 HG12 ' A' ' 36' ' ' ILE . 10.1 t -99.45 -15.93 18.54 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.407 0.683 . . . . 0.0 111.3 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.32 82.97 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.202 -0.777 . . . . 0.0 114.338 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 34' ' ' THR . 13.7 mm -78.76 119.56 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.169 0.984 . . . . 0.0 108.348 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.11 142.52 85.64 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 124.235 0.96 . . . . 0.0 111.24 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.73 -27.67 72.09 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.406 2.737 . . . . 0.0 113.256 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.42 27.04 14.8 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.119 0.39 . . . . 0.0 112.589 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.6 m -142.14 7.66 1.81 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.482 1.113 . . . . 0.0 109.698 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -148.71 149.16 30.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.946 0.898 . . . . 0.0 109.983 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.23 -175.31 3.53 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.312 1.045 . . . . 0.0 108.973 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.542 HG21 ' HD2' ' A' ' 65' ' ' PRO . 49.2 mm -104.49 109.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.27 0.628 . . . . 0.0 109.616 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 34.8 mt -122.04 151.79 40.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 49' ' ' PRO . 17.1 m -132.39 173.72 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.48 0.712 . . . . 0.0 110.907 -174.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.4 -49.01 66.32 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.874 0.734 . . . . 0.0 113.835 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -79.47 158.11 74.18 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.644 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -46.24 104.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.485 2.79 . . . . 0.0 114.624 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HB3' HG22 ' A' ' 45' ' ' VAL . 98.6 Cg_endo -82.81 156.88 15.77 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.886 2.391 . . . . 0.0 112.808 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -75.75 -22.52 56.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.6 0.76 . . . . 0.0 112.147 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.2 m 65.92 35.93 6.25 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.369 1.068 . . . . 0.0 109.014 -171.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.3 pt? -39.59 140.93 0.44 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.922 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.31 106.74 16.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.463 0.705 . . . . 0.0 110.209 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 23' ' ' LEU . 8.5 mp -86.05 96.79 9.98 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.514 0.726 . . . . 0.0 109.429 175.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -109.1 -39.73 5.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.87 0.868 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.447 ' O ' HD13 ' A' ' 23' ' ' LEU . 20.3 t0 -75.63 145.24 41.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.389 0.676 . . . . 0.0 110.693 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.546 ' H ' ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.57 -20.67 15.58 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.093 0.957 . . . . 0.0 110.551 -177.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.45 -19.52 49.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.326 1.05 . . . . 0.0 111.251 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 tt -57.71 126.13 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.667 0.787 . . . . 0.0 111.46 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -106.34 175.9 5.34 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.095 0.958 . . . . 0.0 111.104 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 21.1 mt -74.1 -1.07 18.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.8 0.84 . . . . 0.0 111.473 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.92 -39.04 64.65 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.818 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.54 -48.53 6.81 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 96.1 mt -59.77 139.23 90.07 Favored Pre-proline 0 CA--C 1.558 1.266 0 O-C-N 123.871 0.732 . . . . 0.0 110.36 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HD2' HG21 ' A' ' 43' ' ' ILE . 6.3 Cg_exo -79.2 45.1 1.84 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.436 2.757 . . . . 0.0 113.385 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.499 ' HA ' HD21 ' A' ' 72' ' ' LEU . 2.1 mp -93.41 119.5 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 171.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 36.2 mm-40 -116.47 166.79 11.68 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.027 0.531 . . . . 0.0 109.573 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 p -64.59 109.92 2.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.29 0.636 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 78.57 10.15 86.44 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.11 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.1 t70 -76.65 159.18 30.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.24 0.616 . . . . 0.0 111.353 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.4 ' HE3' ' CB ' ' A' ' 4' ' ' ARG . 2.9 tpt -86.08 101.88 13.35 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.454 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 66' ' ' ILE . 4.6 mm? -102.04 113.18 26.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.267 1.027 . . . . 0.0 108.883 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.9 mp -88.48 99.89 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.67 105.77 5.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.844 170.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.4 149.85 36.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.366 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -110.2 105.02 13.93 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 CA--C 1.567 1.63 0 C-N-CA 123.66 0.784 . . . . 0.0 110.349 172.506 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 9.0 m0 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.462 ' HB3' HD11 ' A' ' 13' ' ' LEU . 54.2 mtt180 -87.22 74.11 9.6 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG11 HG23 ' A' ' 66' ' ' ILE . 34.7 t -87.21 138.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.672 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -89.54 158.2 17.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.573 0.749 . . . . 0.0 110.519 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 28.1 p -142.97 114.57 8.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.214 0.606 . . . . 0.0 109.627 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -79.02 109.61 13.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.57 0 C-N-CA 122.977 0.511 . . . . 0.0 110.313 -174.095 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 32.4 m80 -94.59 160.73 14.5 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.1 -174.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.462 HD11 ' HB3' ' A' ' 2' ' ' ARG . 2.7 tm? -119.14 115.3 23.96 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.556 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -98.79 132.45 44.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 109.207 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.46 173.03 12.02 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.05 12.47 76.64 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 1' ' ' TRP . 98.5 mt -83.54 115.38 22.07 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.369 0.668 . . . . 0.0 109.491 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.3 t -79.23 173.75 12.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.484 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.1 p -64.09 -35.62 81.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.996 0.427 . . . . 0.0 110.595 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -104.72 33.46 3.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.07 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.446 HG21 HD22 ' A' ' 17' ' ' LEU . 74.6 m -69.26 113.01 6.21 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 171.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -77.52 178.28 7.37 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.349 1.059 . . . . 0.0 111.234 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 54' ' ' LEU . 8.4 tt -57.16 -54.9 41.55 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.436 0.695 . . . . 0.0 110.228 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -14.43 63.04 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.231 -174.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.36 -49.41 8.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.611 0.764 . . . . 0.0 109.24 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 43' ' ' ILE . 2.4 tm? -75.51 -64.55 1.05 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.668 1.187 . . . . 0.0 110.464 -170.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.8 -20.17 64.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.23 0.612 . . . . 0.0 111.083 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.24 -43.76 88.08 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 124.011 0.82 . . . . 0.0 111.902 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.75 -36.24 67.66 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 119.509 -0.282 . . . . 0.0 110.268 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.92 -44.47 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.268 0.627 . . . . 0.0 110.343 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.74 66.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.167 0.987 . . . . 0.0 112.116 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.57 -40.01 12.9 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.317 0.647 . . . . 0.0 111.605 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.556 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.8 mm -69.13 -65.97 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.227 1.011 . . . . 0.0 110.629 -173.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.424 HG23 HG12 ' A' ' 36' ' ' ILE . 5.0 t -99.85 -11.87 20.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.291 -175.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.07 86.1 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.499 -0.612 . . . . 0.0 114.122 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.424 HG12 HG23 ' A' ' 34' ' ' THR . 13.3 mm -83.37 118.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.52 146.44 73.04 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.798 0.839 . . . . 0.0 111.474 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.43 -30.86 92.75 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.165 2.577 . . . . 0.0 112.419 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.64 32.55 5.24 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.531 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -141.86 2.12 1.53 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 110.163 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -148.96 163.63 36.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.897 0.879 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 176.03 10.64 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.393 0.677 . . . . 0.0 110.042 173.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.406 HD11 HD11 ' A' ' 26' ' ' LEU . 44.7 mm -84.05 113.8 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 17.7 mt -132.43 123.63 27.06 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 16.3 m -102.78 173.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.975 0.51 . . . . 0.0 112.197 -169.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -46.42 93.78 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 124.353 1.033 . . . . 0.0 114.235 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -79.34 158.3 74.25 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 117.959 -1.019 . . . . 0.0 108.912 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.95 107.1 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.403 2.736 . . . . 0.0 113.628 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 63.1 Cg_endo -77.31 155.86 32.8 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.509 2.139 . . . . 0.0 112.179 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -94.78 34.33 1.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.646 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 62.8 m 75.66 -54.3 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.773 1.629 . . . . 0.0 110.726 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.5 mt 68.01 90.96 0.09 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.869 1.267 . . . . 0.0 110.682 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.22 101.14 13.86 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.801 0.84 . . . . 0.0 110.252 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.662 ' HB3' HD12 ' A' ' 23' ' ' LEU . 6.1 mp -78.05 99.41 6.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -124.87 39.24 4.02 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.186 0.594 . . . . 0.0 111.009 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 59' ' ' ILE . 28.1 t70 -163.59 146.01 9.73 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.591 0.756 . . . . 0.0 109.856 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -76.66 -31.66 57.46 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.953 0.501 . . . . 0.0 111.394 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.65 -3.92 54.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.717 0.807 . . . . 0.0 112.286 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 56' ' ' ASP . 10.7 tt -64.08 123.62 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.108 0.48 . . . . 0.0 110.485 -176.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.7 p -101.89 176.62 5.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -166.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 mt -69.23 -12.19 61.46 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.621 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.97 -22.0 69.77 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.77 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.49 -53.07 3.88 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.84 150.47 92.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.57 43.53 1.51 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.98 2.453 . . . . 0.0 114.661 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.569 HG13 HD21 ' A' ' 72' ' ' LEU . 2.6 mp -73.0 119.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 38.1 mt-30 -118.64 157.24 27.79 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 p -64.02 103.67 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.435 0.694 . . . . 0.0 111.442 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.41 21.97 57.42 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.967 -0.561 . . . . 0.0 113.402 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 9.8 t70 -79.76 160.9 26.02 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.856 0.463 . . . . 0.0 110.294 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 tpt -91.16 98.79 11.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.714 0.805 . . . . 0.0 109.56 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.569 HD21 HG13 ' A' ' 66' ' ' ILE . 6.7 mp -93.83 104.71 16.77 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.8 mp -72.12 90.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -84.24 95.63 4.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.686 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -77.99 153.23 32.61 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.174 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -104.96 99.25 8.87 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 CA--C 1.558 1.28 0 C-N-CA 123.89 0.876 . . . . 0.0 109.846 171.634 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 16.3 m0 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.585 0.231 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.52 ' HB3' HD21 ' A' ' 13' ' ' LEU . 75.4 mtt180 -108.47 71.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.067 0.947 . . . . 0.0 108.684 173.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 66' ' ' ILE . 71.7 t -79.09 123.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.642 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.435 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 66.0 mtt180 -81.79 141.49 33.44 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 14' ' ' LEU . 92.3 m -135.54 105.67 6.3 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.715 0.406 . . . . 0.0 111.19 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -79.84 98.41 7.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 109.981 -175.776 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -109.69 176.25 5.14 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.777 0.831 . . . . 0.0 109.76 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 2' ' ' ARG . 10.4 tt -151.19 116.06 5.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.614 ' HG ' HG13 ' A' ' 33' ' ' ILE . 7.3 mp -90.63 131.02 36.58 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.811 1.244 . . . . 0.0 109.607 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -92.09 164.44 13.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.578 0.751 . . . . 0.0 110.571 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.97 -97.19 1.62 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-O 118.833 -0.982 . . . . 0.0 111.225 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 61' ' ' LEU . 4.1 mm? 42.16 104.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.567 1.547 . . . . 0.0 113.217 -175.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.9 t -73.18 154.2 40.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -62.71 -21.97 66.16 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 121.222 0.534 . . . . 0.0 110.674 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 74.1 mtt180 -110.01 29.99 7.13 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.289 1.036 . . . . 0.0 111.522 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.8 m -66.57 112.0 3.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -65.79 163.43 16.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.307 1.043 . . . . 0.0 110.969 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.433 HD13 HD23 ' A' ' 54' ' ' LEU . 23.5 tp -53.55 -52.2 60.45 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.07 0.948 . . . . 0.0 111.697 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 ptt85 -60.02 -24.1 64.23 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.159 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.26 -38.02 14.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.533 0.733 . . . . 0.0 110.058 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -66.09 0.64 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.534 1.134 . . . . 0.0 110.091 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.81 -17.41 64.51 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.458 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.47 -37.26 85.37 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.687 0.617 . . . . 0.0 112.076 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -75.63 -40.45 56.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.243 0.617 . . . . 0.0 110.419 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.438 ' HB ' HE22 ' A' ' 41' ' ' GLN . 82.1 mt -61.78 -35.83 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.537 0.735 . . . . 0.0 110.926 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -24.99 66.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.128 0.971 . . . . 0.0 112.009 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.01 -42.83 9.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.976 0.911 . . . . 0.0 111.161 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.614 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.1 mm -66.11 -50.69 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 112.011 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.559 HG23 HG12 ' A' ' 36' ' ' ILE . 7.2 t -124.04 -1.32 8.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.122 0.569 . . . . 0.0 111.377 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 -0.23 89.56 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 34' ' ' THR . 11.4 mm -82.54 103.78 10.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.76 152.53 67.95 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.951 0.9 . . . . 0.0 111.426 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.84 -38.51 57.6 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.76 2.974 . . . . 0.0 114.547 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.25 30.45 5.95 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.44 -0.346 . . . . 0.0 113.325 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -132.42 -3.47 3.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.063 0.945 . . . . 0.0 110.09 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.438 HE22 ' HB ' ' A' ' 30' ' ' ILE . 1.5 pt20 -140.19 163.75 31.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.594 0.758 . . . . 0.0 111.376 -171.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -147.97 170.94 16.62 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.767 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 72' ' ' LEU . 49.2 mm -96.61 110.24 24.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.443 -175.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 mt -123.8 159.18 30.09 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.718 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' ' HG3' ' A' ' 49' ' ' PRO . 5.2 m -141.11 -179.21 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.216 1.007 . . . . 0.0 110.27 -171.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.36 -46.15 65.31 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.934 0.771 . . . . 0.0 113.205 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -74.87 162.15 74.69 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.404 171.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 12.6 Cg_endo -53.17 108.63 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.941 2.427 . . . . 0.0 111.867 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 2.8 Cg_exo -74.25 172.81 15.29 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.186 2.591 . . . . 0.0 111.979 -174.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.25 -2.12 57.7 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.495 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.6 m 51.28 65.13 1.58 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 124.119 0.968 . . . . 0.0 109.11 -172.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 mp -67.32 134.04 50.8 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.792 -165.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.35 88.19 5.04 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.433 HD23 HD13 ' A' ' 23' ' ' LEU . 5.5 mp -77.43 88.3 3.8 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 p -97.11 -49.16 5.1 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.999 0.92 . . . . 0.0 110.867 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 59' ' ' ILE . 21.6 t70 -73.39 123.63 24.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.999 0.92 . . . . 0.0 110.255 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.56 -20.49 59.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.997 0.519 . . . . 0.0 112.31 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -89.67 -8.24 52.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.968 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 56' ' ' ASP . 14.7 tt -64.11 123.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 121.404 0.621 . . . . 0.0 110.32 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.456 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 64.8 p -97.34 175.19 6.35 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.469 -170.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.565 HD11 HD12 ' A' ' 17' ' ' LEU . 23.4 mt -69.76 -13.81 62.47 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.55 173.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.15 -29.45 72.9 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.736 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -93.88 -60.75 1.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.55 143.36 86.33 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.715 1.206 . . . . 0.0 111.238 -174.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.13 39.65 0.84 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.552 2.834 . . . . 0.0 114.429 -173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.512 HG13 ' HG ' ' A' ' 72' ' ' LEU . 3.1 mp -87.26 120.56 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 172.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 24.1 mm-40 -119.97 159.28 25.01 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.821 0.848 . . . . 0.0 110.213 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.6 p -68.23 112.05 4.91 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.509 0.723 . . . . 0.0 110.853 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.99 12.82 82.17 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.639 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 20.2 t70 -86.17 160.52 19.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.697 0.799 . . . . 0.0 109.798 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.435 ' HE3' ' HB3' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -95.77 97.59 9.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.017 0.927 . . . . 0.0 110.355 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.512 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.1 mm? -96.55 113.58 25.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.521 0.728 . . . . 0.0 109.622 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.2 mp -78.76 103.2 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.3 t -82.29 104.52 11.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.344 171.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.69 159.71 28.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.294 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -124.49 124.84 43.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 123.488 0.715 . . . . 0.0 111.174 178.384 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . 0.425 ' HB3' HG23 ' A' ' 3' ' ' VAL . 13.2 m0 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.488 ' HG3' HD11 ' A' ' 13' ' ' LEU . 11.0 mpt_? -79.75 67.37 5.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.704 0.802 . . . . 0.0 109.742 173.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 1' ' ' TRP . 72.1 t -77.39 119.95 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.75 0.42 . . . . 0.0 109.875 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -93.99 128.38 40.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 95.8 m -117.79 111.3 18.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.372 0.669 . . . . 0.0 110.402 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 13.9 tppt? -75.41 127.45 33.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.718 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 0.0 109.785 175.32 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -92.51 142.6 27.23 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.858 0.863 . . . . 0.0 108.805 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.488 HD11 ' HG3' ' A' ' 2' ' ' ARG . 2.7 tm? -103.3 105.21 15.43 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.535 ' HG ' HG13 ' A' ' 33' ' ' ILE . 8.2 mp -86.93 139.03 31.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.339 0.655 . . . . 0.0 110.918 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.31 164.2 16.02 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.867 1.267 . . . . 0.0 109.675 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.89 79.53 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.321 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 61' ' ' LEU . 3.6 mm? -82.61 108.32 15.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.466 ' O ' HD12 ' A' ' 61' ' ' LEU . 44.4 t -84.7 170.03 13.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.852 168.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -69.1 -22.59 63.97 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.162 0.506 . . . . 0.0 111.054 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -111.6 23.26 14.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.293 1.037 . . . . 0.0 111.75 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.7 m -63.34 108.35 1.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -69.99 172.07 8.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.096 0.958 . . . . 0.0 111.689 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.6 tp -50.64 -55.82 14.66 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.276 1.031 . . . . 0.0 111.574 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.1 ptm180 -49.51 -37.47 26.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.612 1.165 . . . . 0.0 113.353 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 10.8 mm-40 -85.81 -35.97 20.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.288 0.635 . . . . 0.0 110.962 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.66 -66.07 0.79 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.065 0.946 . . . . 0.0 109.033 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.406 ' HA ' HE22 ' A' ' 41' ' ' GLN . 66.4 mt-30 -67.46 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.272 178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.96 89.58 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.032 0.833 . . . . 0.0 111.959 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -72.95 -45.06 60.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.32 -39.49 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.44 0.696 . . . . 0.0 111.116 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.49 67.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.65 0.78 . . . . 0.0 111.678 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.3 14.83 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.545 0.738 . . . . 0.0 111.351 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.535 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.2 mm -76.46 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.342 1.057 . . . . 0.0 110.914 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.519 HG23 HG12 ' A' ' 36' ' ' ILE . 7.5 t -102.09 -9.96 20.1 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 0.0 111.019 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.65 69.76 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 119.783 -0.454 . . . . 0.0 114.034 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG12 HG23 ' A' ' 34' ' ' THR . 21.2 mm -90.44 127.73 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.67 138.83 61.41 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.782 0.833 . . . . 0.0 110.676 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 -39.31 83.77 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.559 2.839 . . . . 0.0 113.342 -174.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.78 22.08 26.75 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.737 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -124.83 -5.14 7.51 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.234 1.014 . . . . 0.0 109.902 174.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.568 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 1.3 pp0? -130.23 143.77 50.97 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 124.201 1.0 . . . . 0.0 109.236 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -135.05 179.12 6.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.728 0.811 . . . . 0.0 109.341 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 66' ' ' ILE . 45.9 mm -94.47 92.46 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 121.995 0.903 . . . . 0.0 109.077 -174.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.4 mt -110.09 149.33 30.2 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 65' ' ' PRO . 9.4 m -134.02 179.73 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.113 0.565 . . . . 0.0 111.371 -167.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.02 11.01 8.27 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.333 -0.848 . . . . 0.0 114.736 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -144.33 160.72 47.59 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.162 1.385 . . . . 0.0 108.042 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -39.55 109.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.713 2.942 . . . . 0.0 113.99 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -80.68 -171.93 1.38 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.368 2.712 . . . . 0.0 112.172 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -122.73 15.23 10.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.65 0.78 . . . . 0.0 110.735 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.5 m 55.5 73.26 0.43 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.042 0.937 . . . . 0.0 109.474 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.71 108.87 8.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.886 -171.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -97.42 126.65 42.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.297 1.039 . . . . 0.0 108.205 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 mp -100.24 78.98 2.1 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 m -75.05 -28.51 60.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.294 0.638 . . . . 0.0 110.796 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.65 152.65 31.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.453 0.471 . . . . 0.0 109.773 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.54 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -103.46 -29.21 11.32 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.444 0.698 . . . . 0.0 111.641 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -89.62 -11.82 41.49 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.494 0.718 . . . . 0.0 110.753 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.62 134.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 111.695 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.0 p -117.48 179.07 4.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 111.39 -169.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.581 HD11 HD12 ' A' ' 17' ' ' LEU . 40.3 mt -68.49 -13.44 62.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.634 0.774 . . . . 0.0 111.572 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.17 80.03 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.336 0.398 . . . . 0.0 112.396 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -84.74 -55.86 3.88 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.126 0.57 . . . . 0.0 109.534 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.24 152.0 92.33 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.434 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.545 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.2 Cg_exo -69.09 21.65 0.15 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.811 3.007 . . . . 0.0 115.488 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 43' ' ' ILE . 3.2 mp -73.92 116.62 16.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 172.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -118.75 173.92 6.58 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -71.16 101.67 2.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.16 0.584 . . . . 0.0 109.943 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 89.03 20.42 46.44 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.176 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.33 162.28 25.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.037 0.535 . . . . 0.0 111.007 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.409 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 3.6 tpt -102.85 104.73 15.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.947 0.899 . . . . 0.0 109.696 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.417 HD23 HG13 ' A' ' 3' ' ' VAL . 3.7 mm? -105.13 112.16 25.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.044 0.937 . . . . 0.0 108.992 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.82 97.88 4.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.24 104.98 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.155 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.568 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 8.0 pt-20 -76.44 167.55 21.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.854 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.27 103.99 5.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 CA--C 1.551 0.989 0 C-N-CA 123.391 0.676 . . . . 0.0 110.507 173.673 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . 0.457 ' HB3' HG23 ' A' ' 3' ' ' VAL . 14.1 m0 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.551 ' HG2' HE22 ' A' ' 15' ' ' GLN . 82.1 mtt85 -79.19 69.76 5.45 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.381 0.673 . . . . 0.0 109.513 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 1' ' ' TRP . 89.6 t -83.94 129.64 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.346 0.658 . . . . 0.0 110.084 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -88.59 141.1 28.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.36 0.664 . . . . 0.0 109.209 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 71.1 m -138.33 101.34 4.36 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.332 0.653 . . . . 0.0 110.526 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -73.3 112.56 9.48 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.982 0.913 . . . . 0.0 109.734 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 123.394 0.677 . . . . 0.0 110.23 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -89.6 115.29 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.772 0.829 . . . . 0.0 109.636 -174.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.85 104.16 14.56 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.809 0.444 . . . . 0.0 110.548 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.63 127.91 34.08 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 111.076 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.551 HE22 ' HG2' ' A' ' 2' ' ' ARG . 32.3 mm-40 -113.3 176.22 5.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.781 1.233 . . . . 0.0 110.103 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.28 3.45 61.52 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 1' ' ' TRP . 82.5 mt -84.42 129.38 34.87 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 123.804 0.842 . . . . 0.0 111.065 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.458 ' O ' HD12 ' A' ' 61' ' ' LEU . 17.8 m -108.37 -176.56 3.08 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.374 168.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.7 p -66.2 -29.58 69.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.058 0.456 . . . . 0.0 110.69 171.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.98 23.41 8.99 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.88 0.872 . . . . 0.0 112.713 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.3 m -80.51 130.38 35.1 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 82.2 mtm180 -98.83 177.76 5.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.731 0.812 . . . . 0.0 110.384 -174.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 57' ' ' ARG . 5.4 tt -48.16 -59.53 3.33 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.181 1.392 . . . . 0.0 110.717 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.526 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 9.3 ptp180 -61.66 -26.8 68.24 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.637 -173.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 46.9 mt-10 -91.55 -30.04 16.62 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.979 0.912 . . . . 0.0 110.459 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.82 -67.24 0.78 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.749 0.82 . . . . 0.0 109.197 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.4 -16.26 63.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.777 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.45 -39.56 56.48 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.524 0.515 . . . . 0.0 111.929 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -73.83 -35.94 64.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.098 0.559 . . . . 0.0 110.284 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.12 -44.14 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.339 0.656 . . . . 0.0 109.704 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.04 68.07 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.775 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.42 -29.12 23.11 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.61 0.764 . . . . 0.0 111.856 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.1 mt -89.19 -69.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 117.878 0.308 . . . . 0.0 111.069 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.589 HG23 HG12 ' A' ' 36' ' ' ILE . 9.5 t -88.43 -5.48 58.24 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.95 6.55 87.36 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.303 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.589 HG12 HG23 ' A' ' 34' ' ' THR . 11.7 mm -82.61 107.71 14.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.55 145.41 49.6 Favored Pre-proline 0 N--CA 1.48 1.058 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.539 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -54.28 -32.05 69.62 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.474 2.783 . . . . 0.0 113.658 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.86 24.67 19.91 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 116.4 -0.364 . . . . 0.0 113.544 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 m -131.96 4.66 4.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.527 1.131 . . . . 0.0 109.863 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -137.09 149.48 47.4 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.506 1.122 . . . . 0.0 109.347 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -120.19 -166.16 1.27 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.515 HG23 HD12 ' A' ' 72' ' ' LEU . 41.1 mm -123.31 105.7 16.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 4.3 mp -121.14 172.39 8.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.081 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.513 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 2.7 m -139.85 162.02 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 109.869 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.8 87.86 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 124.325 1.016 . . . . 0.0 113.368 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -72.6 155.41 91.03 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 117.756 -1.116 . . . . 0.0 109.597 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -33.61 100.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.397 3.116 0 C-N-CA 124.821 3.681 . . . . 0.0 114.763 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.513 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 99.0 Cg_endo -81.26 158.7 20.08 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.683 2.256 . . . . 0.0 113.421 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 30.5 mm-40 -101.14 90.34 4.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.0 m -47.79 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.636 1.174 . . . . 0.0 111.543 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -99.44 167.53 10.56 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 111.805 179.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.06 144.51 40.07 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.75 93.22 4.78 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -85.47 -47.65 9.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.181 0.592 . . . . 0.0 110.239 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 12.8 t70 -73.25 107.3 5.48 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 -174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.53 -24.58 32.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.93 -7.06 41.08 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.94 0.896 . . . . 0.0 112.272 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 tt -63.39 136.83 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.021 0.528 . . . . 0.0 111.146 -174.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 10.0 m -109.9 168.01 9.74 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.503 0.721 . . . . 0.0 111.601 -164.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 18' ' ' SER . 32.7 mt -59.55 -25.35 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.484 1.114 . . . . 0.0 112.895 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.63 -29.33 74.9 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.422 0.451 . . . . 0.0 112.881 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.57 -45.93 12.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.703 0.801 . . . . 0.0 109.87 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.98 160.04 72.15 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.698 0.799 . . . . 0.0 111.56 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.6 37.32 0.5 Allowed 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.294 2.662 . . . . 0.0 114.403 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 mp -88.28 114.13 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 29.5 mm-40 -118.4 158.48 25.21 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 p -67.46 109.48 3.22 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.506 0.722 . . . . 0.0 111.018 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 88.96 -1.55 83.32 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 21.8 t70 -73.67 159.27 33.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.556 0.742 . . . . 0.0 111.339 -172.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.6 tpt -91.31 102.25 14.96 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.703 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 43' ' ' ILE . 4.0 mm? -100.57 135.81 41.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.489 1.116 . . . . 0.0 108.314 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.9 mp -100.58 113.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 54.7 t -94.08 109.51 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.73 172.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 36' ' ' ILE . 10.1 pt-20 -83.01 159.66 22.14 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 175.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -117.39 119.0 33.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.5 t70 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 122.974 0.51 . . . . 0.0 110.911 178.881 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' TRP . . . . . 0.455 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 33.4 m0 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.54 ' HB3' HD11 ' A' ' 13' ' ' LEU . 71.0 mtm180 -82.85 85.01 7.18 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 69' ' ' GLY . 15.0 t -98.23 146.16 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.766 -175.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HG2' HD23 ' A' ' 13' ' ' LEU . 95.8 mtt180 -88.79 150.84 22.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.592 0.757 . . . . 0.0 110.891 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 27.3 p -125.9 128.17 47.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.467 1.107 . . . . 0.0 108.925 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.2 tppp? -102.3 110.97 23.08 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.019 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.547 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.741 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 74.3 m80 -108.99 162.74 13.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.587 0.755 . . . . 0.0 109.695 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.54 HD11 ' HB3' ' A' ' 2' ' ' ARG . 3.2 tm? -120.92 116.78 25.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.462 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.3 mp -87.74 160.64 17.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.432 0.693 . . . . 0.0 110.98 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -134.91 168.5 18.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.829 1.251 . . . . 0.0 108.273 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.05 82.21 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.014 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 94.3 mt -90.05 118.6 29.72 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.806 0.442 . . . . 0.0 110.072 178.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.6 t -86.4 174.79 8.77 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.478 1.111 . . . . 0.0 109.803 168.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.6 p -69.27 -29.63 67.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.265 0.626 . . . . 0.0 110.576 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 33.72 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.311 0.645 . . . . 0.0 112.285 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HG ' ' A' ' 61' ' ' LEU . 30.6 m -66.89 118.16 9.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -66.76 164.0 18.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.827 0.451 . . . . 0.0 110.763 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.495 HD22 ' HA ' ' A' ' 57' ' ' ARG . 6.0 tt -50.32 -53.58 27.7 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.73 1.212 . . . . 0.0 110.74 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -16.87 63.64 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.374 -173.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -84.3 -45.76 12.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.851 0.86 . . . . 0.0 109.432 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 61' ' ' LEU . 1.6 tm? -69.02 -62.42 1.38 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.156 1.383 . . . . 0.0 110.766 -173.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -63.72 -22.43 66.9 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.753 0.658 . . . . 0.0 111.323 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.89 -38.43 94.25 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 124.015 0.822 . . . . 0.0 112.464 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -73.44 -42.6 61.8 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -61.41 -35.9 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.514 0.726 . . . . 0.0 111.271 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.36 67.42 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.894 0.877 . . . . 0.0 111.587 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.96 -35.97 11.77 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.136 0.974 . . . . 0.0 111.638 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.462 HG13 ' HG ' ' A' ' 14' ' ' LEU . 19.0 mm -76.01 -52.2 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.781 1.232 . . . . 0.0 111.648 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.588 HG23 HG12 ' A' ' 36' ' ' ILE . 7.9 t -115.33 -7.36 12.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.162 0.585 . . . . 0.0 110.717 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 21.36 63.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.57 -0.572 . . . . 0.0 114.073 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.588 HG12 HG23 ' A' ' 34' ' ' THR . 25.1 mm -95.03 124.81 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.679 0.739 . . . . 0.0 109.906 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.97 139.08 87.45 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 123.876 0.87 . . . . 0.0 110.813 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.41 -22.07 48.29 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.726 2.951 . . . . 0.0 114.095 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.45 29.95 11.25 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.823 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.5 m -135.53 -35.75 0.8 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.578 1.151 . . . . 0.0 109.054 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -85.9 142.85 28.56 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.935 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -130.99 170.34 14.61 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 125.234 1.414 . . . . 0.0 107.674 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.483 HG21 ' HB3' ' A' ' 64' ' ' LEU . 44.2 mm -95.95 105.5 17.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 122.082 0.944 . . . . 0.0 109.875 -173.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.6 mt -113.95 155.02 26.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 113.477 -1.692 . . . . 0.0 106.648 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.65 164.86 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 122.723 0.409 . . . . 0.0 109.942 -166.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.17 73.65 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 124.026 0.822 . . . . 0.0 114.193 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -74.96 151.99 86.48 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.147 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -39.66 101.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.812 3.008 . . . . 0.0 113.575 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.39 157.58 41.05 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.93 2.42 . . . . 0.0 112.486 -171.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.22 3.01 55.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.077 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.93 71.29 0.52 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.8 1.24 . . . . 0.0 110.642 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.431 HD12 ' HD3' ' A' ' 65' ' ' PRO . 65.4 mt -79.73 124.69 28.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.656 -173.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -90.46 108.03 19.53 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.385 1.074 . . . . 0.0 109.225 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 8.4 mp -79.75 95.08 5.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.662 0.785 . . . . 0.0 109.413 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.8 t -106.77 25.85 10.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.853 0.861 . . . . 0.0 110.116 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -126.05 -157.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.37 1.068 . . . . 0.0 108.749 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -147.95 -31.39 0.29 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.056 0.844 . . . . 0.0 111.293 173.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.82 -8.9 42.26 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.609 0.764 . . . . 0.0 111.996 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.64 121.72 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 123.337 0.655 . . . . 0.0 110.843 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -92.84 174.64 7.15 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 66' ' ' ILE . 25.0 mt -71.0 -11.34 60.92 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.692 0.797 . . . . 0.0 111.998 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.38 -27.08 72.11 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.293 0.371 . . . . 0.0 112.202 170.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -87.03 -47.81 8.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.486 0.714 . . . . 0.0 110.134 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.7 mm? -80.57 154.87 73.89 Favored Pre-proline 0 CA--C 1.556 1.19 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.743 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HD3' HD12 ' A' ' 52' ' ' LEU . 70.7 Cg_endo -78.93 40.97 1.0 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.188 2.592 . . . . 0.0 114.747 -176.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 61' ' ' LEU . 2.4 mp -76.77 122.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.8 mt-30 -118.43 156.95 28.11 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.8 p -63.39 110.93 2.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.566 0.746 . . . . 0.0 111.274 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 3' ' ' VAL . . . 70.31 30.86 68.97 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.619 0.574 . . . . 0.0 113.481 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 5.9 t70 -84.69 172.53 11.46 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 tpt -98.75 100.6 11.83 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 66' ' ' ILE . 76.2 mt -91.41 143.19 26.87 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -105.67 102.07 13.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.93 106.12 11.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.01 151.72 37.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.523 0.678 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -122.08 146.81 46.84 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.802 -173.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 123.004 0.522 . . . . 0.0 110.445 178.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.4 m0 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 13' ' ' LEU . 48.7 mtm180 -83.86 73.95 10.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.108 0.963 . . . . 0.0 109.141 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.91 136.17 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.375 0.67 . . . . 0.0 111.503 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -89.09 97.35 11.15 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.7 0.8 . . . . 0.0 110.17 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.5 t -81.17 100.05 8.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.778 0.831 . . . . 0.0 110.445 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -74.47 108.99 7.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.76 -172.81 3.9 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.127 0.571 . . . . 0.0 110.23 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -67.3 125.16 25.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.438 0.695 . . . . 0.0 110.556 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.25 -12.37 61.87 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.319 -0.401 . . . . 0.0 112.205 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.38 -159.09 16.03 Favored Glycine 0 C--N 1.345 1.071 0 C-N-CA 122.936 0.303 . . . . 0.0 112.484 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.4 p -71.17 146.8 48.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.047 0.939 . . . . 0.0 111.607 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -134.96 123.19 22.98 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 2' ' ' ARG . 1.8 tm? -91.04 102.58 15.34 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -172.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 33' ' ' ILE . 10.3 mp -92.23 107.03 18.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.45 0.7 . . . . 0.0 110.036 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.549 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 76.6 mt-30 -90.2 -177.13 5.06 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.716 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.13 -19.47 22.09 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.602 -0.726 . . . . 0.0 113.329 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -71.93 114.92 10.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.462 0.705 . . . . 0.0 110.66 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.403 ' O ' HD12 ' A' ' 61' ' ' LEU . 69.0 p -91.96 168.05 11.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.079 0.951 . . . . 0.0 109.163 170.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.2 p -59.26 -33.81 71.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.979 0.511 . . . . 0.0 111.753 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -101.13 24.67 9.09 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.402 0.681 . . . . 0.0 111.841 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 25' ' ' GLU . 73.1 m -72.33 127.4 32.44 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 74.3 mtm180 -79.77 169.16 18.35 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.176 0.59 . . . . 0.0 111.247 -175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 56' ' ' ASP . 7.5 tt -53.53 -54.33 38.83 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.179 1.392 . . . . 0.0 110.989 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 24' ' ' ARG . 15.7 ptt180 -63.94 -26.04 68.41 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.219 -177.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 14.0 mm-40 -77.08 -43.46 34.23 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.6 -66.79 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.726 1.21 . . . . 0.0 110.615 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.5 -21.29 65.39 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.314 0.645 . . . . 0.0 111.312 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.98 -41.95 70.16 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.848 0.717 . . . . 0.0 112.368 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 21.3 mt-30 -67.79 -39.69 84.02 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.6 mt -59.67 -39.8 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 123.652 0.781 . . . . 0.0 111.055 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.2 -24.63 67.74 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 111.788 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.16 -36.07 13.5 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.336 0.654 . . . . 0.0 111.713 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 HD11 ' A' ' 14' ' ' LEU . 12.6 mm -75.62 -68.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.933 0.893 . . . . 0.0 110.4 -174.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.494 HG23 HG12 ' A' ' 36' ' ' ILE . 3.0 t -96.7 -7.2 34.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.396 0.679 . . . . 0.0 110.832 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 6.85 87.95 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 114.01 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.494 HG12 HG23 ' A' ' 34' ' ' THR . 13.8 mm -84.52 114.57 25.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 144.75 64.36 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.584 0.754 . . . . 0.0 110.722 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -55.14 -21.44 27.87 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.651 2.901 . . . . 0.0 114.382 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.61 -20.2 51.98 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 113.778 0.271 . . . . 0.0 113.778 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 80' ' ' ARG . 44.0 m -90.3 -16.5 29.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.18 0.592 . . . . 0.0 111.275 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -108.86 150.89 27.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.016 0.927 . . . . 0.0 110.568 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -130.17 145.87 51.76 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.679 1.192 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.596 HG13 HD21 ' A' ' 54' ' ' LEU . 45.6 mm -81.49 95.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 122.097 0.951 . . . . 0.0 108.872 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.3 mt -117.68 139.39 51.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.755 -1.566 . . . . 0.0 107.039 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 5.2 m -113.31 163.15 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.367 0.667 . . . . 0.0 110.21 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.18 -49.07 82.63 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.884 0.74 . . . . 0.0 113.267 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.424 ' O ' HG23 ' A' ' 45' ' ' VAL . 52.3 p90 -69.71 145.46 94.84 Favored Pre-proline 0 N--CA 1.476 0.872 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.141 169.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -41.22 101.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 124.155 3.237 . . . . 0.0 115.592 -170.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 71.8 Cg_endo -76.66 145.58 26.12 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.243 1.962 . . . . 0.0 111.096 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -91.67 15.88 11.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.286 0.635 . . . . 0.0 110.897 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.9 m 59.85 46.54 11.19 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 124.501 1.12 . . . . 0.0 110.369 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -55.93 130.03 42.07 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.299 -174.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -91.36 111.07 22.4 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.596 HD21 HG13 ' A' ' 43' ' ' ILE . 7.3 mp -72.7 87.9 1.27 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.279 1.031 . . . . 0.0 108.8 177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 p -89.51 26.22 1.77 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.168 0.987 . . . . 0.0 112.2 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.43 ' O ' HD13 ' A' ' 23' ' ' LEU . 10.3 t70 -145.67 -168.37 2.95 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -176.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 -29.16 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.63 0.772 . . . . 0.0 110.957 176.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -90.64 -8.0 51.2 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.876 1.27 . . . . 0.0 110.588 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.5 tt -59.18 131.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.686 1.195 . . . . 0.0 111.414 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -96.33 168.63 10.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.662 0.785 . . . . 0.0 112.559 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 18' ' ' SER . 47.7 mt -69.69 -20.18 63.56 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.918 0.887 . . . . 0.0 111.552 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.12 -28.94 73.18 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.434 174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.07 -39.16 14.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.187 0.595 . . . . 0.0 109.816 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 98.3 mt -79.5 156.66 75.65 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 124.057 0.943 . . . . 0.0 111.438 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -72.94 18.51 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.767 2.978 . . . . 0.0 115.267 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.2 mp -73.05 124.4 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.0 mt-30 -119.06 169.83 9.58 Favored 'General case' 0 C--O 1.245 0.83 0 C-N-CA 123.237 0.615 . . . . 0.0 109.845 176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 p -68.47 96.46 0.69 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.336 0.654 . . . . 0.0 110.879 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.96 36.39 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.382 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 11.1 t70 -80.44 158.01 26.05 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.303 0.641 . . . . 0.0 110.689 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.88 97.93 10.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.57 0.748 . . . . 0.0 109.692 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -94.88 106.97 18.99 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.439 0.696 . . . . 0.0 109.44 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.31 93.28 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.845 0.858 . . . . 0.0 108.825 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -82.75 103.45 10.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.99 170.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.455 ' O ' HG21 ' A' ' 36' ' ' ILE . 11.4 pt-20 -78.75 170.09 17.21 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.203 174.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -129.61 106.99 9.11 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.109 0.964 . . . . 0.0 108.84 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -80.17 -4.01 51.3 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 122.921 0.488 . . . . 0.0 111.478 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 78.66 -51.16 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 126.175 1.79 . . . . 0.0 112.196 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.2 t -71.92 99.6 2.26 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 122.234 1.016 . . . . 0.0 110.332 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.44 ' HB3' ' OG ' ' A' ' 40' ' ' SER . 12.6 ptt180 -149.44 156.56 39.4 Favored Pre-proline 0 N--CA 1.475 0.81 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.344 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.27 89.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.076 2.517 . . . . 0.0 113.008 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -101.24 104.72 15.77 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.31 -9.11 1.72 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.783 0.833 . . . . 0.0 110.335 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 31.7 m -131.54 146.89 63.84 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.851 0.861 . . . . 0.0 110.315 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.01 -14.99 13.29 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.812 2.341 . . . . 0.0 112.209 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.309 1.043 . . . . 0.0 108.56 177.519 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.3 m0 . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.424 ' HB3' HD11 ' A' ' 13' ' ' LEU . 44.7 mtp180 -83.29 83.29 7.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.987 0.915 . . . . 0.0 109.452 174.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 17' ' ' LEU . 69.1 t -100.34 141.94 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.923 0.889 . . . . 0.0 110.535 -175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 71' ' ' MET . 41.1 mmt180 -81.57 135.97 35.57 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.916 0.886 . . . . 0.0 110.559 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 19.8 t -113.33 90.12 3.26 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -82.95 105.39 13.91 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.31 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.2 169.92 14.2 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.384 0.674 . . . . 0.0 110.436 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.592 ' HD3' ' HB3' ' A' ' 76' ' ' GLU . 11.0 ptmm? -71.71 -9.51 58.38 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.096 172.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.78 25.16 17.36 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.175 166.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.38 172.8 36.84 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 117.271 0.535 . . . . 0.0 113.17 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 m -87.64 132.71 33.99 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 77.6 m-70 -123.2 173.74 7.71 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.623 0.769 . . . . 0.0 109.904 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.445 HD12 HE21 ' A' ' 15' ' ' GLN . 2.8 tm? -140.74 110.76 6.55 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 mp -95.32 132.07 40.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.082 0.953 . . . . 0.0 108.52 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.445 HE21 HD12 ' A' ' 13' ' ' LEU . 15.0 mp0 -100.89 -32.91 10.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.104 0.561 . . . . 0.0 110.338 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.48 44.4 3.07 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.767 -0.651 . . . . 0.0 114.109 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 3' ' ' VAL . 95.3 mt -114.52 115.2 26.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 124.134 0.974 . . . . 0.0 109.35 175.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 61' ' ' LEU . 17.3 t -92.38 176.87 6.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.947 0.899 . . . . 0.0 109.475 172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 p -60.63 -36.1 77.79 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.708 0.803 . . . . 0.0 111.858 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -116.35 48.09 1.32 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.388 0.675 . . . . 0.0 111.47 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.9 m -75.84 128.06 34.33 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HG2' HG22 ' A' ' 60' ' ' THR . 61.6 mtm180 -92.14 -177.94 4.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 57' ' ' ARG . 5.9 tt -52.32 -56.91 11.68 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.087 0.955 . . . . 0.0 111.036 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.445 ' HG2' ' OE2' ' A' ' 25' ' ' GLU . 9.0 ptp180 -70.63 -19.58 62.81 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.594 0.559 . . . . 0.0 112.042 -164.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 2.0 pm0 -93.49 -35.02 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.63 0.772 . . . . 0.0 110.976 173.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.418 HD11 HD11 ' A' ' 43' ' ' ILE . 2.0 tm? -71.29 -68.23 0.46 Allowed 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -69.11 -18.44 63.97 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.606 0.762 . . . . 0.0 111.419 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.35 -38.23 62.63 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.844 0.715 . . . . 0.0 112.341 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.468 ' O ' HG12 ' A' ' 33' ' ' ILE . 43.7 mt-30 -70.53 -44.52 67.34 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.9 mt -55.41 -41.35 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 C-N-CA 123.935 0.894 . . . . 0.0 111.476 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.29 -25.18 68.19 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.669 0.788 . . . . 0.0 112.466 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.34 -31.36 16.94 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.676 0.79 . . . . 0.0 111.395 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 29' ' ' GLN . 28.8 mm -79.11 -65.59 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.324 1.05 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.547 HG23 HG12 ' A' ' 36' ' ' ILE . 10.1 t -101.91 -11.74 18.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.75 0.82 . . . . 0.0 111.341 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.37 -18.6 56.78 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.621 -0.544 . . . . 0.0 113.727 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.547 HG12 HG23 ' A' ' 34' ' ' THR . 18.3 mm -67.34 121.5 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 117.045 0.422 . . . . 0.0 111.205 -169.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.75 141.26 80.13 Favored Pre-proline 0 C--N 1.351 0.663 0 O-C-N 124.281 0.988 . . . . 0.0 110.648 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.05 -28.62 70.43 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.394 2.729 . . . . 0.0 112.35 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.91 16.51 54.93 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.286 -0.415 . . . . 0.0 113.369 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.5 m -125.13 -11.29 7.03 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 110.52 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -127.16 155.53 43.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.022 0.929 . . . . 0.0 110.369 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.94 168.47 19.63 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.238 1.015 . . . . 0.0 109.161 170.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.68 HG12 HD11 ' A' ' 54' ' ' LEU . 30.8 mm -80.26 105.0 9.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.423 1.106 . . . . 0.0 109.842 -172.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.93 148.08 44.56 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 112.776 -2.011 . . . . 0.0 106.981 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.452 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 1.6 m -132.25 161.96 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.576 0.75 . . . . 0.0 110.248 -172.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.64 -42.29 96.13 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 123.805 0.69 . . . . 0.0 113.238 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -77.7 158.1 78.75 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.264 168.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -39.65 107.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.095 3.196 . . . . 0.0 115.292 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 67.9 Cg_endo -86.04 158.55 10.05 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.627 2.218 . . . . 0.0 112.345 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -101.84 8.38 41.32 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.9 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.1 m 56.5 68.77 0.81 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.185 0.994 . . . . 0.0 110.221 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.77 114.35 18.62 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.678 -171.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -84.06 155.59 22.61 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.68 HD11 HG12 ' A' ' 43' ' ' ILE . 4.7 mp -122.6 91.71 3.56 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.7 p -82.34 -46.08 14.07 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.397 0.679 . . . . 0.0 110.67 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -78.13 131.63 37.32 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.788 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -70.57 -22.04 62.62 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.728 0.811 . . . . 0.0 112.091 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.29 -1.86 53.23 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.107 0.963 . . . . 0.0 111.306 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.6 tt -64.01 124.09 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 C-N-CA 123.389 0.676 . . . . 0.0 110.893 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 22' ' ' ARG . 50.7 p -95.96 173.56 7.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.164 0.586 . . . . 0.0 112.398 -169.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 18' ' ' SER . 27.0 mt -68.99 -10.77 59.17 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.399 0.679 . . . . 0.0 111.136 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.39 -29.01 73.72 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 112.301 -0.32 . . . . 0.0 112.301 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -88.27 -49.63 6.86 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.276 0.63 . . . . 0.0 110.12 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.8 mm? -81.59 151.77 68.86 Favored Pre-proline 0 CA--C 1.56 1.354 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.743 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.456 ' HD2' HG21 ' A' ' 43' ' ' ILE . 97.9 Cg_endo -77.66 42.79 1.22 Allowed 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.761 2.974 . . . . 0.0 115.185 -178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.476 HD11 HD12 ' A' ' 43' ' ' ILE . 2.3 mp -83.28 112.46 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -109.84 170.66 7.93 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 38.2 p -67.56 105.51 1.88 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.029 0.532 . . . . 0.0 111.013 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.38 20.23 62.73 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.439 -0.346 . . . . 0.0 113.358 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.28 161.35 27.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.775 0.83 . . . . 0.0 110.168 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.48 ' HA ' ' HB2' ' A' ' 4' ' ' ARG . 19.1 ttm -103.89 112.34 25.26 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.245 0.618 . . . . 0.0 109.783 176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -101.05 114.45 28.4 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.574 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.78 96.13 3.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.409 HG21 ' SG ' ' A' ' 5' ' ' CYS . 70.5 t -78.69 101.58 4.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.082 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -80.32 155.82 27.06 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.499 175.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.592 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . 36.3 tt0 -109.61 111.91 23.68 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 169.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -72.14 -8.44 54.73 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.306 0.642 . . . . 0.0 111.037 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 69.17 40.15 1.59 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 124.89 1.276 . . . . 0.0 110.347 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.5 m -96.03 30.99 2.25 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.073 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 67.44 120.18 0.03 OUTLIER Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 125.276 1.43 . . . . 0.0 110.866 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.47 129.1 29.67 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 122.605 2.203 . . . . 0.0 111.665 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt 61.54 101.77 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.03 1.332 . . . . 0.0 111.522 -170.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.23 28.98 5.43 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.041 0.936 . . . . 0.0 109.728 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.8 p -161.59 168.42 11.31 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 124.696 1.198 . . . . 0.0 109.69 -171.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -36.08 -35.73 0.18 Allowed 'Trans proline' 0 C--N 1.398 3.132 0 C-N-CA 124.744 3.629 . . . . 0.0 114.895 171.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 C--O 1.253 1.286 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 164.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.483 ' HB3' HG23 ' A' ' 3' ' ' VAL . 22.0 m0 . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.448 ' HB2' HD11 ' A' ' 13' ' ' LEU . 3.9 ptp180 -87.99 70.85 9.44 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.775 0.798 . . . . 0.0 109.102 169.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 1' ' ' TRP . 76.8 t -77.8 137.28 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.864 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -93.27 140.23 29.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.466 -172.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 12.5 t -122.41 97.94 5.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.018 0.927 . . . . 0.0 111.053 -173.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HE3' ' SD ' ' A' ' 71' ' ' MET . 4.6 tppp? -74.82 102.71 4.8 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -150.88 -172.56 4.23 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.081 0.552 . . . . 0.0 111.015 -173.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -58.1 114.43 2.36 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.158 0.983 . . . . 0.0 111.099 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.92 -8.57 25.47 Favored Glycine 0 N--CA 1.473 1.132 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.911 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.05 -154.56 16.86 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.517 0.58 . . . . 0.0 111.954 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.0 m -84.84 121.39 27.66 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.397 0.679 . . . . 0.0 109.845 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 91.2 m-70 -107.79 179.16 4.31 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.199 1.0 . . . . 0.0 109.517 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 2' ' ' ARG . 2.0 tm? -144.01 122.8 12.65 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -176.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.473 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.2 mp -101.1 146.62 27.22 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.951 0.9 . . . . 0.0 110.394 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -118.39 165.27 14.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.137 1.375 . . . . 0.0 109.312 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.45 4.81 89.28 Favored Glycine 0 N--CA 1.479 1.546 0 N-CA-C 114.157 0.423 . . . . 0.0 114.157 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.7 mt -82.48 130.84 35.19 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.465 0.65 . . . . 0.0 110.525 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.3 m -115.16 179.02 4.07 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.207 1.403 . . . . 0.0 109.159 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.6 p -72.72 -27.34 62.0 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.647 0.379 . . . . 0.0 111.158 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -108.61 25.95 11.11 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.735 0.814 . . . . 0.0 111.233 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 25' ' ' GLU . 7.3 m -66.0 127.66 32.98 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.077 0.551 . . . . 0.0 110.151 170.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -72.9 166.71 22.46 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.356 0.662 . . . . 0.0 111.183 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.673 HD11 ' HB3' ' A' ' 54' ' ' LEU . 10.1 tt -61.2 -45.42 94.66 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.651 1.18 . . . . 0.0 110.618 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -61.53 -30.67 70.79 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.653 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 21' ' ' THR . 6.3 mm-40 -79.88 -44.44 20.44 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 124.087 0.955 . . . . 0.0 109.534 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.56 -65.9 0.61 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.044 0.938 . . . . 0.0 109.718 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.416 ' HA ' HD12 ' A' ' 30' ' ' ILE . 32.4 mt-30 -64.42 -23.11 67.17 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.664 0.602 . . . . 0.0 111.509 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.21 -44.33 86.76 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 124.104 0.878 . . . . 0.0 111.695 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 33' ' ' ILE . 23.7 mt-30 -67.92 -37.33 81.54 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 27' ' ' GLN . 97.4 mt -59.56 -42.03 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.493 0.717 . . . . 0.0 110.823 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.67 -24.97 68.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.805 0.842 . . . . 0.0 111.705 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.4 -32.79 17.11 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.765 0.826 . . . . 0.0 111.571 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.473 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.8 mm -79.83 -69.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.571 0.748 . . . . 0.0 109.96 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.536 HG23 HG12 ' A' ' 36' ' ' ILE . 9.2 t -98.76 -9.45 24.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.442 0.697 . . . . 0.0 111.488 -173.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.48 72.43 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.967 -0.352 . . . . 0.0 113.785 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.536 HG12 HG23 ' A' ' 34' ' ' THR . 24.9 mm -91.19 114.57 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.52 141.42 78.72 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.03 0.932 . . . . 0.0 111.023 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -53.76 -29.54 52.54 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 124.127 3.218 . . . . 0.0 114.572 -172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.96 -23.03 64.71 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 120.001 -0.333 . . . . 0.0 113.743 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.6 m -93.47 1.4 56.82 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.774 0.83 . . . . 0.0 111.562 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.45 169.14 13.96 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.032 0.933 . . . . 0.0 110.781 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 51' ' ' CYS . 44.9 ttp180 -158.81 154.43 26.14 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.055 -169.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 66' ' ' ILE . 37.4 mm -79.68 100.8 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 122.083 0.944 . . . . 0.0 109.674 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.4 mt -121.7 144.57 48.7 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.271 -1.786 . . . . 0.0 106.917 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 47' ' ' TYR . 2.6 m -125.88 164.31 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.493 0.717 . . . . 0.0 110.779 -172.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -36.08 92.75 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.78 0.675 . . . . 0.0 112.857 -176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.446 ' O ' HG23 ' A' ' 45' ' ' VAL . 46.4 p90 -81.72 156.2 70.48 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.177 167.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -43.09 108.36 0.1 Allowed 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 124.227 3.285 . . . . 0.0 114.508 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -85.72 155.14 10.26 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.018 2.479 . . . . 0.0 112.624 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -89.81 6.82 40.04 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.994 0.518 . . . . 0.0 110.696 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HB3' ' NH1' ' A' ' 42' ' ' ARG . 81.5 m 57.36 59.16 3.46 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 124.282 1.033 . . . . 0.0 110.123 -176.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.3 mt -60.84 144.34 52.91 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 113.691 -1.595 . . . . 0.0 113.46 -167.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.45 138.8 31.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.208 0.603 . . . . 0.0 109.682 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.673 ' HB3' HD11 ' A' ' 23' ' ' LEU . 7.0 mp -115.14 87.17 2.6 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.011 0.924 . . . . 0.0 108.74 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.3 m -111.03 19.81 18.09 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.81 0.844 . . . . 0.0 112.654 -170.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HD13 ' A' ' 23' ' ' LEU . 11.1 t70 -141.81 177.75 7.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -120.69 -40.53 2.64 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.496 0.718 . . . . 0.0 111.478 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.24 -16.0 34.38 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.936 0.894 . . . . 0.0 110.327 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.98 141.46 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.258 1.023 . . . . 0.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.6 p -111.75 -178.92 3.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.322 0.582 . . . . 0.0 112.247 -166.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.2 mt -75.94 -4.73 42.62 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.178 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.25 -23.11 76.39 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 112.001 -0.44 . . . . 0.0 112.001 167.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -97.78 -59.09 1.84 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.428 0.691 . . . . 0.0 109.793 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -77.53 116.09 55.05 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.05 65.09 6.12 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.666 2.91 . . . . 0.0 113.816 -173.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 43' ' ' ILE . 1.9 mp -78.27 126.45 38.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 163.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 18.1 mt-30 -117.41 154.61 31.05 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.8 p -64.59 102.68 0.59 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.274 0.629 . . . . 0.0 111.363 -174.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.59 16.19 66.67 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.411 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 10.5 t70 -80.08 160.92 25.61 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 123.489 0.716 . . . . 0.0 109.986 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.447 ' SD ' ' HE3' ' A' ' 6' ' ' LYS . 2.8 tpt -84.18 100.32 11.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.323 177.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -99.36 116.12 30.78 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.55 102.67 13.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 77.9 t -82.61 108.18 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.429 171.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.22 151.22 31.33 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.811 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -109.46 105.04 14.22 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 166.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.05 -20.33 66.14 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 0.0 110.525 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 68.58 12.18 8.6 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.953 1.301 . . . . 0.0 111.831 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.0 t -76.46 -45.33 31.7 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 54.64 107.6 0.03 OUTLIER Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.546 1.538 . . . . 0.0 113.748 172.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.97 157.38 62.05 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.634 2.222 . . . . 0.0 111.447 174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.439 ' HA ' ' HE3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -76.99 81.18 3.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 175.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.05 155.54 9.9 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.098 -1.41 . . . . 0.0 109.542 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 p -154.56 92.49 2.93 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 123.766 0.826 . . . . 0.0 109.561 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.38 78.58 2.29 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.489 2.126 . . . . 0.0 110.433 172.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--O 1.25 1.09 0 C-N-CA 124.374 1.07 . . . . 0.0 109.504 -172.619 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 33.8 m0 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -103.0 160.4 14.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.875 0.87 . . . . 0.0 109.334 170.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.561 HG13 HD23 ' A' ' 72' ' ' LEU . 18.9 t -138.1 136.78 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.834 0.854 . . . . 0.0 109.709 171.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -104.8 95.58 5.97 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.7 p -84.14 102.35 12.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.909 0.484 . . . . 0.0 110.185 -175.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -79.75 99.03 7.26 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -122.68 102.35 8.0 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.25 0.62 . . . . 0.0 109.959 -174.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 60.32 26.55 16.07 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.37 1.068 . . . . 0.0 111.75 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.46 -34.08 6.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.172 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.69 99.0 1.32 Allowed Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -83.55 127.75 33.98 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.261 0.624 . . . . 0.0 109.654 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 96.5 m-70 -131.47 149.37 52.55 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.591 0.356 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.643 ' HB3' HE22 ' A' ' 15' ' ' GLN . 0.1 OUTLIER -98.76 113.47 25.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.207 0.603 . . . . 0.0 109.858 -173.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.466 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.8 mp -89.48 127.4 35.85 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.963 0.905 . . . . 0.0 109.033 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.643 HE22 ' HB3' ' A' ' 13' ' ' LEU . 26.2 mp0 -111.34 161.45 16.05 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 171.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.45 33.61 19.13 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.872 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.19 116.36 28.88 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.2 m -91.36 166.58 12.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.565 0.746 . . . . 0.0 109.606 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 m -64.81 -25.48 67.93 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 120.978 0.418 . . . . 0.0 111.705 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -92.7 3.2 56.05 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.779 0.832 . . . . 0.0 112.788 -176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.444 HG23 ' HB2' ' A' ' 25' ' ' GLU . 56.8 m -58.7 118.61 5.87 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.141 0.496 . . . . 0.0 110.812 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 58' ' ' ASP . 81.8 mtm180 -87.21 -176.41 5.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.03 0.932 . . . . 0.0 111.478 -174.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 54' ' ' LEU . 4.8 tt -54.89 -60.87 2.77 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 123.773 0.829 . . . . 0.0 109.045 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -55.91 -24.56 38.32 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.345 -1.298 . . . . 0.0 113.413 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 1.7 mm-40 -88.91 -53.89 4.39 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.436 ' HB2' HG22 ' A' ' 21' ' ' THR . 2.7 tm? -67.27 -65.78 0.64 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.162 0.985 . . . . 0.0 110.655 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -66.45 -18.83 65.58 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.328 0.392 . . . . 0.0 111.071 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.93 -37.58 60.55 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.713 0.633 . . . . 0.0 112.034 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.456 ' O ' HG12 ' A' ' 33' ' ' ILE . 24.5 mt-30 -70.78 -38.84 73.43 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.88 -38.7 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 C-N-CA 123.803 0.841 . . . . 0.0 110.795 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.43 -24.65 66.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.043 0.937 . . . . 0.0 111.914 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -35.6 13.57 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.924 0.89 . . . . 0.0 111.395 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG13 ' HG ' ' A' ' 14' ' ' LEU . 31.0 mm -72.1 -68.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.781 0.832 . . . . 0.0 110.449 -175.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.421 HG23 HG12 ' A' ' 36' ' ' ILE . 5.2 t -96.44 -16.19 21.33 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.342 0.657 . . . . 0.0 111.036 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.74 11.12 71.47 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.667 -0.518 . . . . 0.0 113.436 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.421 HG12 HG23 ' A' ' 34' ' ' THR . 26.5 mm -85.91 111.88 21.71 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.74 144.45 65.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.863 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.75 -24.81 73.15 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 123.203 2.602 . . . . 0.0 113.559 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.98 19.76 32.51 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 116.474 -0.33 . . . . 0.0 113.253 175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.2 m -135.54 8.37 3.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.694 1.198 . . . . 0.0 110.332 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.452 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 1.6 pt20 -144.47 162.07 37.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.511 0.725 . . . . 0.0 110.831 -177.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -129.37 -172.88 2.85 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.824 1.25 . . . . 0.0 108.645 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.517 HG23 HD12 ' A' ' 72' ' ' LEU . 32.4 mm -112.26 106.65 21.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.61 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 29.8 mt -116.03 134.45 54.94 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.79 175.21 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.479 0.711 . . . . 0.0 111.199 -169.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.7 -44.76 80.04 Favored Glycine 0 C--N 1.357 1.703 0 O-C-N 123.969 0.793 . . . . 0.0 114.186 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -87.0 163.34 40.88 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.536 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 83.1 Cg_exo -45.61 108.52 0.15 Allowed 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 123.572 2.848 . . . . 0.0 113.587 175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 48' ' ' PRO . 2.3 Cg_endo -84.14 172.46 9.62 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.502 2.802 . . . . 0.0 112.493 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -101.64 11.99 37.95 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.929 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 77.9 m 56.03 84.37 0.08 Allowed 'General case' 0 C--N 1.36 1.022 0 C-N-CA 124.272 1.029 . . . . 0.0 109.646 -166.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 69.1 mt -79.68 95.39 5.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.351 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.22 96.14 8.36 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.662 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.455 ' HB3' HD12 ' A' ' 23' ' ' LEU . 8.0 mp -69.85 102.82 2.04 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -89.57 -36.89 15.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.948 0.899 . . . . 0.0 111.757 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 59' ' ' ILE . 34.9 t70 -95.95 130.71 42.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.768 0.827 . . . . 0.0 110.302 -177.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.44 68.08 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.131 0.573 . . . . 0.0 112.306 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 29.1 t70 -92.7 -2.77 55.76 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.855 0.862 . . . . 0.0 111.432 -172.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 56' ' ' ASP . 13.4 tt -67.16 127.29 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.214 0.606 . . . . 0.0 110.748 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -99.24 177.0 5.34 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.928 0.491 . . . . 0.0 111.902 -168.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.8 mt -70.19 -9.88 57.12 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.655 0.782 . . . . 0.0 111.488 173.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.71 -25.85 74.85 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -92.99 -50.77 5.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.763 0.825 . . . . 0.0 110.055 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -91.05 121.72 67.53 Favored Pre-proline 0 N--CA 1.477 0.894 0 CA-C-O 118.413 -0.803 . . . . 0.0 109.007 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.8 75.68 1.62 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.3 2.667 . . . . 0.0 113.583 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.33 131.68 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 168.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 27.9 mt-30 -118.19 155.82 29.84 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.3 t -70.94 111.61 6.47 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.21 17.2 56.2 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 123.604 0.621 . . . . 0.0 112.887 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.9 t70 -81.45 158.61 24.5 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.225 0.536 . . . . 0.0 110.246 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.4 93.69 9.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.783 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.561 HD23 HG13 ' A' ' 3' ' ' VAL . 3.9 mm? -92.36 99.44 12.2 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 4.1 mp -75.71 100.22 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 93.1 t -79.03 102.29 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.01 173.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 7.3 pt-20 -76.84 156.79 31.94 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.219 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -118.31 113.27 21.2 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.22 -17.87 53.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.58 0.752 . . . . 0.0 110.583 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 67.07 29.43 7.93 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.204 1.402 . . . . 0.0 111.135 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.3 m -53.11 -54.25 38.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.519 1.128 . . . . 0.0 111.687 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 54.77 66.94 3.61 Favored Pre-proline 0 CA--C 1.558 1.252 0 O-C-N 124.51 1.131 . . . . 0.0 111.566 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.83 163.72 23.33 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.371 2.048 . . . . 0.0 111.513 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.58 87.64 1.22 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.599 0.714 . . . . 0.0 109.793 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.4 141.94 29.11 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.302 177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 60.0 p -140.68 142.32 28.17 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 123.615 0.766 . . . . 0.0 109.558 -175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.87 -20.51 67.02 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.696 2.264 . . . . 0.0 112.608 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.25 1.101 0 C-N-CA 124.822 1.249 . . . . 0.0 110.555 175.549 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.7 m0 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.868 0.366 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -122.03 56.6 1.08 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.483 1.113 . . . . 0.0 109.241 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.578 ' HB ' HD12 ' A' ' 17' ' ' LEU . 10.8 t -83.81 135.64 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.73 -171.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -95.31 148.73 22.12 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.69 0.796 . . . . 0.0 110.123 -174.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 28.1 p -122.17 104.2 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.459 0.704 . . . . 0.0 110.243 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -74.73 113.47 12.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.771 0.828 . . . . 0.0 109.321 171.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.6 164.1 21.97 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 122.729 0.412 . . . . 0.0 110.199 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.471 ' HD3' ' HB3' ' A' ' 76' ' ' GLU . 26.0 mtpp -63.24 -31.15 72.22 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.169 176.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.74 32.73 6.71 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 123.694 0.621 . . . . 0.0 112.413 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.55 159.85 17.06 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 114.172 0.429 . . . . 0.0 114.172 171.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 m -102.27 115.26 30.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.669 0.788 . . . . 0.0 110.077 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -111.0 179.8 3.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.987 0.915 . . . . 0.0 109.53 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.18 130.46 37.29 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.524 ' HG ' HG13 ' A' ' 33' ' ' ILE . 4.5 mp -96.18 110.73 22.96 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.234 1.014 . . . . 0.0 109.772 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -83.06 -17.49 43.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.558 0.743 . . . . 0.0 109.676 172.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.79 -15.11 81.65 Favored Glycine 0 C--N 1.353 1.476 0 C-N-CA 123.636 0.636 . . . . 0.0 113.54 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.578 HD12 ' HB ' ' A' ' 3' ' ' VAL . 63.3 mt -72.67 114.43 10.8 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 117.336 0.568 . . . . 0.0 109.813 175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.5 m -90.99 -167.08 1.73 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.176 0.991 . . . . 0.0 108.969 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.0 t -77.2 -45.58 26.13 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.779 0.432 . . . . 0.0 110.01 174.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -90.58 17.78 7.09 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.634 1.174 . . . . 0.0 112.794 -169.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.8 m -65.9 115.92 6.51 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.141 0.577 . . . . 0.0 111.876 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -74.43 173.43 10.32 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.179 0.992 . . . . 0.0 110.219 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.8 tp -61.39 -49.12 78.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.989 0.515 . . . . 0.0 111.894 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -19.93 65.31 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.648 -177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -88.85 -38.85 14.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 110.218 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.562 HD11 HD11 ' A' ' 43' ' ' ILE . 1.5 tm? -66.89 -67.21 0.47 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.874 1.27 . . . . 0.0 109.597 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 72.0 mt-30 -69.24 -20.79 63.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.103 0.561 . . . . 0.0 111.769 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.71 -33.15 75.32 Favored Glycine 0 C--N 1.35 1.337 0 O-C-N 123.918 0.761 . . . . 0.0 112.179 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.444 ' NE2' HD23 ' A' ' 17' ' ' LEU . 21.2 mt-30 -87.38 -32.23 19.68 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.286 0.634 . . . . 0.0 110.787 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.87 -39.85 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.089 0.471 . . . . 0.0 110.055 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -61.72 -25.75 67.62 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.193 0.997 . . . . 0.0 111.974 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.05 -26.09 16.2 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.983 0.913 . . . . 0.0 111.748 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.524 HG13 ' HG ' ' A' ' 14' ' ' LEU . 22.3 mm -89.21 -68.42 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.859 0.864 . . . . 0.0 111.257 -174.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.583 HG23 HG12 ' A' ' 36' ' ' ILE . 10.2 t -94.26 -7.69 41.3 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.92 0.488 . . . . 0.0 110.563 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.23 8.28 83.86 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 119.285 -0.731 . . . . 0.0 114.292 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.583 HG12 HG23 ' A' ' 34' ' ' THR . 11.0 mm -86.83 119.91 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 117.859 0.83 . . . . 0.0 109.178 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.98 139.44 82.98 Favored Pre-proline 0 CA--C 1.547 0.853 0 O-C-N 124.165 0.916 . . . . 0.0 110.962 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 19.7 Cg_endo -56.64 -26.05 62.87 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.542 2.828 . . . . 0.0 114.252 -174.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.97 22.51 37.85 Favored Glycine 0 N--CA 1.477 1.395 0 CA-C-N 116.522 -0.308 . . . . 0.0 112.96 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 m -138.23 14.19 2.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.557 1.143 . . . . 0.0 109.949 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.42 171.87 19.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.375 0.67 . . . . 0.0 111.277 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -160.8 -173.85 4.13 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.631 1.172 . . . . 0.0 108.788 175.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.801 HG12 HD21 ' A' ' 54' ' ' LEU . 37.0 mm -106.13 113.34 42.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.2 mt -121.98 133.78 54.82 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.6 m -103.96 166.36 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 122.886 0.474 . . . . 0.0 110.831 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.06 -54.93 33.15 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 124.158 0.911 . . . . 0.0 112.715 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -67.19 151.68 96.89 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.268 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -49.25 106.66 0.12 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.612 2.875 . . . . 0.0 113.446 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.02 155.73 42.86 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 122.55 2.167 . . . . 0.0 111.651 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -89.91 10.81 22.42 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.673 0.789 . . . . 0.0 110.923 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 86.7 m 55.43 79.42 0.16 Allowed 'General case' 0 C--N 1.365 1.253 0 C-N-CA 124.417 1.087 . . . . 0.0 109.528 -167.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.52 138.33 57.73 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.777 -172.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -82.66 100.56 10.28 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.801 HD21 HG12 ' A' ' 43' ' ' ILE . 7.4 mp -98.03 88.84 4.35 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.0 t -126.72 -51.32 1.47 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.483 0.713 . . . . 0.0 111.357 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' O ' HG22 ' A' ' 59' ' ' ILE . 25.1 t70 -75.86 123.36 25.55 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.171 0.589 . . . . 0.0 110.916 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -29.73 52.95 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.7 -19.97 22.99 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 112.144 -169.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 56' ' ' ASP . 12.1 tt -58.87 120.41 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 121.4 0.619 . . . . 0.0 110.747 -174.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.9 p -92.67 177.32 6.14 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.072 0.549 . . . . 0.0 112.28 -170.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.6 mt -68.83 -15.47 63.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.932 0.893 . . . . 0.0 111.362 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.99 78.4 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.271 -0.331 . . . . 0.0 112.271 173.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -96.3 -56.77 2.51 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.747 0.819 . . . . 0.0 109.701 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.5 mt -75.12 118.08 67.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.176 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.15 83.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.614 2.876 . . . . 0.0 114.838 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.446 HG23 HG11 ' A' ' 3' ' ' VAL . 3.1 mp -119.6 127.26 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 165.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 14.3 mt-30 -112.71 161.01 17.36 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.0 p -67.81 112.29 4.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.986 0.514 . . . . 0.0 110.147 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 22.94 59.13 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.188 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 29.0 t70 -82.97 166.27 18.99 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.74 0.816 . . . . 0.0 111.496 -175.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.82 103.66 15.63 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.87 0.868 . . . . 0.0 109.557 176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.432 HD22 HG23 ' A' ' 43' ' ' ILE . 67.2 mt -98.86 104.12 16.13 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.399 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.6 91.98 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -82.13 109.56 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.548 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.91 145.36 38.29 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.471 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . 40.7 tt0 -110.21 102.13 10.84 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.26 -31.21 72.33 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.674 0.79 . . . . 0.0 110.94 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 73.15 14.36 4.63 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.49 1.516 . . . . 0.0 112.569 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.462 HG23 ' HG3' ' A' ' 80' ' ' ARG . 9.3 t -70.62 -35.59 73.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.862 0.465 . . . . 0.0 110.661 175.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.462 ' HG3' HG23 ' A' ' 79' ' ' THR . 77.4 mtp180 -116.79 152.92 49.07 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.027 0.931 . . . . 0.0 108.806 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -70.13 152.06 67.24 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.041 1.827 . . . . 0.0 111.934 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.9 116.58 7.2 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 173.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -155.12 155.28 33.72 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.403 0.681 . . . . 0.0 110.233 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.8 t -117.85 99.58 52.14 Favored Pre-proline 0 CA--C 1.55 0.954 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.55 -22.87 20.6 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.398 2.066 . . . . 0.0 112.494 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 CA--C 1.554 1.114 0 C-N-CA 124.159 0.984 . . . . 0.0 109.298 178.018 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 24.0 m0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 13' ' ' LEU . 14.0 ptp180 -133.9 124.91 27.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.594 HG11 HD22 ' A' ' 72' ' ' LEU . 71.9 t -125.39 135.55 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 120.9 0.381 . . . . 0.0 111.493 -171.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -82.12 110.96 17.81 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.379 1.072 . . . . 0.0 110.008 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 11' ' ' THR . 36.2 t -89.68 90.15 8.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.96 0.904 . . . . 0.0 110.203 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -76.47 103.17 6.33 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.573 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -142.73 176.56 8.95 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.51 0.672 . . . . 0.0 112.157 -170.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HG3' ' HB3' ' A' ' 76' ' ' GLU . 13.6 mmmm -73.18 -6.21 44.29 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.759 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.23 33.53 6.2 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.41 -178.01 52.72 Favored Glycine 0 C--N 1.351 1.405 0 C-N-CA 123.065 0.364 . . . . 0.0 113.113 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 5' ' ' CYS . 15.7 m -101.02 117.99 36.12 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -118.81 178.48 4.47 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.983 0.913 . . . . 0.0 110.493 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 2' ' ' ARG . 3.1 tm? -125.18 131.02 53.27 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.427 ' HG ' HG13 ' A' ' 33' ' ' ILE . 10.5 mp -100.1 132.82 45.24 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.323 0.649 . . . . 0.0 110.698 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -99.0 170.04 9.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.811 0.844 . . . . 0.0 109.996 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.4 23.23 77.63 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.067 172.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.67 133.23 43.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.02 0.528 . . . . 0.0 109.888 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.0 t -116.81 -166.26 1.15 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.354 1.062 . . . . 0.0 108.797 172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.6 p -76.81 -36.4 56.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.292 0.637 . . . . 0.0 111.993 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -104.57 20.55 18.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.926 0.49 . . . . 0.0 111.738 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -61.2 129.03 39.29 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.708 0.803 . . . . 0.0 110.142 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.549 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 78.3 mtm180 -88.19 -179.01 6.07 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.495 0.718 . . . . 0.0 111.848 -171.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 tt -54.27 -63.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.103 0.961 . . . . 0.0 109.573 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -63.91 -15.27 58.68 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.902 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 12.2 mm-40 -87.04 -49.05 7.59 Favored 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -78.93 -66.78 0.82 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.358 1.063 . . . . 0.0 110.182 -172.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -65.7 -19.96 66.1 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.001 0.52 . . . . 0.0 111.149 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.57 72.32 Favored Glycine 0 C--N 1.346 1.116 0 O-C-N 123.749 0.655 . . . . 0.0 111.877 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' ILE . 20.8 mt-30 -72.33 -38.85 68.53 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.8 mt -59.11 -35.9 59.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.6 67.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.702 0.801 . . . . 0.0 111.99 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.43 -28.19 15.62 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.188 0.995 . . . . 0.0 112.065 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 29' ' ' GLN . 27.8 mm -78.95 -61.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.304 1.042 . . . . 0.0 110.415 -174.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 36' ' ' ILE . 3.8 t -109.42 -5.36 15.83 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.812 0.845 . . . . 0.0 111.435 -175.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.15 13.6 81.74 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-O 119.932 -0.371 . . . . 0.0 114.001 174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.467 HG12 HG23 ' A' ' 34' ' ' THR . 24.9 mm -90.88 115.4 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.33 141.88 69.49 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.707 0.803 . . . . 0.0 110.702 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -55.99 -27.64 64.98 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 123.421 2.747 . . . . 0.0 114.133 -174.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.71 -15.23 78.3 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 120.085 -0.286 . . . . 0.0 113.813 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -93.78 -5.75 47.56 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.107 0.963 . . . . 0.0 111.445 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -130.19 161.59 30.81 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.106 0.963 . . . . 0.0 111.148 -174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -134.07 -172.17 2.92 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.244 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.534 HG12 HD11 ' A' ' 54' ' ' LEU . 49.8 mm -107.36 99.15 7.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 173.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.5 mt -112.0 131.33 55.48 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.57 -174.53 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.721 0.808 . . . . 0.0 109.672 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.54 55.88 4.44 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 -173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -147.46 168.31 11.57 Favored Pre-proline 0 N--CA 1.483 1.209 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 168.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.06 100.31 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 121.982 1.788 . . . . 0.0 111.343 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.04 138.74 26.02 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.145 1.897 . . . . 0.0 113.089 -168.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.94 -0.88 23.03 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.891 0.876 . . . . 0.0 111.681 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 80.7 m 61.32 58.24 2.2 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.682 1.193 . . . . 0.0 109.678 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.6 mt -67.18 99.92 0.73 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.113 -176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -86.06 125.7 33.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.534 HD11 HG12 ' A' ' 43' ' ' ILE . 6.4 mp -88.96 106.57 18.51 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 t -111.83 19.6 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.601 0.76 . . . . 0.0 110.825 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 13.7 t70 -134.29 118.02 17.06 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -58.08 -34.26 69.96 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.897 0.879 . . . . 0.0 113.124 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -94.39 -0.71 54.65 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.05 0.94 . . . . 0.0 113.461 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.7 tt -61.6 122.18 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 CA-C-N 118.757 0.708 . . . . 0.0 110.724 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.3 p -90.5 171.59 9.31 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.099 0.56 . . . . 0.0 111.921 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.444 HD13 HG21 ' A' ' 66' ' ' ILE . 21.9 mt -70.63 -7.96 48.21 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.95 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.89 -23.0 78.7 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.235 0.334 . . . . 0.0 112.743 171.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.479 ' HB2' HD22 ' A' ' 64' ' ' LEU . 9.2 m-20 -88.85 -47.29 8.29 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.065 0.546 . . . . 0.0 110.15 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 63' ' ' ASP . 2.5 mm? -90.35 157.31 45.05 Favored Pre-proline 0 CA--C 1.562 1.412 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.099 -177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.94 44.82 1.76 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.495 2.797 . . . . 0.0 114.516 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.612 HG13 HD11 ' A' ' 72' ' ' LEU . 4.0 mp -83.47 124.17 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 169.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -119.94 170.7 9.02 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.545 0.738 . . . . 0.0 109.171 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.8 t -74.63 111.56 9.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.76 13.43 59.43 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.218 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -80.08 170.03 17.01 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 30.7 ttm -117.4 113.74 22.53 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.589 0.756 . . . . 0.0 109.353 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.612 HD11 HG13 ' A' ' 66' ' ' ILE . 3.2 mp -90.64 105.69 17.99 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.476 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.75 89.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 75.3 t -72.11 107.27 2.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.386 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -77.13 159.85 29.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.697 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 78' ' ' GLN . 43.1 tt0 -125.19 121.52 34.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.15 -21.97 66.35 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.51 176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 76' ' ' GLU . 46.3 mt-30 63.36 33.42 13.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.501 1.12 . . . . 0.0 110.937 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.43 HG23 ' HG3' ' A' ' 80' ' ' ARG . 6.4 t -68.82 -33.04 73.17 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.19 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.43 ' HG3' HG23 ' A' ' 79' ' ' THR . 8.1 ppt_? -162.05 153.7 15.69 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.842 0.857 . . . . 0.0 109.641 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.03 164.64 33.04 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.598 2.199 . . . . 0.0 113.015 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -70.98 86.6 0.72 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.89 0.876 . . . . 0.0 109.107 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.01 135.38 33.68 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.871 0.869 . . . . 0.0 110.808 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.7 t -102.94 134.65 19.69 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.574 0.749 . . . . 0.0 109.319 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -58.41 -30.78 92.42 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.948 2.432 . . . . 0.0 112.893 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--O 1.248 1.011 0 C-N-CA 124.063 0.945 . . . . 0.0 109.556 178.189 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 39.3 m0 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -93.24 82.55 4.53 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 66' ' ' ILE . 41.3 t -96.1 136.99 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -87.29 141.75 28.41 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.57 0.748 . . . . 0.0 110.327 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.608 ' SG ' HD13 ' A' ' 14' ' ' LEU . 86.3 m -130.91 101.88 5.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.327 0.651 . . . . 0.0 111.427 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.528 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 12.9 tppt? -74.95 118.69 18.19 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.436 1.094 . . . . 0.0 110.381 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.13 -173.92 4.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.329 0.651 . . . . 0.0 109.416 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.09 130.95 45.0 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.564 0.346 . . . . 0.0 110.107 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.46 -22.44 30.68 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.805 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.41 -163.19 24.66 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 123.172 0.415 . . . . 0.0 112.073 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.5 m -85.12 125.95 33.21 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.424 ' HB3' HG22 ' A' ' 33' ' ' ILE . 77.7 m80 -112.02 112.55 24.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.207 1.003 . . . . 0.0 108.647 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.3 tp -80.07 121.55 25.67 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.093 0.557 . . . . 0.0 110.666 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.608 HD13 ' SG ' ' A' ' 5' ' ' CYS . 8.5 mp -81.41 133.46 35.42 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.391 0.615 . . . . 0.0 110.749 174.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -105.33 153.37 21.73 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.526 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.04 23.82 74.51 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 115.117 0.807 . . . . 0.0 115.117 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD22 HG21 ' A' ' 21' ' ' THR . 78.0 mt -77.17 117.96 19.23 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.672 0.736 . . . . 0.0 110.077 175.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 94.5 p -84.84 161.35 19.94 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.7 p -65.39 -17.6 64.66 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.541 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.584 HH22 ' HA3' ' A' ' 62' ' ' GLY . 6.9 mmp_? -107.22 18.49 21.61 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.144 0.977 . . . . 0.0 112.256 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.482 HG21 HD22 ' A' ' 17' ' ' LEU . 44.0 m -63.31 119.8 10.35 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 120.926 0.393 . . . . 0.0 110.303 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -82.39 176.58 9.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.864 0.866 . . . . 0.0 111.272 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HB2' HG22 ' A' ' 59' ' ' ILE . 5.7 tt -51.33 -60.62 2.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.714 1.206 . . . . 0.0 110.21 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -54.12 -30.43 48.72 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.021 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 21' ' ' THR . 9.0 mm-40 -83.98 -38.74 20.57 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.41 0.684 . . . . 0.0 110.128 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.24 -66.99 0.66 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.225 1.01 . . . . 0.0 109.564 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -67.15 -16.93 64.61 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.87 -42.04 70.97 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.849 0.718 . . . . 0.0 112.022 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.441 ' O ' HG13 ' A' ' 33' ' ' ILE . 24.0 mt-30 -70.22 -39.51 75.06 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.527 HG13 HD21 ' A' ' 14' ' ' LEU . 88.5 mt -57.59 -42.63 81.66 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 123.612 0.765 . . . . 0.0 110.881 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.68 -24.17 67.5 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.034 0.934 . . . . 0.0 112.397 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.51 -35.58 15.0 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.771 0.829 . . . . 0.0 111.435 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 29' ' ' GLN . 25.1 mt -86.32 -64.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.094 0.558 . . . . 0.0 111.109 -171.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.58 HG23 HG12 ' A' ' 36' ' ' ILE . 12.1 t -93.72 -2.86 53.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.557 0.343 . . . . 0.0 110.929 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.41 -10.07 56.18 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.555 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.58 HG12 HG23 ' A' ' 34' ' ' THR . 22.5 mm -71.65 111.46 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.591 0.696 . . . . 0.0 109.949 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.65 144.45 44.69 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 124.135 0.974 . . . . 0.0 111.089 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -58.95 -28.17 86.88 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.082 2.521 . . . . 0.0 113.049 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.08 28.02 9.37 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 123.548 0.53 . . . . 0.0 113.402 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -138.87 11.64 2.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.39 1.076 . . . . 0.0 109.987 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -150.46 161.3 42.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.794 0.838 . . . . 0.0 110.741 -175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -143.32 -168.91 2.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.173 1.389 . . . . 0.0 109.21 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.511 HG12 HD11 ' A' ' 54' ' ' LEU . 24.2 mm -106.83 110.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.562 0.745 . . . . 0.0 109.112 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.6 mm? -120.01 156.6 30.57 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.56 167.72 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.159 0.584 . . . . 0.0 111.046 -174.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.72 -49.32 78.78 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 124.528 1.142 . . . . 0.0 113.041 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -74.12 158.72 85.28 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-O 118.62 -0.705 . . . . 0.0 109.631 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -46.53 111.41 0.36 Allowed 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.225 2.617 . . . . 0.0 114.227 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.72 -176.91 2.66 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.054 2.503 . . . . 0.0 111.614 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -126.0 30.15 5.72 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.4 0.68 . . . . 0.0 110.741 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 34.0 m 55.44 64.27 1.82 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.741 0.816 . . . . 0.0 109.713 -174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.9 mt -70.75 109.35 4.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.98 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.23 115.72 27.8 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.912 1.285 . . . . 0.0 108.921 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 43' ' ' ILE . 4.1 mp -82.7 93.45 7.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.499 0.72 . . . . 0.0 109.229 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.6 p -79.8 -52.58 7.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 111.213 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -83.45 131.67 35.01 Favored 'General case' 0 C--O 1.211 -0.932 0 C-N-CA 123.476 0.71 . . . . 0.0 110.319 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -22.82 61.15 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.726 0.811 . . . . 0.0 112.951 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -91.58 -5.29 54.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.496 1.119 . . . . 0.0 111.252 -175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 23' ' ' LEU . 13.9 tt -59.58 121.07 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.236 0.615 . . . . 0.0 111.626 -174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.3 p -91.37 173.57 7.84 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.502 0.721 . . . . 0.0 111.278 -174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.432 HD13 HG21 ' A' ' 66' ' ' ILE . 45.4 mt -70.26 -4.76 23.42 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.605 0.762 . . . . 0.0 111.643 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.584 ' HA3' HH22 ' A' ' 20' ' ' ARG . . . -78.46 -30.61 48.84 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 120.076 -0.291 . . . . 0.0 112.846 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 -48.98 6.19 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.82 133.05 95.43 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.076 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.6 78.49 0.95 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.816 2.344 . . . . 0.0 111.96 176.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.468 HG23 HG11 ' A' ' 3' ' ' VAL . 2.1 mp -123.23 121.87 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.1 mm-40 -117.9 154.91 31.08 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.753 0.821 . . . . 0.0 109.069 174.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 t -65.25 106.81 1.42 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.709 0.803 . . . . 0.0 110.493 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.25 13.07 62.38 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.235 -0.439 . . . . 0.0 113.87 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.7 t70 -84.77 163.47 19.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.176 0.59 . . . . 0.0 110.447 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.528 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 5.7 tpt -91.83 101.64 14.23 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.468 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.5 mm? -101.61 123.15 45.15 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.231 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.5 mp -91.95 116.18 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.98 110.37 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.218 1.007 . . . . 0.0 108.286 169.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -76.81 138.65 39.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.4 108.77 20.21 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -78.1 -21.92 49.72 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.215 0.606 . . . . 0.0 111.106 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 62.28 28.63 17.08 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.465 1.106 . . . . 0.0 111.861 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -76.55 -6.53 52.31 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.683 0.793 . . . . 0.0 112.083 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -162.18 159.91 21.28 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.968 0.907 . . . . 0.0 109.657 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.82 158.66 56.94 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.077 1.851 . . . . 0.0 110.664 166.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' N ' ' HD3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -140.98 142.26 34.32 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.026 0.531 . . . . 0.0 109.812 -174.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.85 114.89 28.39 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.6 p -102.83 103.41 33.01 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 123.332 0.653 . . . . 0.0 109.974 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.63 163.07 26.95 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.465 2.11 . . . . 0.0 112.08 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 C--O 1.253 1.258 0 C-N-CA 123.565 0.746 . . . . 0.0 109.486 178.037 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 37.0 m0 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -83.47 72.95 10.23 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.367 1.079 . . . . 0.0 109.55 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG13 HD23 ' A' ' 72' ' ' LEU . 95.8 t -80.95 132.67 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.056 -172.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -96.23 127.18 42.0 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.446 0.698 . . . . 0.0 109.585 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' HD13 ' A' ' 14' ' ' LEU . 84.4 m -113.25 114.88 27.34 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.243 0.617 . . . . 0.0 110.36 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -80.37 105.11 11.39 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.682 0.793 . . . . 0.0 108.944 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -128.24 178.64 6.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.294 0.569 . . . . 0.0 111.501 -173.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.547 ' HG3' ' HB3' ' A' ' 76' ' ' GLU . 31.9 mmmt -71.64 -25.06 61.98 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.561 1.144 . . . . 0.0 111.775 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.9 26.82 14.76 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.74 -175.68 42.2 Favored Glycine 0 C--N 1.353 1.48 0 C-N-CA 122.971 0.32 . . . . 0.0 113.348 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.485 HG23 ' HE1' ' A' ' 71' ' ' MET . 20.5 m -86.46 124.13 32.45 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 122.894 0.478 . . . . 0.0 109.811 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.62 166.54 11.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.562 0.745 . . . . 0.0 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -118.27 120.5 37.85 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.658 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -103.35 111.47 23.9 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.022 0.929 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -89.96 171.47 9.55 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.848 0.859 . . . . 0.0 109.248 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.83 3.66 85.56 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.802 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 98.1 mt -95.96 127.52 42.04 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.837 0.855 . . . . 0.0 109.316 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.9 p -116.07 -166.82 1.18 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.952 1.301 . . . . 0.0 109.5 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.2 p -70.01 -45.75 66.58 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.329 0.651 . . . . 0.0 111.432 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -107.18 39.25 1.92 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 25' ' ' GLU . 20.1 m -70.46 122.79 20.31 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 166.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.457 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 26.6 mtm180 -76.24 170.14 16.88 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.622 0.769 . . . . 0.0 111.198 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 54' ' ' LEU . 44.5 tp -57.54 -49.73 75.39 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.679 0.791 . . . . 0.0 111.285 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -56.78 -32.38 65.59 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.752 0.657 . . . . 0.0 112.144 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.509 ' HB2' HG23 ' A' ' 21' ' ' THR . 42.1 mm-40 -78.12 -46.95 19.3 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.392 0.677 . . . . 0.0 109.684 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.09 -62.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.954 1.301 . . . . 0.0 110.812 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 59.2 mt-30 -64.96 -21.89 66.91 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 122.942 0.497 . . . . 0.0 111.707 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.58 -37.71 93.91 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.89 0.744 . . . . 0.0 111.748 173.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -78.71 -37.24 42.04 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 119.261 -0.4 . . . . 0.0 110.514 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -55.97 -46.21 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 123.319 0.647 . . . . 0.0 110.808 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -63.26 -24.46 67.88 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.018 0.927 . . . . 0.0 112.182 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.45 -33.3 16.86 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.718 0.807 . . . . 0.0 111.682 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.658 HG13 ' HG ' ' A' ' 14' ' ' LEU . 20.8 mm -85.13 -62.76 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.149 0.979 . . . . 0.0 111.21 -171.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.454 HG23 HG12 ' A' ' 36' ' ' ILE . 10.2 t -96.21 -11.58 25.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.932 0.493 . . . . 0.0 111.133 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.88 -12.86 68.35 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.938 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 34' ' ' THR . 6.6 mm -75.04 114.17 14.72 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.87 77.62 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.172 0.989 . . . . 0.0 111.233 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 37.0 Cg_endo -61.8 -17.83 57.29 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.089 2.526 . . . . 0.0 112.774 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 20.86 40.51 Favored Glycine 0 C--N 1.352 1.432 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.874 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.2 m -147.34 3.11 0.77 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.892 0.877 . . . . 0.0 111.992 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.443 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 3.7 pp0? -143.56 168.03 20.83 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 122.002 0.905 . . . . 0.0 112.3 177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -153.15 166.41 32.58 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.724 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.618 HG23 HD12 ' A' ' 72' ' ' LEU . 1.8 mp -105.17 112.4 38.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 C-N-CA 123.553 0.741 . . . . 0.0 109.087 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -117.64 169.91 9.19 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' TYR . 6.9 m -121.52 162.63 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-N 118.232 0.469 . . . . 0.0 111.24 -176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.9 -28.25 72.44 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 115.428 -0.805 . . . . 0.0 113.593 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.426 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 45.4 p90 -95.08 173.24 4.58 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.757 -1.116 . . . . 0.0 109.093 172.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 34.2 Cg_exo -40.49 110.62 0.12 Allowed 'Trans proline' 0 C--N 1.399 3.187 0 C-N-CA 123.512 2.808 . . . . 0.0 113.988 173.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.73 159.97 18.98 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.647 2.232 . . . . 0.0 112.349 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -76.79 -14.32 59.93 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.876 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.4 m 66.87 23.5 9.96 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 124.831 1.252 . . . . 0.0 109.476 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.532 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.5 pt? -56.83 129.46 41.47 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 125.698 1.599 . . . . 0.0 112.161 -172.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.28 105.68 17.65 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 43' ' ' ILE . 6.0 mp -74.63 95.93 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.8 p -120.35 6.38 10.67 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.949 0.9 . . . . 0.0 111.74 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 59' ' ' ILE . 12.2 t70 -112.05 114.9 28.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -61.54 -29.39 69.98 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.523 0.729 . . . . 0.0 112.369 -174.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -94.13 -13.44 26.75 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.252 1.021 . . . . 0.0 111.883 -170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 56' ' ' ASP . 13.9 tt -60.69 133.32 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 120.854 0.359 . . . . 0.0 110.462 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 71.2 p -104.59 168.48 9.05 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.735 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.521 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 34.1 mt -67.88 -10.13 50.56 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.473 -178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.66 -39.43 40.68 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -79.17 -35.04 42.56 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.762 0.791 . . . . 0.0 109.282 177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 93.3 mt -80.99 157.68 71.07 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.923 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.2 34.24 0.43 Allowed 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 123.063 2.509 . . . . 0.0 113.089 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 43' ' ' ILE . 2.4 mp -84.61 120.55 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 170.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 35.8 mt-30 -121.54 161.63 22.0 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.122 0.569 . . . . 0.0 109.507 171.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -66.9 114.02 5.4 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.02 0.528 . . . . 0.0 109.747 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.94 8.91 83.45 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.562 0.539 . . . . 0.0 113.883 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -80.44 160.22 25.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.695 0.398 . . . . 0.0 110.076 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.485 ' HE1' HG23 ' A' ' 11' ' ' THR . 0.1 OUTLIER -94.92 101.88 13.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.18 0.992 . . . . 0.0 109.613 -178.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.618 HD12 HG23 ' A' ' 43' ' ' ILE . 3.8 mm? -104.95 109.27 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.792 0.837 . . . . 0.0 108.853 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.7 mp -75.27 105.99 4.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.161 0.584 . . . . 0.0 109.582 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.71 111.89 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.764 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 11.4 pt-20 -80.11 176.29 9.88 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.355 173.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.547 ' HB3' ' HG3' ' A' ' 8' ' ' LYS . 38.6 tt0 -138.51 116.85 11.94 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.61 -19.41 14.36 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.705 0.802 . . . . 0.0 110.03 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.489 ' HG3' ' HG2' ' A' ' 76' ' ' GLU . 26.8 mt-30 59.91 12.94 3.33 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.882 1.273 . . . . 0.0 113.702 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -71.23 -32.23 68.53 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.087 0.555 . . . . 0.0 111.183 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -142.15 79.1 16.39 Favored Pre-proline 0 N--CA 1.483 1.222 0 C-N-CA 124.067 0.947 . . . . 0.0 108.526 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.43 174.9 10.12 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.752 2.301 . . . . 0.0 112.124 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -142.19 106.01 4.71 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.159 0.584 . . . . 0.0 110.333 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.62 106.9 4.55 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.922 0.889 . . . . 0.0 109.018 174.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.8 m -145.73 99.38 4.41 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.908 0.883 . . . . 0.0 108.89 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.46 -25.66 67.51 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.171 2.581 . . . . 0.0 113.168 170.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 52.9 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 123.334 0.654 . . . . 0.0 109.695 172.544 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 23.0 m0 . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.556 ' HB3' HD11 ' A' ' 13' ' ' LEU . 82.2 mtm180 -86.59 86.42 7.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.79 0.836 . . . . 0.0 109.301 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t -99.54 141.61 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.145 0.978 . . . . 0.0 111.237 -170.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -98.87 97.32 8.52 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.684 0.794 . . . . 0.0 111.505 -175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.5 m -80.3 100.91 8.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.564 0.746 . . . . 0.0 110.598 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -76.86 103.4 6.79 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 109.297 176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.601 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -134.46 172.26 13.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.65 0.38 . . . . 0.0 110.656 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -59.26 112.47 1.74 Allowed 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.216 173.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.74 9.36 14.31 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.403 -171.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.79 -166.37 18.04 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 122.943 0.306 . . . . 0.0 113.14 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -81.75 157.8 24.39 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -138.9 120.02 14.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.108 0.563 . . . . 0.0 109.522 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' A' ' 2' ' ' ARG . 2.1 tm? -96.26 98.62 10.44 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.94 141.75 31.02 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.481 0.712 . . . . 0.0 111.433 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -112.84 179.36 3.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.282 1.033 . . . . 0.0 109.234 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.6 28.58 73.56 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.441 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.497 HD22 HG21 ' A' ' 21' ' ' THR . 93.0 mt -106.09 113.73 27.44 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.292 0.637 . . . . 0.0 110.75 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.9 t -95.85 172.09 8.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 0.0 108.923 172.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.4 p -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 122.45 0.3 . . . . 0.0 111.808 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.99 22.07 13.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.817 0.447 . . . . 0.0 111.804 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.497 HG21 HD22 ' A' ' 17' ' ' LEU . 52.4 m -66.47 111.05 3.37 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 170.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.426 ' HG2' HG22 ' A' ' 60' ' ' THR . 86.0 mtt-85 -74.12 -178.6 3.42 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.271 1.028 . . . . 0.0 111.971 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 54' ' ' LEU . 6.8 tt -56.76 -53.98 51.61 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.881 0.872 . . . . 0.0 109.241 174.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -63.29 -22.1 66.66 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.37 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 29' ' ' GLN . 25.3 mm-40 -87.2 -53.43 4.86 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.262 0.625 . . . . 0.0 109.665 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.55 ' HG ' HD21 ' A' ' 61' ' ' LEU . 2.5 tm? -70.89 -65.57 0.72 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.212 1.005 . . . . 0.0 110.191 -176.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -67.43 -17.23 64.63 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 123.64 0.588 . . . . 0.0 110.888 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.45 -37.54 53.4 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 123.753 0.658 . . . . 0.0 112.538 172.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 22.6 mt-30 -68.88 -39.46 79.77 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.406 ' HB ' HE22 ' A' ' 41' ' ' GLN . 85.6 mt -59.68 -37.19 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 C-N-CA 124.02 0.928 . . . . 0.0 111.204 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.73 -24.01 65.37 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.193 0.997 . . . . 0.0 111.926 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.69 -43.26 8.74 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.596 0.758 . . . . 0.0 111.322 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 29' ' ' GLN . 17.0 mm -68.3 -63.32 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.383 1.073 . . . . 0.0 110.237 -172.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 36' ' ' ILE . 8.9 t -109.31 0.99 19.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.67 0.788 . . . . 0.0 111.013 -176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.5 2.2 89.38 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 170.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 34' ' ' THR . 9.8 mm -86.08 107.85 16.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.465 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.96 147.54 98.36 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.564 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -49.95 -33.3 33.51 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 124.11 3.207 . . . . 0.0 114.25 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 13.86 18.48 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 64.3 m -138.99 15.01 2.65 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.769 0.828 . . . . 0.0 110.92 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 2.1 pt20 -146.81 155.26 42.21 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.514 0.725 . . . . 0.0 110.783 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -124.67 -173.91 2.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.169 0.988 . . . . 0.0 109.374 176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.6 mm -110.4 98.28 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 28.4 mt -107.34 139.73 41.36 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 175.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.426 HG11 ' HB2' ' A' ' 65' ' ' PRO . 6.7 m -120.19 178.34 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 122.867 0.467 . . . . 0.0 112.203 -164.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.97 -49.82 57.37 Favored Glycine 0 C--N 1.355 1.617 0 O-C-N 124.301 1.001 . . . . 0.0 113.654 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -79.01 163.11 61.89 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.367 174.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -42.04 104.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.884 3.056 . . . . 0.0 113.924 171.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -76.13 159.11 37.5 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.404 2.069 . . . . 0.0 112.736 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -89.33 8.19 31.85 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.412 1.085 . . . . 0.0 112.145 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 57.0 m 61.67 27.08 16.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.37 1.068 . . . . 0.0 110.264 -169.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -61.62 108.44 0.98 Allowed 'General case' 0 C--N 1.357 0.91 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.751 -173.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -98.48 132.97 43.49 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.685 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.528 ' HB3' HD12 ' A' ' 23' ' ' LEU . 7.1 mp -87.86 88.05 7.54 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.351 1.06 . . . . 0.0 108.359 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.0 t -93.87 13.93 21.06 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.435 0.694 . . . . 0.0 110.57 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.02 117.46 20.94 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.319 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -60.88 -30.28 70.06 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.169 0.987 . . . . 0.0 113.108 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -81.34 -23.44 37.75 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.581 1.152 . . . . 0.0 111.741 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.3 tt -56.16 134.92 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 124.075 0.95 . . . . 0.0 111.734 -173.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.426 HG22 ' HG2' ' A' ' 22' ' ' ARG . 58.9 p -113.55 175.2 5.56 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.54 0.736 . . . . 0.0 111.05 -173.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.55 HD21 ' HG ' ' A' ' 26' ' ' LEU . 50.7 mt -64.36 -22.01 66.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.96 0.504 . . . . 0.0 111.848 177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.22 -17.05 61.03 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.241 0.338 . . . . 0.0 113.232 174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -98.57 -45.31 6.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.672 0.789 . . . . 0.0 111.191 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 52' ' ' LEU . 2.3 mm? -85.91 154.73 58.36 Favored Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 123.108 0.563 . . . . 0.0 110.946 -177.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.426 ' HB2' HG11 ' A' ' 45' ' ' VAL . 2.2 Cg_endo -81.61 41.77 1.2 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.523 2.815 . . . . 0.0 113.083 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.76 108.64 3.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 166.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.597 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 21.0 mm-40 -105.7 166.42 10.47 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.1 p -64.4 99.51 0.3 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.199 0.6 . . . . 0.0 110.953 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.06 35.27 44.55 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.451 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 39.0 t70 -88.52 165.43 14.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.388 0.675 . . . . 0.0 111.047 -178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.52 98.21 11.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.802 0.841 . . . . 0.0 109.615 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 98.96 10.27 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.506 0.722 . . . . 0.0 110.21 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.8 mp -75.96 101.12 2.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 94.5 t -79.42 106.9 11.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.691 173.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 9.1 pt-20 -78.61 169.04 18.88 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.219 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 78' ' ' GLN . 23.8 tt0 -130.34 137.11 49.76 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 170.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.94 -16.97 62.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.07 0.548 . . . . 0.0 111.861 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.506 ' H ' ' HG2' ' A' ' 76' ' ' GLU . 0.1 OUTLIER 71.38 1.23 3.76 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.567 1.147 . . . . 0.0 113.083 175.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -78.42 -10.91 59.89 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.153 0.581 . . . . 0.0 110.626 173.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 65.59 91.75 0.07 OUTLIER Pre-proline 0 C--N 1.361 1.066 0 C-N-CA 125.237 1.415 . . . . 0.0 109.765 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.46 124.71 12.37 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.715 2.277 . . . . 0.0 113.127 -172.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -87.96 122.92 32.15 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.27 177.83 8.52 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.761 0.824 . . . . 0.0 110.709 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.8 p -125.0 90.45 51.04 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.997 0.919 . . . . 0.0 108.852 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.45 85.48 0.06 OUTLIER 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 123.486 2.791 . . . . 0.0 113.248 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.551 1.003 0 C-N-CA 124.77 1.228 . . . . 0.0 108.374 -177.013 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 11.2 m0 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.465 ' HB2' HD11 ' A' ' 13' ' ' LEU . 23.1 ptt180 -88.17 65.39 8.1 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-O 122.689 1.233 . . . . 0.0 109.563 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.539 ' HB ' HD12 ' A' ' 17' ' ' LEU . 43.3 t -79.12 143.53 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.507 -169.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -98.69 142.86 29.72 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.357 1.063 . . . . 0.0 109.943 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.448 ' SG ' HD13 ' A' ' 14' ' ' LEU . 72.1 m -136.39 99.99 4.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.231 1.013 . . . . 0.0 110.076 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -74.41 113.16 11.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.296 1.038 . . . . 0.0 109.433 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -129.52 100.78 5.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.773 0.429 . . . . 0.0 110.228 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HE3' ' HB3' ' A' ' 76' ' ' GLU . 33.5 mmtp 59.57 23.56 12.27 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.065 1.346 . . . . 0.0 112.61 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.51 -31.47 7.79 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.1 87.04 0.48 Allowed Glycine 0 C--N 1.354 1.54 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 m -77.15 111.18 12.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.753 0.821 . . . . 0.0 109.297 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -112.62 152.1 29.33 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.975 0.91 . . . . 0.0 110.861 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER -113.31 112.94 24.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.448 HD13 ' SG ' ' A' ' 5' ' ' CYS . 5.5 mp -102.72 97.34 7.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.749 0.82 . . . . 0.0 109.041 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.446 ' HG3' HD12 ' A' ' 13' ' ' LEU . 78.5 mt-30 -78.86 -11.4 59.99 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.373 0.669 . . . . 0.0 110.951 169.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.52 -9.63 74.06 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.421 0.451 . . . . 0.0 114.049 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.547 HD22 HG21 ' A' ' 21' ' ' THR . 71.1 mt -78.36 125.01 28.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.953 0.501 . . . . 0.0 110.382 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.483 ' O ' HD12 ' A' ' 61' ' ' LEU . 44.5 m -103.43 -178.11 3.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.321 1.449 . . . . 0.0 109.577 171.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 m -65.61 -39.86 91.99 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.92 0.488 . . . . 0.0 112.079 -178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -104.5 29.15 6.33 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.819 0.448 . . . . 0.0 112.165 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.547 HG21 HD22 ' A' ' 17' ' ' LEU . 94.9 m -64.08 104.88 0.78 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 122.84 0.456 . . . . 0.0 111.318 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -66.9 173.63 3.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.904 1.282 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 54' ' ' LEU . 6.3 tt -54.95 -50.87 67.81 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 123.451 0.7 . . . . 0.0 109.873 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.472 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 6.1 ptp180 -56.76 -26.26 56.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.972 0.909 . . . . 0.0 112.712 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 5.5 mm-40 -93.12 -35.46 13.18 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.897 0.879 . . . . 0.0 110.199 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -79.97 -68.69 0.65 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.035 0.934 . . . . 0.0 109.221 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -67.76 -19.01 65.07 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.604 0.565 . . . . 0.0 110.751 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.28 -43.86 77.65 Favored Glycine 0 C--N 1.345 1.051 0 O-C-N 123.929 0.768 . . . . 0.0 112.205 173.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.512 ' NE2' HD23 ' A' ' 17' ' ' LEU . 43.6 mt-30 -73.41 -38.91 65.42 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HB ' HE22 ' A' ' 41' ' ' GLN . 95.6 mt -57.11 -39.14 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 C-N-CA 123.139 0.576 . . . . 0.0 111.249 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.19 68.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.612 0.765 . . . . 0.0 111.694 174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.54 -23.35 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.068 0.947 . . . . 0.0 111.704 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 29' ' ' GLN . 22.2 mm -86.91 -69.38 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.916 0.886 . . . . 0.0 109.886 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.48 HG23 HG12 ' A' ' 36' ' ' ILE . 3.1 t -96.51 -11.73 25.09 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.273 0.629 . . . . 0.0 111.514 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 12.46 77.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 119.848 -0.418 . . . . 0.0 113.92 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.48 HG12 HG23 ' A' ' 34' ' ' THR . 13.2 mm -85.84 113.81 24.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.77 142.26 44.09 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.221 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.66 -24.41 62.57 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 123.226 2.617 . . . . 0.0 113.348 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.29 19.3 53.29 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.337 0.398 . . . . 0.0 113.27 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.9 m -134.6 -3.6 2.62 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 110.247 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.401 HE22 ' HB ' ' A' ' 30' ' ' ILE . 1.0 OUTLIER -123.92 145.67 48.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.613 0.765 . . . . 0.0 109.464 179.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -121.62 168.04 12.22 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 167.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 66' ' ' ILE . 46.5 mm -103.66 112.0 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.5 mm? -113.61 178.69 4.19 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.1 164.7 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.812 0.445 . . . . 0.0 111.311 -171.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.57 1.82 50.23 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 114.507 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -120.21 172.68 4.35 Favored Pre-proline 0 CA--C 1.558 1.268 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -37.45 103.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.017 3.145 . . . . 0.0 113.656 172.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.17 146.14 56.8 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.634 2.222 . . . . 0.0 112.613 -170.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.32 2.38 55.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.725 0.81 . . . . 0.0 110.826 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.0 m 56.14 74.35 0.39 Allowed 'General case' 0 C--N 1.365 1.258 0 C-N-CA 124.749 1.22 . . . . 0.0 110.482 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.7 mt -77.84 101.14 6.62 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.808 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -89.13 104.93 17.44 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.296 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' A' ' 23' ' ' LEU . 5.4 mp -73.85 85.21 1.7 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.2 t -82.41 -21.31 35.81 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.308 1.043 . . . . 0.0 110.984 -174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -107.81 136.98 46.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.884 0.874 . . . . 0.0 109.42 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -78.46 -22.45 47.57 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.579 0.751 . . . . 0.0 111.955 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -93.4 -2.56 54.53 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.448 0.699 . . . . 0.0 111.305 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.82 123.69 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.957 0.503 . . . . 0.0 110.539 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 p -104.51 177.35 4.87 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.891 0.476 . . . . 0.0 111.081 -175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 18' ' ' SER . 28.3 mt -74.55 -5.6 43.74 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.615 178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.13 -27.46 62.05 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.497 0.498 . . . . 0.0 111.902 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -90.92 -42.18 10.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.516 0.726 . . . . 0.0 109.279 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 87.4 mt -78.84 152.22 77.21 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.171 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -78.49 25.49 0.54 Allowed 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 124.14 3.227 . . . . 0.0 114.175 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.503 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.3 mp -77.08 128.69 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.5 mt-30 -118.03 -179.28 3.71 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.801 0.84 . . . . 0.0 108.917 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 p -68.41 -1.45 6.49 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 40.41 0.12 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 17.0 t70 -85.19 163.61 18.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.533 0.733 . . . . 0.0 111.577 -171.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.2 tpt -100.02 103.06 14.58 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.051 0.94 . . . . 0.0 109.508 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.503 ' HG ' HG13 ' A' ' 66' ' ' ILE . 3.2 mm? -109.37 131.24 55.25 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -92.97 114.11 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -86.43 115.66 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.214 1.006 . . . . 0.0 109.079 167.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -87.48 159.51 18.63 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.518 ' HB3' ' HE3' ' A' ' 8' ' ' LYS . 36.8 tt0 -117.2 113.61 22.47 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 172.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.33 -25.48 64.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.061 0.945 . . . . 0.0 109.727 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 45.78 40.52 6.5 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 126.031 1.732 . . . . 0.0 113.2 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -57.05 -42.65 80.91 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.606 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -174.34 150.01 1.46 Allowed Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 124.089 0.956 . . . . 0.0 109.962 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.55 117.26 4.73 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.902 2.402 . . . . 0.0 110.624 171.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -70.81 120.54 16.56 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.79 0.436 . . . . 0.0 111.437 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.39 -2.65 57.48 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.878 0.871 . . . . 0.0 111.501 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.1 m -79.16 152.11 76.23 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.312 1.045 . . . . 0.0 111.402 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.09 132.44 49.31 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.278 2.652 . . . . 0.0 112.825 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.552 1.045 0 C-N-CA 123.914 0.886 . . . . 0.0 109.423 -177.638 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 10.8 m0 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -90.95 83.33 5.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.066 0.946 . . . . 0.0 109.124 -178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.7 t -105.59 141.23 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.734 0.814 . . . . 0.0 111.126 -169.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -88.61 147.28 24.65 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 110.915 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 30.2 p -131.56 115.37 16.03 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.348 0.659 . . . . 0.0 110.4 175.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.574 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 14.3 tppt? -79.7 124.21 28.37 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.403 1.081 . . . . 0.0 109.434 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.4 172.09 15.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.118 0.567 . . . . 0.0 110.044 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.724 ' HE2' ' HB3' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -69.51 -23.58 63.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -178.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.45 20.73 25.34 Favored Glycine 0 C--N 1.349 1.272 0 O-C-N 123.384 0.427 . . . . 0.0 112.502 173.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.32 174.17 28.65 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 123.335 0.493 . . . . 0.0 112.609 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.4 m -85.53 117.94 24.74 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 171.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.67 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.3 m-70 -102.95 177.84 4.73 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 tt -146.86 101.5 3.44 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.0 mp -79.16 113.34 17.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.969 0.908 . . . . 0.0 110.038 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -101.65 -9.39 20.96 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.357 0.663 . . . . 0.0 110.979 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.63 42.03 3.12 Favored Glycine 0 C--N 1.349 1.292 0 C-N-CA 122.827 0.251 . . . . 0.0 113.165 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 HD23 HE22 ' A' ' 29' ' ' GLN . 96.5 mt -118.24 121.97 41.8 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.832 0.853 . . . . 0.0 109.835 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 63.2 p -97.44 171.97 8.05 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.373 1.069 . . . . 0.0 109.337 169.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 m -62.31 -29.34 70.37 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.281 0.632 . . . . 0.0 111.546 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -110.74 29.5 7.69 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.84 0.856 . . . . 0.0 112.142 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -70.88 121.11 17.49 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 166.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtm180 -89.93 169.6 11.09 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 110.093 -173.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 57' ' ' ARG . 24.9 tp -51.99 -51.56 56.43 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.856 0.863 . . . . 0.0 111.715 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 11.8 ptm180 -55.37 -34.1 64.0 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.731 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.563 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 44.0 mt-10 -88.26 -31.28 19.1 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.812 0.845 . . . . 0.0 110.877 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.436 HD11 HD11 ' A' ' 43' ' ' ILE . 2.3 tm? -74.01 -66.4 0.72 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.034 0.934 . . . . 0.0 108.907 -174.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -66.49 -20.84 66.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.192 177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.37 -42.04 90.32 Favored Glycine 0 C--N 1.35 1.338 0 O-C-N 124.013 0.821 . . . . 0.0 111.67 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.455 HE22 HD23 ' A' ' 17' ' ' LEU . 20.9 mt-30 -73.71 -35.76 65.16 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.574 0.349 . . . . 0.0 110.078 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.43 ' HB ' HE22 ' A' ' 41' ' ' GLN . 84.2 mt -62.72 -37.56 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 C-N-CA 123.287 0.635 . . . . 0.0 110.53 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.73 -24.61 67.84 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.813 0.845 . . . . 0.0 112.022 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.47 -25.5 16.21 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.908 0.883 . . . . 0.0 111.804 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.563 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.4 mm -82.4 -65.04 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.331 1.052 . . . . 0.0 110.488 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.556 HG23 HG12 ' A' ' 36' ' ' ILE . 7.1 t -108.77 -0.36 20.0 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.98 0.912 . . . . 0.0 110.953 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.99 11.87 84.74 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-O 119.404 -0.664 . . . . 0.0 114.398 171.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 76' ' ' GLU . 23.0 mm -85.78 131.49 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-N 117.791 0.796 . . . . 0.0 111.442 -175.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.39 130.93 93.64 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.201 1.0 . . . . 0.0 110.335 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -58.05 -24.97 68.56 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.335 2.69 . . . . 0.0 113.42 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.61 -3.57 90.19 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 113.859 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.5 m -107.41 -48.21 3.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.762 0.825 . . . . 0.0 110.309 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.43 HE22 ' HB ' ' A' ' 30' ' ' ILE . 3.2 pt20 -76.91 153.77 34.35 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.269 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.69 168.36 23.85 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.448 1.099 . . . . 0.0 109.075 168.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.444 HG21 ' HD2' ' A' ' 65' ' ' PRO . 43.9 mm -79.41 103.55 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 122.259 1.028 . . . . 0.0 110.364 -174.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.2 mt -122.1 137.19 54.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.985 -1.916 . . . . 0.0 105.964 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 65' ' ' PRO . 16.3 m -125.68 179.1 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 122.733 0.413 . . . . 0.0 111.5 -169.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.65 -48.75 74.9 Favored Glycine 0 C--N 1.358 1.779 0 O-C-N 124.326 1.016 . . . . 0.0 113.654 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -80.7 155.82 73.19 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.929 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -45.29 108.04 0.13 Allowed 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 124.22 3.28 . . . . 0.0 113.593 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.04 169.14 8.97 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.946 2.431 . . . . 0.0 111.524 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.58 25.18 11.21 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.455 0.702 . . . . 0.0 111.417 -174.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 69.1 m 53.2 65.07 1.62 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.03 0.932 . . . . 0.0 110.143 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.86 126.14 26.33 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.182 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -91.04 90.81 8.02 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.836 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mp -74.89 86.17 2.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.9 t -80.58 -41.46 23.99 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.0 0.92 . . . . 0.0 110.872 -174.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 20.9 t0 -81.11 118.2 22.32 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.024 0.53 . . . . 0.0 110.385 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HA ' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.75 -29.13 62.24 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.07 0.948 . . . . 0.0 112.832 174.313 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -93.52 -2.39 54.41 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.761 0.824 . . . . 0.0 112.047 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 14.0 tt -69.73 126.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.989 -0.444 . . . . 0.0 111.177 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -91.12 172.04 8.83 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.37 0.605 . . . . 0.0 112.437 -171.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.491 HD13 HG21 ' A' ' 66' ' ' ILE . 27.6 mt -65.43 -17.78 64.81 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.149 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -28.62 66.77 Favored Glycine 0 C--N 1.36 1.886 0 O-C-N 123.483 0.489 . . . . 0.0 113.14 174.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -87.81 -52.24 5.41 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.129 0.571 . . . . 0.0 110.402 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.9 155.45 82.89 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.969 0.908 . . . . 0.0 111.756 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' HG11 ' A' ' 45' ' ' VAL . 4.4 Cg_exo -80.66 36.65 0.63 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.878 3.052 . . . . 0.0 114.126 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.568 HG13 HD21 ' A' ' 72' ' ' LEU . 2.0 mp -70.89 114.55 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 167.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.631 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 34.4 mt-30 -118.23 148.57 42.27 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 p -65.24 104.07 0.88 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.374 0.67 . . . . 0.0 110.659 -177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.88 11.51 52.98 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 114.113 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.631 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 27.9 t0 -89.53 160.68 16.59 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.273 0.629 . . . . 0.0 111.979 -173.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.574 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 4.8 tpt -96.21 108.31 20.77 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.766 1.226 . . . . 0.0 109.648 -177.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.568 HD21 HG13 ' A' ' 66' ' ' ILE . 11.1 mp -109.67 126.12 53.34 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 0.0 110.288 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -85.88 103.29 12.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.53 111.65 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.618 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -105.99 155.41 19.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.71 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.724 ' HB3' ' HE2' ' A' ' 8' ' ' LYS . 10.0 tp10 -135.87 130.81 34.44 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.985 0.914 . . . . 0.0 109.446 -177.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -89.54 -5.46 57.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.354 0.662 . . . . 0.0 110.632 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.488 ' H ' ' HG3' ' A' ' 76' ' ' GLU . 48.4 mt-30 70.88 26.32 3.7 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.809 1.644 . . . . 0.0 110.169 -173.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.5 m -76.67 -38.56 54.31 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.234 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 66.89 165.46 0.12 Allowed Pre-proline 0 CA--C 1.564 1.502 0 C-N-CA 124.658 1.183 . . . . 0.0 111.269 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.54 121.2 9.22 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.634 1.556 . . . . 0.0 110.264 164.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -70.19 79.69 0.52 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.793 0.837 . . . . 0.0 111.126 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -172.01 169.4 5.65 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.238 1.015 . . . . 0.0 110.368 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.8 p -130.94 91.29 37.04 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 124.003 0.921 . . . . 0.0 109.126 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.32 -51.54 9.82 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.072 2.514 . . . . 0.0 112.028 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.6 p . . . . . 0 CA--C 1.553 1.088 0 C-N-CA 124.298 1.039 . . . . 0.0 108.901 173.01 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 18.8 m0 . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.505 ' HB3' HD11 ' A' ' 13' ' ' LEU . 53.7 mtm180 -116.75 88.05 2.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.017 0.927 . . . . 0.0 108.775 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.487 HG13 HD23 ' A' ' 72' ' ' LEU . 82.3 t -89.43 137.36 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.455 0.702 . . . . 0.0 111.204 -170.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -87.45 138.67 31.27 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.746 0.819 . . . . 0.0 109.075 176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 t -131.99 100.89 5.21 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.474 0.71 . . . . 0.0 111.11 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.488 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.0 tppp? -73.38 144.75 46.3 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 171.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.88 -168.94 2.52 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.733 0.301 . . . . 0.0 111.34 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.65 -28.61 9.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.108 1.363 . . . . 0.0 112.8 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.27 87.14 0.1 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.05 167.04 19.73 Favored Glycine 0 C--N 1.346 1.136 0 C-N-CA 123.251 0.453 . . . . 0.0 113.29 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -106.42 150.54 25.94 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.499 0.72 . . . . 0.0 110.436 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -122.97 164.66 18.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.33 1.452 . . . . 0.0 108.378 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 2' ' ' ARG . 0.3 OUTLIER -128.85 102.55 6.59 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.654 ' HG ' HG13 ' A' ' 33' ' ' ILE . 9.1 mp -81.3 121.77 26.6 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.041 0.936 . . . . 0.0 110.358 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.505 ' NE2' HD12 ' A' ' 13' ' ' LEU . 83.5 mm-40 -98.9 159.92 14.62 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.158 0.983 . . . . 0.0 109.762 174.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.8 10.43 83.13 Favored Glycine 0 C--N 1.343 0.967 0 CA-C-N 116.135 -0.484 . . . . 0.0 114.17 174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.39 137.44 42.71 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.113 0.565 . . . . 0.0 109.609 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -112.66 177.92 4.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.639 1.176 . . . . 0.0 109.36 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.7 p -82.32 -26.85 32.64 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.912 0.387 . . . . 0.0 109.972 170.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -86.8 6.92 29.2 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.926 0.89 . . . . 0.0 112.191 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.426 HG22 ' HB2' ' A' ' 26' ' ' LEU . 93.5 m -62.9 112.34 2.52 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.465 0.65 . . . . 0.0 110.826 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.88 179.36 7.87 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.287 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 57' ' ' ARG . 4.9 tt -57.53 -56.33 23.27 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.74 0.816 . . . . 0.0 109.652 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -20.31 64.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.673 0.789 . . . . 0.0 112.097 -175.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -79.62 -52.81 7.51 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.509 0.724 . . . . 0.0 109.246 172.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.426 ' HB2' HG22 ' A' ' 21' ' ' THR . 2.5 tm? -69.29 -66.72 0.55 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.879 1.272 . . . . 0.0 110.756 -169.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -65.13 -18.3 65.19 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.141 0.576 . . . . 0.0 111.7 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.46 -41.03 46.12 Favored Glycine 0 C--N 1.347 1.156 0 O-C-N 123.7 0.625 . . . . 0.0 111.983 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -70.13 -37.03 75.18 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.105 0.562 . . . . 0.0 110.06 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.1 mt -58.55 -43.73 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 0.0 110.912 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.417 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -60.76 -26.36 67.17 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.761 0.825 . . . . 0.0 111.743 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.51 -27.96 19.95 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.632 0.773 . . . . 0.0 111.769 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.654 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.4 mm -84.27 -70.07 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.115 0.566 . . . . 0.0 110.722 -177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 36' ' ' ILE . 6.4 t -88.53 -16.29 33.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.24 0.616 . . . . 0.0 111.154 -175.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.81 -1.91 85.55 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-O 119.677 -0.513 . . . . 0.0 113.361 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.401 ' H ' HG23 ' A' ' 34' ' ' THR . 18.9 mm -77.64 112.87 16.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.54 144.53 63.61 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 124.022 0.929 . . . . 0.0 110.772 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 31' ' ' ALA . 28.2 Cg_endo -57.85 -24.35 63.78 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.26 2.64 . . . . 0.0 113.212 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.49 19.8 34.32 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.639 -0.255 . . . . 0.0 113.28 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.8 m -140.37 12.62 2.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.458 1.103 . . . . 0.0 110.618 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -148.9 144.03 26.6 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 122.993 0.517 . . . . 0.0 109.81 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -124.8 176.35 6.66 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.279 1.032 . . . . 0.0 108.904 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.3 mm -101.21 101.12 11.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 32.2 mt -116.28 145.58 43.05 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.485 HG22 ' HB3' ' A' ' 49' ' ' PRO . 17.4 m -114.7 168.55 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.299 0.639 . . . . 0.0 110.017 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.25 -48.01 65.72 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.789 0.681 . . . . 0.0 113.77 -175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -80.29 160.87 66.92 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.606 171.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -47.52 110.77 0.33 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.485 ' HB3' HG22 ' A' ' 45' ' ' VAL . 90.8 Cg_endo -81.53 -179.81 5.21 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.273 2.649 . . . . 0.0 112.307 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -96.74 13.46 28.38 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.503 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 19.7 m 54.72 66.43 1.24 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 123.828 0.851 . . . . 0.0 108.706 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.7 mt -65.77 129.24 39.09 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.863 -165.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -103.9 90.14 3.52 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.488 1.115 . . . . 0.0 108.801 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.414 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 9.7 mp -87.49 104.99 16.99 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -100.65 -51.94 3.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.602 0.761 . . . . 0.0 110.562 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' O ' HG22 ' A' ' 59' ' ' ILE . 13.9 t0 -71.71 111.72 7.23 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.116 0.567 . . . . 0.0 111.317 -177.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.546 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -53.09 -25.59 13.4 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.501 1.12 . . . . 0.0 113.554 175.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.51 -2.75 56.0 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.49 0.716 . . . . 0.0 112.11 -173.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 56' ' ' ASP . 15.4 tt -71.78 125.43 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.729 0.412 . . . . 0.0 110.836 -175.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.6 p -89.4 176.01 7.09 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.659 0.743 . . . . 0.0 112.317 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.7 mt -73.52 -7.51 52.12 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.828 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.2 -19.17 71.95 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.395 172.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.35 -52.04 3.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.4 0.68 . . . . 0.0 110.519 175.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.43 148.22 54.92 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.216 0.607 . . . . 0.0 111.144 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 31.51 0.44 Allowed 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.805 3.003 . . . . 0.0 114.936 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.31 117.8 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -120.42 163.42 17.93 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.2 t -71.16 108.53 4.72 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.837 0.455 . . . . 0.0 110.191 -178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.57 0.15 62.87 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.581 0.551 . . . . 0.0 113.206 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.19 156.68 38.34 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.193 0.597 . . . . 0.0 110.549 -178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.2 tpt -92.54 104.58 16.87 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.491 1.117 . . . . 0.0 109.021 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.487 HD23 HG13 ' A' ' 3' ' ' VAL . 4.3 mm? -105.08 115.75 30.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.885 0.874 . . . . 0.0 109.11 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.4 mp -86.79 100.73 10.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -78.21 105.09 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.599 166.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -77.5 161.69 27.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.834 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -116.52 109.4 17.21 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 169.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -78.79 -17.46 55.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.183 0.993 . . . . 0.0 110.92 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 66.54 13.27 9.22 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.514 1.126 . . . . 0.0 113.259 172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 t -72.99 -19.36 61.23 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.89 0.476 . . . . 0.0 111.39 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 43.99 76.04 0.58 Allowed Pre-proline 0 N--CA 1.49 1.561 0 C-N-CA 125.85 1.66 . . . . 0.0 111.589 -176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -87.18 -177.5 2.18 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 123.138 2.559 . . . . 0.0 112.966 -169.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -97.4 22.99 8.05 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.598 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.44 104.19 2.23 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 124.053 0.941 . . . . 0.0 110.488 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.0 t 64.72 77.84 0.28 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 125.16 1.384 . . . . 0.0 111.243 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.9 82.57 0.77 Allowed 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.183 2.589 . . . . 0.0 111.39 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.216 1.007 . . . . 0.0 109.167 -177.404 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 38.5 m0 . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.842 0.353 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -125.17 106.81 10.17 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.469 HG11 HG23 ' A' ' 66' ' ' ILE . 37.3 t -130.75 139.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.922 -0.486 . . . . 0.0 110.35 -173.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -85.02 153.73 22.56 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.005 0.522 . . . . 0.0 111.72 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.545 ' SG ' HD23 ' A' ' 14' ' ' LEU . 95.3 m -130.72 112.14 12.81 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.395 1.078 . . . . 0.0 110.414 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 16.3 tppt? -82.34 107.67 15.19 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.426 1.09 . . . . 0.0 109.305 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.582 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -146.47 177.94 8.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.802 0.335 . . . . 0.0 111.253 -176.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.15 -34.81 75.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.368 1.067 . . . . 0.0 112.304 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.8 26.92 4.52 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.439 -0.346 . . . . 0.0 113.299 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.88 169.86 41.37 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.0 m -89.87 102.98 15.68 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 175.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -101.36 179.21 4.42 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.975 0.91 . . . . 0.0 110.153 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.595 HD22 ' NE2' ' A' ' 15' ' ' GLN . 3.0 tt -135.35 106.27 6.62 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.545 HD23 ' SG ' ' A' ' 5' ' ' CYS . 4.3 mm? -66.0 108.68 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.684 0.794 . . . . 0.0 109.925 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.595 ' NE2' HD22 ' A' ' 13' ' ' LEU . 29.3 mm-40 -76.89 -45.77 26.89 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.199 0.999 . . . . 0.0 110.719 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.81 65.48 3.91 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.533 -0.758 . . . . 0.0 113.382 -174.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.9 mt -118.43 138.55 52.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.06 0.544 . . . . 0.0 110.29 172.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.42 ' O ' HD12 ' A' ' 61' ' ' LEU . 21.3 m -115.75 -176.91 3.03 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.204 1.402 . . . . 0.0 108.722 170.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.2 m -73.47 -33.72 64.99 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.186 0.517 . . . . 0.0 110.681 176.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -104.37 28.18 7.15 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.844 -175.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 26' ' ' LEU . 53.3 m -67.76 105.18 1.85 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.347 0.594 . . . . 0.0 109.686 171.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 25' ' ' GLU . 36.2 mtm-85 -65.92 175.85 1.85 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.757 1.223 . . . . 0.0 111.637 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.488 HD12 ' HB3' ' A' ' 54' ' ' LEU . 7.3 tt -56.39 -57.67 11.3 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.356 0.662 . . . . 0.0 109.28 176.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -50.51 -34.6 25.81 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.9 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 18.6 mm-40 -76.11 -51.03 13.07 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.002 0.429 . . . . 0.0 110.087 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 43' ' ' ILE . 2.4 tm? -70.76 -67.27 0.52 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.317 1.047 . . . . 0.0 110.68 -170.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.432 ' HA ' HE22 ' A' ' 41' ' ' GLN . 40.2 mt-30 -66.55 -20.38 66.01 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.599 0.562 . . . . 0.0 111.618 -176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.22 -37.01 43.59 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.729 0.643 . . . . 0.0 112.192 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.431 ' O ' HG12 ' A' ' 33' ' ' ILE . 22.8 mt-30 -70.63 -39.73 73.53 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.7 mt -62.76 -36.63 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.312 0.645 . . . . 0.0 110.615 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.52 -26.34 68.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.439 0.695 . . . . 0.0 111.536 173.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.81 -23.04 20.72 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.92 0.888 . . . . 0.0 111.766 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 29' ' ' GLN . 16.0 mm -82.78 -70.35 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.372 0.669 . . . . 0.0 110.374 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.44 HG23 HG12 ' A' ' 36' ' ' ILE . 4.8 t -97.77 -7.75 29.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 -170.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.16 19.23 78.72 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-O 119.712 -0.493 . . . . 0.0 113.321 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.44 HG12 HG23 ' A' ' 34' ' ' THR . 11.0 mm -98.49 108.26 21.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.84 155.07 55.13 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.498 1.119 . . . . 0.0 112.157 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.12 -31.71 84.19 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.419 2.746 . . . . 0.0 114.599 -174.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.02 3.1 80.44 Favored Glycine 0 N--CA 1.476 1.353 0 O-C-N 123.124 0.265 . . . . 0.0 113.346 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.412 ' HA ' ' HB3' ' A' ' 77' ' ' ASP . 19.1 m -107.25 -2.93 20.28 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.198 0.999 . . . . 0.0 110.179 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.432 HE22 ' HA ' ' A' ' 27' ' ' GLN . 1.4 pp0? -144.53 162.45 36.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 120.974 0.416 . . . . 0.0 111.86 -176.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -145.48 -176.35 5.08 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.18 1.392 . . . . 0.0 108.885 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.596 HD11 HD11 ' A' ' 26' ' ' LEU . 29.0 mm -105.8 110.63 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.039 0.535 . . . . 0.0 109.723 -174.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 2.1 mm? -121.34 160.18 24.55 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.2 m -131.92 173.58 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.755 0.822 . . . . 0.0 111.125 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.48 -5.1 87.86 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.814 -175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 54.0 p90 -113.51 163.2 19.07 Favored Pre-proline 0 N--CA 1.479 1.017 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 171.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 10.8 Cg_endo -50.89 109.21 0.28 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 122.88 2.387 . . . . 0.0 112.489 -177.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -83.33 169.81 12.33 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.746 2.297 . . . . 0.0 112.159 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -88.08 5.73 39.7 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.706 0.802 . . . . 0.0 111.335 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 90.3 m 56.27 83.05 0.1 Allowed 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -158.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.61 95.6 3.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.245 0.545 . . . . 0.0 110.512 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.75 114.0 20.1 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.143 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.488 ' HB3' HD12 ' A' ' 23' ' ' LEU . 4.7 mp -79.46 84.83 5.3 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 p -67.9 -50.56 55.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.468 -173.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 19.3 t70 -76.25 157.55 32.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.083 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -92.52 -34.78 13.93 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.286 1.034 . . . . 0.0 111.815 -173.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -94.51 -3.07 50.58 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.9 1.28 . . . . 0.0 110.431 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.588 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 15.8 tt -60.85 133.51 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.637 1.175 . . . . 0.0 111.883 -175.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -108.69 -177.9 3.44 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -168.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.578 HD21 ' HG ' ' A' ' 26' ' ' LEU . 49.7 mt -75.64 -10.05 59.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.738 0.815 . . . . 0.0 112.061 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.43 -25.09 73.79 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 168.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.52 -59.33 2.16 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 109.846 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.75 129.79 75.47 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.282 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -63.21 78.26 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.918 3.079 . . . . 0.0 114.053 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.627 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -108.11 108.78 26.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 168.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 12.3 mm100 -103.31 155.05 18.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.972 0.509 . . . . 0.0 109.989 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.6 p -62.79 100.97 0.22 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.786 0.835 . . . . 0.0 111.826 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.53 46.08 8.22 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.608 -176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 6.0 t70 -110.25 169.71 8.56 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.309 0.644 . . . . 0.0 110.374 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.1 tpt -102.18 103.29 13.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.308 0.643 . . . . 0.0 109.991 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.627 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.6 mm? -106.01 114.68 28.96 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.475 0.71 . . . . 0.0 109.679 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 2.8 mp -82.13 108.76 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.667 0.787 . . . . 0.0 109.737 -176.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 75.8 t -82.97 116.42 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.706 1.203 . . . . 0.0 108.933 170.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.439 ' O ' HG21 ' A' ' 36' ' ' ILE . 11.9 pt-20 -82.31 170.23 15.59 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 120.646 0.26 . . . . 0.0 110.699 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -129.57 114.6 16.27 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 40' ' ' SER . 27.7 t70 -94.72 -23.05 17.73 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.342 1.057 . . . . 0.0 110.703 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 63.7 36.02 11.01 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.553 1.141 . . . . 0.0 111.81 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.412 HG22 ' OG ' ' A' ' 40' ' ' SER . 10.1 t -66.95 -22.61 65.93 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 54.94 76.67 0.49 Allowed Pre-proline 0 C--N 1.361 1.092 0 C-N-CA 124.474 1.11 . . . . 0.0 110.727 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.8 171.42 14.39 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 122.914 2.41 . . . . 0.0 112.945 -173.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -67.47 95.24 0.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.0 173.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.65 -9.93 59.76 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.586 0.755 . . . . 0.0 111.671 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 m -107.09 101.64 39.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.837 0.855 . . . . 0.0 109.322 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.87 -14.41 42.96 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.962 2.441 . . . . 0.0 113.449 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.555 1.164 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.861 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 32.0 m0 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -81.16 94.8 6.72 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.9 144.3 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.189 0.995 . . . . 0.0 109.861 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -100.01 141.87 32.25 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.002 0.521 . . . . 0.0 110.903 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 31.2 p -122.85 112.49 17.94 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 0.0 111.369 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HB3' HG13 ' A' ' 73' ' ' ILE . 13.3 tppt? -81.03 106.1 12.77 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.23 -168.12 2.38 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.064 0.546 . . . . 0.0 111.518 -170.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -51.84 -40.32 60.33 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.638 1.175 . . . . 0.0 112.582 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.44 28.86 9.9 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.333 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.49 -153.46 49.22 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.995 0.331 . . . . 0.0 112.785 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 m -83.79 112.76 20.39 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.588 0.755 . . . . 0.0 110.337 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.668 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 21.2 m-70 -104.78 179.31 4.31 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.046 0.939 . . . . 0.0 109.538 175.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' NE2' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -130.66 129.5 42.72 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.437 ' HG ' HG13 ' A' ' 33' ' ' ILE . 5.5 mp -99.98 118.21 35.91 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.48 1.112 . . . . 0.0 109.906 177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.464 ' NE2' HD12 ' A' ' 13' ' ' LEU . 80.8 mm-40 -94.4 156.88 16.28 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.468 0.707 . . . . 0.0 109.199 171.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.68 -7.16 81.72 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.536 -0.591 . . . . 0.0 114.409 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.89 118.57 12.9 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 117.374 0.587 . . . . 0.0 110.072 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.4 m -114.01 172.99 6.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.197 0.999 . . . . 0.0 109.602 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.2 p -59.09 -35.22 73.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.832 0.853 . . . . 0.0 112.728 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -95.64 3.45 53.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.505 0.722 . . . . 0.0 112.636 -174.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 25' ' ' GLU . 45.2 m -55.21 113.15 1.27 Allowed 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 121.586 0.708 . . . . 0.0 111.495 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -72.56 172.18 11.04 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.177 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 54' ' ' LEU . 8.8 tt -59.15 -48.0 83.23 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.677 0.791 . . . . 0.0 110.536 177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.88 -25.15 67.37 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.998 0.519 . . . . 0.0 112.366 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 21' ' ' THR . 64.2 mm-40 -78.73 -53.05 7.54 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.572 0.749 . . . . 0.0 109.875 175.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.06 -55.35 29.98 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.47 1.508 . . . . 0.0 111.236 -173.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 15.1 mm100 -57.78 -34.22 69.36 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.358 1.063 . . . . 0.0 111.967 177.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.73 -34.26 77.61 Favored Glycine 0 C--N 1.349 1.273 0 O-C-N 123.969 0.793 . . . . 0.0 111.678 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -76.52 -39.31 53.35 Favored 'General case' 0 C--O 1.216 -0.693 0 C-N-CA 123.195 0.598 . . . . 0.0 110.408 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 82.7 mt -56.82 -44.19 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.403 0.681 . . . . 0.0 110.7 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.21 -24.16 67.57 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.586 0.754 . . . . 0.0 111.843 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.65 -28.42 19.49 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.79 0.836 . . . . 0.0 112.135 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.437 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.9 mm -91.66 -51.19 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 124.139 0.976 . . . . 0.0 111.782 -171.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.541 HG23 HG12 ' A' ' 36' ' ' ILE . 15.0 t -115.91 -5.88 12.03 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.344 0.658 . . . . 0.0 111.28 -178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.51 -10.32 74.35 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 168.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.541 HG12 HG23 ' A' ' 34' ' ' THR . 4.1 mm -82.4 118.5 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 117.953 0.876 . . . . 0.0 109.778 -174.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.82 149.01 96.84 Favored Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 124.05 0.94 . . . . 0.0 111.3 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HB3' ' HB3' ' A' ' 27' ' ' GLN . 11.7 Cg_endo -50.53 -41.01 54.14 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 124.198 3.265 . . . . 0.0 113.854 -175.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.25 27.53 5.59 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 116.188 -0.46 . . . . 0.0 113.179 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.7 m -146.6 12.99 1.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.616 1.166 . . . . 0.0 109.033 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -155.7 151.05 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.188 0.518 . . . . 0.0 110.402 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -125.96 174.48 8.38 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.491 1.116 . . . . 0.0 108.143 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.514 HG12 HD21 ' A' ' 54' ' ' LEU . 47.3 mm -106.72 114.33 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 1.7 mm? -119.5 166.42 13.13 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 47' ' ' TYR . 4.0 m -129.35 161.26 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.374 0.67 . . . . 0.0 110.462 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.69 -43.57 96.16 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.616 0.573 . . . . 0.0 113.035 -178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.48 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 32.8 p90 -72.77 163.25 69.58 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.161 167.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 47' ' ' TYR . 14.6 Cg_endo -52.61 114.61 1.76 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.904 2.403 . . . . 0.0 114.071 -173.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 9.7 Cg_endo -88.68 178.66 2.75 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.366 2.71 . . . . 0.0 110.919 170.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -127.08 19.94 6.97 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.789 0.835 . . . . 0.0 109.601 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.4 m 57.04 82.37 0.12 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 124.591 1.157 . . . . 0.0 109.602 -164.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.423 HD12 HG22 ' A' ' 43' ' ' ILE . 95.3 mt -53.11 131.11 36.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.593 0.757 . . . . 0.0 111.34 -175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -82.73 106.17 14.35 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.792 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.514 HD21 HG12 ' A' ' 43' ' ' ILE . 7.2 mp -105.35 80.49 1.59 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.816 0.846 . . . . 0.0 109.097 175.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.6 p -102.71 -34.42 9.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.779 0.831 . . . . 0.0 110.945 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' O ' HD13 ' A' ' 23' ' ' LEU . 8.8 t70 -82.61 -175.52 5.8 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.483 0.713 . . . . 0.0 109.95 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -31.1 1.48 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 123.621 0.768 . . . . 0.0 110.795 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.35 -19.58 42.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.876 0.87 . . . . 0.0 110.913 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.96 123.38 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.272 0 C-N-CA 124.163 0.985 . . . . 0.0 111.109 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.7 p -96.54 -179.36 4.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -166.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.9 mt -68.92 -15.41 63.48 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.901 0.88 . . . . 0.0 111.838 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.6 -17.8 73.2 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 116.462 -0.336 . . . . 0.0 112.393 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.76 -63.06 1.17 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.924 0.89 . . . . 0.0 109.616 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.09 116.68 46.81 Favored Pre-proline 0 N--CA 1.486 1.345 0 CA-C-O 117.646 -1.168 . . . . 0.0 107.999 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -55.64 78.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.995 3.13 . . . . 0.0 115.055 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.464 HG13 ' HG ' ' A' ' 72' ' ' LEU . 2.0 mp -110.4 121.66 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 166.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 37.8 mt-30 -119.53 166.22 13.41 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.287 0.635 . . . . 0.0 109.668 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.6 m -63.74 95.92 0.12 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.819 0.848 . . . . 0.0 110.925 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.93 29.41 23.31 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.158 -0.473 . . . . 0.0 113.436 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 23.6 t70 -87.79 160.47 18.02 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.148 0.579 . . . . 0.0 109.893 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.7 tpt -96.9 100.98 12.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 110.261 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.1 mm? -104.94 112.79 26.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.671 0.788 . . . . 0.0 109.429 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.8 mp -81.78 114.47 22.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.76 115.91 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.06 0.944 . . . . 0.0 108.467 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -85.9 179.89 6.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.106 0.479 . . . . 0.0 110.665 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -131.94 106.57 8.13 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -67.64 -13.49 62.13 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.737 1.215 . . . . 0.0 110.9 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 66.44 36.42 5.14 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.642 1.177 . . . . 0.0 111.896 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 m -88.83 41.08 1.0 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 123.759 0.824 . . . . 0.0 110.139 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 53.47 77.7 0.43 Allowed Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 125.023 1.329 . . . . 0.0 110.394 -169.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.61 -176.43 0.42 Allowed 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.153 2.569 . . . . 0.0 113.618 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 82' ' ' LYS . 7.9 mmpt? 75.9 -24.6 0.22 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.263 1.425 . . . . 0.0 113.524 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.39 83.85 1.08 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 167.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.2 t -123.89 107.83 30.79 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.334 -168.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.52 141.65 38.77 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.354 2.036 . . . . 0.0 111.156 165.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.25 1.114 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.459 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . . . . . . . . . 43.9 m0 . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.675 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 78.3 mtm180 -80.35 69.93 6.91 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.151 0.98 . . . . 0.0 109.564 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.487 ' HB ' HD12 ' A' ' 17' ' ' LEU . 96.3 t -79.21 132.95 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.739 0.816 . . . . 0.0 111.142 -171.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.4 ' CB ' ' HE3' ' A' ' 71' ' ' MET . 99.0 mtt180 -84.03 140.82 31.6 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.452 0.701 . . . . 0.0 109.958 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 12' ' ' HIS . 4.0 t -125.37 96.98 5.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.045 0.938 . . . . 0.0 110.255 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -80.1 102.67 9.48 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.67 122.74 35.81 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp 66.27 17.62 10.75 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.854 1.262 . . . . 0.0 112.209 179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.98 -8.76 79.36 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-N 116.454 -0.339 . . . . 0.0 112.955 -174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.78 119.88 6.64 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -79.97 136.05 36.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.749 0.42 . . . . 0.0 110.247 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 5' ' ' CYS . 79.7 m-70 -118.82 178.06 4.62 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.491 1.116 . . . . 0.0 108.42 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 2' ' ' ARG . 1.3 tm? -146.31 114.18 6.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.6 mp -104.97 105.87 16.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.75 1.22 . . . . 0.0 109.224 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.675 ' HG2' ' HG2' ' A' ' 2' ' ' ARG . 78.2 mt-30 -84.17 -17.76 38.95 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.337 0.655 . . . . 0.0 111.067 172.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.62 24.64 4.92 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD12 ' HB ' ' A' ' 3' ' ' VAL . 87.0 mt -110.33 123.95 50.78 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.728 0.811 . . . . 0.0 109.486 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' HD12 ' A' ' 61' ' ' LEU . 25.9 m -113.67 171.43 7.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.546 1.138 . . . . 0.0 108.97 172.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.4 t -57.84 -41.66 82.8 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.002 0.429 . . . . 0.0 112.128 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -92.19 17.05 10.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.654 0.782 . . . . 0.0 112.076 -172.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -68.19 122.41 18.25 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.212 0.605 . . . . 0.0 110.119 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -78.57 177.15 8.8 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.824 0.45 . . . . 0.0 110.952 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 56' ' ' ASP . 7.3 tt -55.08 -50.82 68.21 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.148 0.979 . . . . 0.0 110.537 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -61.38 -30.36 70.49 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.421 -173.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -80.55 -46.66 15.41 Favored 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 122.588 0.355 . . . . 0.0 110.389 170.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.76 -68.31 0.35 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.92 0.888 . . . . 0.0 110.594 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -66.87 -20.65 65.96 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.07 0.548 . . . . 0.0 111.519 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.13 -38.14 59.48 Favored Glycine 0 C--N 1.344 1.025 0 O-C-N 123.885 0.741 . . . . 0.0 112.328 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -74.05 -39.55 63.43 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.127 0.571 . . . . 0.0 109.6 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 98.8 mt -57.46 -40.64 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 123.558 0.743 . . . . 0.0 110.669 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.83 -24.39 67.74 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.055 0.942 . . . . 0.0 111.844 175.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.51 -32.35 15.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.858 0.863 . . . . 0.0 111.786 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG13 ' HG ' ' A' ' 14' ' ' LEU . 18.6 mm -79.94 -65.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.395 1.078 . . . . 0.0 110.283 -174.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.471 HG23 HG12 ' A' ' 36' ' ' ILE . 10.1 t -99.45 -15.93 18.54 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.407 0.683 . . . . 0.0 111.3 -176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.75 1.32 82.97 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-O 119.202 -0.777 . . . . 0.0 114.338 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 34' ' ' THR . 13.7 mm -78.76 119.56 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 118.169 0.984 . . . . 0.0 108.348 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.11 142.52 85.64 Favored Pre-proline 0 N--CA 1.479 1.013 0 O-C-N 124.235 0.96 . . . . 0.0 111.24 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.73 -27.67 72.09 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 123.406 2.737 . . . . 0.0 113.256 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.42 27.04 14.8 Favored Glycine 0 C--N 1.348 1.245 0 C-N-CA 123.119 0.39 . . . . 0.0 112.589 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.6 m -142.14 7.66 1.81 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.482 1.113 . . . . 0.0 109.698 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -148.71 149.16 30.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 123.946 0.898 . . . . 0.0 109.983 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -129.23 -175.31 3.53 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.312 1.045 . . . . 0.0 108.973 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.542 HG21 ' HD2' ' A' ' 65' ' ' PRO . 49.2 mm -104.49 109.82 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.27 0.628 . . . . 0.0 109.616 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 34.8 mt -122.04 151.79 40.48 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 49' ' ' PRO . 17.1 m -132.39 173.72 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 123.48 0.712 . . . . 0.0 110.907 -174.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.4 -49.01 66.32 Favored Glycine 0 C--N 1.356 1.649 0 O-C-N 123.874 0.734 . . . . 0.0 113.835 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -79.47 158.11 74.18 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.644 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -46.24 104.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.485 2.79 . . . . 0.0 114.624 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HB3' HG22 ' A' ' 45' ' ' VAL . 98.6 Cg_endo -82.81 156.88 15.77 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.886 2.391 . . . . 0.0 112.808 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -75.75 -22.52 56.42 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.6 0.76 . . . . 0.0 112.147 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 46.2 m 65.92 35.93 6.25 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.369 1.068 . . . . 0.0 109.014 -171.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.3 pt? -39.59 140.93 0.44 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 112.842 -1.981 . . . . 0.0 113.922 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.31 106.74 16.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.463 0.705 . . . . 0.0 110.209 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HB3' HD12 ' A' ' 23' ' ' LEU . 8.5 mp -86.05 96.79 9.98 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.514 0.726 . . . . 0.0 109.429 175.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -109.1 -39.73 5.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.87 0.868 . . . . 0.0 109.85 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' O ' HD13 ' A' ' 23' ' ' LEU . 20.3 t0 -75.63 145.24 41.23 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.389 0.676 . . . . 0.0 110.693 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.546 ' H ' ' HD2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.57 -20.67 15.58 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.093 0.957 . . . . 0.0 110.551 -177.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.45 -19.52 49.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.326 1.05 . . . . 0.0 111.251 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 tt -57.71 126.13 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.667 0.787 . . . . 0.0 111.46 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 p -106.34 175.9 5.34 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.095 0.958 . . . . 0.0 111.104 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 64' ' ' LEU . 21.1 mt -74.1 -1.07 18.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.8 0.84 . . . . 0.0 111.473 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.92 -39.04 64.65 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.818 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.54 -48.53 6.81 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 61' ' ' LEU . 96.1 mt -59.77 139.23 90.07 Favored Pre-proline 0 CA--C 1.558 1.266 0 O-C-N 123.871 0.732 . . . . 0.0 110.36 175.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HD2' HG21 ' A' ' 43' ' ' ILE . 6.3 Cg_exo -79.2 45.1 1.84 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 123.436 2.757 . . . . 0.0 113.385 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.499 ' HA ' HD21 ' A' ' 72' ' ' LEU . 2.1 mp -93.41 119.5 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 171.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 36.2 mm-40 -116.47 166.79 11.68 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.027 0.531 . . . . 0.0 109.573 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.4 p -64.59 109.92 2.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.29 0.636 . . . . 0.0 110.866 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 78.57 10.15 86.44 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.882 -0.599 . . . . 0.0 114.11 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 28.1 t70 -76.65 159.18 30.46 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.24 0.616 . . . . 0.0 111.353 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.4 ' HE3' ' CB ' ' A' ' 4' ' ' ARG . 2.9 tpt -86.08 101.88 13.35 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.454 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 66' ' ' ILE . 4.6 mm? -102.04 113.18 26.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.267 1.027 . . . . 0.0 108.883 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.9 mp -88.48 99.89 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.67 105.77 5.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.844 170.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.4 149.85 36.85 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.366 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 78' ' ' GLN . 34.7 tt0 -110.2 105.02 13.93 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -76.36 -5.47 47.34 Favored 'General case' 0 CA--C 1.567 1.63 0 C-N-CA 123.66 0.784 . . . . 0.0 110.349 172.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 76' ' ' GLU . 55.3 mt-30 67.94 -86.61 0.03 OUTLIER 'General case' 0 C--N 1.362 1.139 0 C-N-CA 126.073 1.749 . . . . 0.0 108.804 -178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.419 HG23 ' HD3' ' A' ' 81' ' ' PRO . 10.1 t 38.58 -67.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 127.883 2.473 . . . . 0.0 115.524 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 69.8 76.42 0.24 Allowed Pre-proline 0 C--N 1.35 0.621 0 C-N-CA 125.757 1.623 . . . . 0.0 110.699 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD3' HG23 ' A' ' 79' ' ' THR . 45.4 Cg_endo -83.03 -153.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.102 2.535 . . . . 0.0 110.898 175.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -61.07 -33.73 73.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 122.839 0.456 . . . . 0.0 111.246 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 69.64 -72.88 0.1 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.516 1.526 . . . . 0.0 111.342 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -91.81 113.54 59.16 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.186 0.994 . . . . 0.0 108.81 174.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.26 -8.28 14.0 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.592 2.194 . . . . 0.0 112.071 172.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.8 p . . . . . 0 CA--C 1.553 1.078 0 C-N-CA 124.532 1.133 . . . . 0.0 110.565 179.252 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 9.0 m0 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.462 ' HB3' HD11 ' A' ' 13' ' ' LEU . 54.2 mtt180 -87.22 74.11 9.6 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG11 HG23 ' A' ' 66' ' ' ILE . 34.7 t -87.21 138.28 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.672 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -89.54 158.2 17.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.573 0.749 . . . . 0.0 110.519 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 28.1 p -142.97 114.57 8.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.214 0.606 . . . . 0.0 109.627 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -79.02 109.61 13.49 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.95 103.21 4.74 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 122.977 0.511 . . . . 0.0 110.313 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 76' ' ' GLU . 31.0 mmmt 61.47 29.61 18.49 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.717 1.207 . . . . 0.0 111.511 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.39 -27.74 8.24 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.679 -174.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.18 100.25 0.63 Allowed Glycine 0 C--N 1.351 1.412 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -82.92 92.28 7.29 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.653 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 32.4 m80 -94.59 160.73 14.5 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.1 -174.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.462 HD11 ' HB3' ' A' ' 2' ' ' ARG . 2.7 tm? -119.14 115.3 23.96 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.556 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.7 mp -98.79 132.45 44.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.651 0.781 . . . . 0.0 109.207 173.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -138.46 173.03 12.02 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.05 12.47 76.64 Favored Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -168.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 1' ' ' TRP . 98.5 mt -83.54 115.38 22.07 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 123.369 0.668 . . . . 0.0 109.491 177.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.3 t -79.23 173.75 12.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.484 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.1 p -64.09 -35.62 81.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 120.996 0.427 . . . . 0.0 110.595 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -104.72 33.46 3.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.07 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.446 HG21 HD22 ' A' ' 17' ' ' LEU . 74.6 m -69.26 113.01 6.21 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 171.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -77.52 178.28 7.37 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.349 1.059 . . . . 0.0 111.234 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 54' ' ' LEU . 8.4 tt -57.16 -54.9 41.55 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 123.436 0.695 . . . . 0.0 110.228 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -14.43 63.04 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.231 -174.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.36 -49.41 8.16 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.611 0.764 . . . . 0.0 109.24 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD11 HD11 ' A' ' 43' ' ' ILE . 2.4 tm? -75.51 -64.55 1.05 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.668 1.187 . . . . 0.0 110.464 -170.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.8 -20.17 64.75 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.23 0.612 . . . . 0.0 111.083 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.24 -43.76 88.08 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 124.011 0.82 . . . . 0.0 111.902 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -72.75 -36.24 67.66 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 119.509 -0.282 . . . . 0.0 110.268 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.4 mt -58.92 -44.47 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.268 0.627 . . . . 0.0 110.343 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.64 -23.74 66.26 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.167 0.987 . . . . 0.0 112.116 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.57 -40.01 12.9 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.317 0.647 . . . . 0.0 111.605 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.556 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.8 mm -69.13 -65.97 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.227 1.011 . . . . 0.0 110.629 -173.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.424 HG23 HG12 ' A' ' 36' ' ' ILE . 5.0 t -99.85 -11.87 20.37 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.291 -175.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.66 9.07 86.1 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.499 -0.612 . . . . 0.0 114.122 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.424 HG12 HG23 ' A' ' 34' ' ' THR . 13.3 mm -83.37 118.55 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.52 146.44 73.04 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.798 0.839 . . . . 0.0 111.474 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.43 -30.86 92.75 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.165 2.577 . . . . 0.0 112.419 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.64 32.55 5.24 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.531 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -141.86 2.12 1.53 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 110.163 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -148.96 163.63 36.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.897 0.879 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.48 176.03 10.64 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.393 0.677 . . . . 0.0 110.042 173.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.406 HD11 HD11 ' A' ' 26' ' ' LEU . 44.7 mm -84.05 113.8 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 17.7 mt -132.43 123.63 27.06 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 173.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 16.3 m -102.78 173.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 122.975 0.51 . . . . 0.0 112.197 -169.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.09 -46.42 93.78 Favored Glycine 0 C--N 1.352 1.418 0 O-C-N 124.353 1.033 . . . . 0.0 114.235 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -79.34 158.3 74.25 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 117.959 -1.019 . . . . 0.0 108.912 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.95 107.1 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.403 2.736 . . . . 0.0 113.628 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 63.1 Cg_endo -77.31 155.86 32.8 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.509 2.139 . . . . 0.0 112.179 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -94.78 34.33 1.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.646 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 62.8 m 75.66 -54.3 0.63 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.773 1.629 . . . . 0.0 110.726 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.5 mt 68.01 90.96 0.09 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.869 1.267 . . . . 0.0 110.682 169.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -91.22 101.14 13.86 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.801 0.84 . . . . 0.0 110.252 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.662 ' HB3' HD12 ' A' ' 23' ' ' LEU . 6.1 mp -78.05 99.41 6.1 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 174.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.1 t -124.87 39.24 4.02 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.186 0.594 . . . . 0.0 111.009 -172.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 59' ' ' ILE . 28.1 t70 -163.59 146.01 9.73 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.591 0.756 . . . . 0.0 109.856 177.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -76.66 -31.66 57.46 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.953 0.501 . . . . 0.0 111.394 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -92.65 -3.92 54.15 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.717 0.807 . . . . 0.0 112.286 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.469 HG22 ' O ' ' A' ' 56' ' ' ASP . 10.7 tt -64.08 123.62 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.108 0.48 . . . . 0.0 110.485 -176.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.7 p -101.89 176.62 5.15 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -166.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 mt -69.23 -12.19 61.46 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.621 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.97 -22.0 69.77 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.77 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.49 -53.07 3.88 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.84 150.47 92.98 Favored Pre-proline 0 N--CA 1.482 1.168 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 172.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.57 43.53 1.51 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.98 2.453 . . . . 0.0 114.661 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.569 HG13 HD21 ' A' ' 72' ' ' LEU . 2.6 mp -73.0 119.53 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 168.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 38.1 mt-30 -118.64 157.24 27.79 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.2 p -64.02 103.67 0.62 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.435 0.694 . . . . 0.0 111.442 -174.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.41 21.97 57.42 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.967 -0.561 . . . . 0.0 113.402 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 9.8 t70 -79.76 160.9 26.02 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.856 0.463 . . . . 0.0 110.294 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 tpt -91.16 98.79 11.96 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.714 0.805 . . . . 0.0 109.56 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.569 HD21 HG13 ' A' ' 66' ' ' ILE . 6.7 mp -93.83 104.71 16.77 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.554 0.742 . . . . 0.0 109.885 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.8 mp -72.12 90.7 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.4 t -84.24 95.63 4.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.686 171.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -77.99 153.23 32.61 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.174 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 8' ' ' LYS . 40.6 tt0 -104.96 99.25 8.87 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 171.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -72.28 -12.79 61.31 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 123.89 0.876 . . . . 0.0 109.846 171.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 69.9 -80.26 0.04 OUTLIER 'General case' 0 C--N 1.364 1.201 0 C-N-CA 126.243 1.817 . . . . 0.0 109.736 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t 38.55 -62.84 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 128.301 2.641 . . . . 0.0 116.874 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 83.97 80.68 0.07 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 127.055 2.142 . . . . 0.0 108.809 -173.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -88.97 159.9 5.93 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.875 2.384 . . . . 0.0 112.426 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -98.24 100.78 12.1 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.46 135.3 47.11 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.067 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -76.27 134.55 70.38 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.479 0.712 . . . . 0.0 109.732 173.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.48 -41.55 76.91 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.4 2.733 . . . . 0.0 112.978 178.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.556 1.2 0 C-N-CA 123.47 0.708 . . . . 0.0 109.679 -179.823 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 16.3 m0 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.585 0.231 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.52 ' HB3' HD21 ' A' ' 13' ' ' LEU . 75.4 mtt180 -108.47 71.63 0.8 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.067 0.947 . . . . 0.0 108.684 173.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG11 HG23 ' A' ' 66' ' ' ILE . 71.7 t -79.09 123.93 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.642 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.435 ' HB3' ' HE3' ' A' ' 71' ' ' MET . 66.0 mtt180 -81.79 141.49 33.44 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.539 ' SG ' HD13 ' A' ' 14' ' ' LEU . 92.3 m -135.54 105.67 6.3 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.715 0.406 . . . . 0.0 111.19 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -79.84 98.41 7.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.18 96.81 7.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.231 0.612 . . . . 0.0 109.981 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt 70.39 -75.45 0.07 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.953 1.301 . . . . 0.0 111.312 176.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.33 25.42 1.24 Allowed Glycine 0 C--N 1.346 1.101 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.58 105.35 0.57 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -76.98 118.58 19.69 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.131 0.573 . . . . 0.0 109.78 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -109.69 176.25 5.14 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.777 0.831 . . . . 0.0 109.76 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 2' ' ' ARG . 10.4 tt -151.19 116.06 5.22 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.614 ' HG ' HG13 ' A' ' 33' ' ' ILE . 7.3 mp -90.63 131.02 36.58 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.811 1.244 . . . . 0.0 109.607 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -92.09 164.44 13.59 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.578 0.751 . . . . 0.0 110.571 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.97 -97.19 1.62 Allowed Glycine 0 C--N 1.339 0.705 0 CA-C-O 118.833 -0.982 . . . . 0.0 111.225 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 61' ' ' LEU . 4.1 mm? 42.16 104.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.567 1.547 . . . . 0.0 113.217 -175.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.9 t -73.18 154.2 40.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 170.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -62.71 -21.97 66.16 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 121.222 0.534 . . . . 0.0 110.674 171.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.456 ' HA ' ' HB ' ' A' ' 60' ' ' THR . 74.1 mtt180 -110.01 29.99 7.13 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.289 1.036 . . . . 0.0 111.522 178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.8 m -66.57 112.0 3.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 172.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -65.79 163.43 16.72 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.307 1.043 . . . . 0.0 110.969 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.433 HD13 HD23 ' A' ' 54' ' ' LEU . 23.5 tp -53.55 -52.2 60.45 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.07 0.948 . . . . 0.0 111.697 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.3 ptt85 -60.02 -24.1 64.23 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.159 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.26 -38.02 14.53 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.533 0.733 . . . . 0.0 110.058 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -69.83 -66.09 0.64 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.534 1.134 . . . . 0.0 110.091 -173.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.81 -17.41 64.51 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.458 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.47 -37.26 85.37 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.687 0.617 . . . . 0.0 112.076 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -75.63 -40.45 56.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.243 0.617 . . . . 0.0 110.419 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.438 ' HB ' HE22 ' A' ' 41' ' ' GLN . 82.1 mt -61.78 -35.83 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 123.537 0.735 . . . . 0.0 110.926 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -24.99 66.58 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.128 0.971 . . . . 0.0 112.009 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.01 -42.83 9.22 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.976 0.911 . . . . 0.0 111.161 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.614 HG13 ' HG ' ' A' ' 14' ' ' LEU . 17.1 mm -66.11 -50.69 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.735 1.214 . . . . 0.0 112.011 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.559 HG23 HG12 ' A' ' 36' ' ' ILE . 7.2 t -124.04 -1.32 8.29 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.122 0.569 . . . . 0.0 111.377 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.68 -0.23 89.56 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 114.229 0.452 . . . . 0.0 114.229 173.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.559 HG12 HG23 ' A' ' 34' ' ' THR . 11.4 mm -82.54 103.78 10.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.76 152.53 67.95 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.951 0.9 . . . . 0.0 111.426 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -50.84 -38.51 57.6 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.76 2.974 . . . . 0.0 114.547 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.25 30.45 5.95 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 116.44 -0.346 . . . . 0.0 113.325 178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -132.42 -3.47 3.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.063 0.945 . . . . 0.0 110.09 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.438 HE22 ' HB ' ' A' ' 30' ' ' ILE . 1.5 pt20 -140.19 163.75 31.89 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.594 0.758 . . . . 0.0 111.376 -171.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.6 mtm-85 -147.97 170.94 16.62 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 125.413 1.485 . . . . 0.0 108.767 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 72' ' ' LEU . 49.2 mm -96.61 110.24 24.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.443 -175.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 mt -123.8 159.18 30.09 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.823 -1.081 . . . . 0.0 108.718 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' H ' ' HG3' ' A' ' 49' ' ' PRO . 5.2 m -141.11 -179.21 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.216 1.007 . . . . 0.0 110.27 -171.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.36 -46.15 65.31 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 123.934 0.771 . . . . 0.0 113.205 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -74.87 162.15 74.69 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.404 171.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 12.6 Cg_endo -53.17 108.63 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.941 2.427 . . . . 0.0 111.867 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HG3' ' H ' ' A' ' 45' ' ' VAL . 2.8 Cg_exo -74.25 172.81 15.29 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.186 2.591 . . . . 0.0 111.979 -174.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.25 -2.12 57.7 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.495 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 71.6 m 51.28 65.13 1.58 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 124.119 0.968 . . . . 0.0 109.11 -172.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 mp -67.32 134.04 50.8 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.792 -165.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -95.35 88.19 5.04 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.433 HD23 HD13 ' A' ' 23' ' ' LEU . 5.5 mp -77.43 88.3 3.8 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.7 p -97.11 -49.16 5.1 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.999 0.92 . . . . 0.0 110.867 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.438 ' O ' HG22 ' A' ' 59' ' ' ILE . 21.6 t70 -73.39 123.63 24.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.999 0.92 . . . . 0.0 110.255 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -74.56 -20.49 59.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.997 0.519 . . . . 0.0 112.31 -174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -89.67 -8.24 52.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.66 0.784 . . . . 0.0 110.968 -175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 56' ' ' ASP . 14.7 tt -64.11 123.8 17.63 Favored 'Isoleucine or valine' 0 C--N 1.365 1.258 0 CA-C-O 121.404 0.621 . . . . 0.0 110.32 -176.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.456 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 64.8 p -97.34 175.19 6.35 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.469 -170.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.565 HD11 HD12 ' A' ' 17' ' ' LEU . 23.4 mt -69.76 -13.81 62.47 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.55 173.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.15 -29.45 72.9 Favored Glycine 0 C--N 1.354 1.572 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.736 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -93.88 -60.75 1.68 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 171.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.55 143.36 86.33 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 124.715 1.206 . . . . 0.0 111.238 -174.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.13 39.65 0.84 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.552 2.834 . . . . 0.0 114.429 -173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.512 HG13 ' HG ' ' A' ' 72' ' ' LEU . 3.1 mp -87.26 120.56 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 172.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 24.1 mm-40 -119.97 159.28 25.01 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.821 0.848 . . . . 0.0 110.213 176.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.6 p -68.23 112.05 4.91 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.509 0.723 . . . . 0.0 110.853 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.99 12.82 82.17 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.639 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 20.2 t70 -86.17 160.52 19.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.697 0.799 . . . . 0.0 109.798 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.435 ' HE3' ' HB3' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -95.77 97.59 9.8 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.017 0.927 . . . . 0.0 110.355 -176.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.512 ' HG ' HG13 ' A' ' 66' ' ' ILE . 4.1 mm? -96.55 113.58 25.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.521 0.728 . . . . 0.0 109.622 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 2.2 mp -78.76 103.2 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.3 t -82.29 104.52 11.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.344 171.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.69 159.71 28.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.294 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 78' ' ' GLN . 38.5 tt0 -124.49 124.84 43.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 170.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -75.17 -23.62 57.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.488 0.715 . . . . 0.0 111.174 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.498 ' H ' ' HG2' ' A' ' 76' ' ' GLU . 76.9 mt-30 68.41 30.79 5.25 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.968 1.307 . . . . 0.0 110.583 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.6 t -68.27 -10.39 54.34 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.858 0.863 . . . . 0.0 111.945 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 61.32 72.25 0.7 Allowed Pre-proline 0 C--N 1.362 1.138 0 C-N-CA 124.336 1.054 . . . . 0.0 108.499 -175.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -62.88 135.05 49.71 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.389 2.726 . . . . 0.0 114.525 -166.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -65.5 -33.26 75.52 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.437 169.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.81 78.3 0.87 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.25 1.02 . . . . 0.0 109.697 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 41.1 m -95.1 -175.42 0.47 Allowed Pre-proline 0 CA--C 1.563 1.466 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.833 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 84' ' ' SER . 17.7 Cg_exo -40.15 101.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.85 0 C-N-CA 122.939 2.426 . . . . 0.0 113.34 166.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 C--O 1.251 1.182 0 C-N-CA 123.981 0.913 . . . . 0.0 109.253 -173.277 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.425 ' HB3' HG23 ' A' ' 3' ' ' VAL . 13.2 m0 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.488 ' HG3' HD11 ' A' ' 13' ' ' LEU . 11.0 mpt_? -79.75 67.37 5.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.704 0.802 . . . . 0.0 109.742 173.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 1' ' ' TRP . 72.1 t -77.39 119.95 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.75 0.42 . . . . 0.0 109.875 -173.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -93.99 128.38 40.3 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.332 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 95.8 m -117.79 111.3 18.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.372 0.669 . . . . 0.0 110.402 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HE2' ' SD ' ' A' ' 71' ' ' MET . 13.9 tppt? -75.41 127.45 33.16 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.127 0.971 . . . . 0.0 109.718 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.04 -174.26 4.65 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.147 0.579 . . . . 0.0 109.785 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 8' ' ' LYS . 36.3 mtmt -67.21 127.43 32.59 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.77 -5.67 43.5 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 -170.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -160.76 14.0 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 123.211 0.434 . . . . 0.0 112.603 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.9 m -94.73 118.84 32.37 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.423 0.689 . . . . 0.0 109.751 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -92.51 142.6 27.23 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.858 0.863 . . . . 0.0 108.805 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.488 HD11 ' HG3' ' A' ' 2' ' ' ARG . 2.7 tm? -103.3 105.21 15.43 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' HG ' HG13 ' A' ' 33' ' ' ILE . 8.2 mp -86.93 139.03 31.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.339 0.655 . . . . 0.0 110.918 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.31 164.2 16.02 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.867 1.267 . . . . 0.0 109.675 176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.89 79.53 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.321 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 61' ' ' LEU . 3.6 mm? -82.61 108.32 15.91 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.273 0.559 . . . . 0.0 110.009 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.466 ' O ' HD12 ' A' ' 61' ' ' LEU . 44.4 t -84.7 170.03 13.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.852 168.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m -69.1 -22.59 63.97 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.162 0.506 . . . . 0.0 111.054 174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -111.6 23.26 14.12 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.293 1.037 . . . . 0.0 111.75 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.7 m -63.34 108.35 1.3 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -69.99 172.07 8.45 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.096 0.958 . . . . 0.0 111.689 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.6 tp -50.64 -55.82 14.66 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.276 1.031 . . . . 0.0 111.574 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG3' ' HG2' ' A' ' 25' ' ' GLU . 11.1 ptm180 -49.51 -37.47 26.79 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.612 1.165 . . . . 0.0 113.353 176.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 24' ' ' ARG . 10.8 mm-40 -85.81 -35.97 20.35 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.288 0.635 . . . . 0.0 110.962 -176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -74.66 -66.07 0.79 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.065 0.946 . . . . 0.0 109.033 -173.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.406 ' HA ' HE22 ' A' ' 41' ' ' GLN . 66.4 mt-30 -67.46 -19.55 65.37 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.272 178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.85 -39.96 89.58 Favored Glycine 0 C--N 1.347 1.149 0 O-C-N 124.032 0.833 . . . . 0.0 111.959 172.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -72.95 -45.06 60.17 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.32 -39.49 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.44 0.696 . . . . 0.0 111.116 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.4 -25.49 67.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.65 0.78 . . . . 0.0 111.678 176.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.3 14.83 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.545 0.738 . . . . 0.0 111.351 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.535 HG13 ' HG ' ' A' ' 14' ' ' LEU . 25.2 mm -76.46 -63.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.342 1.057 . . . . 0.0 110.914 -174.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.519 HG23 HG12 ' A' ' 36' ' ' ILE . 7.5 t -102.09 -9.96 20.1 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 0.0 111.019 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.02 20.65 69.76 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-O 119.783 -0.454 . . . . 0.0 114.034 172.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG12 HG23 ' A' ' 34' ' ' THR . 21.2 mm -90.44 127.73 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.67 138.83 61.41 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.782 0.833 . . . . 0.0 110.676 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.68 -39.31 83.77 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.559 2.839 . . . . 0.0 113.342 -174.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' HA3' ' HG2' ' A' ' 81' ' ' PRO . . . -89.78 22.08 26.75 Favored Glycine 0 N--CA 1.471 1.011 0 CA-C-N 116.519 -0.31 . . . . 0.0 113.737 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.2 m -124.83 -5.14 7.51 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.234 1.014 . . . . 0.0 109.902 174.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.568 ' HA ' ' HG3' ' A' ' 75' ' ' GLU . 1.3 pp0? -130.23 143.77 50.97 Favored 'General case' 0 C--N 1.347 0.49 0 C-N-CA 124.201 1.0 . . . . 0.0 109.236 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -135.05 179.12 6.52 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.728 0.811 . . . . 0.0 109.341 -178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.521 HD12 HD11 ' A' ' 66' ' ' ILE . 45.9 mm -94.47 92.46 3.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-O 121.995 0.903 . . . . 0.0 109.077 -174.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.4 mt -110.09 149.33 30.2 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 65' ' ' PRO . 9.4 m -134.02 179.73 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.113 0.565 . . . . 0.0 111.371 -167.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.02 11.01 8.27 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 115.333 -0.848 . . . . 0.0 114.736 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -144.33 160.72 47.59 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.162 1.385 . . . . 0.0 108.042 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -39.55 109.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 123.713 2.942 . . . . 0.0 113.99 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -80.68 -171.93 1.38 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 123.368 2.712 . . . . 0.0 112.172 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -122.73 15.23 10.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.65 0.78 . . . . 0.0 110.735 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 82.5 m 55.5 73.26 0.43 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.042 0.937 . . . . 0.0 109.474 -169.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.71 108.87 8.85 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.886 -171.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -97.42 126.65 42.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.297 1.039 . . . . 0.0 108.205 176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.2 mp -100.24 78.98 2.1 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.0 m -75.05 -28.51 60.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.294 0.638 . . . . 0.0 110.796 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.65 152.65 31.58 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.453 0.471 . . . . 0.0 109.773 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' H ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -103.46 -29.21 11.32 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.444 0.698 . . . . 0.0 111.641 -171.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -89.62 -11.82 41.49 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.494 0.718 . . . . 0.0 110.753 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.4 tt -56.62 134.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 111.695 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 76.0 p -117.48 179.07 4.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.758 0.823 . . . . 0.0 111.39 -169.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.581 HD11 HD12 ' A' ' 17' ' ' LEU . 40.3 mt -68.49 -13.44 62.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.634 0.774 . . . . 0.0 111.572 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.81 -31.17 80.03 Favored Glycine 0 C--N 1.348 1.245 0 O-C-N 123.336 0.398 . . . . 0.0 112.396 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -84.74 -55.86 3.88 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.126 0.57 . . . . 0.0 109.534 177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.24 152.0 92.33 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.434 -174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.545 ' HB2' HG11 ' A' ' 45' ' ' VAL . 19.2 Cg_exo -69.09 21.65 0.15 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.811 3.007 . . . . 0.0 115.488 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.521 HD11 HD12 ' A' ' 43' ' ' ILE . 3.2 mp -73.92 116.62 16.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 172.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -118.75 173.92 6.58 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.05 0.94 . . . . 0.0 109.559 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m -71.16 101.67 2.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.16 0.584 . . . . 0.0 109.943 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 89.03 20.42 46.44 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.176 -177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -79.33 162.28 25.7 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.037 0.535 . . . . 0.0 111.007 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.409 ' SD ' ' HE2' ' A' ' 6' ' ' LYS . 3.6 tpt -102.85 104.73 15.02 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.947 0.899 . . . . 0.0 109.696 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.417 HD23 HG13 ' A' ' 3' ' ' VAL . 3.7 mm? -105.13 112.16 25.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.044 0.937 . . . . 0.0 108.992 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.82 97.88 4.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.2 t -75.24 104.98 3.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.155 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.568 ' HG3' ' HA ' ' A' ' 41' ' ' GLN . 8.0 pt-20 -76.44 167.55 21.64 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.854 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.27 103.99 5.26 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.22 -15.87 56.03 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.391 0.676 . . . . 0.0 110.507 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 63.31 27.99 15.55 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.295 1.438 . . . . 0.0 111.376 -173.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -63.45 -38.88 92.83 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.477 0.711 . . . . 0.0 110.567 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 38.91 68.31 1.98 Allowed Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 126.02 1.728 . . . . 0.0 113.981 -172.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HG2' ' HA3' ' A' ' 39' ' ' GLY . 2.5 Cg_endo -83.85 130.19 4.95 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.929 2.419 . . . . 0.0 110.754 172.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -94.37 41.35 1.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.76 0.824 . . . . 0.0 110.917 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.45 99.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.873 173.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.4 p -144.0 86.89 8.24 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.244 1.018 . . . . 0.0 108.587 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.31 -60.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.831 2.354 . . . . 0.0 111.578 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.612 1.165 . . . . 0.0 108.616 177.488 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.457 ' HB3' HG23 ' A' ' 3' ' ' VAL . 14.1 m0 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.551 ' HG2' HE22 ' A' ' 15' ' ' GLN . 82.1 mtt85 -79.19 69.76 5.45 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.381 0.673 . . . . 0.0 109.513 174.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 1' ' ' TRP . 89.6 t -83.94 129.64 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.346 0.658 . . . . 0.0 110.084 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -88.59 141.1 28.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.36 0.664 . . . . 0.0 109.209 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 72' ' ' LEU . 71.1 m -138.33 101.34 4.36 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.332 0.653 . . . . 0.0 110.526 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -73.3 112.56 9.48 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.982 0.913 . . . . 0.0 109.734 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 74' ' ' VAL . . . -144.38 123.53 12.92 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.394 0.677 . . . . 0.0 110.23 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm 56.41 56.58 5.58 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.05 1.34 . . . . 0.0 112.86 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 68.1 26.63 73.99 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.576 -0.738 . . . . 0.0 114.41 174.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.58 144.19 10.5 Favored Glycine 0 C--N 1.345 1.042 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -93.64 102.1 14.27 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -89.6 115.29 26.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.772 0.829 . . . . 0.0 109.636 -174.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 tp -84.85 104.16 14.56 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.809 0.444 . . . . 0.0 110.548 -175.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.63 127.91 34.08 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.91 0.884 . . . . 0.0 111.076 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.551 HE22 ' HG2' ' A' ' 2' ' ' ARG . 32.3 mm-40 -113.3 176.22 5.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.781 1.233 . . . . 0.0 110.103 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.28 3.45 61.52 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.354 0.501 . . . . 0.0 114.354 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 1' ' ' TRP . 82.5 mt -84.42 129.38 34.87 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 123.804 0.842 . . . . 0.0 111.065 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.458 ' O ' HD12 ' A' ' 61' ' ' LEU . 17.8 m -108.37 -176.56 3.08 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.374 168.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 57.7 p -66.2 -29.58 69.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.058 0.456 . . . . 0.0 110.69 171.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -98.98 23.41 8.99 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.88 0.872 . . . . 0.0 112.713 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.3 m -80.51 130.38 35.1 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.29 -0.634 . . . . 0.0 109.29 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 82.2 mtm180 -98.83 177.76 5.18 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.731 0.812 . . . . 0.0 110.384 -174.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 57' ' ' ARG . 5.4 tt -48.16 -59.53 3.33 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.181 1.392 . . . . 0.0 110.717 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.526 ' HG3' ' HG3' ' A' ' 25' ' ' GLU . 9.3 ptp180 -61.66 -26.8 68.24 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.637 -173.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' A' ' 24' ' ' ARG . 46.9 mt-10 -91.55 -30.04 16.62 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.979 0.912 . . . . 0.0 110.459 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -79.82 -67.24 0.78 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.749 0.82 . . . . 0.0 109.197 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -68.4 -16.26 63.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.777 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.45 -39.56 56.48 Favored Glycine 0 C--N 1.348 1.21 0 O-C-N 123.524 0.515 . . . . 0.0 111.929 173.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -73.83 -35.94 64.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.098 0.559 . . . . 0.0 110.284 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.12 -44.14 90.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.339 0.656 . . . . 0.0 109.704 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.53 -25.04 68.07 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.775 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.42 -29.12 23.11 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.61 0.764 . . . . 0.0 111.856 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.1 mt -89.19 -69.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-N 117.878 0.308 . . . . 0.0 111.069 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.589 HG23 HG12 ' A' ' 36' ' ' ILE . 9.5 t -88.43 -5.48 58.24 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.17 0.588 . . . . 0.0 111.649 -174.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.95 6.55 87.36 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.303 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.589 HG12 HG23 ' A' ' 34' ' ' THR . 11.7 mm -82.61 107.71 14.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.55 145.41 49.6 Favored Pre-proline 0 N--CA 1.48 1.058 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.539 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -54.28 -32.05 69.62 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 123.474 2.783 . . . . 0.0 113.658 -170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.86 24.67 19.91 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 116.4 -0.364 . . . . 0.0 113.544 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 m -131.96 4.66 4.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.527 1.131 . . . . 0.0 109.863 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -137.09 149.48 47.4 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.506 1.122 . . . . 0.0 109.347 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -120.19 -166.16 1.27 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.515 HG23 HD12 ' A' ' 72' ' ' LEU . 41.1 mm -123.31 105.7 16.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 4.3 mp -121.14 172.39 8.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.081 177.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.513 ' H ' ' HB3' ' A' ' 49' ' ' PRO . 2.7 m -139.85 162.02 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 109.869 -174.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.49 -47.8 87.86 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 124.325 1.016 . . . . 0.0 113.368 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -72.6 155.41 91.03 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 117.756 -1.116 . . . . 0.0 109.597 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -33.61 100.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.397 3.116 0 C-N-CA 124.821 3.681 . . . . 0.0 114.763 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.513 ' HB3' ' H ' ' A' ' 45' ' ' VAL . 99.0 Cg_endo -81.26 158.7 20.08 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.683 2.256 . . . . 0.0 113.421 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 30.5 mm-40 -101.14 90.34 4.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 169.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 73.0 m -47.79 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.636 1.174 . . . . 0.0 111.543 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 43' ' ' ILE . 0.7 OUTLIER -99.44 167.53 10.56 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.615 1.166 . . . . 0.0 111.805 179.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -111.06 144.51 40.07 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.0 mp -103.75 93.22 4.78 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.5 t -85.47 -47.65 9.73 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.181 0.592 . . . . 0.0 110.239 -177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 59' ' ' ILE . 12.8 t70 -73.25 107.3 5.48 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.299 -174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.53 -24.58 32.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.93 -7.06 41.08 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.94 0.896 . . . . 0.0 112.272 -177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 56' ' ' ASP . 13.4 tt -63.39 136.83 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.021 0.528 . . . . 0.0 111.146 -174.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 10.0 m -109.9 168.01 9.74 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.503 0.721 . . . . 0.0 111.601 -164.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 18' ' ' SER . 32.7 mt -59.55 -25.35 64.47 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.484 1.114 . . . . 0.0 112.895 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.63 -29.33 74.9 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.422 0.451 . . . . 0.0 112.881 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.57 -45.93 12.97 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.703 0.801 . . . . 0.0 109.87 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.98 160.04 72.15 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.698 0.799 . . . . 0.0 111.56 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.6 37.32 0.5 Allowed 'Trans proline' 0 CA--C 1.564 1.997 0 C-N-CA 123.294 2.662 . . . . 0.0 114.403 173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 mp -88.28 114.13 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 170.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 29.5 mm-40 -118.4 158.48 25.21 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.2 p -67.46 109.48 3.22 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.506 0.722 . . . . 0.0 111.018 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 2' ' ' ARG . . . 88.96 -1.55 83.32 Favored Glycine 0 N--CA 1.476 1.324 0 CA-C-N 116.295 -0.411 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 21.8 t70 -73.67 159.27 33.28 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.556 0.742 . . . . 0.0 111.339 -172.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.6 tpt -91.31 102.25 14.96 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.703 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 43' ' ' ILE . 4.0 mm? -100.57 135.81 41.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.489 1.116 . . . . 0.0 108.314 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 1.9 mp -100.58 113.79 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 7' ' ' ALA . 54.7 t -94.08 109.51 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.73 172.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 36' ' ' ILE . 10.1 pt-20 -83.01 159.66 22.14 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.451 175.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -117.39 119.0 33.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 172.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -92.44 -26.1 18.16 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 122.974 0.51 . . . . 0.0 110.911 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 69.52 12.61 8.23 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.393 1.477 . . . . 0.0 113.052 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.1 t -67.54 -29.29 68.64 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.317 0.247 . . . . 0.0 110.986 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 58.85 76.53 0.45 Allowed Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 124.927 1.291 . . . . 0.0 111.403 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -89.91 148.04 4.79 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 122.716 2.278 . . . . 0.0 112.688 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.83 109.04 7.03 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.02 143.95 47.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.115 0.966 . . . . 0.0 109.117 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.3 p -91.21 106.01 14.63 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.13 -44.53 1.77 Allowed 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.323 2.015 . . . . 0.0 111.715 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--O 1.25 1.104 0 C-N-CA 124.775 1.23 . . . . 0.0 107.865 177.308 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' TRP . . . . . 0.455 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 33.4 m0 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.54 ' HB3' HD11 ' A' ' 13' ' ' LEU . 71.0 mtm180 -82.85 85.01 7.18 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 171.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 69' ' ' GLY . 15.0 t -98.23 146.16 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.766 -175.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HG2' HD23 ' A' ' 13' ' ' LEU . 95.8 mtt180 -88.79 150.84 22.73 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.592 0.757 . . . . 0.0 110.891 -177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 12' ' ' HIS . 27.3 p -125.9 128.17 47.15 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.467 1.107 . . . . 0.0 108.925 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.557 ' HB3' ' HA ' ' A' ' 73' ' ' ILE . 5.2 tppp? -102.3 110.97 23.08 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.019 0.928 . . . . 0.0 109.019 -176.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.36 171.04 15.07 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -29.47 62.33 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.83 0.452 . . . . 0.0 110.055 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.65 -15.16 61.51 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.728 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.78 163.89 10.53 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 123.685 0.66 . . . . 0.0 111.778 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.5 m -83.08 112.07 19.46 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 74.3 m80 -108.99 162.74 13.93 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.587 0.755 . . . . 0.0 109.695 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.54 HD11 ' HB3' ' A' ' 2' ' ' ARG . 3.2 tm? -120.92 116.78 25.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.462 ' HG ' HG13 ' A' ' 33' ' ' ILE . 6.3 mp -87.74 160.64 17.99 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.432 0.693 . . . . 0.0 110.98 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -134.91 168.5 18.96 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.829 1.251 . . . . 0.0 108.273 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.17 14.05 82.21 Favored Glycine 0 N--CA 1.467 0.733 0 CA-C-O 119.931 -0.372 . . . . 0.0 114.014 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 1' ' ' TRP . 94.3 mt -90.05 118.6 29.72 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 122.806 0.442 . . . . 0.0 110.072 178.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.6 t -86.4 174.79 8.77 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.478 1.111 . . . . 0.0 109.803 168.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.6 p -69.27 -29.63 67.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.265 0.626 . . . . 0.0 110.576 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.17 33.72 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.311 0.645 . . . . 0.0 112.285 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' HG ' ' A' ' 61' ' ' LEU . 30.6 m -66.89 118.16 9.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -66.76 164.0 18.04 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.827 0.451 . . . . 0.0 110.763 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.495 HD22 ' HA ' ' A' ' 57' ' ' ARG . 6.0 tt -50.32 -53.58 27.7 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.73 1.212 . . . . 0.0 110.74 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -16.87 63.64 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.374 -173.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -84.3 -45.76 12.49 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.851 0.86 . . . . 0.0 109.432 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 61' ' ' LEU . 1.6 tm? -69.02 -62.42 1.38 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.156 1.383 . . . . 0.0 110.766 -173.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -63.72 -22.43 66.9 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 123.753 0.658 . . . . 0.0 111.323 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -65.89 -38.43 94.25 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 124.015 0.822 . . . . 0.0 112.464 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -73.44 -42.6 61.8 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.3 mt -61.41 -35.9 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.514 0.726 . . . . 0.0 111.271 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.36 67.42 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.894 0.877 . . . . 0.0 111.587 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.96 -35.97 11.77 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.136 0.974 . . . . 0.0 111.638 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.462 HG13 ' HG ' ' A' ' 14' ' ' LEU . 19.0 mm -76.01 -52.2 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.781 1.232 . . . . 0.0 111.648 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.588 HG23 HG12 ' A' ' 36' ' ' ILE . 7.9 t -115.33 -7.36 12.34 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.162 0.585 . . . . 0.0 110.717 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 21.36 63.89 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.57 -0.572 . . . . 0.0 114.073 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.588 HG12 HG23 ' A' ' 34' ' ' THR . 25.1 mm -95.03 124.81 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 117.679 0.739 . . . . 0.0 109.906 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' HB2' ' HG3' ' A' ' 81' ' ' PRO . . . -58.97 139.08 87.45 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 123.876 0.87 . . . . 0.0 110.813 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -57.41 -22.07 48.29 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.726 2.951 . . . . 0.0 114.095 -176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.45 29.95 11.25 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.823 174.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.5 m -135.53 -35.75 0.8 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.578 1.151 . . . . 0.0 109.054 176.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -85.9 142.85 28.56 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.935 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -130.99 170.34 14.61 Favored 'General case' 0 C--O 1.248 0.996 0 C-N-CA 125.234 1.414 . . . . 0.0 107.674 170.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.483 HG21 ' HB3' ' A' ' 64' ' ' LEU . 44.2 mm -95.95 105.5 17.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.909 0 CA-C-O 122.082 0.944 . . . . 0.0 109.875 -173.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 73' ' ' ILE . 15.6 mt -113.95 155.02 26.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 113.477 -1.692 . . . . 0.0 106.648 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.65 164.86 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 122.723 0.409 . . . . 0.0 109.942 -166.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.17 73.65 Favored Glycine 0 C--N 1.358 1.773 0 C-N-CA 124.026 0.822 . . . . 0.0 114.193 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -74.96 151.99 86.48 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.147 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -39.66 101.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 123.812 3.008 . . . . 0.0 113.575 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.39 157.58 41.05 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.93 2.42 . . . . 0.0 112.486 -171.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -91.22 3.01 55.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.077 177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.93 71.29 0.52 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.8 1.24 . . . . 0.0 110.642 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.431 HD12 ' HD3' ' A' ' 65' ' ' PRO . 65.4 mt -79.73 124.69 28.82 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.656 -173.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -90.46 108.03 19.53 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.385 1.074 . . . . 0.0 109.225 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . 8.4 mp -79.75 95.08 5.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.662 0.785 . . . . 0.0 109.413 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.8 t -106.77 25.85 10.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.853 0.861 . . . . 0.0 110.116 -176.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -126.05 -157.38 0.79 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.37 1.068 . . . . 0.0 108.749 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HA ' HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -147.95 -31.39 0.29 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 119.056 0.844 . . . . 0.0 111.293 173.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -92.82 -8.9 42.26 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.609 0.764 . . . . 0.0 111.996 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.64 121.72 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 C-N-CA 123.337 0.655 . . . . 0.0 110.843 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.2 p -92.84 174.64 7.15 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -168.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 66' ' ' ILE . 25.0 mt -71.0 -11.34 60.92 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.692 0.797 . . . . 0.0 111.998 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.38 -27.08 72.11 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.293 0.371 . . . . 0.0 112.202 170.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -87.03 -47.81 8.62 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.486 0.714 . . . . 0.0 110.134 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB3' HG21 ' A' ' 43' ' ' ILE . 2.7 mm? -80.57 154.87 73.89 Favored Pre-proline 0 CA--C 1.556 1.19 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.743 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HD3' HD12 ' A' ' 52' ' ' LEU . 70.7 Cg_endo -78.93 40.97 1.0 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.188 2.592 . . . . 0.0 114.747 -176.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 61' ' ' LEU . 2.4 mp -76.77 122.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 70' ' ' ASP . 10.8 mt-30 -118.43 156.95 28.11 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 34.8 p -63.39 110.93 2.09 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.566 0.746 . . . . 0.0 111.274 -175.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' H ' HG22 ' A' ' 3' ' ' VAL . . . 70.31 30.86 68.97 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.619 0.574 . . . . 0.0 113.481 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 67' ' ' GLN . 5.9 t70 -84.69 172.53 11.46 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 tpt -98.75 100.6 11.83 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 66' ' ' ILE . 76.2 mt -91.41 143.19 26.87 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 3.0 mp -105.67 102.07 13.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.5 t -80.93 106.12 11.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.01 151.72 37.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.523 0.678 . . . . 0.0 110.052 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -122.08 146.81 46.84 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.802 -173.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -118.49 -30.9 5.06 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.004 0.522 . . . . 0.0 110.445 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 64.64 32.68 11.21 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.643 1.177 . . . . 0.0 111.047 -175.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -63.55 -14.64 53.25 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.358 1.063 . . . . 0.0 113.328 -174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 61.14 76.99 0.38 Allowed Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.526 1.131 . . . . 0.0 110.25 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' HG3' ' HB2' ' A' ' 37' ' ' ALA . 94.3 Cg_endo -76.27 179.34 6.46 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 122.74 2.294 . . . . 0.0 112.406 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -119.18 138.18 53.12 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.221 1.008 . . . . 0.0 109.281 175.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.5 134.52 39.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.774 0.83 . . . . 0.0 111.05 -174.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.411 ' HA ' ' HD2' ' A' ' 85' ' ' PRO . 17.6 p -129.06 100.7 20.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.263 1.025 . . . . 0.0 108.437 175.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 84' ' ' SER . 12.9 Cg_endo -54.23 -46.53 32.87 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 123.683 2.922 . . . . 0.0 112.948 -177.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--O 1.247 0.957 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 174.68 . . . . . . . . 0 0 . 1 stop_ save_